PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lipsitch, M; Riley, S; Cauchemez, S; Ghani, AC; Ferguson, NM				Lipsitch, Marc; Riley, Steven; Cauchemez, Simon; Ghani, Azra C.; Ferguson, Neil M.			Managing and Reducing Uncertainty in an Emerging Influenza Pandemic.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Riley, Steven] Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Riley, Steven] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Cauchemez, Simon; Ghani, Azra C.; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Ctr Outbreak Anal & Modeling, MRC, London, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Hong Kong; University of Hong Kong; Imperial College London	Lipsitch, M (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.		Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Riley, Steven/0000-0001-7904-4804; Ghani, Azra/0000-0002-0007-4910; Lipsitch, Marc/0000-0003-1504-9213	NIGMS NIH HHS [U54 GM088558, U54 GM088558-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; Medical Research Council [G0600719B] Funding Source: researchfish	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Neustadt Richard E., 1983, EPIDEMIC NEVER WAS P; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; 2009, MMWR MORB MORTAL WKL, V58, P453	5	147	152	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					112	115		10.1056/NEJMp0904380	http://dx.doi.org/10.1056/NEJMp0904380			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467OS	19474417	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000267748900002
J	Vargas-Perez, H; Kee, RTA; Walton, CH; Hansen, DM; Razavi, R; Clarke, L; Bufalino, MR; Allison, DW; Steffensen, SC; van der Kooy, D				Vargas-Perez, Hector; Kee, Ryan Ting-A; Walton, Christine H.; Hansen, D. Micah; Razavi, Rozita; Clarke, Laura; Bufalino, Mary Rose; Allison, David W.; Steffensen, Scott C.; van der Kooy, Derek			Ventral Tegmental Area BDNF Induces an Opiate-Dependent-Like Reward State in Naive Rats	SCIENCE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; NEUROTROPHIC FACTOR; GABA(A) RECEPTORS; PEDUNCULOPONTINE NUCLEUS; NEURONS; COCAINE; MECHANISMS; WITHDRAWAL; ADDICTION; LESIONS	The neural mechanisms underlying the transition from a drug-nondependent to a drug-dependent state remain elusive. Chronic exposure to drugs has been shown to increase brain-derived neurotrophic factor (BDNF) levels in ventral tegmental area (VTA) neurons. BDNF infusions into the VTA potentiate several behavioral effects of drugs, including psychomotor sensitization and cue-induced drug seeking. We found that a single infusion of BDNF into the VTA promotes a shift from a dopamine-independent to a dopamine-dependent opiate reward system, identical to that seen when an opiate-naive rat becomes dependent and withdrawn. This shift involves a switch in the gamma-aminobutyric acid type A (GABA(A)) receptors of VTA GABAergic neurons, from inhibitory to excitatory signaling.	[Vargas-Perez, Hector; Razavi, Rozita; van der Kooy, Derek] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Kee, Ryan Ting-A; Clarke, Laura; Bufalino, Mary Rose; van der Kooy, Derek] Univ Toronto, Inst Med Sci, Toronto, ON M5S 3E1, Canada; [Walton, Christine H.; Hansen, D. Micah; Allison, David W.; Steffensen, Scott C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA	University of Toronto; University of Toronto; Brigham Young University	Vargas-Perez, H (corresponding author), Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada.	vargashector@yahoo.com	Vargas Perez, Hector/F-3176-2015		Canadian Institutes of Health Research; NIH [AA13666]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013666, R01AA020919] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by the Canadian Institutes of Health Research. S.C.S. received funding from NIH (grant AA13666).	BECHARA A, 1992, BEHAV NEUROSCI, V106, P351, DOI 10.1037/0735-7044.106.2.351; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Grimm JW, 2003, J NEUROSCI, V23, P742; Horger BA, 1999, J NEUROSCI, V19, P4110; HYMAN C, 1994, J NEUROSCI, V14, P335; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kippin TE, 2003, EUR J NEUROSCI, V18, P2581, DOI 10.1046/j.1460-9568.2003.02918.x; Laviolette SR, 2004, EUR J NEUROSCI, V20, P2179, DOI 10.1111/j.1460-9568.2004.03665.x; Laviolette SR, 2002, BEHAV BRAIN RES, V129, P17, DOI 10.1016/S0166-4328(01)00327-8; Laviolette SR, 2001, EUR J NEUROSCI, V13, P1009, DOI 10.1046/j.1460-9568.2001.01458.x; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Narita M, 2003, NEUROSCIENCE, V119, P767, DOI 10.1016/S0306-4522(03)00099-X; Numan S, 1999, J COMP NEUROL, V403, P295, DOI 10.1002/(SICI)1096-9861(19990118)403:3<295::AID-CNE2>3.0.CO;2-L; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Steffensen SC, 2001, BRAIN RES, V906, P190, DOI 10.1016/S0006-8993(01)02581-1; Tsai SJ, 2007, MED HYPOTHESES, V68, P410, DOI 10.1016/j.mehy.2006.05.035; Vargas-Perez H, 2007, EUR J NEUROSCI, V25, P3713, DOI 10.1111/j.1460-9568.2007.05599.x; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007	20	148	156	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1732	1734		10.1126/science.1168501	http://dx.doi.org/10.1126/science.1168501			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19478142	Green Accepted			2022-12-28	WOS:000267338200047
J	Yi, JS; Du, M; Zajac, AJ				Yi, John S.; Du, Ming; Zajac, Allan J.			A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CYTOTOXIC T-LYMPHOCYTES; CD8-T-CELL MEMORY; CD4-T-CELL HELP; CELL RESPONSES; MICE; PERSISTENCE; CD4(+); IL-21; EXPANSION	Understanding the factors that regulate the induction, quality, and longevity of antiviral T cell responses is essential for devising rational strategies to prevent or combat infections. In this study, we show that interleukin-21 (IL-21), likely produced by CD4(+) T cells, directly influences the generation of polyfunctional CD8(+) T cells and that the number of CD4(+) T cells that produce IL-21 differs markedly between acute and chronic infections. IL-21 regulates the development of CD8(+) T cell exhaustion and the ability to contain chronic lymphocytic choriomeningitis virus infection. Thus, IL-21 serves as a critical helper factor that shapes the functional quality of antiviral CD8(+) T cells and is required for viral control.	[Yi, John S.; Du, Ming; Zajac, Allan J.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Zajac, AJ (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.	azajac@uab.edu	Yi, John/I-1784-2019	Yi, John/0000-0001-7777-2437	NIH [AI049360, AI067993, T32 AI007051]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049360, T32AI007051, R01AI049360, R01AI067993] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Harrington, P. Goepfert, B. Hahn, G. Shaw, and the members of the Zajac laboratory for discussions and assistance. This work was supported by grants AI049360 and AI067993 (to A.J.Z.) and T32 AI007051 (to J.S.Y.) from the NIH.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; Brandt K, 2007, CYTOKINE GROWTH F R, V18, P223, DOI 10.1016/j.cytogfr.2007.04.003; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; BUCHMEIER MJ, 1999, PERSISTENT VIRAL INF, P575; Dodds MG, 2009, CANCER IMMUNOL IMMUN, V58, P843, DOI 10.1007/s00262-008-0600-8; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	29	397	414	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1572	1576		10.1126/science.1175194	http://dx.doi.org/10.1126/science.1175194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19443735	Green Accepted, Green Published			2022-12-28	WOS:000267130600047
J	Lachmann, HJ; Kone-Paut, I; Kuemmerle-Deschner, JB; Leslie, KS; Hachulla, E; Quartier, P; Gitton, X; Widmer, A; Patel, N; Hawkins, PN				Lachmann, Helen J.; Kone-Paut, Isabelle; Kuemmerle-Deschner, Jasmin B.; Leslie, Kieron S.; Hachulla, Eric; Quartier, Pierre; Gitton, Xavier; Widmer, Albert; Patel, Neha; Hawkins, Philip N.		Canakinumab CAPS Study Grp	Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUCKLE-WELLS-SYNDROME; ANTI-IL-1-BETA MONOCLONAL-ANTIBODY; ONSET STILLS-DISEASE; RHEUMATOID-ARTHRITIS; ANAKINRA; INTERLEUKIN-1; ACZ885; AMYLOIDOSIS; EFFICACY; DEAFNESS	BACKGROUND The cryopyrin-associated periodic syndrome ( CAPS) is a rare inherited inflammatory disease associated with overproduction of interleukin-1. Canakinumab is a human anti-interleukin-1 beta monoclonal antibody. METHODS We performed a three-part, 48-week, double-blind, placebo-controlled, randomized withdrawal study of canakinumab in patients with CAPS. In part 1, 35 patients received 150 mg of canakinumab subcutaneously. Those with a complete response to treatment entered part 2 and were randomly assigned to receive either 150 mg of canakinumab or placebo every 8 weeks for up to 24 weeks. After the completion of part 2 or at the time of relapse, whichever occurred first, patients proceeded to part 3 and received at least two more doses of canakinumab. We evaluated therapeutic responses using disease-activity scores and analysis of levels of C-reactive protein (CRP) and serum amyloid A protein (SAA). RESULTS In part 1 of the study, 34 of the 35 patients (97%) had a complete response to canakinumab. Of these patients, 31 entered part 2, and all 15 patients receiving canakinumab remained in remission. Disease flares occurred in 13 of the 16 patients (81%) receiving placebo (P<0.001). At the end of part 2, median CRP and SAA values were normal (<10 mg per liter for both measures) in patients receiving canakinumab but were elevated in those receiving placebo (P<0.001 and P = 0.002, respectively). Of the 31 patients, 28 (90%) completed part 3 in remission. In part 2, the incidence of suspected infections was greater in the canakinumab group than in the placebo group (P=0.03). Two serious adverse events occurred during treatment with canakinumab: one case of urosepsis and an episode of vertigo. CONCLUSIONS Treatment with subcutaneous canakinumab once every 8 weeks was associated with a rapid remission of symptoms in most patients with CAPS. (ClinicalTrials.gov number, NCT00465985.)	[Lachmann, Helen J.] UCL, Sch Med, Natl Amyloidosis Ctr, London NW3 2PF, England; [Kone-Paut, Isabelle] Hop Kremlin Bicetre, Le Kremlin Bicetre, France; [Quartier, Pierre] Univ Paris 05, Paris, France; [Quartier, Pierre] Hop Necker Enfants Malad, Paris, France; [Kuemmerle-Deschner, Jasmin B.] Univ Klin, Tubingen, Germany; [Leslie, Kieron S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hachulla, Eric] Univ Lille 2, Hop Claude Huriez, Lille, France; [Gitton, Xavier; Widmer, Albert] Novartis Pharmaceut, Basel, Switzerland; [Patel, Neha] Novartis Pharmaceut, E Hanover, NJ USA	University of London; University College London; UCL Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of California System; University of California San Francisco; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Novartis; Novartis	Lachmann, HJ (corresponding author), UCL, Sch Med, Natl Amyloidosis Ctr, Rowland Hill St, London NW3 2PF, England.	h.lachmann@medsch.ucl.ac.uk	HACHULLA, ERIC/R-8488-2018; Kone-paut, Isabelle/AAF-6296-2019	HACHULLA, ERIC/0000-0001-7432-847X; Lachmann, Helen/0000-0001-8378-2498; Quartier, Pierre/0000-0002-1769-549X	Medical Research Council [G7900510] Funding Source: Medline; MRC [G7900510] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alten R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2438; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Dinarello CA, 2005, ARTHRITIS RHEUM-US, V52, P1960, DOI 10.1002/art.21107; Furst DE, 2005, ANN RHEUM DIS, V64, P2, DOI 10.1136/ard.2005.044941; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Kalliolias GD, 2008, EXPERT OPIN INV DRUG, V17, P349, DOI [10.1517/13543784.17.3.349, 10.1517/13543784.17.3.349 ]; Karanikolas G, 2008, RHEUMATOLOGY, V47, P1384, DOI 10.1093/rheumatology/ken223; Kuemmerle-Deschner JB, 2008, CLIN EXP RHEUMATOL, V26, P180; KUMMERLEDESCHNE.J, 2008, ANN RHEUM DIS S, V67, P104; Lachmann H, 2008, CLIN EXP RHEUMATOL, V26, P181; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Leslie KS, 2006, ARCH DERMATOL, V142, P1591, DOI 10.1001/archderm.142.12.1591; Maier J, 2008, J RHEUMATOL, V35, P939; Maksimovic L, 2008, RHEUMATOLOGY, V47, P309, DOI 10.1093/rheumatology/kem318; MUCKLE TJ, 1962, Q J MED, V31, P235; Ross JB, 2008, J CUTAN MED SURG, V12, P8, DOI 10.2310/7750.2008.07050; TEMPLE RJ, 1994, COMMUN STAT THEORY, V23, P499, DOI 10.1080/03610929408831269; Yamazaki T, 2008, ARTHRITIS RHEUM, V58, P864, DOI 10.1002/art.23261	20	585	648	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2416	2425		10.1056/NEJMoa0810787	http://dx.doi.org/10.1056/NEJMoa0810787			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494217				2022-12-28	WOS:000266590500007
J	Milstein, A				Milstein, Arnold			Ending Extra Payment for "Never Events" - Stronger Incentives for Patients' Safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Milstein, Arnold] Mercer Hlth & Benefits, San Francisco, CA USA; [Milstein, Arnold] Pacific Business Grp Hlth, San Francisco, CA USA		Milstein, A (corresponding author), Mercer Hlth & Benefits, San Francisco, CA USA.							Committee on Redesigning Health Insurance Performance Measures PaPIP, 2007, REW PROV PERF AL INC; Encinosa WE, 2008, HEALTH SERV RES, V43, P2067, DOI 10.1111/j.1475-6773.2008.00882.x; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; SACK K, 2008, NY TIMES        0518, pA1; 2003, WASHINGTON POST 0226	5	77	80	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2388	2390		10.1056/NEJMp0809125	http://dx.doi.org/10.1056/NEJMp0809125			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453DN	19494212				2022-12-28	WOS:000266590500002
J	Mercy, JA; Saul, J				Mercy, James A.; Saul, Janet			Creating a Healthier Future Through Early Interventions for Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FOLLOW-UP; PREVENTION; FAMILIES; TRIAL		[Mercy, James A.; Saul, Janet] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Violence Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Mercy, JA (corresponding author), CDC, Natl Ctr Injury Prevent & Control, Div Violence Prevent, Mailstop K60,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	jam2@cdc.gov						Braveman P, 2008, OVERCOMING OBSTACLES; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; *CTR DEV CHILD HAR, SCI BAS FRAM EARL CH; Granado-Villar DC, 2009, PEDIATRICS, V123, P598, DOI 10.1542/peds.2008-3607; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Hill P, 2007, AM J NURS, V107, P73, DOI 10.1097/01.NAJ.0000298080.26456.32; Karoly LA., 2005, EARLY CHILDHOOD INTE; Nowak C, 2008, CLIN CHILD FAM PSYCH, V11, P114, DOI 10.1007/s10567-008-0033-0; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Prinz RJ, 2009, PREV SCI, V10, P1, DOI 10.1007/s11121-009-0123-3; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Reynolds AJ, 2007, ARCH PEDIAT ADOL MED, V161, P730, DOI 10.1001/archpedi.161.8.730; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Taylor T K, 1998, Clin Child Fam Psychol Rev, V1, P41, DOI 10.1023/A:1021848315541; Wandersman A, 2008, AM J COMMUN PSYCHOL, V41, P171, DOI 10.1007/s10464-008-9174-z	15	82	82	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2262	2264		10.1001/jama.2009.803	http://dx.doi.org/10.1001/jama.2009.803			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	452PQ	19491188				2022-12-28	WOS:000266554100025
J	Kahn, HS; Cheng, YJ; Thompson, TJ; Imperatore, G; Gregg, EW				Kahn, Henry S.; Cheng, Yiling J.; Thompson, Theodore J.; Imperatore, Giuseppina; Gregg, Edward W.			Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in US Adults Age 45 to 64 Years	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; SERUM URIC-ACID; ALCOHOL-CONSUMPTION; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; OLDER-ADULTS; FOLLOW-UP; IDENTIFYING INDIVIDUALS	Background: Simple prediction scores could help identify adults at high risk for diabetes. Objective: To derive and validate scoring systems by using longitudinal data from a study that repeatedly tested for incident diabetes. Design: Prospective cohort, divided into derivation and validation samples. Setting: The ARIC (Atherosclerosis Risk in Communities) study, which followed participants for 14.9 years beginning in 1987 to 1989. Participants: 12 729 U. S. adults (baseline age, 45 to 64 years; 22.8% black). Follow-up was 96.1% at 5 years and 72.2% at 10 years. Measurements: Anthropometry, blood pressure, and pulse (basic system) plus a fasting blood specimen assayed for common analytes (enhanced system). Diabetes was identified in 18.9% of participants. Risk score integer points were derived from proportional hazard coefficients associated with baseline categorical variables and quintiles of continuous variables. Results: The basic scoring system included waist circumference (10 to 35 points); maternal diabetes (13 points); hypertension (11 points); and paternal diabetes, short stature, black race, age 55 years or older, increased weight, rapid pulse, and smoking history (<= 8 points each). The enhanced system included glucose (6 to 28 points); waist circumference (5 to 21 points); maternal diabetes (8 points); and triglycerides, black race, paternal diabetes, low high-density lipoprotein cholesterol concentration, short stature, high uric acid, age 55 years or older, hypertension, rapid pulse, and nonuse of alcohol (<= 7 points each). When applied to the validation sample, ascending quintiles of the basic system were associated with a 10-year incidence of diabetes of 5.3%, 8.7%, 15.5%, 24.5%, and 33.0%, respectively. Quintiles of the enhanced system were associated with a 10-year incidence of 3.5%, 6.4%, 11.5%, 19.3%, and 46.1%. Limitations: The risk scoring systems had no question regarding previous gestational diabetes, and knowledge of parental diabetes may be uncertain. The analyzed cohort was restricted by age and race; the systems may be less effective in other samples. Conclusion: Basic information identified adults at high risk for diabetes. Additional data from fasting blood tests better identified those at extreme risk.	[Kahn, Henry S.; Cheng, Yiling J.; Thompson, Theodore J.; Imperatore, Giuseppina; Gregg, Edward W.] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Kahn, HS (corresponding author), CDC, Mail Stop K-10,4770 Buford Highway NE, Atlanta, GA 30341 USA.	hkahn@cdc.gov	Cheng, Yiling J/A-6547-2009; Kahn, Henry S/A-6946-2009	Cheng, Yiling J/0000-0002-5053-0814; Kahn, Henry S/0000-0003-2533-1562; Gregg, Edward/0000-0003-2381-6822	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	By the Centers for Disease Control and Prevention.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Almdal T, 2008, EUR J INTERN MED, V19, P40, DOI 10.1016/j.ejim.2007.05.011; Armas LAG, 2007, J AM ACAD DERMATOL, V57, P588, DOI 10.1016/j.jaad.2007.03.004; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Beulens JWJ, 2008, DIABETES CARE, V31, P2050, DOI 10.2337/dc08-0814; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chien KL, 2008, CLIN CHEM, V54, P310, DOI 10.1373/clinchem.2007.095190; *COLL STUD COORD C, 2008, ARIC LIM ACC DAT NAV; Conen D, 2007, EUR HEART J, V28, P2937, DOI 10.1093/eurheartj/ehm400; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Crandall JP, 2008, NAT CLIN PRACT ENDOC, V4, P382, DOI 10.1038/ncpendmet0843; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Diabet Prevention Program Res Grp, 2006, OBESITY, V14, P2107; Djousse L, 2007, OBESITY, V15, P1758, DOI 10.1038/oby.2007.209; Dotevall A, 2004, DIABETIC MED, V21, P615, DOI 10.1111/j.1464-5491.2004.01189.x; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Efron B, 1993, INTRO BOOTSTRAP, DOI DOI 10.1111/1467-9639.00050; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; FESKENS EJM, 1989, AM J EPIDEMIOL, V130, P1101, DOI 10.1093/oxfordjournals.aje.a115437; Geiss LS, 2006, AM J PREV MED, V30, P371, DOI 10.1016/j.amepre.2005.12.009; Genuth S, 2003, DIABETES CARE, V26, P3160; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; GONEN M, 2007, ANAL RECEIVER OPERAT, P81; Gupta AK, 2008, DIABETES CARE, V31, P982, DOI 10.2337/dc07-1768; Hadaegh F, 2007, DIABETES RES CLIN PR, V76, P449, DOI 10.1016/j.diabres.2006.09.030; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Herman WH, 2003, DIABETES CARE, V26, P36; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; Kahn HS, 2006, DIABETES CARE, V29, P151, DOI 10.2337/diacare.29.1.151; Kanaya AM, 2005, DIABETES CARE, V28, P404, DOI 10.2337/diacare.28.2.404; Kannel WB, 2004, AM HEART J, V148, P16, DOI 10.1016/j.ahj.2003.10.022; Katzmarzyk PT, 2007, DIABETOLOGIA, V50, P538, DOI 10.1007/s00125-006-0554-3; KIRTLAND KA, 2008, STAT SPECIFIC INCIDE; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lee H, 2008, DIABETES RES CLIN PR, V81, P124, DOI 10.1016/j.diabres.2008.02.017; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; LIPTON RB, 1993, AM J EPIDEMIOL, V138, P826, DOI 10.1093/oxfordjournals.aje.a116786; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; McNeely MJ, 2003, DIABETES CARE, V26, P758, DOI 10.2337/diacare.26.3.758; MEDALIE JH, 1975, ARCH INTERN MED, V135, P811, DOI 10.1001/archinte.135.6.811; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Niskanen L, 2006, DIABETES CARE, V29, P709, DOI 10.2337/diacare.29.03.06.dc05-1465; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Pearson TL, 2003, AM J MANAG CARE, V9, P57; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; Sairenchi T, 2008, DIABETES CARE, V31, P583, DOI 10.2337/dc07-1390; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2008, DEUT MED WOCHENSCHR, V133, P878, DOI 10.1055/s-2008-1075664; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Unger RH, 2008, JAMA-J AM MED ASSOC, V299, P1185, DOI 10.1001/jama.299.10.1185; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780	73	140	148	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					741	W134		10.7326/0003-4819-150-11-200906020-00002	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00002			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487709				2022-12-28	WOS:000266530000001
J	Friedland, AE; Lu, TK; Wang, X; Shi, D; Church, G; Collins, JJ				Friedland, Ari E.; Lu, Timothy K.; Wang, Xiao; Shi, David; Church, George; Collins, James J.			Synthetic Gene Networks That Count	SCIENCE			English	Article							MAMMALIAN-CELLS; DIRECTED EVOLUTION; ESCHERICHIA-COLI; EXPRESSION; SWITCH; RIBOREGULATORS; BACTERIOPHAGE; RECOMBINASE; OSCILLATOR; PATTERN	Synthetic gene networks can be constructed to emulate digital circuits and devices, giving one the ability to program and design cells with some of the principles of modern computing, such as counting. A cellular counter would enable complex synthetic programming and a variety of biotechnology applications. Here, we report two complementary synthetic genetic counters in Escherichia coli that can count up to three induction events: the first, a riboregulated transcriptional cascade, and the second, a recombinase-based cascade of memory units. These modular devices permit counting of varied user-defined inputs over a range of frequencies and can be expanded to count higher numbers.	[Friedland, Ari E.; Lu, Timothy K.; Wang, Xiao; Shi, David; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [Friedland, Ari E.; Lu, Timothy K.; Wang, Xiao; Shi, David; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Lu, Timothy K.; Church, George] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Church, George] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA.	jcollins@bu.edu	Lu, Timothy/G-4267-2012; Wang, Xiao/A-8414-2008	Wang, Xiao/0000-0002-4056-0155; church, george/0000-0001-6232-9969; Lu, Timothy/0000-0002-3918-8923	NIH Directors Pioneer Award Program; NSF Frontiers in Integrative Biological Research program; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	NIH Directors Pioneer Award Program; NSF Frontiers in Integrative Biological Research program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the NIH Directors Pioneer Award Program, the NSF Frontiers in Integrative Biological Research program, and the Howard Hughes Medical Institute. Authors contributions are in supporting online materials	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Baker D, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0606-44; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Brock DA, 1999, GENE DEV, V13, P1960, DOI 10.1101/gad.13.15.1960; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Ray A, 1999, MOL CELL BIOL, V19, P31; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	28	416	454	3	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1199	1202		10.1126/science.1172005	http://dx.doi.org/10.1126/science.1172005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478183	Green Accepted			2022-12-28	WOS:000266410100046
J	Marx, CJ				Marx, Christopher J.			Getting in Touch with Your Friends	SCIENCE			English	Editorial Material							COOPERATION; SYMBIOSIS; EVOLUTION; ALTRUISM		Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu						Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Schink B, 2002, ANTON LEEUW INT J G, V81, P257, DOI 10.1023/A:1020579004534; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Waks Z, 2009, APPL ENVIRON MICROB, V75, P1867, DOI 10.1128/AEM.02009-08; Wanner G, 2008, J BACTERIOL, V190, P3721, DOI 10.1128/JB.00027-08	14	29	32	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1150	1151		10.1126/science.1173088	http://dx.doi.org/10.1126/science.1173088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478170				2022-12-28	WOS:000266410100029
J	Glantz, LH; Annas, GJ				Glantz, Leonard H.; Annas, George J.			Handguns, Health, and the Second Amendment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Glantz, Leonard H.; Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Glantz, LH (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Glantz, Leonard/0000-0003-4591-2305; Annas, George/0000-0001-5836-7831				Curfman GD, 2008, NEW ENGL J MED, V358, P1503, DOI 10.1056/NEJMe0802118; FALCONE M, 2008, NY TIMES        1217, pA19; Kumar Anita, 2009, WASH POST, pB; LIPTAK A, 2008, NY TIMES        0525, pA1; MADISON J, FEDERALIST PAPERS, V46; Sunstein CB, 2008, HARVARD LAW REV, V122, P246	6	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2360	2365		10.1056/NEJMhle0900209	http://dx.doi.org/10.1056/NEJMhle0900209			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474436				2022-12-28	WOS:000266367300016
J	Pauly, MV				Pauly, Mark V.			HEALTH CARE 2009 Public Health Care and Health Insurance Reform - Varied Preferences, Varied Options	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania	Pauly, MV (corresponding author), Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA.							Nichols L.M., 2009, MODEST PROPOSAL COMP	1	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2271	2273		10.1056/NEJMp0903388	http://dx.doi.org/10.1056/NEJMp0903388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449YO	19474423				2022-12-28	WOS:000266367300002
J	Anson, L				Anson, Lesley			MEMBRANE PROTEIN BIOPHYSICS	NATURE			English	Editorial Material														Anson, Lesley/0000-0002-0173-954X					0	19	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 21	2009	459	7245					343	343		10.1038/459343a	http://dx.doi.org/10.1038/459343a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458708	Bronze			2022-12-28	WOS:000266243700030
J	Harnden, A				Harnden, Anthony			Practice Easily Missed? Whooping cough	BRITISH MEDICAL JOURNAL			English	Editorial Material							BORDETELLA-PERTUSSIS; PERSISTENT COUGH; INFECTION; CHILDREN; DIAGNOSIS; ADULTS; TOXIN		Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk						Cagney M, 2005, RESPIROLOGY, V10, P359, DOI 10.1111/j.1440-1843.2005.00722.x; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; Dodhia H, 2002, J PUBLIC HEALTH MED, V24, P200, DOI 10.1093/pubmed/24.3.200; Harnden A, 2006, BRIT MED J, V333, P174, DOI 10.1136/bmj.38870.655405.AE; Levenson R, 2007, BRIT MED J, V334, P532, DOI 10.1136/bmj.39120.556296.AE; Litt DJ, 2006, J MED MICROBIOL, V55, P1223, DOI 10.1099/jmm.0.46543-0; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044	10	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 21	2009	338								b1772	10.1136/bmj.b1772	http://dx.doi.org/10.1136/bmj.b1772			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NT	19460804				2022-12-28	WOS:000266270000003
J	Rosenthal, MB				Rosenthal, Meredith B.			HEALTH CARE 2009 What Works in Market-Oriented Health Policy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY; PERFORMANCE		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184				Buntin MB, 2006, HEALTH AFFAIR, V25, pW516, DOI 10.1377/hlthaff.25.w516; Curtin K, 2006, J HEALTHC MANAG, V51, P365, DOI 10.1097/00115514-200611000-00005; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Newhouse JP, 1993, FREE ALL LESSONS RAN; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126	5	21	21	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2157	2160		10.1056/NEJMp0903166	http://dx.doi.org/10.1056/NEJMp0903166			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	447QI	19458362				2022-12-28	WOS:000266206000002
J	Bhattacharya, S; Black, R; Bourgeois, L; Clemens, J; Cravioto, A; Deen, JL; Dougan, G; Glass, R; Grais, RF; Greco, M; Gust, I; Holmgren, J; Kariuki, S; Lambert, PH; Liu, MA; Longini, I; Nair, GB; Norrby, R; Nossal, GJV; Ogra, P; Sansonetti, P; von Seidlein, L; Songane, F; Svennerholm, AM; Steele, D; Walker, R				Bhattacharya, S.; Black, R.; Bourgeois, L.; Clemens, J.; Cravioto, A.; Deen, J. L.; Dougan, Gordon; Glass, R.; Grais, R. F.; Greco, M.; Gust, I.; Holmgren, J.; Kariuki, S.; Lambert, P. -H.; Liu, M. A.; Longini, I.; Nair, G. B.; Norrby, R.; Nossal, G. J. V.; Ogra, P.; Sansonetti, P.; von Seidlein, L.; Songane, F.; Svennerholm, A. -M.; Steele, D.; Walker, R.			The Cholera Crisis in Africa	SCIENCE			English	Editorial Material							VACCINATION; VACCINES		[Cravioto, A.; Deen, J. L.; von Seidlein, L.] Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Bhattacharya, S.] Indian Council Med Res, New Delhi, India; [Black, R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Bourgeois, L.; Steele, D.; Walker, R.] PATH, Enter Vaccine Initiat, Seattle, WA 98107 USA; [Clemens, J.] Int Vaccine Inst, Seoul 151600, South Korea; [Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge CB10 1RQ, England; [Glass, R.] NIH, Fogarty Inst, Bethesda, MD 20892 USA; [Grais, R. F.] Epictr, FR-75011 Paris, France; [Gust, I.; Nossal, G. J. V.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Gust, I.; Nossal, G. J. V.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Holmgren, J.; Svennerholm, A. -M.] Univ Gothenburg, SE-40530 Gothenburg, Sweden; [Kariuki, S.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Lambert, P. -H.] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Liu, M. A.] Karolinska Inst, SE-17177 Stockholm, Sweden; [Longini, I.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Longini, I.] Univ Washington, Seattle, WA 98109 USA; [Nair, G. B.] Natl Inst Cholera & Infect Dis, Kolkata 700010, India; [Norrby, R.] Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; [Ogra, P.] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Sansonetti, P.] Inst Pasteur, INSERM, U786, Unite Pathogenie Microbienne Mol, FR-75724 Paris 15, France; [Songane, F.] Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva, Switzerland	Indian Council of Medical Research (ICMR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Vaccine Institute; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; University of Melbourne; University of Melbourne; University of Gothenburg; Kenya Medical Research Institute; University of Geneva; Karolinska Institutet; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Swedish Institute for Infectious Disease Control; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Deen, JL (corresponding author), Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh.	jdeen@ivi.int		Black, Robert/0000-0001-9926-7984; Holmgren, Jan/0000-0003-1784-5918; Freeman Grais, Rebecca/0000-0002-5037-8218				Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; [Anonymous], 1995, Lancet, V345, P339; [Anonymous], 2009, B WORLD HEALTH ORGAN, V87, P85, DOI 10.2471/BLT.09.010209; Chaignat CL, 2008, EXPERT REV VACCINES, V7, P431, DOI 10.1586/14760584.7.4.431; Fleck F, 2009, B WORLD HEALTH ORGAN, V87, P6, DOI 10.2471/BLT.09.020109; *GOV ZIMB WHO, 2009, ZIMB DAIL CHOL UPD A; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Kapp C, 2009, LANCET, V373, P447, DOI 10.1016/S0140-6736(09)60151-3; Koenig R, 2009, SCIENCE, V323, P860, DOI 10.1126/science.323.5916.860; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Mahalanabis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002323; Naficy A, 1998, JAMA-J AM MED ASSOC, V279, P521, DOI 10.1001/jama.279.7.521; *NAT OUTBR COMM, 2009, CHOL OUTBR S AFR NAT; *PROMED MAIL, 2009, INT SOC INF DIS; *WHO, 2006, WHOCDSNTDIDM20062	16	30	31	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					885	885		10.1126/science.1173890	http://dx.doi.org/10.1126/science.1173890			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443768				2022-12-28	WOS:000266048800018
J	Sullivan, NL; Marquis, KA; Rudner, DZ				Sullivan, Nora L.; Marquis, Kathleen A.; Rudner, David Z.			Recruitment of SMC by ParB-parS Organizes the Origin Region and Promotes Efficient Chromosome Segregation	CELL			English	Article							BACILLUS-SUBTILIS CHROMOSOME; ESCHERICHIA-COLI CHROMOSOME; ASYMMETRIC CELL-DIVISION; PROTEIN SPO0J PARB; REPLICATION INITIATION; SUBCELLULAR-LOCALIZATION; CAULOBACTER-CRESCENTUS; PARTITIONING PROTEINS; ACTIVE SEGREGATION; DNA-REPLICATION	Organization and segregation of replicated chromosomes are essential processes during cell division in all organisms. Similar to eukaryotes, bacteria possess centromere-like DNA sequences (parS) that cluster at the origin of replication and the structural maintenance of chromosomes (SMC) complexes for faithful chromosome segregation. In Bacillus subtilis, parS sites are bound by the partitioning protein Spo0J (ParB), and we show here that Spo0J recruits the SMC complex to the origin. We demonstrate that the SMC complex colocalizes with Spo0J at the origin and that insertion of parS sites near the replication terminus targets SMC to this position leading to defects in chromosome organization and segregation. Consistent with these findings, the subcellular localization of the SMC complex is disrupted in the absence of Spo0J or the parS sites. We propose a model in which recruitment of SMC to the origin by Spo0J-parS organizes the origin region and promotes efficient chromosome segregation.	[Sullivan, Nora L.; Marquis, Kathleen A.; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Rudner, DZ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	rudner@hms.harvard.edu			National Institute of Health [GM073831-01A1]; Hellman Family Faculty Fund; Damon Runyon Cancer Research Foundation [DRS-44-05]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831, R01GM086466] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hellman Family Faculty Fund; Damon Runyon Cancer Research Foundation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N. L. S. and K. A. M. contributed equally to this work. We thank members of the Rudner laboratory past and present, Briana Burton, Rich Losick, Alan Grossman, Adam Brier, Cathy Lee, Matt Waldor, Barbara Meyer, Johannes Walter, and Nancy Kleckner for valuable discussions. We thank Alan Grossman for generously providing numerous strains, plasmids, and antibodies. We thank Bill Burkholder and Dan Kearns for strains and plasmids and Rebecca Roush for preliminary SMC depletion experiments. Support for this work comes in part from the National Institute of Health Grant GM073831-01A1 and the Hellman Family Faculty Fund. D. Z. R. was supported by the Damon Runyon Cancer Research Foundation (DRS-44-05). N. L. S. was supported by a fellowship from NSF.	Autret S, 2001, MOL MICROBIOL, V41, P743, DOI 10.1046/j.1365-2958.2001.02551.x; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Doan T, 2007, MOL MICROBIOL, V64, P500, DOI 10.1111/j.1365-2958.2007.05677.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hayashi M, 2005, FEMS MICROBIOL LETT, V247, P73, DOI 10.1016/j.femsle.2005.04.028; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hirano M, 1998, EMBO J, V17, P7139, DOI 10.1093/emboj/17.23.7139; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jensen RB, 2003, J BACTERIOL, V185, P3068, DOI 10.1128/JB.185.10.3068-3075.2003; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lewis PJ, 1997, MOL MICROBIOL, V25, P945, DOI 10.1111/j.1365-2958.1997.mmi530.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Lindow JC, 2002, MOL MICROBIOL, V46, P997, DOI 10.1046/j.1365-2958.2002.03235.x; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; Meyer BJ., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.8.1, DOI 10.1895/WORMBOOK.1.8.1]; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Niki H, 2000, GENE DEV, V14, P212; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Sharpe ME, 1996, MOL MICROBIOL, V21, P501, DOI 10.1111/j.1365-2958.1996.tb02559.x; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Volkov A, 2003, MOL CELL BIOL, V23, P5638, DOI 10.1128/MCB.23.16.5638-5650.2003; Webb CD, 1998, MOL MICROBIOL, V28, P883, DOI 10.1046/j.1365-2958.1998.00808.x; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	50	207	207	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					697	707		10.1016/j.cell.2009.04.044	http://dx.doi.org/10.1016/j.cell.2009.04.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450517	Green Accepted, Bronze			2022-12-28	WOS:000266114100018
J	de Berker, D				de Berker, David			Fungal Nail Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; TOENAIL ONYCHOMYCOSIS; CONTINUOUS TERBINAFINE; COMPARATIVE EFFICACY; COST-EFFECTIVENESS; ANTIFUNGAL AGENTS; ORAL TERBINAFINE; DIAGNOSTIC-TESTS; DOUBLE-BLIND; ITRACONAZOLE	A 68-year-old man reports changes in his left big toenail. It has been discolored distally for the past 2 years. It has become thickened and difficult to cut and is painful when the man is walking in certain shoes. He is otherwise well. On physical examination, the nail appears thickened, has crumbling yellow material beneath, and is more discolored distally than proximally. The nearby skin is normal, although the inter-digital space of the little toe is macerated. How should his case be managed?	Univ Hosp Bristol, Bristol Royal Infirm, Bristol Dermatol Ctr, Bristol BS2 8HW, Avon, England	Bristol Royal Infirmary; University of Bristol	de Berker, D (corresponding author), Univ Hosp Bristol, Bristol Royal Infirm, Bristol Dermatol Ctr, Bristol BS2 8HW, Avon, England.	david.deberker@uhbristol.nhs.uk						*AM AC DERM GUID O, 1996, J AM ACAD DERMATOL, V34, P116; BADEN HP, 1994, ARCH DERMATOL, V130, P558, DOI 10.1001/archderm.130.5.558; Baran R, 2007, BRIT J DERMATOL, V157, P149, DOI 10.1111/j.1365-2133.2007.07974.x; Cham PMH, 2007, BRIT J DERMATOL, V156, P922, DOI 10.1111/j.1365-2133.2006.07740.x; Chambers WM, 2001, EUR J GASTROEN HEPAT, V13, P1115, DOI 10.1097/00042737-200109000-00021; DANIEL CR, 1992, J AM ACAD DERMATOL, V27, P93, DOI 10.1016/0190-9622(92)70163-A; DENNING DW, 1995, BMJ-BRIT MED J, V311, P1277, DOI 10.1136/bmj.311.7015.1277; Drake LA, 1999, J AM ACAD DERMATOL, V41, P189, DOI 10.1016/S0190-9622(99)70047-2; Dupuy A, 1999, BRIT MED J, V318, P1591, DOI 10.1136/bmj.318.7198.1591; Effendy I, 2005, J EUR ACAD DERMATOL, V19, P8, DOI 10.1111/j.1468-3083.2005.01281.x; Elewski BE, 1997, INT J DERMATOL, V36, P754, DOI 10.1046/j.1365-4362.1997.00163.x; Elewski BE, 1997, ARCH DERMATOL, V133, P1172, DOI 10.1001/archderm.133.9.1172; Epstein E, 2004, J AM ACAD DERMATOL, V50, P151, DOI 10.1016/S0190-9622(03)00339-6; Evans EGV, 1999, BMJ-BRIT MED J, V318, P1031, DOI 10.1136/bmj.318.7190.1031; Fletcher CL, 2004, BRIT J DERMATOL, V150, P701, DOI 10.1111/j.0007-0963.2004.05871.x; Ghannoum MA, 2000, J AM ACAD DERMATOL, V43, P641, DOI 10.1067/mjd.2000.107754; Gupta AK, 2006, J EUR ACAD DERMATOL, V20, P1188, DOI 10.1111/j.1468-3083.2006.01698.x; Gupta Aditya K, 2005, J Drugs Dermatol, V4, P481; Gupta AK, 2000, J AM ACAD DERMATOL, V43, pS70, DOI 10.1067/mjd.2000.109071; Gupta AK, 1997, BRIT J DERMATOL, V136, P786, DOI 10.1111/j.1365-2133.1997.tb03673.x; Gupta AK, 2000, J AM ACAD DERMATOL, V43, P244, DOI 10.1067/mjd.2000.104794; Gupta AK, 2004, BRIT J DERMATOL, V150, P537, DOI 10.1046/j.1365-2133.2003.05728.x; Gupta AK, 2003, DERMATOL CLIN, V21, P481, DOI 10.1016/S0733-8635(03)00025-1; HAY RJ, 1985, CLIN EXP DERMATOL, V10, P111, DOI 10.1111/j.1365-2230.1985.tb00537.x; Heikkila H, 2002, BRIT J DERMATOL, V146, P250, DOI 10.1046/j.1365-2133.2002.04639.x; Koshnick RL, 2007, MYCOSES, V50, P463, DOI 10.1111/j.1439-0507.2007.01422.x; LAUHARANTA J, 1992, CLIN EXP DERMATOL, V17, P41, DOI 10.1111/j.1365-2230.1992.tb00277.x; Lilly KK, 2006, J AM ACAD DERMATOL, V55, P620, DOI 10.1016/j.jaad.2006.03.033; OSullivan DP, 1996, BRIT J CLIN PHARMACO, V42, P559, DOI 10.1111/j.1365-2125.1996.tb00049.x; REINEL D, 1992, DERMATOLOGY, V184, P21, DOI 10.1159/000247612; Roberts DT, 2003, BRIT J DERMATOL, V148, P402, DOI 10.1046/j.1365-2133.2003.05242.x; Schram SE, 2007, J AM ACAD DERMATOL, V56, P525, DOI 10.1016/j.jaad.2006.11.027; Seebacher C, 2007, MYCOSES, V50, P321, DOI 10.1111/j.1439-0507.2006.01351.x; Sigurgceirsson B, 2002, ARCH DERMATOL, V138, P353, DOI 10.1001/archderm.138.3.353; Summerbell RC, 2005, MED MYCOL, V43, P39, DOI 10.1080/13693780410001712043; Svejgaard EL, 2004, MYCOSES, V47, P131, DOI 10.1111/j.1439-0507.2004.00968.x; Szepietowski JC, 2006, ARCH DERMATOL, V142, P1279, DOI 10.1001/archderm.142.10.1279; Tavakkol Amir, 2006, Am J Geriatr Pharmacother, V4, P1, DOI 10.1016/j.amjopharm.2005.12.012; Warshaw EM, 2005, J AM ACAD DERMATOL, V53, P578, DOI 10.1016/j.jaad.2005.04.055; Warshaw EM, 2007, INT J DERMATOL, V46, P1279, DOI 10.1111/j.1365-4632.2007.03362.x; Zaias N, 1996, J AM ACAD DERMATOL, V34, P302, DOI 10.1016/S0190-9622(96)80142-3	41	66	76	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2108	2116		10.1056/NEJMcp0804878	http://dx.doi.org/10.1056/NEJMcp0804878			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439745				2022-12-28	WOS:000266011200009
J	Banatvala, N; Bland, S; Donaldson, L				Banatvala, Nicholas; Bland, Simon; Donaldson, Liam			Working with WHO: the UK's institutional strategy	LANCET			English	Editorial Material									[Banatvala, Nicholas; Donaldson, Liam] Dept Hlth, London SE1 8UG, England; [Bland, Simon] UK Missions United Nations, Geneva, Switzerland		Banatvala, N (corresponding author), Dept Hlth, Wellington House,133-155 Waterloo Rd, London SE1 8UG, England.	nick.banatvala@dh.gsi.gov.uk		Banatvala, Nick/0000-0001-8130-154X				*HM GOV, HLTH GLOB UK GOV STR; HM Government, WHO UK I STRAT 2008; *WHO, 11 GEN PROGR WORK 20; World Health Organization, MED TERM STRAT PLAN	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1827	1829		10.1016/S0140-6736(09)61004-7	http://dx.doi.org/10.1016/S0140-6736(09)61004-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19482201				2022-12-28	WOS:000266616400008
J	Fisher, ES; Berwick, DM; Davis, K				Fisher, Elliott S.; Berwick, Donald M.; Davis, Karen			Achieving Health Care Reform - How Physicians Can Help	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fisher, Elliott S.] Dartmouth Inst Hlth Policy, Lebanon, NH USA; [Fisher, Elliott S.] Dartmouth Med Sch, Lebanon, NH USA; [Berwick, Donald M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA; [Davis, Karen] Commonwealth Fund, New York, NY USA	Dartmouth College; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement; Commonwealth Fund	Fisher, ES (corresponding author), Dartmouth Inst Hlth Policy, Lebanon, NH USA.							Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; National Priorities Partnership, 2008, NAT PRIOR GOALS AL O; Shih A, 2008, ORGANIZING US HLTH C; Steele G. D., 2009, REFORMING HEALTHCARE	5	29	29	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2495	2497		10.1056/NEJMp0903923	http://dx.doi.org/10.1056/NEJMp0903923			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456BS	19458353				2022-12-28	WOS:000266813800002
J	Aksentijevich, I; Masters, SL; Ferguson, PJ; Dancey, P; Frenkel, J; van Royen-Kerkhoff, A; Laxer, R; Tedgard, U; Cowen, EW; Pham, TH; Booty, M; Estes, JD; Sandler, NG; Plass, N; Stone, DL; Turner, ML; Hill, S; Butman, JA; Schneider, R; Babyn, P; El-Shanti, HI; Pope, E; Barron, K; Bing, XY; Laurence, A; Lee, CCR; Chapelle, D; Clarke, GI; Ohson, K; Nicholson, M; Gadina, M; Yang, B; Korman, BD; Gregersen, PK; van Hagen, PM; Hak, AE; Huizing, M; Rahman, P; Douek, DC; Remmers, EF; Kastner, DL; Goldbach-Mansky, R				Aksentijevich, Ivona; Masters, Seth L.; Ferguson, Polly J.; Dancey, Paul; Frenkel, Joost; van Royen-Kerkhoff, Annet; Laxer, Ron; Tedgard, Ulf; Cowen, Edward W.; Pham, Tuyet-Hang; Booty, Matthew; Estes, Jacob D.; Sandler, Netanya G.; Plass, Nicole; Stone, Deborah L.; Turner, Maria L.; Hill, Suvimol; Butman, John A.; Schneider, Rayfel; Babyn, Paul; El-Shanti, Hatem I.; Pope, Elena; Barron, Karyl; Bing, Xinyu; Laurence, Arian; Lee, Chyi-Chia R.; Chapelle, Dawn; Clarke, Gillian I.; Ohson, Kamal; Nicholson, Marc; Gadina, Massimo; Yang, Barbara; Korman, Benjamin D.; Gregersen, Peter K.; van Hagen, P. Martin; Hak, A. Elisabeth; Huizing, Marjan; Rahman, Proton; Douek, Daniel C.; Remmers, Elaine F.; Kastner, Daniel L.; Goldbach-Mansky, Raphaela			An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFANTILE CORTICAL HYPEROSTOSIS; GENE-CLUSTER; ASSOCIATION; MUTATIONS; FAMILY; CIAS1; INFLAMMASOME; SECRETION; ARTHRITIS; CELLS	BACKGROUND Autoinflammatory diseases manifest inflammation without evidence of infection, high-titer autoantibodies, or autoreactive T cells. We report a disorder caused by mutations of IL1RN, which encodes the interleukin-1-receptor antagonist, with prominent involvement of skin and bone. METHODS We studied nine children from six families who had neonatal onset of sterile multifocal osteomyelitis, periostitis, and pustulosis. Response to empirical treatment with the recombinant interleukin-1-receptor antagonist anakinra in the first patient prompted us to test for the presence of mutations and changes in proteins and their function in interleukin-1-pathway genes including IL1RN. RESULTS We identified homozygous mutations of IL1RN in nine affected children, from one family from Newfoundland, Canada, three families from the Netherlands, and one consanguineous family from Lebanon. A nonconsanguineous patient from Puerto Rico was homozygous for a genomic deletion that includes IL1RN and five other interleukin-1-family members. At least three of the mutations are founder mutations; heterozygous carriers were asymptomatic, with no cytokine abnormalities in vitro. The IL1RN mutations resulted in a truncated protein that is not secreted, thereby rendering cells hyperresponsive to interleukin-1 beta stimulation. Patients treated with anakinra responded rapidly. CONCLUSIONS We propose the term deficiency of the interleukin-1-receptor antagonist, or DIRA, to denote this autosomal recessive autoinflammatory disease caused by mutations affecting IL1RN. The absence of interleukin-1-receptor antagonist allows unopposed action of interleukin-1, resulting in life-threatening systemic inflammation with skin and bone involvement. (ClinicalTrials.gov number, NCT00059748.)	[Aksentijevich, Ivona; Masters, Seth L.; Pham, Tuyet-Hang; Booty, Matthew; Plass, Nicole; Stone, Deborah L.; Laurence, Arian; Chapelle, Dawn; Gadina, Massimo; Yang, Barbara; Korman, Benjamin D.; Remmers, Elaine F.; Kastner, Daniel L.; Goldbach-Mansky, Raphaela] NIAMSD, Bethesda, MD 20892 USA; [Cowen, Edward W.; Estes, Jacob D.; Turner, Maria L.; Lee, Chyi-Chia R.] NCI, Bethesda, MD 20892 USA; [Sandler, Netanya G.; Douek, Daniel C.] Vaccine Res Ctr, Bethesda, MD USA; [Barron, Karyl] NIAID, Bethesda, MD 20892 USA; [Hill, Suvimol; Butman, John A.] Ctr Clin, Bethesda, MD USA; [Huizing, Marjan] NHGRI, Bethesda, MD 20892 USA; [Ferguson, Polly J.; Bing, Xinyu] Univ Iowa, Iowa City, IA USA; [Dancey, Paul; Clarke, Gillian I.; Ohson, Kamal; Nicholson, Marc; Rahman, Proton] Mem Univ Newfoundland, St John, NF, Canada; [Frenkel, Joost; van Royen-Kerkhoff, Annet] Univ Utrecht, Utrecht, Netherlands; [Laxer, Ron; Schneider, Rayfel; Babyn, Paul; Pope, Elena] Univ Toronto, Toronto, ON, Canada; [Tedgard, Ulf] Lund Univ, Malmo, Sweden; [El-Shanti, Hatem I.] Shafallah Med Genet Ctr, Doha, Qatar; [Gregersen, Peter K.] Feinstein Inst, Manhasset, NY USA; [van Hagen, P. Martin; Hak, A. Elisabeth] Erasmus Univ, Med Ctr, Rotterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Iowa; Memorial University Newfoundland; Utrecht University; University of Toronto; Lund University; Al Shafallah Center; Northwell Health; Erasmus University Rotterdam; Erasmus MC	Goldbach-Mansky, R (corresponding author), Bldg 10,Rm 6D-47B,10 Ctr Dr, Bethesda, MD 20892 USA.	goldbacr@mail.nih.gov	EL-SHANTI, HATEM/Q-4932-2016; Laurence, Arian/H-5534-2019; Tedgård, Ulf/K-3852-2019; Huizing, Marjan/AAR-8860-2020; Tedgård, Ulf/K-8699-2018; Aksentijevich, Ivona/AAF-1335-2019; Lee, Chyi-Chia R/I-1938-2013; Lee, Chyi-Chia Richard/AAO-1149-2020; Gadina, Massimo/R-4195-2019; Butman, John/J-2780-2013; Butman, John A/A-2694-2008; Masters, Seth L/N-2886-2013; El-Shanti, Hatem/O-5990-2014; Booty, Matthew G/G-9536-2012; Goldbach-Mansky, Raphaela/N-5917-2017; Laurence, Arian/A-8770-2009	EL-SHANTI, HATEM/0000-0001-6230-8316; Laurence, Arian/0000-0003-0942-8292; Tedgård, Ulf/0000-0003-3266-252X; Lee, Chyi-Chia R/0000-0002-5306-7781; Butman, John/0000-0002-1547-9195; Masters, Seth L/0000-0003-4763-576X; El-Shanti, Hatem/0000-0001-6230-8316; Laurence, Arian/0000-0003-0942-8292; Remmers, Elaine F/0000-0002-9522-1249; Utay, Netanya/0000-0002-6407-8670; Korman, Benjamin/0000-0002-4873-2628; Yang, Barbara/0000-0001-5018-095X; Booty, Matthew/0000-0002-0835-3439	Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH); NIAMS; Children's Miracle Network; Peregrine Charities; Hoffmann-La Roche; Amgen; NIH Clinical Research Training Program; Foundation for the NIH; Pfizer; Roche Pharmaceuticals; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041138, ZICAR041181, ZIAAR041083, ZICAR041169] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Children's Miracle Network; Peregrine Charities; Hoffmann-La Roche(Hoffmann-La Roche); Amgen(Amgen); NIH Clinical Research Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH; Pfizer(Pfizer); Roche Pharmaceuticals(Roche Holding); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Human Genome Research Institute (NHGRI).; Dr. Ferguson reports receiving grant support from the National Institutes of Health (NIH) and NIAMS, the Children's Miracle Network, and the Peregrine Charities; Dr. Schneider, consulting and lecture fees and a grant support from Hoffmann-La Roche and grant support from Amgen, the company that makes anakinra; and Dr. Korman, grant support from the NIH Clinical Research Training Program, a public - private partnership between the Foundation for the NIH and Pfizer. Dr. Gregersen reports receiving consulting fees from Roche Pharmaceuticals and holding stock options in Amgen, Illumina, and Genentech. No other potential conflict of interest relevant to this article was reported.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 1997, CELL, V90, P797; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Bernot A, 1997, NAT GENET, V17, P25; Botsios C, 2008, ANN INTERN MED, V149, P284, DOI 10.7326/0003-4819-149-4-200808190-00018; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2007, ARTHRITIS RHEUM-US, V56, P2817, DOI 10.1002/art.22841; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Ferguson PJ, 2006, BONE, V38, P41, DOI 10.1016/j.bone.2005.07.009; Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gensure RC, 2005, J CLIN INVEST, V115, P1250, DOI 10.1172/JCI200522760; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Hacham M, 2000, ADV EXP MED BIOL, V479, P185; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; IVKER RA, 1993, PEDIATR DERMATOL, V10, P277, DOI 10.1111/j.1525-1470.1993.tb00376.x; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; LEUNG VC, 1985, J PEDIATR ORTHOPED, V5, P354, DOI 10.1097/01241398-198505000-00020; Lin HS, 2001, J BIOL CHEM, V276, P20597, DOI 10.1074/jbc.M010095200; Meulenbelt I, 2004, ARTHRITIS RHEUM, V50, P1179, DOI 10.1002/art.20121; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Schilling F, 2003, Z RHEUMATOL, V62, P527, DOI 10.1007/s00393-003-0526-7; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Timms AE, 2004, AM J HUM GENET, V75, P587, DOI 10.1086/424695; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Vitoratos N, 2007, J ENDOCRINOL INVEST, V30, P35, DOI 10.1007/BF03347393; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961	34	628	650	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2426	2437		10.1056/NEJMoa0807865	http://dx.doi.org/10.1056/NEJMoa0807865			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494218	Green Accepted			2022-12-28	WOS:000266590500008
J	Blennow, M; Ewald, U; Fritz, T; Holmgren, PA; Jeppsson, A; Lindberg, E; Lundqvist, A; Lindeberg, SN; Olhager, E; Ostlund, I; Simic, M; Sjors, G; Stigson, L; Fellman, V; Hellstrom-Westas, L; Norman, M; Westgren, M; Holmstrom, G; Laurini, R; Stjernqvist, K; Kallen, K; Lagercrantz, H; Marsal, K; Serenius, F; Wennergren, M; Nilstun, T; Olausson, PO; Stromberg, B				Blennow, Mats; Ewald, Uwe; Fritz, Tomas; Holmgren, Per Ake; Jeppsson, Annika; Lindberg, Eva; Lundqvist, Anita; Lindeberg, Solveig Norden; Olhager, Elisabeth; Ostlund, Ingrid; Simic, Marija; Sjoers, Gunnar; Stigson, Lennart; Fellman, Vineta; Hellstrom-Westas, Lena; Norman, Mikael; Westgren, Magnus; Holmstrom, Gerd; Laurini, Ricardo; Stjernqvist, Karin; Kallen, Karin; Lagercrantz, Hugo; Marsal, Karel; Serenius, Fredrik; Wennergren, Margareta; Nilstun, Tore; Olausson, Petra Otterblad; Stromberg, Bo		EXPRESS Grp	One-Year Survival of Extremely Preterm Infants After Active Perinatal Care in Sweden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEEKS GESTATIONAL-AGE; INTENSIVE-CARE; BIRTH-WEIGHT; POPULATION; MORBIDITY; BORN; MORTALITY; LEVEL; MANAGEMENT; THRESHOLD	Context Up-to-date information on infant survival after extremely preterm birth is needed for assessing perinatal care services, clinical guidelines, and parental counseling. Objective To determine the 1-year survival in all infants born before 27 gestational weeks in Sweden during 2004-2007. Design, Setting, and Patients Population-based prospective observational study of extremely preterm infants (707 live-born and 304 stillbirths) born to 887 mothers in 904 deliveries (102 multiple births) in all obstetric and neonatal units in Sweden from April 1, 2004, to March 31, 2007. Main Outcome Measures Infant survival to 365 days and survival without major neonatal morbidity (intraventricular hemorrhage grade > 2, retinopathy of prematurity stage > 2, periventricular leukomalacia, necrotizing enterocolitis, severe bronchopulmonary dysplasia). Associations between perinatal interventions and survival. Results The incidence of extreme prematurity was 3.3 per 1000 infants. Overall perinatal mortality was 45% (from 93% at 22 weeks to 24% at 26 weeks), with 30% stillbirths, including 6.5% intrapartum deaths. Of live-born infants, 91% were admitted to neonatal intensive care and 70% survived to 1 year of age (95% confidence interval [CI], 67%-73%). The Kaplan-Meier survival estimates for 22, 23, 24, 25, and 26 weeks were 9.8% (95% CI, 4%-23%), 53% ( 95% CI, 44%-63%), 67% (95% CI, 59%-75%), 82% (95% CI, 76%-87%), and 85% ( 95% CI, 81%-90%), respectively. Lower risk of infant death was associated with tocolytic treatment (adjusted for gestational age odds ratio [ OR], 0.43; 95% CI, 0.36-0.52), antenatal corticosteroids (OR, 0.44; 95% CI, 0.24-0.81), surfactant treatment within 2 hours after birth ( OR, 0.47; 95% CI, 0.32-0.71), and birth at a level III hospital (OR, 0.49; 95% CI, 0.32-0.75). Among 1-year survivors, 45% had no major neonatal morbidity. Conclusion During 2004 to 2007, 1-year survival of infants born alive at 22 to 26 weeks of gestation in Sweden was 70% and ranged from 9.8% at 22 weeks to 85% at 26 weeks. JAMA. 2009;301(21):2225-2233 www.jama.com	[Blennow, Mats] Karolinska Univ Hosp, Dept Pediat, Huddinge, Sweden; [Blennow, Mats; Norman, Mikael] Karolinska Inst, Dept Clin Invest Intervent & Technol, Stockholm, Sweden; [Ewald, Uwe] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Fritz, Tomas] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, S-41345 Gothenburg, Sweden; [Holmgren, Per Ake] Umea Univ, Dept Clin Sci Obstetr & Gynecol, Umea, Sweden; [Jeppsson, Annika] Linkoping Univ, Dept Obstet & Gynecol, Linkoping, Sweden; [Lindberg, Eva] Univ Orebro, Dept Pediat, Orebro, Sweden; [Lundqvist, Anita] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Lindeberg, Solveig Norden] Uppsala Univ, Dept Obstet & Gynecol, Uppsala, Sweden; [Olhager, Elisabeth] Linkoping Univ, Dept Pediat, S-58183 Linkoping, Sweden; [Ostlund, Ingrid] Orebro Univ Hosp, Dept Obstet & Gynecol, Orebro, Sweden; [Simic, Marija] Karolinska Univ Hosp Solna, Dept Obstet & Gynecol, Stockholm, Sweden; [Sjoers, Gunnar; Stromberg, Bo] Uppsala Univ, Dept Pediat, Uppsala, Sweden; [Stigson, Lennart] Sahlgrens Univ Hosp, Dept Pediat, Gothenburg, Sweden; [Fellman, Vineta] Lund Univ, Dept Pediat, S-22100 Lund, Sweden; [Hellstrom-Westas, Lena] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Norman, Mikael] Karolinska Univ Hosp, Dept Pediat, Huddinge, Sweden; [Westgren, Magnus] Karolinska Univ Hosp Huddinge, Dept Obstet & Gynecol, Stockholm, Sweden; [Holmstrom, Gerd] Uppsala Univ, Dept Ophthalmol, Uppsala, Sweden; [Laurini, Ricardo] Nordland Hosp, Dept Pathol, Bodo, Norway; [Stjernqvist, Karin] Lund Univ, Dept Psychol, S-22100 Lund, Sweden; [Kallen, Karin] Lund Univ, Ctr Reprod Epidemiol, S-22100 Lund, Sweden; [Lagercrantz, Hugo] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; [Lagercrantz, Hugo] Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Marsal, Karel] Lund Univ, Dept Obstet & Gynecol, S-22100 Lund, Sweden; [Serenius, Fredrik] Umea Univ, Dept Clin Sci, S-90187 Umea, Sweden; [Wennergren, Margareta] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Nilstun, Tore] Lund Univ, Dept Med Eth, S-22100 Lund, Sweden; [Olausson, Petra Otterblad] Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Sahlgrenska University Hospital; Umea University; Linkoping University; Orebro University; Lund University; Uppsala University; Linkoping University; Orebro University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Sahlgrenska University Hospital; Lund University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Lund University; Lund University; Karolinska Institutet; Lund University; Umea University; Sahlgrenska University Hospital; Lund University; National Board of Health & Welfare	Marsal, K (corresponding author), Univ Lund Hosp, Dept Obstet & Gynecol, S-22185 Lund, Sweden.	karel.marsal@med.lu.se	Blennow, Mats/AAX-6202-2021	Blennow, Mats/0000-0001-9517-0261; Simic, Marija/0000-0002-1804-4015; Norman, Mikael/0000-0003-4191-3781; Hellstrom-Westas, Lena/0000-0003-3498-6069	Swedish Research Council [521-2006-3858]; Swedish National Board of Health and Welfare; Swedish government; Evy and Gunnar Sandberg Foundation; Lund University and Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Board of Health and Welfare; Swedish government; Evy and Gunnar Sandberg Foundation; Lund University and Umea University	This study was supported by Swedish Research Council grant 521-2006-3858; and by grants from the Swedish National Board of Health and Welfare and from Grants to Researchers in the Public Health Care from the Swedish government. The grants were administered by Lund University and Umea University and used to compensate the 2 research administrators working part time with conduct of the study and collection and management of the data. Karin Kallen, PhD, reported grant support from the Evy and Gunnar Sandberg Foundation.	BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Chan K, 2001, AM J OBSTET GYNECOL, V185, P220, DOI 10.1067/mob.2001.115280; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Cust A. E., 2003, Archives of Disease in Childhood, V88, pF15, DOI 10.1136/fn.88.1.F15; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Draper ES, 2009, ARCH DIS CHILD-FETAL, V94, pF158, DOI 10.1136/adc.2008.141531; Effer SB, 2002, BJOG-INT J OBSTET GY, V109, P740; El-Metwally D, 2000, J PEDIATR-US, V137, P616, DOI 10.1067/mpd.2000.109143; Evans DJ, 2001, ARCH DIS CHILD-FETAL, V84, pF79, DOI 10.1136/fn.84.2.F79; Field DJ, 2008, BMJ-BRIT MED J, V336, P1221, DOI 10.1136/bmj.39555.670718.BE; Finnstrom O, 1997, ACTA PAEDIATR, V86, P503, DOI 10.1111/j.1651-2227.1997.tb08921.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Hakansson S, 2004, PEDIATRICS, V114, P58, DOI 10.1542/peds.114.1.58; Herber-Jonat S, 2006, AM J OBSTET GYNECOL, V195, P16, DOI 10.1016/j.ajog.2006.02.043; Hoekstra RE, 2004, PEDIATRICS, V113, pE1, DOI 10.1542/peds.113.1.e1; Holmgren PA, 2001, ACTA OBSTET GYN SCAN, V80, P525, DOI 10.1034/j.1600-0412.2001.080006525.x; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Johansson S, 2004, PEDIATRICS, V113, P1230, DOI 10.1542/peds.113.5.1230; Kamper J, 2004, ACTA PAEDIATR, V93, P225, DOI 10.1080/08035250310022298; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Lee SK, 2003, AM J OBSTET GYNECOL, V188, P617, DOI 10.1067/mob.2003.139; Levene M, 2004, ACTA PAEDIATR, V93, P149, DOI 10.1080/08035250310007745; Malloy MH, 2008, PEDIATRICS, V122, P285, DOI 10.1542/peds.2007-2620; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Morse SB, 2000, PEDIATRICS, V105, P1046, DOI 10.1542/peds.105.5.1046; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pignotti MS, 2008, PEDIATRICS, V121, pE193, DOI 10.1542/peds.2007-0513; Rautava L, 2007, PEDIATRICS, V119, pE257, DOI 10.1542/peds.2006-1964; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmitt SK, 2006, PEDIATRICS, V117, P154, DOI 10.1542/peds.2005-0484; Serenius F, 2004, ACTA PAEDIATR, V93, P1081, DOI [10.1080/08035250410027751, 10.1111/j.1651-2227.2004.tb02721.x]; Stark AR, 2007, PEDIATRICS, V119, P401, DOI 10.1542/peds.2006-3180; Sutton L, 1999, PAEDIATR PERINAT EP, V13, P288; Tommiska V, 2007, PEDIATRICS, V119, P29, DOI 10.1542/peds.2006-1472; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; Vanpee M, 2007, ACTA PAEDIATR, V96, P10, DOI 10.1111/j.1651-2227.2007.00063.x; Vento M, 2008, PEDIATRICS, V122, P1113, DOI 10.1542/peds.2008-1422; World Health Organization, WORLD HLTH REP 2005	45	444	460	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2225	2233		10.1001/jama.2009.771	http://dx.doi.org/10.1001/jama.2009.771			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491184	Bronze			2022-12-28	WOS:000266554100020
J	Enard, W; Gehre, S; Hammerschmidt, K; Holter, SM; Blass, T; Somel, M; Bruckner, MK; Schreiweis, C; Winter, C; Sohr, R; Becker, L; Wiebe, V; Nickel, B; Giger, T; Muller, U; Groszer, M; Adler, T; Aguilar, A; Bolle, I; Calzada-Wack, J; Dalke, C; Ehrhardt, N; Favor, J; Fuchs, H; Gailus-Durner, V; Hans, W; Holzlwimmer, G; Javaheri, A; Kalaydjiev, S; Kallnik, M; Kling, E; Kunder, S; Mossbrugger, I; Naton, B; Racz, I; Rathkolb, B; Rozman, J; Schrewe, A; Busch, DH; Graw, J; Ivandic, B; Klingenspor, M; Klopstock, T; Ollert, M; Quintanilla-Martinez, L; Schulz, H; Wolf, E; Wurst, W; Zimmer, A; Fisher, SE; Morgenstern, R; Arendt, T; de Angelis, MH; Fischer, J; Schwarz, J; Paabo, S				Enard, Wolfgang; Gehre, Sabine; Hammerschmidt, Kurt; Hoelter, Sabine M.; Blass, Torsten; Somel, Mehmet; Brueckner, Martina K.; Schreiweis, Christiane; Winter, Christine; Sohr, Reinhard; Becker, Lore; Wiebe, Victor; Nickel, Birgit; Giger, Thomas; Mueller, Uwe; Groszer, Matthias; Adler, Thure; Aguilar, Antonio; Bolle, Ines; Calzada-Wack, Julia; Dalke, Claudia; Ehrhardt, Nicole; Favor, Jack; Fuchs, Helmut; Gailus-Durner, Valerie; Hans, Wolfgang; Hoelzlwimmer, Gabriele; Javaheri, Anahita; Kalaydjiev, Svetoslav; Kallnik, Magdalena; Kling, Eva; Kunder, Sandra; Mossbrugger, Ilona; Naton, Beatrix; Racz, Ildiko; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Busch, Dirk H.; Graw, Jochen; Ivandic, Boris; Klingenspor, Martin; Klopstock, Thomas; Ollert, Markus; Quintanilla-Martinez, Leticia; Schulz, Holger; Wolf, Eckhard; Wurst, Wolfgang; Zimmer, Andreas; Fisher, Simon E.; Morgenstern, Rudolf; Arendt, Thomas; de Angelis, Martin Hrabe; Fischer, Julia; Schwarz, Johannes; Paeaebo, Svante			A Humanized Version of Foxp2 Affects Cortico-Basal Ganglia Circuits in Mice	CELL			English	Article							INHERITED SPEECH; LANGUAGE DISORDER; ULTRASONIC VOCALIZATION; SYNAPTIC PLASTICITY; BRAIN-DEVELOPMENT; GENE; EVOLUTION; EXPRESSION; BEHAVIOR; IDENTIFICATION	It has been proposed that two amino acid substitutions in the transcription factor FOXP2 have been positively selected during human evolution due to effects on aspects of speech and language. Here, we introduce these substitutions into the endogenous Foxp2 gene of mice. Although these mice are generally healthy, they have qualitatively different ultrasonic vocalizations, decreased exploratory behavior and decreased dopamine concentrations in the brain suggesting that the humanized Foxp2 allele affects basal ganglia. In the striatum, a part of the basal ganglia affected in humans with a speech deficit due to a nonfunctional FOXP2 allele, we find that medium spiny neurons have increased dendrite lengths and increased synaptic plasticity. Since mice carrying one nonfunctional Foxp2 allele show opposite effects, this suggests that alterations in cortico-basal ganglia circuits might have been important for the evolution of speech and language in humans. For a video summary of this article, see the Paper-Flick file available with the online Supplemental Data.	[Enard, Wolfgang; Gehre, Sabine; Blass, Torsten; Somel, Mehmet; Schreiweis, Christiane; Wiebe, Victor; Nickel, Birgit; Giger, Thomas; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Hammerschmidt, Kurt; Fischer, Julia] German Primate Ctr, Dept Cognit Ethol, D-37077 Gottingen, Germany; [Hoelter, Sabine M.; Dalke, Claudia; Kallnik, Magdalena; Graw, Jochen; Wurst, Wolfgang] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Munich, Germany; [Brueckner, Martina K.; Arendt, Thomas] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Neuroanat, D-04109 Leipzig, Germany; [Winter, Christine] Univ Med Berlin, Charite Campus Mitte, Dept Psychiat & Psychotherapy, Berlin, Germany; [Sohr, Reinhard; Morgenstern, Rudolf] Univ Med Berlin, Charite Campus Mitte, Inst Pharmacol & Toxicol, Berlin, Germany; [Becker, Lore; Kling, Eva; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; [Becker, Lore; Adler, Thure; Ehrhardt, Nicole; Fuchs, Helmut; Gailus-Durner, Valerie; Hans, Wolfgang; Javaheri, Anahita; Kling, Eva; Naton, Beatrix; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Expt Genet, D-85764 Munich, Germany; [Mueller, Uwe] Univ Leipzig, Inst Immunol, BBZ, D-04103 Leipzig, Germany; [Groszer, Matthias; Fisher, Simon E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Adler, Thure; Kalaydjiev, Svetoslav; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Aguilar, Antonio; Javaheri, Anahita; Ollert, Markus] Tech Univ Munich, Dept Dermatol & Allergy, Div Environm Dermatol & Allergy TUM HMGU, D-80802 Munich, Germany; [Bolle, Ines; Schulz, Holger] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, D-85764 Munich, Germany; [Calzada-Wack, Julia; Hoelzlwimmer, Gabriele; Kunder, Sandra; Mossbrugger, Ilona; Quintanilla-Martinez, Leticia] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Pathol, D-85764 Munich, Germany; [Ehrhardt, Nicole] Univ Marburg, Fac Biol, D-35032 Marburg, Germany; [Favor, Jack] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Munich, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Life & Brain Ctr, Dept Mol Psychiat, D-53105 Bonn, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Gene Ctr, Inst Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Schrewe, Anja; Ivandic, Boris] Heidelberg Univ, Dept Med 3, Div Cardiol, D-69120 Heidelberg, Germany; [Rozman, Jan; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, D-85350 Freising Weihenstephan, Germany; [Rozman, Jan; Klingenspor, Martin] Res Ctr Nutr & Food Sci, ZIEL, D-85350 Freising Weihenstephan, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, D-85350 Freising Weihenstephan, Germany; [Schwarz, Johannes] Univ Leipzig, Dept Neurol, D-04103 Leipzig, Germany; [Schwarz, Johannes] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	Max Planck Society; Deutsches Primatenzentrum (DPZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; University of Oxford; Wellcome Centre for Human Genetics; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; Max Planck Society; Technical University of Munich; Leipzig University; California Institute of Technology	Enard, W (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	enard@eva.mpg.de	Enard, Wolfgang/K-3483-2014; Klingenspor, Martin/D-6930-2011; Rathkolb, Birgit/F-7041-2013; Klingenspor, Martin/K-5033-2019; Becker, Lore/AAJ-1203-2020; Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012; Dalke, Claudia/D-5913-2015; Somel, Mehmet/B-1471-2016; Racz, I./C-3074-2009; Gailus-Durner, Valerie/M-7337-2014; Brückner, Martina . K./A-5201-2017; Hölter, Sabine M./N-5868-2014; Graw, Jochen/D-9336-2013; Naton, Beatrix/B-5392-2013; Schulz, Holger/J-5643-2015; Arendt, Thomas/C-8747-2012; Fisher, Simon E./E-9130-2012; Rozman, Jan/A-2540-2010; Fischer, Julia/B-6674-2008; Becker, Lore/E-3717-2010; Zimmer, Andreas/B-8357-2009	Klingenspor, Martin/0000-0002-4502-6664; Becker, Lore/0000-0002-6890-4984; Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Dalke, Claudia/0000-0002-8040-4464; Racz, I./0000-0002-1549-3616; Hölter, Sabine M./0000-0003-4878-5241; Naton, Beatrix/0000-0002-9453-8877; Schulz, Holger/0000-0002-1157-200X; Fisher, Simon E./0000-0002-3132-1996; Rozman, Jan/0000-0002-8035-8904; Fischer, Julia/0000-0002-5807-0074; Somel, Mehmet/0000-0002-3138-1307; Groszer, Matthias/0000-0002-6209-305X; Graw, Jochen/0000-0003-0298-9660; Arendt, Thomas/0000-0003-4553-1625; Ollert, Markus W./0000-0002-8055-0103; Schreiweis, Christiane/0000-0002-8523-9445; Wolf, Eckhard/0000-0002-0430-9510; Muller, Uwe/0000-0003-1502-9271; Wurst, Wolfgang/0000-0003-4422-7410; Calzada, Julia/0000-0003-0816-9305	Bundesministerium fur Bildung und Forschung [01GS0850, 01GS0851, 01GS0852, 01GS0869, 01GS0853, 01GS0854, 01GS0868]; EU grant [LSHG-2006-037188]; Deutsche Forschungsgemeinschaft; Saxonian Staatsministerium fur Wissenschaft und Kunst; Interdisziplinarem Zentrum fur Klinische Forschung in Leipzig; Royal Society; Max Planck Society	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EU grant(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Saxonian Staatsministerium fur Wissenschaft und Kunst; Interdisziplinarem Zentrum fur Klinische Forschung in Leipzig; Royal Society(Royal Society of London); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are grateful to Ozgene Inc. for generating mice; to Uta Zirkler ( MPI- EVA) for animal care; to Reinhard Seeliger and the German Mouse Clinic technician team ( Maria Kugler, Tamara Halex, Claudia Zeller, Sandra Schadler, Regina Kneuttinger, Bettina Sperling, Elfi Holupirek, Susanne Wittich, Elisabeth Schwarz, Miriam Backs, Eleonore Samson, Christine Fuhrmann-Franz, and Kerstin Kutzner) and the animal caretaker team for expert technical help; to Eunjong Park (MPI-EVA, Neurology Leipzig) for assistance in neuronal cell culture; to Sven-Holger Puppel and Sabrina Reimers ( MPI-EVA) for assistance in generating expression data; and to Christine Green ( MPI-EVA) for comments on the manuscript. This work was supported by NGFN plus grants from the Bundesministerium fur Bildung und Forschung ( 01GS0850 ( I. B., C. C.- W., C. D., J. F., H. F., V. G.- D., W. H., G. H., M. K., S. K., I. M., B., N., J. G., L. Q.- M., H. S., W. W., and M. H. A), 01GS0851 ( L. B., B. R. C. M., E. K., E. W. and Th. K.), 01GS0852 ( T. A., S. K., and D. B.), 01GS0869 ( N. E., J. R., and M. K.), 01GS0853 ( I. R. and A. Z.), 01GS0854 ( A. S. and B. I.), 01GS0868 ( A. A., A. J., and M. O.), by an EU grant ( EUMODIC LSHG-2006-037188, German Mouse Clinic), grants from the Deutsche Forschungsgemeinschaft ( S. G. and J. S., M. K. B. and T. A., Heisenberg grant to J. F.), the Saxonian Staatsministerium fur Wissenschaft und Kunst ( M. K. B. and T. A.), the Interdisziplinarem Zentrum fur Klinische Forschung in Leipzig ( TP C27 to S. G. and J. S.), the Royal Society ( research fellowship to S. E. F.), and the Max Planck Society ( W. E. and S. P.).	Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; Berretta N, 2008, PROG NEUROBIOL, V84, P343, DOI 10.1016/j.pneurobio.2007.12.004; Campbell P, 2009, J COMP NEUROL, V512, P84, DOI 10.1002/cne.21881; Cox RD, 2003, CURR OPIN GENET DEV, V13, P278, DOI 10.1016/S0959-437X(03)00051-0; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; David HN, 2005, BRAIN RES REV, V50, P336, DOI 10.1016/j.brainresrev.2005.09.002; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2004, ANNU REV GENOM HUM G, V5, P351, DOI 10.1146/annurev.genom.5.061903.180040; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; French CA, 2007, GENESIS, V45, P440, DOI 10.1002/dvg.20305; Fuchs H, 2000, MAMM GENOME, V11, P528, DOI 10.1007/s003350010101; FUCHS H, 2006, PHENOTYPING LAB MOUS, P35; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hammerschmidt K., 2008, EVOLUTION COMMUNICAT; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; LIEBERMAN P, 2006, EVOLUTIONARY BIOL LA; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Ohl F, 2001, BEHAV RES METH INS C, V33, P392, DOI 10.3758/BF03195393; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; ROBERTS LH, 1975, ULTRASONICS, V13, P83, DOI 10.1016/0041-624X(75)90052-9; ROBERTS LH, 1975, J ZOOL, V175, P243, DOI 10.1111/j.1469-7998.1975.tb01399.x; Scharff C, 2005, CURR OPIN NEUROBIOL, V15, P694, DOI 10.1016/j.conb.2005.10.004; Schneider I, 2006, J NEUROSCI METH, V157, P82, DOI 10.1016/j.jneumeth.2006.04.002; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Teichmann M, 2008, BRAIN, V131, P1046, DOI 10.1093/brain/awn036; Tettamanti M, 2005, NEUROREPORT, V16, P397, DOI 10.1097/00001756-200503150-00018; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P623, DOI 10.1016/j.neubiorev.2003.08.006; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Wijchers PJEC, 2006, BRAIN RES, V1068, P23, DOI 10.1016/j.brainres.2005.11.022; Zhang JZ, 2002, GENETICS, V162, P1825	65	343	350	4	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					961	971		10.1016/j.cell.2009.03.041	http://dx.doi.org/10.1016/j.cell.2009.03.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490899	Green Submitted, Bronze			2022-12-28	WOS:000266454800025
J	Li, JB; Levanon, EY; Yoon, JK; Aach, J; Xie, B; LeProust, E; Zhang, K; Gao, Y; Church, GM				Li, Jin Billy; Levanon, Erez Y.; Yoon, Jung-Ki; Aach, John; Xie, Bin; LeProust, Emily; Zhang, Kun; Gao, Yuan; Church, George M.			Genome-Wide Identification of Human RNA Editing Sites by Parallel DNA Capturing and Sequencing	SCIENCE			English	Article							ADENOSINE DEAMINASES; HUMAN TRANSCRIPTOME; ENZYME ADAR2; MICE; DEFICIENT; LETHALITY; CHANNELS; TARGETS; BRAIN	Adenosine-to-inosine (A-to-I) RNA editing leads to transcriptome diversity and is important for normal brain function. To date, only a handful of functional sites have been identified in mammals. We developed an unbiased assay to screen more than 36,000 computationally predicted nonrepetitive A-to-I sites using massively parallel target capture and DNA sequencing. A comprehensive set of several hundred human RNA editing sites was detected by comparing genomic DNA with RNAs from seven tissues of a single individual. Specificity of our profiling was supported by observations of enrichment with known features of targets of adenosine deaminases acting on RNA (ADAR) and validation by means of capillary sequencing. This efficient approach greatly expands the repertoire of RNA editing targets and can be applied to studies involving RNA editing-related human diseases.	[Li, Jin Billy; Levanon, Erez Y.; Yoon, Jung-Ki; Aach, John; Zhang, Kun; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Xie, Bin; Gao, Yuan] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [LeProust, Emily] Agilent Technol, Genom Solut Unit, Santa Clara, CA 95051 USA; [Gao, Yuan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA	Harvard University; Harvard Medical School; Virginia Commonwealth University; Agilent Technologies; Virginia Commonwealth University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.		Levanon, Erez Y/A-8128-2012; Gao, Yuan/E-1706-2011; Yoon, Jung-Ki/S-6948-2017; Zhang, Kun/ABE-6349-2020	Levanon, Erez Y/0000-0002-3641-4198; Zhang, Kun/0000-0002-7596-5224; church, george/0000-0001-6232-9969	National Human Genome Research Institute Centers of Excellence in Genomic Science	National Human Genome Research Institute Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank R. Emeson, M. P. Ball, and F. Isaacs for critical reading of the manuscript; P. Wang and Z. Liu (BioChain Institute) for helping collect human samples; M. Higuchi and P. Seeburg for providing ADAR2 mouse brain cDNA; Harvard Biopolymers Facility for help with Illumina sequencing; and A. Ahlford, H. Ebling, and J. Santosuosso for assistance with Sanger sequencing. E.Y.L. was supported by the Machiah foundation. Funding came from National Human Genome Research Institute Centers of Excellence in Genomic Science grant to G.M.C. The Illumina sequencing data are deposited at the National Center for Biotechnology Information Short Read Archive under accession number SRA008181.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Clutterbuck DR, 2005, BIOINFORMATICS, V21, P2590, DOI 10.1093/bioinformatics/bti411; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Gommans WM, 2008, RNA, V14, P2074, DOI 10.1261/rna.816908; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Maas Stefan, 2006, RNA Biol, V3, P1; NISHIKURA K, 1991, EMBO J, V10, P3523, DOI 10.1002/j.1460-2075.1991.tb04916.x; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Singh M, 2007, J BIOL CHEM, V282, P22448, DOI 10.1074/jbc.M700265200; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Tian N, 2008, RNA, V14, P211, DOI 10.1261/rna.797108	25	406	428	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1210	1213		10.1126/science.1170995	http://dx.doi.org/10.1126/science.1170995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478186				2022-12-28	WOS:000266410100049
J	Mukhtar, MS; Nishimura, MT; Dangl, J				Mukhtar, M. Shahid; Nishimura, Marc T.; Dangl, Jeff			NPR1 in Plant Defense: It's Not over 'til It's Turned over	CELL			English	Editorial Material							SYSTEMIC ACQUIRED-RESISTANCE; TRANSCRIPTION FACTORS; NEGATIVE REGULATION; ARABIDOPSIS; REQUIRES; DOMAIN		[Mukhtar, M. Shahid; Nishimura, Marc T.; Dangl, Jeff] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dangl, J (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu		Nishimura, Marc Tad/0000-0003-4666-6900; Mukhtar, Shahid/0000-0002-1104-6931	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066025] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066025, R01GM066025] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x	9	57	65	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					804	806		10.1016/j.cell.2009.05.010	http://dx.doi.org/10.1016/j.cell.2009.05.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490889	Bronze			2022-12-28	WOS:000266454800011
J	Altman, DG; Vergouwe, Y; Royston, P; Moons, KGM				Altman, Douglas G.; Vergouwe, Yvonne; Royston, Patrick; Moons, Karel G. M.			Prognosis and prognostic research: validating a prognostic model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXTERNAL VALIDATION; POSTOPERATIVE MORTALITY; PRESCHOOL-CHILDREN; ACUTE COUGH; COMPLICATIONS; ACCURACY; IMPACT; RISK		[Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England; [Vergouwe, Yvonne; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Royston, Patrick] MRC, Clin Trials Unit, London NW1 2DA, England	University of Oxford; Utrecht University; Utrecht University Medical Center; Medical Research Council Clinical Trials Unit	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England.	doug.altman@csm.ox.ac.uk			Medical Research Council [MC_EX_G0800814] Funding Source: researchfish; MRC [MC_U122861386, MC_EX_G0800814] Funding Source: UKRI; Cancer Research UK Funding Source: Medline; Medical Research Council [MC_U122861386] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; ALTMAN DG, 2007, TREATING INDIVIDUALS, P213; Alves A, 2005, ARCH SURG-CHICAGO, V140, P278, DOI 10.1001/archsurg.140.3.278; Alves A, 2007, ANN SURG, V246, P91, DOI 10.1097/SLA.0b013e3180602ff5; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Confalonieri M, 2005, EUR RESPIR J, V25, P348, DOI 10.1183/09031936.05.00085304; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hay AD, 2004, BRIT J GEN PRACT, V54, P9; Hay AD, 2007, BRIT J GEN PRACT, V57, P530; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hubacek J, 2006, AM HEART J, V151, P308, DOI 10.1016/j.ahj.2005.04.032; Iezzoni LI, 1999, J GEN INTERN MED, V14, P388, DOI 10.1046/j.1525-1497.1999.04049.x; Ivanov J, 2000, ANN THORAC SURG, V70, P162, DOI 10.1016/S0003-4975(00)01387-4; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Loeb M, 1999, J CLIN EPIDEMIOL, V52, P1239, DOI 10.1016/S0895-4356(99)00104-3; Mackillop WJ, 1997, J CLIN EPIDEMIOL, V50, P21, DOI 10.1016/S0895-4356(96)00316-2; MILLER ME, 1991, STAT MED, V10, P1213, DOI 10.1002/sim.4780100805; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sauerbrei W, 1999, J ROY STAT SOC C-APP, V48, P313, DOI 10.1111/1467-9876.00155; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; van den Bosch JE, 2005, ANAESTHESIA, V60, P323, DOI 10.1111/j.1365-2044.2005.04121.x; VANHOUWELINGEN HC, 1995, STAT MED, V14, P1999, DOI 10.1002/sim.4780141806; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539; Yap CH, 2006, EUR J CARDIO-THORAC, V29, P441, DOI 10.1016/j.ejcts.2005.12.046	29	900	911	5	75	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2009	338								b605	10.1136/bmj.b605	http://dx.doi.org/10.1136/bmj.b605			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WU	19477892				2022-12-28	WOS:000266502400003
J	Fuchs, VR				Fuchs, Victor R.			HEALTH CARE 2009 The Proposed Government Health Insurance Company - No Substitute for Real Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V298, P1323, DOI 10.1001/jama.298.11.1323; Kohn KT, 2000, ERR IS HUMAN BUILDIN; ROBINSON JC, 2005, HLTH AFF MILLWOOD S; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; 2009, NY TIMES        0407, pA28	5	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2273	2275		10.1056/NEJMp0903655	http://dx.doi.org/10.1056/NEJMp0903655			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449YO	19474424				2022-12-28	WOS:000266367300003
J	Calvert, M; Shankar, A; McManus, RJ; Lester, H; Freemantle, N				Calvert, Melanie; Shankar, Aparna; McManus, Richard J.; Lester, Helen; Freemantle, Nick			Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PAY-FOR-PERFORMANCE; DEPRIVATION; INDICATORS; MANAGEMENT; PHYSICIANS; ETHNICITY; CONTRACT; UK	Objectives To examine the management of diabetes between 2001 and 2007 in the United Kingdom and to assess whether changes in the quality of care reflect existing temporal trends or are a direct result of the implementation of the quality and outcomes framework. Design Retrospective cohort study. Setting 147 general practices (annual list size over 1 million) across the UK. Patients People with type 1 or type 2 diabetes. Main outcome measures Annual prevalence of diabetes and attainment of process and clinical outcomes over the three years before and the three years after the introduction of the quality and outcomes framework. Results Significant improvements in process and intermediate outcome measures were observed during the six year period, with consecutive annual improvements observed before the introduction of incentives. However, the current diagnostic case definition for the quality and outcomes framework does not capture up to two thirds of people with type 1 diabetes and a third of people with type 2 diabetes. After the introduction of the quality and outcomes framework, existing trends of improvement in glycaemic control, cholesterol levels, and blood pressure were attenuated, particularly in people with diabetes who did not meet the case definition of the quality and outcomes framework. The introduction of the quality and outcomes framework did not lead to improvement in the management of patients with type 1 diabetes, nor to a reduction in the number of patients with type 2 diabetes who had HbA(1c) levels greater than 10%. Introduction of the quality and outcomes framework may have increased the number of patients with type 2 diabetes with HbA(1c) levels of <= 7.5%; odds ratio 1.05 (95% confidence interval 1.01 to 1.09; P=0.02). Conclusions The management of people with diabetes has improved since the late 1990s, but the impact of the quality and outcomes framework on care is not straightforward; upper thresholds may need to be removed or targets made more challenging if people are to benefit. Many patients in whom care may be suboptimal may not be captured in the quality and outcomes framework assessment.	[Calvert, Melanie; McManus, Richard J.; Freemantle, Nick] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; [Lester, Helen] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England	University of Birmingham; University of Manchester	Calvert, M (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	m.calvert@bham.ac.uk	Shankar, Aparna/S-9592-2019; Calvert, Melanie/F-7055-2011	Calvert, Melanie/0000-0002-1856-837X; Shankar, Aparna/0000-0002-7948-8189; Freemantle, Nick/0000-0001-5807-5740	national primary care postdoctoral award [2005-7]; National Institute for Health Research [CDF/01/017] Funding Source: researchfish	national primary care postdoctoral award; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was sponsored by Pfizer. Analyses and interpretation were done independently of the sponsor. RJM was supported by a national primary care postdoctoral award 2005-7.	Ashworth M, 2007, BRIT J GEN PRACT, V57, P441; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Carey IM, 2007, BRIT J GEN PRACT, V57, P486; Carey IM, 2004, INT J MED INFORM, V73, P443, DOI 10.1016/j.ijmedinf.2004.02.002; *DIAB UK, 2008, CAUS RISK FACT; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; DORSETT R, 2008, ETHNIC MINORITIES IN; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; Gray J, 2007, J GEN INTERN MED, V22, P1317, DOI 10.1007/s11606-007-0267-4; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harvey J. N., 2002, Journal of Epidemiology and Community Health, V56, P18, DOI 10.1136/jech.56.1.18; Hippisley-Cox J, 2004, BRIT MED J, V329, P1267, DOI 10.1136/bmj.38279.588125.7C; Hippisley-Cox J, 2006, BMJ-BRIT MED J; HIPPISLEYCOX J, 2007, FINAL REPORT INFORM; *INF CTR HLTH SOC, 2008, NAT QOF TABL 2006 20; Institute of Medicine, 2007, REW PROV PERF AL INC; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; Millett C, 2007, PLOS MED, V4, P1087, DOI 10.1371/journal.pmed.0040191; Millett C, 2007, J ROY SOC MED, V100, P275, DOI 10.1258/jrsm.100.6.275; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; *ROYAL COLL GEN PR, 2007, GMS CONTR OV RES GUI; *SCOTT CLIN INF MA, 2009, MAK IT WORK YOU READ; Tahrani AA, 2007, BRIT J GEN PRACT, V57, P483; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	26	105	105	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2009	338								b1870	10.1136/bmj.b1870	http://dx.doi.org/10.1136/bmj.b1870			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WT	19474024	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000266502300004
J	Kahn, R				Kahn, Richard			Diabetes technology-now and in the future	LANCET			English	Editorial Material							BLOOD-GLUCOSE; HEALTH; CARE; QUALITY; THERAPY		Amer Diabet Assoc, Alexandria, VA 22307 USA	American Diabetes Association	Kahn, R (corresponding author), Amer Diabet Assoc, Alexandria, VA 22307 USA.	RKahn@diabetes.org						Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Davidson MB, 2007, CURR DIABETES REV, V3, P280, DOI 10.2174/157339907782330058; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922; Sarol JN, 2005, CURR MED RES OPIN, V21, P173, DOI 10.1185/030079904X20286; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Simon J, 2008, BRIT MED J, V336, P1177, DOI 10.1136/bmj.39526.674873.BE; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	15	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1741	1743		10.1016/S0140-6736(09)60960-0	http://dx.doi.org/10.1016/S0140-6736(09)60960-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465215				2022-12-28	WOS:000266337300007
J	Mol, A				Mol, Annemarie			The art of medicine Living with diabetes: care beyond choice and control	LANCET			English	Editorial Material									Univ Amsterdam, Dept Anthropol & Sociol, NL-1012 DK Amsterdam, Netherlands	University of Amsterdam	Mol, A (corresponding author), Univ Amsterdam, Dept Anthropol & Sociol, Oudezijds Achterburgwal 185, NL-1012 DK Amsterdam, Netherlands.	a.mol@uva.nl						[Anonymous], 2007, INCLUSION POLITICS D; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Moser I, 2008, GEOFORUM, V39, P98, DOI 10.1016/j.geoforum.2006.12.007; Pols J, 2006, SCI TECHNOL HUM VAL, V31, P409, DOI 10.1177/0162243906287544; Struhkamp R, 2009, SCI TECHNOL HUM VAL, V34, P55, DOI 10.1177/0162243907312954	5	52	52	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1756	1757		10.1016/S0140-6736(09)60971-5	http://dx.doi.org/10.1016/S0140-6736(09)60971-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19480076				2022-12-28	WOS:000266337300016
J	Rajamani, K; Colman, PG; Li, LP; Best, JD; Voysey, M; D'Emden, MC; Loakso, M; Baker, JR; Keech, AC				Rajamani, Kushwin; Colman, Peter G.; Li, Li Ping; Best, James D.; Voysey, Merryn; D'Emden, Michael C.; Loakso, Markku; Baker, John R.; Keech, Anthony C.		FIELD Study Investigators	Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial	LANCET			English	Article							RISK; SURVIVAL; DISEASE; HEALTH; COSTS; AMPK	Background Amputations in people with type 2 diabetes mellitus substantially impair their quality of life and impose high costs on health-care systems. Our aim was to assess the effect of fenofibrate on amputation events in a large cohort of patients with type 2 diabetes. Methods In the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, 9795 patients aged 50-75 years with type 2 diabetes were randomly assigned by computer-generated randomisation sequence to receive fenofibrate 200 mg per day (n=4895) or matching placebo (n=4900) for 5 years' duration. Information about non-traumatic amputation-a prespecified tertiary endpoint of the study-was routinely gathered. Clinicians who were masked to treatment allocation adjudicated amputations as minor or major (below or above the ankle, respectively). Amputations were also classified on the basis of whether or not large-vessel disease was present in the limb, to distinguish those related to large-artery atherosclerosis from those predominantly related to microvascular disease. Analysis was by intention to treat (ITT). The FIELD study is registered as an International Standard Randomised Controlled Trial, number ISRCTN64783481. Findings All 9795 patients were included in the ITT population. 115 patients had one or more non-traumatic lower-limb amputations due to diabetes. Previous cardiovascular disease, microvascular disease, previous non-traumatic amputation or skin ulcer, smoking, and longer duration of diabetes were more frequent in patients who had amputations during the trial than in those who had other cardiovascular events or in those who had neither event (all p<0.001 for three-way comparison). Mean lipid concentrations differed between patients who had on-study amputations and those who had other cardiovascular events or neither event, but by no more than 0.2 mmol/L. The risks of first amputation (45 vs 70 events; hazard ratio [HR] 0.64, 95% CI 0.44-0.94; p=0.02) and minor amputation events without known large-vessel disease (18 vs 34 events; 0.53, 0.30-0.94; p=0.027) were lower for patients assigned to fenofibrate than for patients assigned to placebo, with no difference between groups in risk of major amputations (24 vs 26 events; 0.93, 0.53-1.62; p=0.79). Interpretation Classic markers of macrovascular and microvascular risk were associated with lower extremity amputations in patients with type 2 diabetes. Treatment with fenofibrate was associated with a lower risk of amputations, particularly minor amputations without known large-vessel disease, probably through non-lipid mechanisms. These findings could lead to a change in standard treatment for the prevention of diabetes-related lower-limb amputations. Funding Laboratoires Fournier SA (now part of Solvay Pharmaceuticals) and National Health and Medical Research Council of Australia.	[Rajamani, Kushwin; Li, Li Ping; Voysey, Merryn; Keech, Anthony C.] Univ Sydney, Clin Trials Ctr, NHMRC, Camperdown, NSW 1450, Australia; [Colman, Peter G.] Royal Melbourne Hosp, Dept Endocrinol & Diabet, Melbourne, Vic, Australia; [Best, James D.] Univ Melbourne, Sch Med, Melbourne, Vic, Australia; [D'Emden, Michael C.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Loakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Baker, John R.] Middlemore Hosp, Auckland 6, New Zealand	University of Sydney; Royal Melbourne Hospital; University of Melbourne; Royal Brisbane & Women's Hospital; University of Eastern Finland	Rajamani, K (corresponding author), Univ Sydney, Clin Trials Ctr, NHMRC, Locked Bag 77, Camperdown, NSW 1450, Australia.		d'Emden, Michael/G-3388-2015	d'Emden, Michael/0000-0002-0149-639X; Best, James/0000-0002-5239-9274; Colman, Peter/0000-0001-8718-6175; Voysey, Merryn/0000-0001-6324-6559	Laboratoires Fournier SA, Dijon, France; National Health and Medical Research Council (NHMRC) of Australia; NHMRC Clinical Trials Centre, University of Sydney, Australia; National Heart Foundation of Australia, Diabetes Australia, Diabetes New Zealand; Finnish Diabetes Association	Laboratoires Fournier SA, Dijon, France; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Clinical Trials Centre, University of Sydney, Australia(University of Sydney); National Heart Foundation of Australia, Diabetes Australia, Diabetes New Zealand(National Heart Foundation of Australia); Finnish Diabetes Association	This study was supported by a grant from Laboratoires Fournier SA, Dijon, France (now part of Solvay Pharmaceuticals), and by the National Health and Medical Research Council (NHMRC) of Australia and was coordinated independently by the NHMRC Clinical Trials Centre, University of Sydney, Australia, and overseen by the study Management Committee. We thank the National Heart Foundation of Australia, Diabetes Australia, Diabetes New Zealand, and the Finnish Diabetes Association for endorsing the study. We also thank R Pike, V Gebski, and D Tse for their assistance on this manuscript, and the many patients who participated in the FIELD study.	[Anonymous], 2005, TIM ACT DIAB FOOT CA; Barter P, 2004, CARDIOVASC DIABETOL, V3, DOI 10.1186/1475-2840-3-9; BILD DE, 1989, DIABETES CARE, V12, P24, DOI 10.2337/diacare.12.1.24; Collet D., 2003, MODELLING SURVIVAL D; Collins R, 2003, LANCET, V361, P2005; Davis WA, 2006, DIABETOLOGIA, V49, P2634, DOI 10.1007/s00125-006-0431-0; Deplanque D, 2003, J NEUROSCI, V23, P6264; EDMONDS ME, 1986, Q J MED, V60, P763; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gordois A, 2003, DIABETES CARE, V26, P1790, DOI 10.2337/diacare.26.6.1790; Gordois A, 2003, DIABET FOOT, V6, P62; Harrell FE, 1986, P 11 ANN SAS US GROU, P823; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Kim J, 2007, EXP EYE RES, V84, P886, DOI 10.1016/j.exer.2007.01.009; Koh KK, 2005, DIABETES CARE, V28, P1419, DOI 10.2337/diacare.28.6.1419; KUK AYC, 1984, BIOMETRIKA, V71, P587; LAWLESS JF, 1987, CAN J STAT, V15, P209, DOI 10.2307/3314912; Losada M, 1997, DOC OPHTHALMOL, V93, P223, DOI 10.1007/BF02569062; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Murabito JM, 1997, CIRCULATION, V96, P44; Murakami H, 2006, BIOCHEM BIOPH RES CO, V341, P973, DOI 10.1016/j.bbrc.2006.01.052; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Petersen M, 2003, DIABETES CARE, V26, P917; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rosenson RS, 2009, DIABETES METAB SYND, V3, P17, DOI 10.1016/j.dsx.2008.10.004; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ryan KE, 2007, ATHEROSCLEROSIS, V194, pE123, DOI 10.1016/j.atherosclerosis.2006.11.007; Scott R, 2009, DIABETES CARE, V32, P493, DOI 10.2337/dc08-1543; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Sheahan MG, 2005, J VASC SURG, V42, P476, DOI 10.1016/j.jvs.2005.05.003; SIGNORINI DF, 1993, STAT MED, V12, P2343, DOI 10.1002/sim.4780122410; Tennvall GR, 2000, J DIABETES COMPLICAT, V14, P235; Tseng Chin-Hsiao, 2006, CMAJ, V174, P319, DOI 10.1503/cmaj.050680; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yusuf S, 2000, NEW ENGL J MED, V342, P145	40	210	220	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1780	1788		10.1016/S0140-6736(09)60698-X	http://dx.doi.org/10.1016/S0140-6736(09)60698-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465233	Green Published			2022-12-28	WOS:000266337300033
J	Senthil, R; Maskell, S; Hartley, B; Aladangady, N				Senthil, Radhalakshmi; Maskell, Scott; Hartley, Benjamin; Aladangady, Narendra			Blue episodes in a neonate	LANCET			English	Editorial Material							VALLECULAR CYST		[Senthil, Radhalakshmi; Aladangady, Narendra] Homerton Univ Hosp NHS Fdn Trust, Neonatal Unit, London E9 6SR, England; [Maskell, Scott; Hartley, Benjamin] Great Ormond St Hosp Sick Children, Paediat ENT Dept, London WC1N 3JH, England; [Aladangady, Narendra] London Sch Med & Dent, Dept Child Hlth, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; Queen Mary University London	Senthil, R (corresponding author), Homerton Univ Hosp NHS Fdn Trust, Neonatal Unit, London E9 6SR, England.	radsenkar@gmail.com						Chow P. Y., 2002, Hong Kong Medical Journal, V8, P464; Cuillier F, 2002, ULTRASOUND OBST GYN, V20, P623, DOI 10.1046/j.1469-0705.2002.00860.x; Gutierrez JP, 1999, PEDIATR PULM, V27, P282, DOI 10.1002/(SICI)1099-0496(199904)27:4<282::AID-PPUL10>3.0.CO;2-G; Kamble VA, 1999, ANESTHESIOLOGY, V91, P872, DOI 10.1097/00000542-199909000-00043; Ruben R J, 1975, Can J Otolaryngol, V4, P180	5	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2009	373	9676					1734	1734		10.1016/S0140-6736(09)60656-5	http://dx.doi.org/10.1016/S0140-6736(09)60656-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RP	19447251				2022-12-28	WOS:000266209800018
J	Shi, YM; Tyson, GW; DeLong, EF				Shi, Yanmei; Tyson, Gene W.; DeLong, Edward F.			Metatranscriptomics reveals unique microbial small RNAs in the ocean's water column	NATURE			English	Article							NONCODING RNAS; GENES; EXPRESSION; IDENTIFICATION; RIBOSWITCHES; PREDICTION; SEQUENCES; ALIGNMENT; DATABASE	Microbial gene expression in the environment has recently been assessed via pyrosequencing of total RNA extracted directly from natural microbial assemblages. Several such 'metatranscriptomic' studies(1,2) have reported that many complementary DNA sequences shared no significant homology with known peptide sequences, and so might represent transcripts from uncharacterized proteins. Here we report that a large fraction of cDNA sequences detected in microbial metatranscriptomic data sets are comprised of well-known small RNAs ( sRNAs) 3, as well as new groups of previously unrecognized putative sRNAs ( psRNAs). These psRNAs mapped specifically to intergenic regions of microbial genomes recovered from similar habitats, displayed characteristic conserved secondary structures and were frequently flanked by genes that indicated potential regulatory functions. Depth-dependent variation of psRNAs generally reflected known depth distributions of broad taxonomic groups(4), but fine-scale differences in the psRNAs within closely related populations indicated potential roles in niche adaptation. Genome-specific mapping of a subset of psRNAs derived from predominant planktonic species such as Pelagibacter revealed recently discovered as well as potentially new regulatory elements. Our analyses show that metatranscriptomic data sets can reveal new information about the diversity, taxonomic distribution and abundance of sRNAs in naturally occurring microbial communities, and indicate their involvement in environmentally relevant processes including carbon metabolism and nutrient acquisition.	[Shi, Yanmei; Tyson, Gene W.; DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu	Tyson, Gene W/C-6558-2013	Tyson, Gene W/0000-0001-8559-9427	Craig Venter Institute; Gordon and Betty Moore Foundation for the genome sequence of Pelagibacter [HTCC7211]; Gordon and Betty Moore Foundation; National Science Foundation Microbial Observatory [MCB-0348001]; Department of Energy Genomics GTL Program; Department of Energy Microbial Genomics Program; NSF Science and Technology award; C-MORE	Craig Venter Institute; Gordon and Betty Moore Foundation for the genome sequence of Pelagibacter; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation Microbial Observatory(National Science Foundation (NSF)); Department of Energy Genomics GTL Program(United States Department of Energy (DOE)); Department of Energy Microbial Genomics Program(United States Department of Energy (DOE)); NSF Science and Technology award(National Science Foundation (NSF)); C-MORE	We are grateful to the University of Hawaii HOT team, and the captain and crew of the RV Kilo Moana for their expert assistance at sea. We also thank S. Schuster for collaboration and advice on pyrosequencing, J. Eppley for help with computational analyses and discussion, and J. Maresca, A. Martinez, J. McCarren and V. Rich for their comments on this manuscript. We thank S. Giovannoni, J. Tripp and M. Schwalbach for sharing their in press manuscript on Pelagibacter riboswitches, and S. Giovannoni, U. Stingl, the J. Craig Venter Institute and the Gordon and Betty Moore Foundation for the genome sequence of Pelagibacter strain HTCC7211. This work was supported by the Gordon and Betty Moore Foundation, National Science Foundation Microbial Observatory Award MCB-0348001, the Department of Energy Genomics GTL Program, the Department of Energy Microbial Genomics Program, and an NSF Science and Technology award, C-MORE. This article is a contribution from the NSF Science and Technology Center for Microbial Oceanography: Research and Education (C- MORE).	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Brantl S, 2004, TRENDS MICROBIOL, V12, P473, DOI 10.1016/j.tim.2004.09.008; Bruttin A, 1996, VIROLOGY, V219, P96, DOI 10.1006/viro.1996.0226; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; EDDY S, 2007, INFERNAL USERS GUIDE; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Holste D, 2000, J MOL EVOL, V51, P353, DOI 10.1007/s002390010097; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; JASON S, 2000, SIGBIO NEWSL, V20, P13; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Re M, 2007, LECT NOTES ARTIF INT, V4578, P544; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schattner P, 2002, NUCLEIC ACIDS RES, V30, P2076, DOI 10.1093/nar/30.9.2076; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Storz G, 2007, CURR OPIN MICROBIOL, V10, P93, DOI 10.1016/j.mib.2007.03.017; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wendisch VF, 2001, ANAL BIOCHEM, V290, P205, DOI 10.1006/abio.2000.4982; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126	46	192	202	2	82	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					266	U154		10.1038/nature08055	http://dx.doi.org/10.1038/nature08055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444216				2022-12-28	WOS:000266036100044
J	Porter, ME				Porter, Michael E.			Health Care 2009: A Strategy for Health Care Reform - Toward a Value-Based System.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Porter, ME (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							Porter M.E., 2006, REDEFINING HLTH CARE; PORTER ME, 2007, W GERMAN HEADACHE CT; PORTER ME, 2009, GLOBAL HLTH PARTNER; Porter ME, 2008, ANN SURG, V248, P503, DOI 10.1097/SLA.0b013e31818a43af; Teperi J., 2009, FINNISH HLTH CARE SY	5	610	617	2	101	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					109	112		10.1056/NEJMp0904131	http://dx.doi.org/10.1056/NEJMp0904131			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467OS	19494209				2022-12-28	WOS:000267748900001
J	Brangwynne, CP; Eckmann, CR; Courson, DS; Rybarska, A; Hoege, C; Gharakhani, J; Julicher, F; Hyman, AA				Brangwynne, Clifford P.; Eckmann, Christian R.; Courson, David S.; Rybarska, Agata; Hoege, Carsten; Gharakhani, Joebin; Juelicher, Frank; Hyman, Anthony A.			Germline P Granules Are Liquid Droplets That Localize by Controlled Dissolution/Condensation	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; CELL; PROTEINS; EMBRYOS; SEGREGATION; DEGRADATION; ASYMMETRY; POLARITY; LESSONS	In sexually reproducing organisms, embryos specify germ cells, which ultimately generate sperm and eggs. In Caenorhabditis elegans, the first germ cell is established when RNA and protein-rich P granules localize to the posterior of the one-cell embryo. Localization of P granules and their physical nature remain poorly understood. Here we show that P granules exhibit liquid-like behaviors, including fusion, dripping, and wetting, which we used to estimate their viscosity and surface tension. As with other liquids, P granules rapidly dissolved and condensed. Localization occurred by a biased increase in P granule condensation at the posterior. This process reflects a classic phase transition, in which polarity proteins vary the condensation point across the cell. Such phase transitions may represent a fundamental physicochemical mechanism for structuring the cytoplasm.	[Brangwynne, Clifford P.; Eckmann, Christian R.; Rybarska, Agata; Hoege, Carsten; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Brangwynne, Clifford P.; Gharakhani, Joebin; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Brangwynne, Clifford P.; Courson, David S.; Gharakhani, Joebin; Juelicher, Frank; Hyman, Anthony A.] Marine Biol Lab, Woods Hole, MA 02543 USA	Max Planck Society; Max Planck Society; Marine Biological Laboratory - Woods Hole	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	hyman@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Julicher, Frank/B-1828-2009	Hyman, Anthony A/0000-0003-3664-154X; Julicher, Frank/0000-0003-4731-9185	Helen Hay Whitney Foundation fellowship	Helen Hay Whitney Foundation fellowship	We thank T. Mitchison for advice and discussion, together with students of the MBL Physiology Course 2008; and S. Grill, N. Goehring, and members of the Hyman and Eckmann Laboratories for helpful comments. We thank S. Hell, R. Medda, and B. Harke for assistance with stimulated emission depletion microscopy. Some strains used in this study were obtained from the Caenorhabditis Genetics Center. C.P.B. is supported by a fellowship from the Helen Hay Whitney Foundation.	Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; [Anonymous], 1983, PHASE TRANSITIONS CR; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; DAOUD M, 1999, SOFT MATTER PHYS; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hird SN, 1996, DEVELOPMENT, V122, P1303; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Spike CA, 2003, CURR BIOL, V13, pR837, DOI 10.1016/j.cub.2003.10.016; Strasser MJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-58; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060	21	1414	1430	59	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1729	1732		10.1126/science.1172046	http://dx.doi.org/10.1126/science.1172046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19460965				2022-12-28	WOS:000267338200046
J	Hamburg, MA; Sharfstein, JM				Hamburg, Margaret A.; Sharfstein, Joshua M.			The FDA as a Public Health Agency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hamburg, Margaret A.; Sharfstein, Joshua M.] US FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Hamburg, MA (corresponding author), US FDA, Silver Spring, MD USA.								0	52	52	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2493	2495		10.1056/NEJMp0903764	http://dx.doi.org/10.1056/NEJMp0903764			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456BS	19470577				2022-12-28	WOS:000266813800001
J	Schuur, EAG; Vogel, JG; Crummer, KG; Lee, H; Sickman, JO; Osterkamp, TE				Schuur, Edward A. G.; Vogel, Jason G.; Crummer, Kathryn G.; Lee, Hanna; Sickman, James O.; Osterkamp, T. E.			The effect of permafrost thaw on old carbon release and net carbon exchange from tundra	NATURE			English	Article							CLIMATE-CHANGE; SOIL CARBON; DYNAMICS; DECOMPOSITION; TEMPERATURE; RADIOCARBON; ECOSYSTEMS; FEEDBACKS; SINK	Permafrost soils in boreal and Arctic ecosystems store almost twice as much carbon(1,2) as is currently present in the atmosphere(3). Permafrost thaw and the microbial decomposition of previously frozen organic carbon is considered one of the most likely positive climate feedbacks from terrestrial ecosystems to the atmosphere in a warmer world(1,2,4-7). The rate of carbon release from permafrost soils is highly uncertain, but it is crucial for predicting the strength and timing of this carbon-cycle feedback effect, and thus how important permafrost thaw will be for climate change this century and beyond(1,2,4-7). Sustained transfers of carbon to the atmosphere that could cause a significant positive feedback to climate change must come from old carbon, which forms the bulk of the permafrost carbon pool that accumulated over thousands of years(8-11). Here we measure net ecosystem carbon exchange and the radiocarbon age of ecosystem respiration in a tundra landscape undergoing permafrost thaw(12) to determine the influence of old carbon loss on ecosystem carbon balance. We find that areas that thawed over the past 15 years had 40 per cent more annual losses of old carbon than minimally thawed areas, but had overall net ecosystem carbon uptake as increased plant growth offset these losses. In contrast, areas that thawed decades earlier lost even more old carbon, a 78 per cent increase over minimally thawed areas; this old carbon loss contributed to overall net ecosystem carbon release despite increased plant growth. Our data document significant losses of soil carbon with permafrost thaw that, over decadal timescales, overwhelms increased plant carbon uptake(13-15) at rates that could make permafrost a large biospheric carbon source in a warmer world.	[Schuur, Edward A. G.; Vogel, Jason G.; Crummer, Kathryn G.; Lee, Hanna] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Sickman, James O.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Osterkamp, T. E.] Univ Alaska, Inst Geophys, Fairbanks, AK 99775 USA	State University System of Florida; University of Florida; University of California System; University of California Riverside; University of Alaska System; University of Alaska Fairbanks	Schuur, EAG (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	tschuur@ufl.edu		Lee, Hanna/0000-0002-2003-4377	NASA New Investigator Program; NSF Bonanza Creek LTER Program; NSF DEB Ecosystems Program; National Park Service; Directorate For Geosciences [0806271] Funding Source: National Science Foundation	NASA New Investigator Program(National Aeronautics & Space Administration (NASA)); NSF Bonanza Creek LTER Program(National Science Foundation (NSF)); NSF DEB Ecosystems Program(National Science Foundation (NSF)); National Park Service; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was made possible by assistance from G. Adema, T. Chapin, S. DeBiasio, L. Gutierrez, M. Mack, M. Schieber, E. Tissier, C. Trucco, W. Vicars, E. Wilson, C. Wuthrich, L. Yocum, and the researchers and technicians of the Bonanza Creek LTER. This work relied on funds from the following sources: NASA New Investigator Program, NSF Bonanza Creek LTER Program, NSF DEB Ecosystems Program, and a cooperative agreement with the National Park Service.	Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Delisle G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029323; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Field CB, 2007, 1 STATE CARBON CYCLE, P21; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Lawrence DM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL025080; Levin I, 2000, RADIOCARBON, V42, P69, DOI 10.1017/S0033822200053066; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Myneni RB, 1998, J GEOPHYS RES-ATMOS, V103, P6145, DOI 10.1029/97JD03603; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Osterkamp TE, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000578; Osterkamp TE, 1999, PERMAFROST PERIGLAC, V10, P17, DOI 10.1002/(SICI)1099-1530(199901/03)10:1&lt;17::AID-PPP303&gt;3.0.CO;2-4; Osterkamp TE, 2005, GLOBAL PLANET CHANGE, V49, P187, DOI 10.1016/j.gloplacha.2005.09.001; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Schirrmeister L, 2002, QUATERN INT, V89, P97, DOI 10.1016/S1040-6182(01)00083-0; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2007, ECOSYSTEMS, V10, P280, DOI 10.1007/s10021-007-9024-0; SHAVER GR, 1992, BIOSCIENCE, V42, P433, DOI 10.2307/1311862; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Vitt DH, 2000, CAN J FOREST RES, V30, P283, DOI 10.1139/x99-214; ZIMOV SA, 2006, GEOPHYS RES LETT, V33, DOI DOI 10.1029/2006GL027484; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	30	762	806	26	678	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					556	559		10.1038/nature08031	http://dx.doi.org/10.1038/nature08031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478781				2022-12-28	WOS:000266370500036
J	Bromirski, PD				Bromirski, Peter D.			Earth Vibrations	SCIENCE			English	Editorial Material							OSCILLATIONS; GENERATION; EXCITATION		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Bromirski, PD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	pbromirski@ucsd.edu						Aster RC, 2008, SEISMOL RES LETT, V79, P194, DOI 10.1785/gssrl.79.2.194; Bromirski PD, 1999, J GEOPHYS RES-OCEANS, V104, P20753, DOI 10.1029/1999JC900156; Bromirski PD, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000768; Bromirski PD, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000265; Bromirski PD, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; Gerstoft P, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031091; Gerstoft P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036111; HASSELMANN K, 1963, REV GEOPHYS, V1, P177, DOI 10.1029/RG001i002p00177; Herbers THC, 1995, J GEOPHYS RES-OCEANS, V100, P24863, DOI 10.1029/95JC02680; Kurrle D, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033125; LONGUETHIGGINS MS, 1950, PHILOS TR R SOC S-A, V243, P1, DOI 10.1098/rsta.1950.0012; MCNAMARA D, 2007, EOS T AGU S, V88; McNamara DE, 2004, B SEISMOL SOC AM, V94, P1517, DOI 10.1785/012003001; Nishida K, 2000, SCIENCE, V287, P2244, DOI 10.1126/science.287.5461.2244; Rhie J, 2004, NATURE, V431, P552, DOI 10.1038/nature02942; Rhie J, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001274; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Tanimoto T, 2005, GEOPHYS J INT, V160, P276, DOI 10.1111/J.1365-246X.2004.02484.X; Webb SC, 2008, GEOPHYS J INT, V174, P542, DOI 10.1111/j.1365-246X.2008.03801.x; Webb SC, 2007, NATURE, V445, P754, DOI 10.1038/nature05536	20	36	43	6	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1026	1027		10.1126/science.1171839	http://dx.doi.org/10.1126/science.1171839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460996				2022-12-28	WOS:000266246700029
J	Guerin, E; Cambray, G; Sanchez-Alberola, N; Campoy, S; Erill, I; Da Re, S; Gonzalez-Zorn, B; Barbe, J; Ploy, MC; Mazel, D				Guerin, Emilie; Cambray, Guillaume; Sanchez-Alberola, Neus; Campoy, Susana; Erill, Ivan; Da Re, Sandra; Gonzalez-Zorn, Bruno; Barbe, Jordi; Ploy, Marie-Cecile; Mazel, Didier			The SOS Response Controls Integron Recombination	SCIENCE			English	Article							ANTIBIOTIC-RESISTANCE		[Cambray, Guillaume; Mazel, Didier] CNRS, URA 2171, Inst Pasteur, F-75015 Paris, France; [Guerin, Emilie; Da Re, Sandra; Ploy, Marie-Cecile] Univ Limoges, Fac Med, EA3175, INSERM,Equipe Avenir, F-87000 Limoges, France; [Sanchez-Alberola, Neus; Campoy, Susana; Barbe, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Erill, Ivan] CSIC, CNM, IMB, Biomed Applicat Grp, Barcelona 08193, Spain; [Gonzalez-Zorn, Bruno] Univ Complutense Madrid, Dept Sanidad Anim, E-28040 Madrid, Spain; [Gonzalez-Zorn, Bruno] Univ Complutense Madrid, VISAVET Ctr Vigilancia Sanitaria Vet, E-28040 Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); CSIC - Instituto de Microelectronica de Barcelona (IMB-CNM); Complutense University of Madrid; Complutense University of Madrid	Mazel, D (corresponding author), CNRS, URA 2171, Inst Pasteur, F-75015 Paris, France.	mazel@pasteur.fr	Sanz, Mar/G-2116-2011; Erill, Ivan/H-9405-2015; campoy, susana/E-4346-2010; studies, IT VISAVET Account for bibliometric/C-3115-2014; Cambray, Guillaume/A-9476-2015; Mazel, Didier/F-9200-2013; Da Re, Sandra/F-6383-2011; Barbe, Jordi/G-5212-2015; Ploy, Marie-Cécile/O-7501-2016; Campoy, Susana/C-7335-2008	Erill, Ivan/0000-0002-7280-7191; campoy, susana/0000-0003-1369-0197; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Cambray, Guillaume/0000-0003-0087-2469; Mazel, Didier/0000-0001-6482-6002; Da Re, Sandra/0000-0003-3579-9185; Barbe, Jordi/0000-0003-4408-013X; Campoy, Susana/0000-0003-1369-0197	Ministere de l Enseignement Superieur et de la Recherche; Conseil Regional du Limousin; Fondation pour la Recherche Medicale (FRM); Institut National de la Sante et de la Recherche Medicale; Institut Pasteur; Centre National de la Recherche Scientifique; European Union [STREP CRAB, LSHM-CT-2005-019023, MED-VET-NET, FOOD-CT-2004-506122]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-01078/BMC, GEN2006-27767-E/PAT]; Catalunya Generalitat [2005SGR-533]	Ministere de l Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Conseil Regional du Limousin(Region Nouvelle-Aquitaine); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalunya Generalitat	M.-C.P. acknowledges support by grants from the Ministere de l Enseignement Superieur et de la Recherche, the Conseil Regional du Limousin, the Fondation pour la Recherche Medicale (FRM), and Institut National de la Sante et de la Recherche Medicale; D.M. from the Institut Pasteur, the Centre National de la Recherche Scientifique, the FRM, and the European Union (STREP CRAB, LSHM-CT-2005-019023); J.B. from the Spanish Ministerio de Ciencia e Innovacion (MICINN) (BFU2008-01078/BMC) and the Catalunya Generalitat (2005SGR-533); and B.G.Z. from the MICINN (GEN2006-27767-E/PAT) and European Union (MED-VET-NET and FOOD-CT-2004-506122). The GenBank accessions for the sequences shown in Fig. 1 are AF055586 [GenBank] (Vch CI), AY014398 [GenBank] (Vme CI), AY014399 [GenBank] (Vpa CI), AY181034 [GenBank] (Vna CI), AF034958 [GenBank] (cl1-MI), AJ001816 [GenBank] (cl2-MI), AB070224 [GenBank] (cl3-MI), and AJ277063 [GenBank] (cl5-MI).	Aertsen A, 2006, TRENDS MICROBIOL, V14, P421, DOI 10.1016/j.tim.2006.08.006; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462	5	287	307	8	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1034	1034		10.1126/science.1172914	http://dx.doi.org/10.1126/science.1172914			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460999				2022-12-28	WOS:000266246700032
J	Simon, SH				Simon, Steven H.			A Sound (and Light) Way to Measure Confined Electrons	SCIENCE			English	Editorial Material							COLLECTIVE EXCITATIONS		Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England	University of Oxford	Simon, SH (corresponding author), Univ Oxford, Rudolf Peierls Ctr Theoret Phys, S Parks Rd, Oxford OX1 3NP, England.	s.simon1@physics.ox.ac.uk	Simon, Steven/AAS-9956-2021	Simon, Steven/0000-0001-7757-5978				Eriksson MA, 1999, PHYS REV LETT, V82, P2163, DOI 10.1103/PhysRevLett.82.2163; GIRVIN SM, 1986, PHYS REV B, V33, P2481, DOI 10.1103/PhysRevB.33.2481; Groshaus JG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046804; Heinonen O, 1998, COMPOSITE FERMIONS U; Kukushkin IV, 2009, SCIENCE, V324, P1044, DOI 10.1126/science.1171472; NOZIERES P, 1990, THEORY QUANTUM LIQUI, V2; Prange R. E., 1990, QUANTUM HALL EFFECT; WILLETT RL, 1993, PHYS REV B, V47, P7344, DOI 10.1103/PhysRevB.47.7344	8	4	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1022	1023		10.1126/science.1173828	http://dx.doi.org/10.1126/science.1173828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460992				2022-12-28	WOS:000266246700025
J	Dixon, BS; Beck, GJ; Vazquez, MA; Greenberg, A; Delmez, JA; Allon, M; Dember, LM; Himmelfarb, J; Gassman, JJ; Greene, T; Radeva, MK; Davidson, IJ; Ikizler, TA; Braden, GL; Fenves, AZ; Kaufman, JS; Cotton, JR; Martin, KJ; McNeil, JW; Rahman, A; Lawson, JH; Whiting, JF; Hu, B; Meyers, CM; Kusek, JW; Feldman, HI				Dixon, Bradley S.; Beck, Gerald J.; Vazquez, Miguel A.; Greenberg, Arthur; Delmez, James A.; Allon, Michael; Dember, Laura M.; Himmelfarb, Jonathan; Gassman, Jennifer J.; Greene, Tom; Radeva, Milena K.; Davidson, Ingemar J.; Ikizler, T. Alp; Braden, Gregory L.; Fenves, Andrew Z.; Kaufman, James S.; Cotton, James R., Jr.; Martin, Kevin J.; McNeil, James W.; Rahman, Asif; Lawson, Jeffery H.; Whiting, James F.; Hu, Bo; Meyers, Catherine M.; Kusek, John W.; Feldman, Harold I.		DAC Study Grp	Effect of Dipyridamole plus Aspirin on Hemodialysis Graft Patency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUSCLE CELL-PROLIFERATION; VASCULAR ACCESS SURVIVAL; PRACTICE PATTERNS; PREVENTION; FISTULAS; OUTCOMES; FAILURE; ASSOCIATION; CLOPIDOGREL; INHIBITION	BACKGROUND Arteriovenous graft stenosis leading to thrombosis is a major cause of complications in patients undergoing hemodialysis. Procedural interventions may restore patency but are costly. Although there is no proven pharmacologic therapy, dipyridamole may be promising because of its known vascular antiproliferative activity. METHODS We conducted a randomized, double-blind, placebo-controlled trial of extended-release dipyridamole, at a dose of 200 mg, and aspirin, at a dose of 25 mg, given twice daily after the placement of a new arteriovenous graft until the primary outcome, loss of primary unassisted patency (i.e., patency without thrombosis or requirement for intervention), was reached. Secondary outcomes were cumulative graft failure and death. Primary and secondary outcomes were analyzed with the use of a Cox proportional-hazards regression with adjustment for prespecified covariates. RESULTS At 13 centers in the United States, 649 patients were randomly assigned to receive dipyridamole plus aspirin (321 patients) or placebo (328 patients) over a period of 4.5 years, with 6 additional months of follow-up. The incidence of primary unassisted patency at 1 year was 23% (95% confidence interval [CI], 18 to 28) in the placebo group and 28% (95% CI, 23 to 34) in the dipyridamole-aspirin group, an absolute difference of 5 percentage points. Treatment with dipyridamole plus aspirin significantly prolonged the duration of primary unassisted patency (hazard ratio, 0.82; 95% CI, 0.68 to 0.98; P = 0.03) and inhibited stenosis. The incidences of cumulative graft failure, death, the composite of graft failure or death, and serious adverse events (including bleeding) did not differ significantly between study groups. CONCLUSIONS Treatment with dipyridamole plus aspirin had a significant but modest effect in reducing the risk of stenosis and improving the duration of primary unassisted patency of newly created grafts. (ClinicalTrials.gov number, NCT00067119.)	[Dixon, Bradley S.] Univ Iowa, Coll Med, Iowa City, IA 52242 USA; [Dixon, Bradley S.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Beck, Gerald J.; Gassman, Jennifer J.; Radeva, Milena K.; Hu, Bo] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Vazquez, Miguel A.; Davidson, Ingemar J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Fenves, Andrew Z.] Baylor Med Ctr, Dallas, TX USA; [Cotton, James R., Jr.] Tyler Nephrol Associates, Tyler, TX USA; [Greenberg, Arthur; Lawson, Jeffery H.] Duke Univ, Durham, NC USA; [Delmez, James A.] Washington Univ, St Louis, MO 63130 USA; [Martin, Kevin J.] St Louis Univ, St Louis, MO 63103 USA; [Allon, Michael] Univ Alabama Birmingham, Birmingham, AL USA; [Dember, Laura M.] Boston Univ, Boston, MA 02215 USA; [Himmelfarb, Jonathan; Whiting, James F.] Maine Med Ctr, Portland, ME USA; [Greene, Tom] Univ Utah, Salt Lake City, UT USA; [Ikizler, T. Alp] Vanderbilt Univ, Nashville, TN USA; [Braden, Gregory L.] Baystate Med Ctr, Springfield, MA USA; [McNeil, James W.] Vasc Surg Associates, Baton Rouge, LA USA; [Rahman, Asif] Charleston Area Med Ctr, Charleston, WV USA; [Meyers, Catherine M.; Kusek, John W.] NIDDK, NIH, Bethesda, MD USA; [Feldman, Harold I.] Univ Penn, Philadelphia, PA 19104 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University; Washington University (WUSTL); Saint Louis University; University of Alabama System; University of Alabama Birmingham; Boston University; Maine Medical Center; Utah System of Higher Education; University of Utah; Vanderbilt University; Baystate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pennsylvania	Dixon, BS (corresponding author), Univ Iowa, Coll Med, E-300D GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	bradley-dixon@uiowa.edu		Ikizler, Talat/0000-0002-5717-4218; Dixon, Bradley/0000-0002-2534-3259; Greenberg, Arthur/0000-0002-2838-8401	National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health [U01DK058981, U01DK058982, U01DK058973, U01DK058985, U01DK058978, U01DK058968, U01DK058986, U01DK058966]; Boehringer Ingelheim Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK058978, U01DK058968, U01DK058986, U01DK058981, U01DK058973, U01DK058982, U01DK058966, U01DK058985] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (under cooperative agreements U01DK058981, U01DK058982, U01DK058973, U01DK058985, U01DK058978, U01DK058968, U01DK058986, and U01DK058966) and Boehringer Ingelheim Pharmaceuticals, which also provided the extended- release dipyridamole plus aspirin and matched placebo.	Allon M, 2007, CLIN J AM SOC NEPHRO, V2, P786, DOI 10.2215/CJN.00860207; CHESEBRO JH, 1984, NEW ENGL J MED, V310, P209, DOI 10.1056/NEJM198401263100401; Cinat ME, 1999, ANN VASC SURG, V13, P191, DOI 10.1007/s100169900241; Crowther MA, 2002, J AM SOC NEPHROL, V13, P2331, DOI 10.1097/01.ASN.0000027356.16598.99; Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164; DEPNER TA, 1995, ASAIO J, V41, pM745, DOI 10.1097/00002480-199507000-00112; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Dixon BS, 2005, CLIN TRIALS, V2, P400, DOI 10.1191/1740774505cn110oa; Dorffler-Melly J, 2005, COCHRANE DB SYST REV, V1; Dubey RK, 1998, HYPERTENSION, V31, P516, DOI 10.1161/01.HYP.31.1.516; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; FAXON DP, 1984, AM J CARDIOL, V53, pC72, DOI 10.1016/0002-9149(84)90751-3; Feldman HI, 1996, J AM SOC NEPHROL, V7, P523; Gibson KD, 2001, J VASC SURG, V34, P694, DOI 10.1067/mva.2001.117890; Gradzki R, 2001, AM J KIDNEY DIS, V38, P1240, DOI 10.1053/ajkd.2001.29220; Halkes PHA, 2006, LANCET, V367, P1665; HESS H, 1985, LANCET, V1, P415; Himmelfarb J, 2007, JAMA-J AM MED ASSOC, V297, P2630, DOI 10.1001/jama.297.23.2630; Hodges TC, 1997, J VASC SURG, V26, P1009, DOI 10.1016/S0741-5214(97)70014-4; INGERMANWOJENSKI CM, 1988, EXP MOL PATHOL, V48, P116, DOI 10.1016/0014-4800(88)90050-0; Kaufman JS, 2003, J AM SOC NEPHROL, V14, P2313, DOI 10.1097/01.ASN.0000081661.10246.33; Miller PE, 2000, AM J KIDNEY DIS, V36, P68, DOI 10.1053/ajkd.2000.8269; Reddan D, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022422.79790.A8; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Saran R, 2002, AM J KIDNEY DIS, V40, P1255, DOI 10.1053/ajkd.2002.36895; SINGH JP, 1994, J AM COLL CARDIOL, V23, P665, DOI 10.1016/0735-1097(94)90752-8; Spergel LM, 2007, J NEPHROL, V20, P288; SREEDHARA R, 1994, KIDNEY INT, V45, P1477, DOI 10.1038/ki.1994.192; The ESPRIT Study Group, 2007, LANCET, V369, P274; U.S. Renal Data System, 2006, 2006 ANN DAT REP ATL; *US REN DAT SYST, 2007, 2007 ANN DAT REP ATL; WANG SK, 1987, BIOMETRICS, V43, P193, DOI 10.2307/2531959; Woods JD, 1997, AM J KIDNEY DIS, V30, P50, DOI 10.1016/S0272-6386(97)90564-3; Xue JL, 2003, AM J KIDNEY DIS, V42, P1013, DOI 10.1016/j.ajkd.2003.07.004; Yevzlin AS, 2006, SEMIN DIALYSIS, V19, P535, DOI 10.1111/j.1525-139X.2006.00218.x	35	193	201	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2191	2201		10.1056/NEJMoa0805840	http://dx.doi.org/10.1056/NEJMoa0805840			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458364	Green Accepted			2022-12-28	WOS:000266206000006
J	Fairen, AG; Davila, AF; Gago-Duport, L; Amils, R; McKay, CP				Fairen, Alberto G.; Davila, Alfonso F.; Gago-Duport, Luis; Amils, Ricardo; McKay, Christopher P.			Stability against freezing of aqueous solutions on early Mars	NATURE			English	Article							CARBON-DIOXIDE CLOUDS; WATER; ATMOSPHERES; CLIMATE; EARTH	Many features of the Martian landscape are thought to have been formed by liquid water flow(1,2) and water-related mineralogies on the surface of Mars are widespread and abundant(3). Several lines of evidence, however, suggest that Mars has been cold with mean global temperatures well below the freezing point of pure water(4). Martian climate modellers(5,6) considering a combination of greenhouse gases at a range of partial pressures find it challenging to simulate global mean Martian surface temperatures above 273 K, and local thermal sources(7,8) cannot account for the widespread distribution of hydrated and evaporitic minerals throughout the Martian landscape(3). Solutes could depress the melting point of water(9,10) in a frozen Martian environment, providing a plausible solution to the early Mars climate paradox. Here we model the freezing and evaporation processes of Martian fluids with a composition resulting from the weathering of basalts, as reflected in the chemical compositions at Mars landing sites. Our results show that a significant fraction of weathering fluids loaded with Si, Fe, S, Mg, Ca, Cl, Na, K and Al remain in the liquid state at temperatures well below 273 K. We tested our model by analysing the mineralogies yielded by the evolution of the solutions: the resulting mineral assemblages are analogous to those actually identified on the Martian surface. This stability against freezing of Martian fluids can explain saline liquid water activity on the surface of Mars at mean global temperatures well below 273 K.	[Fairen, Alberto G.; Davila, Alfonso F.; McKay, Christopher P.] NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA; [Gago-Duport, Luis] Univ Vigo, Dept Geociencias Marinas, Vigo 36200, Spain; [Amils, Ricardo] CSIC INTA, Ctr Astrobiol, Madrid 28850, Spain; [Amils, Ricardo] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Fairen, AG (corresponding author), NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA.	alberto.g.fairen@nasa.gov	Davila, Alfonso/A-2198-2013; Gago-Duport, Luis/ABG-3623-2020; Amils, Ricardo/X-2706-2019	Davila, Alfonso/0000-0002-0977-9909; Gago-Duport, Luis/0000-0002-5536-2565; 	ORAU-NPP	ORAU-NPP	Work by A. G. F. and A. F. D. was supported by ORAU-NPP. We thank J. Kasting and J. Kargel for reviews that significantly improved the paper.	Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Chevrier V, 2007, NATURE, V448, P60, DOI 10.1038/nature05961; Colaprete A, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001967; Debye P, 1923, PHYS Z, V24, P185; Fairen AG, 2009, PLANET SPACE SCI, V57, P276, DOI 10.1016/j.pss.2008.11.008; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Gaidos E, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002000; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Griffith LL, 1997, J GEOPHYS RES-PLANET, V102, P9135, DOI 10.1029/96JE02939; Halevy I, 2007, SCIENCE, V318, P1903, DOI 10.1126/science.1147039; Johnson SS, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002962; Karunatillake S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002859; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Kasting JF, 1997, SCIENCE, V276, P1213, DOI 10.1126/science.276.5316.1213; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; Kuz'min R. O., 1998, Solar System Research, V32, P187; Marion GM, 2008, GEOCHIM COSMOCHIM AC, V72, P242, DOI 10.1016/j.gca.2007.10.012; Marion GM, 2008, ADV ASTROBIOL BIOGEO, P101; Osterloo MM, 2008, SCIENCE, V319, P1651, DOI 10.1126/science.1150690; PARKHURST DL, 1999, 994259 US GEOL RES I; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pitzer KS., 1995, THERMODYNAMICS; SAGAN C, 1973, SCIENCE, V181, P1045, DOI 10.1126/science.181.4104.1045; Segura TL, 2002, SCIENCE, V298, P1977, DOI 10.1126/science.1073586; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432	30	96	97	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					401	404		10.1038/nature07978	http://dx.doi.org/10.1038/nature07978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458717	Green Published			2022-12-28	WOS:000266243700040
J	Ho, MC; Menetret, JF; Tsuruta, H; Allen, KN				Ho, Meng-Chiao; Menetret, Jean-Francois; Tsuruta, Hiro; Allen, Karen N.			The origin of the electrostatic perturbation in acetoacetate decarboxylase	NATURE			English	Article							ACTIVE-SITE; ENZYMATIC DECARBOXYLATION; MECHANISM; SOFTWARE; LYSINE; RESOLUTION; SYSTEM; PK(A); MODEL	Acetoacetate decarboxylase (AADase) has long been cited as the prototypical example of the marked shifts in the pK(a) values of ionizable groups that can occur in an enzyme active site. In 1966, it was hypothesized that in AADase the origin of the large pK(a) perturbation (-4.5 log units) observed in the nucleophilic Lys 115 results from the proximity of Lys 116, marking the first proposal of microenvironment effects in enzymology. The electrostatic perturbation hypothesis has been demonstrated in a number of enzymes, but never for the enzyme that inspired its conception, owing to the lack of a three-dimensional structure. Here we present the X-ray crystal structures of AADase and of the enamine adduct with the substrate analogue 2,4-pentanedione. Surprisingly, the shift of the pK(a) of Lys 115 is not due to the proximity of Lys 116, the side chain of which is oriented away from the active site. Instead, Lys 116 participates in the structural anchoring of Lys 115 in a long, hydrophobic funnel provided by the novel fold of the enzyme. Thus, AADase perturbs the pK(a) of the nucleophile by means of a desolvation effect by placement of the side chain into the protein core while enforcing the proximity of polar residues, which facilitate decarboxylation through electrostatic and steric effects.	[Ho, Meng-Chiao; Menetret, Jean-Francois; Allen, Karen N.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Tsuruta, Hiro] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA	Boston University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Allen, KN (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	drkallen@bu.edu	Allen, Karen N./J-7045-2019; Ho, Meng-Chiao/H-2448-2015	Allen, Karen N./0000-0001-7296-0551; Ho, Meng-Chiao/0000-0002-5424-4524	National Science Foundation; Offices of Biological and Environmental Research (BER); Basic Energy Sciences (BES) of the US Department of Energy (DOE); National Center for Research Resources (NCRR) of the National Institutes of Health (NIH)	National Science Foundation(National Science Foundation (NSF)); Offices of Biological and Environmental Research (BER); Basic Energy Sciences (BES) of the US Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Research Resources (NCRR) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank A. Murzin for provisional classification of the AADase fold and C. Akey for valuable advice on the execution and interpretation of the electron microscopy work. We also thank H. Robinson and A. Soares for help with data collection. This work was supported by a grant to K. N. A. from the National Science Foundation. Data for this study were measured at Beamlines X12B, X25 and X29A of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research (BER) and of Basic Energy Sciences (BES) of the US Department of Energy (DOE), and from the National Center for Research Resources (NCRR) of the National Institutes of Health (NIH). Small-angle X-ray scattering analyses were carried out at the Stanford Synchrotron Radiation Lightsource, funded by DOE, BES. The SSRL Structural Molecular Biology Program is supported by DOE, BER, and by NIH, NCRR. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CROSBY J, 1970, J AM CHEM SOC, V92, P2891, DOI 10.1021/ja00712a048; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRIDOVICH I, 1968, J BIOL CHEM, V243, P1043; FRIDOVICH I, 1962, J AM CHEM SOC, V84, P3208, DOI 10.1021/ja00875a050; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GarciaMoreno B, 1997, BIOPHYS CHEM, V64, P211, DOI 10.1016/S0301-4622(96)02238-7; Gerlt JA, 2007, NATURE, V447, P543, DOI 10.1038/447543a; HAMILTON GA, 1959, J AM CHEM SOC, V81, P6332, DOI 10.1021/ja01532a058; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Highbarger LA, 1996, BIOCHEMISTRY-US, V35, P41, DOI 10.1021/bi9518306; KOKESH FC, 1971, J AM CHEM SOC, V93, P7270, DOI 10.1021/ja00755a025; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAURSEN RA, 1966, J AM CHEM SOC, V88, P3426, DOI 10.1021/ja00966a044; Lee JK, 1997, SCIENCE, V276, P942, DOI 10.1126/science.276.5314.942; Ludtke SJ, 2004, STRUCTURE, V12, P1129, DOI 10.1016/j.str.2004.05.006; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; O'Leary M. H., 1992, MECH CATALYSIS, P239; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; RASHIN AA, 1985, J PHYS CHEM-US, V89, P5588, DOI 10.1021/j100272a006; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; STITES WE, 1991, J MOL BIOL, V221, P7, DOI 10.1016/0022-2836(91)80195-Z; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1997, PROTEINS, V27, P110; TAGAKI W, 1968, BIOCHEMISTRY-US, V7, P891, DOI 10.1021/bi00843a001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tjioe E, 2007, J APPL CRYSTALLOGR, V40, P782, DOI 10.1107/S002188980702420X; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; WARREN S, 1966, BIOCHEMISTRY-US, V5, P817, DOI 10.1021/bi00867a002; WESTHEIMER FH, 1995, TETRAHEDRON, V51, P3, DOI 10.1016/0040-4020(94)00865-R; WIESENBORN DP, 1988, APPL ENVIRON MICROB, V54, P2717, DOI 10.1128/AEM.54.11.2717-2722.1988	39	78	81	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					393	U107		10.1038/nature07938	http://dx.doi.org/10.1038/nature07938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458715				2022-12-28	WOS:000266243700038
J	Kodama, S; Saito, K; Tanaka, S; Maki, M; Yachi, Y; Asumi, M; Sugawara, A; Totsuka, K; Shimano, H; Ohashi, Y; Yamada, N; Sone, H				Kodama, Satoru; Saito, Kazumi; Tanaka, Shiro; Maki, Miho; Yachi, Yoko; Asumi, Mihoko; Sugawara, Ayumi; Totsuka, Kumiko; Shimano, Hitoshi; Ohashi, Yasuo; Yamada, Nobuhiro; Sone, Hirohito			Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; PHYSICAL-FITNESS; FOLLOW-UP; EXERCISE CAPACITY; MYOCARDIAL-INFARCTION; ASYMPTOMATIC WOMEN; CARE PROFESSIONALS; METABOLIC SYNDROME; PROGNOSTIC VALUE; RISK-EVALUATION	Context Epidemiological studies have indicated an inverse association between cardiorespiratory fitness (CRF) and coronary heart disease (CHD) or all-cause mortality in healthy participants. Objective To define quantitative relationships between CRF and CHD events, cardiovascular disease (CVD) events, or all-cause mortality in healthy men and women. Data Sources and Study Selection A systematic literature search was conducted for observational cohort studies using MEDLINE (1966 to December 31, 2008) and EMBASE (1980 to December 31, 2008). The Medical Subject Headings search terms used included exercise tolerance, exercise test, exercise/physiology, physical fitness, oxygen consumption, cardiovascular diseases, myocardial ischemia, mortality, mortalities, death, fatality, fatal, incidence, or morbidity. Studies reporting associations of baseline CRF with CHD events, CVD events, or all-cause mortality in healthy participants were included. Data Extraction Two authors independently extracted relevant data. CRF was estimated as maximal aerobic capacity (MAC) expressed in metabolic equivalent (MET) units. Participants were categorized as low CRF (<7.9 METs), intermediate CRF (7.9-10.8 METs), or high CRF (>= 10.9 METs). CHD and CVD were combined into 1 outcome (CHD/CVD). Risk ratios (RRs) for a 1-MET higher level of MAC and for participants with lower vs higher CRF were calculated with a random-effects model. Data Synthesis Data were obtained from 33 eligible studies (all-cause mortality, 102 980 participants and 6910 cases; CHD/CVD, 84 323 participants and 4485 cases). Pooled RRs of all-cause mortality and CHD/CVD events per 1-MET higher level of MAC (corresponding to 1-km/h higher running/jogging speed) were 0.87 (95% confidence interval [CI], 0.84-0.90) and 0.85 (95% CI, 0.82-0.88), respectively. Compared with participants with high CRF, those with low CRF had an RR for all-cause mortality of 1.70 (95% CI, 1.51-1.92; P < .001) and for CHD/CVD events of 1.56 (95% CI, 1.39-1.75; P < .001), adjusting for heterogeneity of study design. Compared with participants with intermediate CRF, those with low CRF had an RR for all-cause mortality of 1.40 (95% CI, 1.32-1.48; P < .001) and for CHD/CVD events of 1.47 (95% CI, 1.35-1.61; P < .001), adjusting for heterogeneity of study design. Conclusions Better CRF was associated with lower risk of all-cause mortality and CHD/CVD. Participants with a MAC of 7.9 METs or more had substantially lower rates of all-cause mortality and CHD/CVD events compared with those with aMAC of less 7.9 METs.	[Kodama, Satoru; Saito, Kazumi; Maki, Miho; Yachi, Yoko; Asumi, Mihoko; Sugawara, Ayumi; Totsuka, Kumiko; Shimano, Hitoshi; Yamada, Nobuhiro; Sone, Hirohito] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Mito, Ibaraki 3100015, Japan; [Tanaka, Shiro] Kyoto Univ Hosp, Dept Clin Trial Design & Management, Translat Res Ctr, Kyoto 606, Japan; [Ohashi, Yasuo] Univ Tokyo, Dept Biostat Epidemiol & Prevent Hlth Sci, Tokyo, Japan	University of Tsukuba; Kyoto University; University of Tokyo	Sone, H (corresponding author), Univ Tsukuba, Inst Clin Med, Dept Internal Med, 3-2-7 Miya Machi, Mito, Ibaraki 3100015, Japan.	hsone@md.tsukuba.ac.jp	Sone, Hirohito/ABC-9346-2021; Shimano, Hitoshi/AAI-5648-2020; 田中, 司朗/GON-6916-2022; Shimano, Hitoshi/V-1761-2019	Sone, Hirohito/0000-0003-1263-2817; 田中, 司朗/0000-0001-6817-5235; Shimano, Hitoshi/0000-0002-5562-5572	Japan Society for the Promotion of Science (JSPS); Ministry of Health, Labor and Welfare, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Drs Kodama and Sone are recipients of a Grant-in-Aid for Scientific Research and Postdoctoral Research Fellowship, respectively, both from the Japan Society for the Promotion of Science (JSPS). This study was also supported by Ministry of Health, Labor and Welfare, Japan.	Aijaz B, 2008, AM HEART J, V156, P783, DOI 10.1016/j.ahj.2008.05.026; Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; ALLEN WH, 1980, CIRCULATION, V62, P522, DOI 10.1161/01.CIR.62.3.522; *AM COLL SPORTS ME, 2000, GUID EX TEST PRESCR, P25; American College of Sports Medicine, 2007, ACSMS HLTH REL PHYS; American College of Sports Medicine, 2006, ACSMS MET CALC HDB; [Anonymous], 1972, EX TEST TRAIN APP HL; ARRAIZ GA, 1992, J CLIN EPIDEMIOL, V45, P419, DOI 10.1016/0895-4356(92)90043-M; Balady GJ, 2004, CIRCULATION, V110, P1920, DOI 10.1161/01.CIR.0000143226.40607.71; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borodulin K, 2005, EUR J CARDIOV PREV R, V12, P126, DOI 10.1097/00149831-200504000-00006; BRUCE RA, 1980, AM J CARDIOL, V46, P371, DOI 10.1016/0002-9149(80)90003-X; CONWAY TL, 1992, PREV MED, V21, P723, DOI 10.1016/0091-7435(92)90079-W; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; CUMMING GR, 1975, CAN MED ASSOC J, V112, P578; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5; Erikssen G, 2004, EUR HEART J, V25, P978, DOI 10.1016/j.ehj.2004.04.009; Farrell SW, 2004, OBES RES, V12, P824, DOI 10.1038/oby.2004.99; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; Gulati M, 2005, AM J CARDIOL, V96, P369, DOI 10.1016/j.amjcard.2005.03.078; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; GYNTELBERG F, 1980, SCAND J WORK ENV HEA, V6, P170, DOI 10.5271/sjweh.2619; HEIN HO, 1992, J INTERN MED, V232, P471, DOI 10.1111/j.1365-2796.1992.tb00619.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; JETTE M, 1976, CAN MED ASSOC J, V114, P680; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Kampert JB, 1996, ANN EPIDEMIOL, V6, P452, DOI 10.1016/S1047-2797(96)00059-2; Katzmarzyk PT, 2005, DIABETES CARE, V28, P391, DOI 10.2337/diacare.28.2.391; Laukkanen JA, 2007, J INTERN MED, V262, P263, DOI 10.1111/j.1365-2796.2007.01807.x; Laukkanen JA, 2008, EUR J CARDIOV PREV R, V15, P285, DOI 10.1097/HJR.0b013e3282f37a33; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Miller GJ, 2005, INT J EPIDEMIOL, V34, P1387, DOI 10.1093/ije/dyi193; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Noonan V, 2000, PHYS THER, V80, P782, DOI 10.1093/ptj/80.8.782; PETERS RK, 1983, JAMA-J AM MED ASSOC, V249, P3052, DOI 10.1001/jama.249.22.3052; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rywik TM, 2002, CIRCULATION, V106, P2787, DOI 10.1161/01.CIR.0000039329.47437.3B; Sanders LF, 2006, MED SCI SPORT EXER, V38, P701, DOI 10.1249/01.mss.0000210193.49210.b5; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; Sawada S, 1999, Nihon Koshu Eisei Zasshi, V46, P113; SLATTERY ML, 1988, AM J EPIDEMIOL, V127, P571, DOI 10.1093/oxfordjournals.aje.a114832; SOBOLSKI J, 1987, AM J EPIDEMIOL, V125, P601, DOI 10.1093/oxfordjournals.aje.a114573; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stevens J, 2004, INT J OBESITY, V28, P1463, DOI 10.1038/sj.ijo.0802770; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sui XM, 2007, AM J EPIDEMIOL, V165, P1413, DOI 10.1093/aje/kwm031; SWAIN DP, 1994, MED SCI SPORT EXER, V26, P112; Talbot LA, 2002, AM J CARDIOL, V89, P1187, DOI 10.1016/S0002-9149(02)02302-0; Villeneuve PJ, 1998, EPIDEMIOLOGY, V9, P626, DOI 10.1097/00001648-199811000-00011; Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wilson TM, 2000, AM J PHYSIOL-HEART C, V278, pH829, DOI 10.1152/ajpheart.2000.278.3.H829	66	1863	1923	4	167	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					2024	2035		10.1001/jama.2009.681	http://dx.doi.org/10.1001/jama.2009.681			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454641				2022-12-28	WOS:000266159600027
J	Cole, DG; Snell, WJ				Cole, Douglas G.; Snell, William J.			SnapShot: Intraflagellar Transport	CELL			English	Editorial Material							CAENORHABDITIS-ELEGANS; CHLAMYDOMONAS; IFT		[Cole, Douglas G.] Univ Idaho, Moscow, ID 83843 USA; [Snell, William J.] UT SW Med Ctr, Dallas, TX USA	Idaho; University of Idaho; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cole, DG (corresponding author), Univ Idaho, Moscow, ID 83843 USA.				NIGMS NIH HHS [R01 GM025661] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025661] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Harris E.H., 2009, CHLAMYDOMONAS SOURCE, V1; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044	10	52	58	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 15	2009	137	4					784	U202		10.1016/j.cell.2009.04.053	http://dx.doi.org/10.1016/j.cell.2009.04.053			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450523	Bronze			2022-12-28	WOS:000266114100025
J	Moser, M; Legate, KR; Zent, R; Fassler, R				Moser, Markus; Legate, Kyle R.; Zent, Roy; Faessler, Reinhard			The Tail of Integrins, Talin, and Kindlins	SCIENCE			English	Review							BETA(3) CYTOPLASMIC DOMAIN; GLYCOPROTEIN-IIB-IIIA; CELL-MATRIX ADHESION; BINDING-LIKE DOMAIN; STRUCTURAL BASIS; PLATELET-AGGREGATION; I/LWEQ MODULE; TRANSMEMBRANE SEGMENT; LEUKOCYTE ADHESION; FOCAL ADHESIONS	Integrins are transmembrane cell-adhesion molecules that carry signals from the outside to the inside of the cell and vice versa. Like other cell surface receptors, integrins signal in response to ligand binding; however, events within the cell can also regulate the affinity of integrins for ligands. This feature is important in physiological situations such as those in blood, in which cells are always in close proximity to their ligands, yet cell-ligand interactions occur only after integrin activation in response to specific external cues. This review focuses on the mechanisms whereby two key proteins, talin and the kindlins, regulate integrin activation by binding the tails of integrin-beta subunits.	[Moser, Markus; Legate, Kyle R.; Faessler, Reinhard] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Zent, Roy] Vanderbilt Univ Sch Med, Dept Med, Dept Nephrol, Nashville, TN 37232 USA; [Zent, Roy] Vet Affairs Hosp, Nashville, TN 37232 USA	Max Planck Society; Vanderbilt University	Moser, M (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.			Legate, Kyle/0000-0003-3243-579X	Marie Curie Incoming International Fellowship; Merit Award from the Department of Veterans Affairs [DK65138, DK 69921, DK075594]; Deutsche Forschungsgemeinschaft; Max Planck Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065138, R01DK075594, R01DK069921] Funding Source: NIH RePORTER	Marie Curie Incoming International Fellowship(European Commission); Merit Award from the Department of Veterans Affairs(US Department of Veterans Affairs); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Ginsberg, M. Costell, and S. Wickstrom for reading and commenting on the manuscript and M. Iglesias for artwork. We apologize to all whose papers have not been cited because of space constraints. K.R.L. is the recipient of a Marie Curie Incoming International Fellowship under the 6th Framework Programme. R.Z. is funded by a Merit Award from the Department of Veterans Affairs, DK65138, DK 69921, DK075594, and is an Established Investigator of the American Heart Association. M.M. and R.F. are supported by the Deutsche Forschungsgemeinschaft and the Max Planck Society.	Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Franco SJ, 2006, CELL MOTIL CYTOSKEL, V63, P563, DOI 10.1002/cm.20145; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Herz C, 2006, J BIOL CHEM, V281, P36082, DOI 10.1074/jbc.M606259200; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; KUIJPERS TW, 2008, BLOOD           1208; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; McCleverty CJ, 2007, PROTEIN SCI, V16, P1223, DOI 10.1110/ps.072798707; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Sakai T, 2001, P NATL ACAD SCI USA, V98, P3808, DOI 10.1073/pnas.240456398; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200	75	556	573	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					895	899		10.1126/science.1163865	http://dx.doi.org/10.1126/science.1163865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443776				2022-12-28	WOS:000266048800026
J	Powner, MW; Gerland, B; Sutherland, JD				Powner, Matthew W.; Gerland, Beatrice; Sutherland, John D.			Synthesis of activated pyrimidine ribonucleotides in prebiotically plausible conditions	NATURE			English	Article							NUCLEOSIDES; RNA; PHOSPHORYLATION; PHOSPHORUS; CHEMISTRY; PHOSPHATE; EVOLUTION; MINERALS; CYTIDINE; ORIGIN	At some stage in the origin of life, an informational polymer must have arisen by purely chemical means. According to one version of the 'RNA world' hypothesis(1-3) this polymer was RNA, but attempts to provide experimental support for this have failed(4,5). In particular, although there has been some success demonstrating that 'activated' ribonucleotides can polymerize to form RNA(6,7), it is far from obvious how such ribonucleotides could have formed from their constituent parts ( ribose and nucleobases). Ribose is difficult to form selectively(8,9), and the addition of nucleobases to ribose is inefficient in the case of purines(10) and does not occur at all in the case of the canonical pyrimidines(11). Here we show that activated pyrimidine ribonucleotides can be formed in a short sequence that bypasses free ribose and the nucleobases, and instead proceeds through arabinose amino-oxazoline and anhydronucleoside intermediates. The starting materials for the synthesis-cyanamide, cyanoacetylene, glycolaldehyde, glyceraldehyde and inorganic phosphate-are plausible prebiotic feedstock molecules(12-15), and the conditions of the synthesis are consistent with potential early-Earth geochemical models. Although inorganic phosphate is only incorporated into the nucleotides at a late stage of the sequence, its presence from the start is essential as it controls three reactions in the earlier stages by acting as a general acid/base catalyst, a nucleophilic catalyst, a pH buffer and a chemical buffer. For prebiotic reaction sequences, our results highlight the importance of working with mixed chemical systems in which reactants for a particular reaction step can also control other steps.	[Powner, Matthew W.; Gerland, Beatrice; Sutherland, John D.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England	University of Manchester	Sutherland, JD (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	john.sutherland@manchester.ac.uk		Powner, Matthew/0000-0002-6368-3190	UK Engineering and Physical Sciences Research Council; EPSRC [EP/D05592X/1, EP/E032753/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E032753/1, EP/D05592X/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been funded by the UK Engineering and Physical Sciences Research Council through the provision of a postdoctoral fellowship ( B. G.) and a PhD studentship ( M. W. P.). We thank J. Raftery and M. Helliwell for X-ray crystallography.	Anastasi C, 2007, CHEM BIODIVERS, V4, P721, DOI 10.1002/cbdv.200790060; Anastasi C, 2006, ANGEW CHEM INT EDIT, V45, P6176, DOI 10.1002/anie.200601267; Bryant DE, 2006, CHEM COMMUN, P2344, DOI 10.1039/b602651f; COCKERILL AF, 1976, SYNTHESIS-STUTTGART, P591; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; ESCHENMOSER A, 1992, CHEM SOC REV, V21, P1, DOI 10.1039/cs9922100001; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; FERRIS JP, 1970, J AM CHEM SOC, V92, P6598, DOI 10.1021/ja00725a036; FULLER WD, 1972, J MOL BIOL, V67, P25, DOI 10.1016/0022-2836(72)90383-X; Joyce GF, 2006, COLD SPRING HARB MON, V43, P23; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kofoed J, 2005, ORG BIOMOL CHEM, V3, P1850, DOI 10.1039/b501512j; LOHRMANN R, 1968, SCIENCE, V161, P64, DOI 10.1126/science.161.3836.64; LOHRMANN R, 1971, SCIENCE, V171, P490, DOI 10.1126/science.171.3970.490; MILLER N, 1968, P NATL ACAD SCI USA, V59, P34, DOI 10.1073/pnas.59.1.34; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Pasek MA, 2005, ASTROBIOLOGY, V5, P515, DOI 10.1089/ast.2005.5.515; Powner MW, 2007, CHEMBIOCHEM, V8, P1170, DOI 10.1002/cbic.200700098; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; ROBERTSON MP, 1995, NATURE, V375, P772, DOI 10.1038/375772a0; SANCHEZ R A, 1970, Journal of Molecular Biology, V47, P531, DOI 10.1016/0022-2836(70)90320-7; SANCHEZ RA, 1966, SCIENCE, V154, P784, DOI 10.1126/science.154.3750.784; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; SHANNAHOFF DH, 1973, J ORG CHEM, V38, P593, DOI 10.1021/jo00943a040; Springsteen G, 2004, J AM CHEM SOC, V126, P9578, DOI 10.1021/ja0483692; TAPIERO CM, 1971, NATURE, V231, P42, DOI 10.1038/231042a0; Thaddeus P, 2006, PHILOS T R SOC B, V361, P1681, DOI 10.1098/rstb.2006.1897; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098; Woese C, 1967, GENETIC CODE, P179	30	789	811	15	408	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					239	242		10.1038/nature08013	http://dx.doi.org/10.1038/nature08013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	445FR	19444213				2022-12-28	WOS:000266036100038
J	Bjorndal, A				Bjorndal, Arild			Improving social policy and practice: knowledge matters	LANCET			English	Editorial Material									Univ Oslo, Norwegian Knowledge Ctr Hlth Serv, Inst Gen Practice & Community Med, N-0130 Oslo, Norway	Norwegian Knowledge Centre for Health Services; University of Oslo	Bjorndal, A (corresponding author), Univ Oslo, Norwegian Knowledge Ctr Hlth Serv, Inst Gen Practice & Community Med, N-0130 Oslo, Norway.	arb@nokc.no						*C UN MEX STAT, 2004, GEN LAW SOC DEV TITL; CAMPBELL DT, 1969, AM PSYCHOL, V24, P409, DOI 10.1037/h0027982; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Miech RA, 2009, AM J PREV MED, V36, P126, DOI 10.1016/j.amepre.2008.09.041; NOONAN E, 2009, BETTER EVIDENCE BETT; PEAR R, 2009, NY TIMES        0215; PETROSINO A, 2004, CAMPBELL SYST REV, V2; WEISBURD D, POLICE SCI IN PRESS; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P1166, DOI 10.1001/jama.2009.320	10	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2009	373	9678					1829	1831		10.1016/S0140-6736(09)60783-2	http://dx.doi.org/10.1016/S0140-6736(09)60783-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19446328				2022-12-28	WOS:000266616400009
J	Dabelea, D				Dabelea, Dana			The accelerating epidemic of childhood diabetes	LANCET			English	Editorial Material							TRENDS; YOUTH; MELLITUS; SEARCH		Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Denver, CO 80045 USA	Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Dabelea, D (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Denver, CO 80045 USA.	Dana.Dabelea@ucdenver.edu						Bell RA, 2009, DIABETES CARE, V32, pS102, DOI 10.2337/dc09-S202; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; GREEN A, 2008, EPIDEMIOLOGY PEDIAT, P35; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Milton B, 2006, DIABETIC MED, V23, P821, DOI 10.1111/j.1464-5491.2006.01796.x; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Rewers A, 2008, PEDIATRICS, V121, pE1258, DOI 10.1542/peds.2007-1105; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; Vehik K, 2007, DIABETES CARE, V30, P503, DOI 10.2337/dc06-1837	12	106	115	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					1999	2000		10.1016/S0140-6736(09)60874-6	http://dx.doi.org/10.1016/S0140-6736(09)60874-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19481250				2022-12-28	WOS:000267080100004
J	Gu, LC; Wang, B; Kulkarni, A; Geders, TW; Grindberg, RV; Gerwick, L; Hakansson, K; Wipf, P; Smith, JL; Gerwick, WH; Sherman, DH				Gu, Liangcai; Wang, Bo; Kulkarni, Amol; Geders, Todd W.; Grindberg, Rashel V.; Gerwick, Lena; Hakansson, Kristina; Wipf, Peter; Smith, Janet L.; Gerwick, William H.; Sherman, David H.			Metamorphic enzyme assembly in polyketide diversification	NATURE			English	Article							CYANOBACTERIUM LYNGBYA-MAJUSCULA; BIOSYNTHETIC GENE-CLUSTER; PEPTIDE SYNTHETASE; BARBAMIDE BIOSYNTHESIS; BACTERIAL SYMBIONT; MASS-SPECTROMETRY; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; NATURAL-PRODUCT; CURACIN-A	Natural product chemical diversity is fuelled by the emergence and ongoing evolution of biosynthetic pathways in secondary metabolism(1). However, co-evolution of enzymes for metabolic diversification is not well understood, especially at the biochemical level. Here, two parallel assemblies with an extraordinarily high sequence identity from Lyngbya majuscula forma beta-branched cyclopropane in the curacin A pathway (Cur), and a vinyl chloride group in the jamaicamide pathway (Jam). The components include a halogenase, a 3-hydroxy-3-methylglutaryl enzyme cassette for polyketide beta-branching, and an enoyl reductase domain. The halogenase from CurA, and the dehydratases (ECH(1)s), decarboxylases (ECH(2)s) and enoyl reductase domains from both Cur and Jam, were assessed biochemically to determine the mechanisms of cyclopropane and vinyl chloride formation. Unexpectedly, the polyketide beta-branching pathway was modified by introduction of a gamma-chlorination step on (S)-3-hydroxy-3-methylglutaryl mediated by Cur halogenase, a non-haem Fe(II), alpha-ketoglutarate-dependent enzyme(2). In a divergent scheme, Cur ECH2 was found to catalyse formation of the alpha,beta enoyl thioester, whereas Jam ECH2 formed a vinyl chloride moiety by selectively generating the corresponding beta, gamma enoyl thioester of the 3-methyl-4-chloroglutaconyl decarboxylation product. Finally, the enoyl reductase domain of CurF specifically catalysed an unprecedented cyclopropanation on the chlorinated product of Cur ECH2 instead of the canonical alpha,beta C=C saturation reaction. Thus, the combination of chlorination and polyketide beta-branching, coupled with mechanistic diversification of ECH2 and enoyl reductase, leads to the formation of cyclopropane and vinyl chloride moieties. These results reveal a parallel interplay of evolutionary events in multienzyme systems leading to functional group diversity in secondary metabolites.	[Gu, Liangcai; Geders, Todd W.; Smith, Janet L.; Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gu, Liangcai; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Wang, Bo; Hakansson, Kristina; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Kulkarni, Amol; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Kulkarni, Amol; Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA 15260 USA; [Grindberg, Rashel V.; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Grindberg, Rashel V.; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Sherman, DH (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	davidhs@umich.edu	Hakansson, Kristina/G-9428-2016; Gu, Liangcai/E-4600-2010; Gu, Liangcai/U-6908-2019; Wipf, Peter/AAG-1771-2021	Hakansson, Kristina/0000-0003-1926-0542; Wipf, Peter/0000-0001-7693-5863	National Institutes of Health; Eli Lilly Co.; Rackham Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly Co.(Eli Lilly); Rackham Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. T. Walsh and C. T. Calderone for ACP constructs; S. M. Chernyak, H. Liu and J. Byun for mass spectrometry assistance; P. C. Lopez for NMR assistance; T. M. Ramsey for chiral cyclopronanecarboxylic acid; and D. L. Akey for discussions. This work was supported by grants from the National Institutes of Health ( to D. H. S. and J. L. S.), a graduate fellowship from Eli Lilly & Co. and a Rackham Predoctoral Fellowship ( to L. G.).	Austin MB, 2008, NAT CHEM BIOL, V4, P217, DOI 10.1038/nchembio0408-217; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Calderone CT, 2007, CHEM BIOL, V14, P835, DOI 10.1016/j.chembiol.2007.06.008; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Fischbach MA, 2007, NAT CHEM BIOL, V3, P353, DOI 10.1038/nchembio0707-353; Flatt PM, 2006, J NAT PROD, V69, P938, DOI 10.1021/np050523q; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Geders TW, 2007, J BIOL CHEM, V282, P35954, DOI 10.1074/jbc.M703921200; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Kelly WL, 2007, BIOCHEMISTRY-US, V46, P359, DOI 10.1021/bi061930j; KOPKA J, 1995, ANAL BIOCHEM, V224, P51, DOI 10.1006/abio.1995.1007; Neumann CS, 2008, J AM CHEM SOC, V130, P14022, DOI 10.1021/ja8064667; Nordling E, 2002, EUR J BIOCHEM, V269, P4267, DOI 10.1046/j.1432-1033.2002.03114.x; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Pulsawat N, 2007, GENE, V393, P31, DOI 10.1016/j.gene.2006.12.035; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Verdier-Pinard P, 1998, MOL PHARMACOL, V53, P62, DOI 10.1124/mol.53.1.62	29	137	142	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					731	735		10.1038/nature07870	http://dx.doi.org/10.1038/nature07870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494914	Green Accepted			2022-12-28	WOS:000266608600050
J	Cook, NR; Ridker, PM				Cook, Nancy R.; Ridker, Paul M.			Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures	ANNALS OF INTERNAL MEDICINE			English	Article							PENCINA,M.J. ET-AL.; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; ROC CURVE; AREA; ABILITY; MARKER; VALIDATION; SCORE; AGE	Models for risk prediction are widely used in clinical practice to stratify risk and assign treatment strategies. The contribution of new biomarkers has largely been based on the area under the receiver-operating characteristic curve, but this measure can be insensitive to important changes in absolute risk. Methods based on risk stratification have recently been proposed to compare predictive models. Such methods include the reclassification calibration statistic, the net reclassification improvement, and the integrated discrimination improvement. This article demonstrates the use of reclassification measures and illustrates their performance for well-known cardiovascular risk predictors in a cohort of women. These measures are targeted at evaluating the potential of new models and markers to change risk strata and alter treatment decisions.	[Cook, Nancy R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent,Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cook, NR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent,Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	ncook@rics.bwh.harvard.edu			National Heart, Lung, and Blood Institute; National Cancer Institute [HL-43851, CA-47988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Donald W. Reynolds Foundation (Dr. Ridker), and the Leducq Foundation (Dr. Ridker). The overall Women's Health Study is supported by grants from the National Heart, Lung, and Blood Institute and the National Cancer Institute (HL-43851 and CA-47988).	BAKER SG, 2009, J R STAT A IN PRESS; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland S, 2008, STAT MED, V27, P199, DOI 10.1002/sim.2995; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Holme I, 2008, J INTERN MED, V264, P30, DOI 10.1111/j.1365-2796.2008.01925.x; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2008, STAT MED, V27, P173, DOI 10.1002/sim.2991; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rietbrock S, 2008, AM HEART J, V156, P57, DOI 10.1016/j.ahj.2008.03.010; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198	27	384	388	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					795	W143		10.7326/0003-4819-150-11-200906020-00007	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487714	Green Accepted			2022-12-28	WOS:000266530000006
J	Krum, H				Krum, Henry			Change page Consider beta blockers for patients with heart failure	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADRENERGIC-BLOCKADE; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; CARVEDILOL; TOLERABILITY; MORTALITY; XL		Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Monash University	Krum, H (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu.au						Colucci WS, 2007, CIRCULATION, V116, P49, DOI 10.1161/CIRCULATIONAHA.106.666016; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Franciosa JA, 2004, AM HEART J, V148, P718, DOI 10.1016/j.ahj.2004.04.006; Hjalmarson A, 1999, LANCET, V353, P2001; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Krum H, 2000, HEART, V84, P615, DOI 10.1136/heart.84.6.615; Krum H, 2006, EUR J HEART FAIL, V8, P302, DOI 10.1016/j.ejheart.2005.08.002; Krum H, 2006, MED J AUSTRALIA, V185, P549, DOI 10.5694/j.1326-5377.2006.tb00690.x; Lechat P, 1999, LANCET, V353, P9; Lenzen MJ, 2005, EUR HEART J, V26, P2706, DOI 10.1093/eurheartj/ehi499; Maggioni AP, 2003, HEART, V89, P299, DOI 10.1136/heart.89.3.299; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; SACKNERBERNSTEIN JD, 1995, JAMA-J AM MED ASSOC, V274, P1462, DOI 10.1001/jama.274.18.1462	15	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2009	338								b1728	10.1136/bmj.b1728	http://dx.doi.org/10.1136/bmj.b1728			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AA	19487328				2022-12-28	WOS:000266725700001
J	Saikrishnan, K; Powell, B; Cook, NJ; Webb, MR; Wigley, DB				Saikrishnan, Kayarat; Powell, Benjamin; Cook, Nicola J.; Webb, Martin R.; Wigley, Dale B.			Mechanistic Basis of 5 '-3 ' Translocation in SF1B Helicases	CELL			English	Article							SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURES; PCRA HELICASE; SH3 DOMAINS; INORGANIC-PHOSPHATE; STRUCTURAL BASIS; RNA HELICASE; PROTEIN; GENE; REVEALS	Superfamily 1B (SF1B) helicases translocate in a 5'-3' direction and are required for a range of cellular activities across all domains of life. However, structural analyses to date have focused on how SF1A helicases achieve 3'-5' movement along nucleic acids. We present crystal structures of the complex between the SF1B helicase RecD2 from Deinococcus radiodurans and ssDNA in the presence and absence of an ATP analog. These snapshots of the reaction pathway reveal a nucleotide binding-induced conformational change of the two motor domains that is broadly reminiscent of changes observed in other SF1 and SF2 helicases. Together with biochemical data, the structures point to a step size for translocation of one base per ATP hydrolyzed. Moreover, the structures also reveal a mechanism for nucleic acid translocation in the 5'-3' direction by SF1B helicases that is surprisingly different from that of 3'-5' translocation by SF1A enzymes, and explains the molecular basis of directionality.	[Saikrishnan, Kayarat; Cook, Nicola J.; Wigley, Dale B.] London Res Inst, Clare Hall Labs, Canc Res UK, Potters Bar EN6 3LD, Herts, England; [Powell, Benjamin; Webb, Martin R.] Natl Inst Med Res, MRC, London NW7 1AA, England	Cancer Research UK; MRC National Institute for Medical Research	Wigley, DB (corresponding author), London Res Inst, Clare Hall Labs, Canc Res UK, Blanche Lane, Potters Bar EN6 3LD, Herts, England.	dale.wigley@cancer.org.uk		Webb, Martin/0000-0002-0134-9621	Cancer Research UK; Medical Research Council; Medical Research Council [MC_U117512742] Funding Source: researchfish; MRC [MC_U117512742] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank EMBO for a fellowship ( K. S.) and J. Yeeles for the gift of E. coli SSB. The work was funded by Cancer Research UK ( D. B. W.) and the Medical Research Council ( B. P. and M. R. W.).	ABDELMONEM M, 1983, P NATL ACAD SCI-BIOL, V80, P4659, DOI 10.1073/pnas.80.15.4659; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; KRELL H, 1979, EUR J BIOCHEM, V93, P387, DOI 10.1111/j.1432-1033.1979.tb12835.x; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Martinez-Senac MM, 2005, BIOCHEMISTRY-US, V44, P16967, DOI 10.1021/bi0512851; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; SAHA A, 2006, EMBO J, V27, P2222; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Servinsky MD, 2007, J BACTERIOL, V189, P5101, DOI 10.1128/JB.00409-07; Seybert A, 2000, J VIROL, V74, P9586, DOI 10.1128/JVI.74.20.9586-9593.2000; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Sistla S, 2004, CRIT REV BIOCHEM MOL, V39, P1, DOI 10.1080/10409230490440532; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang JL, 2004, J BIOL CHEM, V279, P52024, DOI 10.1074/jbc.M408645200; Webb Martin R., 2003, P131; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zarrinpar A., 2003, SCI STKE, V2003, DOI [10.1126/stke.2003.179.re8, DOI 10.1126/STKE.2003.179.RE8]	57	99	103	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					849	859		10.1016/j.cell.2009.03.036	http://dx.doi.org/10.1016/j.cell.2009.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490894	Bronze			2022-12-28	WOS:000266454800016
J	Vinces, MD; Legendre, M; Caldara, M; Hagihara, M; Verstrepen, KJ				Vinces, Marcelo D.; Legendre, Matthieu; Caldara, Marina; Hagihara, Masaki; Verstrepen, Kevin J.			Unstable Tandem Repeats in Promoters Confer Transcriptional Evolvability	SCIENCE			English	Article							GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; NUCLEOSOME POSITIONS; GENOME; VARIABILITY; EVOLUTION; YEAST	Relative to most regions of the genome, tandemly repeated DNA sequences display a greater propensity to mutate. A search for tandem repeats in the Saccharomyces cerevisiae genome revealed that the nucleosome-free region directly upstream of genes (the promoter region) is enriched in repeats. As many as 25% of all gene promoters contain tandem repeat sequences. Genes driven by these repeat-containing promoters show significantly higher rates of transcriptional divergence. Variations in repeat length result in changes in expression and local nucleosome positioning. Tandem repeats are variable elements in promoters that may facilitate evolutionary tuning of gene expression by affecting local chromatin structure.	[Vinces, Marcelo D.; Legendre, Matthieu; Caldara, Marina; Verstrepen, Kevin J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Vinces, Marcelo D.; Verstrepen, Kevin J.] Katholieke Univ Leuven, Flanders Inst Biotechnol VIB, Lab Syst Biol, B-3001 Heverlee, Belgium; [Vinces, Marcelo D.; Verstrepen, Kevin J.] Katholieke Univ Leuven, CMPG, Genet & Genom Grp, B-3001 Heverlee, Belgium; [Legendre, Matthieu] Univ Mediterranee Parc Sci Luminy, CNRS, UPR 2589, Struct & Genom Informat Lab,IFR 88, FR-13288 Marseille, France; [Hagihara, Masaki] Osaka Univ, Inst Sci & Ind Res, Ibaraki 5670047, Japan	Harvard University; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Osaka University	Verstrepen, KJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, 52 Oxford St, Cambridge, MA 02138 USA.	Kevin.Verstrepen@biw.vib-kuleuven.be	Verstrepen, Kevin/AAA-4343-2021	Verstrepen, Kevin/0000-0002-3077-6219; Legendre, Matthieu/0000-0002-8413-2910	NIH National Institute for General Medical Studies [P50GM068763]; Human Frontier Science Program (HFSP) award [RGY79/2007]; Flemish Institute for Biotechnology (VIB); Fonds Wetenschappelijk Onderzoek Vlaanderen Odysseus program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIH National Institute for General Medical Studies; Human Frontier Science Program (HFSP) award(Human Frontier Science Program); Flemish Institute for Biotechnology (VIB); Fonds Wetenschappelijk Onderzoek Vlaanderen Odysseus program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Calderon, B. (Sze Ham) Chan, and B. Breaux for their contributions; B. Stern, E. OShea, A. Murray, A. Rowat, and A. New for critique of the manuscript; and the anonymous reviewers for their useful suggestions. Research in the lab of K.J.V. is supported by NIH National Institute for General Medical Studies grant P50GM068763, Human Frontier Science Program (HFSP) award RGY79/2007, the Flemish Institute for Biotechnology (VIB), and the Fonds Wetenschappelijk Onderzoek Vlaanderen Odysseus program. M.D.V. acknowledges the Ford Foundation and the Belgian American Education Foundation.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; King DG, 1997, ENDEAVOUR, V21, P36, DOI 10.1016/S0160-9327(97)01005-3; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Pennisi E, 2008, SCIENCE, V321, P760, DOI 10.1126/science.321.5890.760; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; Streelman JT, 2002, PHYSIOL GENOMICS, V9, P1, DOI 10.1152/physiolgenomics.00105.2001; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	25	244	253	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1213	1216		10.1126/science.1170097	http://dx.doi.org/10.1126/science.1170097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478187	Green Accepted, Green Published			2022-12-28	WOS:000266410100050
J	Benn, PA; Chapman, AR				Benn, Peter A.; Chapman, Audrey R.			Practical and Ethical Considerations of Noninvasive Prenatal Diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DNA; ANEUPLOIDY		[Benn, Peter A.] Univ Connecticut, Ctr Hlth, Div Human Genet, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Chapman, Audrey R.] Univ Connecticut, Ctr Hlth, Dept Community Med & Hlth Care, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Benn, PA (corresponding author), Univ Connecticut, Ctr Hlth, Div Human Genet, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	benn@nso1.uchc.edu						Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P217; BENN PA, 2004, GENETIC DISORDERS FE; Bianchi DW, 2006, OBSTET GYNECOL, V107, P216, DOI 10.1097/01.AOG.0000199427.83503.d0; Chachkin CJ, 2007, AM J LAW MED, V33, P9, DOI 10.1177/009885880703300101; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Egan JFX, 2004, AM J OBSTET GYNECOL, V191, P1044, DOI 10.1016/j.ajog.2004.06.050; EICHENWALD K, 1997, NY TIMES        0523, pD3; Eichenwald Kurt, 1997, N Y Times Web, pD3; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Maron JL, 2007, AM J MED GENET C, V145C, P5, DOI 10.1002/ajmg.c.30115; Seror V, 2009, PRENATAL DIAG, V29, P120, DOI 10.1002/pd.2183; *US DEP HHS, 2008, US SYST OV GEN TEST; WRIGHT C, CELL FREE FETAL NUCL	15	55	55	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2154	2156		10.1001/jama.2009.707	http://dx.doi.org/10.1001/jama.2009.707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19470991				2022-12-28	WOS:000266328800028
J	Havlin, S				Havlin, Shlomo			Phone Infections	SCIENCE			English	Editorial Material							MOBILE COMMUNICATION-NETWORKS		Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel	Bar Ilan University	Havlin, S (corresponding author), Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel.	havlin@ophir.ph.biu.ac.il	Havlin, Shlomo/ABF-1527-2020					Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; HEMPEL S, 2007, STRANGE CASE BROAD S; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053	7	6	6	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1023	1024		10.1126/science.1174658	http://dx.doi.org/10.1126/science.1174658			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460993				2022-12-28	WOS:000266246700026
J	Bowler, C; Karl, DM; Colwell, RR				Bowler, Chris; Karl, David M.; Colwell, Rita R.			Microbial oceanography in a sea of opportunity	NATURE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; GENE-EXPRESSION; DEEP-SEA; OCEAN; GENOME; BIODIVERSITY; BIOGEOGRAPHY; BIOSPHERE; FIXATION; ATLANTIC		[Bowler, Chris] Ecole Normale Super, Dept Biol, CNRS, UMR8186, Paris, France; [Bowler, Chris] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [Karl, David M.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA; [Colwell, Rita R.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Stazione Zoologica Anton Dohrn di Napoli; University of Hawaii System; University System of Maryland; University of Maryland College Park	Bowler, C (corresponding author), Ecole Normale Super, Dept Biol, CNRS, UMR8186, 46 Rue Ulm, Paris, France.	cbowler@biologie.ens.fr	Bowler, Chris/AAC-6256-2019; Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721; Bowler, Chris/0000-0003-3835-6187	Div Of Molecular and Cellular Bioscience [0753659] Funding Source: National Science Foundation; PHS HHS [1R01A139129-01] Funding Source: Medline	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alam M, 2007, P NATL ACAD SCI USA, V104, P17801, DOI 10.1073/pnas.0705599104; Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Colwell RR, 1998, SCIENCE, V279, P968, DOI 10.1126/science.279.5353.963g; Curtin TB, 2008, OCEANOGRAPHY, V21, P44, DOI 10.5670/oceanog.2008.34; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; John DE, 2007, ISME J, V1, P517, DOI 10.1038/ismej.2007.70; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Kolber Z, 2007, OCEANOGRAPHY, V20, P79, DOI 10.5670/oceanog.2007.51; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Murray AE, 2007, PHILOS T R SOC B, V362, P2259, DOI 10.1098/rstb.2006.1944; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Prasady PWC, 2008, INT J ELECTRON, V95, P111, DOI 10.1080/00207210701828770; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Short SM, 2007, ENVIRON MICROBIOL, V9, P1591, DOI 10.1111/j.1462-2920.2007.01258.x; Stemmann L, 2008, ICES J MAR SCI, V65, P433, DOI 10.1093/icesjms/fsn010; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	39	67	76	3	69	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					180	184		10.1038/nature08056	http://dx.doi.org/10.1038/nature08056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445FR	19444203				2022-12-28	WOS:000266036100027
J	Zhang, DW; Shao, J; Lin, J; Zhang, N; Lu, BJ; Lin, SC; Dong, MQ; Han, JH				Zhang, Duan-Wu; Shao, Jing; Lin, Juan; Zhang, Na; Lu, Bao-Ju; Lin, Sheng-Cai; Dong, Meng-Qiu; Han, Jiahuai			RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis	SCIENCE			English	Article							RECEPTOR-INTERACTING PROTEIN; NF-KAPPA-B; KINASE; PATHWAY; CYTOTOXICITY; INHIBITION; INVOLVEMENT; DOMAIN	Necrosis can be induced by stimulating death receptors with tumor necrosis factor (TNF) or other agonists; however, the underlying mechanism differentiating necrosis from apoptosis is largely unknown. We identified the protein kinase receptor-interacting protein 3 (RIP3) as a molecular switch between TNF-induced apoptosis and necrosis in NIH 3T3 cells and found that RIP3 was required for necrosis in other cells. RIP3 did not affect RIP1-mediated apoptosis but was required for RIP1-mediated necrosis and the enhancement of necrosis by the caspase inhibitor zVAD. By activating key enzymes of metabolic pathways, RIP3 regulates TNF-induced reactive oxygen species production, which partially accounts for RIP3's ability to promote necrosis. Our data suggest that modulation of energy metabolism in response to death stimuli has an important role in the choice between apoptosis and necrosis.	[Zhang, Duan-Wu; Shao, Jing; Lin, Juan; Zhang, Na; Lin, Sheng-Cai; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China; [Lu, Bao-Ju; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Xiamen University; National Institute of Biological Sciences, Beijing	Han, JH (corresponding author), Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China.	jhan@xmu.edu.cn	Zhang, Duanwu/AAH-1627-2020; Han, J/G-4671-2010; Lin, SC/G-4666-2010	Zhang, Duanwu/0000-0003-2946-846X; 	NSFC-CIHR [30611120526]; 973 program [2009CB22200]	NSFC-CIHR(Canadian Institutes of Health Research (CIHR)); 973 program(National Basic Research Program of China)	This work was supported by grants NSFC-CIHR 30611120526 and 973 program 2009CB22200.	Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Goossens V, 1996, J BIOL CHEM, V271, P192, DOI 10.1074/jbc.271.1.192; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Luschen S, 2000, J BIOL CHEM, V275, P24670, DOI 10.1074/jbc.M003280200; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wallach D, 2008, CELL DEATH DIFFER, V15, P1533, DOI 10.1038/cdd.2008.41; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	23	1346	1429	11	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					332	336		10.1126/science.1172308	http://dx.doi.org/10.1126/science.1172308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19498109				2022-12-28	WOS:000268036600049
J	Badis, G; Berger, MF; Philippakis, AA; Talukder, S; Gehrke, AR; Jaeger, SA; Chan, ET; Metzler, G; Vedenko, A; Chen, XY; Kuznetsov, H; Wang, CF; Coburn, D; Newburger, DE; Morris, Q; Hughes, TR; Bulyk, ML				Badis, Gwenael; Berger, Michael F.; Philippakis, Anthony A.; Talukder, Shaheynoor; Gehrke, Andrew R.; Jaeger, Savina A.; Chan, Esther T.; Metzler, Genita; Vedenko, Anastasia; Chen, Xiaoyu; Kuznetsov, Hanna; Wang, Chi-Fong; Coburn, David; Newburger, Daniel E.; Morris, Quaid; Hughes, Timothy R.; Bulyk, Martha L.			Diversity and Complexity in DNA Recognition by Transcription Factors	SCIENCE			English	Article							BINDING SPECIFICITIES; GENE-REGULATION; PROTEIN; SEQUENCE; REPRESSOR; IDENTIFICATION; MICROARRAYS; EXPRESSION; DOMAIN; SITES	Sequence preferences of DNA binding proteins are a primary mechanism by which cells interpret the genome. Despite the central importance of these proteins in physiology, development, and evolution, comprehensive DNA binding specificities have been determined experimentally for only a few proteins. Here, we used microarrays containing all 10-base pair sequences to examine the binding specificities of 104 distinct mouse DNA binding proteins representing 22 structural classes. Our results reveal a complex landscape of binding, with virtually every protein analyzed possessing unique preferences. Roughly half of the proteins each recognized multiple distinctly different sequence motifs, challenging our molecular understanding of how proteins interact with their DNA binding sites. This complexity in DNA recognition may be important in gene regulation and in the evolution of transcriptional regulatory networks.	[Badis, Gwenael; Talukder, Shaheynoor; Chen, Xiaoyu; Coburn, David; Morris, Quaid; Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Berger, Michael F.; Philippakis, Anthony A.; Gehrke, Andrew R.; Jaeger, Savina A.; Newburger, Daniel E.; Bulyk, Martha L.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Philippakis, Anthony A.; Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Berger, Michael F.; Philippakis, Anthony A.; Bulyk, Martha L.] Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; [Talukder, Shaheynoor; Chan, Esther T.; Morris, Quaid; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Metzler, Genita; Kuznetsov, Hanna] MIT, Dept Biol, Cambridge, MA 02139 USA; [Vedenko, Anastasia] Wellesley Coll, Dept Biol, Wellesley, MA 02481 USA; [Wang, Chi-Fong] MIT, Dept Phys, Cambridge, MA 02139 USA; [Morris, Quaid] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Morris, Quaid; Hughes, Timothy R.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; University of Toronto; Massachusetts Institute of Technology (MIT); Wellesley College; Massachusetts Institute of Technology (MIT); University of Toronto; University of Toronto; Harvard University; Brigham & Women's Hospital	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	t.hughes@utoronto.ca; mlbulyk@receptor.med.harvard.edu	Badis-Breard, Gwenael/AAE-3783-2019; Morris, Quaid/ABE-8343-2020	Badis-Breard, Gwenael/0000-0003-2078-3076; Morris, Quaid/0000-0002-2760-6999; Chan, Esther/0000-0002-2406-2623	Canadian Institutes of Health Research [MOP-77721]; Genome Canada through the Ontario Genomics Institute; Ontario Research Fund; Canadian Institute for Advanced Research; NSF; Canadian Foundation for Innovation; NIH/National Human Genome Research Institute [R01 HG003985]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Research Fund; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); NSF(National Science Foundation (NSF)); Canadian Foundation for Innovation(Canada Foundation for Innovation); NIH/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by funding from the Canadian Institutes of Health Research (MOP-77721 and postdoctoral fellowship to G.B.); Genome Canada through the Ontario Genomics Institute, the Ontario Research Fund, and the Canadian Institute for Advanced Research (to T.R.H.); NSF (to M.F.B.); the Canadian Foundation for Innovation and Ontario Research Fund (to Q.M.); and grant R01 HG003985 from NIH/National Human Genome Research Institute (to M.L.B.). We thank L. Pena-Castillo, A. Cheung, M. Chan, S. Bhinder, F. Breard, P. Qureshi, S. Mnaimneh, M. Kekis, F. Khalid, J. Holroyd, D. Terterov, and K. Robasky for technical assistance and S. Gisselbrecht, K. Struhl, and S. Sunyaev for critical reading of the manuscript. PBM data are available at http://the_brain.bwh.harvard.edu/pbms/webworks/ and also via the publicly available UniPROBE database (31).	BARASH Y, 2003, P 7 ANN INT C COMP C; Benos PV, 2002, BIOESSAYS, V24, P466, DOI 10.1002/bies.10073; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bosher JM, 1996, ONCOGENE, V13, P1701; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Lee MLT, 2002, BIOMETRICS, V58, P981, DOI 10.1111/j.0006-341X.2002.00981.x; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Orlov SV, 2007, FEBS J, V274, P4848, DOI 10.1111/j.1742-4658.2007.06006.x; PFEIFER K, 1987, CELL, V49, P19, DOI 10.1016/0092-8674(87)90751-3; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	33	689	700	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1720	1723		10.1126/science.1162327	http://dx.doi.org/10.1126/science.1162327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19443739	Green Accepted			2022-12-28	WOS:000267338200043
J	Hofzumahaus, A; Rohrer, F; Lu, KD; Bohn, B; Brauers, T; Chang, CC; Fuchs, H; Holland, F; Kita, K; Kondo, Y; Li, X; Lou, SR; Shao, M; Zeng, LM; Wahner, A; Zhang, YH				Hofzumahaus, Andreas; Rohrer, Franz; Lu, Keding; Bohn, Birger; Brauers, Theo; Chang, Chih-Chung; Fuchs, Hendrik; Holland, Frank; Kita, Kazuyuki; Kondo, Yutaka; Li, Xin; Lou, Shengrong; Shao, Min; Zeng, Limin; Wahner, Andreas; Zhang, Yuanhang			Amplified Trace Gas Removal in the Troposphere	SCIENCE			English	Article							OZONE PRODUCTION; ATMOSPHERIC OXIDATION; BOUNDARY-LAYER; ATLANTIC-OCEAN; OH REACTIVITY; HO2; RADICALS; FOREST; CH3C(O)O-2; PHASE	The degradation of trace gases and pollutants in the troposphere is dominated by their reaction with hydroxyl radicals (OH). The importance of OH rests on its high reactivity, its ubiquitous photochemical production in the sunlit atmosphere, and most importantly on its regeneration in the oxidation chain of the trace gases. In the current understanding, the recycling of OH proceeds through HO2 reacting with NO, thereby forming ozone. A recent field campaign in the Pearl River Delta, China, quantified tropospheric OH and HO2 concentrations and turnover rates by direct measurements. We report that concentrations of OH were three to five times greater than expected, and we propose the existence of a pathway for the regeneration of OH independent of NO, which amplifies the degradation of pollutants without producing ozone.	[Hofzumahaus, Andreas; Rohrer, Franz; Lu, Keding; Bohn, Birger; Brauers, Theo; Fuchs, Hendrik; Holland, Frank; Li, Xin; Lou, Shengrong; Wahner, Andreas] Forschungszentrum Julich, Inst Chem & Dynam Geosphare Troposphare 2, D-52425 Julich, Germany; [Lu, Keding; Li, Xin; Shao, Min; Zeng, Limin; Zhang, Yuanhang] Peking Univ, Coll Environm Sci & Engn, Beijing 100871, Peoples R China; [Chang, Chih-Chung] Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan; [Kita, Kazuyuki] Ibaraki Univ, Fac Sci, Ibaraki 3108512, Japan; [Kondo, Yutaka] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Lou, Shengrong] Shanghai Jiao Tong Univ, Sch Environm Sci & Technol, Shanghai 200240, Peoples R China	Helmholtz Association; Research Center Julich; Peking University; Academia Sinica - Taiwan; Ibaraki University; University of Tokyo; Shanghai Jiao Tong University	Rohrer, F (corresponding author), Forschungszentrum Julich, Inst Chem & Dynam Geosphare Troposphare 2, D-52425 Julich, Germany.	f.rohrer@fz-juelich.de; yhzhang@pku.edu.cn	Chang, Chih-Chung/AAQ-4509-2021; Lu, Keding/A-7282-2012; Fuchs, Hendrik/I-9157-2012; Lou, Shengrong/AAN-6984-2020; SHAO, Min/C-7351-2014; Li, Xin/F-9498-2011; Wahner, Andreas/J-4129-2012; Zhang, Yuanhang/F-7038-2011; Holland, Frank/J-8812-2012; Rohrer, Franz/I-2052-2012; Brauers, Theo/A-8444-2008; Hofzumahaus, Andreas/I-9420-2012; Kondo, Yutaka/D-1459-2012; Zeng, Limin/D-3948-2013; Bohn, Birger/J-4130-2012	Lu, Keding/0000-0001-9425-9520; Fuchs, Hendrik/0000-0003-1263-0061; Lou, Shengrong/0000-0001-6059-2149; Wahner, Andreas/0000-0001-8948-1928; Holland, Frank/0000-0002-2278-4761; Rohrer, Franz/0000-0003-3436-3419; Brauers, Theo/0000-0001-6671-8566; Hofzumahaus, Andreas/0000-0003-2876-0880; Bohn, Birger/0000-0003-4177-3934	Academic Sinica, Taiwan	Academic Sinica, Taiwan	We thank the PRiDe PRD 2006 campaign team (2002CB410801), especially L. J. Zhong, M. Hu, N. Takegawa, Y. Miyazaki, M. Koike, R. Haseler, and A. Oebel, for technical help and support at the field site, and J. L. Wang for help in the in situ measurement of VOCs. C.C. thanks Academic Sinica, Taiwan, for financial support of this work. Discussions with S. C. Liu and D. H. Ehhalt are gratefully acknowledged.	Aumont B, 2005, ATMOS CHEM PHYS, V5, P2497, DOI 10.5194/acp-5-2497-2005; BRASSEUR GP, 2003, ATMOSPHERIC CHEM CHA; Brauers T, 2001, J GEOPHYS RES-ATMOS, V106, P7399, DOI 10.1029/2000JD900679; Creasey DJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003206; Di Carlo P, 2004, SCIENCE, V304, P722, DOI 10.1126/science.1094392; Dillon TJ, 2008, ATMOS CHEM PHYS, V8, P4877, DOI 10.5194/acp-8-4877-2008; Ehhalt DH, 1999, PHYS CHEM CHEM PHYS, V1, P5401, DOI 10.1039/a905097c; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Hasson AS, 2004, J PHYS CHEM A, V108, P5979, DOI 10.1021/jp048873t; Heard DE, 2003, CHEM REV, V103, P5163, DOI 10.1021/cr020522s; Holland F, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001393; Jenkin ME, 2007, PHYS CHEM CHEM PHYS, V9, P3149, DOI 10.1039/b702757e; Kleinman LI, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002529; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; Li SP, 2008, SCIENCE, V319, P1657, DOI 10.1126/science.1151443; LIU SC, 1987, J GEOPHYS RES-ATMOS, V92, P4191, DOI 10.1029/JD092iD04p04191; Read KA, 2008, NATURE, V453, P1232, DOI 10.1038/nature07035; Ren XR, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009166; Rohrer F, 2006, NATURE, V442, P184, DOI 10.1038/nature04924; Sadanaga Y, 2005, ENVIRON SCI TECHNOL, V39, P8847, DOI 10.1021/es049457p; Shirley TR, 2006, ATMOS CHEM PHYS, V6, P2753, DOI 10.5194/acp-6-2753-2006; Tan D, 2001, J GEOPHYS RES-ATMOS, V106, P24407, DOI 10.1029/2001JD900016; Thornton JA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000932	24	409	422	25	456	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1702	1704		10.1126/science.1164566	http://dx.doi.org/10.1126/science.1164566			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19498111				2022-12-28	WOS:000267338200037
J	Jost, JD; Home, JP; Amini, JM; Hanneke, D; Ozeri, R; Langer, C; Bollinger, JJ; Leibfried, D; Wineland, DJ				Jost, J. D.; Home, J. P.; Amini, J. M.; Hanneke, D.; Ozeri, R.; Langer, C.; Bollinger, J. J.; Leibfried, D.; Wineland, D. J.			Entangled mechanical oscillators	NATURE			English	Article							CURRENT SITUATION; QUANTUM; IONS; STATES	Hallmarks of quantum mechanics include superposition and entanglement. In the context of large complex systems, these features should lead to situations as envisaged in the 'Schrodinger's cat'(1) thought experiment (where the cat exists in a superposition of alive and dead states entangled with a radioactive nucleus). Such situations are not observed in nature. This may be simply due to our inability to sufficiently isolate the system of interest from the surrounding environment(2,3)- a technical limitation. Another possibility is some as-yet-undiscovered mechanism that prevents the formation of macroscopic entangled states(4). Such a limitation might depend on the number of elementary constituents in the system(5) or on the types of degrees of freedom that are entangled. Tests of the latter possibility have been made with photons, atoms and condensed matter devices(6,7). One system ubiquitous to nature where entanglement has not been previously demonstrated consists of distinct mechanical oscillators. Here we demonstrate deterministic entanglement of separated mechanical oscillators, consisting of the vibrational states of two pairs of atomic ions held in different locations. We also demonstrate entanglement of the internal states of an atomic ion with a distant mechanical oscillator. These results show quantum entanglement in a degree of freedom that pervades the classical world. Such experiments may lead to the generation of entangled states of larger-scale mechanical oscillators(8-10), and offer possibilities for testing non-locality with mesoscopic systems(11). In addition, the control developed here is an important ingredient for scaling-up quantum information processing with trapped atomic ions(12-14).	[Jost, J. D.; Home, J. P.; Amini, J. M.; Hanneke, D.; Bollinger, J. J.; Leibfried, D.; Wineland, D. J.] Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA; [Ozeri, R.] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Langer, C.] Lockheed Martin, Denver, CO 80127 USA	National Institute of Standards & Technology (NIST) - USA; Weizmann Institute of Science; Lockheed Martin	Jost, JD (corresponding author), Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA.	john.d.jost@gmail.com	Hanneke, David/E-6941-2011; Jost, John D/F-4701-2010	Hanneke, David/0000-0001-9278-7231; jost, john/0000-0002-1698-8602; Home, Jonathan/0000-0002-4093-1550	IARPA; NIST Quantum Information Program; Lindemann Trust fellowship	IARPA; NIST Quantum Information Program; Lindemann Trust fellowship	This work was supported by IARPA and the NIST Quantum Information Program. We hank J. Britton, Y. Colombe and H. Uys for comments on the manuscript. J. P. H. acknowledges support from the Lindemann Trust fellowship. This paper is a contribution by the National Institute of Standards and Technology and not subject to US copyright.	ASPECT A, 2002, QUANTUM UNSPEAKABLES, pCH9; Aspelmeyer M, 2008, PHYS WORLD, V21, P22; Ball P, 2008, NATURE, V453, P22, DOI 10.1038/453022a; Bassi A, 2003, PHYS REP, V379, P257, DOI 10.1016/S0370-1573(03)00103-0; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; Herrmann M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.013006; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Kielpinski D, 2001, SCIENCE, V291, P1013, DOI 10.1126/science.1057357; King BE, 1998, PHYS REV LETT, V81, P1525, DOI 10.1103/PhysRevLett.81.1525; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; LEGGETT AJ, 2002, J PHYS CONDENS MATT, V415, pR451; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Mancini S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120401; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; Milman P, 2005, EUR PHYS J D, V32, P233, DOI 10.1140/epjd/e2004-00171-6; Ozeri R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042329; Pan J.-W., 2008, MULTIPHOTON ENTANGLE; Roos CF, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.040302; Rowe MA, 2002, QUANTUM INF COMPUT, V2, P257; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schleich W. P., 2001, QUANTUM OPTICS PHASE; Schlosshauer M, 2008, NATURE, V453, P39, DOI 10.1038/453039a; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P844, DOI 10.1007/BF01491987; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schroedinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI [DOI 10.1007/BF01491914, 10.1007/BF01491914]; Schwab KC, 2005, PHYS TODAY, V58, P36, DOI 10.1063/1.2012461; Southwell K, 2008, NATURE, V453, P1003, DOI 10.1038/4531003a; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037	31	119	120	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					683	U84		10.1038/nature08006	http://dx.doi.org/10.1038/nature08006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494911	Green Submitted			2022-12-28	WOS:000266608600039
J	Espinosa, EJ; Calero, M; Sridevi, K; Pfeffer, SR				Espinosa, Eric J.; Calero, Monica; Sridevi, Khambhampaty; Pfeffer, Suzanne R.			RhoBTB3: A Rho GTPase-Family ATPase Required for Endosome to Golgi Transport	CELL			English	Article							NUCLEOTIDE SPECIFICITY; ESCHERICHIA-COLI; RAB9 GTPASE; NETWORK; TRAFFICKING; PROTEINS; TIP47; EXPRESSION; MECHANISM; COMPLEX	Rho GTPases are key regulators of the actin-based cytoskeleton; Rab GTPases are key regulators of membrane traffic. We report here that the atypical Rho GTPase family member, RhoBTB3, binds directly to Rab9 GTPase and functions with Rab9 in protein transport from endosomes to the trans Golgi network. Gene replacement experiments show that RhoBTB3 function in cultured cells requires both RhoBTB30s N-terminal, Rho-related domain and C-terminal sequences that are important for Rab9 interaction. Biochemical analysis reveals that RhoBTB3 binds and hydrolyzes ATP rather than GTP. Rab9 binding opens the autoinhibited RhoBTB3 protein to permit maximal ATP hydrolysis. Because RhoBTB3 interacts with TIP47 on membranes, we propose that it may function to release this cargo selection protein from vesicles to permit their efficient docking and fusion at the Golgi.	[Espinosa, Eric J.; Calero, Monica; Sridevi, Khambhampaty; Pfeffer, Suzanne R.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pfeffer@stanford.edu			Leukemia and Lymphoma Society [NIDDK R37-37332]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332, R37DK037332] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a grant ( NIDDK R37-37332) to S. R. P. K. S. was a fellow of the Leukemia and Lymphoma Society. We thank Dr. Jonathan Reddy for the original yeast two-hybrid screen, Garret Hayes and Leonie Kastner for screening 54 Rab GTPases, and Margaret Cooke and Humsa Venkatesan for help with RhoBTB3 mutagenesis. Drs. Tim Fenn and Maika Deffieu provided invaluable help with structure modeling and blue native gels, respectively.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; ALTMAN D, 2004, BIOCHEM J, V377, P327; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Chang FK, 2006, J MOL BIOL, V364, P302, DOI 10.1016/j.jmb.2006.09.026; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; HWANG YW, 1987, J BIOL CHEM, V262, P13081; Itin C, 1999, MOL BIOL CELL, V10, P2191, DOI 10.1091/mbc.10.7.2191; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; Krise JP, 2000, J BIOL CHEM, V275, P25188, DOI 10.1074/jbc.M001138200; KUZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530, DOI 10.1073/pnas.83.22.8530; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Lutkenhaus J, 2003, MOL MICROBIOL, V48, P295, DOI 10.1046/j.1365-2958.2003.03427.x; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; NADEAU K, 1993, J BIOL CHEM, V268, P1479; Ramos S, 2002, GENE, V298, P147, DOI 10.1016/S0378-1119(02)00980-0; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Salas-Vidal E, 2005, GENOMICS, V86, P25, DOI 10.1016/j.ygeno.2005.03.010; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Sincock PM, 2003, TRAFFIC, V4, P18, DOI 10.1034/j.1600-0854.2003.40104.x; Siripurapu V, 2005, J MOL BIOL, V346, P83, DOI 10.1016/j.jmb.2004.11.043; Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200; Sousa R, 2006, TRAFFIC, V7, P1596, DOI 10.1111/j.1600-0854.2006.00497.x; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; SWAMY M, 2006, SCI STKE, V345, P14; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Ybe JA, 1996, PROTEIN SCI, V5, P814; ZHONG JM, 1995, J BIOL CHEM, V270, P10002, DOI 10.1074/jbc.270.17.10002	47	68	72	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					938	948		10.1016/j.cell.2009.03.043	http://dx.doi.org/10.1016/j.cell.2009.03.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490898	Green Accepted, Bronze			2022-12-28	WOS:000266454800023
J	Bentley-Lewis, R				Bentley-Lewis, Rhonda			Gestational diabetes mellitus: an opportunity of a lifetime	LANCET			English	Editorial Material							WOMEN; GLUCOSE		Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Bentley-Lewis, R (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA.	rbentleylewis@partners.org			NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR023333] Funding Source: NIH RePORTER; NCRR NIH HHS [K23 RR023333, K23 RR023333-02] Funding Source: Medline; NIMHD NIH HHS [L32 MD001077, L32 MD001077-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; American Diabetes Association Gestational diabetes mellitus, 2000, DIABETES CARE S1, V23, P77; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bentley-Lewis R, 2008, NAT CLIN PRACT ENDOC, V4, P552, DOI 10.1038/ncpendmet0965; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Casey BM, 1997, OBSTET GYNECOL, V90, P869, DOI 10.1016/S0029-7844(97)00542-5; HARRIS M, 1979, DIABETES, V28, P1039; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim C, 2007, DIABETES CARE, V30, P1314, DOI 10.2337/dc06-2517; KJOS SL, 1993, OBSTET GYNECOL, V82, P451; KRITZSILVERSTEIN D, 1989, NEW ENGL J MED, V321, P1214, DOI 10.1056/NEJM198911023211802; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; World Health Organization, 1999, WHO DEF DIAGN CLASS	14	25	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1738	1740		10.1016/S0140-6736(09)60958-2	http://dx.doi.org/10.1016/S0140-6736(09)60958-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19465213	Green Accepted			2022-12-28	WOS:000266337300005
J	Fazio, S; Linton, MF				Fazio, Sergio; Linton, MacRae F.			Fenofibrate and risk of minor amputations in diabetes	LANCET			English	Editorial Material							METAANALYSIS; PREVENTION; PEOPLE		[Fazio, Sergio; Linton, MacRae F.] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Atherosclerosis Res Unit, Nashville, TN 37232 USA	Vanderbilt University	Fazio, S (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Atherosclerosis Res Unit, Nashville, TN 37232 USA.	Sergio.fazio@vanderbilt.edu			NHLBI NIH HHS [R01 HL086988, R01 HL086988-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086988] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter P, 2004, CARDIOVASC DIABETOL, V3, DOI 10.1186/1475-2840-3-9; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Collins R, 2003, LANCET, V361, P2005; Douglas K, 2006, ANN INTERN MED, V145, P117, DOI 10.7326/0003-4819-145-2-200607180-00009; Feingold KR, 2007, J LIPID RES, V48, P2529, DOI 10.1194/jlr.E700004-JLR200; Heart Protection Study Collaborati, 2007, J VASC SURG, V45, P645, DOI 10.1016/j.jvs.2006.12.054; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Komuves LG, 2000, J INVEST DERMATOL, V115, P353, DOI 10.1046/j.1523-1747.2000.00073.x; Lincoln NB, 2008, DIABETOLOGIA, V51, P1954, DOI 10.1007/s00125-008-1110-0; Rajamani K, 2009, LANCET, V373, P1780, DOI 10.1016/S0140-6736(09)60698-X; Van Damme Hendrik, 2007, Clin Podiatr Med Surg, V24, P569, DOI 10.1016/j.cpm.2007.03.007	15	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1740	1741		10.1016/S0140-6736(09)60959-4	http://dx.doi.org/10.1016/S0140-6736(09)60959-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465214				2022-12-28	WOS:000266337300006
J	Sandman, PM				Sandman, Peter M.			Pandemics: good hygiene is not enough	NATURE			English	Editorial Material											Sandman, PM (corresponding author), 59 Ridgeview Rd, Princeton, NJ 08540 USA.	peter@psandman.com							0	27	27	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 21	2009	459	7245					322	323		10.1038/459322a	http://dx.doi.org/10.1038/459322a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458694	Green Published			2022-12-28	WOS:000266243700017
J	Gostin, LO				Gostin, Lawrence O.			Regulating the Safety of Pharmaceuticals The FDA, Preemption, and the Public's Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TORT LITIGATION; LIABILITY		Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V300, P1939, DOI 10.1001/jama.2008.513; *FOOD DRUG ADM SCI, 2007, SCI MISS RISK REP SU; Gostin L., 2008, PUBLIC HLTH LAW POWE; Gostin LO, 2008, JAMA-J AM MED ASSOC, V299, P2313, DOI 10.1001/jama.299.19.2313; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Kesselheim AS, 2009, NEW ENGL J MED, V360, P559, DOI 10.1056/NEJMp0809403; Kessler DA, 2008, GEORGETOWN LAW J, V96, P461; MCGARITY THOMAS O., 2008, PREEMPTION WAR FEDER; *US HR, 2008, FDA CAR STAFF OBJ AG; 2006, FED REG, V71, P3922	10	5	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					2036	2037		10.1001/jama.2009.680	http://dx.doi.org/10.1001/jama.2009.680			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454642				2022-12-28	WOS:000266159600028
J	Miller, DL; Kubista, KD; Rutter, GM; Ruan, M; de Heer, WA; First, PN; Stroscio, JA				Miller, David L.; Kubista, Kevin D.; Rutter, Gregory M.; Ruan, Ming; de Heer, Walt A.; First, Phillip N.; Stroscio, Joseph A.			Observing the Quantization of Zero Mass Carriers in Graphene	SCIENCE			English	Article							EPITAXIAL GRAPHENE; DIRAC-FERMIONS; GRAPHITE; GAS	Application of a magnetic field to conductors causes the charge carriers to circulate in cyclotron orbits with quantized energies called Landau levels (LLs). These are equally spaced in normal metals and two-dimensional electron gases. In graphene, however, the charge carrier velocity is independent of their energy (like massless photons). Consequently, the LL energies are not equally spaced and include a characteristic zero-energy state (the n = 0 LL). With the use of scanning tunneling spectroscopy of graphene grown on silicon carbide, we directly observed the discrete, non-equally-spaced energy-level spectrum of LLs, including the hallmark zero-energy state of graphene. We also detected characteristic magneto-oscillations in the tunneling conductance and mapped the electrostatic potential of graphene by measuring spatial variations in the energy of the n = 0 LL.	[Miller, David L.; Kubista, Kevin D.; Ruan, Ming; de Heer, Walt A.; First, Phillip N.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Rutter, Gregory M.; Stroscio, Joseph A.] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA	University System of Georgia; Georgia Institute of Technology; National Institute of Standards & Technology (NIST) - USA	First, PN (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	first@physics.gatech.edu; joseph.stroscio@nist.gov			NSF [ECCS-0804908, ECCS-0521041]; Semiconductor Research Corporation Nanoelectronics Research Initiative (INDEX program); W. M. Keck Foundation; Division Of Materials Research [0804908] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Semiconductor Research Corporation Nanoelectronics Research Initiative (INDEX program); W. M. Keck Foundation(W.M. Keck Foundation); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. MacDonald, H. Min, M. Stiles, and the NIST graphene team for valuable comments and discussions and C. Berger, N. Sharma, M. Sprinkle, S. Blankenship, A. Band, and F. Hess for their technical contributions to this work. Portions of this work were supported by NSF (grant ECCS-0804908), the Semiconductor Research Corporation Nanoelectronics Research Initiative (INDEX program), and the W. M. Keck Foundation. Graphene production facilities were developed under NSF grant ECCS-0521041.	Arikawa M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.205401; Ashcroft N.W., 1976, SOLID STATE PHYS; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Bostwick A, 2007, NAT PHYS, V3, P36, DOI 10.1038/nphys477; de Heer WA, 2007, SOLID STATE COMMUN, V143, P92, DOI 10.1016/j.ssc.2007.04.023; Deacon RS, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.081406; Gusynin VP, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.125124; Hass J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.125504; Henriksen EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.087403; Li G, 2007, NAT PHYS, V3, P623, DOI 10.1038/nphys653; Li GH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176804; Luk'yanchuk IA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166402; Martin J, 2008, NAT PHYS, V4, P144, DOI 10.1038/nphys781; Matsui T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.226403; Morgenstern M, 2000, PHYS REV LETT, V84, P5588, DOI 10.1103/PhysRevLett.84.5588; Morgenstern M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.056804; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Orlita M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267601; Pong WT, 2005, J PHYS D APPL PHYS, V38, pR329, DOI 10.1088/0022-3727/38/21/R01; Rollings E, 2006, J PHYS CHEM SOLIDS, V67, P2172, DOI 10.1016/j.jpcs.2006.05.010; Rossi E, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.166803; Rutter GM, 2008, J VAC SCI TECHNOL A, V26, P938, DOI 10.1116/1.2944257; Sadowski ML, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266405; Sharapov SG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075104; Toke C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235417; Trevisanutto PE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226405; Yan J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.136804; Zhang Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136806; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	31	388	398	9	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					924	927		10.1126/science.1171810	http://dx.doi.org/10.1126/science.1171810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443780				2022-12-28	WOS:000266048800034
J	Powner, DJ				Powner, David J.			Certification of brain death: take care	LANCET			English	Editorial Material							APNEA TEST; DIAGNOSIS; VARIABILITY		[Powner, David J.] Univ Texas Med Sch Houston, Dept Neurosurg, Houston, TX 77030 USA; [Powner, David J.] Univ Texas Med Sch Houston, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Powner, DJ (corresponding author), Univ Texas Med Sch Houston, Dept Neurosurg, Houston, TX 77030 USA.	david.j.powner@uth.tmc.edu						ALJUMAH M, 1992, CRIT CARE MED, V20, P1564; EARNEST MP, 1986, NEUROLOGY, V36, P542, DOI 10.1212/WNL.36.4.542; Greer DM, 2008, NEUROLOGY, V70, P284, DOI 10.1212/01.wnl.0000296278.59487.c2; Levesque S, 2006, CRIT CARE MED, V34, P2213, DOI 10.1097/01.CCM.0000215114.46127.DA; Powner DJ, 2004, CRIT CARE MED, V32, P1284, DOI 10.1097/01.ccm.0000127265.62431.0d; Powner DJ, 2003, CRIT CARE MED, V31, P1241, DOI 10.1097/01.CCM.0000059643.45027.96; Sharpe MD, 2004, NEUROCRIT CARE, V1, P363, DOI 10.1385/NCC:1:3:363; Shewmon DA, 1998, NEUROLOGY, V51, P1538, DOI 10.1212/WNL.51.6.1538; Wang MY, 2002, NEUROSURGERY, V51, P731, DOI 10.1227/01.NEU.0000024156.53597.IA; Wijdicks EFM, 2008, NEUROLOGY, V71, P1240, DOI 10.1212/01.wnl.0000327612.69106.4c; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; Wu XL, 2008, CHINESE MED J-PEKING, V121, P1169, DOI 10.1097/00029330-200807010-00004	13	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2009	373	9675					1587	1589		10.1016/S0140-6736(09)60887-4	http://dx.doi.org/10.1016/S0140-6736(09)60887-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19427942				2022-12-28	WOS:000266066300009
J	Saini, P; Eyler, DE; Green, R; Dever, TE				Saini, Preeti; Eyler, Daniel E.; Green, Rachel; Dever, Thomas E.			Hypusine-containing protein eIF5A promotes translation elongation	NATURE			English	Article							SYNTHESIS INITIATION-FACTORS; YEAST; PURIFICATION; MECHANISM; BINDING; CELLS; GENE	Translation elongation factors facilitate protein synthesis by the ribosome. Previous studies identified two universally conserved translation elongation factors, EF-Tu in bacteria (known as eEF1A in eukaryotes) and EF-G (eEF2), which deliver aminoacyl-tRNAs to the ribosome and promote ribosomal translocation, respectively(1). The factor eIF5A (encoded by HYP2 and ANB1 in Saccharomyces cerevisiae), the sole protein in eukaryotes and archaea to contain the unusual amino acid hypusine (N-epsilon-(4-amino-2-hydroxybutyl)lysine)(2), was originally identified based on its ability to stimulate the yield (endpoint) of methionylpuromycin synthesis-a model assay for first peptide bond synthesis thought to report on certain aspects of translation initiation(3,4). Hypusine is required for eIF5A to associate with ribosomes(5,6) and to stimulate methionyl-puromycin synthesis(7). Because eIF5A did not stimulate earlier steps of translation initiation(8), and depletion of eIF5A in yeast only modestly impaired protein synthesis(9), it was proposed that eIF5A function was limited to stimulating synthesis of the first peptide bond or that eIF5A functioned on only a subset of cellular messenger RNAs. However, the precise cellular role of eIF5A is unknown, and the protein has also been linked to mRNA decay, including the nonsense-mediated mRNA decay pathway(10,11), and to nucleocytoplasmic transport(12,13). Here we use molecular genetic and biochemical studies to show that eIF5A promotes translation elongation. Depletion or inactivation of eIF5A in the yeast S. cerevisiae resulted in the accumulation of polysomes and an increase in ribosomal transit times. Addition of recombinant eIF5A from yeast, but not a derivative lacking hypusine, enhanced the rate of tripeptide synthesis in vitro. Moreover, inactivation of eIF5A mimicked the effects of the eEF2 inhibitor sordarin, indicating that eIF5A might function together with eEF2 to promote ribosomal translocation. Because eIF5A is a structural homologue of the bacterial protein EF-P-14,P-15, we propose that eIF5A/EF-P is a universally conserved translation elongation factor.	[Saini, Preeti; Dever, Thomas E.] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Eyler, Daniel E.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; Johns Hopkins University	Dever, TE (corresponding author), NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	tdever@nih.gov	Dever, Thomas/GSE-0966-2022	Dever, Thomas/0000-0001-7120-9678	HHMI; NIH; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Acknowledgements We thank T. G. Kinzy for providing anti-yeast eEF1A, eEF2 and eEF3 antisera, as well as constructs for the purification of eEF2 and eEF3; J. Lorsch for providing constructs for purification of yeast initiation factors; J. Dinmann for frameshifting reporter vectors, and A. Hinnebusch, T. G. Kinzy, A. Jivotovskaya, D. Shelton, C. Grant, J. Lorsch and members of the Dever and Hinnebusch laboratories for comments and discussion. Salary support provided by HHMI (R. G.) and NIH (D. E. E.). This work was supported in part by the Intramural Research Program of the NIH, NICHD (to T. E. D.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; BENNE R, 1978, J BIOL CHEM, V253, P3078; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; GALLIE DR, 1991, MOL GEN GENET, V228, P258, DOI 10.1007/BF00282474; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Harger JW, 2001, VIROLOGY, V286, P216, DOI 10.1006/viro.2001.0997; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; KANG HA, 1994, J BIOL CHEM, V269, P3934; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302; Ortiz PA, 2005, NUCLEIC ACIDS RES, V33, P5740, DOI 10.1093/nar/gki882; PARK MH, 1991, J BIOL CHEM, V266, P7988; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Schrader R, 2006, J BIOL CHEM, V281, P35336, DOI 10.1074/jbc.M601460200; SCHREIER MH, 1977, J MOL BIOL, V116, P727, DOI 10.1016/0022-2836(77)90268-6; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; SMIRNOV VN, 1976, FEBS LETT, V66, P12, DOI 10.1016/0014-5793(76)80573-X; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zhang SA, 1997, RNA, V3, P234; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	35	294	308	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					118	U129		10.1038/nature08034	http://dx.doi.org/10.1038/nature08034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424157	Green Accepted			2022-12-28	WOS:000265801300041
J	Kim, N; Jinks-Robertson, S				Kim, Nayun; Jinks-Robertson, Sue			dUTP incorporation into genomic DNA is linked to transcription in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSLESION SYNTHESIS; REPAIR; DAMAGE; RECOMBINATION; SPECIFICITIES; PROTEINS	Highly activated transcription is associated with eukaryotic genome instability, resulting in increased rates of mitotic recombination and mutagenesis. The association between high transcription and genome stability is probably due to a variety of factors including an enhanced accumulation of DNA damage, transcription-associated supercoiling, collision between replication forks and the transcription machinery, and the persistence of RNA-DNA hybrids(1). In the case of transcription-associated mutagenesis, we previously showed that there is a direct proportionality between the level of transcription and themutation rate in the yeast Saccharomyces cerevisiae(2), and that the molecular nature of the mutations is affected by highly activated transcription(2,3). Here we show that the accumulation of apurinic/apyrimidinic sites is greatly enhanced in highly transcribed yeast DNA. We further demonstrate that most apurinic/apyrimidinic sites in highly transcribed DNA are derived from the removal of uracil, the presence of which is linked to direct incorporation of dUTP in place of dTTP. These results show an unexpected relationship between transcription and the fidelity of DNA synthesis, and raise intriguing cell biological issues with regard to nucleotide pool compartmentalization.	[Kim, Nayun; Jinks-Robertson, Sue] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Jinks-Robertson, S (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	sue.robertson@duke.edu			National Institutes of Health [R01 GM038464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Boiteux for providing the p424-GAL-DUT1 plasmid. We thank members of the laboratory and T. Petes for discussions and comments on the manuscript. This work was supported by a grant from the National Institutes of Health ( R01 GM038464).	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; Harfe BD, 1999, MOL CELL BIOL, V19, P4766; Harfe BD, 2000, MOL CELL, V6, P1491, DOI 10.1016/S1097-2765(00)00145-3; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Lippert MJ, 2004, MOL CELL BIOL, V24, P4801, DOI 10.1128/MCB.24.11.4801-4809.2004; Minesinger BK, 2005, GENETICS, V169, P1939, DOI 10.1534/genetics.104.033894; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; Senturker S, 1998, NUCLEIC ACIDS RES, V26, P5270, DOI 10.1093/nar/26.23.5270; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Swanson RL, 1999, MOL CELL BIOL, V19, P2929; You HJ, 1999, BIOCHEMISTRY-US, V38, P11298, DOI 10.1021/bi991121i	15	54	56	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1150	1153		10.1038/nature08033	http://dx.doi.org/10.1038/nature08033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19448611	Green Accepted			2022-12-28	WOS:000267636700048
J	Lim, B; Jiang, MJ; Camargo, PHC; Cho, EC; Tao, J; Lu, XM; Zhu, YM; Xia, YN				Lim, Byungkwon; Jiang, Majiong; Camargo, Pedro H. C.; Cho, Eun Chul; Tao, Jing; Lu, Xianmao; Zhu, Yimei; Xia, Younan			Pd-Pt Bimetallic Nanodendrites with High Activity for Oxygen Reduction	SCIENCE			English	Article							PLATINUM NANOPARTICLES; CRYSTAL-SURFACES; FACILE SYNTHESIS; NANOCRYSTALS; ELECTROCATALYSTS; ALLOYS; CARBON	Controlling the morphology of Pt nanostructures can provide a great opportunity to improve their catalytic properties and increase their activity on a mass basis. We synthesized Pd-Pt bimetallic nanodendrites consisting of a dense array of Pt branches on a Pd core by reducing K2PtCl4 with L-ascorbic acid in the presence of uniform Pd nanocrystal seeds in an aqueous solution. The Pt branches supported on faceted Pd nanocrystals exhibited relatively large surface areas and particularly active facets toward the oxygen reduction reaction (ORR), the rate-determining step in a proton-exchange membrane fuel cell. The Pd-Pt nanodendrites were two and a half times more active on the basis of equivalent Pt mass for the ORR than the state-of-the-art Pt/C catalyst and five times more active than the first-generation supportless Pt-black catalyst.	[Lim, Byungkwon; Camargo, Pedro H. C.; Cho, Eun Chul; Lu, Xianmao; Xia, Younan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Jiang, Majiong] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Tao, Jing; Zhu, Yimei] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA	Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Brookhaven National Laboratory	Xia, YN (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	xia@biomed.wustl.edu	Camargo, Pedro HC/L-3773-2019; Camargo, Pedro H. C./D-9547-2011; Jiang, Majiong/I-3630-2013; Jiang, Maijong/E-3794-2012; Lu, Xianmao/E-4622-2010; Xia, Younan/E-8499-2011	Camargo, Pedro HC/0000-0002-7815-7919; Camargo, Pedro H. C./0000-0002-7815-7919; Lu, Xianmao/0000-0002-7422-2867; 	Washington University in St. Louis; Korea Government [KRF-2006-352-D00067, KRF-2007-357-D00070]; Fulbright Program; Brazilian Ministry of Education; U.S. DOE Basic Energy Sciences [DEAC02-98CH10886]	Washington University in St. Louis; Korea Government(Korean Government); Fulbright Program; Brazilian Ministry of Education; U.S. DOE Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by startup funds from Washington University in St. Louis. B.L. was also partially supported by postdoctoral fellowships from the Korea Research Foundation funded by the Korean Government (KRF-2006-352-D00067). P.H.C.C. was also supported in part by the Fulbright Program and the Brazilian Ministry of Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). E.C.C. was also partially supported by postdoctoral fellowships from the Korea Research Foundation funded by the Korean Government (KRF-2007-357-D00070). J.T. and Y.Z. were supported by the U.S. DOE/Basic Energy Sciences (DEAC02-98CH10886). We thank H. Yang for technical assistance with the electrochemical measurements.	Adzic RR, 2007, TOP CATAL, V46, P249, DOI 10.1007/s11244-007-9003-x; BLAKELY DW, 1977, SURF SCI, V65, P419, DOI 10.1016/0039-6028(77)90457-5; Bratlie KM, 2007, NANO LETT, V7, P3097, DOI 10.1021/nl0716000; Chen JY, 2005, ANGEW CHEM INT EDIT, V44, P2589, DOI 10.1002/anie.200462668; Chen W, 2008, J PHYS CHEM C, V112, P3891, DOI 10.1021/jp7110204; Ciacchi LC, 2003, J PHYS CHEM B, V107, P1755, DOI 10.1021/jp026698f; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Habas SE, 2007, NAT MATER, V6, P692, DOI 10.1038/nmat1957; Kuzume A, 2007, J ELECTROANAL CHEM, V599, P333, DOI 10.1016/j.jelechem.2006.05.006; Lee HJ, 2008, J AM CHEM SOC, V130, P5406, DOI 10.1021/ja800656y; Lim BW, 2008, NANO LETT, V8, P4043, DOI 10.1021/nl802959b; Lim B, 2008, NANO LETT, V8, P2535, DOI 10.1021/nl8016434; MALLOUK TE, 1990, NATURE, V343, P515, DOI 10.1038/343515b0; Markovic N, 1997, J ELECTROCHEM SOC, V144, P1591, DOI 10.1149/1.1837646; Markovic NM, 2001, FUEL CELLS, V1, P105, DOI 10.1002/1615-6854(200107)1:2<105::AID-FUCE105>3.0.CO;2-9; Markovic NM, 2002, SURF SCI REP, V45, P121, DOI 10.1016/S0167-5729(01)00022-X; MARKOVIC NM, 1994, J ELECTROANAL CHEM, V377, P249, DOI 10.1016/0022-0728(94)03467-2; Mayrhofer KJJ, 2008, ELECTROCHIM ACTA, V53, P3181, DOI 10.1016/j.electacta.2007.11.057; MUKERJEE S, 1995, J ELECTROCHEM SOC, V142, P1409, DOI 10.1149/1.2048590; MUKERJEE S, 1993, J ELECTROANAL CHEM, V357, P201, DOI 10.1016/0022-0728(93)80380-Z; Narayanan R, 2004, NANO LETT, V4, P1343, DOI 10.1021/nl0495256; Perry ML, 2002, J ELECTROCHEM SOC, V149, pS59, DOI 10.1149/1.1488651; Schmidt TJ, 1998, J ELECTROCHEM SOC, V145, P2354, DOI 10.1149/1.1838642; Song H, 2005, J PHYS CHEM B, V109, P188, DOI 10.1021/jp0464775; Song YJ, 2004, J AM CHEM SOC, V126, P635, DOI 10.1021/ja037474t; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Teng XW, 2006, SMALL, V2, P249, DOI 10.1002/smll.200500244; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Vielstich W, 2003, HDB FUEL CELLS FUNDA; Wang C, 2008, ANGEW CHEM INT EDIT, V47, P3588, DOI 10.1002/anie.200800073; YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569	33	2587	2628	59	3088	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1302	1305		10.1126/science.1170377	http://dx.doi.org/10.1126/science.1170377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19443738				2022-12-28	WOS:000266635100038
J	Grove, TL; Till, CB; Lev, E; Chatterjee, N; Medard, E				Grove, T. L.; Till, C. B.; Lev, E.; Chatterjee, N.; Medard, E.			Kinematic variables and water transport control the formation and location of arc volcanoes	NATURE			English	Article							MANTLE WEDGE; SUBDUCTION; CONSEQUENCES; REGION; SLABS; H2O	The processes that give rise to arc magmas at convergent plate margins have long been a subject of scientific research and debate(1-6). A consensus has developed that the mantle wedge overlying the subducting slab(3,4) and fluids and/or melts from the subducting slab itself(6-11) are involved in the melting process. However, the role of kinematic variables such as slab dip and convergence rate in the formation of arc magmas is still unclear. The depth to the top of the subducting slab beneath volcanic arcs, usually similar to 110 +/- 20 km, was previously thought to be constant among arcs(3,6,12). Recent studies(13,14) revealed that the depth of intermediate-depth earthquakes underneath volcanic arcs, presumably marking the slab wedge interface, varies systematically between similar to 60 and 173 km and correlates with slab dip and convergence rate. Water-rich magmas (over 4-6wt% H2O) are found in subduction zones with very different subduction parameters, including those with a shallow-dipping slab (north Japan), or steeply dipping slab (Marianas). Here we propose a simple model to address how kinematic parameters of plate subduction relate to the location of mantle melting at subduction zones. We demonstrate that the location of arc volcanoes is controlled by a combination of conditions: [GRAPHICS] melting in the wedge is induced at the overlap of regions in the wedge that are hotter than the melting curve (solidus) of vapour-saturated peridotite and regions where hydrous minerals both in the wedge and in the subducting slab break down. These two limits for melt generation, when combined with the kinematic parameters of slab dip and convergence rate, provide independent constraints on the thermal structure of the wedge and accurately predict the location of mantle wedge melting and the position of arc volcanoes.	[Grove, T. L.; Till, C. B.; Lev, E.; Chatterjee, N.; Medard, E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Grove, TL (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	tlgrove@mit.edu	Till, Christy/Y-1173-2019; Grove, Timothy/M-9638-2013; Chatterjee, Nilanjan/J-3191-2019; Till, Christy/D-7771-2012; Till, Christy/B-4338-2012; Medard, Etienne/H-6710-2013	Till, Christy/0000-0001-8924-2206; Grove, Timothy/0000-0003-0628-1969; Chatterjee, Nilanjan/0000-0002-4175-5405; Lev, Einat/0000-0002-8174-0558; Medard, Etienne/0000-0002-7040-7442	NSF	NSF(National Science Foundation (NSF))	We thank the reviewers for their constructive comments. This research was supported by the NSF.	DAVIES JH, 1992, J GEOPHYS RES-SOL EA, V97, P2037, DOI 10.1029/91JB02571; England P, 2004, GEOPHYS J INT, V159, P1138, DOI 10.1111/j.1365-246X.2004.02419.x; England P, 2004, GEOPHYS J INT, V156, P377, DOI 10.1111/j.1365-246X.2003.02132.x; Fumagalli P, 2005, J PETROL, V46, P555, DOI 10.1093/petrology/egh088; Gill J.B., 1981, OROGENIC ANDESITES P, DOI [10.1007/978-3-642-68012-0, DOI 10.1007/978-3-642-68012-0]; Grove TL, 2006, EARTH PLANET SC LETT, V249, P74, DOI 10.1016/j.epsl.2006.06.043; Iwamori H, 1998, EARTH PLANET SC LETT, V160, P65, DOI 10.1016/S0012-821X(98)00080-6; JARRARD RD, 1986, REV GEOPHYS, V24, P217, DOI 10.1029/RG024i002p00217; Kelemen P., 2003, GEOPHYS MONOGR SER, V138, P293, DOI DOI 10.1029/138GM13; Kelemen PB, 1998, EARTH PLANET SC LETT, V164, P387, DOI 10.1016/S0012-821X(98)00233-7; Kincaid C, 1997, J GEOPHYS RES-SOL EA, V102, P12295, DOI 10.1029/96JB03553; KIRBY SH, 1991, SCIENCE, V252, P216, DOI 10.1126/science.252.5003.216; MCKENZIE DP, 1969, GEOPHYS J ROY ASTR S, V18, P1, DOI 10.1111/j.1365-246X.1969.tb00259.x; MEDARD E, 2006, J GEOPHYS RES, V111, pE1103; MOLNAR P, 1990, J GEOPHYS RES-SOLID, V95, P4833, DOI 10.1029/JB095iB04p04833; MORAN AE, 1992, EARTH PLANET SC LETT, V111, P331, DOI 10.1016/0012-821X(92)90188-2; Pawley A, 2003, CONTRIB MINERAL PETR, V144, P449, DOI 10.1007/s00410-002-0409-y; PEACOCK SM, 1994, EARTH PLANET SC LETT, V121, P227, DOI 10.1016/0012-821X(94)90042-6; PLANK T, 1993, NATURE, V362, P739, DOI 10.1038/362739a0; RINGWOOD A, 1975, J GEOL SOC, V130, P183; Schmidt MW, 1998, EARTH PLANET SC LETT, V163, P361, DOI 10.1016/S0012-821X(98)00142-3; Stern CR, 1996, CONTRIB MINERAL PETR, V123, P263, DOI 10.1007/s004100050155; Syracuse EM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001045; Tatsumi Y., 2005, GSA TODAY, V15, P4, DOI [DOI 10.1130/1052-5173(2005)015[4:TSFHI0]2.0.C0;2, DOI 10.1130/1052-5173(2005)015[4:TSFHIO]2.0.CO;2]; TILL CB, 2007, AGU FALL M S; TOKSOZ MN, 1971, J GEOPHYS RES, V76, P1113, DOI 10.1029/JB076i005p01113; van Keken PE, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000256; van Keken PE, 2008, PHYS EARTH PLANET IN, V171, P187, DOI 10.1016/j.pepi.2008.04.015; WYLLIE PJ, 1982, GEOL SOC AM BULL, V93, P468, DOI 10.1130/0016-7606(1982)93<468:SPATEP>2.0.CO;2; YOGODZINSKI GM, 1995, GEOL SOC AM BULL, V107, P505, DOI 10.1130/0016-7606(1995)107<0505:MAITWA>2.3.CO;2	30	136	140	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					694	697		10.1038/nature08044	http://dx.doi.org/10.1038/nature08044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494913				2022-12-28	WOS:000266608600042
J	Funakoshi, M; Tomko, RJ; Kobayashi, H; Hochstrasser, M				Funakoshi, Minoru; Tomko, Robert J., Jr.; Kobayashi, Hideki; Hochstrasser, Mark			Multiple Assembly Chaperones Govern Biogenesis of the Proteasome Regulatory Particle Base	CELL			English	Article							26 S-PROTEASOME; 20S PROTEASOME; PROTEIN-DEGRADATION; ATPASE SUBUNITS; YEAST; COMPLEX; IDENTIFICATION; RECOGNITION; DESTRUCTION; ACTIVATION	The central protease of eukaryotes, the 26S proteasome, has a 20S proteolytic core particle (CP) and an attached 19S regulatory particle ( RP). The RP is further subdivided into lid and base subcomplexes. Little is known about RP assembly. Here, we show that four conserved assembly factors govern biogenesis of the yeast RP base. Nas2 forms a complex with the Rpt4 and Rpt5 ATPases and enhances 26S proteasome formation in vivo and in vitro. Other RP subcomplexes contain Hsm3, which is related to mammalian proteasome subunit S5b. Hsm3 also contributes to base assembly. Larger Hsm3-containing complexes include two additional proteins, Nas6 and Rpn14, which function as assembly chaperones as well. Specific deletion combinations affecting these four factors cause severe perturbations to RP assembly. Our results demonstrate that proteasomal RP biogenesis requires multiple, functionally overlapping chaperones and suggest a model in which subunits form specific subcomplexes that then assemble into the base.	[Funakoshi, Minoru; Tomko, Robert J., Jr.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kobayashi, Hideki] Okayama Univ, Ctr Fac Dev, Okayama 7008530, Japan	Yale University; Okayama University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Tomko Jr., Robert/0000-0003-2515-1078; Hochstrasser, Mark/0000-0002-1131-5484	Japan Society for the Promotion of Science Postdoctoral Fellowship; National Institutes of Health [GM046904, GM083050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083050, R37GM046904, R01GM046904] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Enenkel, D. Finley, T. Kodadek, W. Tansey, and D. H. Wolf for antibodies and A. Kusmierczyk and M. Kunjappu for comments on the manuscript. M. F. was supported in part by a Japan Society for the Promotion of Science Postdoctoral Fellowship. This work was supported initially by National Institutes of Health grant GM046904 and more recently by GM083050 to M. H.	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Fedorova IV, 2000, GENETICS, V154, P495; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; GUTHRIE C, 2002, GUIDE YEAST GENETICS, V350; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Heinemeyer W, 2004, CELL MOL LIFE SCI, V61, P1562, DOI 10.1007/s00018-004-4130-z; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Russell SJ, 1996, J BIOL CHEM, V271, P32810, DOI 10.1074/jbc.271.51.32810; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Whitby FG, 2007, STRUCTURE, V15, P137, DOI 10.1016/j.str.2007.01.009	41	127	136	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					887	899		10.1016/j.cell.2009.04.061	http://dx.doi.org/10.1016/j.cell.2009.04.061			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19446322	Green Accepted, Bronze			2022-12-28	WOS:000266454800019
J	Paterson, AM; Vanguri, VK; Sharpe, AH				Paterson, Alison M.; Vanguri, Vijay K.; Sharpe, Arlene H.			SnapShot: B7/CD28 Costimulation	CELL			English	Editorial Material							CO-STIMULATION; LIGANDS; CTLA-4; PD-1		[Paterson, Alison M.; Vanguri, Vijay K.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Paterson, AM (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.							Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Freeman GJ, 2008, P NATL ACAD SCI USA, V105, P10275, DOI 10.1073/pnas.0805459105; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kroczek RA, 2004, CURR OPIN IMMUNOL, V16, P321, DOI 10.1016/j.coi.2004.03.002; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	9	32	35	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 29	2009	137	5					974	U346		10.1016/j.cell.2009.05.015	http://dx.doi.org/10.1016/j.cell.2009.05.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490900	Bronze			2022-12-28	WOS:000266454800027
J	Wang, D; Bushnell, DA; Huang, XH; Westover, KD; Levitt, M; Kornberg, RD				Wang, Dong; Bushnell, David A.; Huang, Xuhui; Westover, Kenneth D.; Levitt, Michael; Kornberg, Roger D.			Structural Basis of Transcription: Backtracked RNA Polymerase II at 3.4 Angstrom Resolution	SCIENCE			English	Article							ELONGATION-FACTOR TFIIS; IN-VIVO; TERNARY COMPLEXES; ALPHA-AMANITIN; ACTIVE-CENTER; TRIGGER LOOP; FACTOR-SII; FACTOR S; CLEAVAGE; FIDELITY	Transcribing RNA polymerases oscillate between three stable states, two of which, pre- and posttranslocated, were previously subjected to x-ray crystal structure determination. We report here the crystal structure of RNA polymerase II in the third state, the reverse translocated, or "backtracked" state. The defining feature of the backtracked structure is a binding site for the first backtracked nucleotide. This binding site is occupied in case of nucleotide misincorporation in the RNA or damage to the DNA, and is termed the "P" site because it supports proofreading. The predominant mechanism of proofreading is the excision of a dinucleotide in the presence of the elongation factor SII (TFIIS). Structure determination of a cocrystal with TFIIS reveals a rearrangement whereby cleavage of the RNA may take place.	[Wang, Dong; Bushnell, David A.; Huang, Xuhui; Westover, Kenneth D.; Levitt, Michael; Kornberg, Roger D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	Westover, Ken/AAZ-1795-2020; Huang, Xuhui/ABE-3207-2021; Levitt, Michael/E-4582-2012; Wang, Dong/C-8943-2012	Westover, Ken/0000-0003-3653-5923; Huang, Xuhui/0000-0002-7119-9358; Levitt, Michael/0000-0002-8414-7397; 	NIH [GM049985, GM036559, GM041455]; Leukemia and Lymphoma Society; NIH Pathway to Independence Award [K99 GM085136]; NIH Roadmap for Medical Research Grant [U54 GM072970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM085136, R01GM049985, R37GM041455, U54GM072970, R37GM036659, R01GM036659, R01GM041455, R00GM085136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM049985 and GM036559 to R.D.K. D.W. was supported by a special fellow award from the Leukemia and Lymphoma Society and the NIH Pathway to Independence Award (K99 GM085136). X.H. and M.L. were supported by NIH Roadmap for Medical Research Grant U54 GM072970 and NIH grant GM041455. Portions of the research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. Portions of this research were conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory, on behalf of the DOE, Office of Basic Energy Sciences. The Berkeley Center for Structural Biology is supported in part by the DOE, Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences. We thank C. D. Kaplan for providing TFIIS E291H mutant for structural studies. PDB accession codes: 13-nt oligomer backtracked pol II, 3GTJ; 18-nt oligomer backtracked pol II, 3GTK; 12-nt oligomer backtracked pol II, 3GTG; and 13-nt oligomer backtracked pol II with TFIIS, 3GTM.	Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gu WG, 1995, J BIOL CHEM, V270, P30441, DOI 10.1074/jbc.270.51.30441; GU WG, 1993, J BIOL CHEM, V268, P25604; Guglielmi B, 2007, P NATL ACAD SCI USA, V104, P16062, DOI 10.1073/pnas.0704534104; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Koyama H, 2003, GENES CELLS, V8, P779, DOI 10.1046/j.1365-2443.2003.00677.x; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1993, CELL MOL BIOL RES, V39, P331; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; SEHGAL PB, 1976, SCIENCE, V194, P431, DOI 10.1126/science.982026; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shimoaraiso M, 1997, J BIOL CHEM, V272, P26550, DOI 10.1074/jbc.272.42.26550; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toulme F, 1999, EMBO J, V18, P5052, DOI 10.1093/emboj/18.18.5052; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	50	177	179	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1203	1206		10.1126/science.1168729	http://dx.doi.org/10.1126/science.1168729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478184	Green Accepted			2022-12-28	WOS:000266410100047
J	Doyal, L				Doyal, Len			Personal View Euthanasia and free speech in Ireland	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, London WC1E 7HU, England	University of London	Doyal, L (corresponding author), Univ London, London WC1E 7HU, England.	l.doyal@qmul.ac.uk						Battin MP, 2007, J MED ETHICS, V33, P591, DOI 10.1136/jme.2007.022335; Doyal L, 2001, BMJ-BRIT MED J, V323, P1079, DOI 10.1136/bmj.323.7321.1079; DOYAL L, 2009, IRISH TIMES     0424; DOYAL L, 2006, 1 DO NO HARM, P461; Doyal Len., 2006, CLIN ETHICS, V1, P65, DOI DOI 10.1258/147775006777254579; Lewis P, 2007, J LAW MED ETHICS, V35, P197, DOI 10.1111/j.1748-720X.2007.00124.x; MINIHAN M, 2009, IRISH TIMES     0418; 2009, PRIME TIME      0428	8	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2009	338								b2109	10.1136/bmj.b2109	http://dx.doi.org/10.1136/bmj.b2109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	451WT	19474015				2022-12-28	WOS:000266502300015
J	Schnitzbauer, AA; Lamby, PE; Mutzbauer, I; Schlitt, HJ; Geissler, EK				Schnitzbauer, Andreas A.; Lamby, Philipp E.; Mutzbauer, Ingrid; Schlitt, Hans J.; Geissler, Edward K.		SiLVER05 Study Grp	Procedures for ethical review for clinical trials within the EU	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MULTICENTER		[Mutzbauer, Ingrid; Schlitt, Hans J.; Geissler, Edward K.; SiLVER05 Study Grp] Univ Regensburg, Med Ctr, Dept Surg, D-93053 Regensburg, Germany	University of Regensburg	Geissler, EK (corresponding author), Univ Regensburg, Med Ctr, Dept Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	edward.geissler@klinik.uni-regensburg.de	Schlitt, Hans J./ABG-4368-2020; Geissler, Edward/R-4131-2016					Dreier G, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P445, DOI 10.1007/s00103-005-1019-4; Emanuel EJ, 2006, PLOS MED, V3, P941, DOI 10.1371/journal.pmed.0030309; Heidenreich K, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P415, DOI 10.1007/s00103-005-1015-8; Maskell NA, 2003, QJM-INT J MED, V96, P305, DOI 10.1093/qjmed/hcg042; Tully J, 2000, BRIT MED J, V320, P1179, DOI 10.1136/bmj.320.7243.1179; 200500536236 EUDRACT	6	9	9	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2009	338								b1893	10.1136/bmj.b1893	http://dx.doi.org/10.1136/bmj.b1893			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	448NU	19465471				2022-12-28	WOS:000266270100005
J	Western, D; Behrensmeyer, AK				Western, David; Behrensmeyer, Anna K.			Bone Assemblages Track Animal Community Structure over 40 Years in an African Savanna Ecosystem	SCIENCE			English	Article							DEATH ASSEMBLAGES; FIDELITY; PRESERVATION; ABUNDANCE; CLIMATE; SIZE	Reconstructing ancient communities depends on how accurately fossil assemblages retain information about living populations. We report a high level of fidelity between modern bone assemblages and living populations based on a 40-year study of the Amboseli ecosystem in southern Kenya. Relative abundance of 15 herbivorous species recorded in the bone assemblage accurately tracks the living populations through major changes in community composition and habitat over intervals as short as 5 years. The aggregated bone sample provides an accurate record of community structure time-averaged over four decades. These results lay the groundwork for integrating paleobiological and contemporary ecological studies across evolutionary and ecological time scales. Bone surveys also provide a useful method of assessing population changes and community structure for modern vertebrates.	[Western, David] African Conservat Ctr, Nairobi, Kenya; [Behrensmeyer, Anna K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, MRC 121, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Western, D (corresponding author), African Conservat Ctr, Box 62844, Nairobi, Kenya.	dwestern@africaonline.co.ke; behrensa@si.edu			Ford Foundation; Wildlife Conservation Society; Liz Claiborne Art Ortenberg Foundation; National Geographic Society [1508, 4339-90, 7525-03]; Simithsonian Institution	Ford Foundation; Wildlife Conservation Society; Liz Claiborne Art Ortenberg Foundation; National Geographic Society(National Geographic Society); Simithsonian Institution	D.W.'s ecological studies have been supported by the Ford Foundation, Wildlife Conservation Society, and Liz Claiborne Art Ortenberg Foundation. We acknowledge the statistical assistance of V. Mose, T. Faith, G. Hunt, S. Kidwell, and A. Tomasovych and the field support of D. Maitumo. A.K.B.'s taphonomic research has been supported by the National Geographic Society (grants 1508, 4339-90, and 7525-03) and the Simithsonian Institution. Particular thanks are due to D.D. Boaz, J. Altmann, E. Kanga, F. Odock, and many other individuals who provided essential advice and help with the bone surveys. Permission for the studies was granted by the Office of the President, Kenya, and institutional support over the years was provided by the Kenya Wildlife Service and the National Museums of Kenya.	Altmann J, 2002, AFR J ECOL, V40, P248, DOI 10.1046/j.1365-2028.2002.00366.x; BADGLEY C, 1986, Palaios, V1, P328, DOI 10.2307/3514695; Behrensmeyer A.K., 1980, P72; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; BEHRENSMEYER AK, 1979, PALEOBIOLOGY, V5, P12, DOI 10.1017/S0094837300006254; Behrensmeyer Anna K., 1992, P15; Brown J.H., 1995, MACROECOLOGY; Damuth J., 1990, BODY SIZE MAMMALIAN; FAITH JT, 2008, BIENN M PAL SOC S AF; Hadly EA, 1999, PALAEOGEOGR PALAEOCL, V149, P389, DOI 10.1016/S0031-0182(98)00214-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Kidwell SM, 2007, P NATL ACAD SCI USA, V104, P17701, DOI 10.1073/pnas.0707194104; Miller J, 2008, J VERTEBR PALEONTOL, V28, p116A; Pennycuick C.J., 1972, East African Wildlife Journal, V10, P175; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; POWELL EN, 1992, PALAEOGEOGR PALAEOCL, V95, P209, DOI 10.1016/0031-0182(92)90142-R; Reed DN, 2007, VERTEBR PALEOBIOL PA, P217, DOI 10.1007/978-1-4020-3098-7_9; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Sokal RR, 1995, BIOMETRY; Terry RC, 2008, PALAIOS, V23, P402, DOI 10.2110/palo.2007.p07-071r; Tomasovych A, 2009, PALEOBIOLOGY, V35, P94, DOI 10.1666/08024.1; Western D, 2004, AFR J ECOL, V42, P111, DOI 10.1111/j.1365-2028.2004.00506.x; Western D., 1980, P41; WESTERN D, 1975, East African Wildlife Journal, V13, P265; WESTERN D, 1979, AFR J ECOL, V17, P185, DOI 10.1111/j.1365-2028.1979.tb00256.x; WESTERN D, 1973, NATURE, V241, P104, DOI 10.1038/241104a0; Western D., 2006, AFRICAN J ECOLOGY, V45, P302, DOI DOI 10.1111/J.1365-2028.2006	30	69	71	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1061	1064		10.1126/science.1171155	http://dx.doi.org/10.1126/science.1171155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461002				2022-12-28	WOS:000266246700039
J	Campbell-Lendrum, D; Bertollini, R; Neira, M; Ebi, K; McMichael, A				Campbell-Lendrum, Diarmid; Bertollini, Roberto; Neira, Maria; Ebi, Kristie; McMichael, Anthony			Health and climate change: a roadmap for applied research	LANCET			English	Editorial Material									[Campbell-Lendrum, Diarmid; Bertollini, Roberto; Neira, Maria] WHO, Publ Hlth & Environm Dept, CH-1277 Geneva, Switzerland; [Ebi, Kristie] Carnegie Inst, Intergovernmental Panel Climate Change Tech Suppo, Stanford, CA USA; [McMichael, Anthony] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	World Health Organization; Carnegie Institution for Science; Australian National University	Campbell-Lendrum, D (corresponding author), WHO, Publ Hlth & Environm Dept, CH-1277 Geneva, Switzerland.	campbelllendrumd@who.int						[Anonymous], 2008, LANCET, V372, P1855, DOI 10.1016/S0140-6736(08)61789-4; [Anonymous], 2009, PROT HLTH CLIM CHANG; WHO, 2008, 61 WORLD HLTH ASS	3	41	42	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 16	2009	373	9676					1663	1665		10.1016/S0140-6736(09)60926-0	http://dx.doi.org/10.1016/S0140-6736(09)60926-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RP	19447242				2022-12-28	WOS:000266209800006
J	Duggavathi, R; Murphy, BD				Duggavathi, Rajesha; Murphy, Bruce D.			Ovulation Signals	SCIENCE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; PREOVULATORY FOLLICLES; GRANULOSA-CELLS; DIFFERENTIATION; EXPRESSION; DEFECTS; RIP140; MAPKS		[Duggavathi, Rajesha] McGill Univ, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Murphy, Bruce D.] Univ Montreal, Ctr Rech & Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada	McGill University; Universite de Montreal	Duggavathi, R (corresponding author), McGill Univ, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	raj.duggavathi@mcgill.ca; bruce.d.murphy@umontreal.ca	Duggavathi, Raj/GSJ-3503-2022	Murphy, Bruce/0000-0001-7158-3360				Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Ho PC, 2008, CELL SIGNAL, V20, P1911, DOI 10.1016/j.cellsig.2008.07.001; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Murphy BD, 2000, BIOL REPROD, V63, P2, DOI 10.1095/biolreprod63.1.2; Nelson-Degrave VL, 2005, MOL ENDOCRINOL, V19, P379, DOI 10.1210/me.2004-0178; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Pedram A, 2009, J BIOL CHEM, V284, P3488, DOI 10.1074/jbc.M806249200; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Su YQ, 2006, BIOL REPROD, V75, P859, DOI 10.1095/biolreprod.106.052613; Tullet JMA, 2005, ENDOCRINOLOGY, V146, P4127, DOI 10.1210/en.2005-0348	13	31	31	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					890	891		10.1126/science.1174130	http://dx.doi.org/10.1126/science.1174130			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443772				2022-12-28	WOS:000266048800022
J	Mobbs, D; Yu, RJ; Meyer, M; Passamonti, L; Seymour, B; Calder, AJ; Schweizer, S; Frith, CD; Dalgleish, T				Mobbs, Dean; Yu, Rongjun; Meyer, Marcel; Passamonti, Luca; Seymour, Ben; Calder, Andrew J.; Schweizer, Susanne; Frith, Chris D.; Dalgleish, Tim			A Key Role for Similarity in Vicarious Reward	SCIENCE			English	Article							OTHERS		[Mobbs, Dean; Yu, Rongjun; Meyer, Marcel; Passamonti, Luca; Calder, Andrew J.; Schweizer, Susanne; Dalgleish, Tim] MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Meyer, Marcel] Univ Birmingham, Dept Psychol, Birmingham B15 2TT, W Midlands, England; [Passamonti, Luca] ISN, CNR, I-87050 Cosenza, Italy; [Seymour, Ben; Frith, Chris D.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Seymour, Ben] ESRC Ctr Econ Learning & Social Evolut UCL, London WC1H OAN, England; [Frith, Chris D.] Aarhus Univ, Ctr Funct Integrat Neurosci, DK-800 Aarhus, Denmark	University of Birmingham; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); University of London; University College London; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of London; University College London; Aarhus University	Mobbs, D (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England.	dean.mobbs@mrc-cbu.cam.ac.uk	Frith, Chris D/A-2171-2009; Passamonti, Luca/I-7057-2019; Schweizer, Susanne/X-4313-2018; Yu, Rongjun/AAV-2615-2020; Dalgleish, Tim/E-8341-2010	Frith, Chris D/0000-0002-8665-0690; Passamonti, Luca/0000-0002-7937-0615; Schweizer, Susanne/0000-0001-6153-8291; Yu, Rongjun/0000-0003-0123-1524; Dalgleish, Tim/0000-0002-7304-2231; Seymour, Ben/0000-0003-1724-5832	MRC; MRC [MC_U105579214] Funding Source: UKRI; Economic and Social Research Council [RES-538-28-1001] Funding Source: researchfish; Medical Research Council [MC_U105579215, MC_U105579214] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Ewbank, R. Henson, and E. Hill for their help. This work was conducted at the Cognition and Brain Sciences Unit and supported by the MRC.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Park JH, 2005, EVOL HUM BEHAV, V26, P158, DOI 10.1016/j.evolhumbehav.2004.08.013; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022	9	199	204	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					900	900		10.1126/science.1170539	http://dx.doi.org/10.1126/science.1170539			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443777	Green Accepted			2022-12-28	WOS:000266048800027
J	Currie, RJ; Watkinson, A				Currie, R. J.; Watkinson, A.			Picture quiz Unwell man with abdominal pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							EMPHYSEMATOUS PYELONEPHRITIS; PERCUTANEOUS DRAINAGE; MANAGEMENT; GAS		[Currie, R. J.; Watkinson, A.] Royal Devon & Exeter Hosp, Dept Radiol, Exeter EX2 5DW, Devon, England	University of Exeter	Currie, RJ (corresponding author), Royal Devon & Exeter Hosp, Dept Radiol, Barrack Rd, Exeter EX2 5DW, Devon, England.	r.currie@nhs.net						Chen MT, 1997, J UROLOGY, V157, P1569, DOI 10.1016/S0022-5347(01)64797-9; Huang JJ, 2000, ARCH INTERN MED, V160, P797, DOI 10.1001/archinte.160.6.797; Joseph RC, 1996, RADIOGRAPHICS, V16, P295, DOI 10.1148/radiographics.16.2.8966288; MICHAELI J, 1984, J UROLOGY, V131, P203, DOI 10.1016/S0022-5347(17)50309-2; Narlawar RS, 2004, CLIN RADIOL, V59, P192, DOI 10.1016/S0009-9260(03)00295-2; Portnoy O, 2007, EMERG RADIOL, V14, P83, DOI 10.1007/s10140-007-0599-8; SCHULTZ EH, 1962, J UROLOGY, V87, P762, DOI 10.1016/S0022-5347(17)65043-2; Somani BK, 2008, J UROLOGY, V179, P1844, DOI 10.1016/j.juro.2008.01.019; Wan YL, 1996, RADIOLOGY, V198, P433, DOI 10.1148/radiology.198.2.8596845	9	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 13	2009	338								b1635	10.1136/bmj.b1635	http://dx.doi.org/10.1136/bmj.b1635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	446IZ	19439768				2022-12-28	WOS:000266116600002
J	Ahmad, F; Hogg-Johnson, S; Stewart, DE; Skinner, HA; Glazier, RH; Levinson, W				Ahmad, Farah; Hogg-Johnson, Sheilah; Stewart, Donna E.; Skinner, Harvey A.; Glazier, Richard H.; Levinson, Wendy			Computer-Assisted Screening for Intimate Partner Violence and Control A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-PROFESSIONALS SCREEN; DOMESTIC VIOLENCE; CARE PROVIDERS; BATTERED WOMEN; HELP-SEEKING; ABUSE; INTERVENTION; PREVALENCE; RISK; DISCLOSURE	Background: Intimate partner violence and control (IPVC) is prevalent and can be a serious health risk to women. Objective: To assess whether computer-assisted screening can improve detection of women at risk for IPVC in a family practice setting. Design: Randomized trial. Randomization was computer-generated. Allocation was concealed by using opaque envelopes that recruiters opened after patient consent. Patients and providers, but not outcome assessors, were blinded to the study intervention. Setting: An urban, academic, hospital-affiliated family practice clinic in Toronto, Ontario, Canada. Participants: Adult women in a current or recent relationship. Intervention: Computer-based multirisk assessment report attached to the medical chart. The report was generated from information provided by participants before the physician visit (n = 144). Control participants received standard medical care (n = 149). Measurements: Initiation of discussion about risk for IPVC (discussion opportunity) and detection of women at risk based on review of audiotaped medical visits. Results: The overall prevalence of any type of violence or control was 22% (95% CI, 17% to 27%). In adjusted analyses based on complete cases (n = 282), the intervention increased opportunities to discuss IPVC (adjusted relative risk, 1.4 [CI, 1.1 to 1.9]) and increased detection of IPVC (adjusted relative risk, 2.0 [CI, 0.9 to 4.1]). Participants recognized the benefits of computer screening but had some concerns about privacy and interference with physician interactions. Limitation: The study was done at 1 clinic, and no measures of women's use of services or health outcomes were used. Conclusion: Computer screening effectively detected IPVC in a busy family medicine practice, and it was acceptable to patients.	[Ahmad, Farah] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; Inst Work & Hlth, Toronto, ON M5G 2E9, Canada; Univ Hlth Network, Womens Hlth Program, Toronto, ON M5G 2C4, Canada; York Univ, Toronto, ON M3J 1P3, Canada; St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada	University of Toronto; Institute for Work & Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; York University - Canada; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Ahmad, F (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada.	farah.ahmad@utoronto.ca	Glazier, Richard H/E-5255-2012; Stewart, Donna Eileen E/J-2844-2016; Ahmad, Farah/B-4261-2008	Stewart, Donna Eileen E/0000-0002-8157-7746; Ahmad, Farah/0000-0001-9747-1148	Canadian Institutes of Health Research [IGF 63976, FOW 68219]; Institute of Gender & Health, Ontario Women's Health Council; Strategic Training on Health Care, Place & Technology Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Gender & Health, Ontario Women's Health Council; Strategic Training on Health Care, Place & Technology Program	The study contributed toward doctoral and fellowship training of Dr. Ahmad, which was funded by the Canadian Institutes of Health Research ( grants IGF 63976 and FOW 68219): Institute of Gender & Health, Ontario Women's Health Council, and Strategic Training on Health Care, Place & Technology Program. The authors gratefully acknowledge the support of the Ontario Ministry of Health and Long-Term Care. Support from the Centre for Research on Inner City Health, The Keenan Research Centre, in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, is much appreciated.	ADAY LA, 1996, DESIGNING CONDUCTING, P143; Ahmad F, 2007, CAN FAM PHYSICIAN, V53, P461; Ahmad F, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.955; *AM AC FAM PHYS, 2005, VIOL POS PAP AAFP PO; Bauer HM, 2000, J HEALTH CARE POOR U, V11, P33; Berg AO, 2004, ANN INTERN MED, V140, P382, DOI 10.7326/0003-4819-140-5-200403020-00021; Bradley F, 2002, BRIT MED J, V324, P271, DOI 10.1136/bmj.324.7332.271; BROWN JB, 1993, J FAM PRACTICE, V36, P185; BROWN R, 2002, ROADMAPS CLIN PRACTI; Bybee D, 2005, AM J COMMUN PSYCHOL, V36, P85, DOI 10.1007/s10464-005-6234-5; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Carroll JC, 2005, CAN MED ASSOC J, V173, P253, DOI 10.1503/cmaj.1040610; Chemlak D, 2005, J OBSTET GYNAECOL CA, V27, P365; Cohen Marsha M, 2004, BMC Womens Health, V4 Suppl 1, pS22, DOI 10.1186/1472-6874-4-S1-S22; Cole TB, 2000, JAMA-J AM MED ASSOC, V284, P551, DOI 10.1001/jama.284.5.551; Dearwater SR, 1998, JAMA-J AM MED ASSOC, V280, P433, DOI 10.1001/jama.280.5.433; Duterte EE, 2008, J WOMENS HEALTH, V17, P85, DOI 10.1089/jwh.2007.0460; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; Garimella R, 2000, J WOMEN HEALTH GEN-B, V9, P405, DOI 10.1089/15246090050020727; Gerbert B, 1999, WOMEN HEALTH, V29, P115, DOI 10.1300/J013v29n03_08; Gerbert B, 1999, MED CARE, V37, P104, DOI 10.1097/00005650-199901000-00014; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kernic MA, 2000, AM J PUBLIC HEALTH, V90, P1416, DOI 10.2105/AJPH.90.9.1416; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; Meinert CL., 1986, CLIN TRIALS DESIGN C; Nelson HD, 2004, ANN INTERN MED, V140, P387, DOI 10.7326/0003-4819-140-5-200403020-00015; Neuendorf K.A., 2002, CONTENT ANAL GUIDEBO; NORTON LB, 1995, OBSTET GYNECOL, V85, P321, DOI 10.1016/0029-7844(94)00429-H; O'Leary K D, 1999, Violence Vict, V14, P3; Parker B, 1999, RES NURS HEALTH, V22, P59; PIANTADOSI S, 1997, CLIN TRIALS METHODOL; Plichta SB, 2001, WOMEN HEALTH ISS, V11, P244, DOI 10.1016/S1049-3867(01)00085-8; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; REIDY R, 1991, PUBLIC HEALTH REP, V106, P360; Rhodes KV, 2007, ANN INTERN MED, V147, P620, DOI 10.7326/0003-4819-147-9-200711060-00006; Rhodes KV, 2006, ARCH INTERN MED, V166, P1107, DOI 10.1001/archinte.166.10.1107; Rhodes KV, 2002, ANN EMERG MED, V40, P476, DOI 10.1067/mem.2002.127181; Rhodes KV, 2001, ANN EMERG MED, V37, P284, DOI 10.1067/mem.2001.110818; RHODES KV, 2005, FAMILY VIOLENCE PREV, V1, pE14; Rodriguez MA, 1999, JAMA-J AM MED ASSOC, V282, P468, DOI 10.1001/jama.282.5.468; Rodriguez MA, 2001, J FAM PRACTICE, V50, P338; Rodriguez MA, 1996, ARCH FAM MED, V5, P153, DOI 10.1001/archfami.5.3.153; Sackett L A, 1999, Violence Vict, V14, P105; Sansone R A, 1997, Violence Vict, V12, P165; SKINNER HA, 1993, ADDICTIVE BEHAV LIFE, P89; *STAT CAN, 2005, 85224XIE STAT CAN; *STATACORP, 2003, STAT STAT SOFTW REL; SUGG NK, 1992, JAMA-J AM MED ASSOC, V267, P3157, DOI 10.1001/jama.267.23.3157; Taket A, 2004, PLOS MED, V1, P7, DOI 10.1371/journal.pmed.0010004; Taket A, 2003, BRIT MED J, V327, P673, DOI 10.1136/bmj.327.7416.673; Titus K, 1996, JAMA-J AM MED ASSOC, V275, P1863, DOI 10.1001/jama.275.24.1863; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; *US DEP JUST, 2003, NCJ197838 US DEP JUS; Waalen J, 2000, AM J PREV MED, V19, P230, DOI 10.1016/S0749-3797(00)00229-4; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Wagner PJ, 1998, ARCH FAM MED, V7, P25, DOI 10.1001/archfami.7.1.25; WARSHAW C, 1996, IMPROVING HLTH CARE; Warshaw C, 1989, GENDER SOC, V3, P506, DOI 10.1177/089124389003004008; Wathen CN, 2003, CAN MED ASSOC J, V169, P582; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; World Health Organization, 2002, WORLD REPORT VIOLENC, P89; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zink T, 2004, ANN FAM MED, V2, P231, DOI 10.1370/afm.74; 1995, AM FAM PHYS, V52, P1209	67	61	61	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2009	151	2					93	W24		10.7326/0003-4819-151-2-200907210-00124	http://dx.doi.org/10.7326/0003-4819-151-2-200907210-00124			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	478RH	19487706				2022-12-28	WOS:000268605300003
J	Hadjur, S; Williams, LM; Ryan, NK; Cobb, BS; Sexton, T; Fraser, P; Fisher, AG; Merkenschlager, M				Hadjur, Suzana; Williams, Luke M.; Ryan, Natalie K.; Cobb, Bradley S.; Sexton, Tom; Fraser, Peter; Fisher, Amanda G.; Merkenschlager, Matthias			Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus	NATURE			English	Article							CCCTC-BINDING FACTOR; GENE-EXPRESSION; CELL DIFFERENTIATION; INTERFERON-GAMMA; CONTROL REGION; CTCF; TRANSCRIPTION; CHROMATIN; CONFORMATION; GENOME	Cohesin-mediated sister chromatid cohesion is essential for chromosome segregation and post-replicative DNA repair(1,2). In addition, evidence from model organisms(3-6) and from human genetics(7) suggests that cohesin is involved in the control of gene expression(8,9). This non-canonical role has recently been rationalized by the findings that mammalian cohesin complexes are recruited to a subset of DNase I hypersensitive sites and to conserved noncoding sequences by the DNA-binding protein CTCF10-13. CTCF functions at insulators (which control interactions between enhancers and promoters) and at boundary elements (which demarcate regions of distinct chromatin structure)(14), and cohesin contributes to its enhancer-blocking activity(10,11). The underlying mechanisms remain unknown, and the full spectrum of cohesin functions remains to be determined. Here we show that cohesin forms the topological and mechanistic basis for cell-type-specific long-range chromosomal interactions in cis at the developmentally regulated cytokine locus IFNG. Hence, the ability of cohesin to constrain chromosome topology is used not only for the purpose of sister chromatid cohesion(1,2), but also to dynamically define the spatial conformation of specific loci. This new aspect of cohesin function is probably important for normal development(3-6) and disease(7).	[Hadjur, Suzana; Williams, Luke M.; Ryan, Natalie K.; Cobb, Bradley S.; Fisher, Amanda G.; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Sexton, Tom; Fraser, Peter] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB2 4AT, England	Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Merkenschlager, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Cane Rd, London W12 0NN, England.	matthias.merkenschlager@csc.mrc.ac.uk	Fraser, Peter/B-7549-2009; Ryan, Natalie K/H-1539-2011	Merkenschlager, Matthias/0000-0003-2889-3288; Sexton, Thomas/0000-0002-7824-1846; Fraser, Peter/0000-0002-0041-1227	Medical Research Council, UK; BBSRC [BBS/E/B/0000C151] Funding Source: UKRI; MRC [MC_U120027516, G117/530] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C151] Funding Source: researchfish; Medical Research Council [G117/530, MC_U120027516] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Messi, F. Sallusto and L. Bruno for help and advice with human T cells, L. Aragon for discussions, M. Leleu and M. Spivakov for help with informatics, D. Dormann for help with image analysis and E. Ng, E. O'Connor and P. Hexley for cell sorting. Supported by the Medical Research Council, UK.	Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Liu JL, 2008, ANNU REV GENOM HUM G, V9, P303, DOI 10.1146/annurev.genom.9.081307.164211; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884	30	396	404	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					410	U130		10.1038/nature08079	http://dx.doi.org/10.1038/nature08079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19458616	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000267979000042
J	Dhruva, SS; Phurrough, SE; Salive, ME; Redberg, RF				Dhruva, Sanket S.; Phurrough, Steve E.; Salive, Marcel E.; Redberg, Rita F.			CMS's Landmark Decision on CT Colonography - Examining the Relevant Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dhruva, Sanket S.; Redberg, Rita F.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Phurrough, Steve E.] Agcy Healthcare Res & Qual, Rockville, MD USA; [Salive, Marcel E.] CMS, Div Med & Surg Sci, Baltimore, MD USA	University of California System; University of California San Francisco; Agency for Healthcare Research & Quality	Dhruva, SS (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							*CTR MED MED SERV, CAG00396N CTR MED ME; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; GRANGKER K, CMS MADE WRONG DECIS; PEAR R, 2009, NY TIMES        0818, pA1; Redberg RF, 2008, NEW ENGL J MED, V359, P2309, DOI 10.1056/NEJMp0805920	5	44	46	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2699	2701		10.1056/NEJMp0904408	http://dx.doi.org/10.1056/NEJMp0904408			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19474419				2022-12-28	WOS:000267286600003
J	Vassilopoulos, S; Esk, C; Hoshino, S; Funke, BH; Chen, CY; Plocik, AM; Wright, WE; Kucherlapati, R; Brodsky, FM				Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Funke, Birgit H.; Chen, Chih-Ying; Plocik, Alex M.; Wright, Woodring E.; Kucherlapati, Raju; Brodsky, Frances M.			A Role for the CHC22 Clathrin Heavy-Chain Isoform in Human Glucose Metabolism	SCIENCE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; COATED VESICLES; PLASMA-MEMBRANE; GLUT4; TRAFFICKING; GLUCOSE-TRANSPORTER-4; MECHANISMS	Intracellular trafficking of the glucose transporter GLUT4 from storage compartments to the plasma membrane is triggered in muscle and fat during the body's response to insulin. Clathrin is involved in intracellular trafficking, and in humans, the clathrin heavy-chain isoform CHC22 is highly expressed in skeletal muscle. We found a role for CHC22 in the formation of insulin-responsive GLUT4 compartments in human muscle and adipocytes. CHC22 also associated with expanded GLUT4 compartments in muscle from type 2 diabetic patients. Tissue-specific introduction of CHC22 in mice, which have only a pseudogene for this protein, caused aberrant localization of GLUT4 transport pathway components in their muscle, as well as features of diabetes. Thus, CHC22-dependent membrane trafficking constitutes a species-restricted pathway in human muscle and fat with potential implications for type 2 diabetes.	[Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Chen, Chih-Ying; Brodsky, Frances M.] Univ Calif San Francisco, Sch Pharm, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Chen, Chih-Ying; Brodsky, Frances M.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Chen, Chih-Ying; Brodsky, Frances M.] Univ Calif San Francisco, Sch Med, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Vassilopoulos, Stephane; Esk, Christopher; Hoshino, Sachiko; Chen, Chih-Ying; Brodsky, Frances M.] Univ Calif San Francisco, George Williams Hooper Fdn, Sch Med, San Francisco, CA 94143 USA; [Funke, Birgit H.; Plocik, Alex M.; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School	Brodsky, FM (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	frances.brodsky@ucsf.edu	Kucherlapati, Raju/ABC-8807-2021; vassilopoulos, stephane/AAF-3865-2021; vassilopoulos, stéphane/F-6041-2014	vassilopoulos, stephane/0000-0003-0172-330X; Esk, Christopher/0000-0003-1833-0801; Plocik, Alex/0000-0001-9489-6466; Brodsky, Frances/0000-0002-1334-9258	NIH [GM038093, HD47863]; Muscular Dystrophy Association award; Fondation Recherche Medicale, France; UCSF School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association award; Fondation Recherche Medicale, France(Fondation pour la Recherche Medicale); UCSF School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Ohkoshi, A. Ishii, and A. Tamaoka for providing tissue samples from the archives of the Department of Neurology, Institute of Clinical Medicine, University of Tsukuba; P. Ursell for providing tissue samples from the Department of Pathology, UCSF; M. Birnbaum, J. Pessin, J. Bonifacino, and J. Hopwood for antibodies; E. Unger (UCSF Diabetes Center) and M. Yuneva (George Williams Hooper Foundation) for technical advice; and A. Klip (University of Toronto) for helpful discussion. This work was supported by NIH grants GM038093 to F.M.B. and HD47863 to R.K.; a research grant and a career development award from the Muscular Dystrophy Association to W.E.W. and S.H., respectively; a grant from the Fondation Recherche Medicale, France to S.V.; and a Research Evaluation and Allocation Committee grant from the UCSF School of Medicine to F.M.B. Some images were acquired at the Nikon Imaging Center at UCSF.	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Fazakerley DJ, 2009, J CELL SCI, V122, P727, DOI 10.1242/jcs.041178; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gillingham AK, 1999, J CELL SCI, V112, P4793; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Liu SH, 2001, EMBO J, V20, P272, DOI 10.1093/emboj/20.1.272; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; MUNOZ P, 1995, BIOCHEM J, V312, P393, DOI 10.1042/bj3120393; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Towler MC, 2004, MOL BIOL CELL, V15, P3181, DOI 10.1091/mbc.E04-03-0249; Wakeham DE, 2005, P NATL ACAD SCI USA, V102, P7209, DOI 10.1073/pnas.0502058102; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	30	80	82	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1192	1196		10.1126/science.1171529	http://dx.doi.org/10.1126/science.1171529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478182	Green Accepted			2022-12-28	WOS:000266410100044
J	Thanbichler, M				Thanbichler, Martin			Closing the Ring: A New Twist to Bacterial Chromosome Condensation	CELL			English	Editorial Material							BACILLUS-SUBTILIS; DNA-REPLICATION; SMC PROTEIN; SEGREGATION; INITIATION		Max Planck Inst Terr Microbiol, Independent Jr Res Grp Prokaryot Cell Biol, D-35043 Marburg, Germany	Max Planck Society	Thanbichler, M (corresponding author), Max Planck Inst Terr Microbiol, Independent Jr Res Grp Prokaryot Cell Biol, Karl Von Frisch Str, D-35043 Marburg, Germany.	thanbichler@mpi-marburg.mpg.de	Thanbichler, Martin/E-6035-2010					Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101	8	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 15	2009	137	4					598	600		10.1016/j.cell.2009.04.055	http://dx.doi.org/10.1016/j.cell.2009.04.055			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450506	Bronze			2022-12-28	WOS:000266114100006
J	Boyer, LV; Theodorou, AA; Berg, RA; Mallie, J; Chavez-Mendez, A; Garcia-Ubbelohde, W; Hardiman, S; Alagon, A				Boyer, Leslie V.; Theodorou, Andreas A.; Berg, Robert A.; Mallie, Joanne; Chavez-Mendez, Ariana; Garcia-Ubbelohde, Walter; Hardiman, Stephen; Alagon, Alejandro		Arizona Envenomation Investigators	Antivenom for Critically Ill Children with Neurotoxicity from Scorpion Stings	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRUROIDES-SCULPTURATUS; NA+-CHANNELS; ENVENOMATION; PEPTIDES	BACKGROUND Clinically significant scorpion envenomation by Centruroides sculpturatus produces a dramatic neuromotor syndrome and respiratory insufficiency that often necessitate intensive supportive care. We hypothesized that a scorpion-specific F(ab')(2) antivenom would promptly resolve clinical symptoms in children with this syndrome. METHODS In a randomized, double-blind study, the efficacy of scorpion-specific F(ab')(2) antivenom, as compared with placebo, was assessed in 15 children 6 months to 18 years of age who were admitted to a pediatric intensive care unit with clinically significant signs of scorpion envenomation. The primary end point was the resolution of the clinical syndrome within 4 hours after administration of the study drug. Secondary end points included the total dose of concomitant midazolam for sedation and quantitative plasma venom levels, before and after treatment. RESULTS The clinical syndrome resolved more rapidly among recipients of the antivenom than among recipients of placebo, with a resolution of symptoms in all eight antivenom recipients versus one of seven placebo recipients within 4 hours after treatment (P = 0.001). More midazolam was administered in the placebo recipients than in the antivenom recipients (mean cumulative dose, 4.61 vs. 0.07 mg per kilogram of body weight; P = 0.01). Plasma venom concentrations were undetectable in all eight antivenom recipients but in only one placebo recipient 1 hour after treatment (P = 0.001). CONCLUSIONS Among critically ill children with neurotoxic effects of scorpion envenomation, intravenous administration of scorpion-specific F(ab')(2) antivenom resolved the clinical syndrome within 4 hours, reduced the need for concomitant sedation with midazolam, and reduced the levels of circulating unbound venom. (ClinicalTrials.gov number, NCT00685230.)	[Boyer, Leslie V.] Univ Arizona, Hlth Sci Ctr, VIPER Inst, Tucson, AZ 85721 USA; [Berg, Robert A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Chavez-Mendez, Ariana; Alagon, Alejandro] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Garcia-Ubbelohde, Walter] Inst Bioclon, Mexico City, DF, Mexico; [Hardiman, Stephen] Stephen Hardiman Stat, Hackettstown, NJ USA	University of Arizona; University of Arizona Health Sciences; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Universidad Nacional Autonoma de Mexico	Boyer, LV (corresponding author), Univ Arizona, Hlth Sci Ctr, VIPER Inst, 1295 N Martin Ave, Tucson, AZ 85721 USA.	boyer@pharmacy.arizona.edu		Boyer, Leslie/0000-0002-7622-2326	Food and Drug Administration [FD-R-002385-01]; Arizona Biomedical Research Commission [0001]	Food and Drug Administration(United States Department of Health & Human Services); Arizona Biomedical Research Commission	Supported by grants from the Food and Drug Administration (FD-R-002385-01) and the Arizona Biomedical Research Commission (0001).	Banner W, 1999, ANN EMERG MED, V34, P669, DOI 10.1016/S0196-0644(99)70171-X; BERG RA, 1991, PEDIATRICS, V87, P930; Bronstein AC, 2007, CLIN TOXICOL, V45, P815, DOI 10.1080/15563650701754763; Calderon-Aranda ES, 1996, ENVENOMINGS THEIR TR, P311; Celis A, 2007, REV PANAM SALUD PUBL, V21, P373, DOI 10.1590/S1020-49892007000500005; Chavez-Mendez A., 2007, 9 PAN AM C INT SOC T; CHAVEZHARO A, 2005, 7 EXP M ENV CUERN MO; Corona M, 2001, TOXICON, V39, P1893, DOI 10.1016/S0041-0101(01)00174-X; CURRY SC, 1984, J TOXICOL-CLIN TOXIC, V21, P417; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; ESTEVEZ J, 2000, 4 EXP M ENV CUERN MO; Gibly R, 1999, ANN EMERG MED, V34, P620, DOI 10.1016/S0196-0644(99)70164-2; LoVecchio F, 1999, ANN EMERG MED, V34, P615, DOI 10.1016/S0196-0644(99)70176-9; Riley BD, 2006, ANN EMERG MED, V47, P398, DOI 10.1016/j.annemergmed.2005.11.042; Stahnke H L, 1972, Ariz Med, V29, P490; Valdez-Cruz NA, 2004, BIOCHIMIE, V86, P387, DOI 10.1016/j.biochi.2004.05.005; Vazquez H, 2005, TOXICON, V46, P797, DOI 10.1016/j.toxicon.2005.08.010	17	106	112	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2090	2098		10.1056/NEJMoa0808455	http://dx.doi.org/10.1056/NEJMoa0808455			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439743	Bronze			2022-12-28	WOS:000266011200007
J	Conard, NJ				Conard, Nicholas J.			A female figurine from the basal Aurignacian of Hohle Fels Cave in southwestern Germany	NATURE			English	Article							WESTERN EURASIA; LATE MIDDLE; EUROPE	Despite well over 100 years of research and debate, the origins of art remain contentious(1-3). In recent years, abstract depictions have been documented at southern African sites dating to similar to 75 kyr before present ( BP) 4,5, and the earliest figurative art, which is often seen as an important proxy for advanced symbolic communication, has been documented in Europe as dating to between 30 and 40 kyr BP2. Here I report the discovery of a female mammoth-ivory figurine in the basal Aurignacian deposit at Hohle Fels Cave in the Swabian Jura of southwestern Germany during excavations in 2008. This figurine was produced at least 35,000 calendar years ago, making it one of the oldest known examples of figurative art. This discovery predates the well-known Venuses from the Gravettian culture by at least 5,000 years and radically changes our views of the context and meaning of the earliest Palaeolithic art.	Univ Tubingen, Abt Altere Urgeschichte & Quartarokol, Inst Ur & Fruhgeschichte & Archaol Mittelalters, D-72070 Tubingen, Germany	Eberhard Karls University of Tubingen	Conard, NJ (corresponding author), Univ Tubingen, Abt Altere Urgeschichte & Quartarokol, Inst Ur & Fruhgeschichte & Archaol Mittelalters, D-72070 Tubingen, Germany.	nicholas.conard@uni-tuebingen.de		Conard, Nicholas/0000-0002-4633-0385	Deutsche Forschungsgemeinschaft; University of Tubingen; Heidelberger Akademie der Wissenschaften; Landesamt fur Denkmalpflege Baden-Wurttemberg; Alb-Donau-Kreis; Heidelberg Cement; Museumsgesellschaft Schelklingen; Gesellschaft fur Urgeschichte	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen; Heidelberger Akademie der Wissenschaften; Landesamt fur Denkmalpflege Baden-Wurttemberg; Alb-Donau-Kreis; Heidelberg Cement; Museumsgesellschaft Schelklingen; Gesellschaft fur Urgeschichte	Many colleagues, including S. Bailey, H. Bocherens, M. Bolus, S. Feine, H. Floss, P. Goldberg, P. Grootes, B. L. Hardy, T. Higham, M. Hofreiter, P. Kronneck, M. Kucera, L. Moreau, S. C. Munzel, D. Richter, F. H. Smith, H.-P. Uerpmann and S. Wolf have contributed to this research. I am particularly indebted to M. Malina for assistance during excavation and laboratory work, to R. Ehmann for the conservation of the Venus, to C. E. Miller for discussions on stratigraphy and to B. Ligouis for his microscopic images of the Venus. This research has been supported by the Deutsche Forschungsgemeinschaft, the University of Tubingen, the Heidelberger Akademie der Wissenschaften, the Landesamt fur Denkmalpflege Baden-Wurttemberg, the Alb-Donau-Kreis, Heidelberg Cement, the Museumsgesellschaft Schelklingen and the Gesellschaft fur Urgeschichte.	Antl-Weiser W., 2008, FRAU VENUS WILLENDOR; Bar-Yosef O., 2007, RETHINKING HUMAN REV, P207; BARYOSEF O, 2006, P S TRAB ARQ I PORT, V45; Brock F, 2007, RADIOCARBON, V49, P187, DOI 10.1017/S0033822200042107; BROGLIO A., 2002, PREISTORIA VERONESE, V5, P11; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Clottes J, 2001, GROTTE CHAUVET ART O; Conard NJ, 2008, J HUM EVOL, V55, P886, DOI 10.1016/j.jhevol.2008.08.006; Conard NJ, 2004, NATURE, V430, P198, DOI 10.1038/nature02690; Conard NJ, 2003, NATURE, V426, P830, DOI 10.1038/nature02186; Conard NJ, 2003, J HUM EVOL, V44, P331, DOI 10.1016/S0047-2484(02)00202-6; CONARD NJ, 2006, P S TRAB ARQ, V45, P211; CONARD NJ, 2003, P S 6 1 14 C UISPP T, V33, P165; Delporte Henri, 1993, IMAGE FEMME ART PREH; Floss H., 2007, CHEMINS ART AURIGNAC; HAHN J, 1986, KKRAFT AGGRESSION BO; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Joris O, 2008, J HUM EVOL, V55, P782, DOI 10.1016/j.jhevol.2008.04.002; LEROIGOURHAM A, 1995, PREHISTORIE ART OCCI; Lewis-Williams D., 2002, MIND CAVE; Neugebauer-Maresch C., 1989, GERMANIA, V67, P551; Parkington J.E., 2005, TOOLS SYMBOLS EARLY, P475; Richter D, 2000, J ARCHAEOL SCI, V27, P71, DOI 10.1006/jasc.1999.0458; Roebroeks W., 2000, HUNTERS GOLDEN AGE; Svoboda Jiri, 2008, Petrkovice. On Shouldered Points and Female Figurines, P193; Vogelsang R.., 1998, MIDDLE STONE AGE FUN; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; ZILHAO J, 2003, P S TRAB ARQ, V33, P313	28	200	207	2	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					248	252		10.1038/nature07995	http://dx.doi.org/10.1038/nature07995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445FR	19444215				2022-12-28	WOS:000266036100040
J	Vano-Galvan, S; Jaen, P				Vano-Galvan, Sergio; Jaen, Pedro			Extravasation of Epirubicin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vano-Galvan, Sergio; Jaen, Pedro] Hosp Ramon & Cajal, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal	Vano-Galvan, S (corresponding author), Hosp Ramon & Cajal, E-28034 Madrid, Spain.	sergiovano@yahoo.es		Vano-Galvan, Sergio/0000-0003-2773-7494					0	3	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2117	2117		10.1056/NEJMicm0800614	http://dx.doi.org/10.1056/NEJMicm0800614			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439746				2022-12-28	WOS:000266011200010
J	Antommaria, AHM; Trotochaud, K; Kinlaw, K; Hopkins, PN; Frader, J				Antommaria, Armand H. Matheny; Trotochaud, Karen; Kinlaw, Kathy; Hopkins, Paul N.; Frader, Joel			Policies on Donation After Cardiac Death at Children's Hospitals A Mixed-Methods Analysis of Variation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Although authoritative bodies have promulgated guidelines for donation after cardiac death (DCD) and the Joint Commission requires hospitals to address DCD, little is known about actual hospital policies. Objective To characterize DCD policies in children's hospitals and evaluate variation among policies. Design, Setting, and Participants Mixed-methods analysis of policies collected between November 2007 and January 2008 from hospitals in the United States, Puerto Rico, and Canada in 2 membership categories of the National Association of Children's Hospitals and Related Institutions. Main Outcome Measures Status of DCD policy development and content of the policies based on coding categories developed in part from authoritative statements. Results One hundred five of 124 eligible hospitals responded, a response rate of 85%. Seventy-six institutions (72%; 95% confidence interval [CI], 64%-82%) had DCD policies, 20 (19%; 95% CI, 12%-28%) were developing policies; and 7 (7%; 95% CI, 3%-14%) neither had nor were developing policies. We received and analyzed 73 unique, approved policies. Sixty-one policies (84%; 95% CI, 73%-91%) specify criteria or tests for declaring death. Four policies require total waiting periods prior to organ recovery at variance with professional guidelines: 1 less than 2 minutes and 3 longer than 5 minutes. Sixty-four policies (88%; 95% CI, 78%-94%) preclude transplant personnel from declaring death and 37 (51%; 95% CI, 39%-63%) prohibit them from involvement in premortem management. While 65 policies (89%; 95% CI, 80%-95%) indicate the importance of palliative care, only 5 (7%; 95% CI, 2%-15%) recommend or require palliative care consultation. Of 68 polices that indicate where withdrawal of life-sustaining treatment can or should take place, 37 policies (54%; 95% CI, 42%-67%) require it to occur in the operating room and 3 policies (4%; 95% CI, 1%-12%) require it to occur in the intensive care unit. Conclusions Most children's hospitals have developed or are developing DCD policies. There is, however, considerable variation among policies. JAMA. 2009;301(18):1902-1908 www.jama.com	[Antommaria, Armand H. Matheny] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84113 USA; [Hopkins, Paul N.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84113 USA; [Trotochaud, Karen; Kinlaw, Kathy] Emory Univ, Ctr Eth, Atlanta, GA 30322 USA; [Frader, Joel] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Emory University; Northwestern University; Feinberg School of Medicine	Antommaria, AHM (corresponding author), Univ Utah, Sch Med, Dept Pediat, 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 USA.	armand.antommaria@hsc.utah.edu	Frader, Joel/A-8610-2010	Frader, Joel/0000-0001-5620-2400	Division of Pediatric Inpatient Medicine; University of Utah School of Medicine; Study Design and Biostatistics Center of the Center for Clinical and Translational Science; University of Utah; National Center for Research Resources [UL1-RR025764, C06-RR11234]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764, C06RR011234] Funding Source: NIH RePORTER	Division of Pediatric Inpatient Medicine; University of Utah School of Medicine; Study Design and Biostatistics Center of the Center for Clinical and Translational Science; University of Utah; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was sponsored by the Division of Pediatric Inpatient Medicine, University of Utah School of Medicine, the Study Design and Biostatistics Center of the Center for Clinical and Translational Science, University of Utah, and Public Health Services research grants UL1-RR025764 and C06-RR11234 from the National Center for Research Resources.	Arnold Robert M., 1993, Kennedy Institute of Ethics Journal, V3, P103; Babbie E, 2012, PRACTICE SOCIAL RES; Bernat JL, 2006, J CLIN ETHIC, V17, P122; Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; DeVita MA, 2001, CRIT CARE MED, V29, P1826; Dillman D.A., 2007, MAIL INTERNET SURVEY, V2nd; Greer DM, 2008, NEUROLOGY, V70, P284, DOI 10.1212/01.wnl.0000296278.59487.c2; Harrison CH, 2008, TRANSPL P, V40, P1044, DOI 10.1016/j.transproceed.2008.03.064; Institute of Medicine National Academy of Sciences, 2000, NONH BEAT ORG TRANSP; Joint Commission on Accreditation of Healthcare Organizations, 2006, Jt Comm Perspect, V26, P7; Morgan SE, 2008, HEALTH COMMUN, V23, P23, DOI 10.1080/10410230701805158; Naim MY, 2008, CRIT CARE MED, V36, P1729, DOI 10.1097/CCM.0b013e318174dd3d; *NAT AC SCI I MED, 1997, NONH BEAT ORG TRANSP; *NAT ASS CHILDR HO, MEMB CRIT; Sim J, 2005, PHYS THER, V85, P257; *UN NETW ORG SHAR, WHO WE AR MEMB; 2007, ATTACHMENT 3 APPENDI	17	43	44	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1902	1908		10.1001/jama.2009.637	http://dx.doi.org/10.1001/jama.2009.637			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	444JX	19436017	Bronze			2022-12-28	WOS:000265978400028
J	Stein, RA				Stein, Richard A.			Lessons From Outbreaks of H1N1 Influenza	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE RESPIRATORY SYNDROME; PANDEMIC INFLUENZA; TRANSMISSION; INFECTION; VIRUS; SARS; TRAVEL; PIGS	A new H1N1 triple-reassortant "swine" influenza virus was recently described in individuals from the United States and Mexico who presented with respiratory symptoms, and the same virus was subsequently confirmed in patients from several countries around the world. The circumstances surrounding the emergence of this pathogen, and the factors that facilitated the initial cross-species transmission, are still incompletely understood. It became apparent in the early days of the outbreak that the virus can be directly transmitted between humans. Pathogens that originate in animal reservoirs and subsequently acquire the potential for human-to-human transmission have caused outbreaks throughout human history. Although each outbreak is marked by its own particularities, it is important to remember the teachings that emerge from previous epidemics and pandemics. Integrating the important lessons of the past will provide the best opportunity to understand host-pathogen interaction and the most powerful approach to implementing effective prophylactic and therapeutic measures.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Stein, RA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ras2@princeton.edu						[Anonymous], PREPARING INFLUENZA; Bassetti S, 2005, EMERG INFECT DIS, V11, P637, DOI 10.3201/eid1104.040639; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; *CDC, 1988, MMWR-MORBID MORTAL W, V37, P661; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; MACKENZIE D, 2009, DEADLY NEW FLU VIRUS; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; Oxford JS, 2005, VACCINE, V23, P940, DOI 10.1016/j.vaccine.2004.06.035; Pascoe Neil, 2006, Tex Nurs, V80, P6; ROSENTHAL E, 2003, NY TIMES        0410, pA8; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293; Weingartl HM, 2009, J VIROL, V83, P4287, DOI 10.1128/JVI.02399-08; Wenzel RP, 2005, ARCH MED RES, V36, P610, DOI 10.1016/j.arcmed.2005.03.040; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Wu W, 2004, CHINESE MED J-PEKING, V117, P14; 2003, WKLY EPIDEMIOL REC, V78, P145	25	18	20	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2009	151	1					59	62		10.7326/0003-4819-151-1-200907070-00123	http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00123			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BF	19470591				2022-12-28	WOS:000267946100007
J	Wang, GG; Song, JK; Wang, ZX; Dormann, HL; Casadio, F; Li, HT; Luo, JL; Patel, DJ; Allis, CD				Wang, Gang G.; Song, Jikui; Wang, Zhanxin; Dormann, Holger L.; Casadio, Fabio; Li, Haitao; Luo, Jun-Li; Patel, Dinshaw J.; Allis, C. David			Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger	NATURE			English	Article							HISTONE H3; DEVELOPMENTAL REGULATORS; LYSINE-4 TRIMETHYLATION; PROTEIN STRUCTURES; PLANT HOMEODOMAIN; METHYLATION; TRANSCRIPTION; POLYCOMB; DIFFERENTIATION; MACROPHAGES	Histone H3 lysine 4 methylation (H3K4me) has been proposed as a critical component in regulating gene expression, epigenetic states, and cellular identities(1). The biological meaning of H3K4me is interpreted by conserved modules including plant homeodomain (PHD) fingers that recognize varied H3K4me states(1,2). The dysregulation of PHD fingers has been implicated in several human diseases, including cancers and immune or neurological disorders(3). Here we report that fusing an H3K4-trimethylation (H3K4me3)binding PHD finger, such as the carboxy-terminal PHD finger of PHF23 or JARID1A (also known as KDM5A or RBBP2), to a common fusion partner nucleoporin-98 (NUP98) as identified in human leukaemias(4,5), generated potent oncoproteins that arrested haematopoietic differentiation and induced acute myeloid leukaemia in murine models. In these processes, a PHD finger that specifically recognizes H3K4me3/2 marks was essential for leukaemogenesis. Mutations in PHD fingers that abrogated H3K4me3 binding also abolished leukaemic transformation. NUP98-PHD fusion prevented the differentiation-associated removal of H3K4me3 at many loci encoding lineage-specific transcription factors (Hox(s), Gata3, Meis1, Eya1 and Pbx1), and enforced their active gene transcription in murine haematopoietic stem/progenitor cells. Mechanistically, NUP98-PHD fusions act as 'chromatin boundary factors', dominating over polycomb-mediated gene silencing to 'lock' developmentally critical loci into an active chromatin state (H3K4me3 with induced histone acetylation), a state that defined leukaemia stem cells. Collectively, our studies represent, to our knowledge, the first report that deregulation of the PHD finger, an 'effector' of specific histone modification, perturbs the epigenetic dynamics on developmentally critical loci, catastrophizes cellular fate decision-making, and even causes oncogenesis during mammalian development.	[Wang, Gang G.; Dormann, Holger L.; Casadio, Fabio; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Song, Jikui; Wang, Zhanxin; Li, Haitao; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Luo, Jun-Li] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Scripps Research Institute; State University System of Florida; University of Florida	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu	Wang, G Greg/L-6666-2014; Li, Haitao/B-2668-2012; Hu, Ruogu/B-2203-2008	Wang, G Greg/0000-0002-7210-9940; Li, Haitao/0000-0001-6741-293X; 	Leukemia & Lymphoma Society Fellow award; Choh-Hao Li Memorial Fund Scholar award; Boehringer Ingelheim Foundation; National Institutes of Health (NIH); Rockefeller University; Abby RockefellerMauze Trust; Dewitt Wallace and Maloris Foundations; US Department of Defense CDMRP; Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE [K99CA151683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society Fellow award; Choh-Hao Li Memorial Fund Scholar award; Boehringer Ingelheim Foundation(Boehringer Ingelheim); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Abby RockefellerMauze Trust; Dewitt Wallace and Maloris Foundations; US Department of Defense CDMRP(United States Department of Defense); Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Baker, P. Chi, A. Ruthenberg and A. Xiao for critical reading and help in manuscript preparation, C. Hughes for antibodies, and other Allis laboratory members for their advice. We are extremely grateful to M. Kamps and S. Rafii for shared plasmids and expert advice. Thanks to E. Coutavas, W. Chen, E. Ezhkova and the R. Roeder laboratory for help on cell and animal work. G. G. W. is supported by a Leukemia & Lymphoma Society Fellow award and a Choh-Hao Li Memorial Fund Scholar award; H. L. D. is supported by a predoctoral Boehringer Ingelheim Foundation fellowship; This research was supported by the National Institutes of Health (NIH) grant and funds of Rockefeller University to C. D. A., funds of Abby RockefellerMauze Trust and the Dewitt Wallace and Maloris Foundations to D. J. P., US Department of Defense CDMRP grant to J.-L. L., and a joint Starr Foundation Cancer Consortium grant.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; BOITE S, 2006, J MICROSC-OXFORD, V224, P213; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gong W, 2005, INT J BIOCHEM CELL B, V37, P1054, DOI 10.1016/j.biocel.2004.09.008; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore MAS, 2007, ANN NY ACAD SCI, V1106, P114, DOI 10.1196/annals.1392.019; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Reader JC, 2007, LEUKEMIA, V21, P842, DOI 10.1038/sj.leu.2404579; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; van Zutven LJCM, 2006, GENE CHROMOSOME CANC, V45, P437, DOI 10.1002/gcc.20308; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	53	318	322	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					847	U6		10.1038/nature08036	http://dx.doi.org/10.1038/nature08036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19430464	Green Accepted			2022-12-28	WOS:000267084500040
J	Reza, A; Breiding, MJ; Gulaid, J; Mercy, JA; Blanton, C; Mthethwa, Z; Bamrah, S; Dahlberg, LL; Anderson, M				Reza, Avid; Breiding, Matthew J.; Gulaid, Jama; Mercy, James A.; Blanton, Curtis; Mthethwa, Zodwa; Bamrah, Sapna; Dahlberg, Lind L.; Anderson, Mark			Sexual violence and its health consequences for female children in Swaziland: a cluster survey study	LANCET			English	Article							REPRODUCTIVE HEALTH; BEHAVIOR; ABUSE; PREVENTION; PROGRAMS; YOUTH	Background Despite concern, few studies have been done about sexual violence against girls younger than 18 years of age in sub-Saharan Africa. We report the prevalence and circumstances of sexual violence in girls in Swaziland, and assess the negative health consequences. Methods We obtained data from a nationally representative sample of girls and women aged 13-24 years from selected households in Swaziland between May 15, 2007, and June 16, 2007, with a two-stage cluster design. The questionnaire examined demographics, type of sexual violence that took place before the respondent was 18 years of age, circumstances of the incident, and health-related conditions. Information was gathered from 1244 women and girls (response rate 96.3%), of whom 1242 provided retrospective responses to questions about sexual violence. We used regression models adjusted for relevant demographics to estimate the odds ratios for the associations between sexual violence and health-related conditions. Findings 33.2% (95% CI 29.9-36.7) of respondents reported an incident of sexual violence before they reached 18 years of age. The most common perpetrators of the first incident were men or boys from the respondent's neighbourhood (32.3% [28.8-36.1]) and boyfriends or husbands (26.2% [22.2-30.7]). The first incident most often took place in the respondent's own home (26.1% [21.6-31.2]). Sexual violence was associated with reported lifetime experience of sexually transmitted diseases (adjusted OR 3.69 [95% CI 1.78-7.66]), pregnancy complications or miscarriages (3.54 [1.47-8.55]), unwanted pregnancy (2.92 [1.87-4.55]), and self-report of feeling depressed (2.30 [1.70-3.11]). Interpretation Knowledge of the high prevalence of sexual violence against girls in Swaziland and its associated serious health-related conditions and behaviours should be used to develop effective prevention strategies.	[Reza, Avid] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Int Emergency & Refugee Hlth Branch, Atlanta, GA 30341 USA; [Gulaid, Jama; Mthethwa, Zodwa] UNICEF, Mbabane, Eswatini	Centers for Disease Control & Prevention - USA	Reza, A (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Int Emergency & Refugee Hlth Branch, 4770 Buford Highway,NE Mailstop F-60, Atlanta, GA 30341 USA.	afr6@cdc.gov			US Centers for Disease Control and Prevention	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	We thank the survey participants who openly shared their experience of violence in the hopes that this information would ultimately help to prevent violence. and the field team members who took great care in interviewing children and youth oil the sensitive topic of violence and always placed the privacy and safety of the participants first. We thank Nonhlanhla Dlamini for her expertise and logistical support in conducting the training and survey, and Nonhlanhla Hleta-Nkambule, Tizie Maphalala, Allies Zwane and the Central statistics office, Thomas Simon, Rachel Jewkes, Kathleen C Basile, Lynn Jenkins, Michele Lynberg, Susan Settergren, George T Bicego, Basia Tomczyk, Diane M Hall, and Stacy De Jesus for their crucial input. We also thank Yuko Kusamichi and Michael Gerber for providing logistical support, and Kristin Becknell for undertaking the background literature search. The US Centers for Disease Control and Prevention contributed funding indirectly by covering the travel cost and salaries of its staff.	[Anonymous], PUTTING WOMEN 1 ETHI; [Anonymous], 1998, S AFR DEM HLTH SURV; BREIDING M, 2007, 5092 CDC IRB; Buga GAB, 1996, S AFR MED J, V86, P523; Buseh AG, 2004, CULT HEALTH SEX, V6, P355, DOI 10.1080/13691050410001668711; *CEN OFF, 2007, MAN EN POP HOUS CENS; *CENTR STAT OFF, 2000, SWAZ MULT IND CULST, P11; *DEP GEND WOM HLTH, 2001, WHO PUTT WOM 1 ETH S; Duvvury N., 2007, EVALUATION STEPPING; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; Family Health International, BEH SURV SURV GUID R; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2007, PEDIATRICS, V120, P640, DOI 10.1542/peds.2007-0754; Gibson LE, 2000, CHILD ABUSE NEGLECT, V24, P1115, DOI 10.1016/S0145-2134(00)00179-4; *HUM RIGHTS WATCH, SCAR SCH SEX VIOL GI; Jewekes R., 2002, WORLD REPORT VIOLENC, P147; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2002, LANCET, V359, P319, DOI 10.1016/S0140-6736(02)07530-X; Jewkes R, 2001, SOC SCI MED, V52, P733, DOI 10.1016/S0277-9536(00)00177-5; JEWKES R, 2002, STEPPING STONES S AF; KANDUZA A, 2003, STUDY ABUSE SCH GOIN; Kendall-Tackett K. A., 2003, TREATING LIFETIME HL; *KINGD SWAZ, 2006, NAT PLAN ACT ORPPH V; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; KNIGHT ED, LONGSCAN INVESITGATO, V3; Matasha E, 1998, AIDS CARE, V10, P571, DOI 10.1080/09540129848433; *NAT CTR HLTH STAT, 1997, AN REP GUID 3 NAT HL; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; UNAIDS, 2008 REP GLOB AIDS E; *UNICEF, 2005, EV LIHL LEK CHILD PR; *US CDCP, 2003, SWAZ GLOB SCH BAS ST; WHO, 2006, GLOB EST HLTH CONS D; WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037//0022-006X.63.3.343	33	112	113	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1966	1972		10.1016/S0140-6736(09)60247-6	http://dx.doi.org/10.1016/S0140-6736(09)60247-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19428100	Green Submitted			2022-12-28	WOS:000266832500031
J	Hofheinz, M; Wang, H; Ansmann, M; Bialczak, RC; Lucero, E; Neeley, M; O'Connell, AD; Sank, D; Wenner, J; Martinis, JM; Cleland, AN				Hofheinz, Max; Wang, H.; Ansmann, M.; Bialczak, Radoslaw C.; Lucero, Erik; Neeley, M.; O'Connell, A. D.; Sank, D.; Wenner, J.; Martinis, John M.; Cleland, A. N.			Synthesizing arbitrary quantum states in a superconducting resonator	NATURE			English	Article							WIGNER FUNCTION; GENERATION	The superposition principle is a fundamental tenet of quantum mechanics. It allows a quantum system to be 'in two places at the same time', because the quantum state of a physical system can simultaneously include measurably different physical states. The preparation and use of such superposed states forms the basis of quantum computation and simulation(1). The creation of complex superpositions in harmonic systems (such as the motional state of trapped ions(2), microwave resonators(3-5) or optical cavities(6)) has presented a significant challenge because it cannot be achieved with classical control signals. Here we demonstrate the preparation and measurement of arbitrary quantum states in an electromagnetic resonator, superposing states with different numbers of photons in a completely controlled and deterministic manner. We synthesize the states using a superconducting phase qubit to phase-coherently pump photons into the resonator, making use of an algorithm(7) that generalizes a previously demonstrated method of generating photon number (Fock) states in a resonator(8). We completely characterize the resonator quantum state using Wigner tomography, which is equivalent to measuring the resonator's full density matrix.	[Hofheinz, Max; Wang, H.; Ansmann, M.; Bialczak, Radoslaw C.; Lucero, Erik; Neeley, M.; O'Connell, A. D.; Sank, D.; Wenner, J.; Martinis, John M.; Cleland, A. N.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Cleland, AN (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	Cleland@physics.ucsb.edu	Hofheinz, Max/F-3288-2010; Wang, Haohua/G-8875-2011; Wenner, James/G-3777-2014; Cleland, Andrew/AAG-7581-2019	Wang, Haohua/0000-0001-5380-4297; Wenner, James/0000-0001-7107-4734; 	NSF [CCF-0507227]; IARPA [W911NF-04-1-0204]	NSF(National Science Foundation (NSF)); IARPA	Devices were made at the UCSB Nanofabrication Facility, a part of the NSF-funded National Nanotechnology Infrastructure Network. We thank M. Geller for discussions. This work was supported by IARPA (grant W911NF-04-1-0204) and by the NSF (grant CCF-0507227).	Banaszek K, 1999, PHYS REV A, V60, P674, DOI 10.1103/PhysRevA.60.674; Banaszek K, 1996, PHYS REV LETT, V76, P4344, DOI 10.1103/PhysRevLett.76.4344; Ben-Kish A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.037902; Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Breitenbach G, 1997, NATURE, V387, P471, DOI 10.1038/387471a0; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Haroche S., 2006, EXPLORING QUANTUM; Hofheinz M, 2008, NATURE, V454, P310, DOI 10.1038/nature07136; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; Law CK, 1996, PHYS REV LETT, V76, P1055, DOI 10.1103/PhysRevLett.76.1055; Liu YX, 2004, EUROPHYS LETT, V67, P941, DOI 10.1209/epl/i2004-10144-3; Lutterbach LG, 1997, PHYS REV LETT, V78, P2547, DOI 10.1103/PhysRevLett.78.2547; Lvovsky AI, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.011801; MARTINIS JM, 1985, PHYS REV LETT, V55, P1543, DOI 10.1103/PhysRevLett.55.1543; Neeley M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180508; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Niskanen AO, 2007, SCIENCE, V316, P723, DOI 10.1126/science.1141324; Plantenberg JH, 2007, NATURE, V447, P836, DOI 10.1038/nature05896; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; VOGEL K, 1993, PHYS REV LETT, V71, P1816, DOI 10.1103/PhysRevLett.71.1816; Wang H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.240401; Wigner E, 1932, PHYS REV, V40, P0749, DOI 10.1103/PhysRev.40.749	29	626	641	2	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					546	549		10.1038/nature08005	http://dx.doi.org/10.1038/nature08005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478780				2022-12-28	WOS:000266370500034
J	Volandes, AE; Paasche-Orlow, MK; Barry, MJ; Gillick, MR; Minaker, KL; Chang, YC; Cook, EF; Abbo, ED; El-Jawahri, A; Mitchell, SL				Volandes, Angelo E.; Paasche-Orlow, Michael K.; Barry, Michael J.; Gillick, Muriel R.; Minaker, Kenneth L.; Chang, Yuchiao; Cook, E. Francis; Abbo, Elmer D.; El-Jawahri, Areej; Mitchell, Susan L.			Video decision support tool for advance care planning in dementia: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE CARE; PATIENT PREFERENCES; END; STABILITY; COMMUNICATION; RESUSCITATION; PHYSICIANS; DIRECTIVES; ETHNICITY; ATTITUDES	Objective To evaluate the effect of a video decision support tool on the preferences for future medical care in older people if they develop advanced dementia, and the stability of those preferences after six weeks. Design Randomised controlled trial conducted between 1 September 2007 and 30 May 2008. Setting Four primary care clinics (two geriatric and two adult medicine) affiliated with three academic medical centres in Boston. Participants Convenience sample of 200 older people (>= 65 years) living in the community with previously scheduled appointments at one of the clinics. Mean age was 75 and 58% were women. Intervention Verbal narrative alone (n=106) or with a video decision support tool (n=94). Main outcome measures Preferred goal of care: life prolonging care (cardiopulmonary resuscitation, mechanical ventilation), limited care (admission to hospital, antibiotics, but not cardiopulmonary resuscitation), or comfort care (treatment only to relieve symptoms). Preferences after six weeks. The principal category for analysis was the difference in proportions of participants in each group who preferred comfort care. Results Among participants receiving the verbal narrative alone, 68 (64%) chose comfort care, 20 (19%) chose limited care, 15 (14%) chose life prolonging care, and three (3%) were uncertain. In the video group, 81 (86%) chose comfort care, eight (9%) chose limited care, four (4%) chose life prolonging care, and one (1%) was uncertain (chi(2)=13.0, df=3, P=0.003). Among all participants the factors associated with a greater likelihood of opting for comfort care were being a college graduate or higher, good or better health status, greater health literacy, white race, and randomisation to the video arm. In multivariable analysis, participants in the video group were more likely to prefer comfort care than those in the verbal group (adjusted odds ratio 3.9, 95% confidence interval 1.8 to 8.6). Participants were re-interviewed after six weeks. Among the 94/106 (89%) participants re-interviewed in the verbal group, 27 (29%) changed their preferences (kappa=0.35). Among the 84/94 (89%) participants re-interviewed in the video group, five (6%) changed their preferences (kappa=0.79) (P<0.001 for difference). Conclusion Older people who view a video depiction of a patient with advanced dementia after hearing a verbal description of the condition are more likely to opt for comfort as their goal of care compared with those who solely listen to a verbal description. They also have more stable preferences over time. Trial registration Clinicaltrials.gov NCT00704886.	[Volandes, Angelo E.; Barry, Michael J.; Minaker, Kenneth L.; Chang, Yuchiao] Massachusetts Gen Hosp, Dept Med, Gen Med Unit, Boston, MA 02114 USA; [Paasche-Orlow, Michael K.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Gillick, Muriel R.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Harvard Pilgrim, Boston, MA 02215 USA; [Cook, E. Francis] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Abbo, Elmer D.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Mitchell, Susan L.] Hebrew SeniorLife, Boston, MA 02131 USA	Harvard University; Massachusetts General Hospital; Boston University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Chicago; Harvard University; Hebrew SeniorLife	Volandes, AE (corresponding author), Massachusetts Gen Hosp, Dept Med, Gen Med Unit, 50 Staniford St, Boston, MA 02114 USA.	avolandes@partners.org	Paasche-Orlow, Michael/ABF-7919-2020	Paasche-Orlow, Michael/0000-0002-9276-7190	Foundation for Informed Medical Decision Making; Alzheimer's Association; Hartford Foundation; NATIONAL INSTITUTE ON AGING [K24AG033640] Funding Source: NIH RePORTER	Foundation for Informed Medical Decision Making; Alzheimer's Association(Alzheimer's Association); Hartford Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AEV was supported by a George Bennett Fellowship from the Foundation for Informed Medical Decision Making, a New Investigator Research Grant from the Alzheimer's Association, and a Center for Excellence Career Development Award from the Hartford Foundation. Role of the sponsor: None of the foundations participated in the collection, analysis, or interpretation of the data or in preparation, review, or approval of the manuscript.	Abbo ED, 2008, J PALLIAT MED, V11, P555, DOI 10.1089/jpm.2007.0255; Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; CARALIS PV, 1993, J CLIN ETHIC, V4, P155; Carmel S, 1999, SOC SCI MED, V49, P303, DOI 10.1016/S0277-9536(99)00121-5; Covinsky KE, 2000, J AM GERIATR SOC, V48, pS187, DOI 10.1111/j.1532-5415.2000.tb03131.x; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; DANIS M, 1994, ANN INTERN MED, V120, P567, DOI 10.7326/0003-4819-120-7-199404010-00006; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; Ditto PH, 2003, HEALTH PSYCHOL, V22, P605, DOI 10.1037/0278-6133.22.6.605; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; EMANUEL LL, 1994, ARCH INTERN MED, V154, P209, DOI 10.1001/archinte.1994.00420020131014; EMANUEL LL, 1995, J AM GERIATR SOC, V43, P440, DOI 10.1111/j.1532-5415.1995.tb05821.x; Evans R, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e21; EVERHART MA, 1990, CHEST, V97, P159, DOI 10.1378/chest.97.1.159; FINUCANE TE, 1988, J GEN INTERN MED, V3, P322, DOI 10.1007/BF02595788; Frosch DL, 2003, J GEN INTERN MED, V18, P781, DOI 10.1046/j.1525-1497.2003.20911.x; GARRETT JM, 1993, J GEN INTERN MED, V8, P361, DOI 10.1007/BF02600073; GILLICK MR, 1995, ANN INTERN MED, V123, P621, DOI 10.7326/0003-4819-123-8-199510150-00009; Gillick MR, 2007, PSYCHOL DECISION MAK, P193; Grant BK, 1998, DOCUMENTING DOCUMENT; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Hopp FP, 2000, J AM GERIATR SOC, V48, P658, DOI 10.1111/j.1532-5415.2000.tb04724.x; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Khangura S, 2008, PATIENT EDUC COUNS, V73, P456, DOI 10.1016/j.pec.2008.07.035; KLESSIG J, 1992, WESTERN J MED, V157, P316; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Lockhart LK, 2001, DEATH STUD, V25, P299, DOI 10.1080/07481180126279; Lynn J, 1997, J AM GERIATR SOC, V45, P526; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; *NAT CANC I, 1997, MAK HLTH COMM PROGR; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; OBRIEN LA, 1995, JAMA-J AM MED ASSOC, V274, P1775, DOI 10.1001/jama.274.22.1775; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rosenfeld KE, 1996, ARCH INTERN MED, V156, P1558, DOI 10.1001/archinte.156.14.1558; Roter DL, 2000, ARCH INTERN MED, V160, P3477, DOI 10.1001/archinte.160.22.3477; SACHS GA, 1995, J AM GERIATR SOC, V43, P553, DOI 10.1111/j.1532-5415.1995.tb06106.x; Sclan S G, 1992, Int Psychogeriatr, V4 Suppl 1, P55; Smith AK, 2006, ARCH INTERN MED, V166, P1597, DOI 10.1001/archinte.166.15.1597; Straton JB, 2004, J AM GERIATR SOC, V52, P577, DOI 10.1111/j.1532-5415.2004.52165.x; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915; Tulsky JA, 1996, ARCH INTERN MED, V156, P1285, DOI 10.1001/archinte.156.12.1285; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; Volandes AE, 2008, J PALLIAT MED, V11, P700, DOI 10.1089/jpm.2007.0172; Volandes AE, 2008, J PALLIAT MED, V11, P754, DOI 10.1089/jpm.2007.0224; Volandes AE, 2007, ARCH INTERN MED, V167, P828, DOI 10.1001/archinte.167.8.828; Winterbottom A, 2008, SOC SCI MED, V67, P2079, DOI 10.1016/j.socscimed.2008.09.037; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501	53	192	193	3	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2009	338								b1964	10.1136/bmj.b2159	http://dx.doi.org/10.1136/bmj.b2159			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	451WU	19477893	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000266502400001
J	Black, C				Black, Carol			Advancing 21st-Century Medical Professionalism A Multistakeholder Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Acad Med Royal Coll, London W1G 8AX, England		Black, C (corresponding author), Acad Med Royal Coll, 70 Wimpole St, London W1G 8AX, England.	profblack@btinternet.com						*AC MED ROYAL COLL, CONS STAT ROL DOCT; Batmangelich Sorush, 2004, J Contin Educ Health Prof, V24, P134, DOI 10.1002/chp.1340240303; Brennan TA, 2002, ACAD MED, V77, P973, DOI 10.1097/00001888-200210000-00008; Darzi A., 2008, HIGH QUALITY CARE AL; *DEP HLTH WHIT PAP, 2007, TRUST ASS SAF REG HL; DONALDSON L, 2008, MED REVALIDATION PRI; *GEN MED COUNC, 2005, DEV MED REG VIS FUT; IRVINE D, 2006, SHORT HIST GEN MED C; *MERR COMM, 1975, REP COMM INQ REG MED; *NAT HLTH SERV I I, 2008, MED LEAD COMP FRAM; Royal College of Physicians, 2005, DOCT SOC MED PROF CH	11	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2156	2158		10.1001/jama.2009.735	http://dx.doi.org/10.1001/jama.2009.735			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19470992				2022-12-28	WOS:000266328800029
J	Klein, BEK; Klein, R				Klein, Barbara E. K.; Klein, Ronald			Forecasting Age-Related Macular Degeneration Through 2050	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BEAVER DAM EYE; MACULOPATHY; SMOKING; PERIOD		[Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison	Klein, BEK (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, 610 N Walnut St,Room 407 WARF, Madison, WI 53726 USA.	kleinb@epi.ophth.wisc.edu		Klein, Ronald/0000-0002-4428-6237				Delcourt C, 2007, EUR J CLIN NUTR, V61, P1341, DOI 10.1038/sj.ejcn.1602685; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Klein R, 1998, AM J EPIDEMIOL, V147, P103; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P674, DOI 10.1001/archopht.121.5.674; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2008, OPHTHALMOLOGY, V115, P1460, DOI 10.1016/j.ophtha.2008.01.026; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klein R, 2006, AM J OPHTHALMOL, V142, P539, DOI 10.1016/j.ajo.2006.06.015; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481	12	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2152	2153		10.1001/jama.2009.729	http://dx.doi.org/10.1001/jama.2009.729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19475785				2022-12-28	WOS:000266328800027
J	Resnik, DB				Resnik, David B.			Parent-Investigators A Dilemma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									NIEHS, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnik, DB (corresponding author), NIEHS, NIH, Box 12233 Mail Drop CR 03, Res Triangle Pk, NC 27709 USA.	resnikd@niehs.nih.gov			Intramural NIH HHS [ZIA ES102646-02] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102646] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMDUR RJ, 2005, I REV BOARD MANAGEME; Appelbaum PS, 2008, HASTINGS CENT REP, V38, P5; *BBC, HIST FIG E JENN 1749; Belluck Pam, 2009, NEW YORK TIMES  1202, pAl; Fromme EK, 2008, ANN INTERN MED, V149, P825, DOI 10.7326/0003-4819-149-11-200812020-00011; LEVINE RJ, 1988, ETHICS REGULATION CL; Ross LF, 2008, CHILDREN MED RES ACC; *US DEP HHS, OFF HUM RES PROT POL; *WORLD MED ASS, POL WORLD MED ASS DE	9	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2159	2161		10.1001/jama.2009.728	http://dx.doi.org/10.1001/jama.2009.728			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19470993	Green Accepted			2022-12-28	WOS:000266328800030
J	Reece, EA; Leguizamon, G; Wiznitzer, A				Reece, E. Albert; Leguizamon, Gustavo; Wiznitzer, Arnon			Gestational diabetes: the need for a common ground	LANCET			English	Review							GLUCOSE-TOLERANCE TEST; SKELETAL-MUSCLE; EARLY-PREGNANCY; HIGH PREVALENCE; RISK-FACTORS; MELLITUS; WOMEN; INSULIN; GLYBURIDE; DIAGNOSIS	Gestational diabetes mellitus is a substantial and growing health concern in many parts of the world. Certain populations are especially vulnerable to developing this condition because of genetic, social, and environmental factors. Gestational diabetes has serious, long-term consequences for both baby and mother, including a predisposition to obesity, metabolic syndrome, and diabetes later in life. Early detection and intervention can greatly improve outcomes for women with this condition and their babies. Unfortunately, screening and diagnostic tests are not uniform worldwide, which could lead not only to underdiagnosis but also undermanagement of the illness. Here, we report the controversies surrounding the causes, screening, diagnosis, management, and prevention of gestational diabetes, and give specific recommendations for research studies to address the major issues of this medical condition.	[Reece, E. Albert] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Leguizamon, Gustavo] CEMIC Univ, Ctr Med Educ & Clin Res, Dept Obstet & Gynecol, Buenos Aires, DF, Argentina; [Wiznitzer, Arnon] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Obstet & Gynecol, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel	University System of Maryland; University of Maryland Baltimore; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Ben Gurion University; Soroka Medical Center	Reece, EA (corresponding author), Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, 655 W Baltimore St,Room 14-029, Baltimore, MD 21201 USA.	deanmed@som.umaryland.edu						Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Agarwal MM, 2008, GYNECOL OBSTET INVES, V66, P178, DOI 10.1159/000140602; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Berger Howard, 2002, J Obstet Gynaecol Can, V24, P894; Bianco AT, 1998, OBSTET GYNECOL, V91, P97, DOI 10.1016/S0029-7844(97)00578-4; Bottalico JN, 2007, SEMIN PERINATOL, V31, P176, DOI 10.1053/j.semperi.2007.03.006; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Carpenter MW, 2001, DIABETES CARE, V24, P1259, DOI 10.2337/diacare.24.7.1259; CARR S, 1989, OBSTET GYNECOL, V73, P727; CATALANO PM, 1995, AM J OBSTET GYNECOL, V172, P1464, DOI 10.1016/0002-9378(95)90479-4; Chawla Alka, 2006, Tidsskr Nor Laegeforen, V126, P1041; Cheung NW, 2005, AUST NZ J OBSTET GYN, V45, P479, DOI 10.1111/j.1479-828X.2005.00480.x; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; COUSINS L, 1984, AM J OBSTET GYNECOL, V150, P455, DOI 10.1016/S0002-9378(84)90420-4; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; DORNHORST A, 1992, DIABETIC MED, V9, P820, DOI 10.1111/j.1464-5491.1992.tb01900.x; ELLIOTT BD, 1991, AM J OBSTET GYNECOL, V165, P807, DOI 10.1016/0002-9378(91)90421-M; Enquobahrie DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.022; Erem C, 2003, EUR J EPIDEMIOL, V18, P39, DOI 10.1023/A:1022585101209; FRANZ MJ, 1994, DIABETES CARE, V17, P490, DOI 10.2337/diacare.17.5.490; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Glueck CJ, 2004, HUM REPROD, V19, P1323, DOI 10.1093/humrep/deh263; Gottlieb AG, 2007, OBSTET GYN CLIN N AM, V34, P501, DOI 10.1016/j.ogc.2007.07.002; GRANDJEAN H, 1980, AM J OBSTET GYNECOL, V138, P790, DOI 10.1016/S0002-9378(16)32737-5; Gruendhammer M, 2003, EUR J OBSTET GYN R B, V108, P131; HARLASS FE, 1991, AM J OBSTET GYNECOL, V164, P564, DOI 10.1016/S0002-9378(11)80021-9; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Ho FLW, 2007, ANN ACAD MED SINGAP, V36, P672; Hollander MH, 2007, OBSTET GYNECOL SURV, V62, P125, DOI 10.1097/01.ogx.0000253303.92229.59; *INS ASP PREGN STU, 2008, AM J OBSTET GYNECOL, V198, P186; Jakubowicz DJ, 2002, J CLIN ENDOCR METAB, V87, P524, DOI 10.1210/jc.87.2.524; JARRETT RJ, 1993, BMJ-BRIT MED J, V306, P37, DOI 10.1136/bmj.306.6869.37; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Jones C W, 2001, Neonatal Netw, V20, P17; JOVANOVICPETERSON L, 1991, AM J OBSTET GYNECOL, V164, P103, DOI 10.1016/0002-9378(91)90637-7; Kapoor N, 2007, CURR OPIN OBSTET GYN, V19, P586, DOI 10.1097/GCO.0b013e3282f20aad; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Kremer CI, 2004, AM J OBSTET GYNECOL, V190, P1438, DOI 10.1016/j.ajog.2004.02.032; Kumari AS, 2001, INT J GYNECOL OBSTET, V73, P101, DOI 10.1016/S0020-7292(00)00391-X; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; LANGER O, 1989, AM J OBSTET GYNECOL, V161, P646, DOI 10.1016/0002-9378(89)90371-2; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; Lapolla A, 2008, ACTA DIABETOL, V45, P61, DOI 10.1007/s00592-008-0024-0; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Lemen PM, 1998, AM J OBSTET GYNECOL, V178, P1251, DOI 10.1016/S0002-9378(98)70330-8; Major CA, 1998, OBSTET GYNECOL, V91, P600, DOI 10.1016/S0029-7844(98)00003-9; Marquette G P, 1985, Am J Perinatol, V2, P7, DOI 10.1055/s-2007-999901; MARQUETTE GP, 1985, OBSTET GYNECOL, V66, P181; McLachlan K, 2007, AUST NZ J OBSTET GYN, V47, P186, DOI 10.1111/j.1479-828X.2007.00716.x; Metzger BE, 1998, DIABETES CARE, V21, pB161; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Moore TR, 2007, DIABETES CARE, V30, pS209, DOI 10.2337/dc07-s218; Murata GH, 2004, DIABETES RES CLIN PR, V65, P61, DOI 10.1016/j.diabres.2003.11.013; Murphy HR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1680; NASRAT HA, 1991, INT J GYNECOL OBSTET, V34, P27, DOI 10.1016/0020-7292(91)90534-C; Nicholson W, 2009, OBSTET GYNECOL, V113, P193, DOI 10.1097/AOG.0b013e318190a459; Nicholson Wanda K, 2008, Evid Rep Technol Assess (Full Rep), P1; Ornoy Asher, 2005, Pediatr Endocrinol Rev, V3, P104; Phaloprakarn C, 2008, J OBSTET GYNAECOL RE, V34, P331, DOI 10.1111/j.1447-0756.2007.00693.x; Pratipanawatr W, 2001, DIABETES, V50, P2572, DOI 10.2337/diabetes.50.11.2572; Reece E A, 2002, J Matern Fetal Neonatal Med, V12, P362, DOI 10.1080/jmf.12.6.362.364; REECE EA, 2005, CONTEMP OBSTET GYNEC, V50, P42; Robitaille J, 2008, GENET MED, V10, P240, DOI 10.1097/GIM.0b013e31816b8710; SALVESEN DR, 1993, AM J OBSTET GYNECOL, V168, P1363, DOI 10.1016/S0002-9378(11)90766-2; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Shaat N, 2006, DIABETOLOGIA, V49, P1545, DOI 10.1007/s00125-006-0258-8; Shirazian Nahid, 2008, Endocr Pract, V14, P312; Sivan E, 2004, J ULTRAS MED, V23, P339, DOI 10.7863/jum.2004.23.3.339; Snapp CA, 2008, BIOL RES NURS, V10, P145, DOI 10.1177/1099800408323728; Tamborlane WV, 2008, DIABETES TECHNOL THE, V10, P310, DOI 10.1089/dia.2007.0302; TANIR HM, 2005, CLIN EXP OBSTET GYN, V3, P241; Turok DK, 2003, AM FAM PHYSICIAN, V68, P1767; Vambergue A, 2008, DIABETIC MED, V25, P58, DOI 10.1111/j.1464-5491.2007.02306.x; Vohr BR, 2008, J MATERN-FETAL NEO M, V21, P149, DOI 10.1080/14767050801929430; WALKINSHAW SA, 2003, COCHRANE DB SYST REV, V2; World Health Organization, DIAB PROGR COUNTR RE; Yogev Y, 2009, SEMIN FETAL NEONAT M, V14, P94, DOI 10.1016/j.siny.2009.01.001; Yogev Y, 2009, SEMIN FETAL NEONAT M, V14, P77, DOI 10.1016/j.siny.2008.09.002; Zarate A, 2000, Ginecol Obstet Mex, V68, P42; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543; [No title captured]	87	406	419	0	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1789	1797		10.1016/S0140-6736(09)60515-8	http://dx.doi.org/10.1016/S0140-6736(09)60515-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465234				2022-12-28	WOS:000266337300034
J	Cash, SS; Halgren, E; Dehghani, N; Rossetti, AO; Thesen, T; Wang, C; Devinsky, O; Kuzniecky, R; Doyle, W; Madsen, JR; Bromfield, E; Eross, L; Halasz, P; Karmos, G; Csercsa, R; Wittner, L; Ulbert, I				Cash, Sydney S.; Halgren, Eric; Dehghani, Nima; Rossetti, Andrea O.; Thesen, Thomas; Wang, ChunMao; Devinsky, Orrin; Kuzniecky, Ruben; Doyle, Werner; Madsen, Joseph R.; Bromfield, Edward; Eross, Lorand; Halasz, Peter; Karmos, George; Csercsa, Richard; Wittner, Lucia; Ulbert, Istvan			The Human K-Complex Represents an Isolated Cortical Down-State	SCIENCE			English	Article							SLOW-WAVE SLEEP; NEOCORTICAL NEURONS; NETWORK MECHANISMS; OSCILLATION; MODEL; HZ	The electroencephalogram (EEG) is a mainstay of clinical neurology and is tightly correlated with brain function, but the specific currents generating human EEG elements remain poorly specified because of a lack of microphysiological recordings. The largest event in healthy human EEGs is the K-complex (KC), which occurs in slow-wave sleep. Here, we show that KCs are generated in widespread cortical areas by outward dendritic currents in the middle and upper cortical layers, accompanied by decreased broadband EEG power and decreased neuronal firing, which demonstrate a steep decline in network activity. Thus, KCs are isolated "down-states," a fundamental cortico-thalamic processing mode already characterized in animals. This correspondence is compatible with proposed contributions of the KC to sleep preservation and memory consolidation.	[Cash, Sydney S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Epilepsy Div, Boston, MA 02114 USA; [Halgren, Eric; Dehghani, Nima] Univ Calif San Diego, Dept Radiol, San Diego, CA 92093 USA; [Halgren, Eric; Dehghani, Nima] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Halgren, Eric; Dehghani, Nima] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA; [Thesen, Thomas; Wang, ChunMao; Devinsky, Orrin; Kuzniecky, Ruben; Doyle, Werner] NYU, Sch Med, Comprehens Epilepsy Ctr, New York, NY 10016 USA; [Madsen, Joseph R.] Childrens Hosp, Boston, MA 02115 USA; [Rossetti, Andrea O.; Bromfield, Edward] Brigham & Womens Hosp, Boston, MA 02115 USA; [Eross, Lorand; Wittner, Lucia; Ulbert, Istvan] Natl Inst Neurosurg, H-1145 Budapest, Hungary; [Halasz, Peter] Epilepsy Ctr, Natl Inst Psychiat & Neurol, H-1145 Budapest, Hungary; [Karmos, George; Csercsa, Richard; Wittner, Lucia; Ulbert, Istvan] Hungarian Acad Sci, Inst Psychol, H-1394 Budapest, Hungary; [Halasz, Peter; Karmos, George; Ulbert, Istvan] Peter Pazmany Catholic Univ, Dept Informat Technol, H-1083 Budapest, Hungary	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; New York University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Cash, SS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Epilepsy Div, Boston, MA 02114 USA.	scash@partners.org	Rossetti, Andrea O./A-6712-2008; Ulbert, Istvan/F-2213-2010; Wittner, Lucia/C-9386-2013	Rossetti, Andrea O./0000-0002-7878-172X; Wittner, Lucia/0000-0001-6800-0953; Dehghani, Nima/0000-0003-2032-8903; Eross, Lorand/0000-0002-5796-5546; Devinsky, Orrin/0000-0003-0044-4632	National Institute of Neurogical Disorders and Stroke (NIH) [NS18741, NS44623]; Neuroprobes [IST-027017, OTKA49122, ETT135/2006]; Janos Szentagothai Knowledge Center [RET 05/2004]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044623, R01NS018741] Funding Source: NIH RePORTER	National Institute of Neurogical Disorders and Stroke (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neuroprobes; Janos Szentagothai Knowledge Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institute of Neurogical Disorders and Stroke (NIH) grants NS18741 and NS44623 to E.H. and Neuroprobes IST-027017, OTKA49122, ETT135/2006, Janos Szentagothai Knowledge Center RET 05/2004 grants to I.U. We thank L. Papp for technical support; and L. Grand, A. Magony, B. Dombovari, and D. Fabo for support in data analysis and recording. The authors dedicate this work to the memory of Edward Bromfield, who passed away on 10 May 2009.	Amzica F, 1998, NEUROSCIENCE, V82, P671; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Buzsaki G., 2006, RHYTHMS BRAIN; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; LOOMIS AL, 1938, J NEUROPHYSIOL S, V13, P231; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; *NAT I NEUR DIS ST, NS18741 NIH NAT I NE; Numminen J, 1996, ELECTROEN CLIN NEURO, V99, P544; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Ulbert I, 2001, J NEUROSCI METH, V106, P69, DOI 10.1016/S0165-0270(01)00330-2; Velasco M, 2002, CLIN NEUROPHYSIOL, V113, P25, DOI 10.1016/S1388-2457(01)00707-6; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wennberg RA, 2003, CLIN NEUROPHYSIOL, V114, P1403, DOI 10.1016/S1388-2457(03)00152-4	27	234	237	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1084	1087		10.1126/science.1169626	http://dx.doi.org/10.1126/science.1169626			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461004	Green Accepted			2022-12-28	WOS:000266246700045
J	Ndekha, MJ; Oosterhout, JJG; Zijlstra, EE; Manary, M; Saloojee, H; Manary, MJ				Ndekha, MacDonald J.; Oosterhout, Joep J. Gvan; Zijlstra, Eduard E.; Manary, Micah; Saloojee, Haroon; Manary, Mark J.			Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOME-BASED THERAPY; EARLY MORTALITY; RURAL DISTRICT; SOUTH-AFRICA; FOOD; DETERMINANTS; PREVALENCE; ADHERENCE; CHILDREN; RWANDA	Objective To investigate the effect of two different food supplements on body mass index (BMI) in wasted Malawian adults with HIV who were starting antiretroviral therapy. Design Randomised, investigator blinded, controlled trial. Setting Large, public clinic associated with a referral hospital in Blantyre, Malawi. Participants 491 adults with BMI < 18.5. Interventions Ready-to-use fortified spread (n = 245) or corn-soy blend (n = 246). Main outcome measures Primary outcomes: changes in BMI and fat-free body mass after 3.5 months. Secondary outcomes: survival, CD4 count, HIV viral load, quality of life, and adherence to antiretroviral therapy. Results The mean BMI at enrolment was 16.5. After 14 weeks, patients receiving fortified spread had a greater increase in BMI and fat-free body mass than those receiving corn-soy blend: 2.2 (SD 1.9) v 1.7 (SD 1.6) (difference 0.5, 95% confidence interval 0.2 to 0.8), and 2.9 (SD 3.2) v 2.2 (SD 3.0) kg (difference 0.7 kg, 0.2 to 1.2 kg), respectively. The mortality rate was 27% for those receiving fortified spread and 26% for those receiving corn-soy blend. No significant differences in the CD4 count, HIV viral load, assessment of quality of life, or adherence to antiretroviral therapy were noted between the two groups. Conclusion Supplementary feeding with fortified spread resulted in a greater increase in BMI and lean body mass than feeding with corn-soy blend. Trial registration Current Controlled Trials ISRCTN67515515.	[Ndekha, MacDonald J.; Manary, Mark J.] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; [Oosterhout, Joep J. Gvan; Zijlstra, Eduard E.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Manary, Micah; Saloojee, Haroon] Univ Witwatersrand, Dept Paediat, Johannesburg, South Africa; [Manary, Mark J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Manary, Mark J.] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA	University of Malawi; University of Malawi; University of Witwatersrand; Washington University (WUSTL); Baylor College of Medicine	Manary, MJ (corresponding author), St Louis Childrens Hosp, Dept Pediat, 1 Childrens Pl, St Louis, MO 63110 USA.	manary@kids.wustl.edu	Saloojee, Haroon/J-5642-2019	Saloojee, Haroon/0000-0002-8298-7210; Manary, Mark/0000-0003-2733-9568	Academy for Educational Development (AED); AIDS Care Research in Africa (ACRiA)	Academy for Educational Development (AED); AIDS Care Research in Africa (ACRiA)	This study was supported by the USAID funded Food and Nutrition Technical Assistance (FANTA) Project of the Academy for Educational Development (AED) and AIDS Care Research in Africa (ACRiA). The AED provided expert review before making a funding decision, and the comments of those reviewers were considered in formulation of the final design. After agreeing to fund the study, neither sponsor played a role in the implementation, data collection, data analyses, or writing of this report.	[Anonymous], 2000, MEAS HLTH DAYS; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Bowie C, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-12; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Caulfield Laura E., 1999, Food and Nutrition Bulletin, V20, P183; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Dannhauser A, 1999, EUR J CLIN NUTR, V53, P165, DOI 10.1038/sj.ejcn.1600691; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hoddinott J., 2002, 136 FCND INT FOOD PO; Kotler DP, 1996, AM J CLIN NUTR, V64, P489; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Leyna G H, 2007, East Afr Med J, V84, P163; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Mahlungulu S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004536.pub2; Manary MJ, 2006, FOOD NUTR BULL, V27, pS83, DOI 10.1177/15648265060273S305; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mwaniki Angela, ACHIEVING FOOD SECUR; Ndekha MJ, 2005, ACTA PAEDIATR, V94, P222, DOI 10.1080/08035250410022503; *ORC MACR, 2005, MAL DEM HLTH SURV 20; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; TJON A, 1990, ANN TROP PAEDIATR, V10, P411; van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Waterlow JC, 1992, PROTEIN ENERGY MALNU; World Health Organisation, 2003, NUTR REQ PEOPL LIV H; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	31	72	73	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2009	338								b1867	10.1136/bmj.b1867	http://dx.doi.org/10.1136/bmj.b1867			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NU	19465470	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000266270100004
J	Gruber, S; Errington, J				Gruber, Stephan; Errington, Jeff			Recruitment of Condensin to Replication Origin Regions by ParB/SpoOJ Promotes Chromosome Segregation in B. subtilis	CELL			English	Article							BACILLUS-SUBTILIS; SMC PROTEIN; ESCHERICHIA-COLI; DNA-BINDING; CAULOBACTER-CRESCENTUS; STRUCTURAL MAINTENANCE; SPO0J; BACTERIAL; PARB; INITIATION	Proper segregation of DNA replication products is essential in all cells. In Bacillus subtilis, two protein complexes have been implicated in this process: the ParAB homologs, Soj and SpoOJ, and the bacterial Smc/ScpAB complex, also called condensin. Here we demonstrate that Smc is highly enriched in the region around the origin of replication, specifically near parS sites to which SpoOJ binds and at highly transcribed genes. Furthermore, we find that efficient recruitment of Smc to a large region around the origin of replication depends on the presence of SpoOJ. We show that SpoOJ performs two independent functions: regulation of initiation of DNA replication via Soj and promotion of chromosome segregation by Smc recruitment. Our results demonstrate a direct functional interaction between two widely conserved systems involved in chromosome replication and segregation.	[Gruber, Stephan; Errington, Jeff] Univ Newcastle, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Errington, J (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jeff.errington@ncl.ac.uk	Gruber, Stephan/AFC-4848-2022; Gruber, Stephan/G-5686-2012; Errington, Jeff/G-1832-2011	Gruber, Stephan/0000-0002-0150-0395; Errington, Jeff/0000-0002-6977-9388	BBSRC; European Molecular Biology Organization (EMBO); International Human Frontier Science Program Organization (HFSPO)	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program)	We are grateful to Alan Grossman for kindly providing the alpha-Smc antibody. We thank Mark Leaver, Heath Murray, Jan-Willem Veening, and Ling Juan Wu for plasmids, strains, and reagents and for critical reading of the manuscript. This work was supported by a BBSRC grant to J. E. S. G. was supported by postdoctoral fellowships from the European Molecular Biology Organization (EMBO) and the International Human Frontier Science Program Organization (HFSPO).	Autret S, 2001, MOL MICROBIOL, V41, P743, DOI 10.1046/j.1365-2958.2001.02551.x; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lindow JC, 2002, MOL MICROBIOL, V46, P997, DOI 10.1046/j.1365-2958.2002.03235.x; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodionov O, 2004, MOL MICROBIOL, V52, P1215, DOI 10.1111/j.1365-2958.2004.04055.x; SANSEAU P, 1990, ANAL BIOCHEM, V189, P142, DOI 10.1016/0003-2697(90)90060-M; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Soppa J, 2001, GENE, V278, P253, DOI 10.1016/S0378-1119(01)00733-8; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656	34	221	221	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					685	696		10.1016/j.cell.2009.02.035	http://dx.doi.org/10.1016/j.cell.2009.02.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450516	Bronze			2022-12-28	WOS:000266114100017
J	Swanson, RM				Swanson, Richard M.			Photovoltaics Power Up	SCIENCE			English	Editorial Material									SunPower Corp, San Jose, CA 95134 USA		Swanson, RM (corresponding author), SunPower Corp, 3939 N 1st St, San Jose, CA 95134 USA.	richard.swanson@sunpowercorp.com		Swanson, Richard M./0000-0003-3242-8039				MINTS P, 2007, RENEWABLE ENERGY SEP; Schulz M., 2009, WALL STREET J, pA15; Swanson RM, 2006, PROG PHOTOVOLTAICS, V14, P443, DOI 10.1002/pip.709; 2008, PHOTON INT       DEC, P84	4	56	57	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					891	892		10.1126/science.1169616	http://dx.doi.org/10.1126/science.1169616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443773				2022-12-28	WOS:000266048800023
J	Natale, F; Cirillo, C; Di Marco, GM; di Vetta, LS; Aronne, L; Siciliano, A; Mocerino, R; Tedesco, MA; Golino, P; Calabro, R				Natale, Francesco; Cirillo, Chiara; Di Marco, Giovanni Maria; di Vetta, Lucia Scotto; Aronne, Luigi; Siciliano, Alessandro; Mocerino, Rose; Tedesco, Michele A.; Golino, Paolo; Calabro, Raffaele			When chewing gum is more than just a bad habit	LANCET			English	Editorial Material							CAFFEINE		[Natale, Francesco; Cirillo, Chiara; Di Marco, Giovanni Maria; di Vetta, Lucia Scotto; Aronne, Luigi; Siciliano, Alessandro; Mocerino, Rose; Tedesco, Michele A.; Golino, Paolo; Calabro, Raffaele] Univ Naples 2, Dept Cardiol, Monaldi Hosp, I-80121 Naples, Italy	Universita della Campania Vanvitelli	Natale, F (corresponding author), Univ Naples 2, Dept Cardiol, Monaldi Hosp, Via L Bianchi 1, I-80121 Naples, Italy.	natalefrancesco@hotmail.com		GOLINO, Paolo/0000-0002-3590-6983; Calabro, Raffaele/0000-0001-9546-8914; Cirillo, Chiara/0000-0002-1882-0088; natale, francesco/0000-0001-7824-6033				*AM PSYCH ASS, 2000, DIAGN STAT MAN MENT, P212; Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055; Fredholm BB, 1999, PHARMACOL REV, V51, P83; HENMAN AR, 1982, J ETHNOPHARMACOL, V6, P311, DOI 10.1016/0378-8741(82)90054-X; Kamimori GH, 2002, INT J PHARM, V234, P159, DOI 10.1016/S0378-5173(01)00958-9	5	2	2	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2009	373	9678					1918	1918		10.1016/S0140-6736(09)60730-3	http://dx.doi.org/10.1016/S0140-6736(09)60730-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19482217				2022-12-28	WOS:000266616400035
J	Bilous, R; Chaturvedi, N; Sjolie, AK; Fuller, J; Klein, R; Orchard, T; Porta, M; Parving, HH				Bilous, Rudy; Chaturvedi, Nish; Sjolie, Anne Katrin; Fuller, John; Klein, Ronald; Orchard, Trevor; Porta, Massimo; Parving, Hans-Henrik			Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes Three Randomized Trials	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	41st Annual Meeting of the American-Society-of-Nephrology/Annual Renal Week	NOV 04-09, 2008	Philadelphia, PA	Amer Soc Nephrol			RISK-FACTORS; NEPHROPATHY; RETINOPATHY; MELLITUS; PROGRESSION; PREVENTION; IRBESARTAN; INCIPIENT; PREDICTOR; MORTALITY	Background: Microalbuminuria in diabetes is strongly predictive of nephropathy, end-stage renal disease, and premature cardiovascular morbidity and mortality. Effective preventive therapies are therefore a clinical priority. Objective: To determine whether the angiotensin-receptor blocker candesartan compared with placebo affects microalbuminuria incidence or rate of change in albuminuria in type 1 and type 2 diabetes. Design: 3 randomized trials of the DIRECT (Diabetic Retinopathy Candesartan Trials) Program. Setting: 309 secondary care centers. Patients: 3326 and 1905 patients with type 1 and type 2 diabetes, respectively. Most were normotensive, and all had normoalbuminuria (median urinary albumin excretion rate, 5.0 mu g/min). Intervention: Candesartan, 16mg/d increasing to32mg/d, versus placebo. Assignment was done centrally using an interactive voiceresponse system. Patients, caregivers, and researchers were blinded to treatment assignment. During a median follow-up of 4.7 years, 793 patients discontinued therapy and 63 were lost to follow-up. Measurements: Urinary albumin excretion rate, assessed annually by 2 overnight collections; if it was 20 mu g/min or greater, then 2 further collections were done. The primary end point was new microalbuminuria (3 or 4 collections of urinary albumin excretion rate >= 20 mu g/min). The secondary end point was rate of change in albuminuria. Results: Individual and pooled results of the 3 trials showed that candesartan had little effect on risk for microalbuminuria (pooled hazard ratio, 0.95 [95% Cl, 0.78 to 1.16]; P = 0.60). Pooled results showed that the annual rate of change in albuminuria was 5.53% lower (CI, 0.73% to 10.14%; P = 0.024) with candesartan than with placebo. Limitations: Investigators recruited mainly normotensive patients or patients with well-controlled hypertension who were at low overall vascular risk, which resulted in a low rate of microalbuminuria. Studies were powered for retinal and not renal end points. Conclusion: Candesartan, 32 mg/d, for 4.7 years did not prevent microalbuminuria in mainly normotensive patients with type 1 or type 2 diabetes. Primary Funding Source: AstraZeneca and Takeda.	Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bilous, Rudy] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; S Tees Hosp NHS Trust, Middlesbrough, Cleveland, England; UCL, London, England; Imperial Coll Healthcare NHS Trust, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England; Odense Univ Hosp, DK-5000 Odense, Denmark; Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Turin, Turin, Italy; Aarhus Univ, Copenhagen, Denmark; Univ Copenhagen, Rigshosp, Copenhagen, Denmark	Newcastle University - UK; James Cook University Hospital; University of London; University College London; Imperial College London; University of Southern Denmark; Odense University Hospital; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Turin; Aarhus University; Rigshospitalet; University of Copenhagen	Bilous, R (corresponding author), James Cook Univ Hosp, Marton Rd, Middlesbrough TS4 3BW, Cleveland, England.	rudy.bilous@stees.nhs.uk	Porta, Massimo/G-6146-2011; McManus, Ruth/G-3938-2011; Chaturvedi, Nishi/C-7761-2013	Klein, Ronald/0000-0002-4428-6237; Porta, Massimo/0000-0002-3407-6017; orchard, trevor/0000-0001-9552-3215				Alioum A, 1996, BIOMETRICS, V52, P512, DOI 10.2307/2532891; [Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; BORCHJOHNSEN K, 1987, BMJ-BRIT MED J, V294, P1651, DOI 10.1136/bmj.294.6588.1651; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chaturvedi N, 1997, LANCET, V349, P1787, DOI 10.1016/S0140-6736(96)10244-0; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; COONROD BA, 1993, DIABETES CARE, V16, P1376, DOI 10.2337/diacare.16.10.1376; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Rossing K, 2003, DIABETES CARE, V26, P150, DOI 10.2337/diacare.26.1.150; Rossing P, 2002, DIABETES CARE, V25, P859, DOI 10.2337/diacare.25.5.859; RUDBERG S, 1993, DIABETOLOGIA, V36, P1309, DOI 10.1007/BF00400811; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Senn S, 2000, STAT MED, V19, P861, DOI 10.1002/(SICI)1097-0258(20000330)19:6<861::AID-SIM407>3.0.CO;2-F; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sjolie AK, 2002, J RENIN-ANGIO-ALDO S, V3, P255; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; STEPHENSON JM, 1995, DIABETOLOGIA, V38, P599; Strippoli GFM, 2005, J AM SOC NEPHROL, V16, P3081, DOI 10.1681/ASN.2004080634; Sun JG, 2005, SCAND J STAT, V32, P49, DOI 10.1111/j.1467-9469.2005.00414.x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; VIBERTI GC, 1982, LANCET, V1, P1430; Warnold I, 2005, J RENIN-ANGIO-ALDO S, V6, P25	27	168	179	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2009	151	1					11	U27		10.7326/0003-4819-151-1-200907070-00120	http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00120			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	470BF	19451554				2022-12-28	WOS:000267946100002
J	Merritt, JM; Bondybey, VE; Heaven, MC				Merritt, Jeremy M.; Bondybey, Vladimir E.; Heaven, Michael C.			Beryllium Dimer-Caught in the Act of Bonding	SCIENCE			English	Article							GROUND-STATE; CONFIGURATION-INTERACTION; SPECTROSCOPIC CONSTANTS; MOLECULAR-STRUCTURE; POTENTIAL CURVES; BINDING-ENERGY; BE-2; ATOMS	The beryllium dimer is a deceptively simple molecule that, in spite of having only eight electrons, poses difficult challenges for ab initio quantum chemical methods. More than 100 theoretical investigations of the beryllium dimer have been published, reporting a wide range of bond lengths and dissociation energies. In contrast, there have been only a handful of experimental studies that provide data against which these models could be tested. Ultimately, the uncertain extrapolation behavior associated with the available data has prevented quantitative comparisons with theory. In our experiment, we resolve this issue by recording and analyzing spectra that sample all the bound vibrational levels of the beryllium dimer molecule's electronic ground state. After more than 70 years of research on this problem, the experimental data and theoretical models for the dimer are finally reconciled.	[Merritt, Jeremy M.; Heaven, Michael C.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Bondybey, Vladimir E.] Tech Univ Munich, D-8046 Garching, Germany	Emory University; Technical University of Munich	Heaven, MC (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	mheaven@emory.edu	Heaven, Michael/AAC-7755-2019	Heaven, Michael/0000-0003-4738-2408	NSF [CHE-0518094]	NSF(National Science Foundation (NSF))	We are grateful for the financial support of this work provided by NSF (grant CHE-0518094). V.E.B. thanks Die Deutsche Forschungsgemeinschaft for partial support of his visit to Emory University.	Bartlett JH, 1931, PHYS REV, V38, P1615, DOI 10.1103/PhysRev.38.1615; BENDER CF, 1967, J CHEM PHYS, V47, P4972, DOI 10.1063/1.1701748; BONDYBEY VE, 1984, CHEM PHYS LETT, V109, P436, DOI 10.1016/0009-2614(84)80339-5; BONDYBEY VE, 1985, SCIENCE, V227, P125, DOI 10.1126/science.227.4683.125; BONDYBEY VE, 1984, J CHEM PHYS, V80, P568, DOI 10.1063/1.446434; BROM JM, 1975, J CHEM PHYS, V62, P3122, DOI 10.1063/1.430926; Bucinsky L, 2009, J COMPUT CHEM, V30, P65, DOI 10.1002/jcc.21030; Czuchaj E, 2003, THEOR CHEM ACC, V110, P28, DOI 10.1007/s00214-003-0449-z; Czuchaj E, 2001, THEOR CHEM ACC, V107, P27, DOI 10.1007/s002140100296; Evangelisti S, 1996, CHEM PHYS LETT, V252, P437, DOI 10.1016/0009-2614(96)00177-7; EVANGELISTI S, 1994, CHEM PHYS, V185, P47, DOI 10.1016/0301-0104(94)00103-0; FRAGA S, 1961, J CHEM PHYS, V35, P669, DOI 10.1063/1.1731987; FRAGA S, 1962, J CHEM PHYS, V36, P1127, DOI 10.1063/1.1732704; Gdanitz RJ, 1999, CHEM PHYS LETT, V312, P578, DOI 10.1016/S0009-2614(99)00985-9; HARRISON RJ, 1983, CHEM PHYS LETT, V98, P97, DOI 10.1016/0009-2614(83)87105-X; Herzberg G, 1929, Z PHYS, V57, P601, DOI 10.1007/BF01343078; Herzberg L, 1933, Z PHYS, V84, P571, DOI 10.1007/BF01330403; Krapp A, 2006, CHEM-EUR J, V12, P9196, DOI 10.1002/chem.200600564; Le Roy R.J., 2006, CP662R U WAT CHEM PH; Le Roy RJ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2064947; LENGSFIELD BH, 1983, J CHEM PHYS, V79, P1891, DOI 10.1063/1.445966; Martin JML, 1999, CHEM PHYS LETT, V303, P399, DOI 10.1016/S0009-2614(99)00214-6; Merritt JM, 2008, PHYS CHEM CHEM PHYS, V10, P4006, DOI 10.1039/b803975e; NORTHRUP FJ, 1992, ANNU REV PHYS CHEM, V43, P127, DOI 10.1146/annurev.physchem.43.1.127; Patkowski K, 2007, J PHYS CHEM A, V111, P12822, DOI 10.1021/jp076412c; PETERSSON GA, 1989, CHEM PHYS LETT, V160, P494, DOI 10.1016/0009-2614(89)80052-1; ROEGGEN I, 1987, CHEM PHYS LETT, V140, P349, DOI 10.1016/0009-2614(87)80745-5; Roeggen I, 1996, INT J QUANTUM CHEM, V60, P453, DOI 10.1002/(SICI)1097-461X(1996)60:1<453::AID-QUA44>3.0.CO;2-A; Spirko V, 2006, J MOL SPECTROSC, V235, P268, DOI 10.1016/j.jms.2005.11.012	29	163	163	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1548	1551		10.1126/science.1174326	http://dx.doi.org/10.1126/science.1174326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19460963				2022-12-28	WOS:000267130600040
J	Best, JA				Best, Jennifer A.			Is There a Doctor in the House?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jabest@u.washington.edu							0	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2191	2192		10.1001/jama.2009.753	http://dx.doi.org/10.1001/jama.2009.753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491174				2022-12-28	WOS:000266554100001
J	Matthews, PC; Berendt, AR; McNally, MA; Byren, I				Matthews, Philippa C.; Berendt, Anthony R.; McNally, Martin A.; Byren, Ivor			Diagnosis and management of prosthetic joint infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK-FACTORS; RETROSPECTIVE ANALYSIS; KNEE ARTHROPLASTY; DEBRIDEMENT; THERAPY; HIP; RETENTION; RIFAMPICIN		[Matthews, Philippa C.; Berendt, Anthony R.; McNally, Martin A.; Byren, Ivor] Nuffield Orthopaed Ctr NHS Trust, Bone Infect Unit, Oxford OX3 7LD, England; [Matthews, Philippa C.; Berendt, Anthony R.; Byren, Ivor] John Radcliffe Hosp, Oxford Radcliffe Hosp NHS Trust, Dept Infect Dis, Oxford OX3 9DU, England; [Matthews, Philippa C.] Univ Oxford, Oxford OX1 1SY, England	Nuffield Orthopaedic Centre; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Matthews, PC (corresponding author), Nuffield Orthopaed Ctr NHS Trust, Bone Infect Unit, Oxford OX3 7LD, England.	p.matthews@doctors.org.uk	Matthews, Philippa/P-7810-2019	Matthews, Philippa/0000-0002-4036-4269				Aboltins CA, 2007, CLIN MICROBIOL INFEC, V13, P586, DOI 10.1111/j.1469-0691.2007.01691.x; Atkins BL, 1998, J CLIN MICROBIOL, V36, P2932, DOI 10.1128/JCM.36.10.2932-2939.1998; Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991; Berbari EF, 2007, CLIN INFECT DIS, V45, P1113, DOI 10.1086/522184; Berdal JE, 2005, CLIN MICROBIOL INFEC, V11, P843, DOI 10.1111/j.1469-0691.2005.01230.x; Betsch BY, 2008, CLIN INFECT DIS, V46, P1221, DOI 10.1086/529436; Choong PFM, 2007, ACTA ORTHOP, V78, P755, DOI 10.1080/17453670710014527; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Edwards C, 2008, J BONE JOINT SURG BR, V90B, P770, DOI 10.1302/0301-620X.90B6.20194; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Ince A, 2005, J BONE JOINT SURG BR, V87B, P814, DOI 10.1302/0301-620X.87B6.15920; Jamsen E, 2009, J BONE JOINT SURG AM, V91A, P38, DOI 10.2106/JBJS.G.01686; Laffer RR, 2006, CLIN MICROBIOL INFEC, V12, P433, DOI 10.1111/j.1469-0691.2006.01378.x; Marculescu CE, 2006, CLIN INFECT DIS, V42, P471, DOI 10.1086/499234; Matthews PC, 2007, J ANTIMICROB CHEMOTH, V60, P356, DOI 10.1093/jac/dkm210; Mittal Y, 2007, J BONE JOINT SURG AM, V89A, P1227, DOI 10.2106/JBJS.E.01192; Moran E, 2007, J INFECTION, V55, P1, DOI 10.1016/j.jinf.2007.01.007; Muller Michael, 2008, J Orthop Surg Res, V3, P31, DOI 10.1186/1749-799X-3-31; Parvizi J, 2008, CLIN ORTHOP RELAT R, V466, P2628, DOI 10.1007/s11999-008-0471-5; Pavoni GL, 2004, CLIN MICROBIOL INFEC, V10, P831, DOI 10.1111/j.1469-0691.2004.00928.x; Phillips JE, 2006, J BONE JOINT SURG BR, V88B, P943, DOI 10.1302/0301-620X.88B7.17150; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Trampuz A, 2005, SWISS MED WKLY, V135, P243; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537	25	81	85	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2009	338								b1773	10.1136/bmj.b1773	http://dx.doi.org/10.1136/bmj.b1773			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WV	19482869				2022-12-28	WOS:000266502500001
J	Uprichard, J; Bain, BJ				Uprichard, James; Bain, Barbara J.			Rational testing Investigating suspected anaemia	BRITISH MEDICAL JOURNAL			English	Editorial Material							MYELODYSPLASTIC SYNDROMES		[Uprichard, James; Bain, Barbara J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Haematol, London W2 1NY, England	Imperial College London	Bain, BJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Haematol, St Marys Hosp & Hammersmith Hosp Campuses, London W2 1NY, England.	b.bain@ic.ac.uk						AUL C, 1995, LEUKEMIA LYMPHOMA, V16, P247, DOI 10.3109/10428199509049764; Bain BJ, 2005, NEW ENGL J MED, V353, P498, DOI 10.1056/NEJMra043442; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Jadersten M, 2008, J CLIN ONCOL, V26, P3607, DOI 10.1200/JCO.2007.15.4906; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Savage DG, 2000, AM J MED SCI, V319, P343, DOI 10.1097/00000441-200006000-00001	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 22	2009	338								b1644	10.1136/bmj.b1644	http://dx.doi.org/10.1136/bmj.b1644			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NU	19465463				2022-12-28	WOS:000266270100001
J	Nogueira, HM; Gama, RD				Nogueira, Hugo Mesquita; Gama, Rita Dinis			Bull's-Eye Maculopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nogueira, Hugo Mesquita; Gama, Rita Dinis] Inst Oftalmol Dr Gama Pinto, P-1169 Lisbon, Portugal		Nogueira, HM (corresponding author), Inst Oftalmol Dr Gama Pinto, P-1169 Lisbon, Portugal.	hugo_fcml@hotmail.com	Gama, Rita/AAH-6650-2021	Gama, Rita/0000-0001-6200-3694					0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2224	2224		10.1056/NEJMicm0708021	http://dx.doi.org/10.1056/NEJMicm0708021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458367				2022-12-28	WOS:000266206000009
J	Nuckols, TK; Bhattacharya, J; Wolman, DM; Ulmer, C; Escarce, JJ				Nuckols, Teryl K.; Bhattacharya, Jay; Wolman, Dianne Miller; Ulmer, Cheryl; Escarce, Jose J.			Cost Implications of Reduced Work Hours and Workloads for Resident Physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PREVENTABLE ADVERSE EVENTS; GRADUATE MEDICAL-EDUCATION; INTENSIVE-CARE UNITS; DUTY HOURS RESTRICTIONS; DRUG EVENTS; HOURS REFORM; HOSPITAL CHARACTERISTICS; ACCREDITATION COUNCIL; MALPRACTICE CLAIMS; SURGERY RESIDENTS	BACKGROUND Although the Accreditation Council for Graduate Medical Education (ACGME) limits the work hours of residents, concerns about fatigue persist. A new Institute of Medicine (IOM) report recommends, among other changes, improved adherence to the 2003 ACGME limits, naps during extended shifts, a 16-hour limit for shifts without naps, and reduced workloads. METHODS We used published data to estimate labor costs associated with transferring excess work from residents to substitute providers, and we examined the effects of our assumptions in sensitivity analyses. Next, using a probability model to represent labor costs as well as mortality and costs associated with preventable adverse events, we determined the net costs to major teaching hospitals and cost-effectiveness across a range of hypothetical changes in the rate of preventable adverse events. RESULTS Annual labor costs from implementing the IOM recommendations were estimated to be $1.6 billion (in 2006 U. S. dollars) across all ACGME-accredited programs ($1.1 billion to $2.5 billion in sensitivity analyses). From a 10% decrease to a 10% increase in preventable adverse events, net costs per admission ranged from $99 to $183 for major teaching hospitals and from $17 to $266 for society. With 2.5% to 11.3% decreases in preventable adverse events, costs to society per averted death ranged from $3.4 million to $0. CONCLUSIONS Implementing the four IOM recommendations would be costly, and their effectiveness is unknown. If highly effective, they could prevent patient harm at reduced or no cost from the societal perspective. However, net costs to teaching hospitals would remain high.	[Nuckols, Teryl K.; Escarce, Jose J.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Nuckols, Teryl K.; Escarce, Jose J.] RAND Corp, Santa Monica, CA USA; [Bhattacharya, Jay] Stanford Univ, Stanford, CA 94305 USA; [Wolman, Dianne Miller; Ulmer, Cheryl] Natl Acad Sci, Inst Med, Washington, DC 20418 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation; Stanford University; National Academies of Sciences, Engineering & Medicine	Nuckols, TK (corresponding author), 911 Broxton Plaza, Los Angeles, CA 90095 USA.	tnuckols@mednet.ucla.edu	Scott, Teryl Nuckols/AAH-9711-2021		Institute of Medicine	Institute of Medicine	Supported by the Institute of Medicine, under contract to the Agency for Healthcare Research and Quality.	*ACCR COUNC GRAD M, 2008, ACGMES APPR LIM RES; Accreditation Council for Graduate Medical Education, GLOSS TERMS; *ACGME, DUT HOURS LANG; *AM COUNC GRAD MED, 2001, ACGMES ROL PROT ED P; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Arora VM, 2008, JAMA-J AM MED ASSOC, V300, P1146, DOI 10.1001/jama.300.10.1146; *ASS AM MED COLL, TEACH HOSP AAMC COTH; *ASS AM MED COLL, 2007, AAMC SURV HOU STIP B; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BERRY WD, 2003, COST LIVING INDEX US; Bhavsar J, 2007, AM J MED, V120, P968, DOI 10.1016/j.amjmed.2007.07.026; BRENNAN TA, 1991, JAMA-J AM MED ASSOC, V265, P3265, DOI 10.1001/jama.265.24.3265; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; Brotherton SE, 2007, JAMA-J AM MED ASSOC, V298, P1081, DOI 10.1001/jama.298.9.1081; Brotherton SE, 2004, JAMA-J AM MED ASSOC, V292, P1032, DOI 10.1001/jama.292.9.1032; Buch KE, 2008, J SURG EDUC, V65, P50, DOI 10.1016/j.jsurg.2007.07.002; *BUR CENS, 2000, CURR POP SURV ANN DE; *BUR CENS, 2003, CURR POP SURV ANN SO; *BUR CENS, 2003, STAT POP EST ANN TIM; *BUR CENS, 2001, CURR POP SURV ANN DE; *BUR CENS, 2005, CURR POP SURV ANN SO; *BUR CENS, 2002, CURR POP SURV ANN DE; *BUR CENS, 2004, CURR POP SURV ANN SO; *BUR LAB STAT, 2003, NAT COMP SURV; *BUR LAB STAT, 2003, EMPL COST IND; *BUR LAB STAT, 2006, EMPL COST EMPL COMP; *BUR LAB STAT, 2006, NAT COMP SURV OCC WA; *BUR LAB STAT, 2003, EMPL COST IND JUN 19; *BUR LAB STAT, 2006, CONS PRIC IND URB CO; *BUR LAB STAT, 2006, EMPL COST IND N AM I; *BUR LAB STAT, 2003, CONS PRINC IND URB C; Carpenter RO, 2006, AM J SURG, V191, P527, DOI 10.1016/j.amjsurg.2006.01.002; Carpenter Robert O, 2006, Curr Surg, V63, P448, DOI 10.1016/j.cursur.2006.06.003; Chao S., 2008, CREATING BUSINESS CA; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; COGME, 2005, PHYS WORKF POL GUID; Cohen-Gadol AA, 2005, NEUROSURGERY, V56, P398, DOI 10.1227/01.NEU.0000147999.64356.57; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Cull WL, 2006, PEDIATRICS, V118, pE1805, DOI 10.1542/peds.2006-0210; Davenport DL, 2008, SURGERY, V144, P332, DOI 10.1016/j.surg.2008.03.038; de Virgilio Christian, 2006, Curr Surg, V63, P435, DOI 10.1016/j.cursur.2006.03.006; Encinosa WE, 2008, HEALTH SERV RES, V43, P2067, DOI 10.1111/j.1475-6773.2008.00882.x; GROVER A, 2006, ANN WORKF M ASS AM M; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Hayward RA, 2007, HEALTH SERV RES, V42, P1718, DOI 10.1111/j.1475-6773.2006.00661.x; *HLTH FOR LLC, 2003, AM HOSP ASS ANN SURV; Horwitz LI, 2007, ANN INTERN MED, V147, P97, DOI 10.7326/0003-4819-147-2-200707170-00163; Horwitz LI, 2006, J GEN INTERN MED, V21, P961, DOI 10.1007/BF02743145; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Institute of Medicine, 2008, RES DUT HOURS ENH SL; Jagsi R, 2006, ACAD MED, V81, P1059, DOI 10.1097/01.ACM.0000246685.96372.5e; Kane RL, 2005, AM J MED, V118, P767, DOI 10.1016/j.amjmed.2005.02.011; Kaushal R, 2007, CRIT CARE MED, V35, P2479, DOI 10.1097/01.CCM.0000284510.04248.66; Kirton OC, 2007, ARCH SURG-CHICAGO, V142, P336, DOI 10.1001/archsurg.142.4.336; KNICKMAN JR, 1992, ACAD MED, V67, P429, DOI 10.1097/00001888-199207000-00003; Kusuma SK, 2007, J BONE JOINT SURG AM, V89A, P679, DOI 10.2106/JBJS.F.00526; Landrigan CP, 2008, PEDIATRICS, V122, P250, DOI 10.1542/peds.2007-2306; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Lundberg S, 2006, ACAD MED, V81, P1021, DOI 10.1097/01.ACM.0000246677.36103.ad; Mathur Mudit, 2005, Pediatr Crit Care Med, V6, P14, DOI 10.1097/01.PCC.0000149133.50687.A1; Maviglia SM, 2007, ARCH INTERN MED, V167, P788, DOI 10.1001/archinte.167.8.788; Maxwell S, 2007, NEW ENGL J MED, V356, P1853, DOI 10.1056/NEJMsa063258; Mello Michelle M, 2007, J EMPIR LEGAL STUD, V4, P835, DOI [10.1111/j.17401461.2007.00108.x, DOI 10.1111/J.1740-1461.2007.00108.X]; *MGMA, 2006, PHYS COMP PROD SURV; Morton JM, 2004, AM J SURG, V188, P225, DOI 10.1016/j.amjsurg.2004.06.011; Needleman B, 2006, HEALTH AFFAIR, V25, P571; Needleman J, 2006, HEALTH AFFAIR, V25, P204, DOI 10.1377/hlthaff.25.1.204; NUCKOLS T, 2008, COST ANAL I MED PROJ; Nuckols TK, 2008, MED CARE, V46, P17, DOI 10.1097/MLR.0b013e3181589bed; Nuckols TK, 2005, J GEN INTERN MED, V20, P873, DOI 10.1111/j.1525-1497.2005.0133.x; Nuthalapaty FS, 2006, AM J OBSTET GYNECOL, V194, P282, DOI 10.1016/j.ajog.2005.07.053; Ogden PE, 2006, ACAD MED, V81, P1026, DOI 10.1097/01.ACM.0000246688.93566.28; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Peterson LE, 2006, ACAD MED, V81, P1032, DOI 10.1097/01.ACM.0000246689.33152.52; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Rothberg MB, 2005, MED CARE, V43, P785, DOI 10.1097/01.mlr.0000170408.35854.fa; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Rothschild JM, 2002, ARCH INTERN MED, V162, P2414, DOI 10.1001/archinte.162.21.2414; Schmidek JM, 2005, JT COMM J QUAL PATIE, V31, P690, DOI 10.1016/S1553-7250(05)31090-7; Sehgal NL, 2008, J HOSP MED, V3, P247, DOI 10.1002/jhm.311; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Thomas EJ, 2000, J GEN INTERN MED, V15, P211, DOI 10.1046/j.1525-1497.2000.015004211.x; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Thomas EJ, 2002, ANN INTERN MED, V137, P147, DOI 10.7326/0003-4819-137-2-200207160-00026; Thomas EJ, 1999, INQUIRY-J HEALTH CAR, V36, P255; Thomas EJ, 2002, ANN INTERN MED, V136, P812, DOI 10.7326/0003-4819-136-11-200206040-00009; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Thornlow DK, 2006, MED CARE, V44, P265, DOI 10.1097/01.mlr.0000199668.42261.a3; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Weeks W B, 2001, Jt Comm J Qual Improv, V27, P533; Weeks William B, 2003, Jt Comm J Qual Saf, V29, P51; Woods D, 2005, PEDIATRICS, V115, P155, DOI 10.1542/peds.2004-0410; Wu RC, 2007, J EVAL CLIN PRACT, V13, P440, DOI 10.1111/j.1365-2753.2006.00738.x; WYNN BO, 2006, WR369ASPE RAND CORP; Zhan CL, 2006, HEALTH AFFAIR, V25, P1386, DOI 10.1377/hlthaff.25.5.1386; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	103	90	91	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2202	2215		10.1056/NEJMsa0810251	http://dx.doi.org/10.1056/NEJMsa0810251			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458365				2022-12-28	WOS:000266206000007
J	Phillips, R; Ursell, T; Wiggins, P; Sens, P				Phillips, Rob; Ursell, Tristan; Wiggins, Paul; Sens, Pierre			Emerging roles for lipids in shaping membrane-protein function	NATURE			English	Review							MECHANOSENSITIVE CHANNEL; LARGE-CONDUCTANCE; BILAYER DEFORMATION; LATERAL PRESSURES; CURVATURE; MSCL; MODULATION; MODELS; INCLUSIONS; HYPOTHESIS	Studies of membrane proteins have revealed a direct link between the lipid environment and the structure and function of some of these proteins. Although some of these effects involve specific chemical interactions between lipids and protein residues, many can be understood in terms of protein-induced perturbations to the membrane shape. The free-energy cost of such perturbations can be estimated quantitatively, and measurements of channel gating in model systems of membrane proteins with their lipid partners are now confirming predictions of simple models.	[Phillips, Rob; Ursell, Tristan] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Wiggins, Paul] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sens, Pierre] ESPCI, CNRS, UMR Gulliver, F-7083 Paris, France	California Institute of Technology; Massachusetts Institute of Technology (MIT); Whitehead Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu	sens, pierre/C-3537-2011	sens, pierre/0000-0003-4523-3791	US National Science Foundation; National Institutes of Health [R01 GM084211]; Director's Pioneer Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's Pioneer Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to many people for insights and comments. In particular, we thank O. Andersen, M. Bialecka, F. Brown, N. Dan, L. Haswell, S. Johnson, J. Kondev, R. MacKinnon, C. Morris, D. Rees, D. Reeves, F. Sachs, D. Schmidt, S. Scheuring, S. Sukharev, M. Turner, S. White and M. Widom. We are also grateful to several anonymous reviewers for insightful comments. In addition, we are grateful to the US National Science Foundation and the National Institutes of Health for support through NIH Award number R01 GM084211 and the Director's Pioneer Award. The reference list for this article was constrained by length limits, and as a result the references cited here are representative rather than comprehensive. We apologize to those whose references are not cited as a result of either space limitations or our ignorance.	Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Arkhipov A, 2008, BIOPHYS J, V95, P2806, DOI 10.1529/biophysj.108.132563; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Boal D. H., 2002, MECH CELL; Bond PJ, 2007, P NATL ACAD SCI USA, V104, P2631, DOI 10.1073/pnas.0606822104; BRUINSMA R, 1994, BIOPHYS J, V67, P746, DOI 10.1016/S0006-3495(94)80535-1; Calabrese B, 2002, BIOPHYS J, V83, P2560, DOI 10.1016/S0006-3495(02)75267-3; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen X, 2008, BIOPHYS J, V95, P563, DOI 10.1529/biophysj.107.128488; Dan N, 1998, BIOPHYS J, V75, P1410, DOI 10.1016/S0006-3495(98)74059-7; DAN N, 1993, LANGMUIR, V9, P2768, DOI 10.1021/la00035a005; Dupuy AD, 2008, P NATL ACAD SCI USA, V105, P2848, DOI 10.1073/pnas.0712379105; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Elmore DE, 2003, BIOPHYS J, V85, P1512, DOI 10.1016/S0006-3495(03)74584-6; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Gil T, 1998, BBA-REV BIOMEMBRANES, V1376, P245, DOI 10.1016/S0304-4157(98)00022-7; Goforth RL, 2003, J GEN PHYSIOL, V121, P477, DOI 10.1085/jgp.200308797; Golestanian R, 1996, PHYS REV E, V54, P6725, DOI 10.1103/PhysRevE.54.6725; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; Jeon J, 2008, BIOPHYS J, V94, P3497, DOI 10.1529/biophysj.107.109850; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; LEIBLER S, 1986, J PHYS-PARIS, V47, P507, DOI 10.1051/jphys:01986004703050700; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Markin VS, 2004, PHYS BIOL, V1, P110, DOI 10.1088/1478-3967/1/2/007; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Marsh D, 2006, CHEM PHYS LIPIDS, V144, P146, DOI 10.1016/j.chemphyslip.2006.08.004; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; MOURITSEN OG, 1984, BIOPHYS J, V46, P141, DOI 10.1016/S0006-3495(84)84007-2; Muller MM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061407; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Petsko G., 2004, PROTEIN STRUCTURE FU; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Sens P, 2004, BIOPHYS J, V86, P2049, DOI 10.1016/S0006-3495(04)74266-6; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Turner MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.118103; Turner MS, 1999, BIOPHYS J, V76, P564, DOI 10.1016/S0006-3495(99)77224-3; Ursell T, 2007, PLOS COMPUT BIOL, V3, P803, DOI 10.1371/journal.pcbi.0030081; Ursell Tristan, 2008, V1, P37, DOI 10.1007/978-1-4020-6426-5_2; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Weikl TR, 1998, PHYS REV E, V57, P6988, DOI 10.1103/PhysRevE.57.6988; Wiggins P, 2005, BIOPHYS J, V88, P880, DOI 10.1529/biophysj.104.047431; Wiggins P, 2004, P NATL ACAD SCI USA, V101, P4071, DOI 10.1073/pnas.0307804101; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	63	717	727	4	294	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					379	385		10.1038/nature08147	http://dx.doi.org/10.1038/nature08147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458714	Green Accepted			2022-12-28	WOS:000266243700036
J	Kalyanasundaram, A; Berger, P				Kalyanasundaram, Arun; Berger, Peter			Fractional flow reserve-guided PCI reduced major adverse cardiac outcomes compared with angiography-guided PCI in multivessel CAD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION		[Kalyanasundaram, Arun; Berger, Peter] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Kalyanasundaram, A (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.							Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-7	10.7326/0003-4819-150-10-200905190-02007	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451563				2022-12-28	WOS:000266285300027
J	Heisenberg, M				Heisenberg, Martin			Is free will an illusion?	NATURE			English	Editorial Material									Univ Wurzburg, Dept Biol, D-97070 Wurzburg, Germany	University of Wurzburg	Heisenberg, M (corresponding author), Univ Wurzburg, Dept Biol, D-97070 Wurzburg, Germany.	heisenberg@biozentrum.uni-wuerzburg.de						HEISENBERG M, 1983, NATURWISSENSCHAFTEN, V70, P70, DOI 10.1007/BF00365500; Heisenberg M., 1984, STUDIES BRAIN FUNCTI, V12; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Wegner DM, 2002, BRADFORD BOOKS, P1	5	54	54	0	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					164	165		10.1038/459164a	http://dx.doi.org/10.1038/459164a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445FR	19444190	Bronze			2022-12-28	WOS:000266036100016
J	Abdi, Z				Abdi, Zeinab			The paediatric analgesia wheel: are you ready to roll?	LANCET			English	Editorial Material							MEDICATION ERRORS; RESIDENTS		Leicester Royal Infirm, Leicester LE1 5WW, Leics, England	University of Leicester	Abdi, Z (corresponding author), Leicester Royal Infirm, Infirm Sq, Leicester LE1 5WW, Leics, England.	zeinababdi@hotmail.com						*GEN MED COUNC, 2007, RES PREV CAUS PRESCR; Glover ML, 2002, ACAD MED, V77, P1007, DOI 10.1097/00001888-200210000-00013; Hart AR, 2008, ARCH DIS CHILD, V93, P636, DOI 10.1136/adc.2008.139410; Heaton A, 2008, BRIT J CLIN PHARMACO, V66, P128, DOI 10.1111/j.1365-2125.2008.03197.x; Hixson R, 2009, ARCH DIS CHILD, V94, P268, DOI 10.1136/adc.2008.142380; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; MENON L, 2006, PAEDIAT PERINAT DRUG, V7, P118; National Patient Safety Agency, 2007, SAF DOS IMPR US MED; Rowe C, 1998, ARCH DIS CHILD, V79, P56, DOI 10.1136/adc.79.1.56; Western Australia Commissioner for Children and Young People, 2020, NAT SERV FRAM CHILDR; Wong ICK, 2009, ARCH DIS CHILD, V94, P161, DOI 10.1136/adc.2007.116442; Wong IC, 2004, DRUG SAFETY, V27, P661, DOI 10.2165/00002018-200427090-00004	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1831	1832		10.1016/S0140-6736(09)61005-9	http://dx.doi.org/10.1016/S0140-6736(09)61005-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19482202				2022-12-28	WOS:000266616400010
J	Saveanu, L; Carroll, O; Weimershaus, M; Guermonprez, P; Firat, E; Lindo, V; Greer, F; Davoust, J; Kratzer, R; Keller, SR; Niedermann, G; van Endert, P				Saveanu, Loredana; Carroll, Oliver; Weimershaus, Mirjana; Guermonprez, Pierre; Firat, Elke; Lindo, Vivian; Greer, Fiona; Davoust, Jean; Kratzer, Roland; Keller, Susanna R.; Niedermann, Gabriele; van Endert, Peter			IRAP Identifies an Endosomal Compartment Required for MHC Class I Cross-Presentation	SCIENCE			English	Article							INSULIN-REGULATED AMINOPEPTIDASE; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; DENDRITIC CELLS; PEPTIDES; CROSSPRESENTATION; GLUT4; MOLECULES; NETWORK; PATHWAY	Major histocompatibility complex (MHC) class I molecules present peptides, produced through cytosolic proteasomal degradation of cellular proteins, to cytotoxic T lymphocytes. In dendritic cells, the peptides can also be derived from internalized antigens through a process known as cross-presentation. The cellular compartments involved in cross-presentation remain poorly defined. We found a role for peptide trimming by insulin-regulated aminopeptidase (IRAP) in cross-presentation. In human dendritic cells, IRAP was localized to a Rab14(+) endosomal storage compartment in which it interacted with MHC class I molecules. IRAP deficiency compromised cross-presentation in vitro and in vivo but did not affect endogenous presentation. We propose the existence of two pathways for proteasome-dependent cross-presentation in which final peptide trimming involves IRAP in endosomes and involves the related aminopeptidases in the endoplasmic reticulum.	[Saveanu, Loredana; Carroll, Oliver; Weimershaus, Mirjana; Davoust, Jean; Kratzer, Roland; van Endert, Peter] INSERM, U580, F-75015 Paris, France; [Saveanu, Loredana; Carroll, Oliver; Weimershaus, Mirjana; Davoust, Jean; Kratzer, Roland; van Endert, Peter] Univ Paris 05, Fac Med Rene Descartes, F-75015 Paris, France; [Guermonprez, Pierre] INSERM, U653, F-75006 Paris, France; [Guermonprez, Pierre] Inst Curie, Ctr Rech, F-75006 Paris, France; [Firat, Elke; Niedermann, Gabriele] Univ Hosp Freiburg, Clin Radiotherapy, D-79106 Freiburg, Germany; [Lindo, Vivian; Greer, Fiona] M SCAN Ltd, Wokingham RG41 2TZ, Berks, England; [Keller, Susanna R.] Univ Virginia, Dept Internal Med, Div Endocrinol, Charlottesville, VA 22908 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Freiburg; University of Virginia	van Endert, P (corresponding author), INSERM, U580, F-75015 Paris, France.	peter.van-endert@inserm.fr	van Endert, Peter/R-4606-2017; Saveanu, Loredana/K-6821-2017; SAVEANU, Loredana/Q-1241-2019; Guermonprez, Pierre/ABE-7718-2020; Davoust, Jean/ABB-6720-2020	van Endert, Peter/0000-0003-3782-0750; SAVEANU, Loredana/0000-0003-3138-7968; Guermonprez, Pierre/0000-0001-5621-2262; Davoust, Jean/0000-0002-3098-7665	European Commission [PROTARVAC]; INSERM fellowships; Deutsche Forschungsgemeinschaft; Medical Faculty of the University of Freiburg	European Commission(European CommissionEuropean Commission Joint Research Centre); INSERM fellowships; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Freiburg	We thank Metabolex Inc. for an anti-IRAP serum, N. Shastri for an anti-ERAP serum, B. Rocha for HY mice, O. Lantz for TAP knockout mice, L. Chatenoud for OT-II mice, B. Fouquet and N. Merzougui for technical help, and A. M. Lennon-Dumesnil for critical reading of the manuscript. Supported by grant PROTARVAC of the European Commission (P.v.E., F.G., G.N.), by INSERM fellowships (O.C., R.K.), and by grants from the Deutsche Forschungsgemeinschaft and from the Medical Faculty of the University of Freiburg (G.N.).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; Keller SR, 2002, J BIOL CHEM, V277, P17677, DOI 10.1074/jbc.M202037200; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Monu N, 2007, CURR OPIN IMMUNOL, V19, P66, DOI 10.1016/j.coi.2006.11.017; Ramachandra L, 1999, IMMUNOL REV, V168, P217, DOI 10.1111/j.1600-065X.1999.tb01295.x; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Wallis MG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1092, DOI 10.1152/ajpendo.00440.2007; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271	21	181	185	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					213	217		10.1126/science.1172845	http://dx.doi.org/10.1126/science.1172845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19498108	Green Published			2022-12-28	WOS:000267802000051
J	Archibald, AM; Stairs, IH; Ransom, SM; Kaspi, VM; Kondratiev, VI; Lorimer, DR; McLaughlin, MA; Boyles, J; Hessels, JWT; Lynch, R; van Leeuwen, J; Roberts, MSE; Jenet, F; Champion, DJ; Rosen, R; Barlow, BN; Dunlap, BH; Remillard, RA				Archibald, Anne M.; Stairs, Ingrid H.; Ransom, Scott M.; Kaspi, Victoria M.; Kondratiev, Vladislav I.; Lorimer, Duncan R.; McLaughlin, Maura A.; Boyles, Jason; Hessels, Jason W. T.; Lynch, Ryan; van Leeuwen, Joeri; Roberts, Mallory S. E.; Jenet, Frederick; Champion, David J.; Rosen, Rachel; Barlow, Brad N.; Dunlap, Bart H.; Remillard, Ronald A.			A Radio Pulsar/X-ray Binary Link	SCIENCE			English	Article							SAX J1808.4-3658; MILLISECOND PULSAR; 1ST J102347.6+003841; NEUTRON-STARS; QUIESCENCE; EVOLUTION; TUCANAE; ORBIT	Radio pulsars with millisecond spin periods are thought to have been spun up by the transfer of matter and angular momentum from a low-mass companion star during an x-ray-emitting phase. The spin periods of the neutron stars in several such low-mass x-ray binary (LMXB) systems have been shown to be in the millisecond regime, but no radio pulsations have been detected. Here we report on detection and follow-up observations of a nearby radio millisecond pulsar (MSP) in a circular binary orbit with an optically identified companion star. Optical observations indicate that an accretion disk was present in this system within the past decade. Our optical data show no evidence that one exists today, suggesting that the radio MSP has turned on after a recent LMXB phase.	[Archibald, Anne M.; Kaspi, Victoria M.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Stairs, Ingrid H.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Stairs, Ingrid H.; Champion, David J.] CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Stairs, Ingrid H.] Swinburne Univ Technol, Ctr Astrophys & Super Comp, Hawthorn, Vic 3122, Australia; [Ransom, Scott M.; Kondratiev, Vladislav I.] NRAO, Charlottesville, VA 22901 USA; [Kondratiev, Vladislav I.; Lorimer, Duncan R.; McLaughlin, Maura A.; Boyles, Jason] W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA; [Kondratiev, Vladislav I.] PN Lebedev Phys Inst, Ctr Astro Space, Moscow 117997, Russia; [Lorimer, Duncan R.; McLaughlin, Maura A.; Boyles, Jason; Rosen, Rachel] Natl Radio Astron Observ, Green Bank, WV 24944 USA; [Hessels, Jason W. T.; van Leeuwen, Joeri] Netherlands Inst Radio Astron, NL-7990 AA Dwingeloo, Netherlands; [Hessels, Jason W. T.; van Leeuwen, Joeri] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; [Lynch, Ryan] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Roberts, Mallory S. E.] Eureka Sci, Oakland, CA 94602 USA; [Jenet, Frederick] Univ Texas Brownsville, Dept Phys & Astron, Brownsville, TX 78520 USA; [Barlow, Brad N.; Dunlap, Bart H.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Remillard, Ronald A.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA	McGill University; University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swinburne University of Technology; National Radio Astronomy Observatory (NRAO); West Virginia University; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; National Radio Astronomy Observatory (NRAO); University of Amsterdam; University of Virginia; Eureka Scientific; University of Texas System; University of Texas Rio Grande Valley; University of North Carolina; University of North Carolina Chapel Hill; Massachusetts Institute of Technology (MIT)	Archibald, AM (corresponding author), McGill Univ, Dept Phys, 3600 Rue Univ, Montreal, PQ H3A 2T8, Canada.	aarchiba@physics.mcgill.ca	Lorimer, Duncan/ABH-7909-2020; Kondratiev, Vladislav I./N-1105-2015; Hessels, Jason/GTO-3261-2022	Kondratiev, Vladislav I./0000-0001-8864-7471; Hessels, Jason/0000-0003-2317-1446; Ransom, Scott/0000-0001-5799-9714; McLaughlin, Maura/0000-0001-7697-7422; Roberts, Mallory/0000-0002-9396-9720; Champion, David/0000-0003-1361-7723; Barlow, Brad/0000-0002-8558-4353; van Leeuwen, Joeri/0000-0001-8503-6958; Archibald, Anne/0000-0003-0638-3340	West Virginia Experimental Program to Stimulate Competitive Research (EPSCoR); Alfred P. Sloan fellow; NWO Veni Fellow; Lorne Trottier Chair in Astrophysics and Cosmology; Canada Research Chair program; NSERC; Fonds Quebecois de la Recherche sur la Nature et les Technologies; Canadian Institute for Advanced Research; Canada Foundation for Innovation (CFI); Australia Telescope National Facility Distinguished Visitor program; Swinburne University of Technology Visiting Distinguished Researcher Scheme	West Virginia Experimental Program to Stimulate Competitive Research (EPSCoR); Alfred P. Sloan fellow(Alfred P. Sloan Foundation); NWO Veni Fellow; Lorne Trottier Chair in Astrophysics and Cosmology; Canada Research Chair program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Australia Telescope National Facility Distinguished Visitor program; Swinburne University of Technology Visiting Distinguished Researcher Scheme	We thank J. Condon of the NRAO for pointing out that J1023 lay within our survey beam, B. Stappers for help with WSRT observations and analysis, and S. Bogdanov, J. Thorstensen, and Z. Wang for useful discussions. The Robert C. Byrd GBT is operated by the NRAO, which is a facility of the U.S. NSF operated under cooperative agreement by Associated Universities, Inc. The Arecibo Observatory is part of the National Astronomy and Ionosphere Center, which is operated by Cornell University under a cooperative agreement with NSF. The Parkes Observatory radio telescope is part of the Australia Telescope, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. The WSRT is operated by the Netherlands Institute for Radio Astronomy, with support from the Netherlands Foundation for Scientific Research NWO. We thank the directors of all four facilities for their generous allocation of exploratory time to this project. ASP and GASP are collaborations funded by the Natural Sciences and Engineering Research Council of Canada NSERC and NSF, I.H.S. and J.v.L. thank their co-developers D. Backer, D. Nice, P. Demorest, R. Ferdman, I. Cognard, and R. Ramachandran for their hardware and or software contributions, and P. Demorest and W. van Straten for making the PSRCHIVE software compatible with ASP GASP data. We further thank M. Bailes, S. Kulkarni, and the others in the Caltech Green Bank Swinburne Recorder collaboration for the use of some of their computer nodes during GASP observations. J.R.B., V.I.K., D.R.L., and M.A.M. are supported by a West Virginia Experimental Program to Stimulate Competitive Research (EPSCoR) Research Challenge Grant. M.A.M. is an Alfred P. Sloan fellow. J.W.T.H. is an NWO Veni Fellow. V.M.K. is supported via the Lorne Trottier Chair in Astrophysics and Cosmology, the Canada Research Chair program, an NSERC Discovery Grant, the Fonds Quebecois de la Recherche sur la Nature et les Technologies, the Canadian Institute for Advanced Research, and the Canada Foundation for Innovation (CFI). I.H.S. received support from NSERC, the CFI, the Australia Telescope National Facility Distinguished Visitor program, and the Swinburne University of Technology Visiting Distinguished Researcher Scheme.	BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; Bogdanov S, 2005, ASTROPHYS J, V630, P1029, DOI 10.1086/432249; Bond HE, 2002, PUBL ASTRON SOC PAC, V114, P1359, DOI 10.1086/344381; Burderi L, 2003, ASTRON ASTROPHYS, V404, pL43, DOI 10.1051/0004-6361:20030669; CAMILO F, 2005, ASP C SER, V328, P147; Campana S, 1998, ASTRON ASTROPHYS REV, V8, P279, DOI 10.1007/s001590050012; Chakrabarty D, 1998, NATURE, V394, P346, DOI 10.1038/28561; Cordes J. M., 2002, PREPRINT; Deloye CJ, 2008, MON NOT R ASTRON SOC, V391, P1619, DOI 10.1111/j.1365-2966.2008.14021.x; FRUCHTER AS, 1988, NATURE, V334, P686, DOI 10.1038/334686a0; Grindlay JE, 2002, ASTROPHYS J, V581, P470, DOI 10.1086/344150; Heinke CO, 2009, ASTROPHYS J, V691, P1035, DOI 10.1088/0004-637X/691/2/1035; Homer L, 2006, ASTRON J, V131, P562, DOI 10.1086/498346; ILLARIONOV AF, 1975, ASTRON ASTROPHYS, V39, P185; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; Shklovskii I. S., 1970, SOV ASTRON, V13, P562; STAPPERS BW, 1996, ASTROPHYS J, V456, pL119; Szkody P, 2003, ASTRON J, V126, P1499, DOI 10.1086/377346; TAURIS TM, 2006, EVOLUTION COMPACT ST, P623; Thorstensen JR, 2005, ASTRON J, V130, P759, DOI 10.1086/431326; Wijnands R, 1998, NATURE, V394, P344, DOI 10.1038/28557; Zacharias N., 2004, BAAS, V36, P1418	23	375	378	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1411	1414		10.1126/science.1172740	http://dx.doi.org/10.1126/science.1172740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19460964	Green Submitted			2022-12-28	WOS:000266878700036
J	Gebhardt, JCM; Rief, M				Gebhardt, J. Christof M.; Rief, Matthias			Force Signaling in Biology	SCIENCE			English	Editorial Material							VON-WILLEBRAND-FACTOR; MOLECULES		[Gebhardt, J. Christof M.; Rief, Matthias] Tech Univ Munich, Phys Dept E22, D-85748 Munich, Germany; [Rief, Matthias] Munich Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany	Technical University of Munich; University of Munich	Gebhardt, JCM (corresponding author), Tech Univ Munich, Phys Dept E22, James Franck Str, D-85748 Munich, Germany.	mrief@ph.tum.de	Gebhardt, J. Christof M./M-4851-2017	Gebhardt, J. Christof M./0000-0003-1900-600X				BAUSCH A, 2009, 486B9 SFB; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905	12	11	12	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 5	2009	324	5932					1278	1280		10.1126/science.1175874	http://dx.doi.org/10.1126/science.1175874			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498156				2022-12-28	WOS:000266635100029
J	Guinovart, JJ				Guinovart, Joan J.			Mind the Gap: Bringing Scientists and Society Together	CELL			English	Editorial Material									Univ Barcelona, Inst Res Biomed, Spanish Sci Soc, Chair Confederat, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Guinovart, JJ (corresponding author), Univ Barcelona, Inst Res Biomed, Spanish Sci Soc, Chair Confederat, E-08028 Barcelona, Spain.	guinovart@irbbarcelona.org							0	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 29	2009	137	5					793	795		10.1016/j.cell.2009.05.017	http://dx.doi.org/10.1016/j.cell.2009.05.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490884	Bronze			2022-12-28	WOS:000266454800006
J	Orme, CM; Bogan, JS				Orme, Charisse M.; Bogan, Jonathan S.			Sorting Out Diabetes	SCIENCE			English	Editorial Material							GLUT4 GLUCOSE TRANSPORTERS; INSULIN-RESISTANCE; CLATHRIN COAT; TRAFFICKING; DEFECTS		[Orme, Charisse M.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Orme, CM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, 333 Cedar St, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466				Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Fazakerley DJ, 2009, J CELL SCI, V122, P727, DOI 10.1242/jcs.041178; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gaulton KJ, 2008, DIABETES, V57, P3136, DOI 10.2337/db07-1731; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; Rubin BR, 2009, VITAM HORM, V80, P155, DOI 10.1016/S0083-6729(08)00607-9; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529	14	6	6	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1155	1156		10.1126/science.1174841	http://dx.doi.org/10.1126/science.1174841			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478173				2022-12-28	WOS:000266410100032
J	Scholl, C; Frohling, S; Dunn, IF; Schinzel, AC; Barbie, DA; Kim, SY; Silver, SJ; Tamayo, P; Wadlow, RC; Ramaswamy, S; Dohner, K; Bullinger, L; Sandy, P; Boehm, JS; Root, DE; Jacks, T; Hahn, WC; Gilliland, DG				Scholl, Claudia; Froehling, Stefan; Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Silver, Serena J.; Tamayo, Pablo; Wadlow, Raymond C.; Ramaswamy, Sridhar; Doehner, Konstanze; Bullinger, Lars; Sandy, Peter; Boehm, Jesse S.; Root, David E.; Jacks, Tyler; Hahn, William C.; Gilliland, D. Gary			Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells	CELL			English	Article							LENTIVIRAL RNAI LIBRARY; K-RAS ONCOGENE; MULTIPLE-MYELOMA; TUMOR-CELLS; N-RAS; GROWTH; SCREEN; MUTATIONS; SURVIVAL; GENES	An alternative to therapeutic targeting of oncogenes is to perform "synthetic lethality'' screens for genes that are essential only in the context of specific cancer-causing mutations. We used high-throughput RNA interference (RNAi) to identify synthetic lethal interactions in cancer cells harboring mutant KRAS, the most commonly mutated human oncogene. We find that cells that are dependent on mutant KRAS exhibit sensitivity to suppression of the serine/threonine kinase STK33 irrespective of tissue origin, whereas STK33 is not required by KRAS-independent cells. STK33 promotes cancer cell viability in a kinase activity-dependent manner by regulating the suppression of mitochondrial apoptosis mediated through S6K1-induced inactivation of the death agonist BAD selectively in mutant KRAS-dependent cells. These observations identify STK33 as a target for treatment of mutant KRAS-driven cancers and demonstrate the potential of RNAi screens for discovering functional dependencies created by oncogenic mutations that may enable therapeutic intervention for cancers with "undruggable'' genetic alterations.	[Scholl, Claudia; Froehling, Stefan; Hahn, William C.; Gilliland, D. Gary] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Dunn, Ian F.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Hahn, William C.; Gilliland, D. Gary] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Med Oncol, Boston, MA 02115 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Hahn, William C.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Hahn, William C.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Silver, Serena J.; Tamayo, Pablo; Ramaswamy, Sridhar; Boehm, Jesse S.; Root, David E.; Jacks, Tyler; Hahn, William C.; Gilliland, D. Gary] Broad Inst Harvard, Cambridge, MA 02142 USA; [Dunn, Ian F.; Schinzel, Anna C.; Barbie, David A.; Kim, So Young; Silver, Serena J.; Tamayo, Pablo; Ramaswamy, Sridhar; Boehm, Jesse S.; Root, David E.; Jacks, Tyler; Hahn, William C.; Gilliland, D. Gary] MIT, Cambridge, MA 02142 USA; [Barbie, David A.; Wadlow, Raymond C.; Ramaswamy, Sridhar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; [Wadlow, Raymond C.; Ramaswamy, Sridhar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc Res, Boston, MA 02114 USA; [Wadlow, Raymond C.; Ramaswamy, Sridhar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Ramaswamy, Sridhar; Gilliland, D. Gary] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Doehner, Konstanze; Bullinger, Lars] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Sandy, Peter; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sandy, Peter; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Gilliland, D. Gary] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Gilliland, D. Gary] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Ulm University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hahn, WC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu; ggilliland@rics.bwh.harvard.edu	Bullinger, Lars/AAL-7965-2020	Boehm, Jesse/0000-0002-6795-6336; Wadlow, Raymond/0000-0003-1959-5406; Bullinger, Lars/0000-0002-5890-5510	National Institutes of Health [R33 CA128625, U54 CA112962, P01 CA095616, P01 CA66996]; Starr Cancer Consortium; Doris Duke Charitable Foundation; MPD Foundation; Leukemia and Lymphoma Society; Deutsche Forschungsgemeinschaft [SCHO 1215/1-1, FR 2113/1-1]; Brain Science Foundation; NATIONAL CANCER INSTITUTE [R33CA128625, RC2CA148268, P01CA095616, U54CA112962, P01CA066996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); MPD Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Brain Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Maricel Gozo for technical support, the Broad Institute RNAi Platform for assistance with high-throughput screening, and John Blenis, Benjamin G. Neel, Demetrios Kalaitzidis, Michael G. Kharas, Thomas Kindler, Steven W. Lane, Stephen M. Sykes, and members of the Gilliland and Hahn laboratories for valuable discussions and reagents. This work was supported by National Institutes of Health grants R33 CA128625, U54 CA112962, P01 CA095616 ( to W. C. H.), and P01 CA66996 ( to D. G. G.), and grants from the Starr Cancer Consortium ( to W. C. H. and D. G. G.), the Doris Duke Charitable Foundation ( to D. G. G.), the MPD Foundation ( to D. G. G), and the Leukemia and Lymphoma Society ( to D. G. G.). C. S. and S. F. were supported by grants SCHO 1215/1-1 and FR 2113/1-1 from the Deutsche Forschungsgemeinschaft. I. F. D. was supported by the Brain Science Foundation.	BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; CHEN TR, 1995, CANCER GENET CYTOGEN, V81, P103, DOI 10.1016/0165-4608(94)00225-Z; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Crowder C, 2003, ONCOGENE, V22, P649, DOI 10.1038/sj.onc.1206180; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; Demunter A, 2001, CANCER RES, V61, P4916; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Downward J, 2004, ONCOGENE, V23, P8376, DOI 10.1038/sj.onc.1208073; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Jimeno A, 2008, CANCER RES, V68, P2841, DOI 10.1158/0008-5472.CAN-07-5200; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koinuma K, 2006, ONCOGENE, V25, P139, DOI 10.1038/sj.onc.1209009; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Lin SR, 1998, BRIT J CANCER, V77, P1060, DOI 10.1038/bjc.1998.177; Lin SR, 2000, BRIT J CANCER, V82, P1035; LUCCHESI JC, 1968, GENETICS, V59, P37; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mujica AO, 2001, GENE, V280, P175, DOI 10.1016/S0378-1119(01)00780-6; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PEI L, 1994, J CLIN ENDOCR METAB, V78, P842, DOI 10.1210/jc.78.4.842; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarthy AV, 2007, MOL CANCER THER, V6, P269, DOI 10.1158/1535-7163.MCT-06-0560; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Simons A, 2001, GENOME RES, V11, P266, DOI 10.1101/gr.154201; Smakman N, 2006, CANCER RES, V66, P5403, DOI 10.1158/0008-5472.CAN-05-4108; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stockwell BR, 1999, CHEM BIOL, V6, P71, DOI 10.1016/S1074-5521(99)80004-0; SUZUKI Y, 1990, ONCOGENE, V5, P1037; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; Wang JY, 2006, ONCOL REP, V16, P1245; Westbrook TF, 2005, COLD SH Q B, V70, P435, DOI 10.1101/sqb.2005.70.031; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	63	428	449	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					821	834		10.1016/j.cell.2009.03.017	http://dx.doi.org/10.1016/j.cell.2009.03.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490892	Bronze, Green Published			2022-12-28	WOS:000266454800014
J	Stone, KW; Gundogdu, K; Turner, DB; Li, XQ; Cundiff, ST; Nelson, KA				Stone, Katherine W.; Gundogdu, Kenan; Turner, Daniel B.; Li, Xiaoqin; Cundiff, Steven T.; Nelson, Keith A.			Two-Quantum 2D FT Electronic Spectroscopy of Biexcitons in GaAs Quantum Wells	SCIENCE			English	Article							2-DIMENSIONAL INFRARED-SPECTROSCOPY; NONLINEAR-OPTICAL RESPONSE; HEAVY-HOLE; MANY-BODY; SEMICONDUCTORS; COHERENCES; EXCITONS	The motions of electrons in solids may be highly correlated by strong, long-range Coulomb interactions. Correlated electron-hole pairs (excitons) are accessed spectroscopically through their allowed single-quantum transitions, but higher-order correlations that may strongly influence electronic and optical properties have been far more elusive to study. Here we report direct observation of bound exciton pairs (biexcitons) that provide incisive signatures of four-body correlations among electrons and holes in gallium arsenide (GaAs) quantum wells. Four distinct, mutually coherent, ultrashort optical pulses were used to create coherent exciton states, transform these successively into coherent biexciton states and then new radiative exciton states, and finally to read out the radiated signals, yielding biexciton binding energies through a technique closely analogous to multiple-quantum two-dimensional Fourier transform (2D FT) nuclear magnetic resonance spectroscopy. A measured variation of the biexciton dephasing rate indicated still higher-order correlations.	[Stone, Katherine W.; Gundogdu, Kenan; Turner, Daniel B.; Nelson, Keith A.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Li, Xiaoqin] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Cundiff, Steven T.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Cundiff, Steven T.] Natl Inst Stand & Technol, Boulder, CO 80309 USA	Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Nelson, KA (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	kanelson@mit.edu	Cundiff, Steven T/B-4974-2009	Cundiff, Steven T/0000-0002-7119-5197; Turner, Daniel/0000-0002-3148-5317	NSF [CHE-0616939]; National Defense Science and Engineering Graduate Fellowship Program; Army Research Office; Welch Foundation	NSF(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship Program; Army Research Office; Welch Foundation(The Welch Foundation)	This work was supported in part by NSF grant CHE-0616939. The authors thank M. Kira for helpful discussions. D.T. thanks the National Defense Science and Engineering Graduate Fellowship Program for financial support. X.L. acknowledges support from the Army Research Office and the Welch Foundation. A patent application for the optical setup presented here is currently being filed.	Abramavicius D, 2008, P NATL ACAD SCI USA, V105, P8525, DOI 10.1073/pnas.0802926105; Birkedal D, 1996, PHYS REV LETT, V76, P672, DOI 10.1103/PhysRevLett.76.672; Boyd R. W., 2003, NONLINEAR OPTICS; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Chemla DS, 2001, NATURE, V411, P549, DOI 10.1038/35079000; Chen G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117901; Chernyak V, 1998, J CHEM PHYS, V109, P9587, DOI 10.1063/1.477621; Ernst R.R., 1990, PRINCIPLES NUCL MAGN; Ferrio KB, 1996, PHYS REV B, V54, pR5231, DOI 10.1103/PhysRevB.54.R5231; Fulmer EC, 2004, J CHEM PHYS, V120, P8067, DOI 10.1063/1.1649725; Galiana G, 2008, SCIENCE, V322, P421, DOI 10.1126/science.1163242; Gilliot P, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125209; Haug H., 2004, QUANTUM THEORY OPTIC, V4th ed.; LEO K, 1990, PHYS REV LETT, V65, P1340, DOI 10.1103/PhysRevLett.65.1340; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Li XQ, 2003, SCIENCE, V301, P809, DOI 10.1126/science.1083800; MAYER EJ, 1994, PHYS REV B, V50, P14730, DOI 10.1103/PhysRevB.50.14730; Meier T, 2000, PHYS REV B, V62, P12605, DOI 10.1103/PhysRevB.62.12605; Meier T., 2007, COHERENT SEMICONDUCT; PANTKE KH, 1993, PHYS REV B, V47, P2413, DOI 10.1103/PhysRevB.47.2413; Phillips MC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.183602; Richter W, 2000, CONCEPT MAGNETIC RES, V12, P396, DOI 10.1002/1099-0534(2000)12:6<396::AID-CMR3>3.3.CO;2-P; Rupasov VI, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.125321; SAIKI T, 1994, PHYS REV B, V49, P7817, DOI 10.1103/PhysRevB.49.7817; Shacklette JM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045309; Shah J., 1999, ULTRAFAST SPECTROSCO; Smirl AL, 1999, PHYS REV B, V60, P8267, DOI 10.1103/PhysRevB.60.8267; Sul S, 2006, J PHYS CHEM B, V110, P19891, DOI 10.1021/jp062039h; Tian PF, 2003, SCIENCE, V300, P1553, DOI 10.1126/science.1083433; Vaughan JC, 2007, J PHYS CHEM A, V111, P4873, DOI 10.1021/jp0662911; Voss T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.115311; WANG HL, 1993, PHYS REV LETT, V71, P1261, DOI 10.1103/PhysRevLett.71.1261; WANG HL, 1994, SOLID STATE COMMUN, V91, P869, DOI 10.1016/0038-1098(94)90004-3; WEGENER M, 1990, PHYS REV A, V42, P5675, DOI 10.1103/PhysRevA.42.5675; Yang L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.057402; Yang LJ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125302; Yang LJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075335; Yu P. Y., 1999, FUNDAMENTALS SEMICON; Zhang TH, 2007, P NATL ACAD SCI USA, V104, P14227, DOI 10.1073/pnas.0701273104	39	228	229	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1169	1173		10.1126/science.1170274	http://dx.doi.org/10.1126/science.1170274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478176				2022-12-28	WOS:000266410100037
J	Weis, VM; Allemand, D				Weis, Virginia M.; Allemand, Denis			What Determines Coral Health?	SCIENCE			English	Editorial Material							REEF-BUILDING CORALS; THERMAL-STRESS; OXIDATIVE STRESS; GENE-EXPRESSION; SEA-ANEMONE; MECHANISMS; SYMBIOSIS; PROTEIN; BIOMINERALIZATION; ACIDIFICATION		[Weis, Virginia M.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Allemand, Denis] Ctr Sci Monaco, MC-98000 Monaco, Monaco; [Allemand, Denis] Univ Nice Sophia Antipolis, Dept Sci Vie, Nice 2, France	Oregon State University; UDICE-French Research Universities; Universite Cote d'Azur	Weis, VM (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	weisv@science.oregonstate.edu	Weis, Virginia/T-5095-2019	Weis, Virginia/0000-0002-1826-2848				Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Amer AO, 2002, CURR OPIN MICROBIOL, V5, P56, DOI 10.1016/S1369-5274(02)00286-2; Chen MC, 2005, BIOCHEM BIOPH RES CO, V338, P1607, DOI 10.1016/j.bbrc.2005.10.133; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; KLEYPAS JA, 2006, NSF NOAA USGS; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Relman DA, 2008, NAT REV MICROBIOL, V6, P721, DOI 10.1038/nrmicro1990; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; TAMBUTTE S, 2007, HDB BIOMINERALIZATIO, V1, P243; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Wood-Charlson EM, 2009, DEV COMP IMMUNOL, V33, P881, DOI 10.1016/j.dci.2009.01.008; Zoccola D, 2009, MAR BIOTECHNOL, V11, P260, DOI 10.1007/s10126-008-9141-6	26	61	62	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1153	1155		10.1126/science.1172540	http://dx.doi.org/10.1126/science.1172540			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478172				2022-12-28	WOS:000266410100031
J	Heiden, MGV; Cantley, LC; Thompson, CB				Heiden, Matthew G. Vander; Cantley, Lewis C.; Thompson, Craig B.			Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation	SCIENCE			English	Review							AEROBIC GLYCOLYSIS; TRANSFORMED-CELLS; PYRUVATE-KINASE; CANCER; GROWTH; GLUTAMINE; MUTATIONS; EXPRESSION; APOPTOSIS; SURVIVAL	In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect." Aerobic glycolysis is an inefficient way to generate adenosine 5'-triphosphate (ATP), however, and the advantage it confers to cancer cells has been unclear. Here we propose that the metabolism of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell. Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-associated mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP production. A better understanding of the mechanistic links between cellular metabolism and growth control may ultimately lead to better treatments for human cancer.	[Heiden, Matthew G. Vander; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Heiden, Matthew G. Vander; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Heiden, Matthew G. Vander] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Thompson, Craig B.] Univ Penn, Abramson Canc Ctr, Dept Canc Biol, Philadelphia, PA 19104 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	lewis_cantley@hms.harvard.edu; craig@mail.med.upenn.edu	Cantley, Lewis C/D-1800-2014; Lorkiewicz, Pawel/A-2126-2011; Jansen, Heiko T./A-5770-2008	Cantley, Lewis C/0000-0002-1298-7653; Lorkiewicz, Pawel/0000-0002-1755-9826; Jansen, Heiko T./0000-0003-0178-396X	Damon Runyon Cancer Research Foundation; National Cancer Institute (NCI); NIH; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA105463, T32CA009172, R01CA092660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Van den Abbeele (Department of Imaging, Dana-Farber Cancer Institute, Boston) for the FDG-PET image. We also thank K. D. Courtney, A. J. Shaywitz, and K. D. Swanson for thoughtful discussions and critical reading of the manuscript and the Damon Runyon Cancer Research Foundation for support (to M.G.V.H.). M.G.V.H. receives grant support from the National Cancer Institute (NCI) and NIH; L.C.C. receives grant support from the NIH; and C.B.T. receives grant support from the NCI, NIH, and Abramson Family Cancer Research Institute to study aspects of cancer cell metabolism. M.G.V.H., L.C.C., and C.B.T. hold patents related to the targeting of cancer cell metabolism and have financial interests in Agios Pharmaceuticals, a company that seeks to exploit alterations in cancer metabolism for novel therapeutics.	Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Ben-Haim S, 2009, J NUCL MED, V50, P88, DOI 10.2967/jnumed.108.054205; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; ELMAGHRABI MR, 1984, J CELL BIOCHEM, V26, P1, DOI 10.1002/jcb.240260102; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; GRANOT D, 1991, P NATL ACAD SCI USA, V88, P5724, DOI 10.1073/pnas.88.13.5724; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lehninger A., 1993, PRINCIPLES BIOCH; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; NOLOP KB, 1987, CANCER, V60, P2682, DOI 10.1002/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO;2-H; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vander Heiden MG, 1999, MOL CELL, V3, P159; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; WEINHOUSE S, 1976, Z KREBSFORSCH KLIN O, V87, P115; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	46	9624	9787	126	1858	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1029	1033		10.1126/science.1160809	http://dx.doi.org/10.1126/science.1160809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460998	Green Accepted			2022-12-28	WOS:000266246700031
J	Jack, A				Jack, Andrew			Feature Pandemic Flu The problem with flu vaccines	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				WHO, 2009, REC STRAT ADV GROUP; WYMAN O, 2009, INFLUENZA VACCINE SU	2	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 21	2009	338								b2065	10.1136/bmj.b2065	http://dx.doi.org/10.1136/bmj.b2065			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NT	19460800				2022-12-28	WOS:000266270000009
J	Rittenhouse, DR; Shortell, SM				Rittenhouse, Diane R.; Shortell, Stephen M.			The Patient-Centered Medical Home Will It Stand the Test of Health Reform?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE; SYSTEMS		[Shortell, Stephen M.] Univ Calif Berkeley, Div Hlth Policy & Management, Sch Publ Hlth, Berkeley, CA 94720 USA; [Rittenhouse, Diane R.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Rittenhouse, Diane R.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shortell, SM (corresponding author), Univ Calif Berkeley, Div Hlth Policy & Management, Sch Publ Hlth, Berkeley, CA 94720 USA.	shortell@berkeley.edu						*AM AC FAM PRACT, STAT MED HOM LEG; *CTR MED MED SERV, DEM PROJ EV REP MED; Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Friedberg MW, 2009, J GEN INTERN MED, V24, P162, DOI 10.1007/s11606-008-0856-x; Lee Thomas H, 2008, N Engl J Med, V359, pe24, DOI 10.1056/NEJMp0809050; Liebhaber Allison, 2007, Track Rep, P1; *NAT COMM QUAL ASS, PPC PAT CTR MED; *PAT CTR PRIM CAR, PAT CTR PRIM CAR PIL; Rittenhouse DR, 2008, HEALTH AFFAIR, V27, P1246, DOI 10.1377/hlthaff.27.5.1246; Rosenthal TC, 2008, J AM BOARD FAM MED, V21, P427, DOI 10.3122/jabfm.2008.05.070287; Ross Murray, 2009, Perm J, V13, P8; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	14	276	277	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					2038	2040		10.1001/jama.2009.691	http://dx.doi.org/10.1001/jama.2009.691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454643				2022-12-28	WOS:000266159600029
J	Reichen, J				Reichen, J.			Evidence is insufficient to evaluate effectiveness of antiviral therapies for chronic hepatitis B	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LAMIVUDINE; INFECTION; CIRRHOSIS		Univ Clin Visceral Surg & Med, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern	Reichen, J (corresponding author), Univ Clin Visceral Surg & Med, Inselspital, Bern, Switzerland.							Lin SM, 1999, HEPATOLOGY, V29, P971, DOI 10.1002/hep.510290312; Papatheodoridis GV, 2005, HEPATOLOGY, V42, P121, DOI 10.1002/hep.20760; Runyon BA, 2007, GASTROENTEROLOGY, V133, P1029, DOI 10.1053/j.gastro.2007.07.017; Shamliyan TA, 2009, ANN INTERN MED, V150, P111, DOI 10.7326/0003-4819-150-2-200901200-00101; van Zonneveld M, 2004, HEPATOLOGY, V39, P804, DOI 10.1002/hep.20128; Yao FY, 2001, HEPATOLOGY, V34, P411, DOI 10.1053/jhep.2001.26512	6	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-6	10.7326/0003-4819-150-10-200905190-02006	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451562				2022-12-28	WOS:000266285300026
J	Maxmen, A				Maxmen, Amy			Will Scientists Cast Their Votes?	CELL			English	Editorial Material																			0	0	0	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 15	2009	137	4					595	597		10.1016/j.cell.2009.05.001	http://dx.doi.org/10.1016/j.cell.2009.05.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450505	Bronze			2022-12-28	WOS:000266114100005
J	Frohlich, A; Kisielow, J; Schmitz, I; Freigang, S; Shamshiev, AT; Weber, J; Marsland, BJ; Oxenius, A; Kopf, M				Froehlich, Anja; Kisielow, Jan; Schmitz, Iwana; Freigang, Stefan; Shamshiev, Abdijapar T.; Weber, Jacqueline; Marsland, Benjamin J.; Oxenius, Annette; Kopf, Manfred			IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection	SCIENCE			English	Article							HOMEOSTATIC PROLIFERATION; IN-VIVO; RESPONSES; EFFECTOR; HIV-1	Chronic viral infection is often associated with the dysfunction of virus-specific T cells. Our studies using Il21r-deficient (Il21r(-/-)) mice now suggest that interleukin-21 (IL-21) is critical for the long-term maintenance and functionality of CD8(+) T cells and the control of chronic lymphocytic choriomeningitis virus infection in mice. Cell-autonomous IL-21 receptor (IL-21R)-dependent signaling by CD8(+) T cells was required for sustained cell proliferation and cytokine production during chronic infection. Il21r(-/-) mice showed normal CD8(+) T cell expansion, effector function, memory homeostasis, and recall responses during acute and after resolved infection with several other nonpersistent viruses. These data suggest that IL-21R signaling is required for the maintenance of polyfunctional T cells during chronic viral infections and have implications for understanding the immune response to other persisting antigens, such as tumors.	[Froehlich, Anja; Kisielow, Jan; Schmitz, Iwana; Freigang, Stefan; Shamshiev, Abdijapar T.; Weber, Jacqueline; Marsland, Benjamin J.; Kopf, Manfred] ETH, Inst Integrat Biol, Zurich, Switzerland; [Oxenius, Annette] ETH, Inst Microbiol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kopf, M (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	Manfred.Kopf@ethz.ch	Freigang, Stefan/A-8682-2013; Kopf, Manfred/B-6907-2009; Oxenius, Annette/G-7794-2015	Freigang, Stefan/0000-0003-4438-7828; Kopf, Manfred/0000-0002-0628-7140; Kisielow, Jan/0000-0002-4482-5202	Swiss National Science Foundation [310030_124922]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was funded by Swiss National Science Foundation 310030_124922.	Altfeld M, 2000, CURR OPIN IMMUNOL, V12, P375, DOI 10.1016/S0952-7915(00)00103-5; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Picker LJ, 2000, CURR OPIN IMMUNOL, V12, P381, DOI 10.1016/S0952-7915(00)00104-7; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799	17	340	354	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1576	1580		10.1126/science.1172815	http://dx.doi.org/10.1126/science.1172815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19478140				2022-12-28	WOS:000267130600048
J	Farias, OJ; Latune, CL; Walborn, SP; Davidovich, L; Ribeiro, PHS				Farias, O. Jimenez; Latune, C. Lombard; Walborn, S. P.; Davidovich, L.; Souto Ribeiro, P. H.			Determining the Dynamics of Entanglement	SCIENCE			English	Article							SUDDEN-DEATH	The estimation of the entanglement of multipartite systems undergoing decoherence is important for assessing the robustness of quantum information processes. It usually requires access to the final state and its full reconstruction through quantum tomography. General dynamical laws may simplify this task. We found that when one of the parties of an initially entangled two-qubit system is subject to a noisy channel, a single universal curve describes the dynamics of entanglement for both pure and mixed states, including those for which entanglement suddenly disappears. Our result, which is experimentally demonstrated using a linear optics setup, leads to a direct and efficient determination of entanglement through the knowledge of the initial state and single-party process tomography alone, foregoing the need to reconstruct the final state.	[Farias, O. Jimenez; Latune, C. Lombard; Walborn, S. P.; Davidovich, L.; Souto Ribeiro, P. H.] Univ Fed Rio de Janeiro, Inst Fis, BR-21941972 Rio De Janeiro, Brazil; [Farias, O. Jimenez] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Latune, C. Lombard] Ecole Normale Super, F-75005 Paris, France	Universidade Federal do Rio de Janeiro; Universidad Nacional Autonoma de Mexico; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Ribeiro, PHS (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Caixa Postal 68528, BR-21941972 Rio De Janeiro, Brazil.	phsr@if.ufrj.br	Walborn, Stephen/P-9966-2019; quantica, Inct Informacao/H-9493-2013; Farías, Osvaldo Jiménez/L-3652-2013; Souto Ribeiro, PH/GYA-0054-2022; Ribeiro, Paulo/GYA-1014-2022; Souto Ribeiro, PH/C-4893-2013	Souto Ribeiro, PH/0000-0002-0060-1717; Souto Ribeiro, PH/0000-0002-0060-1717; Jimenez Farias, Osvaldo/0000-0002-9075-0678; Walborn, Stephen/0000-0002-3346-8625	graduate fellowship from Consejo Nacional de Ciencia y Tecnologia; Instituto de Ciencias Nucleares UNAM; CNPq; CAPES; PRONEX; FUJB; FAPERJ	graduate fellowship from Consejo Nacional de Ciencia y Tecnologia; Instituto de Ciencias Nucleares UNAM(Universidad Nacional Autonoma de Mexico); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEX; FUJB; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	We thank A. Buchleitner, M. Hor-Meyll, F. de Melo, and M. Tiersch for helpful discussions. Supported by a graduate fellowship from Consejo Nacional de Ciencia y Tecnologia and Instituto de Ciencias Nucleares UNAM (O.J.F.) and by a graduate fellowship from the Brazilian funding agencies CNPq, CAPES, PRONEX, FUJB, and FAPERJ. This work was performed as part of the Brazilian National Institute of Science and Technology for Quantum Information.	Almeida MP, 2007, SCIENCE, V316, P579, DOI 10.1126/science.1139892; Altepeter JB, 2005, ADV ATOM MOL OPT PHY, V52, P105, DOI 10.1016/S1049-250X(05)52003-2; Altepeter JB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.193601; Aolita L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.080501; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Konrad T, 2008, NAT PHYS, V4, P99, DOI 10.1038/nphys885; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Salles A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.022322; Santos MF, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.040305; Simon C, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052327; Walther P, 2005, NATURE, V434, P169, DOI 10.1038/nature03347; Weisskopf V, 1930, Z PHYS, V63, P54, DOI 10.1007/BF01336768; Werner R. F, 2002, QUANTUM INFORM INTRO, P14; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Yu T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140404; Yu T, 2009, SCIENCE, V323, P598, DOI 10.1126/science.1167343	19	57	58	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1414	1417		10.1126/science.1171544	http://dx.doi.org/10.1126/science.1171544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19443736				2022-12-28	WOS:000266878700037
J	Valenti, S; Pastorello, A; Cappellaro, E; Benetti, S; Mazzali, PA; Manteca, J; Taubenberger, S; Elias-Rosa, N; Ferrando, R; Harutyunyan, A; Hentunen, VP; Nissinen, M; Pian, E; Turatto, M; Zampieri, L; Smartt, SJ				Valenti, S.; Pastorello, A.; Cappellaro, E.; Benetti, S.; Mazzali, P. A.; Manteca, J.; Taubenberger, S.; Elias-Rosa, N.; Ferrando, R.; Harutyunyan, A.; Hentunen, V. P.; Nissinen, M.; Pian, E.; Turatto, M.; Zampieri, L.; Smartt, S. J.			A low-energy core-collapse supernova without a hydrogen envelope	NATURE			English	Article							GAMMA-RAY BURST; SN 2005HK; EVOLUTION; SPECTROSCOPY; MODELS; 2002CX; STARS	The final fate of massive stars depends on many factors. Theory suggests that some with initial masses greater than 25 to 30 solar masses end up as Wolf-Rayet stars, which are deficient in hydrogen in their outer layers because of mass loss through strong stellar winds. The most massive of these stars have cores which may form a black hole and theory predicts that the resulting explosion of some of them produces ejecta of low kinetic energy, a faint optical luminosity and a small mass fraction of radioactive nickel(1-3). An alternative origin for low-energy supernovae is the collapse of the oxygen-neon core of a star of 7-9 solar masses(4,5). No weak, hydrogen-deficient, core-collapse supernovae have hitherto been seen. Here we report that SN 2008ha is a faint hydrogen-poor supernova. We propose that other similar events have been observed but have been misclassified as peculiar thermonuclear supernovae (sometimes labelled SN 2002cx-like events(6)). This discovery could link these faint supernovae to some long-duration gamma-ray bursts, because extremely faint, hydrogen-stripped core-collapse supernovae have been proposed to produce such long gamma-ray bursts, the afterglows of which do not show evidence of associated supernovae(7-9).	[Valenti, S.; Pastorello, A.; Smartt, S. J.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Cappellaro, E.; Benetti, S.; Mazzali, P. A.; Harutyunyan, A.; Zampieri, L.] INAF Osservatorio Astron Padova, I-35122 Padua, Italy; [Mazzali, P. A.; Taubenberger, S.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Manteca, J.] Begues Observ, Barcelona 08859, Spain; [Elias-Rosa, N.] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Harutyunyan, A.] Fdn Galileo Galilei INAF, E-38700 Tenerife, Spain; [Hentunen, V. P.; Nissinen, M.] Taurus Hill Observ, Kangaslampi 79480, Finland; [Hentunen, V. P.] Univ Turku, Dept Phys & Astron, Tuorla Observ, FI-21500 Piikkio, Finland; [Pian, E.] INAF Osservatorio Astron Trieste, I-34131 Trieste, Italy; [Turatto, M.] INAF Osservatorio Astrofis Catania, I-95123 Catania, Italy	Queens University Belfast; Istituto Nazionale Astrofisica (INAF); Max Planck Society; California Institute of Technology; Istituto Nazionale Astrofisica (INAF); University of Turku; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF)	Valenti, S (corresponding author), Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland.	s.valenti@qub.ac.uk	Valenti, Stefano/M-5924-2017; Elias-Rosa, Nancy/D-3759-2014	Valenti, Stefano/0000-0001-8818-0795; Elias-Rosa, Nancy/0000-0002-1381-9125; Cappellaro, Enrico/0000-0001-5008-8619; Pian, Elena/0000-0001-8646-4858; Zampieri, Luca/0000-0002-6516-1329; Mazzali, Paolo/0000-0001-6876-8284; Turatto, Massimo/0000-0002-9719-3157; Benetti, Stefano/0000-0002-3256-0016	European Science Foundation EURYI Awards; PRIN of Italian Ministry of University and Science Research; STFC [ST/G009465/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G009465/1] Funding Source: researchfish	European Science Foundation EURYI Awards(European Science Foundation (ESF)); PRIN of Italian Ministry of University and Science Research(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work, conducted as part of the European Science Foundation EURYI Awards scheme, was supported by funds from the Participating Organisations of EURYI and the EC Sixth Framework Programme. The work of S. B., E. C. and M. T. was supported by grants of the PRIN of Italian Ministry of University and Science Research. This paper is based on observations collected at TNG, NOT, LT ( La Palma Canary Island, Spain), at Ekar ( Asiago Observatory, Italy), at the Begues Observatory and Arguines Observatory telescopes ( Barcelona and Segorbe, Spain), at the Taurus Hill Observatory ( Varkaus, Finland), at the Calar Alto Observatory ( Spain) and at the ESO-UT2 (Paranal, Chile). Our analysis included data from the SUSPECT Archive (http://bruford.nhn.ou.edu/,suspect/index1. html). This manuscript made use of information contained in the Bright Supernova web pages ( D. Bishop), as part of the Rochester Academy of Sciences.	ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Benetti S, 2001, MON NOT R ASTRON SOC, V322, P361, DOI 10.1046/j.1365-8711.2001.04122.x; Branch D, 2004, PUBL ASTRON SOC PAC, V116, P903, DOI 10.1086/425081; Della Valle M, 2006, NATURE, V444, P1050, DOI 10.1038/nature05374; Filippenko A. V., 2007, CENTRAL BUREAU ELECT, V926, P1; Filippenko A. V., 2007, CENTRAL BUREAU ELECT, V817, P1; FILIPPENKO AV, 1992, ASTROPHYS J, V384, pL15, DOI 10.1086/186252; FOLEY RJ, 2008, CENTRAL BUREAU ELECT, V1576; Fryer CL, 2006, ASTROPHYS J, V650, P1028, DOI 10.1086/506250; Fynbo JPU, 2006, NATURE, V444, P1047, DOI 10.1038/nature05375; Gal-Yam A, 2006, NATURE, V444, P1053, DOI 10.1038/nature05373; Gamezo VN, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.211102; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; Jha S, 2006, ASTRON J, V132, P189, DOI 10.1086/504599; Kitaura FS, 2006, ASTRON ASTROPHYS, V450, P345, DOI 10.1051/0004-6361:20054703; Li WD, 2003, PUBL ASTRON SOC PAC, V115, P453, DOI 10.1086/374200; MacFadyen AI, 2001, ASTROPHYS J, V550, P410, DOI 10.1086/319698; Matheson T, 2003, ASTROPHYS J, V599, P394, DOI 10.1086/379228; Mazzali PA, 2001, ASTROPHYS J, V547, P988, DOI 10.1086/318428; Mazzali PA, 2007, SCIENCE, V315, P825, DOI 10.1126/science.1136259; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; NOMOTO K, 1984, ASTROPHYS J, V277, P791, DOI 10.1086/161749; Pastorello A, 2004, MON NOT R ASTRON SOC, V347, P74, DOI 10.1111/j.1365-2966.2004.07173.x; Pastorello A, 2009, MON NOT R ASTRON SOC, V394, P2266, DOI 10.1111/j.1365-2966.2009.14505.x; Patat F, 2001, ASTROPHYS J, V555, P900, DOI 10.1086/321526; Phillips MM, 2007, PUBL ASTRON SOC PAC, V119, P360, DOI 10.1086/518372; PUCKETT T, 2008, CENTRAL BUREAU ELECT, V1567; Sahu DK, 2008, ASTROPHYS J, V680, P580, DOI 10.1086/587772; Valenti S, 2008, ASTROPHYS J LETT, V673, pL155, DOI 10.1086/527672	30	150	151	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					674	677		10.1038/nature08023	http://dx.doi.org/10.1038/nature08023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494909	Green Submitted, Green Published			2022-12-28	WOS:000266608600037
J	Luo, J; Emanuele, MJ; Li, DN; Creighton, CJ; Schlabach, MR; Westbrook, TF; Wong, KK; Elledge, SJ				Luo, Ji; Emanuele, Michael J.; Li, Danan; Creighton, Chad J.; Schlabach, Michael R.; Westbrook, Thomas F.; Wong, Kwok-Kin; Elledge, Stephen J.			A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; SMALL-MOLECULE INHIBITOR; XENOPUS-LAEVIS EGGS; HUMAN CANCER-CELLS; POLO-LIKE KINASE-1; K-RAS; LUNG ADENOCARCINOMA; ACTIVATING MUTATIONS; MITOTIC ENTRY; N-RAS	Oncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understanding of the vulnerabilities of these cancers is lacking. We undertook a genome-wide RNAi screen to identify synthetic lethal interactions with the KRAS oncogene. We discovered a diverse set of proteins whose depletion selectively impaired the viability of Ras mutant cells. Among these we observed a strong enrichment for genes with mitotic functions. We describe a pathway involving the mitotic kinase PLK1, the anaphase-promoting complex/cyclosome, and the proteasome that, when inhibited, results in prometaphase accumulation and the subsequent death of Ras mutant cells. Gene expression analysis indicates that reduced expression of genes in this pathway correlates with increased survival of patients bearing tumors with a Ras transcriptional signature. Our results suggest a previously underappreciated role for Ras in mitotic progression and demonstrate a pharmacologically tractable pathway for the potential treatment of cancers harboring Ras mutations.	[Luo, Ji; Emanuele, Michael J.; Schlabach, Michael R.; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Howard Hughes Med Inst, Boston, MA 02115 USA; [Luo, Ji; Emanuele, Michael J.; Schlabach, Michael R.; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Dept Genet, Boston, MA 02115 USA; [Li, Danan; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Li, Danan; Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Dana Farber Canc Ctr, Dept Med Oncol, Boston, MA 02115 USA; [Creighton, Chad J.] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, Dan L Duncan Canc Ctr, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Howard Hughes Med Inst, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		wong, kwok kin/0000-0001-6323-235X	AACR Prevent Cancer Foundation AstraZeneca Fellowship in Translational Lung Cancer Research; Damon Runyon Cancer Research Foundation [DRG-1996-08]; NIH [R01 CA122794, R01 AG2400401, P30 CA125123]; DF/HCC Lung Cancer SPORE grant [P50 CA090578]; Susan G. Komen for the Cure Foundation [KG090355]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA122794, ZIABC011304, P30CA125123, P50CA090578] Funding Source: NIH RePORTER	AACR Prevent Cancer Foundation AstraZeneca Fellowship in Translational Lung Cancer Research; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DF/HCC Lung Cancer SPORE grant; Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Bert Vogelstein and Victor Velculescu for the DLD-1 and HCT116 cells and Dr. Nathanael Gray and SAI Advantium for help with the synthesis of BI-2536. We thank Matthew Buttarazzi, Nicholas Kwiatkowski, Dror Berel, and Dr. Chandra Miduturu for technical assistance and Drs. Greg Hannon, Nicole Solimini, Tim Mitchison, and Randal King for helpful discussions. J. L. is supported by the AACR Prevent Cancer Foundation AstraZeneca Fellowship in Translational Lung Cancer Research. M. J. E. is the Philip O'Bryan Montgomery Jr., MD fellow of the Damon Runyon Cancer Research Foundation (DRG-1996-08). K.-K. W. is supported by NIH grants R01 CA122794 and R01 AG2400401 and the DF/HCC Lung Cancer SPORE grant P50 CA090578. C. J. C. and T. F. W. are supported in part by NIH grant P30 CA125123. T. F. W. is supported by the Susan G. Komen for the Cure Foundation ( KG090355). This work is supported by grants from NIH and DOD to S. J. E., and S. J. E. is an investigator with the Howard Hughes Medical Institute.	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bezieau S, 2001, HUM MUTAT, V18, P212, DOI 10.1002/humu.1177; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Li J, 2005, MOL CELL BIOL, V25, P767, DOI 10.1128/MCB.25.2.767-778.2005; Li YL, 2007, CANCER RES, V67, P6657, DOI 10.1158/0008-5472.CAN-06-3234; Liu PC, 1996, BLOOD, V88, P2699, DOI 10.1182/blood.V88.7.2699.bloodjournal8872699; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ogata A, 1997, J IMMUNOL, V159, P2212; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Rowley M, 2002, ONCOGENE, V21, P8769, DOI 10.1038/sj.onc.1205387; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarthy AV, 2007, MOL CANCER THER, V6, P269, DOI 10.1158/1535-7163.MCT-06-0560; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Whitehurst AW, 2008, MOL CELL BIOL, V28, P3190, DOI 10.1128/MCB.02291-07; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	50	755	776	3	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					835	848		10.1016/j.cell.2009.05.006	http://dx.doi.org/10.1016/j.cell.2009.05.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490893	Green Accepted, Bronze			2022-12-28	WOS:000266454800015
J	Wuhr, M; Mitchison, TJ; Field, CM				Wuehr, Martin; Mitchison, Timothy J.; Field, Christine M.			Size and Speed Go Hand in Hand in Cytokinesis	CELL			English	Editorial Material							ACTIN; DYNAMICS		[Wuehr, Martin; Mitchison, Timothy J.; Field, Christine M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Field, CM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	christine_field@hms.harvard.edu	Wühr, Martin/A-2447-2009	Wühr, Martin/0000-0002-0244-8947	NIGMS NIH HHS [R01 GM039565] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039565] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; He XY, 1997, EXP CELL RES, V233, P252, DOI 10.1006/excr.1997.3585; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Rappaport R., 1996, Developmental and Cell Biology Series, V32, pi; Schroeder T E, 1975, Soc Gen Physiol Ser, V30, P305; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Zumdieck A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000696	9	0	0	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					798	800		10.1016/j.cell.2009.05.012	http://dx.doi.org/10.1016/j.cell.2009.05.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490886	Bronze			2022-12-28	WOS:000266454800008
J	Gonnermann, HM; Mukhopadhyay, S				Gonnermann, Helge M.; Mukhopadhyay, Sujoy			Preserving noble gases in a convecting mantle	NATURE			English	Article							EARTHS MANTLE; ISOTOPIC EVIDENCE; HELIUM; EVOLUTION; RESERVOIRS; CONSTRAINTS; SYSTEMATICS; CIRCULATION; BASALTS; FLUXES	High (3)He/(4)He ratios sampled at many ocean islands are usually attributed to an essentially undegassed lower-mantle reservoir with high (3)He concentrations(1-4). A large and mostly undegassed mantle reservoir is also required to balance the Earth's (40)Ar budget, because only half of the (40)Ar produced from the radioactive decay of 40 K is accounted for by the atmosphere and upper mantle(5). However, geophysical(6,7) and geochemical observations(8) suggest slab subduction into the lower mantle, implying that most or all of Earth's mantle should have been processed by partial melting beneath mid-ocean ridges and hotspot volcanoes. This should have left noble gases in both the upper and the lower mantle extensively outgassed, contrary to expectations from (3)He/(4)He ratios and the Earth's (40)Ar budget. Here we suggest a simple solution: recycling and mixing of noble-gas-depleted slabs dilutes the concentrations of noble gases in the mantle, thereby decreasing the rate of mantle degassing and leaving significant amounts of noble gases in the processed mantle. As a result, even when the mass flux across the 660-km seismic discontinuity is equivalent to approximately one lower-mantlemass over the Earth's history, high (3)He contents, high (3)He/(4)He ratios and (40)Ar concentrations high enough to satisfy the (40)Ar mass balance of the Earth can be preserved in the lower mantle. The differences in (3)He/(4)He ratios between mid-ocean-ridge basalts and ocean island basalts, as well as high concentrations of (3)He and (40)Ar in the mantle source of ocean island basalts(4), can be explained within the framework of different processing rates for the upper and the lower mantle. Hence, to preserve primitive noble gas signatures, we find no need for hidden reservoirs or convective isolation of the lower mantle for any length of time.	[Gonnermann, Helge M.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Mukhopadhyay, Sujoy] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Rice University; Harvard University	Gonnermann, HM (corresponding author), Rice Univ, Dept Earth Sci, Houston, TX 77005 USA.	helge@rice.edu; sujoy@eps.harvard.edu	Gonnermann, Helge M/B-1054-2012		University of Hawaii; SOEST Young Investigator programme; US National Science Foundation [EAR 0509721]	University of Hawaii; SOEST Young Investigator programme; US National Science Foundation(National Science Foundation (NSF))	We thank R. O'Connell, A. Dziewonski, C. Langmuir, E. Hellebrand for discussions and D. Graham for a thorough review of the manuscript. H. M. G. was in part supported by the University of Hawaii, SOEST Young Investigator programme. S. M. was in part supported by US National Science Foundation grant EAR 0509721.	Albarede F, 1998, CHEM GEOL, V145, P413, DOI 10.1016/S0009-2541(97)00152-6; Albarede F, 2001, EARTH PLANET SC LETT, V189, P59, DOI 10.1016/S0012-821X(01)00350-8; Albarede F, 2008, SCIENCE, V319, P943, DOI 10.1126/science.1150060; ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; Allegre CJ, 1996, GEOPHYS RES LETT, V23, P3555, DOI 10.1029/96GL03373; ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Coltice N, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027707; FARLEY KA, 1995, J GEOPHYS RES-SOL EA, V100, P3829, DOI 10.1029/94JB02913; Fukao Y, 2001, REV GEOPHYS, V39, P291, DOI 10.1029/1999RG000068; Gonnermann HM, 2007, NATURE, V449, P1037, DOI 10.1038/nature06240; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; GRAND SP, 1997, GSA TODAY, V7, P7; Gu YJ, 2001, J GEOPHYS RES-SOL EA, V106, P11169, DOI 10.1029/2001JB000340; Harper CL, 1996, SCIENCE, V273, P1814, DOI 10.1126/science.273.5283.1814; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; Heber VS, 2007, GEOCHIM COSMOCHIM AC, V71, P1041, DOI 10.1016/j.gca.2006.11.010; HOFMANN AW, 1986, EARTH PLANET SC LETT, V79, P33, DOI 10.1016/0012-821X(86)90038-5; JACOBSEN SB, 1979, J GEOPHYS RES, V84, P7411, DOI 10.1029/JB084iB13p07411; Kellogg JB, 2002, EARTH PLANET SC LETT, V204, P183, DOI 10.1016/S0012-821X(02)00981-0; KELLOGG LH, 1990, EARTH PLANET SC LETT, V99, P276, DOI 10.1016/0012-821X(90)90116-F; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Kustowski B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005169; OCONNELL RJ, 1980, EOS, V61, P373; ONions RK, 1996, EARTH PLANET SC LETT, V139, P213, DOI 10.1016/0012-821X(96)00004-0; Parman SW, 2007, NATURE, V446, P900, DOI 10.1038/nature05691; Porcelli D, 2008, EARTH PLANET SC LETT, V269, P175, DOI 10.1016/j.epsl.2008.02.002; STAUDACHER T, 1988, EARTH PLANET SC LETT, V89, P173, DOI 10.1016/0012-821X(88)90170-7; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0	31	83	86	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 28	2009	459	7246					560	U88		10.1038/nature08018	http://dx.doi.org/10.1038/nature08018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478782				2022-12-28	WOS:000266370500037
J	Barry, JM				Barry, John M.			Pandemics: avoiding the mistakes of 1918	NATURE			English	Editorial Material									[Barry, John M.] Tulane Univ, Ctr Bioenvironm Res, New Orleans, LA 70112 USA; [Barry, John M.] Xavier Univ, New Orleans, LA 70112 USA	Tulane University; Xavier University of Louisiana	Barry, JM (corresponding author), Tulane Univ, Ctr Bioenvironm Res, New Orleans, LA 70112 USA.	jbarry@tulane.edu						Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Jordan EO., 1927, EPIDEMIC INFLUENZA S; TURNER CE, 1622 US NAT ARCH; MAYORS ANN REPORT 19	4	45	48	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 21	2009	459	7245					324	325		10.1038/459324a	http://dx.doi.org/10.1038/459324a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458695	Green Published, Bronze			2022-12-28	WOS:000266243700018
J	Craythorne, EE; Wong, S; Jones, RM; du Vivier, AWP				Craythorne, E. E.; Wong, S.; Jones, R. Morris; du Vivier, A. W. P.			Picture Quiz A characteristic rash	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS LARVA MIGRANS; TRAVELERS; TUNGIASIS		[Craythorne, E. E.; Wong, S.; Jones, R. Morris; du Vivier, A. W. P.] Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Craythorne, EE (corresponding author), Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England.	emma_craythorne@hotmail.com						Blackwell V, 2001, BRIT J DERMATOL, V145, P434, DOI 10.1046/j.1365-2133.2001.04406.x; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Heukelbach J, 2002, TROP MED INT HEALTH, V7, P907, DOI 10.1046/j.1365-3156.2002.00961.x; Heukelbach J, 2007, J TRAVEL MED, V14, P374, DOI 10.1111/j.1708-8305.2007.00156.x; Heukelbach Jorg, 2003, Travel Med Infect Dis, V1, P213, DOI 10.1016/j.tmaid.2003.10.003; JELINEK T, 1994, CLIN INFECT DIS, V19, P1062, DOI 10.1093/clinids/19.6.1062; LEDERMAN ER, 2008, INT J INFECT DIS, V593, P602; 2008, CURR OPIN INFECT DIS, V21, P495	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2009	338								b1451	10.1136/bmj.b1451	http://dx.doi.org/10.1136/bmj.b1451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NS	19457971				2022-12-28	WOS:000266269900001
J	Hofius, D; Schultz-Larsen, T; Joensen, J; Tsitsigiannis, DI; Petersen, NHT; Mattsson, O; Jorgensen, LB; Jones, JDG; Mundy, J; Petersen, M				Hofius, Daniel; Schultz-Larsen, Torsten; Joensen, Jan; Tsitsigiannis, Dimitrios I.; Petersen, Nikolaj H. T.; Mattsson, Ole; Jorgensen, Lise Bolt; Jones, Jonathan D. G.; Mundy, John; Petersen, Morten			Autophagic Components Contribute to Hypersensitive Cell Death in Arabidopsis	CELL			English	Article							PLANT INNATE IMMUNITY; PSEUDOMONAS-SYRINGAE; RESISTANCE; GENES; DEFENSE; ATG8; MACROAUTOPHAGY; APOPTOSIS; RESPONSES; THALIANA	Autophagy has been implicated as a prosurvival mechanism to restrict programmed cell death (PCD) associated with the pathogen-triggered hypersensitive response (HR) during plant innate immunity. This model is based on the observation that HR lesions spread in plants with reduced autophagy gene expression. Here, we examined receptor-mediated HR PCD responses in autophagy-deficient Arabidopsis knockout mutants (atg), and show that infection-induced lesions are contained in atg mutants. We also provide evidence that HR cell death initiated via Toll/Interleukin-1 (TIR)-type immune receptors through the defense regulator EDS1 is suppressed in atg mutants. Furthermore, we demonstrate that PCD triggered by coiled-coil (CC)-type immune receptors via NDR1 is either autophagy-independent or engages autophagic components with cathepsins and other unidentified cell death mediators. Thus, autophagic cell death contributes to HR PCD and can function in parallel with other prodeath pathways.	[Hofius, Daniel; Schultz-Larsen, Torsten; Joensen, Jan; Petersen, Nikolaj H. T.; Mattsson, Ole; Jorgensen, Lise Bolt; Mundy, John; Petersen, Morten] Univ Copenhagen, Copenhagen Bioctr, Dept Biol, DK-2200 Copenhagen, Denmark; [Tsitsigiannis, Dimitrios I.; Jones, Jonathan D. G.] John Innes Ctr, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Petersen, M (corresponding author), Univ Copenhagen, Copenhagen Bioctr, Dept Biol, DK-2200 Copenhagen, Denmark.	shutko@bio.ku.dk	Tsitsigiannis, Dimitrios/F-1009-2017; Petersen, Morten/J-5023-2014; mundy, john/A-2361-2013; Jones, Jonathan DG/J-5129-2012; Schultz-Larsen, Torsten/F-6845-2014	Tsitsigiannis, Dimitrios/0000-0003-2006-6106; Petersen, Morten/0000-0002-3035-5991; mundy, john/0000-0001-7490-4588; Jones, Jonathan DG/0000-0002-4953-261X; Schultz-Larsen, Torsten/0000-0001-6759-0074	Danish Cancer Society [DP03048]; Research Council [274-06-0460, 272-06-0049]; European Union [LSHG-CT-2004-511983]; Danish Agricultural Research Council [23-02-0101, 23-04-0143]	Danish Cancer Society(Danish Cancer Society); Research Council; European Union(European Commission); Danish Agricultural Research Council	We thank Suksawad Vongvisuttikun, Henriette Larsen, and Lis Munk Frederiksen for technical assistance. We also thank Yoshinori Ohsumi (National Institute for Basic Biology, Okazaki, Japan) and Kohki Yoshimoto (RIKEN Plant Science Center, Yokohama, Japan) for carefully reading versions of this manuscript and providing binary plasmids carrying GFP-ATG8s as well as seeds of atg9 and atg4a/b. We are grateful to R. Vierstra (University of Wisconsin, Madison, WI) for providing seeds of atg7 and atg5. Finally, we thank J. Chang (Oregon State University, Corvallis, OR) for providing modified Pf0-1 strains. This work was funded by grants to J. M. from the Danish Cancer Society (DP03048) and Research Council (274-06-0460, 272-06-0049), and the European Union (LSHG-CT-2004-511983) as well as to M. P. (23-02-0101) and D. H. (23-04-0143) from the Danish Agricultural Research Council.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bassham DC, 2006, AUTOPHAGY, V2, P2, DOI 10.4161/auto.2092; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; BOZZOLA JJ, 1999, ELECT MICROSCOPY PRI, V2; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harrison-Lowe NJ, 2008, AUTOPHAGY, V4, P339, DOI 10.4161/auto.5629; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moriyasu Y, 2003, PLANT CELL PHYSIOL, V44, P795, DOI 10.1093/pcp/pcg100; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Patel S, 2008, AUTOPHAGY, V4, P20, DOI 10.4161/auto.5056; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Seay M, 2006, CELL MICROBIOL, V8, P899, DOI 10.1111/j.1462-5822.2006.00715.x; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Woltering EJ, 2004, TRENDS PLANT SCI, V9, P469, DOI 10.1016/j.tplants.2004.08.001; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	46	271	290	10	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					773	783		10.1016/j.cell.2009.02.036	http://dx.doi.org/10.1016/j.cell.2009.02.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450522	Bronze			2022-12-28	WOS:000266114100024
J	Mehra, A; Shi, M; Baker, CL; Colot, HV; Loros, JJ; Dunlap, JC				Mehra, Arun; Shi, Mi; Baker, Christopher L.; Colot, Hildur V.; Loros, Jennifer J.; Dunlap, Jay C.			A Role for Casein Kinase 2 in the Mechanism Underlying Circadian Temperature Compensation	CELL			English	Article							PERIOD LENGTH; FREQUENCY DETERMINES; NEUROSPORA CLOCK; PROTEIN; PHOSPHORYLATION; DROSOPHILA; RHYTHMS; GENE; TIME; CK2	Temperature compensation of circadian clocks is an unsolved problem with relevance to the general phenomenon of biological compensation. We identify casein kinase 2 (CK2) as a key regulator of temperature compensation of the Neurospora clock by determining that two long-standing clock mutants, chrono and period-3, displaying distinctive alterations in compensation encode the beta 1 and alpha subunits of CK2, respectively. Reducing the dose of these subunits, particularly beta 1, significantly alters temperature compensation without altering the enzyme's Q(10). By contrast, other kinases and phosphatases implicated in clock function do not play appreciable roles in temperature compensation. CK2 exerts its effects on the clock by directly phosphorylating FREQUENCY (FRQ), and this phosphorylation is compromised in CK2 hypomorphs. Finally, mutation of certain putative CK2 phosphosites on FRQ, shown to be phosphorylated in vivo, predictably alters temperature compensation profiles effectively phenocopying CK2 mutants.	[Mehra, Arun; Shi, Mi; Baker, Christopher L.; Colot, Hildur V.; Loros, Jennifer J.; Dunlap, Jay C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Loros, Jennifer J.; Dunlap, Jay C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Dunlap, JC (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA.	jay.c.dunlap@dartmouth.edu	Shi, Mi/A-5884-2012; Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Shi, Mi/0000-0002-3044-912X; Dunlap, Jay/0000-0003-1577-0457	Canadian Institutes of Health Research Postdoctoral Fellowship; National Institutes of Health [R01 GM34985, P01 GM68087, R01 GM083336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034985, P01GM068087, R01GM083336] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L. Larrondo kindly provided strains 1061-1 and 1066-6. We thank C. Hammell for technical assistance with GST-FRQ purification, P. Ruoff for helpful discussions, and R. Lambreghts and H. Benchabane for critical reading of the manuscript. This work was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship to A. M. and by grants from the National Institutes of Health to J.C.D. (R01 GM34985 and P01 GM68087) and to J. J. L. and J. C. D. (R01 GM083336).	Akman OE, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.28; Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 2005, MOL CELL BIOCHEM, V274, P141, DOI 10.1007/s11010-005-2943-1; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; BARRETT RK, 1995, J NEUROSCI, V15, P5681; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Diernfellner A, 2007, FEBS LETT, V581, P5759, DOI 10.1016/j.febslet.2007.11.043; Dunlap JC, 2007, COLD SPRING HARB SYM, V72, P57, DOI 10.1101/sqb.2007.72.072; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Dunlap JC, 2006, CURR OPIN MICROBIOL, V9, P579, DOI 10.1016/j.mib.2006.10.008; Dunlap JC, 2005, METHOD ENZYMOL, V393, P3, DOI 10.1016/S0076-6879(05)93001-2; Edwards KD, 2005, GENETICS, V170, P387, DOI 10.1534/genetics.104.035238; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; GARDNER GF, 1981, PLANT PHYSIOL, V68, P1244, DOI 10.1104/pp.68.6.1244; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Hong CI, 1997, CHRONOBIOL INT, V14, P521, DOI 10.3109/07420529709001473; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; Kalmus H., 1935, Biologia Generalis Wien, V11, P93; KALMUS HANS, 1934, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V20, P405; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; Kurosawa G, 2005, J THEOR BIOL, V233, P453, DOI 10.1016/j.jtbi.2004.10.012; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; LAKINTHOMAS PI, 1991, J BIOL RHYTHM, V6, P281, DOI 10.1177/074873049100600401; Lambreghts R, 2009, GENETICS, V181, P767, DOI 10.1534/genetics.108.089292; Larrondo LF, 2009, EUKARYOT CELL, V8, P800, DOI 10.1128/EC.00072-09; Leloup JC, 1997, CHRONOBIOL INT, V14, P511, DOI 10.3109/07420529709001472; Lin JM, 2005, J NEUROSCI, V25, P11175, DOI 10.1523/JNEUROSCI.2159-05.2005; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Mizoguchi T, 2006, INT REV CYTOL, V250, P47, DOI 10.1016/S0074-7696(06)50002-6; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; NJUS D, 1977, J COMP PHYSIOL, V117, P335, DOI 10.1007/BF00691559; Nowrousian M, 2003, GENETICS, V164, P923; Pagano MA, 2005, MOL CELL BIOCHEM, V274, P23, DOI 10.1007/s11010-005-3116-y; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Price JL, 1997, CHRONOBIOL INT, V14, P455, DOI 10.3109/07420529709001468; Rothenfluh A, 2000, GENETICS, V156, P665; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Ruoff P, 1997, CHRONOBIOL INT, V14, P499, DOI 10.3109/07420529709001471; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SMITH RF, 1982, MOL GEN GENET, V185, P30, DOI 10.1007/BF00333786; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Takeuchi T, 2007, J THEOR BIOL, V246, P195, DOI 10.1016/j.jtbi.2006.12.028; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; Tosini G, 1998, NEUROREPORT, V9, P1001, DOI 10.1097/00001756-199804200-00009; Wahl O., 1932, Zeitschrift fuer Vergleichende Physiologie Berlin, V16, P529; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Yde CW, 2005, J MOL BIOL, V347, P399, DOI 10.1016/j.jmb.2005.01.003	70	82	84	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					749	760		10.1016/j.cell.2009.03.019	http://dx.doi.org/10.1016/j.cell.2009.03.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450520	Green Accepted, Bronze			2022-12-28	WOS:000266114100022
J	Penuelas, J; Rutishauser, T; Filella, I				Penuelas, Josep; Rutishauser, This; Filella, Iolanda			Phenology Feedbacks on Climate Change	SCIENCE			English	Editorial Material							HEAT-WAVE		[Penuelas, Josep; Rutishauser, This; Filella, Iolanda] Univ Autonoma Barcelona, Global Ecol Unit, Ctr Ecol Res & Forestry Applicat CREAF CEAB CSIC, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Penuelas, J (corresponding author), Univ Autonoma Barcelona, Global Ecol Unit, Ctr Ecol Res & Forestry Applicat CREAF CEAB CSIC, E-08193 Barcelona, Spain.	josep.penuelas@uab.cat; this@creaf.uab.cat; i.filella@creaf.uab.cat	Penuelas, Josep/D-9704-2011; Filella, Iolanda/A-2860-2015	Penuelas, Josep/0000-0002-7215-0150; Filella, Iolanda/0000-0001-6262-5733				[Anonymous], 2007, PHYS SCI BAS CONTR W; Bonan G.B., 2008, ECOLOGICAL CLIMATOLO, DOI [10.1017/CBO9781107339200, DOI 10.1017/CBO9781107339200]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Fischer EM, 2007, J CLIMATE, V20, P5081, DOI 10.1175/JCLI4288.1; Fitzjarrald DR, 2001, J CLIMATE, V14, P598, DOI 10.1175/1520-0442(2001)014<0598:CCOLPI>2.0.CO;2; Garbulsky MF, 2008, GLOBAL CHANGE BIOL, V14, P2860, DOI 10.1111/j.1365-2486.2008.01684.x; Jiang XY, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010756; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P2657, DOI 10.5194/acp-8-2657-2008; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Penuelas J, 2003, TRENDS PLANT SCI, V8, P105, DOI 10.1016/S1360-1385(03)00008-6; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Schwartz MD, 1996, J CLIMATE, V9, P803, DOI 10.1175/1520-0442(1996)009<0803:ETSDID>2.0.CO;2; Steltzer H, 2009, SCIENCE, V324, P886, DOI 10.1126/science.1171542; Stockli R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000781; Zaitchik BF, 2006, INT J CLIMATOL, V26, P743, DOI 10.1002/joc.1280	17	540	574	29	337	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					887	888		10.1126/science.1173004	http://dx.doi.org/10.1126/science.1173004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443770				2022-12-28	WOS:000266048800020
J	Rohwer, F; Thurber, RV				Rohwer, Forest; Thurber, Rebecca Vega			Viruses manipulate the marine environment	NATURE			English	Review							COMPLETE GENOME SEQUENCE; FUNCTIONAL NUCLEAR GENES; TRANSFER AGENT GENES; LARGE DNA VIRUSES; EMILIANIA-HUXLEYI; PHOTOSYNTHESIS GENES; COCCOLITH FORMATION; CASPASE ACTIVATION; ELYSIA-CHLOROTICA; SEA	Marine viruses affect Bacteria, Archaea and eukaryotic organisms and are major components of the marine food web. Most studies have focused on their role as predators and parasites, but many of the interactions between marine viruses and their hosts are much more complicated. A series of recent studies has shown that viruses have the ability to manipulate the life histories and evolution of their hosts in remarkable ways, challenging our understanding of this almost invisible world.	[Rohwer, Forest; Thurber, Rebecca Vega] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Thurber, Rebecca Vega] Florida Int Univ, Dept Biol Sci, N Miami, FL 33181 USA	California State University System; San Diego State University; State University System of Florida; Florida International University	Thurber, RV (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	rvegathurber@gmail.com	Rohwer, Forest/AAC-5315-2019	Rohwer, Forest/0000-0003-1548-5429				Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Best SM, 2004, VIROLOGY, V320, P191, DOI 10.1016/j.virol.2003.11.025; Best SM, 2002, VIROLOGY, V292, P224, DOI 10.1006/viro.2001.1238; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Chiura HX, 1997, AQUAT MICROB ECOL, V13, P75, DOI 10.3354/ame013075; CHIURA HX, 2002, MICROB ENV, V17, P53; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Comeau AM, 2006, ENVIRON MICROBIOL, V8, P1164, DOI 10.1111/j.1462-2920.2006.01006.x; Culley AI, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-69; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Fuhrman JA, 2003, NATURE, V424, P1001, DOI 10.1038/4241001a; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236, DOI 10.4319/lo.1995.40.7.1236; Gobler CJ, 1997, LIMNOL OCEANOGR, V42, P1492, DOI 10.4319/lo.1997.42.7.1492; Green BJ, 2000, PLANT PHYSIOL, V124, P331, DOI 10.1104/pp.124.1.331; Jiang SC, 1998, MICROBIAL ECOL, V35, P235, DOI 10.1007/s002489900079; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; KLAVENESS D, 1971, ARCH MIKROBIOL, V75, P382, DOI 10.1007/BF00407700; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Mannisto RH, 1999, VIROLOGY, V262, P355, DOI 10.1006/viro.1999.9837; MOEBUS K, 1980, HELGOLANDER MEERESUN, V34, P1, DOI 10.1007/BF01983537; Mondy WL, 2003, INVERTEBR BIOL, V122, P126; Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106; Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12; Monier A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-456; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Mujer CV, 1996, P NATL ACAD SCI USA, V93, P12333, DOI 10.1073/pnas.93.22.12333; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Paul JH, 2005, APPL ENVIRON MICROB, V71, P3311, DOI 10.1128/AEM.71.6.3311-3320.2005; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pierce SK, 2006, INTEGR COMP BIOL, V46, pE110; Pierce SK, 2007, SYMBIOSIS, V43, P57; Pierce SK, 1999, BIOL BULL, V197, P1, DOI 10.2307/1542990; Pierce SK, 2003, BIOL BULL-US, V204, P237, DOI 10.2307/1543594; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Sano E, 2004, APPL ENVIRON MICROB, V70, P5842, DOI 10.1128/AEM.70.10.5842-5846.2004; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; SPENCER R, 1955, NATURE, V175, P690, DOI 10.1038/175690a0; Stanton TB, 2007, ANAEROBE, V13, P43, DOI 10.1016/j.anaerobe.2007.03.004; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; SUTTLE CA, 1994, MICROBIAL ECOL, V28, P237, DOI 10.1007/BF00166813; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; TORRELLA F, 1979, APPL ENVIRON MICROB, V37, P774, DOI 10.1128/AEM.37.4.774-778.1979; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73; Wilson WH, 2002, DEEP-SEA RES PT II, V49, P2951, DOI 10.1016/S0967-0645(02)00065-6; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P231; ZoBell C., 1946, MARINE MICROBIOLOGY	73	395	414	8	227	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					207	212		10.1038/nature08060	http://dx.doi.org/10.1038/nature08060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444207				2022-12-28	WOS:000266036100031
J	Garcia, V; Fusil, S; Bouzehouane, K; Enouz-Vedrenne, S; Mathur, ND; Barthelemy, A; Bibes, M				Garcia, V.; Fusil, S.; Bouzehouane, K.; Enouz-Vedrenne, S.; Mathur, N. D.; Barthelemy, A.; Bibes, M.			Giant tunnel electroresistance for non-destructive readout of ferroelectric states	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; JUNCTIONS; PHYSICS	Ferroelectrics possess a polarization that is spontaneous, stable and electrically switchable(1), and submicrometre-thick ferroelectric films are currently used as non-volatile memory elements with destructive capacitive readout(2). Memories based on tunnel junctions with ultrathin ferroelectric barriers would enable non-destructive resistive readout(3). However, the achievement of room-temperature polarization stability and switching at very low thickness is challenging(4,5). Here we use piezoresponse force microscopy at room temperature to show robust ferroelectricity down to 1 nm in highly strained BaTiO3 films; we also use room-temperature conductive-tip atomic force microscopy to demonstrate resistive readout of the polarization state through its influence on the tunnel current(6,7). The resulting electroresistance effect scales exponentially with ferroelectric film thickness, reaching similar to 75,000% at 3 nm. Our approach exploits the otherwise undesirable leakage current-dominated by tunnelling at these very low thicknesses-to read the polarization state without destroying it. We demonstrate scalability down to 70 nm, corresponding to potential densities of >16 Gbit inch(-2). These results pave the way towards ferroelectric memories with simplified architectures, higher densities and faster operation, and should inspire further exploration of the interplay between quantum tunnelling and ferroelectricity at the nanoscale.	[Garcia, V.; Fusil, S.; Bouzehouane, K.; Barthelemy, A.; Bibes, M.] Unite Mixte Phys CNRS Thales, F-91767 Palaiseau, France; [Garcia, V.; Fusil, S.; Bouzehouane, K.; Barthelemy, A.; Bibes, M.] Univ Paris Sud, F-91405 Orsay, France; [Garcia, V.; Mathur, N. D.] Univ Cambridge, Dept Mat Sci, Cambridge CB2 3QZ, England; [Fusil, S.] Univ dEvry Val dEssonne, F-91025 Evry, France; [Enouz-Vedrenne, S.] Thales Res & Technol, F-91767 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge; UDICE-French Research Universities; Universite Paris Saclay; Thales Group	Bibes, M (corresponding author), Unite Mixte Phys CNRS Thales, 1 Av A Fresnel,Campus Ecole Polytech, F-91767 Palaiseau, France.	manuel.bibes@thalesgroup.com	Bibes, Manuel/AAC-5764-2019; Garcia, Vincent/C-9359-2012; BARTHELEMY, Agnès/ABB-5522-2020; Bibes, Manuel/C-5899-2013	Bibes, Manuel/0000-0002-6704-3422; Garcia, Vincent/0000-0002-7230-8130; Bibes, Manuel/0000-0002-6704-3422	France-UKPMCAlliance programme; French RTRA Triangle de la Physique; EU STRP Macomufi; EU STRP CoMePhS; UK EPSRC [EP/E026206/I]; French ANR Femmes; French ANR Alicante	France-UKPMCAlliance programme; French RTRA Triangle de la Physique; EU STRP Macomufi; EU STRP CoMePhS; UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); French ANR Femmes(French National Research Agency (ANR)); French ANR Alicante(French National Research Agency (ANR))	We thank H. Bea, C. Israel, M. Vickers and B. Warot-Fonrose for technical support, and H. Kohlstedt for discussions. This work was supported by the France-UKPMCAlliance programme, the French RTRA Triangle de la Physique, EU STRP Macomufi, EU STRP CoMePhS, UK EPSRC EP/E026206/I, the French ANR Femmes and the French ANR Alicante.	Bea H, 2006, JPN J APPL PHYS 2, V45, pL187, DOI 10.1143/JJAP.45.L187; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Chu YH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2750524; Contreras JR, 2003, APPL PHYS LETT, V83, P4595, DOI 10.1063/1.1627944; Dawber M, 2005, REV MOD PHYS, V77, P1083, DOI 10.1103/RevModPhys.77.1083; Despont L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094110; Gajek M, 2007, NAT MATER, V6, P296, DOI 10.1038/nmat1860; Ghosez Ph., 2006, HDB THEORETICAL COMP, P623; Houze F, 1996, APPL PHYS LETT, V69, P1975, DOI 10.1063/1.117179; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Kim YS, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880443; KOHISTEDT H, 2005, PHYS REV B, V72; KOHISTEDT H, 2002, MAT RES SOC S P, V688; Lichtensteiger C, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2433757; Paruch P, 2001, APPL PHYS LETT, V79, P530, DOI 10.1063/1.1388024; Petraru A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2972135; Planes J, 2001, APPL PHYS LETT, V79, P2993, DOI 10.1063/1.1413717; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; Takahashi R, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890485; Thompson C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3013512; Tsymbal EY, 2006, SCIENCE, V313, P181, DOI 10.1126/science.1126230; Tybell T, 1999, APPL PHYS LETT, V75, P856, DOI 10.1063/1.124536; Velev JP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.137201; Velev JP, 2009, NANO LETT, V9, P427, DOI 10.1021/nl803318d; Zhuravlev MY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246802	26	708	721	12	533	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					81	84		10.1038/nature08128	http://dx.doi.org/10.1038/nature08128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19483675				2022-12-28	WOS:000267545200033
J	Pearce, EL; Walsh, MC; Cejas, PJ; Harms, GM; Shen, H; Wang, LS; Jones, RG; Choi, YW				Pearce, Erika L.; Walsh, Matthew C.; Cejas, Pedro J.; Harms, Gretchen M.; Shen, Hao; Wang, Li-San; Jones, Russell G.; Choi, Yongwon			Enhancing CD8 T-cell memory by modulating fatty acid metabolism	NATURE			English	Article							REGULATES LIPID-METABOLISM; CD8-T-CELL MEMORY; MAMMALIAN TARGET; CD4-T-CELL HELP; CUTTING EDGE; HOMEOSTASIS; ACTIVATION; EXPRESSION; RAPAMYCIN; GROWTH	CD8 T cells, which have a crucial role in immunity to infection and cancer, are maintained in constant numbers, but on antigen stimulation undergo a developmental program characterized by distinct phases encompassing the expansion and then contraction of antigen-specific effector (T-E) populations, followed by the persistence of long-lived memory (T-M) cells(1,2). Although this predictable pattern of CD8 T-cell responses is well established, the underlying cellular mechanisms regulating the transition to T-M cells remain undefined(1,2). Here we show that tumour necrosis factor (TNF) receptor-associated factor 6 (TRAF6), an adaptor protein in the TNF-receptor and interleukin-1R/Toll-like receptor superfamily, regulates CD8 T-M-cell development after infection by modulating fatty acid metabolism. We show that mice with a T-cell-specific deletion of TRAF6 mount robust CD8 T-E-cell responses, but have a profound defect in their ability to generate T-M cells that is characterized by the disappearance of antigen-specific cells in the weeks after primary immunization. Microarray analyses revealed that TRAF6-deficient CD8 T cells exhibit altered expression of genes that regulate fatty acid metabolism. Consistent with this, activated CD8 T cells lacking TRAF6 display defective AMP-activated kinase activation and mitochondrial fatty acid oxidation (FAO) in response to growth factor withdrawal. Administration of the anti-diabetic drug metformin restored FAO and CD8 T-M-cell generation in the absence of TRAF6. This treatment also increased CD8 T-M cells in wild-type mice, and consequently was able to considerably improve the efficacy of an experimental anti-cancer vaccine.	[Pearce, Erika L.; Walsh, Matthew C.; Cejas, Pedro J.; Harms, Gretchen M.; Wang, Li-San; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Shen, Hao] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Sch Med, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Jones, Russell G.] McGill Univ, Dept Physiol, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; McGill University	Choi, YW (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu	Jones, Russell Graham/ABD-5261-2021; Jones, Russell/AAC-2861-2022; shen, hao/HGF-0551-2022	Jones, Russell Graham/0000-0003-2250-4675; 	NIH; CIHR; NCI Institutional Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064909] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NCI Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Krawczyk, C. King, M. Farrar, Y. Paterson, Z.- K. Pan and E. J. Pearce. This work is supported in part by grants from the NIH (Y. C., H. S.), CIHR (R. G. J.) and an NCI Institutional Training Grant (E. L. P.).	Albert MH, 2005, BLOOD, V105, P1355, DOI 10.1182/blood-2004-08-3305; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Karst AM, 2006, CANCER RES, V66, P9221, DOI 10.1158/0008-5472.CAN-05-3633; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	40	1035	1069	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					103	U118		10.1038/nature08097	http://dx.doi.org/10.1038/nature08097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19494812	Green Accepted, Bronze			2022-12-28	WOS:000267545200038
J	Wang, DO; Kim, SM; Zhao, YL; Hwang, H; Miura, SK; Sossin, WS; Martin, KC				Wang, Dan Ohtan; Kim, Sang Mok; Zhao, Yali; Hwang, Hongik; Miura, Satoru K.; Sossin, Wayne S.; Martin, Kelsey C.			Synapse- and Stimulus-Specific Local Translation During Long-Term Neuronal Plasticity	SCIENCE			English	Article							APLYSIA SENSORY NEURONS; PROTEIN-SYNTHESIS; MESSENGER-RNAS; HIPPOCAMPAL-NEURONS; MEMORY STORAGE; FACILITATION; EXPRESSION; LOCALIZATION; IDENTIFICATION; POLYRIBOSOMES	Long-term memory and synaptic plasticity require changes in gene expression and yet can occur in a synapse-specific manner. Messenger RNA localization and regulated translation at synapses are thus critical for establishing synapse specificity. Using live-cell microscopy of photoconvertible fluorescent protein translational reporters, we directly visualized local translation at synapses during long-term facilitation of Aplysia sensory-motor synapses. Translation of the reporter required multiple applications of serotonin, was spatially restricted to stimulated synapses, was transcript-and stimulus-specific, and occurred during long-term facilitation but not during long-term depression of sensory-motor synapses. Translational regulation only occurred in the presence of a chemical synapse and required calcium signaling in the postsynaptic motor neuron. Thus, highly regulated local translation occurs at synapses during long-term plasticity and requires trans-synaptic signals.	[Wang, Dan Ohtan; Kim, Sang Mok; Zhao, Yali; Hwang, Hongik; Martin, Kelsey C.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Kim, Sang Mok] Univ Calif Los Angeles, Interdepartmental Program Neurosci, Los Angeles, CA 90095 USA; [Miura, Satoru K.; Martin, Kelsey C.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; McGill University	Martin, KC (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, BSRB 390B,615 Charles E Young Dr S, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu	Wang, Dan Ohtan/AAF-5704-2019; Wang, Dan Ohtan/E-1953-2011; Miura, Satoru/GZH-1685-2022	Wang, Dan Ohtan/0000-0002-3126-8558; Miura, Satoru/0000-0002-6698-9435	NIH [NS045324]; Canadian Institute of Health Research [MT-15121]; Nakajima Foundation fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Nakajima Foundation fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Braslow and K. Cadenas for assistance with image analysis; R. Grambo for assistance with figures; D. Black, C. Heusner, E. Meer, and L. Zipursky for critical reading of the manuscript; and G. Weinmaster and Martin laboratory members for helpful discussions. This work was supported by NIH grant NS045324, a W. M. Keck Foundation Young Scholar Award and Eleanor Leslie Term Chair from the UCLA Brain Research Institute (to K.C.M.), Canadian Institute of Health Research grant MT-15121 (to W.S.S.), and a fellowship from the Nakajima Foundation (to S.K.M.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alberini CM, 1999, J EXP BIOL, V202, P2887; BRUNET JF, 1991, SCIENCE, V252, P856, DOI 10.1126/science.1840700; Cai DC, 2008, CURR BIOL, V18, P920, DOI 10.1016/j.cub.2008.05.038; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hu JY, 2006, J NEUROSCI, V26, P1026, DOI 10.1523/JNEUROSCI.4258-05.2006; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Liu K, 2003, J NEUROBIOL, V56, P275, DOI 10.1002/neu.10242; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; MACKEY SL, 1987, P NATL ACAD SCI USA, V84, P8730, DOI 10.1073/pnas.84.23.8730; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Moccia R, 2003, J NEUROSCI, V23, P9409; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Santarelli L, 1996, J NEUROBIOL, V31, P297, DOI 10.1002/(SICI)1097-4695(199611)31:3<297::AID-NEU3>3.3.CO;2-P; STEWARD O, 1982, J NEUROSCI, V2, P284; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Suzuki T, 2007, NEUROSCI RES, V57, P61, DOI 10.1016/j.neures.2006.09.009; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	32	150	154	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1536	1540		10.1126/science.1173205	http://dx.doi.org/10.1126/science.1173205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19443737	Green Accepted			2022-12-28	WOS:000267130600036
J	Koplan, JP; Bond, TC; Merson, MH; Reddy, KS; Rodriguez, MH; Sewankambo, NK; Wasserheit, JN				Koplan, Jeffrey P.; Bond, T. Christopher; Merson, Michael H.; Reddy, K. Srinath; Henry Rodriguez, Mario; Sewankambo, Nelson K.; Wasserheit, Judith N.		Consortium Univ Global Hlth Execut	Towards a common definition of global health	LANCET			English	Editorial Material									[Koplan, Jeffrey P.] Emory Univ, Robert W Woodruff Hlth Sci Ctr, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Bond, T. Christopher] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Merson, Michael H.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Reddy, K. Srinath] Publ Hlth Fdn India, Delhi, India; [Henry Rodriguez, Mario] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Sewankambo, Nelson K.] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Wasserheit, Judith N.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Emory University; Emory University; Rollins School Public Health; Duke University; Public Health Foundation of India; Instituto Nacional de Salud Publica; Makerere University; University of Washington; University of Washington Seattle	Koplan, JP (corresponding author), Emory Univ, Robert W Woodruff Hlth Sci Ctr, Emory Global Hlth Inst, 1440 Clifton Rd,Suite 410, Atlanta, GA 30322 USA.	jkoplan@emory.edu		Sewankambo, Nelson/0000-0001-9362-053X; Bond, T. Christopher/0000-0003-4274-5492				[Anonymous], 1988, FUT PUBL HLTH; Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831; *BROWN U INT HLTH, WELC INT HLTH I; *GLOB HLTH ED CONS, GLOB VS INT; Institute of Medicine, 2008, US COMM GLOB HLTH RE; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Merson M, 2006, INT PUBLIC HLTH DIS; Porter R., 1997, GREATEST BENEFIT MAN; Winslow CEA, 1920, MOD MED, V2, P183	9	721	752	6	131	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1993	1995		10.1016/S0140-6736(09)60332-9	http://dx.doi.org/10.1016/S0140-6736(09)60332-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456GT	19493564	Green Submitted			2022-12-28	WOS:000266832500035
J	Butler, G; Rasmussen, MD; Lin, MF; Santos, MAS; Sakthikumar, S; Munro, CA; Rheinbay, E; Grabherr, M; Forche, A; Reedy, JL; Agrafioti, I; Arnaud, MB; Bates, S; Brown, AJP; Brunke, S; Costanzo, MC; Fitzpatrick, DA; de Groot, PWJ; Harris, D; Hoyer, LL; Hube, B; Klis, FM; Kodira, C; Lennard, N; Logue, ME; Martin, R; Neiman, AM; Nikolaou, E; Quail, MA; Quinn, J; Santos, MC; Schmitzberger, FF; Sherlock, G; Shah, P; Silverstein, KAT; Skrzypek, MS; Soll, D; Staggs, R; Stansfield, I; Stumpf, MPH; Sudbery, PE; Srikantha, T; Zeng, QD; Berman, J; Berriman, M; Heitman, J; Gow, NAR; Lorenz, MC; Birren, BW; Kellis, M; Cuomo, CA				Butler, Geraldine; Rasmussen, Matthew D.; Lin, Michael F.; Santos, Manuel A. S.; Sakthikumar, Sharadha; Munro, Carol A.; Rheinbay, Esther; Grabherr, Manfred; Forche, Anja; Reedy, Jennifer L.; Agrafioti, Ino; Arnaud, Martha B.; Bates, Steven; Brown, Alistair J. P.; Brunke, Sascha; Costanzo, Maria C.; Fitzpatrick, David A.; de Groot, Piet W. J.; Harris, David; Hoyer, Lois L.; Hube, Bernhard; Klis, Frans M.; Kodira, Chinnappa; Lennard, Nicola; Logue, Mary E.; Martin, Ronny; Neiman, Aaron M.; Nikolaou, Elissavet; Quail, Michael A.; Quinn, Janet; Santos, Maria C.; Schmitzberger, Florian F.; Sherlock, Gavin; Shah, Prachi; Silverstein, Kevin A. T.; Skrzypek, Marek S.; Soll, David; Staggs, Rodney; Stansfield, Ian; Stumpf, Michael P. H.; Sudbery, Peter E.; Srikantha, Thyagarajan; Zeng, Qiandong; Berman, Judith; Berriman, Matthew; Heitman, Joseph; Gow, Neil A. R.; Lorenz, Michael C.; Birren, Bruce W.; Kellis, Manolis; Cuomo, Christina A.			Evolution of pathogenicity and sexual reproduction in eight Candida genomes	NATURE			English	Article							ALBICANS GENOME; MATING-TYPE; SEQUENCE; YEASTS; VIRULENCE; LODDEROMYCES; PARAPSILOSIS; MEIOSIS; FAMILY; CODON	Candida species are the most common cause of opportunistic fungal infection worldwide. Here we report the genome sequences of six Candida species and compare these and related pathogens and non-pathogens. There are significant expansions of cell wall, secreted and transporter gene families in pathogenic species, suggesting adaptations associated with virulence. Large genomic tracts are homozygous in three diploid species, possibly resulting from recent recombination events. Surprisingly, key components of the mating and meiosis pathways are missing from several species. These include major differences at the mating-type loci (MTL); Lodderomyces elongisporus lacks MTL, and components of the alpha 1/alpha 2 cell identity determinant were lost in other species, raising questions about how mating and cell types are controlled. Analysis of the CUG leucine-to-serine genetic-code change reveals that 99% of ancestral CUG codons were erased and new ones arose elsewhere. Lastly, we revise the Candida albicans gene catalogue, identifying many new genes.	[Lin, Michael F.; Sakthikumar, Sharadha; Grabherr, Manfred; Kodira, Chinnappa; Zeng, Qiandong; Birren, Bruce W.; Kellis, Manolis; Cuomo, Christina A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Butler, Geraldine; Fitzpatrick, David A.; Logue, Mary E.] Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Rasmussen, Matthew D.; Lin, Michael F.; Rheinbay, Esther; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Santos, Manuel A. S.; Santos, Maria C.] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Santos, Manuel A. S.; Santos, Maria C.] Univ Aveiro, CESAM, P-3810193 Aveiro, Portugal; [Munro, Carol A.; Brown, Alistair J. P.; Nikolaou, Elissavet; Stansfield, Ian; Gow, Neil A. R.] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Rheinbay, Esther] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Forche, Anja; Berman, Judith] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Reedy, Jennifer L.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Agrafioti, Ino; Stumpf, Michael P. H.] Univ London Imperial Coll Sci Technol & Med, Ctr Bioinformat, London SW7 2AY, England; [Arnaud, Martha B.; Costanzo, Maria C.; Schmitzberger, Florian F.; Sherlock, Gavin; Shah, Prachi; Skrzypek, Marek S.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Bates, Steven] Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England; [Brunke, Sascha; Hube, Bernhard; Martin, Ronny] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, D-07745 Jena, Germany; [de Groot, Piet W. J.; Klis, Frans M.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1090 GB Amsterdam, Netherlands; [Harris, David; Lennard, Nicola; Quail, Michael A.; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Hoyer, Lois L.] Univ Illinois, Dept Pathobiol, Urbana, IL 61802 USA; [Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Quinn, Janet] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Silverstein, Kevin A. T.; Staggs, Rodney] Univ Minnesota, Mason Canc Ctr, Biostat & Bioinformat Grp, Minneapolis, MN 55455 USA; [Soll, David; Srikantha, Thyagarajan] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Sudbery, Peter E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Lorenz, Michael C.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University College Dublin; Massachusetts Institute of Technology (MIT); Universidade de Aveiro; Universidade de Aveiro; University of Aberdeen; Boston University; University of Minnesota System; University of Minnesota Twin Cities; Duke University; Imperial College London; Stanford University; University of Exeter; Hans Knoll Institute (HKI); University of Amsterdam; Wellcome Trust Sanger Institute; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Newcastle University - UK; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Sheffield; University of Texas System; University of Texas Health Science Center Houston	Cuomo, CA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	geraldine.butler@ucd.ie; manoli@mit.edu; cuomo@broad.mit.edu	Santos, Manuel/E-6704-2010; Santos, Conceição/ABE-6172-2020; Berman, Judith/ABA-8528-2021; Heitman, Joseph/ABC-6006-2021; Klis, Frans M/B-9085-2008; Munro, Carol A/A-5175-2011; santos, conceição/GQQ-7378-2022; Kellis, Manolis/ABE-7385-2020; Quail, michael/ABE-6131-2020; dos Santos, Maria/B-7426-2012; Cuomo, Christina/L-2222-2019; Brunke, Sascha/G-1486-2012; Berman, Judith/AAS-5115-2021; Zeng, Qiandong/AAF-3305-2019; Brown, Alistair J.P./B-6627-2014; De Groot, Piet/L-7737-2014; Berriman, Matthew/A-7618-2011; GOW, Neil/AAS-5323-2021; Sherlock, Gavin J/E-9110-2012; Quinn, Janet/AAR-9957-2021; Hoyer, Lois/G-2004-2015	Santos, Manuel/0000-0002-0437-1146; Santos, Conceição/0000-0003-4129-6381; Berman, Judith/0000-0002-8577-0084; Klis, Frans M/0000-0003-0079-9492; Kellis, Manolis/0000-0001-7113-9630; Cuomo, Christina/0000-0002-5778-960X; Brunke, Sascha/0000-0001-7740-4570; De Groot, Piet/0000-0002-3112-6947; Berriman, Matthew/0000-0002-9581-0377; GOW, Neil/0000-0002-2776-5850; Agrafioti, Ino/0000-0002-6374-2322; Neiman, Aaron/0000-0002-6600-6996; Bates, Steven/0000-0003-0489-5705; Hoyer, Lois/0000-0002-0827-4984; Nikolaou, Elissavet/0000-0003-4797-4710; Brown, Alistair JP/0000-0003-1406-4251; Hube, Bernhard/0000-0002-6028-0425; Munro, Carol/0000-0003-0761-1755; Sherlock, Gavin/0000-0002-1692-4983; Grabherr, Manfred/0000-0001-8792-6508; Lorenz, Michael/0000-0002-7881-8027; Quinn, Janet/0000-0002-8732-7676; Fitzpatrick, David/0000-0001-7345-6998; Butler, Geraldine/0000-0002-1770-5301	US National Human Genome Research Institute (NHGRI); Fungal Genome Initiative at the Broad Institute; Wellcome Trust; NHGRI; National Institute of Allergy and Infectious Disease; US National Institutes of Health (NIH); Department of Health and Human Services; Science Foundation Ireland; NIH; US National Science Foundation; Sloan Foundation; Biotechnology and Biological Sciences Research Council [BB/F00513X/1, BB/F013566/1, BB/F007892/1] Funding Source: researchfish; Medical Research Council [G0400284] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075096, R01AI050113] Funding Source: NIH RePORTER; BBSRC [BB/F013566/1, BB/F00513X/1, BB/F007892/1] Funding Source: UKRI; MRC [G0400284] Funding Source: UKRI	US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Fungal Genome Initiative at the Broad Institute; Wellcome Trust(Wellcome TrustEuropean Commission); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the US National Human Genome Research Institute (NHGRI) for support under the Fungal Genome Initiative at the Broad Institute. We thank C. Kurtzman for providing the sequenced strains of L. elongisporus, C. guilliermondii and C. lusitaniae, M. Koehrsen for Broad Institute website support, D. Park for informatics support and K. Wolfe and A. Regev for comments on the manuscript. We acknowledge the contributions of the Broad Institute Sequencing Platform and A. Barron, L. Clark, C. Corton, D. Ormond, D. Saunders, K. Seeger and R. Squares from the Wellcome Trust Sanger Institute for the C. parapsilosis sequencing and assembly. N. A. R. G., A. J. P. B., M. B. and co-workers were supported by the Wellcome Trust; M. G., S. S., Q. Z., C. K., B. W. B. and C. A. C. were supported by NHGRI and the National Institute of Allergy and Infectious Disease, US National Institutes of Health (NIH), Department of Health and Human Services; G. B. and co-workers were supported by Science Foundation Ireland; J. B., A. F., J. H., A. M. N. and co- workers were supported by the NIH; and M. K., M. D. R. and M. F. L. by the NIH, the US National Science Foundation and the Sloan Foundation.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Bates S, 2007, INFECT IMMUN, V75, P2922, DOI 10.1128/IAI.00102-07; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Chau AS, 2005, ANTIMICROB AGENTS CH, V49, P3646, DOI 10.1128/AAC.49.9.3646-3651.2005; CHU WS, 1993, J BACTERIOL, V175, P6637, DOI 10.1128/jb.175.20.6637-6651.1993; Daniels KJ, 2006, EMBO J, V25, P2240, DOI 10.1038/sj.emboj.7601099; de los Santos T, 2003, GENETICS, V164, P81; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Forche A, 2004, EUKARYOT CELL, V3, P705, DOI 10.1128/EC.3.3.705-714.2004; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Legrand M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040001; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Lockhart SR, 2002, GENETICS, V162, P737; Logue ME, 2005, EUKARYOT CELL, V4, P1009, DOI 10.1128/EC.4.6.1009-1017.2005; Massey SE, 2003, GENOME RES, V13, P544, DOI 10.1101/gr.811003; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Noble SM, 2007, ANNU REV GENET, V41, P193, DOI 10.1146/annurev.genet.41.042007.170146; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; SLUTSKY B, 1985, SCIENCE, V230, P666, DOI 10.1126/science.3901258; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tzung KW, 2001, P NATL ACAD SCI USA, V98, P3249, DOI 10.1073/pnas.061628798; van het Hoog M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r52; VANDERWA.JP, 1966, ANTON VAN LEE J M S, V32, P1; VANDERWALT JP, 1977, A VAN LEEUW J MICROB, V43, P205, DOI 10.1007/BF00395675; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0; Zhang J, 1997, DIAGN MICR INFEC DIS, V27, P63, DOI 10.1016/S0732-8893(97)00002-3; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	40	727	1448	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					657	662		10.1038/nature08064	http://dx.doi.org/10.1038/nature08064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19465905	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000266608600034
J	Rehman, HU				Rehman, H. U.			Case report Persistently raised alkaline phosphatase in a woman with osteomalacia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADULT CELIAC-DISEASE; TRANSGLUTAMINASE ANTIBODIES; LIVER; DIAGNOSIS		Regina QuAppelle Hlth Reg, Dept Gen Internal Med, Regina, SK S4P 0W5, Canada		Rehman, HU (corresponding author), Regina QuAppelle Hlth Reg, Dept Gen Internal Med, Regina, SK S4P 0W5, Canada.	habib31@sasktel.net						Bernstein CN, 2003, EUR J GASTROEN HEPAT, V15, P857, DOI 10.1097/00042737-200308000-00004; Bode S, 1996, SCAND J GASTROENTERO, V31, P54, DOI 10.3109/00365529609031627; Collin P, 2005, EUR J GASTROEN HEPAT, V17, P85, DOI 10.1097/00042737-200501000-00017; Dickey W, 2000, AM J GASTROENTEROL, V95, P712, DOI 10.1111/j.1572-0241.2000.01838.x; DICKEY W, 1995, J CLIN GASTROENTEROL, V20, P290, DOI 10.1097/00004836-199506000-00006; Fasano A, 2003, NEW ENGL J MED, V348, P2568, DOI 10.1056/NEJMe030050; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; FISHMAN WH, 1990, CLIN BIOCHEM, V23, P99, DOI 10.1016/0009-9120(90)80019-F; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hopper AD, 2007, BRIT MED J, V335, P558, DOI 10.1136/bmj.39316.442338.AD; JODL J, 1977, ACTA U CAROL MED, V78, P65; Kaukinen K, 2002, EUR J GASTROEN HEPAT, V14, P311, DOI 10.1097/00042737-200203000-00017; Lo WS, 2003, DIGEST DIS SCI, V48, P395, DOI 10.1023/A:1021956200382; Minuk GY, 1998, CAN J GASTROENTEROL, V12, P417, DOI 10.1155/1998/943498; Rubio-Tapia A, 2007, HEPATOLOGY, V46, P1650, DOI 10.1002/hep.21949	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2009	338								b1874	10.1136/bmj.b1874	http://dx.doi.org/10.1136/bmj.b1874			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AG	19493950				2022-12-28	WOS:000266726300005
J	Roehr, B				Roehr, Bob			US health reform: Obama's top priority	BRITISH MEDICAL JOURNAL			English	Editorial Material												bobroehr@aol.com							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2009	338								b2143	10.1136/bmj.b2143	http://dx.doi.org/10.1136/bmj.b2143			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AG	19493923				2022-12-28	WOS:000266726300010
J	Sowers, JR; Whaley-Connell, A; Epstein, M				Sowers, James R.; Whaley-Connell, Adam; Epstein, Murray			Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension	ANNALS OF INTERNAL MEDICINE			English	Review							PLASMA-RENIN ACTIVITY; BLOOD-PRESSURE; MINERALOCORTICOID RECEPTOR; CARDIOVASCULAR-DISEASE; INSULIN SENSITIVITY; RENAL-DISEASE; OBESITY; ASSOCIATION; BLOCKADE; SECRETION	The prevalence of obesity, diabetes, hypertension, and cardiovascular and chronic kidney disease is increasing in developed countries. Obesity, insulin resistance, and hypertension commonly cluster with other risk factors for cardiovascular and chronic kidney disease to form the metabolic syndrome. Emerging evidence supports a paradigm shift in our understanding of the renin-angiotensin-aldosterone system and in aldosterone's ability to promote insulin resistance and participate in the pathogenesis of the metabolic syndrome and resistant hypertension. Recent data suggest that excess circulating aldosterone promotes the development of both disorders by impairing insulin metabolic signaling and endothelial function, which in turn leads to insulin resistance and cardiovascular and renal structural and functional abnormalities. Indeed, hyperaldosteronism is associated with impaired pancreatic beta-cell function, skeletal muscle insulin sensitivity, and elevated production of proinflammatory adipokines from adipose tissue, which results in systemic inflammation and impaired glucose tolerance. Accumulating evidence indicates that the cardiovascular and renal abnormalities associated with insulin resistance are mediated in part by aldosterone acting on the mineralocorticoid receptor. Although we have known that mineralocorticoid receptor blockade attenuates cardiovascular and renal injury, only recently have we learned that mineralocorticoid receptor blockade improves pancreatic insulin release, insulin-mediated glucose utilization, and endothelium-dependent vasorelaxation. In summary, aldosterone excess has detrimental metabolic effects that contribute to the metabolic syndrome and endothelial dysfunction, which in turn contribute to the development of resistant hypertension as well as cardiovascular disease and chronic kidney disease.	[Epstein, Murray] Univ Miami, Sch Med, Vet Affairs Med Ctr, Nephrol Sect, Miami, FL 33125 USA; Univ Missouri, Columbia, MO USA; Harry S Truman & Miami Vet Affairs Med Ctr, Miami, FL USA	University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Missouri System; University of Missouri Columbia	Epstein, M (corresponding author), Univ Miami, Sch Med, Vet Affairs Med Ctr, Nephrol Sect, 1201 NW 16th St, Miami, FL 33125 USA.	murraye@gate.net		Whaley-Connell, Adam/0000-0001-8955-5560	National Institutes of Health [R01 HL73101-01A1]; Department of Veterans Affairs [VISN-15]; National Kidney Foundation; Missouri Kidney Program; South Florida Veterans Affairs Foundation for Research and Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Kidney Foundation; Missouri Kidney Program; South Florida Veterans Affairs Foundation for Research and Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the National Institutes of Health (grant R01 HL73101-01A1 NIH/NHLBI) and the Department of Veterans Affairs (Merit Review) (Dr. Sowers); the Department of Veterans Affairs VISN-15, National Kidney Foundation, and the Missouri Kidney Program (Dr. Whaley-Connell) and the South Florida Veterans Affairs Foundation for Research and Education (Dr. Epstein).	Bochud M, 2006, HYPERTENSION, V48, P239, DOI 10.1161/01.HYP.0000231338.41548.fc; Bomback AS, 2008, KIDNEY INT, V74, P1216, DOI 10.1038/ki.2008.429; Brown NJ, 2008, HYPERTENSION, V51, P161, DOI 10.1161/HYPERTENSIONAHA.107.095489; Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Catena C, 2006, J CLIN ENDOCR METAB, V91, P3457, DOI 10.1210/jc.2006-0736; CONN JW, 1965, NEW ENGL J MED, V273, P1135, DOI 10.1056/NEJM196511182732106; Cooper SA, 2007, AM J PHYSIOL-HEART C, V293, pH2009, DOI 10.1152/ajpheart.00522.2007; Dall'Asta C, 2009, NUTR METAB CARDIOVAS, V19, P110, DOI 10.1016/j.numecd.2008.06.001; DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650; Ehrhart-Bornstein M, 2004, ENDOCR RES, V30, P865, DOI 10.1081/ERC-200044122; Ehrhart-Bornstein M, 2003, P NATL ACAD SCI USA, V100, P14211, DOI 10.1073/pnas.2336140100; Eide IK, 2004, J HYPERTENS, V22, P2217, DOI 10.1097/00004872-200411000-00026; Epstein M, 2006, CLIN J AM SOC NEPHRO, V1, P940, DOI 10.2215/CJN.00240106; Epstein M, 2006, AM J MED, V119, P912, DOI 10.1016/j.amjmed.2006.03.038; Fallo F, 2006, J CLIN ENDOCR METAB, V91, P454, DOI 10.1210/jc.2005-1733; Fallo F, 2007, AM J HYPERTENS, V20, P855, DOI 10.1016/j.amjhyper.2007.03.012; Fletcher EC, 2002, J APPL PHYSIOL, V92, P627, DOI 10.1152/japplphysiol.00152.2001; Freel EM, 2007, CLIN ENDOCRINOL, V67, P832, DOI 10.1111/j.1365-2265.2007.02971.x; Gaddam KK, 2008, ARCH INTERN MED, V168, P1159, DOI 10.1001/archinte.168.11.1159; Gallay BJ, 2001, AM J KIDNEY DIS, V37, P699, DOI 10.1016/S0272-6386(01)80117-7; Giacchetti G, 2007, J HYPERTENS, V25, P177, DOI 10.1097/HJH.0b013e3280108e6f; Goodfriend TL, 2007, HYPERTENSION, V49, P763, DOI 10.1161/01.HYP.0000259806.91169.01; Goodfriend TL, 2004, HYPERTENSION, V43, P358, DOI 10.1161/01.HYP.0000113294.06704.64; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Hayden Melvin R, 2008, J Cardiometab Syndr, V3, P129, DOI 10.1111/j.1559-4572.2008.00006.x; Hitomi H, 2007, HYPERTENSION, V50, P750, DOI 10.1161/HYPERTENSIONAHA.107.093955; Kidambi S, 2007, HYPERTENSION, V49, P704, DOI 10.1161/01.HYP.0000253258.36141.c7; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Lamounier-Zepter V, 2006, CURR HYPERTENS REP, V8, P30, DOI 10.1007/s11906-006-0038-3; Lastra G, 2008, AM J PHYSIOL-ENDOC M, V295, pE110, DOI 10.1152/ajpendo.00258.2007; Liu SL, 2003, CIRCULATION, V108, P2400, DOI 10.1161/01.CIR.0000093188.53554.44; Makhanova N, 2008, HYPERTENSION, V51, P134, DOI 10.1161/HYPERTENSIONAHA.107.098897; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Manrique Camila, 2005, J Clin Hypertens (Greenwich), V7, P471, DOI 10.1111/j.1524-6175.2005.04617.x; Min LJ, 2007, CARDIOVASC RES, V76, P506, DOI 10.1016/j.cardiores.2007.07.008; Mosso LM, 2007, J HYPERTENS, V25, P2125, DOI 10.1097/HJH.0b013e3282861fa4; Nagase M, 2006, J AM SOC NEPHROL, V17, P3438, DOI 10.1681/ASN.2006080944; Pimenta E, 2008, HYPERTENSION, V51, P339, DOI 10.1161/HYPERTENSIONAHA.107.100701; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; RONDINONE CM, 1993, ENDOCRINOLOGY, V132, P2421, DOI 10.1210/en.132.6.2421; Schiffrin EL, 2006, HYPERTENSION, V47, P312, DOI 10.1161/01.HYP.0000201443.63240.a7; SIMPSON SA, 1954, EXPERIENTIA, V10, P132, DOI 10.1007/BF02158515; Sowers JR, 2007, KIDNEY INT, V71, P719, DOI 10.1038/sj.ki.5002006; Stas S, 2007, ENDOCRINOLOGY, V148, P3773, DOI 10.1210/en.2006-1691; Stowasser M, 2007, HYPERTENSION, V49, P761, DOI 10.1161/01.HYP.0000260141.30703.0c; Strauch B, 2003, J HUM HYPERTENS, V17, P349, DOI 10.1038/sj.jhh.1001554; TUCK ML, 1981, NEW ENGL J MED, V304, P930, DOI 10.1056/NEJM198104163041602; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; WEHLING M, 1992, AM J PHYSIOL, V263, pE974, DOI 10.1152/ajpendo.1992.263.5.E974; Wei YZ, 2009, HYPERTENSION, V53, P158, DOI 10.1161/HYPERTENSIONAHA.108.121954; WHALEYCONNELL A, 2009, AM J PHYSL IN PRESS; Williams JS, 2003, J CLIN ENDOCR METAB, V88, P2364, DOI 10.1210/jc.2003-030490	56	270	287	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					776	W138		10.7326/0003-4819-150-11-200906020-00005	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487712	Green Accepted			2022-12-28	WOS:000266530000004
J	Kaneko, T; Hamazaki, J; Iemura, S; Sasaki, K; Furuyama, K; Natsume, T; Tanaka, K; Murata, S				Kaneko, Takeumi; Hamazaki, Jun; Iemura, Shun-ichiro; Sasaki, Katsuhiro; Furuyama, Kaori; Natsume, Tohru; Tanaka, Keiji; Murata, Shigeo			Assembly Pathway of the Mammalian Proteasome Base Subcomplex Is Mediated by Multiple Specific Chaperones	CELL			English	Article							19S REGULATORY PARTICLE; 26 S-PROTEASOME; DEUBIQUITINATING ENZYME; UBIQUITIN SYSTEM; 20S PROTEASOMES; CDNA CLONING; PROTEIN; DEGRADATION; EXPRESSION; GANKYRIN	The 26S proteasome is an enzymatic complex that degrades ubiquitinated proteins in eukaryotic cells. It is composed of the 20S core particle (CP) and the 19S regulatory particle (RP). The latter is further divided into the lid and base subcomplexes. While the mechanism involved in the assembly of the CP is well investigated, that of the RP is poorly understood. Here, we show that the formation of the mammalian base subcomplex involves three distinct modules, where specific pairs of ATPase subunits are associated with the distinct chaperones p28, S5b, or p27. The process of base formation starts from association of the p28-Rpt3-Rpt6-Rpn14 complex with the S5b-Rpt1-Rpt2-Rpn1 complex, followed by incorporation of the p27-Rpt5-Rpt4 complex and Rpn2, where p28, S5b, and p27 regulate the associations between the modules. These chaperones dissociate before completion of 26S proteasome formation. Our results demonstrate that base assembly is facilitated by multiple proteasome-dedicated chaperones, like CP assembly.	[Kaneko, Takeumi; Hamazaki, Jun; Furuyama, Kaori; Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Biol Informat Res Ctr, Natl Inst Adv Ind Sci & Technol, Kohtoh Ku, Tokyo 1350064, Japan; [Sasaki, Katsuhiro; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Metropolitan Institute of Medical Science	Murata, S (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	smurata@mol.f.u-tokyo.ac.jp	Natsume, Tohru/M-7627-2018; Murata, Shigeo/A-1426-2010; hamazaki, jun/AAG-4823-2019	Natsume, Tohru/0000-0002-1510-2582; Murata, Shigeo/0000-0002-3177-3503; hamazaki, jun/0000-0002-7145-3424	Ministry of Education, Science, and Culture of Japan; Takeda Science Foundation; Target Protein Project of MEXT; New Energy and Industrial Technology Development Organization	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Target Protein Project of MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan ( MEXT; to S. M. and K. T.), the Takeda Science Foundation ( to S. M. and K. T.), Target Protein Project of MEXT ( to K. T.), and the New Energy and Industrial Technology Development Organization ( to T. N.).	Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hori T, 1998, GENE, V216, P113, DOI 10.1016/S0378-1119(98)00309-6; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Vidal-Taboada JM, 2000, BIOCHEM BIOPH RES CO, V272, P156, DOI 10.1006/bbrc.2000.2726; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wang ZX, 2001, WORLD J GASTROENTERO, V7, P821, DOI 10.3748/wjg.v7.i6.821; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	44	144	151	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					914	925		10.1016/j.cell.2009.05.008	http://dx.doi.org/10.1016/j.cell.2009.05.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490896	Bronze			2022-12-28	WOS:000266454800021
J	Fabian, AC; Zoghbi, A; Ross, RR; Uttley, P; Gallo, LC; Brandt, WN; Blustin, AJ; Boller, T; Caballero-Garcia, MD; Larsson, J; Miller, JM; Miniutti, G; Ponti, G; Reis, RC; Reynolds, CS; Tanaka, Y; Young, AJ				Fabian, A. C.; Zoghbi, A.; Ross, R. R.; Uttley, P.; Gallo, L. C.; Brandt, W. N.; Blustin, A. J.; Boller, T.; Caballero-Garcia, M. D.; Larsson, J.; Miller, J. M.; Miniutti, G.; Ponti, G.; Reis, R. C.; Reynolds, C. S.; Tanaka, Y.; Young, A. J.			Broad line emission from iron K- and L-shell transitions in the active galaxy 1H 0707-495	NATURE			English	Article							X-RAY VARIABILITY; NARROW-LINE; BLACK-HOLE; SEYFERT-1 GALAXY-1H-0707-495; GALACTIC NUCLEI; REFLECTION; DISK; 1H-0707-495; BINARIES; SPECTRA	Since the 1995 discovery of the broad iron K-line emission from the Seyfert galaxy MCG-6-30-15 (ref. 1), broad iron K lines have been found in emission from several other Seyfert galaxies(2), from accreting stellar-mass black holes(3) and even from accreting neutron stars(4). The iron K line is prominent in the reflection spectrum(5,6) created by the hard-X-ray continuum irradiating dense accreting matter. Relativistic distortion(7) of the line makes it sensitive to the strong gravity and spin of the black hole(8). The accompanying iron L-line emission should be detectable when the iron abundance is high. Here we report the presence of both iron K and iron L emission in the spectrum of the narrow-line Seyfert 1 galaxy(9) 1H 0707-495. The bright iron L emission has enabled us to detect a reverberation lag of about 30 s between the direct X-ray continuum and its reflection from matter falling into the black hole. The observed reverberation timescale is comparable to the light-crossing time of the innermost radii around a supermassive black hole. The combination of spectral and timing data on 1H 0707-495 provides strong evidence that we are witnessing emission from matter within a gravitational radius, or a fraction of a light minute, from the event horizon of a rapidly spinning, massive black hole.	[Fabian, A. C.; Zoghbi, A.; Blustin, A. J.; Caballero-Garcia, M. D.; Larsson, J.; Reis, R. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Ross, R. R.] Coll Holy Cross, Dept Phys, Worcester, MA 01610 USA; [Uttley, P.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Gallo, L. C.] St Marys Univ, Dept Phys & Astron, Halifax, NS B3H 3C3, Canada; [Brandt, W. N.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Boller, T.; Tanaka, Y.] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Miller, J. M.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Miniutti, G.] LAEFF, Ctr Astrobiol CSIC INTA, LAEX, E-28691 Madrid, Spain; [Ponti, G.] Lab APC, UMR 7164, F-75205 Paris, France; [Reynolds, C. S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Reynolds, C. S.] Univ Maryland, Ctr Theory & Computat, College Pk, MD 20742 USA; [Young, A. J.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England	University of Cambridge; College of the Holy Cross; University of Southampton; Saint Marys University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Max Planck Society; University of Michigan System; University of Michigan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Bristol	Fabian, AC (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	acf@ast.cam.ac.uk	Zoghbi, Abderahmen/A-8445-2017; Miniutti, Giovanni/L-2721-2014; Caballero-Garcia, Maria D./D-5659-2017; Boller, Thomas/AAT-8934-2021; Brandt, William N/N-2844-2015	Zoghbi, Abderahmen/0000-0002-0572-9613; Miniutti, Giovanni/0000-0003-0707-4531; Caballero-Garcia, Maria D./0000-0001-7920-4564; Brandt, William N/0000-0002-0167-2453; Young, Andrew/0000-0003-3626-9151; Ponti, Gabriele/0000-0003-0293-3608; /0000-0003-0065-2933; reis, rubens/0000-0002-6618-2412; Reynolds, Christopher/0000-0002-1510-4860; Miller, Jon/0000-0003-2869-7682	ESA; USA (NASA); Algerian Higher Education Ministry; UK Science and Technology Facilities Council (STFC); Spanish Ministerio de Ciencia e Innovacion; French National Research Agency; Science and Technology Facilities Council [ST/G002339/1, PP/D00571X/1, PP/D003636/2] Funding Source: researchfish; STFC [ST/G002339/1, PP/D003636/2] Funding Source: UKRI	ESA(European Space Agency); USA (NASA)(National Aeronautics & Space Administration (NASA)); Algerian Higher Education Ministry; UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); French National Research Agency(French National Research Agency (ANR)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	A. C. F. thanks the Royal Society for support. This work is based on observations made with XMM-Newton, a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA member states and the USA (NASA). A. Z. acknowledges the support of the Algerian Higher Education Ministry and the UK Science and Technology Facilities Council (STFC). C. S. R., W. N. B., G. M., G. P. and R. C. R., and A. J. B. acknowledge support from the US National Science Foundation, NASA, the Spanish Ministerio de Ciencia e Innovacion, the French National Research Agency and the UK STFC for support, respectively.	Arevalo P, 2006, MON NOT R ASTRON SOC, V367, P801, DOI 10.1111/j.1365-2966.2006.09989.x; Bian W, 2003, MON NOT R ASTRON SOC, V343, P164, DOI 10.1046/j.1365-8711.2003.06650.x; Boller T, 2002, MON NOT R ASTRON SOC, V329, pL1, DOI 10.1046/j.1365-8711.2002.05040.x; Brenneman LW, 2006, ASTROPHYS J, V652, P1028, DOI 10.1086/508146; Cackett EM, 2008, ASTROPHYS J, V674, P415, DOI 10.1086/524936; Fabian AC, 2004, MON NOT R ASTRON SOC, V353, P1071, DOI 10.1111/j.1365-2966.2004.08036.x; FABIAN AC, 1989, MON NOT R ASTRON SOC, V238, P729, DOI 10.1093/mnras/238.3.729; Gallo LC, 2004, MON NOT R ASTRON SOC, V353, P1064, DOI 10.1111/j.1365-2966.2004.08248.x; Gallo LC, 2006, MON NOT R ASTRON SOC, V368, P479, DOI 10.1111/j.1365-2966.2006.10137.x; GUILBERT PW, 1988, MON NOT R ASTRON SOC, V233, P475, DOI 10.1093/mnras/233.2.475; LAOR A, 1991, ASTROPHYS J, V376, P90, DOI 10.1086/170257; Miller JM, 2007, ANNU REV ASTRON ASTR, V45, P441, DOI 10.1146/annurev.astro.45.051806.110555; Nandra K, 2007, MON NOT R ASTRON SOC, V382, P194, DOI 10.1111/j.1365-2966.2007.12331.x; OSTERBROCK DE, 1985, ASTROPHYS J, V297, P166, DOI 10.1086/163513; ROSS RR, 1993, MON NOT R ASTRON SOC, V261, P74, DOI 10.1093/mnras/261.1.74; Ross RR, 2005, MON NOT R ASTRON SOC, V358, P211, DOI 10.1111/j.1365-2966.2005.08797.x; Shara MM, 2002, ASTROPHYS J, V571, P830, DOI 10.1086/340062; TANAKA Y, 1995, NATURE, V375, P659, DOI 10.1038/375659a0; Tanaka Y, 2004, PUBL ASTRON SOC JPN, V56, pL9, DOI 10.1093/pasj/56.3.L9; Uttley P, 2005, MON NOT R ASTRON SOC, V359, P345, DOI 10.1111/j.1365-2966.2005.08886.x	20	405	409	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					540	542		10.1038/nature08007	http://dx.doi.org/10.1038/nature08007			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478778	Green Accepted			2022-12-28	WOS:000266370500032
J	Hirschfield, GM; Gibbs, P; Griffiths, WJH				Hirschfield, G. M.; Gibbs, P.; Griffiths, W. J. H.			Adult liver transplantation: what non-specialists need to know	BMJ-BRITISH MEDICAL JOURNAL			English	Review							UNITED-KINGDOM; HEPATITIS-C; ALLOCATION; SURVIVAL; IRELAND; OBESITY; IMPACT; DONOR; MODEL		[Hirschfield, G. M.] Univ Toronto, Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Gibbs, P.; Griffiths, W. J. H.] Addenbrookes Hosp, Hepatol & Liver Transplant Serv, Cambridge, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Hirschfield, GM (corresponding author), Univ Toronto, Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada.	gideon.hirschfield@uhn.on.ca	Hirschfield, Gideon M/M-2143-2015	Hirschfield, Gideon M/0000-0002-6736-2255				Brown RS, 2008, GASTROENTEROLOGY, V134, P1802, DOI 10.1053/j.gastro.2008.02.092; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Dawwas MF, 2007, GUT, V56, P1606, DOI 10.1136/gut.2006.111369; Desai R, 2008, LIVER TRANSPLANT, V14, P1473, DOI 10.1002/lt.21561; Everhart JE, 1998, LIVER TRANSPLANT SUR, V4, P285, DOI 10.1002/lt.500040402; FREEMAN RBJ, 2008, LIVER TRANSPLANT, V12, pS128; Freeman RB, 2008, HEPATOLOGY, V47, P1052, DOI 10.1002/hep.22135; Fung JJ, 2001, LIVER TRANSPLANT, V7, pS109, DOI 10.1053/jlts.2001.28645; Gane EJ, 2008, LIVER TRANSPLANT, V14, pS36, DOI 10.1002/lt.21646; Ghobrial RM, 2008, GASTROENTEROLOGY, V135, P468, DOI 10.1053/j.gastro.2008.04.018; Haddad EM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005161; Hodson EM, 2008, COCHRANE DB SYST REV, V2; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Leonard J, 2008, AM J TRANSPLANT, V8, P667, DOI 10.1111/j.1600-6143.2007.02100.x; Lucey MR, 2008, AM J TRANSPLANT, V8, P196, DOI 10.1111/j.1600-6143.2007.02086.x; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; O'Grady JG, 2002, LANCET, V360, P1119, DOI 10.1016/S0140-6736(02)11196-2; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Playford EG, 2006, EUR J CLIN MICROBIOL, V25, P549, DOI 10.1007/s10096-006-0182-3; Pomfret EA, 2007, AM J TRANSPLANT, V7, P1376, DOI 10.1111/j.1600-6143.2007.01782.x; Rosen HR, 2008, GASTROENTEROLOGY, V134, P1789, DOI 10.1053/j.gastro.2008.02.062; Saliba F, 2007, LIVER TRANSPLANT, V13, P136, DOI 10.1002/lt.21010; Samuel D, 2008, J HEPATOL, V48, P697, DOI 10.1016/j.jhep.2008.02.009; Schmeding M, 2007, ANN TRANSPL, V12, P15; Sheiner PA, 2000, TRANSPLANTATION, V69, P781; Srinivasan A, 2005, NEW ENGL J MED, V352, P1103, DOI 10.1056/NEJMoa043018; *TRANSPL UK, UK TRANSPL ACT REP 2; van der Meulen JHP, 2007, TRANSPLANTATION, V84, P572, DOI 10.1097/01.tp.0000280540.76370.37; Yao FY, 2008, HEPATOLOGY, V48, P819, DOI 10.1002/hep.22412	30	9	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2009	338								b1670	10.1136/bmj.b1670	http://dx.doi.org/10.1136/bmj.b1670			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NU	19465469				2022-12-28	WOS:000266270100003
J	Lake, JK; Ostling, A				Lake, Jeffrey K.; Ostling, Annette			Comment on "Functional Traits and Niche-Based Tree Community Assembly in an Amazonian Forest"	SCIENCE			English	Editorial Material							LEAF TRAITS; PLASTICITY; LIGHT	Kraft et al. (Reports, 24 October 2008, p. 580) used a variety of metrics describing the distribution of functional traits within a tropical forest community to demonstrate simultaneous environmental filtering and niche differentiation. We discuss how these results could have arisen from sampling design and statistical assumptions, suggesting alternative approaches that could better resolve these questions.	[Lake, Jeffrey K.; Ostling, Annette] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lake, JK (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Kraus Nat Sci Bldg,830 N Univ, Ann Arbor, MI 48109 USA.	lakejk@umich.edu						GOLDBERG DE, 1983, AM J BOT, V70, P1098, DOI 10.2307/2442821; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; PETERSON CJ, 1995, J ECOL, V83, P449, DOI 10.2307/2261598; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Rozendaal DMA, 2006, FUNCT ECOL, V20, P207, DOI 10.1111/j.1365-2435.2006.01105.x; Sack L, 2006, AM J BOT, V93, P829, DOI 10.3732/ajb.93.6.829	8	16	18	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1015c	U31		10.1126/science.1169721	http://dx.doi.org/10.1126/science.1169721			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460986				2022-12-28	WOS:000266246700019
J	Ziegler, AD; Fox, JM; Xu, JC				Ziegler, Alan D.; Fox, Jefferson M.; Xu, Jianchu			The Rubber Juggernaut	SCIENCE			English	Editorial Material							FOREST		[Ziegler, Alan D.] Natl Univ Singapore, Dept Geog, Singapore 117570, Singapore; [Fox, Jefferson M.] East West Ctr, Honolulu, HI 96848 USA; [Xu, Jianchu] Kunming Inst Bot, World Agroforestry Ctr, Kunming, Peoples R China	National University of Singapore; East West Center; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Ziegler, AD (corresponding author), Natl Univ Singapore, Dept Geog, Singapore 117570, Singapore.	adz@nus.edu.sg	Xu, Jianchu/Y-2890-2019; , dr dr/AAA-5406-2022; ZIEGLER, ALAN/A-5463-2012	ZIEGLER, ALAN/0000-0001-5305-2136; Fox, Jefferson/0000-0002-0508-654X				Cyranoski D, 2008, NATURE, V451, P871, DOI 10.1038/451871a; Douglas I, 2006, GEOGR RES-AUST, V44, P123, DOI 10.1111/j.1745-5871.2006.00373.x; Forsyth Tim, 2008, FOREST GUARDIANS FOR; Fox J, 2000, BIOSCIENCE, V50, P521, DOI 10.1641/0006-3568(2000)050[0521:SCANOP]2.0.CO;2; Guardiola-Claramonte M, 2008, ECOHYDROLOGY, V1, P13, DOI 10.1002/eco.3; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Li HM, 2008, FOREST ECOL MANAG, V255, P16, DOI 10.1016/j.foreco.2007.06.051; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Manivong V, 2008, AGROFOREST SYST, V74, P113, DOI 10.1007/s10457-008-9136-3; McMorrow J, 2001, GLOBAL ENVIRON CHANG, V11, P217, DOI 10.1016/S0959-3780(00)00059-5; Padoch C, 2007, GEOGR TIDSSKR-DEN, V107, P29, DOI 10.1080/00167223.2007.10801373; Qiu J, 2009, NATURE, V457, P246, DOI 10.1038/457246a; Schmidt-Vogt D., 2001, Journal of Tropical Forest Science, V13, P748; Sidle RC, 2006, FOREST ECOL MANAG, V224, P199, DOI 10.1016/j.foreco.2005.12.019	14	297	329	9	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1024	1025		10.1126/science.1173833	http://dx.doi.org/10.1126/science.1173833			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460994				2022-12-28	WOS:000266246700027
J	Jaramillo, R; Feng, YJ; Lang, JC; Islam, Z; Srajer, G; Littlewood, PB; McWhan, DB; Rosenbaum, TF				Jaramillo, R.; Feng, Yejun; Lang, J. C.; Islam, Z.; Srajer, G.; Littlewood, P. B.; McWhan, D. B.; Rosenbaum, T. F.			Breakdown of the Bardeen-Cooper-Schrieffer ground state at a quantum phase transition	NATURE			English	Article							SPIN-DENSITY WAVES; X-RAY-SCATTERING; ITINERANT ANTIFERROMAGNETISM; CHROMIUM; SUPERCONDUCTIVITY; CHARGE; TEMPERATURE; CRITICALITY; DEPENDENCE; GAS	Advances in solid-state and atomic physics are exposing the hidden relationships between conventional and exotic states of quantum matter. Prominent examples include the discovery of exotic superconductivity proximate to conventional spin and charge order(1,2), and the crossover from long-range phase order to preformed pairs achieved in gases of cold fermions(3-5) and inferred for copper oxide superconductors(5). The unifying theme is that incompatible ground states can be connected by quantum phase transitions. Quantum fluctuations about the transition are manifestations of the competition between qualitatively distinct organizing principles(6,7), such as a long-wavelength density wave and a short-coherence-length condensate. They may even give rise to 'protected' phases, like fluctuation-mediated superconductivity that survives only in the vicinity of an antiferromagnetic quantum critical point(8,9). However, few model systems that demonstrate continuous quantum phase transitions have been identified, and the complex nature of many systems of interest hinders efforts to more fully understand correlations and fluctuations near a zero-temperature instability. Here we report the suppression of magnetism by hydrostatic pressure in elemental chromium, a simple cubic metal that demonstrates a subtle form of itinerant antiferromagnetism(10-16) formally equivalent to the Bardeen-Cooper-Schrieffer (BCS) state in conventional superconductors. By directly measuring the associated charge order in a diamond anvil cell at low temperatures, we find a phase transition at pressures of similar to 10 GPa driven by fluctuations that destroy the BCS-like state but preserve the strong magnetic interaction between itinerant electrons and holes. Chromium is unique among stoichiometric magnetic metals studied so far in that the quantum phase transition is continuous, allowing experimental access to the quantum singularity and a direct probe of the competition between conventional and exotic order in a theoretically tractable material.	[Jaramillo, R.; Feng, Yejun; Rosenbaum, T. F.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Jaramillo, R.; Feng, Yejun; Rosenbaum, T. F.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Feng, Yejun; Lang, J. C.; Islam, Z.; Srajer, G.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Littlewood, P. B.] Univ Cambridge, Cavendish Lab, Cambridge CB3 OHE, England; [McWhan, D. B.] MIT, Dept Phys, Cambridge, MA 02139 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Cambridge; Massachusetts Institute of Technology (MIT)	Rosenbaum, TF (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	tfr@uchicago.edu	Feng, Yejun/A-5417-2009; Littlewood, Peter B/B-7746-2008; Littlewood, Peter/M-4960-2019	Feng, Yejun/0000-0003-3667-056X; /0000-0003-3116-6719	US National Science Foundation (NSF) Division of Materials Research; US NSF Earth Sciences; Department of Energy (DOE) Geosciences; US DOE Office of Basic Energy Sciences	US National Science Foundation (NSF) Division of Materials Research(National Science Foundation (NSF)); US NSF Earth Sciences(National Science Foundation (NSF)); Department of Energy (DOE) Geosciences(United States Department of Energy (DOE)); US DOE Office of Basic Energy Sciences(United States Department of Energy (DOE))	We are grateful to J. Pluth for assistance with sample preparation, V. Prakapenka and GeoSoilEnviroCARS (Advanced Photon Source (APS), Argonne National Laboratory) for technical support and G. Aeppli for many discussions. The work at the University of Chicago was supported by the US National Science Foundation (NSF) Division of Materials Research. GeoSoilEnviroCARS is supported by the US NSF Earth Sciences and Department of Energy (DOE) Geosciences. Use of APS is supported by the US DOE Office of Basic Energy Sciences.	Broun DM, 2008, NAT PHYS, V4, P170, DOI 10.1038/nphys909; Chen QJ, 2005, PHYS REP, V412, P1, DOI 10.1016/j.physrep.2005.02.005; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; DELAND SM, 1991, PHYS REV LETT, V66, P2026, DOI 10.1103/PhysRevLett.66.2026; FAWCETT E, 1988, REV MOD PHYS, V60, P209, DOI 10.1103/RevModPhys.60.209; Feng Y, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1938954; Feng Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137201; Gegenwart P, 2007, SCIENCE, V315, P969, DOI 10.1126/science.1136020; Giamarchi T, 2008, NAT PHYS, V4, P198, DOI 10.1038/nphys893; HILL JP, 1995, PHYS REV B, V51, P10336, DOI 10.1103/PhysRevB.51.10336; Jaramillo R, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184418; Lee M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187201; MCWHAN DB, 1967, PHYS REV LETT, V19, P846, DOI 10.1103/PhysRevLett.19.846; Morosan E, 2006, NAT PHYS, V2, P544, DOI 10.1038/nphys360; Nagaosa N, 1997, SCIENCE, V275, P1078, DOI 10.1126/science.275.5303.1078; OVERHAUSER AW, 1962, PHYS REV, V128, P1437, DOI 10.1103/PhysRev.128.1437; Pfleiderer C, 2005, J PHYS-CONDENS MAT, V17, pS987, DOI 10.1088/0953-8984/17/11/031; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Rice TM, 1970, PHYS REV B-SOLID ST, V2, P3619, DOI 10.1103/PhysRevB.2.3619; RICE TM, 1969, J APPL PHYS, V40, P1337, DOI 10.1063/1.1657663; Sachdev S, 2000, SCIENCE, V288, P475, DOI 10.1126/science.288.5465.475; Schroder A, 1998, PHYS REV LETT, V80, P5623, DOI 10.1103/PhysRevLett.80.5623; Sokolov DA, 2008, PHYSICA B, V403, P1276, DOI 10.1016/j.physb.2007.10.125; Strempfer J, 2000, EUR PHYS J B, V14, P63, DOI 10.1007/s100510050107; SWEETLAND E, 1990, PHYS REV LETT, V65, P3165, DOI 10.1103/PhysRevLett.65.3165; WERNER SA, 1967, PHYS REV, V155, P528, DOI 10.1103/PhysRev.155.528; Yeh A, 2002, NATURE, V419, P459, DOI 10.1038/nature01044; YOUNG CY, 1974, J PHYS F MET PHYS, V4, P1304, DOI 10.1088/0305-4608/4/8/023	30	40	40	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					405	409		10.1038/nature08008	http://dx.doi.org/10.1038/nature08008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458718				2022-12-28	WOS:000266243700041
J	White, SH				White, Stephen H.			Biophysical dissection of membrane proteins	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; CRYSTAL-STRUCTURE; MECHANISM; BACTERIORHODOPSIN; EVOLUTION; TRANSPORT; DYNAMICS; INSIGHTS; REVEALS; MODEL	The first atomic-resolution structure of a membrane protein was solved in 1985. Twenty-four years and more than 180 unique structures later, what have we have learned? An examination of the atomic details of several diverse membrane proteins reveals some remarkable biophysical features and suggests that we can expect to achieve much more in the decades to come.	[White, Stephen H.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [White, Stephen H.] Univ Calif Irvine, Ctr Biomembrane Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	White, SH (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	stephen.white@uci.edu	White, Stephen H/B-1053-2009; White, Stephen/N-1507-2019	White, Stephen H/0000-0001-8540-7907; 	National Institute of General Medical Science; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM086685] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institute of General Medical Science and the National Institute of Neurological Disorders and Stroke.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; LENARD J, 1966, P NATL ACAD SCI USA, V56, P1828, DOI 10.1073/pnas.56.6.1828; Lindahl E, 2008, CURR OPIN STRUC BIOL, V18, P425, DOI 10.1016/j.sbi.2008.02.003; MADDY AH, 1965, SCIENCE, V150, P1616, DOI 10.1126/science.150.3703.1616; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Oliveira L, 2004, FEBS LETT, V564, P269, DOI 10.1016/S0014-5793(04)00320-5; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARDO L, 1992, P NATL ACAD SCI USA, V89, P4009, DOI 10.1073/pnas.89.9.4009; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	50	208	214	4	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					344	346		10.1038/nature08142	http://dx.doi.org/10.1038/nature08142			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458709				2022-12-28	WOS:000266243700031
J	Zijlstra, P; Chon, JWM; Gu, M				Zijlstra, Peter; Chon, James W. M.; Gu, Min			Five-dimensional optical recording mediated by surface plasmons in gold nanorods	NATURE			English	Article							DATA-STORAGE; NANOCOMPOSITE	Multiplexed optical recording provides an unparalleled approach to increasing the information density beyond 10(12) bits per cm(3) (1 Tbit cm(-3)) by storing multiple, individually addressable patterns within the same recording volume. Although wavelength(1-3), polarization(4-8) and spatial dimensions(9-13) have all been exploited for multiplexing, these approaches have never been integrated into a single technique that could ultimately increase the information capacity by orders of magnitude. The major hurdle is the lack of a suitable recording medium that is extremely selective in the domains of wavelength and polarization and in the three spatial domains, so as to provide orthogonality in all five dimensions. Here we show true five-dimensional optical recording by exploiting the unique properties of the longitudinal surface plasmon resonance (SPR) of gold nanorods. The longitudinal SPR exhibits an excellent wavelength and polarization sensitivity, whereas the distinct energy threshold required for the photothermal recording mechanism provides the axial selectivity. The recordings were detected using longitudinal SPR-mediated two-photon luminescence, which we demonstrate to possess an enhanced wavelength and angular selectivity compared to conventional linear detection mechanisms. Combined with the high cross-section of two-photon luminescence, this enabled non-destructive, crosstalk-free readout. This technique can be immediately applied to optical patterning, encryption and data storage, where higher data densities are pursued.	[Zijlstra, Peter; Chon, James W. M.; Gu, Min] Swinburne Univ Technol, Fac Engn & Ind Sci, Ctr Micro Photon, Hawthorn, Vic 3122, Australia	Swinburne University of Technology	Chon, JWM (corresponding author), Swinburne Univ Technol, Fac Engn & Ind Sci, Ctr Micro Photon, POB 218, Hawthorn, Vic 3122, Australia.	JChon@groupwise.swin.edu.au	Gu, Min/B-6627-2008; Chon, James/M-3400-2015; Zijlstra, Peter/A-7512-2010	Chon, James/0000-0002-3813-3744; Zijlstra, Peter/0000-0001-9804-2265	Australian Research Council	Australian Research Council(Australian Research Council)	We acknowledge the LINTEC Corporation for supplying the pressure-sensitive adhesive and the Australian Research Council for financial support. We thank R. Evans, W. Rowlands and D. Buso for carefully reading the manuscript.	Alasfar S, 1999, APPL OPTICS, V38, P6201, DOI 10.1364/AO.38.006201; Bouhelier A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.267405; Chang SS, 1999, LANGMUIR, V15, P701, DOI 10.1021/la980929l; Chon JWM, 2007, ADV FUNCT MATER, V17, P875, DOI 10.1002/adfm.200600565; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; Day D, 2001, ADV MATER, V13, P1005, DOI 10.1002/1521-4095(200107)13:12/13<1005::AID-ADMA1005>3.0.CO;2-7; Ditlbacher H, 2000, OPT LETT, V25, P563, DOI 10.1364/OL.25.000563; Dulkeith E, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205424; Habenicht A, 2005, SCIENCE, V309, P2043, DOI 10.1126/science.1116505; HEANUE JF, 1994, SCIENCE, V265, P749, DOI 10.1126/science.265.5173.749; Kawata S, 2000, CHEM REV, V100, P1777, DOI 10.1021/cr980073p; Li XP, 2007, OPT LETT, V32, P277, DOI 10.1364/OL.32.000277; Link S, 2000, J PHYS CHEM B, V104, P6152, DOI 10.1021/jp000679t; Moerner W. E., 1988, PERSISTENT SPECTRAL; Mohamed MB, 2000, CHEM PHYS LETT, V317, P517, DOI 10.1016/S0009-2614(99)01414-1; MOORADIAN A, 1969, PHYS REV LETT, V22, P185, DOI 10.1103/PhysRevLett.22.185; Niidome Y, 2003, JPN J APPL PHYS 1, V42, P1749, DOI 10.1143/JJAP.42.1749; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Novo C, 2006, PHYS CHEM CHEM PHYS, V8, P3540, DOI 10.1039/b604856k; Perez-Juste J, 2005, ADV FUNCT MATER, V15, P1065, DOI 10.1002/adfm.200400591; Pham HH, 2004, ADV MATER, V16, P516, DOI 10.1002/adma.200306156; Ramakrishna G, 2008, J AM CHEM SOC, V130, P5032, DOI 10.1021/ja800341v; Sonnichsen C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077402; STRICKLER JH, 1991, OPT LETT, V16, P1780, DOI 10.1364/OL.16.001780; TANAKA T, 2007, INT S OPT MEM; Wang HF, 2005, P NATL ACAD SCI USA, V102, P15752, DOI 10.1073/pnas.0504892102; Wilson O, 2002, ADV MATER, V14, P1000, DOI 10.1002/1521-4095(20020704)14:13/14<1000::AID-ADMA1000>3.0.CO;2-H; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Zijlstra P, 2007, OPT EXPRESS, V15, P12151, DOI 10.1364/OE.15.012151; Zijlstra P, 2006, J PHYS CHEM B, V110, P19315, DOI 10.1021/jp0635866	30	955	994	20	599	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					410	413		10.1038/nature08053	http://dx.doi.org/10.1038/nature08053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458719				2022-12-28	WOS:000266243700042
J	Detsky, AS				Detsky, Allan S.			My Father's Voice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												adetsky@mtsinai.on.ca							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					1968	1969		10.1001/jama.2009.601	http://dx.doi.org/10.1001/jama.2009.601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454627				2022-12-28	WOS:000266159600001
J	Elley, CR; Kenealy, T				Elley, C. Raina; Kenealy, Tim			Intensive primary care treatment reduced cardiovascular risk factors at 1 year in screen-detected type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Elley, C. Raina; Kenealy, Tim] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Elley, CR (corresponding author), Univ Auckland, Auckland 1, New Zealand.							Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Janssen PGH, 2009, BRIT J GEN PRACT, V59, P43, DOI 10.3399/bjgp09X394851; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-9	10.7326/0003-4819-150-10-200905190-02009	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451565				2022-12-28	WOS:000266285300029
J	Rabkin, SW				Rabkin, Simon W.			Benazepril plus amlodipine reduced cardiovascular risk more than benazepril plus hydrochlorothiazide	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Rabkin, SW (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.							Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-8	10.7326/0003-4819-150-10-200905190-02008	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451564				2022-12-28	WOS:000266285300028
J	Bamber, JL; Riva, REM; Vermeersen, BLA; LeBrocq, AM				Bamber, Jonathan L.; Riva, Riccardo E. M.; Vermeersen, Bert L. A.; LeBrocq, Anne M.			Reassessment of the Potential Sea-Level Rise from a Collapse of the West Antarctic Ice Sheet	SCIENCE			English	Article							EARTH; MODEL	Theory has suggested that the West Antarctic Ice Sheet may be inherently unstable. Recent observations lend weight to this hypothesis. We reassess the potential contribution to eustatic and regional sea level from a rapid collapse of the ice sheet and find that previous assessments have substantially overestimated its likely primary contribution. We obtain a value for the global, eustatic sea-level rise contribution of about 3.3 meters, with important regional variations. The maximum increase is concentrated along the Pacific and Atlantic seaboard of the United States, where the value is about 25% greater than the global mean, even for the case of a partial collapse.	[Bamber, Jonathan L.] Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; [Riva, Riccardo E. M.; Vermeersen, Bert L. A.] Delft Univ Technol, Delft Inst Earth Observat & Space Syst, NL-2629 HS Delft, Netherlands; [LeBrocq, Anne M.] Univ Durham, Dept Geog, Durham DH1 3LE, England	University of Bristol; Delft University of Technology; Durham University	Bamber, JL (corresponding author), Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England.	j.bamber@bristol.ac.uk	Bamber, Jonathan/C-7608-2011	Bamber, Jonathan/0000-0002-2280-2819; Riva, Riccardo/0000-0002-2042-5669	UK Natural Environment Research Council [NE/E004032/1]; Colorado University Cooperative Institute for Research in Environmental Sciences (CIRES) fellowship; NERC [NE/E004032/1] Funding Source: UKRI; Natural Environment Research Council [NE/E004032/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Colorado University Cooperative Institute for Research in Environmental Sciences (CIRES) fellowship; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank R. Bindschadler, R. Thomas, D. Vaughan, and four anonymous referees for helpful and constructive comments on a draft of the paper. J.L.B. was supported by UK Natural Environment Research Council grant NE/E004032/1 and a Colorado University Cooperative Institute for Research in Environmental Sciences (CIRES) fellowship.	Alley R.B., 2001, W ANTARCTIC ICE SHEE, V77, P1, DOI [10.1029/AR077p0001, DOI 10.1029/AR077P0001]; Bamber JL, 2009, CRYOSPHERE, V3, P101, DOI 10.5194/tc-3-101-2009; CLARK JA, 1977, NATURE, V269, P206, DOI 10.1038/269206a0; Clark PU, 2002, SCIENCE, V295, P2438; Di Donato G, 2000, TECTONOPHYSICS, V320, P409, DOI 10.1016/S0040-1951(00)00042-1; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FARRELL WE, 1976, GEOPHYS J ROY ASTR S, V46, P647, DOI 10.1111/j.1365-246X.1976.tb01252.x; Fox D, 2008, SCIENCE, V320, P1152, DOI 10.1126/science.320.5880.1152; Holt JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025561; HUGHES T, 1975, REV GEOPHYS, V13, P502, DOI 10.1029/RG013i004p00502; HUGHES T, 1973, J GEOPHYS RES, V78, P7884, DOI 10.1029/JC078i033p07884; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Milne GA, 1998, GEOPHYS J INT, V133, P1, DOI 10.1046/j.1365-246X.1998.1331455.x; Mitrovica JX, 2009, SCIENCE, V323, P753, DOI 10.1126/science.1166510; MITROVICA JX, 1991, J GEOPHYS RES-SOL EA, V96, P20053, DOI 10.1029/91JB01284; Mitrovica JX, 2003, GEOPHYS J INT, V154, P253, DOI 10.1046/j.1365-246X.2003.01942.x; Scherer RP, 1998, SCIENCE, V281, P82, DOI 10.1126/science.281.5373.82; STAMMER D, 2008, J GEOPHYS RES, V113, P16; Thomas R., 1979, J GLACIOL, V24, P167, DOI DOI 10.3189/S0022143000014726; THOMAS RH, 1979, NATURE, V277, P355, DOI 10.1038/277355a0; Tol RSJ, 2006, J RISK RES, V9, P467, DOI 10.1080/13669870600717632; Vaughan DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025588; Vaughan DG, 2002, CLIMATIC CHANGE, V52, P65, DOI 10.1023/A:1013038920600; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	26	309	319	0	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					901	903		10.1126/science.1169335	http://dx.doi.org/10.1126/science.1169335			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443778				2022-12-28	WOS:000266048800028
J	Virshup, DM; Forger, DB				Virshup, David M.; Forger, Daniel B.			Keeping the Beat in the Rising Heat	CELL			English	Editorial Material							CIRCADIAN GENE-EXPRESSION; CLOCK		[Virshup, David M.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Forger, Daniel B.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Forger, Daniel B.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA	National University of Singapore; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Virshup, DM (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore.	david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009; Forger, Daniel/C-5552-2015	Virshup, David M/0000-0001-6976-850X; Forger, Daniel/0000-0001-7581-4031				Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015	9	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 15	2009	137	4					602	604		10.1016/j.cell.2009.04.051	http://dx.doi.org/10.1016/j.cell.2009.04.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450508	Bronze			2022-12-28	WOS:000266114100008
J	Lee, HC; Chang, SS; Choudhary, S; Aalto, AP; Maiti, M; Bamford, DH; Liu, Y				Lee, Heng-Chi; Chang, Shwu-Shin; Choudhary, Swati; Aalto, Antti P.; Maiti, Mekhala; Bamford, Dennis H.; Liu, Yi			qiRNA is a new type of small interfering RNA induced by DNA damage	NATURE			English	Article							NEUROSPORA-CRASSA; PROTEIN; TRANSCRIPTION; SIRNA; METHYLATION; SENSITIVITY; HISTIDINE; INTERACTS; MUTANTS; PATHWAY	RNA interference pathways use small RNAs to mediate gene silencing in eukaryotes. In addition to small interfering RNAs (siRNAs) and microRNAs, several types of endogenously produced small RNAs have important roles in gene regulation, germ cell maintenance and transposon silencing(1-4). The production of some of these RNAs requires the synthesis of aberrant RNAs (aRNAs) or pre-siRNAs, which are specifically recognized by RNA-dependent RNA polymerases to make double-stranded RNA. The mechanism for aRNA synthesis and recognition is largely unknown. Here we show that DNA damage induces the expression of the Argonaute protein QDE-2 and a new class of small RNAs in the filamentous fungus Neurospora crassa. This class of small RNAs, known as qiRNAs because of their interaction with QDE-2, are about 20-21 nucleotides long (several nucleotides shorter than Neurospora siRNAs), with a strong preference for uridine at the 59 end, and originate mostly from the ribosomal DNA locus. The production of qiRNAs requires the RNA-dependent RNA polymerase QDE-1, the Werner and Bloom RecQ DNA helicase homologue QDE-3 and dicers. qiRNA biogenesis also requires DNA-damage-induced aRNAs as precursors, a process that is dependent on both QDE-1 and QDE-3. Notably, our results suggest that QDE-1 is the DNA-dependent RNA polymerase that produces aRNAs. Furthermore, the Neurospora RNA interference mutants show increased sensitivity to DNA damage, suggesting a role for qiRNAs in the DNA-damage response by inhibiting protein translation.	[Lee, Heng-Chi; Chang, Shwu-Shin; Choudhary, Swati; Maiti, Mekhala; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Aalto, Antti P.; Bamford, Dennis H.] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Aalto, Antti P.; Bamford, Dennis H.] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Helsinki; University of Helsinki	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	yi.liu@UTSouthwestern.edu		Bamford, Dennis/0000-0002-6438-8118; Lee, Heng-Chi/0000-0001-8154-906X	Welch Foundation; National Institutes of Health (NIH); Academy of Finland Finnish Centre of Excellence [1213467, 1213992]; Helsinki Graduate School in Biotechnology and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084283, R01GM068496] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland Finnish Centre of Excellence(Academy of Finland); Helsinki Graduate School in Biotechnology and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Wang and H. Yuan for technical assistance, and C. Tang for critical comments on the manuscript. We thank Q. Liu and X. Liu for assistance in small RNA cloning, and E. Selker for providing an rDNA plasmid. The work was supported by funds from the Welch Foundation and the National Institutes of Health (NIH) to Y. L. and the Academy of Finland Finnish Centre of Excellence Programme 2006-2011 ( 1213467, 1213992) to D. H. B. A. P. A. is a fellow of the Helsinki Graduate School in Biotechnology and Molecular Biology.	Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Calabrese JM, 2006, RNA, V12, P2092, DOI 10.1261/rna.224606; Catalanotto C, 2006, FEMS MICROBIOL LETT, V254, P182, DOI 10.1111/j.1574-6968.2005.00037.x; Catalanotto C, 2004, MOL CELL BIOL, V24, P2536, DOI 10.1128/MCB.24.6.2536-2545.2004; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; CHARY P, 1994, GENETICS, V137, P723; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; HOWARD CA, 1988, CURR GENET, V13, P391, DOI 10.1007/BF00365660; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Makeyev EV, 2000, EMBO J, V19, P124, DOI 10.1093/emboj/19.1.124; Nolan T, 2008, NUCLEIC ACIDS RES, V36, P532, DOI 10.1093/nar/gkm1071; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SRIVASTAVA VK, 1988, MUTAT RES, V200, P45, DOI 10.1016/0027-5107(88)90070-X; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105	31	200	220	0	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					274	U163		10.1038/nature08041	http://dx.doi.org/10.1038/nature08041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444217	Green Accepted			2022-12-28	WOS:000266036100046
J	Stalpers, XL; Smink-Bol, M; Verweij, PE; Wesseling, P; van Dijk, GW				Stalpers, Xenia L.; Smink-Bol, Mijke; Verweij, Paul E.; Wesseling, Pieter; van Dijk, Gert W.			Fatal consequences of an ear infection	LANCET			English	Editorial Material									[Stalpers, Xenia L.; van Dijk, Gert W.] Canisius Wilhelmina Hosp, Dept Neurol, NL-6532 SZ Nijmegen, Netherlands; [Wesseling, Pieter] Canisius Wilhelmina Hosp, Dept Pathol, NL-6532 SZ Nijmegen, Netherlands; [Smink-Bol, Mijke; Wesseling, Pieter] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Verweij, Paul E.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital; Radboud University Nijmegen; Radboud University Nijmegen	Stalpers, XL (corresponding author), Canisius Wilhelmina Hosp, Dept Neurol, Weg Door Jonkerbos 100, NL-6532 SZ Nijmegen, Netherlands.	x.stalpers@cwz.nl	Verweij, P.E./H-8108-2014; Wesseling, P./H-8114-2014	Verweij, P.E./0000-0002-8600-9860; Wesseling, P./0000-0001-5453-5201				BENHAM RW, 1948, J INVEST DERMATOL, V10, P99, DOI 10.1038/jid.1948.18; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; KERSHAW P, 1990, ARCH NEUROL-CHICAGO, V47, P468, DOI 10.1001/archneur.1990.00530040126029	3	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1658	1658		10.1016/S0140-6736(09)60699-1	http://dx.doi.org/10.1016/S0140-6736(09)60699-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19427961				2022-12-28	WOS:000266066300037
J	Schweickert, WD; Pohlman, MC; Pohlman, AS; Nigos, C; Pawlik, AJ; Esbrook, CL; Spears, L; Miller, M; Franczyk, M; Deprizio, D; Schmidt, GA; Bowman, A; Barr, R; McCallister, KE; Hall, JB; Kress, JP				Schweickert, William D.; Pohlman, Mark C.; Pohlman, Anne S.; Nigos, Celerina; Pawlik, Amy J.; Esbrook, Cheryl L.; Spears, Linda; Miller, Megan; Franczyk, Mietka; Deprizio, Deanna; Schmidt, Gregory A.; Bowman, Amy; Barr, Rhonda; McCallister, Kathryn E.; Hall, Jesse B.; Kress, John P.			Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial	LANCET			English	Article							INTENSIVE-CARE-UNIT; RESPIRATORY-DISTRESS-SYNDROME; CONFUSION ASSESSMENT METHOD; AGITATION-SEDATION SCALE; GUILLAIN-BARRE-SYNDROME; ACUTE LUNG INJURY; CRITICAL ILLNESS; OLDER-ADULTS; DAILY INTERRUPTION; ACQUIRED WEAKNESS	Background Long-term complications of critical illness include intensive care unit (ICU)-acquired weakness and neuropsychiatric disease. Immobilisation secondary to sedation might potentiate these problems. We assessed the efficacy of combining daily interruption of sedation with physical and occupational therapy on functional outcomes in patients receiving mechanical ventilation in intensive care. Methods Sedated adults (a:18 years of age) in the ICU who had been on mechanical ventilation for less than 72 h, were expected to continue for at least 24 h, and who met criteria for baseline functional independence were eligible for enrolment in this randomised controlled trial at two university hospitals. We randomly assigned 104 patients by computer-generated, permuted block randomisation to early exercise and mobilisation (physical and occupational therapy) during periods of daily interruption of sedation (intervention; n=49) or to daily interruption of sedation with therapy as ordered by the primary care team (control; n=55). The primary endpoint-the number of patients returning to independent functional status at hospital discharge-was defined as the ability to perform six activities of daily living and the ability to walk independently. Therapists who undertook patient assessments were blinded to treatment assignment. Secondary endpoints included duration of delirium and ventilator-free days during the first 28 days of hospital stay. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00322010. Findings All 104 patients were included in the analysis. Return to independent functional status at hospital discharge occurred in 29 (59%) patients in the intervention group compared with 19 (35%) patients in the control group (p=0.02; odds ratio 2.7 [95% CI 1.2-6.1]). Patients in the intervention group had shorter duration of delirium (median 2.0 days, IQR 0.0-6.0 vs 4.0 days, 2.0-8.0; p=0.02), and more ventilator-free days (23.5 days, 7.4-25.6 vs 21.1 days, 0.0-23.8; p=0.05) during the 28-day follow-up period than did controls. There was one serious adverse event in 498 therapy sessions (desaturation less than 80%). Discontinuation of therapy as a result of patient instability occurred in 19 (4%) of all sessions, most commonly for perceived patient-ventilator asynchrony. Interpretation A strategy for whole-body rehabilitation-consisting of interruption of sedation and physical and occupational therapy in the earliest days of critical illness-was safe and well tolerated, and resulted in better functional outcomes at hospital discharge, a shorter duration of delirium, and more ventilator-free days compared with standard care. Funding None.	[Schweickert, William D.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA; [Pohlman, Mark C.; Pohlman, Anne S.; Nigos, Celerina; McCallister, Kathryn E.; Hall, Jesse B.; Kress, John P.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [Pawlik, Amy J.; Esbrook, Cheryl L.; Spears, Linda; Miller, Megan; Franczyk, Mietka; Deprizio, Deanna] Univ Chicago, Therapy Serv Dept, Chicago, IL 60637 USA; [Schmidt, Gregory A.; Bowman, Amy] Univ Iowa, Dept Internal Med, Div Pulm Dis Crit Care & Occupat Med, Iowa City, IA 52242 USA; [Barr, Rhonda] Univ Iowa, Dept Rehabil Therapies, Iowa City, IA 52242 USA	University of Pennsylvania; University of Chicago; University of Chicago; University of Iowa; University of Iowa	Kress, JP (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care, 5841 S Maryland,MC 6026, Chicago, IL 60637 USA.	jkress@medicine.bsd.uchicago.edu		Schmidt, Gregory/0000-0002-5013-6323				Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Bigatello LM, 2007, CRIT CARE MED, V35, P2491, DOI 10.1097/01.CCM.0000287589.16724.B2; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Collin C, 1988, Int Disabil Stud, V10, P61; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; De Jonghe B, 2005, CRIT CARE MED, V33, P120, DOI 10.1097/01.CCM.0000150268.04228.68; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; De Jonghe B, 2007, CRIT CARE CLIN, V23, P55, DOI 10.1016/j.ccc.2006.11.001; De Jonghe Bernard, 2004, Curr Opin Crit Care, V10, P47, DOI 10.1097/00075198-200402000-00008; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Griffiths RD, 1995, NUTRITION, V11, P428; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hodgin KE, 2009, CRIT CARE MED, V37, P561, DOI 10.1097/CCM.0b013e3181957449; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Ip SPS, 1999, CRIT CARE MED, V27, P2351, DOI 10.1097/00003246-199911000-00005; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KLEYWEG RP, 1988, NEUROLOGY, V38, P1639, DOI 10.1212/WNL.38.10.1639; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 1996, AM J RESP CRIT CARE, V153, P1012, DOI 10.1164/ajrccm.153.3.8630539; Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB; MAHONEY F I, 1965, Md State Med J, V14, P61; Marcantonio ER, 2003, J AM GERIATR SOC, V51, P4, DOI 10.1034/j.1601-5215.2002.51002.x; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Mudge AM, 2008, J AM GERIATR SOC, V56, P630, DOI 10.1111/j.1532-5415.2007.01607.x; NARAIN P, 1988, J AM GERIATR SOC, V36, P775, DOI 10.1111/j.1532-5415.1988.tb04259.x; Needham DM, 2007, J CRIT CARE, V22, P275, DOI 10.1016/j.jcrc.2007.02.001; Poon WS, 2005, ACT NEUR S, V93, P207; Pun BT, 2007, CHEST, V132, P624, DOI 10.1378/chest.06-1795; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Sager MA, 1996, ARCH INTERN MED, V156, P645, DOI 10.1001/archinte.156.6.645; Schweickert WD, 2004, CRIT CARE MED, V32, P1272, DOI 10.1097/01.CCM.0000127263.54807.79; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2008, CRIT CARE, V12, DOI 10.1186/cc6151; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Tesch PA, 2008, J APPL PHYSIOL, V105, P902, DOI 10.1152/japplphysiol.90558.2008; Thomsen GE, 2008, CRIT CARE MED, V36, P1119, DOI 10.1097/CCM.0b013e318168f986; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Weinert CR, 2007, CRIT CARE MED, V35, P393, DOI 10.1097/01.CCM.0000254339.18639.1D; Yohannes AM, 2005, AGE AGEING, V34, P491, DOI 10.1093/ageing/afi163	53	1825	1965	4	263	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2009	373	9678					1874	1882		10.1016/S0140-6736(09)60658-9	http://dx.doi.org/10.1016/S0140-6736(09)60658-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19446324				2022-12-28	WOS:000266616400030
J	Frenk, J				Frenk, Julio			Reinventing primary health care: the need for systems integration	LANCET			English	Editorial Material							ALMA-ATA; MEXICO; REFORM		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Frenk, J (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	jfrenk@hsph.harvard.edu						Bryant J., 1969, HLTH DEV WORLD; Chan M, 2008, LANCET, V372, P865, DOI 10.1016/S0140-6736(08)61372-0; Conrad P, 2007, MED SOC; Cueto M, 2004, AM J PUBLIC HEALTH, V94, P1864, DOI 10.2105/AJPH.94.11.1864; FRENK J, 1990, ACAD MED, V65, P676, DOI 10.1097/00001888-199011000-00004; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Frenk J, 2009, LANCET, V373, P1406, DOI 10.1016/S0140-6736(09)60800-X; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; GOEL S, BHORE COMMITTEE NATL; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Ignatieff M., 2000, RIGHTS REVOLUTION; Illich I., 1977, LIMITS MED MED NEMES; Kark Sidney, 2001, PROMOTING COMMUNITY; King M, 1966, MED CARE DEV COUNTRI; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Longlett S K, 2001, J Am Board Fam Pract, V14, P54; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; PORTER D, 1999, HLTH CIVILIZATION ST, P291; Roemer M.I., 1976, HLTH CARE SYSTEMS WO; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Sepulveda J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, pXIII; WEBSTER C, 1995, HLTH MATTERS, V22, P5; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805; YACH D, 1993, AM J PUBLIC HEALTH, V83, P1045	28	105	112	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 11	2009	374	9684					170	173		10.1016/S0140-6736(09)60693-0	http://dx.doi.org/10.1016/S0140-6736(09)60693-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	472EG	19439350	Green Submitted			2022-12-28	WOS:000268111600034
J	Moseley, JB; Mayeux, A; Paoletti, A; Nurse, P				Moseley, James B.; Mayeux, Adeline; Paoletti, Anne; Nurse, Paul			A spatial gradient coordinates cell size and mitotic entry in fission yeast	NATURE			English	Article							PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; CONTRACTILE RING; GENETIC-CONTROL; DIVISION PLANE; CYTOKINESIS; MITOSIS; MID1P; INDUCER; GROWTH	Many eukaryotic cell types undergo size-dependent cell cycle transitions controlled by the ubiquitous cyclin-dependent kinase Cdk1 (refs 1-4). The proteins that control Cdk1 activity are well described but their links with mechanisms monitoring cell size remain elusive. In the fission yeast Schizosaccharomyces pombe, cells enter mitosis and divide at a defined and reproducible size owing to the regulated activity of Cdk1 (refs 2, 3). Here we show that the cell polarity protein kinase Pom1, which localizes to cell ends(5), regulates a signalling network that contributes to the control of mitotic entry. This network is located at cortical nodes in the middle of interphase cells, and these nodes contain the Cdk1 inhibitor Wee1, the Wee1-inhibitory kinases Cdr1 (also known as Nim1) and Cdr2, and the anillin-like protein Mid1. Cdr2 establishes the hierarchical localization of other proteins in the nodes, and receives negative regulatory signals from Pom1. Pom1 forms a polar gradient extending from the cell ends towards the cell middle and acts as a dose-dependent inhibitor of mitotic entry, working through the Cdr2 pathway. As cells elongate, Pom1 levels decrease at the cell middle, leading to mitotic entry. We propose that the Pom1 polar gradient and the medial cortical nodes generate information about cell size and coordinate this with mitotic entry by regulating Cdk1 through Pom1, Cdr2, Cdr1 and Wee1.	[Moseley, James B.; Nurse, Paul] Rockefeller Univ, New York, NY 10065 USA; [Mayeux, Adeline; Paoletti, Anne] CNRS, UMR144, F-75248 Paris 05, France; [Mayeux, Adeline; Paoletti, Anne] Ctr Rech, Inst Curie, F-75248 Paris 05, France	Rockefeller University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Moseley, JB (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	jmoseley@rockefeller.edu	PAOLETTI, Anne/CAF-4643-2022	PAOLETTI, Anne/0000-0002-9004-559X	American Cancer Society [PF-07-129-01-MBC]; ANR [BLAN06-3_135468]; ARC [4934]; FRM [INE20071110973]; Breast Cancer Research Foundation; Rockefeller University	American Cancer Society(American Cancer Society); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); Breast Cancer Research Foundation; Rockefeller University	We thank members of the Nurse laboratory for discussions and critical reading of the manuscript, A. Puszynska for technical assistance, The Rockefeller University Bio-Imaging Resource Center for assistance with microscopy, The Rockefeller University Proteomics Resource Center for mass spectrometry, K. Gould, J.-Q. Wu, T. Pollard, J. Bahler, F. Chang and K. Sawin for yeast strains, plasmids and antibodies, and S. Martin for sharing unpublished data and for discussions. J. B. M. was supported by a postdoctoral fellowship from the American Cancer Society (PF-07-129-01-MBC); A. P. by funding from ANR (BLAN06-3_135468), ARC (no. 4934) and FRM (INE20071110973); and P. N. by the Breast Cancer Research Foundation and The Rockefeller University.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; RUSSELL P, 1987, CELL, V49, P569, DOI 10.1016/0092-8674(87)90459-4; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0	29	273	281	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					857	U8		10.1038/nature08074	http://dx.doi.org/10.1038/nature08074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19474789				2022-12-28	WOS:000267084500042
J	Wang, XY; Ren, XF; Kahen, K; Hahn, MA; Rajeswaran, M; Maccagnano-Zacher, S; Silcox, J; Cragg, GE; Efros, AL; Krauss, TD				Wang, Xiaoyong; Ren, Xiaofan; Kahen, Keith; Hahn, Megan A.; Rajeswaran, Manju; Maccagnano-Zacher, Sara; Silcox, John; Cragg, George E.; Efros, Alexander L.; Krauss, Todd D.			RETRACTED: Non-blinking semiconductor nanocrystals (Retracted article. See vol. 527, 2015)	NATURE			English	Article; Retracted Publication							SINGLE-QUANTUM-DOT; CADMIUM SELENIDE NANOCRYSTALS; FLUORESCENCE INTERMITTENCY; SPECTROSCOPY; SUPPRESSION; EMISSION; DYNAMICS	The photoluminescence from a variety of individual molecules(1) and nanometre-sized crystallites(2) is defined by large intensity fluctuations, known as 'blinking', whereby their photoluminescence turns 'on' and 'off' intermittently, even under continuous photoexcitation(2). For semiconductor nanocrystals, it was originally proposed(3) that these 'off' periods corresponded to a nanocrystal with an extra charge. A charged nanocrystal could have its photoluminescence temporarily quenched owing to the high efficiency of non-radiative ( for example, Auger) recombination processes between the extra charge and a subsequently excited electron-hole pair; photoluminescence would resume only after the nanocrystal becomes neutralized again. Despite over a decade of research, completely non-blinking nanocrystals(4,5) have not been synthesized and an understanding of the blinking phenomenon(6) remains elusive. Here we report ternary core/shell CdZnSe/ZnSe semiconductor nanocrystals that individually exhibit continuous, non-blinking photoluminescence. Unexpectedly, these nanocrystals strongly photoluminesce despite being charged, as indicated by a multi-peaked photoluminescence spectral shape and short lifetime. To model the unusual photoluminescence properties of the CdZnSe/ZnSe nanocrystals, we softened the abrupt confinement potential of a typical core/shell nanocrystal, suggesting that the structure is a radially graded alloy of CdZnSe into ZnSe. As photoluminescence blinking severely limits the usefulness of nanocrystals in applications requiring a continuous output of single photons, these non-blinking nanocrystals may enable substantial advances in fields ranging from single-molecule biological labelling(7) to low-threshold lasers(8).	[Wang, Xiaoyong; Hahn, Megan A.; Krauss, Todd D.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Krauss, Todd D.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Ren, Xiaofan; Kahen, Keith; Rajeswaran, Manju] Eastman Kodak Co, Rochester, NY 14650 USA; [Maccagnano-Zacher, Sara; Silcox, John] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14583 USA; [Cragg, George E.; Efros, Alexander L.] USN, Res Lab, Washington, DC 20375 USA	University of Rochester; University of Rochester; Eastman Kodak; Cornell University; United States Department of Defense; United States Navy; Naval Research Laboratory	Krauss, TD (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	keith.kahen@kodak.com; efros@dave.nrl.navy.mil; krauss@chem.rochester.edu	Krauss, Todd/GQA-6399-2022; Wang, Xiaoyong/F-9542-2012; Wang, Xiaoyong/D-5956-2012	Krauss, Todd/0000-0002-4860-874X; 	DOE [DE-FC26-06NT42864]; NSF [CHE 0616378, CHE 0619418, EEC-0117770, DMR-9632275]; NYSTAR; University of Rochester Center for Electronic Imaging Systems; Cornell Center for Nanoscale Systems; Office of Naval Research; Alexander von Humboldt Foundation	DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NYSTAR; University of Rochester Center for Electronic Imaging Systems; Cornell Center for Nanoscale Systems; Office of Naval Research(Office of Naval Research); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We acknowledge financial support by the DOE (DE-FC26-06NT42864), NSF (CHE 0616378, CHE 0619418, EEC-0117770, DMR-9632275), NYSTAR, University of Rochester Center for Electronic Imaging Systems, the Cornell Center for Nanoscale Systems, the Office of Naval Research and the Alexander von Humboldt Foundation ( A. L. E.).	Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chen Y, 2008, J AM CHEM SOC, V130, P5026, DOI 10.1021/ja711379k; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Crooker SA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.186802; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dekel E, 1998, PHYS REV LETT, V80, P4991, DOI 10.1103/PhysRevLett.80.4991; Efros AL, 1997, PHYS REV LETT, V78, P1110, DOI 10.1103/PhysRevLett.78.1110; Efros AL, 1996, PHYS REV B, V54, P4843, DOI 10.1103/PhysRevB.54.4843; Empedocles SA, 1996, PHYS REV LETT, V77, P3873, DOI 10.1103/PhysRevLett.77.3873; Fomenko V, 2008, NANO LETT, V8, P287, DOI 10.1021/nl0726609; Frantsuzov P, 2008, NAT PHYS, V4, P519, DOI 10.1038/nphys1001; Hartschuh A, 2003, SCIENCE, V301, P1354, DOI 10.1126/science.1087118; HELLWEGE KH, 1983, SEMICONDUCTORS PHY B, V17; Hohng S, 2004, J AM CHEM SOC, V126, P1324, DOI 10.1021/ja039686w; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; Krauss TD, 1999, PHYS REV LETT, V83, P4840, DOI 10.1103/PhysRevLett.83.4840; Kuno M, 2001, J CHEM PHYS, V115, P1028, DOI 10.1063/1.1377883; Landsberg P., 1991, RECOMBINATION SEMICO; Mahler B, 2008, NAT MATER, V7, P659, DOI 10.1038/nmat2222; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Michler P, 2000, NATURE, V406, P968, DOI 10.1038/35023100; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Nozik AJ, 2001, ANNU REV PHYS CHEM, V52, P193, DOI 10.1146/annurev.physchem.52.1.193; Paskov PP, 2000, PHYSICA E, V6, P440, DOI 10.1016/S1386-9477(99)00212-X; Shimizu KT, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.205316; Talapin DV, 2004, J PHYS CHEM B, V108, P18826, DOI 10.1021/jp046481g; Yu ZH, 2005, NANO LETT, V5, P565, DOI 10.1021/nl048245n; Zhong XH, 2003, J AM CHEM SOC, V125, P8589, DOI 10.1021/ja035096m	30	528	545	4	363	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					686	689		10.1038/nature08072	http://dx.doi.org/10.1038/nature08072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19430463				2022-12-28	WOS:000266608600040
J	Noordam, C; Dhir, V; McNelis, JC; Schlereth, F; Hanley, NA; Krone, N; Smeitink, JA; Smeets, R; Sweep, FCGJ; Claahsen-van der Grinten, HL; Arlt, W				Noordam, Cees; Dhir, Vivek; McNelis, Joanne C.; Schlereth, Florian; Hanley, Neil A.; Krone, Nils; Smeitink, Jan A.; Smeets, Roel; Sweep, Fred C. G. J.; Claahsen-van der Grinten, Hedi L.; Arlt, Wiebke			Inactivating PAPSS2 Mutations in a Patient with Premature Pubarche	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYSTIC-OVARY-SYNDROME; SPONDYLOEPIMETAPHYSEAL DYSPLASIA; DEHYDROEPIANDROSTERONE; SULFATE; REPLACEMENT; ADRENARCHE; EXPRESSION; CONVERSION; ISOFORMS; CRITERIA	Dehydroepiandrosterone (DHEA) sulfotransferase, known as SULT2A1, converts the androgen precursor DHEA to its inactive sulfate ester, DHEAS, thereby preventing the conversion of DHEA to an active androgen. SULT2A1 requires 3'-phosphoadenosine-5'-phosphosulfate (PAPS) for catalytic activity. We have identified compound heterozygous mutations in the gene encoding human PAPS synthase 2 (PAPSS2) in a girl with premature pubarche, hyperandrogenic anovulation, very low DHEAS levels, and increased androgen levels. In vitro coincubation of human SULT2A1 and wild-type or mutant PAPSS2 proteins confirmed the inactivating nature of the mutations. These observations indicate that PAPSS2 deficiency is a monogenic adrenocortical cause of androgen excess.	[Arlt, Wiebke] Univ Birmingham, Sch Clin & Expt Med, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TT, W Midlands, England; [Noordam, Cees; Smeitink, Jan A.; Smeets, Roel; Claahsen-van der Grinten, Hedi L.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Metab & Endocrine Disorders, NL-6525 ED Nijmegen, Netherlands; [Sweep, Fred C. G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Chem Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Hanley, Neil A.] Univ Manchester, Endocrine Sci Res Grp, Manchester Acad Sci Ctr, Manchester, Lancs, England	University of Birmingham; Radboud University Nijmegen; Radboud University Nijmegen; University of Manchester	Arlt, W (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Rm 225,Wolfson Dr, Birmingham B15 2TT, W Midlands, England.	w.arlt@bham.ac.uk	Krone, Nils/D-4535-2009; Smeitink, Jan/C-1351-2013; der Grinten, Hedi Claahsen-van/L-4247-2015; Noordam, Cees/AAL-9015-2021; Noordam, C./H-8077-2014; Arlt, Wiebke/B-6310-2009; Sweep, C.G.J./H-8096-2014; Krone, Nils/I-3280-2019	Noordam, Cees/0000-0001-9735-5921; Noordam, C./0000-0001-9735-5921; Arlt, Wiebke/0000-0001-5106-9719; Sweep, C.G.J./0000-0003-1103-3070; Hanley, Neil/0000-0003-3234-4038; Krone, Nils/0000-0002-3402-4727	United Kingdom Medical Research Council [G116/172]; Wellcome Trust [GR079865M]; United Kingdom National Institute for Health Research; Medical Research Council [G116/172] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a grant from the United Kingdom Medical Research Council (G116/172, to Dr. Arlt), a doctoral training grant (to Dr. McNelis), a grant from the Wellcome Trust (GR079865M, to Dr. Krone), and a grant from the United Kingdom National Institute for Health Research (to Dr. Hanley).	Ahmad M, 1998, AM J MED GENET, V78, P468; Arlt W, 1998, J CLIN ENDOCR METAB, V83, P1928, DOI 10.1210/jc.83.6.1928; Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Auchus RJ, 2004, CLIN ENDOCRINOL, V60, P288, DOI 10.1046/j.1365-2265.2003.01858.x; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Escobar-Morreale HF, 2005, ENDOCR REV, V26, P251, DOI 10.1210/er.2004-0004; Fuda H, 2002, BIOCHEM J, V365, P497, DOI 10.1042/BJ20020044; Fuda H, 2002, J BIOL CHEM, V277, P36161, DOI 10.1074/jbc.M207165200; Goodarzi MO, 2006, BEST PRACT RES CL EN, V20, P193, DOI 10.1016/j.beem.2006.02.005; Goto M, 2006, J CLIN INVEST, V116, P953, DOI 10.1172/JCI25091; Hammer F, 2005, J CLIN ENDOCR METAB, V90, P3600, DOI 10.1210/jc.2004-2386; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Ibanez L, 2000, ENDOCR REV, V21, P671, DOI 10.1210/er.21.6.671; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Kurima K, 1998, P NATL ACAD SCI USA, V95, P12071; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Stelzer C, 2007, DEV DYNAM, V236, P1313, DOI 10.1002/dvdy.21137; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; SWINKELS LMJW, 1990, CLIN CHEM, V36, P2042; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Witchel SF, 2006, MOL CELL ENDOCRINOL, V254, P146, DOI 10.1016/j.mce.2006.04.028; Xu ZH, 2002, PHARMACOGENETICS, V12, P11, DOI 10.1097/00008571-200201000-00003	29	103	105	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2310	2318		10.1056/NEJMoa0810489	http://dx.doi.org/10.1056/NEJMoa0810489			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474428				2022-12-28	WOS:000266367300007
J	Junge, W; Sielaff, H; Engelbrecht, S				Junge, Wolfgang; Sielaff, Hendrik; Engelbrecht, Siegfried			Torque generation and elastic power transmission in the rotary F0F1-ATPase	NATURE			English	Review							COLI ATP SYNTHASE; BOVINE HEART-MITOCHONDRIA; COUPLING PROTON MOVEMENTS; C SUBUNIT OLIGOMER; ESCHERICHIA-COLI; F-ATPASE; CATALYTIC SITES; B-SUBUNIT; OXIDATIVE-PHOSPHORYLATION; NUCLEOTIDE DEPENDENCE	Adenosine triphosphate (ATP), the universal fuel of the cell, is synthesized from adenosine diphosphate (ADP) and inorganic phosphate (Pi) by 'ATP synthase' (FOF1-ATPase). During respiration or photosynthesis, an electrochemical potential difference of protons is set up across the respective membranes. This powers the enzyme's electrical rotary nanomotor (F-O), which drives the chemical nanomotor (F-1) by elastic mechanical-power transmission, producing ATP with high kinetic efficiency. Attempts to understand in detail the mechanisms of torque generation in this simple and robust system have been both aided and complicated by a wealth of sometimes conflicting data.	[Junge, Wolfgang; Sielaff, Hendrik; Engelbrecht, Siegfried] Univ Osnabruck, Dept Biophys, D-49076 Osnabruck, Germany	University Osnabruck	Junge, W (corresponding author), Univ Osnabruck, Dept Biophys, Barbarastr 11, D-49076 Osnabruck, Germany.	junge@uos.de	Junge, Wolfgang/F-6289-2012	Sielaff, Hendrik/0000-0001-5231-7286	Deutsche Forschungsgemeinschaft; Volkswagenstiftung; European Union; Fonds der Chemie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen); European Union(European Commission); Fonds der Chemie	We thank D. Cherepanov and O. P nke for their contributions to elastic coupling, G. Hikade and H. Kenneweg for technical assistance, and J. Weber for discussions. We acknowledge financial support from Deutsche Forschungsgemeinschaft, Volkswagenstiftung, European Union and Fonds der Chemie.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Bockmann RA, 2003, BIOPHYS J, V85, P1482, DOI 10.1016/S0006-3495(03)74581-0; Bockmann RA, 2002, NAT STRUCT BIOL, V9, P198, DOI 10.1038/nsb760; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Boyer PD, 2002, FEBS LETT, V512, P29, DOI 10.1016/S0014-5793(02)02293-7; BOYER PD, 1979, MEMBRANE BIOENERGETI, P476; Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; Cherepanov DA, 2001, BIOPHYS J, V81, P1234, DOI 10.1016/S0006-3495(01)75781-5; Cherepanov DA, 2003, BIOPHYS J, V85, P1307, DOI 10.1016/S0006-3495(03)74565-2; Diez M, 2004, BIOCHEMISTRY-US, V43, P1054, DOI 10.1021/bi0357098; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; Dittrich M, 2005, J BIOENERG BIOMEMBR, V37, P441, DOI 10.1007/s10863-005-9487-7; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Dunn SD, 2000, J BIOENERG BIOMEMBR, V32, P347, DOI 10.1023/A:1005571818730; Feniouk BA, 2005, BBA-BIOENERGETICS, V1706, P184, DOI 10.1016/j.bbabio.2004.10.010; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Feniouk BA, 2008, PURPLE BACTERIA, P475; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; GROTH G, 1993, BIOCHEMISTRY-US, V32, P8103, DOI 10.1021/bi00083a008; Gumbiowski K, 2001, J BIOL CHEM, V276, P42287, DOI 10.1074/jbc.M106884200; Hasler K, 1999, BIOCHEMISTRY-US, V38, P13759, DOI 10.1021/bi991236m; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Junge W, 2006, PHOTOSYNTH RES, V87, P233, DOI 10.1007/s11120-005-9016-x; Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Junge W., 2008, PRIMARY PROCESSES 2, P447; Krulwich TA, 1998, ADV MICROB PHYSIOL, V40, P401, DOI 10.1016/S0065-2911(08)60136-8; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Ma JP, 2002, STRUCTURE, V10, P921, DOI 10.1016/S0969-2126(02)00789-X; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Muller M, 2004, EUR J BIOCHEM, V271, P3914, DOI 10.1111/j.1432-1033.2004.04328.x; Muller M, 2002, J BIOL CHEM, V277, P23308, DOI 10.1074/jbc.M201998200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Panke O, 1999, BBA-BIOENERGETICS, V1412, P118, DOI 10.1016/S0005-2728(99)00059-6; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; PENEFSKY HS, 1960, J BIOL CHEM, V235, P3330; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sabbert D, 1997, P NATL ACAD SCI USA, V94, P4401, DOI 10.1073/pnas.94.9.4401; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SCHNEIDER E, 1985, EMBO J, V4, P515, DOI 10.1002/j.1460-2075.1985.tb03658.x; Seelert H, 2003, J MOL BIOL, V333, P337, DOI 10.1016/j.jmb.2003.08.046; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Steigmiller S, 2008, P NATL ACAD SCI USA, V105, P3745, DOI 10.1073/pnas.0708356105; Sun S, 2003, EUR BIOPHYS J BIOPHY, V32, P676, DOI 10.1007/s00249-003-0335-6; VIK SB, 1994, J BIOL CHEM, V269, P30364; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; Weber J, 2004, J BIOL CHEM, V279, P11253, DOI 10.1074/jbc.M312576200; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER J, 1995, J BIOL CHEM, V270, P21045, DOI 10.1074/jbc.270.36.21045; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Zhang D, 2003, BIOCHEMISTRY-US, V42, P331, DOI 10.1021/bi026649t; 2004, RASMOL V 2 7 2 1 1	80	282	286	7	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 21	2009	459	7245					364	370		10.1038/nature08145	http://dx.doi.org/10.1038/nature08145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458712				2022-12-28	WOS:000266243700034
J	Ferri, M; Adhikari, N				Ferri, Mauricio; Adhikari, Neill			Implementation of an evidence-based feeding guideline did not reduce mortality in intensive care units	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; NUTRITION SUPPORT		[Ferri, Mauricio; Adhikari, Neill] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Ferri, M (corresponding author), Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.							Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P74, DOI 10.1177/014860710302700174; Jain MK, 2006, CRIT CARE MED, V34, P2362, DOI 10.1097/01.CCM.0000234044.91893.9C; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-13	10.7326/0003-4819-150-10-200905190-02013	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451569				2022-12-28	WOS:000266285300033
J	Agwu, K; Llewelyn, M				Agwu, Kenechukwu; Llewelyn, Megan		Undergrad Int Hlth UCL	Compensation for the brain drain from developing countries	LANCET			English	Editorial Material									[Agwu, Kenechukwu; Llewelyn, Megan; Undergrad Int Hlth UCL] UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England	University of London; University College London	Agwu, K (corresponding author), UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England.	kenechukwu.agwu@ucl.ac.uk						Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Baynham M., 2005, DISLOCATIONS RELOCAT; Mackintosh Maureen, 2006, J INT DEV, V18, P757, DOI DOI 10.1002/JID.1312; Martineau T, 2004, HEALTH POLICY, V70, P1, DOI 10.1016/j.healthpol.2004.01.006; Mensah K, 2005, SKILLS DRAIN HLTH PR; *PHYS HUM RIGHT, 2004, ACT PLAN PREV BRAIN; *WHO, 2006, 301 WHO; WHO, 2006, WORK TOG HLTH WORLD; *WHO, 2008, INT RECR HLTH PERS	9	16	16	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 16	2009	373	9676					1665	1666		10.1016/S0140-6736(09)60927-2	http://dx.doi.org/10.1016/S0140-6736(09)60927-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RP	19447243				2022-12-28	WOS:000266209800007
J	Martin, M				Martin, Miguel			Unravelling the mystery of the TACT trial	LANCET			English	Editorial Material							EARLY BREAST-CANCER; ADJUVANT CHEMOTHERAPY; DOCETAXEL		Hosp Clin San Carlos, Dept Med Oncol, Madrid 28040, Spain	Hospital Clinico San Carlos	Martin, M (corresponding author), Hosp Clin San Carlos, Dept Med Oncol, Madrid 28040, Spain.	mmartin@geicam.org	Martin, Miguel/AAJ-9242-2020; Martin, Miguel/V-6589-2019	Martin, Miguel/0000-0001-9237-3231; 				BIANCO AR, 2006, J CLIN ONCOL 1 S, V24; Bonneterre J, 2005, J CLIN ONCOL, V23, P2686, DOI 10.1200/JCO.2005.05.059; Bradshaw DM, 1998, J CLIN ONCOL, V16, P3674, DOI 10.1200/JCO.1998.16.11.3674; Bria E, 2006, CANCER-AM CANCER SOC, V106, P2337, DOI 10.1002/cncr.21886; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; de Azambuja E, 2009, J CLIN ONCOL, V27, P720, DOI 10.1200/JCO.2008.17.2155; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; Ellis P, 2009, LANCET, V373, P1681, DOI 10.1016/S0140-6736(09)60740-6; Ferguson T, 2007, COCHRANE DB SYST REV, V4; Francis P, 2008, JNCI-J NATL CANCER I, V100, P121, DOI 10.1093/jnci/djm287; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Lage H, 2000, Lancet Oncol, V1, P169, DOI 10.1016/S1470-2045(00)00032-2; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056	14	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2009	373	9676					1662	1663		10.1016/S0140-6736(09)60925-9	http://dx.doi.org/10.1016/S0140-6736(09)60925-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RP	19447241				2022-12-28	WOS:000266209800005
J	Jin, ZY; Li, Y; Pitti, R; Lawrence, D; Pham, VC; Lill, JR; Ashkenazi, A				Jin, Zhaoyu; Li, Yun; Pitti, Robert; Lawrence, David; Pham, Victoria C.; Lill, Jennie R.; Ashkenazi, Avi			Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; INDUCED CELL-DEATH; UBIQUITIN LIGASES; ACTIVATION; RECEPTOR; PROTEIN; DEGRADATION; AUTOPHAGY; PATHWAYS	Cell-surface death receptors such as DR4 and DR5 trigger apoptosis through a death-inducing signaling complex (DISC) that recruits the apical protease caspase-8. Apoptosis commitment requires efficient activation and autocatalytic release of caspase-8 into the cytoplasm to engage executioner caspases. While DISC recruitment initiates caspase-8 stimulation, full activation of the protease depends on further molecular aggregation events that are not fully understood. Here, we show that death receptor ligation induces polyubiquitination of caspase-8, through a previously unknown interaction of the DISC with a cullin3 (CUL3)-based E3 ligase. CUL3-mediated caspase-8 polyubiquitination required the RING box protein RBX1, whereas the deubiquitinase A20 reversed this modification. The ubiquitin-binding protein p62/sequestosome-1 promoted aggregation of CUL3-modified caspase-8 within p62-dependent foci, leading to full activation and processing of the enzyme and driving commitment to cell death. These results identify a mechanism that positively controls apoptosis signaling by polyubiquitination and aggregation of a key initiator caspase.	[Jin, Zhaoyu; Li, Yun; Pitti, Robert; Lawrence, David; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [Pham, Victoria C.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Austin CD, 2006, P NATL ACAD SCI USA, V103, P10283, DOI 10.1073/pnas.0604044103; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Israel A, 2006, TRENDS IMMUNOL, V27, P395, DOI 10.1016/j.it.2006.07.003; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KIM I, 2006, SCI STKE, V330, pPE18; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zornig M, 2001, BBA-REV CANCER, V1551, pF1, DOI 10.1016/S0304-419X(01)00031-2	46	473	492	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					721	735		10.1016/j.cell.2009.03.015	http://dx.doi.org/10.1016/j.cell.2009.03.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19427028	Bronze			2022-12-28	WOS:000266114100020
J	Tavakoli, NP; Wang, H; Dupuis, M; Hull, R; Ebel, GD; Gilmore, EJ; Faust, PL				Tavakoli, Norma P.; Wang, Heng; Dupuis, Michelle; Hull, Rene; Ebel, Gregory D.; Gilmore, Emily J.; Faust, Phyllis L.			Brief Report: Fatal Case of Deer Tick Virus Encephalitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POWASSAN VIRUS; BORNE ENCEPHALITIS; NEW-ENGLAND; INFECTION; TRANSMISSION; PHYLOGENY; REGION	Deer tick virus is related to Powassan virus, a tickborne encephalitis virus. A 62-year-old man presented with a meningoencephalitis syndrome and eventually died. Analyses of tissue samples obtained during surgery and at autopsy revealed a widespread necrotizing meningoencephalitis. Nucleic acid was extracted from formalin-fixed tissue, and the presence of deer tick virus was verified on a flavivirus-specific polymerase-chain-reaction (PCR) assay, followed by sequence confirmation. Immunohistochemical analysis with antisera specific for deer tick virus identified numerous immunoreactive neurons, with prominent involvement of large neurons in the brain stem, cerebellum, basal ganglia, thalamus, and spinal cord. This case demonstrates that deer tick virus can be a cause of fatal encephalitis.	[Tavakoli, Norma P.; Wang, Heng; Dupuis, Michelle; Hull, Rene] New York City Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Tavakoli, Norma P.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA; [Ebel, Gregory D.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Gilmore, Emily J.] Columbia Univ, Dept Neurol, New York, NY USA; [Faust, Phyllis L.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Gilmore, Emily J.; Faust, Phyllis L.] New York Presbyterian Hosp, New York, NY USA	New York City Department of Health & Mental Hygiene; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of New Mexico; Columbia University; Columbia University; NewYork-Presbyterian Hospital	Tavakoli, NP (corresponding author), Empire State Plaza,POB 509, Albany, NY 12201 USA.	norma.tavakoli@wadsworth.org	Ebel, Gregory/D-8324-2017; Ebel, Gregory/ABG-1052-2021		NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067380] Funding Source: NIH RePORTER	NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beasley DWC, 2001, VIRUS RES, V79, P81, DOI 10.1016/S0168-1702(01)00330-6; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; Ebel GD, 2000, AM J TROP MED HYG, V63, P36, DOI 10.4269/ajtmh.2000.63.36; Ebel GD, 2001, J GEN VIROL, V82, P1657, DOI 10.1099/0022-1317-82-7-1657; Ebel GD, 1999, EMERG INFECT DIS, V5, P570, DOI 10.3201/eid0504.990423; EMBIL JA, 1983, ARCH INTERN MED, V143, P341, DOI 10.1001/archinte.143.2.341; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746; Gholam BIA, 1999, CAN MED ASSOC J, V161, P1419; GOLDFIELD M, 1973, AM J TROP MED HYG, V22, P78, DOI 10.4269/ajtmh.1973.22.78; Kuno G, 2001, AM J TROP MED HYG, V65, P671, DOI 10.4269/ajtmh.2001.65.671; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; LOVE S, 2008, GREENFIELDS NEUROPAT, P1323; McLEAN D M, 1959, Can Med Assoc J, V80, P708; MCLEAN DM, 1962, CAN MED ASSOC J, V86, P971; Penn RG, 2006, CLIN INFECT DIS, V42, P680, DOI 10.1086/500216; Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709; Ravindra KV, 2004, CLIN INFECT DIS, V38, P1257, DOI 10.1086/383325; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavakoli NP, 2007, J CLIN MICROBIOL, V45, P1523, DOI 10.1128/JCM.00209-07; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; Thompson C, 2001, CLIN INFECT DIS, V33, P676, DOI 10.1086/322681; WILSON MS, 1979, CAN MED ASSOC J, V121, P320; [No title captured]	28	73	74	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2099	2107		10.1056/NEJMoa0806326	http://dx.doi.org/10.1056/NEJMoa0806326			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439744	Green Accepted, Bronze			2022-12-28	WOS:000266011200008
J	Wu, D				Wu, David			Beyond the Numbers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												djwu@comcast.net		Wu, David/0000-0003-1973-7777					0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1860	1860		10.1001/jama.2009.638	http://dx.doi.org/10.1001/jama.2009.638			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444JX	19436004				2022-12-28	WOS:000265978400001
J	Jakob, SM; Takala, J				Jakob, Stephan M.; Takala, Jukka			Physical and occupational therapy during sedation stops	LANCET			English	Editorial Material							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; RESPIRATORY-FAILURE; SKELETAL-MUSCLE; BED REST		[Jakob, Stephan M.; Takala, Jukka] Univ Bern, Dept Intens Care, CH-3010 Bern, Switzerland; [Jakob, Stephan M.; Takala, Jukka] Univ Hosp Bern, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Jakob, SM (corresponding author), Univ Bern, Dept Intens Care, CH-3010 Bern, Switzerland.	stephan.jakob@insel.ch						Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Ferrando AA, 1997, J APPL PHYSIOL, V82, P807, DOI 10.1152/jappl.1997.82.3.807; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Griffiths RD, 1995, NUTRITION, V11, P428; Hodgin KE, 2009, CRIT CARE MED, V37, P561, DOI 10.1097/CCM.0b013e3181957449; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Nava S, 1998, ARCH PHYS MED REHAB, V79, P849, DOI 10.1016/S0003-9993(98)90369-0; Ruokonen E, 2009, INTENS CARE MED, V35, P282, DOI 10.1007/s00134-008-1296-0; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Weinert CR, 2007, CRIT CARE MED, V35, P393, DOI 10.1097/01.CCM.0000254339.18639.1D	15	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1824	1826		10.1016/S0140-6736(09)60866-7	http://dx.doi.org/10.1016/S0140-6736(09)60866-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19446327				2022-12-28	WOS:000266616400006
J	Mosher, RA; Melnyk, CW; Kelly, KA; Dunn, RM; Studholme, DJ; Baulcombe, DC				Mosher, Rebecca A.; Melnyk, Charles W.; Kelly, Krystyna A.; Dunn, Ruth M.; Studholme, David J.; Baulcombe, David C.			Uniparental expression of PolIV-dependent siRNAs in developing endosperm of Arabidopsis	NATURE			English	Article							RNA-POLYMERASE-IV; DNA-METHYLATION; GENE; MEDEA; TRANSPOSONS; MICRORNAS	Most eukaryotes produce small RNA (sRNA) mediators of gene silencing that bind to Argonaute proteins and guide them, by base pairing, to an RNA target. MicroRNAs (miRNAs) that normally target messenger RNAs for degradation or translational arrest are the best-understood class of sRNAs. However, in Arabidopsis thaliana flowers, miRNAs account for only 5% of the sRNA mass and less than 0.1% of the sequence complexity. The remaining sRNAs form a complex population of more than 100,000 different small interfering RNAs (siRNAs) transcribed from thousands of loci(1-5). The biogenesis of most of the siRNAs in Arabidopsis are dependent on RNA polymerase IV (PolIV), a homologue of DNA-dependent RNA polymerase II2,3,6. A subset of these PolIV-dependent (p4)-siRNAs are involved in stress responses, and others are associated with epigenetic modifications to DNA or chromatin; however, the biological role is not known for most of them. Here we show that the predominant phase of p4-siRNA accumulation is initiated in the maternal gametophyte and continues during seed development. Expression of p4-siRNAs in developing endosperm is specifically from maternal chromosomes. Our results provide the first evidence for a link between genomic imprinting and RNA silencing in plants.	[Mosher, Rebecca A.; Melnyk, Charles W.; Kelly, Krystyna A.; Dunn, Ruth M.; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Studholme, David J.] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baulcombe, DC (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	dcb40@cam.ac.uk	Mosher, Rebecca/F-4800-2010; Studholme, David/H-6790-2019; Melnyk, Charles W/R-2846-2017	Mosher, Rebecca/0000-0003-2195-0825; Studholme, David/0000-0002-3010-6637; Melnyk, Charles W/0000-0003-3251-800X; Baulcombe, David/0000-0003-0780-6878	Gatsby Charitable Foundation; SIROCCO [LSHG-CT-2006-037900]; National Science Foundation; Commonwealth and NSERC Scholarships; Royal Society Research	Gatsby Charitable Foundation; SIROCCO; National Science Foundation(National Science Foundation (NSF)); Commonwealth and NSERC Scholarships; Royal Society Research(Royal Society of London)	We thank I. Furner for met1-1 seed and A. Davis for photography. This work was supported by the Gatsby Charitable Foundation, the European Union Sixth Framework Programme Integrated Project SIROCCO (grant LSHG-CT-2006-037900), a postdoctoral fellowship from the National Science Foundation (to R. A. M.), and Commonwealth and NSERC Scholarships (to C. W. M.). D. C. B. is funded as a Royal Society Research Professor.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	21	235	243	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					283	U151		10.1038/nature08084	http://dx.doi.org/10.1038/nature08084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19494814				2022-12-28	WOS:000267761000046
J	Nimura, K; Ura, K; Shiratori, H; Ikawa, M; Okabe, M; Schwartz, RJ; Kaneda, Y				Nimura, Keisuke; Ura, Kiyoe; Shiratori, Hidetaka; Ikawa, Masato; Okabe, Masaru; Schwartz, Robert J.; Kaneda, Yasufumi			A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome	NATURE			English	Article							CHROMATIN; GENE; METHYLATION; PROTEIN; HEART; SALL4; SET2; TBX5; METHYLTRANSFERASE; PURIFICATION	Diverse histone modifications are catalysed and recognized by various specific proteins, establishing unique modification patterns that act as transcription signals(1,2). In particular, histone H3 trimethylation at lysine 36 (H3K36me3) is associated with actively transcribed regions and has been proposed to provide landmarks for continuing transcription(3,4); however, the control mechanisms and functions of H3K36me3 in higher eukaryotes are unknown. Here we show that the H3K36me3-specific histone methyltransferase (HMTase) Wolf-Hirschhorn syndrome candidate 1 (WHSC1, also known as NSD2 or MMSET) functions in transcriptional regulation together with developmental transcription factors whose defects overlap with the human disease Wolf Hirschhorn syndrome (WHS)(5,6). We found that mouse Whsc1, one of five putative Set2 homologues(2,7,8), governed H3K36me3 along euchromatin by associating with the cell-type-specific transcription factors Sall1, Sall4 and Nanog in embryonic stem cells, and Nkx2-5 in embryonic hearts, regulating the expression of their target genes. Whsc1-deficient mice showed growth retardation and various WHS-like midline defects, including congenital cardiovascular anomalies. The effects of Whsc1 haploin sufficiency were increased in Nkx2-5 heterozygous mutant hearts, indicating their functional link. We propose that WHSC1 functions together with developmental transcription factors to prevent the inappropriate transcription that can lead to various pathophysiologies.	[Nimura, Keisuke; Ura, Kiyoe; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Suita, Osaka 5650871, Japan; [Shiratori, Hidetaka] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; [Ikawa, Masato; Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; [Schwartz, Robert J.] Ctr Mol Dev & Dis, Inst Biosci & Technol, Houston, TX 77030 USA	Osaka University; Osaka University; Osaka University	Ura, K (corresponding author), Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	kiyoeura@gts.med.osaka-u.ac.jp; kaneday@gts.med.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Nimura, Keisuke/AAE-9925-2020; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Naito Foundation; Osaka University	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Osaka University	Acknowledgements We thank T. Richmond, R. Nishinakamura, H. Kurumizaka and M. Shirai for providing reagents and mice; S. Khochbin, S. Hirose, J. Godde and J. Takeuchi for their critical reading of the manuscript; and H. Niwa, H. Hamada, M. Yamamoto, S. Ohishi, H. Nakagami and members of the GTS laboratory for discussion and support. This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and the Naito Foundation, and by funds from Osaka University for female researchers.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; HIRSCHHORN K, 1961, AM J MED, V31, P442, DOI 10.1016/0002-9343(61)90128-0; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saeki H, 2005, P NATL ACAD SCI USA, V102, P5697, DOI 10.1073/pnas.0409824102; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; URA K, 2002, METH MOL B, V181, P309; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200	38	274	288	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					287	U157		10.1038/nature08086	http://dx.doi.org/10.1038/nature08086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19483677				2022-12-28	WOS:000267761000047
J	Patterson, CC; Dahquist, GG; Gyurus, E; Green, A; Soltesz, G				Patterson, Christopher C.; Dahquist, Gisela G.; Gyurus, Eva; Green, Anders; Soltesz, Gyula		EURODIAB Study Grp	Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study	LANCET			English	Article							AGED LESS-THAN-15 YEARS; MISSING LINK; YOUNG-ADULTS; ONSET; MELLITUS; CHILDREN; PERIOD; YORKSHIRE; DISEASE; SWEDEN	Background The incidence of type 1 diabetes in children younger than 15 years is increasing. Prediction of future incidence of this disease will enable adequate fund allocation for delivery of care to be planned. We aimed to establish 15-year incidence trends for childhood type 1 diabetes in European centres, and thereby predict the future burden of childhood diabetes in Europe. Methods 20 population-based EURODIAB registers in 17 countries registered 29311 new cases of type 1 diabetes, diagnosed in children before their 15th birthday during a 15-year period, 1989-2003. Age-specific log linear rates of increase were estimated in five geographical regions, and used in conjunction with published incidence rates and population projections to predict numbers of new cases throughout Europe in 2005, 2010, 2015, and 2020. Findings Ascertainment was better than 90% in most registers. All but two registers showed significant yearly increases in incidence, ranging from 0.6% to 9.3%. The overall annual increase was 3.9% (95% Cl 3.6-4.2), and the increases in the age groups 0-4 years, 5-9 years, and 10-14 years were 5.4% (4.8-6.1), 4.3% (3.8-4.8), and 2.9% (2.5-3.3), respectively. The number of new cases in Europe in 2005 is estimated as 15000, divided between the 0-4 year, 5-9 year, and 10-14 year age-groups in the ratio 24%, 35%, and 41%, respectively. In 2020, the predicted number of new cases is 24400, with a doubling in numbers in children younger than 5 years and a more even distribution across age-groups than at present (29%, 37%, and 34%, respectively). Prevalence under age 15 years is predicted to rise from 94 000 in 2005, to 160 000 in 2020. Interpretation If present trends continue, doubling of new cases of type 1 diabetes in European children younger than 5 years is predicted between 2005 and 2020, and prevalent cases younger than 15 years will rise by 70%. Adequate health-care resources to meet these children's needs should be made available.	[Patterson, Christopher C.] Queens Univ Belfast, Ctr Publ Hlth, Epidemiol Res Grp, Mulhouse Bldg,Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland; [Dahquist, Gisela G.] Umea Univ, Dept Clin Sci, Umea, Sweden; [Gyurus, Eva; Soltesz, Gyula] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [Green, Anders] Univ So Denmark, Inst Publ Hlth, Dept Epidemiol, Odense, Denmark; [Green, Anders] S Odense Univ Hosp, Ctr Natl Clin Database, Odense, Denmark	Queens University Belfast; Umea University; University of Pecs; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Patterson, CC (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Epidemiol Res Grp, Mulhouse Bldg,Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland.	c.patterson@qub.ac.uk	Polanska, Joanna/A-5271-2008; Polanska, Joanna/H-4513-2013; Green, Anders/T-8788-2019	Polanska, Joanna/0000-0001-8004-9864; Green, Anders/0000-0002-5059-3655; Cinek, Ondrej/0000-0002-0526-8714; Sjoberg, Lena/0000-0002-5420-5189; Jarosz-Chobot, Przemyslawa/0000-0002-1120-0994; Weets, Ilse/0000-0002-9007-5203; Sumnik, Zdenek/0000-0002-6462-6462; Cardwell, Chris/0000-0002-2689-4335; Gorus, Frans/0000-0002-9007-6177; Svensson, Jannet/0000-0002-9365-0728; Albert Goday Arno, Albert/0000-0001-7356-1595; Mortensen, Henrik Bindesbol/0000-0001-9231-8363; Battelino, Tadej/0000-0002-0273-4732; de Beaufort, Carine/0000-0003-4310-6799	Czech Ministry of Eduction [MSM 0021620814]; Finnish National Institute for Health and Welfare; German Paediatric Surveillance Unit, Dusseldorf University and DPV Science Initiative, Ulm University; Hungarian Childhood Diabetes Epidemiology Group; Northern Ireland Childhood Diabetes Group, Bart's-Oxford study group; Yorkshire Paediatric Diabetes Specialist Interest Group; Health Quality Information Partnership, Department of Health, England; Swedish Research Council [07531]; European Community [MR4*/029/UK, BMH1-CT92-0043, BMH4-CT96-0577, IC20-CT96-0070]; Diabetes UK; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish	Czech Ministry of Eduction; Finnish National Institute for Health and Welfare; German Paediatric Surveillance Unit, Dusseldorf University and DPV Science Initiative, Ulm University; Hungarian Childhood Diabetes Epidemiology Group; Northern Ireland Childhood Diabetes Group, Bart's-Oxford study group; Yorkshire Paediatric Diabetes Specialist Interest Group; Health Quality Information Partnership, Department of Health, England; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); Diabetes UK(Diabetes UK); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We thank Gerda Brutti, who was administrator for the EURODIAB study group during its first decade, the Austrian Diabetes Incidence Study Group, the Czech Childhood Diabetes Register (supported by Czech Ministry of Eduction grant MSM 0021620814), the Finnish National Institute for Health and Welfare, the German Paediatric Surveillance Unit, Dusseldorf University and DPV Science Initiative, Ulm University, the Hungarian Childhood Diabetes Epidemiology Group, the Northern Ireland Childhood Diabetes Group, Bart's-Oxford study group (register funded by Diabetes UK), the Yorkshire Paediatric Diabetes Specialist Interest Group (register funded by the Health Quality Information Partnership, Department of Health, England), and the Swedish Childhood Diabetes Study Group (register funded by the Swedish Research Council, Project number 07531). The collaboration was supported in part by European Community Concerted Action Program grants (MR4*/029/UK, BMH1-CT92-0043, BMH4-CT96-0577, and IC20-CT96-0070).	Aamodt G, 2007, DIABETES CARE, V30, P884, DOI 10.2337/dc06-1568; [Anonymous], WORLD POPULATION PRO; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bishop YM, 1974, DISCRETE MULTIVARIAT; Bruno G, 2001, DIABETOLOGIA, V44, P22, DOI 10.1007/s001250051575; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Dahlquist G, 2006, DIABETOLOGIA, V49, P20, DOI 10.1007/s00125-005-0076-4; Dahlquist G, 2002, DIABETES CARE, V25, P1755; *EUROSTAT, EUROSTAT EST 2005 PO; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Hermann R, 2003, DIABETOLOGIA, V46, P420, DOI 10.1007/s00125-003-1045-4; Joner G, 2004, DIABETES CARE, V27, P1618, DOI 10.2337/diacare.27.7.1618; Kaufman FR, 2007, PEDIATR DIABETES, V8, P4, DOI 10.1111/j.1399-5448.2007.00327.x; Kyvik KO, 2004, DIABETOLOGIA, V47, P377, DOI 10.1007/s00125-004-1331-9; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; Moltchanova E, 2005, STAT MED, V24, P2989, DOI 10.1002/sim.2166; Patterson CC, 2001, DIABETOLOGIA, V44, pB9, DOI 10.1007/PL00002961; Pundziute-Lycka A, 2004, ACTA PAEDIATR, V93, P1519, DOI 10.1080/08035250410026680; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; Schober E, 2008, EUR J PEDIATR, V167, P293, DOI 10.1007/s00431-007-0480-5; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; SOLTESZ G, 2006, DIABETES ATLAS, P153; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; Weets I, 2002, DIABETES CARE, V25, P840, DOI 10.2337/diacare.25.5.840; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548	31	1204	1245	0	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2027	2033		10.1016/S0140-6736(09)60568-7	http://dx.doi.org/10.1016/S0140-6736(09)60568-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DJ	19481249				2022-12-28	WOS:000267080100029
J	Olive, KP; Jacobetz, MA; Davidson, CJ; Gopinathan, A; McIntyre, D; Honess, D; Madhu, B; Goldgraben, MA; Caldwell, ME; Allard, D; Frese, KK; DeNicola, G; Feig, C; Combs, C; Winter, SP; Ireland-Zecchini, H; Reichelt, S; Howat, WJ; Chang, A; Dhara, M; Wang, LF; Ruckert, F; Grutzmann, R; Pilarsky, C; Izeradjene, K; Hingorani, SR; Huang, P; Davies, SE; Plunkett, W; Egorin, M; Hruban, RH; Whitebread, N; McGovern, K; Adams, J; Iacobuzio-Donahue, C; Griffiths, J; Tuveson, DA				Olive, Kenneth P.; Jacobetz, Michael A.; Davidson, Christian J.; Gopinathan, Aarthi; McIntyre, Dominick; Honess, Davina; Madhu, Basetti; Goldgraben, Mae A.; Caldwell, Meredith E.; Allard, David; Frese, Kristopher K.; DeNicola, Gina; Feig, Christine; Combs, Chelsea; Winter, Stephen P.; Ireland-Zecchini, Heather; Reichelt, Stefanie; Howat, William J.; Chang, Alex; Dhara, Mousumi; Wang, Lifu; Rueckert, Felix; Gruetzmann, Robert; Pilarsky, Christian; Izeradjene, Kamel; Hingorani, Sunil R.; Huang, Pearl; Davies, Susan E.; Plunkett, William; Egorin, Merrill; Hruban, Ralph H.; Whitebread, Nigel; McGovern, Karen; Adams, Julian; Iacobuzio-Donahue, Christine; Griffiths, John; Tuveson, David A.			Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer	SCIENCE			English	Article							DUCTAL ADENOCARCINOMA; SONIC HEDGEHOG; GEMCITABINE; GROWTH; METASTASIS; DIAGNOSIS; SURVIVAL; THERAPY; TUMORS; TRIAL	Pancreatic ductal adenocarcinoma (PDA) is among the most lethal human cancers in part because it is insensitive to many chemotherapeutic drugs. Studying a mouse model of PDA that is refractory to the clinically used drug gemcitabine, we found that the tumors in this model were poorly perfused and poorly vascularized, properties that are shared with human PDA. We tested whether the delivery and efficacy of gemcitabine in the mice could be improved by coadministration of IPI-926, a drug that depletes tumor-associated stromal tissue by inhibition of the Hedgehog cellular signaling pathway. The combination therapy produced a transient increase in intratumoral vascular density and intratumoral concentration of gemcitabine, leading to transient stabilization of disease. Thus, inefficient drug delivery may be an important contributor to chemoresistance in pancreatic cancer.	[Olive, Kenneth P.; Jacobetz, Michael A.; Gopinathan, Aarthi; McIntyre, Dominick; Honess, Davina; Madhu, Basetti; Goldgraben, Mae A.; Caldwell, Meredith E.; Allard, David; Frese, Kristopher K.; DeNicola, Gina; Feig, Christine; Winter, Stephen P.; Ireland-Zecchini, Heather; Reichelt, Stefanie; Howat, William J.; Griffiths, John; Tuveson, David A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 ORE, England; [Davidson, Christian J.; Gopinathan, Aarthi; DeNicola, Gina; Combs, Chelsea; Wang, Lifu] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Chang, Alex; Dhara, Mousumi; Hruban, Ralph H.; Iacobuzio-Donahue, Christine] Sidney Canc Ctr, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21287 USA; [Chang, Alex; Dhara, Mousumi; Hruban, Ralph H.; Iacobuzio-Donahue, Christine] Sidney Canc Ctr, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21287 USA; [Chang, Alex; Dhara, Mousumi; Hruban, Ralph H.; Iacobuzio-Donahue, Christine] Johns Hopkins Univ, Baltimore, MD 21287 USA; [Wang, Lifu] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, Shanghai 200025, Peoples R China; [Rueckert, Felix; Gruetzmann, Robert; Pilarsky, Christian] Univ Hosp Dresden, Dept Surg, D-01307 Dresden, Germany; [Izeradjene, Kamel; Hingorani, Sunil R.] Fred Hutchinson Canc Res Ctr, Clin Res & Publ Hlth Sci Div, Seattle, WA 98109 USA; [Izeradjene, Kamel; Hingorani, Sunil R.] Univ Washington, Seattle, WA 98109 USA; [Huang, Pearl] Merck & Co Inc, Oncol Franchise, N Wales, PA 19454 USA; [Davies, Susan E.] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England; [Plunkett, William] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Egorin, Merrill] Univ Pittsburgh, Med Ctr, Div Hematol & Oncol, Pittsburgh, PA 15213 USA; [Whitebread, Nigel; McGovern, Karen; Adams, Julian] Infin Pharmaceut, Cambridge, MA 01239 USA	Cancer Research UK; CRUK Cambridge Institute; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Shanghai Jiao Tong University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Merck & Company; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tuveson, DA (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 ORE, England.	david.tuveson@cancer.org.uk	Griffiths, John R/F-2853-2010; Madhu, Basetti/AAW-9665-2020; McIntyre, Dominick/F-2998-2010; Iacobuzio-Donahue, Christine/ABF-1295-2020	Madhu, Basetti/0000-0001-5844-856X; McIntyre, Dominick/0000-0002-0269-6545; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Olive, Kenneth/0000-0002-3392-8994; Goldgraben, Mae/0000-0002-1111-2804; DeNicola, Gina/0000-0001-6611-6696; Feig, Christine/0000-0003-1385-7049; Reichelt, Stefanie/0000-0003-4151-0712; Hingorani, Sunil/0000-0002-3869-8729; Pilarsky, Christian/0000-0002-7968-3283	Lustgarten Foundation; University of Cambridge; Cancer Research UK; The Li Ka Shing Foundation; Hutchison Whampoa Limited; National Institute for Health Research Cambridge Biomedical Research Centre; NIH [CA101973, CA111292, CA084291, CA105490, K08 CA106610, CA15704, CA114028, F32CA123939-02, F32CA123887-01]; Mead Foundation; University of Pennsylvania GlaxoSmithKline Alternative Drug Discovery Initiative; NATIONAL CANCER INSTITUTE [F32CA123887, U01CA105490, K08CA114028, U01CA084291, K08CA106610, R01CA101973, P30CA015704, F32CA123939] Funding Source: NIH RePORTER	Lustgarten Foundation; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); The Li Ka Shing Foundation; Hutchison Whampoa Limited; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mead Foundation; University of Pennsylvania GlaxoSmithKline Alternative Drug Discovery Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the animal care staffs of the Cambridge Research Institute (CRI), University of Pennsylvania Translational Research Labs, FHCRC, and University Hospital Dresden as well as the histology and genomics cores at CRI, and P. Calses for technical assistance. We also thank B. Bean of Transnetyx Inc. for developing high-throughput genotyping assays for the KPC mice. This research was supported by the Lustgarten Foundation, the University of Cambridge and Cancer Research UK, The Li Ka Shing Foundation and Hutchison Whampoa Limited, the National Institute for Health Research Cambridge Biomedical Research Centre, and NIH (grants CA101973, CA111292, CA084291, and CA105490 to D.A.T.; K08 CA106610 to C.I.-D.; and CA15704 and CA114028 to S.R.H.). S.R.H. was supported by a grant from the Mead Foundation. Preliminary studies were supported by a grant from the University of Pennsylvania GlaxoSmithKline Alternative Drug Discovery Initiative. K.P.O. and K.K.F. were supported by NIH under Ruth L. Kirschstein National Research Service Awards F32CA123939-02 (K.P.O.) and F32CA123887-01 (K.K.F.). In addition to being an officer of Infinity Pharmaceuticals, J.A. is a member of the Senior Advisory Boards of Constellation Pharma and Auspex Pharma. Cancer Research Technology, which is associated with Cancer Research UK, has filed a U.S. provisional patent application related to this work.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bruns CJ, 2002, INT J CANCER, V102, P101, DOI 10.1002/ijc.10681; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cook N, 2008, METHOD ENZYMOL, V439, P73, DOI 10.1016/S0076-6879(07)00406-5; Duan JX, 2008, J MED CHEM, V51, P2412, DOI 10.1021/jm701028q; EGORIN MJ, 1974, CANCER RES, V34, P2243; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Langer SJ, 2002, NUCLEIC ACIDS RES, V30, P3067, DOI 10.1093/nar/gkf421; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Sakamoto H, 2008, ULTRASOUND MED BIOL, V34, P525, DOI 10.1016/j.ultrasmedbio.2007.09.018; SCHULTZ RM, 1993, ONCOL RES, V5, P223; Shimamura T, 2007, CANCER RES, V67, P9903, DOI 10.1158/0008-5472.CAN-06-4558; Sofuni A, 2005, J GASTROENTEROL, V40, P518, DOI 10.1007/s00535-005-1578-z; Tempero M, 2003, J CLIN ONCOL, V21, P3402, DOI 10.1200/JCO.2003.09.140; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	27	2287	2354	15	410	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1457	1461		10.1126/science.1171362	http://dx.doi.org/10.1126/science.1171362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19460966	Green Accepted			2022-12-28	WOS:000266878700050
J	Matsumoto, M; Hikosaka, O				Matsumoto, Masayuki; Hikosaka, Okihide			Two types of dopamine neuron distinctly convey positive and negative motivational signals	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE; NUCLEUS-ACCUMBENS; LATERAL HABENULA; AVERSIVE STIMULI; DISCHARGE RATE; REWARD; STRIATUM; PRIMATE	Midbrain dopamine neurons are activated by reward or sensory stimuli predicting reward(1-4). These excitatory responses increase as the reward value increases(5). This response property has led to a hypothesis that dopamine neurons encode value-related signals and are inhibited by aversive events. Here we show that this is true only for a subset of dopamine neurons. We recorded the activity of dopamine neurons in monkeys (Macaca mulatta) during a Pavlovian procedure with appetitive and aversive outcomes (liquid rewards and airpuffs directed at the face, respectively). We found that some dopamine neurons were excited by reward-predicting stimuli and inhibited by airpuff-predicting stimuli, as the value hypothesis predicts. However, a greater number of dopamine neurons were excited by both of these stimuli, inconsistent with the hypothesis. Some dopamine neurons were also excited by both rewards and airpuffs themselves, especially when they were unpredictable. Neurons excited by the airpuff-predicting stimuli were located more dorsolaterally in the substantia nigra pars compacta, whereas neurons inhibited by the stimuli were located more ventromedially, some in the ventral tegmental area. A similar anatomical difference was observed for their responses to actual airpuffs. These findings suggest that different groups of dopamine neurons convey motivational signals in distinct manners.	[Matsumoto, Masayuki; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Matsumoto, M (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	matsumotom@nei.nih.gov			Intramural Research Program at the National Institutes of Health, National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Hong, E. Bromberg-Martin, M. Yasuda, S. Yamamoto and Y. Tachibana for discussion, M. K. Smith for his histological expertise, J. W. McClurkin, A. M. Nichols, T. W. Ruffner, A. V. Hays and L. P. Jensen for technical assistance, and G. Tansey, D. Parker and B. Nagy for animal care. This research was supported by the Intramural Research Program at the National Institutes of Health, National Eye Institute.	CARLI M, 1985, NATURE, V313, P679, DOI 10.1038/313679a0; CHIODO LA, 1980, BRAIN RES, V189, P544, DOI 10.1016/0006-8993(80)90366-2; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Davies RM, 2006, J NEUROPHYSIOL, V96, P906, DOI 10.1152/jn.01030.2005; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KITAMA T, 1991, NEUROSCI RES, V12, P287, DOI 10.1016/0168-0102(91)90118-I; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P625, DOI 10.1016/0306-4522(94)90182-1; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Richardson R T, 1991, Adv Exp Med Biol, V295, P233; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360	29	872	879	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					837	U4		10.1038/nature08028	http://dx.doi.org/10.1038/nature08028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19448610	Green Accepted			2022-12-28	WOS:000267084500038
J	Wilson, D; Hurtado, RM; Digumarthy, S				Wilson, Douglas; Hurtado, Rocio M.; Digumarthy, Subba			A Woman with AIDS and Tuberculosis with Progressive Cough, Dyspnea, and Wasting Extensively drug-resistant Mycobacterium tuberculosis infection in a patient with HIV/AIDS.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	2nd Annual Workshop on Advanced Clinical Care - AidsIEEE International Conference on Computer Design	OCT 02, 2008OCT 12-15, 2008	Durban, SOUTH AFRICALake Tahoe, CA	IEEE, IEEE Circuits & Syst Soc, IEEE Comp Soc			MULTIDRUG-RESISTANT; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; SOUTH-AFRICA; THERAPY; LIMA; PERU; DIAGNOSIS; STRAINS		[Wilson, Douglas] Edendale Hosp, Dept Med, Pietermaritzburg, South Africa; [Wilson, Douglas] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Med, Durban, South Africa; [Hurtado, Rocio M.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Digumarthy, Subba] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hurtado, Rocio M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Digumarthy, Subba] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wilson, D (corresponding author), Edendale Hosp, Dept Med, Pietermaritzburg, South Africa.							Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Churchyard GJ, 2000, S AFR MED J, V90, P472; Condos Rany, 2008, Chest, V134, P187, DOI 10.1378/chest.07-1988; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gerntholtz TE, 2006, KIDNEY INT, V69, P1885, DOI 10.1038/sj.ki.5000351; Grau S, 2006, INT J ANTIMICROB AG, V28, P249, DOI 10.1016/j.ijantimicag.2006.03.029; Hot A, 2007, INFECT DIS CLIN N AM, V21, P1013, DOI 10.1016/j.idc.2007.08.003; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kwon YS, 2008, CLIN INFECT DIS, V47, P496, DOI 10.1086/590005; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Pachas AMC, 2004, INT J TUBERC LUNG D, V8, P52; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; *S AFR TURB CONTR, 2000, PRACT GUID 2000; Smego RA, 2003, INT J TUBERC LUNG D, V7, P208; Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961; Theron LC, 2008, EDUC CHANGE, V12, P45, DOI 10.1080/16823200809487194; Waisman JL, 2001, MEDICINA-BUENOS AIRE, V61, P810; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; *WHO, 1999, PUBL WHO; *WHO, 2006, PUBL WHO	29	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2456	2464		10.1056/NEJMcpc0902226	http://dx.doi.org/10.1056/NEJMcpc0902226			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	453DN	19494222	Bronze			2022-12-28	WOS:000266590500013
J	Strasburger, VC				Strasburger, Victor C.			Media and Children What Needs to Happen Now?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PEDIATRICIANS		Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA	University of New Mexico	Strasburger, VC (corresponding author), Univ New Mexico, Sch Med, MSC10 5590,1 Univ New Mexico, Albuquerque, NM 87131 USA.	vstrasburger@salud.unm.edu						Barkin SL, 2008, PEDIATRICS, V122, pE15, DOI 10.1542/peds.2007-2611; Becker AE, 2002, BRIT J PSYCHIAT, V180, P509, DOI 10.1192/bjp.180.6.509; Borzekowski DLG, 2008, HDB CHILDREN MEDIA, P432, DOI DOI 10.1002/9781444302752.CH19; Brown Jane D, 2007, Adolesc Med State Art Rev, V18, P484; Bushman BJ, 2006, ARCH PEDIAT ADOL MED, V160, P348, DOI 10.1001/archpedi.160.4.348; Gantz W, 2007, FOOD THOUGHT TELEVIS; Gentile DA, 2004, PEDIATRICS, V114, P1235, DOI 10.1542/peds.2003-1121-L; Hogan Marjorie J, 2008, Adolesc Med State Art Rev, V19, P521; Hogan MJ, 2008, EDUC PSYCHOL HANDB, P537; Jordan Amy B, 2008, Adolesc Med State Art Rev, V19, P431; Rideout V. J., 2005, GENERATION M MEDIA L; Strasburger V. C., 2009, CHILDREN ADOLESCENTS; Strasburger VC, 2007, J PEDIATR-US, V151, P334, DOI 10.1016/j.jpeds.2007.05.040; Strasburger VC, 2009, J ADOLESCENT HEALTH, V44, P203, DOI 10.1016/j.jadohealth.2008.12.019; Titus-Ernstoff L, 2008, PEDIATRICS, V121, P15, DOI 10.1542/peds.2007-0051	15	18	18	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2265	2266		10.1001/jama.2009.572	http://dx.doi.org/10.1001/jama.2009.572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491189				2022-12-28	WOS:000266554100026
J	Kliiman, K; Altraja, A				Kliiman, Kai; Altraja, Alan			Predictors of Extensively Drug-Resistant Pulmonary Tuberculosis	ANNALS OF INTERNAL MEDICINE			English	Article							MULTIDRUG-RESISTANT; RISK-FACTORS; TREATMENT OUTCOMES; TB PATIENTS; COUNTRIES; RUSSIA	Background: About 40 000 cases of extensively drug-resistant tuberculosis emerge worldwide annually, but the predictors of extensive drug resistance are unclear. Objective: To identify risk factors for extensively drug-resistant tuberculosis and multidrug-resistant but non-extensively drug-resistant tuberculosis in patients with culture-confirmed pulmonary tuberculosis. Design: Cross-sectional, countrywide study. Setting: Estonia, a country with 1 of the world's highest rates of extensively drug-resistant and multidrug-resistant tuberculosis. Patients: All patients with culture-confirmed pulmonary tuberculosis with clinical or radiologic evidence of active disease detected from January 2003 to December 2005. Measurements: Risk determinants from patients' demographic characteristics, socioeconomic variables, and tuberculosis-related data or HIV status. Results: Of 1163 patients, 60 (5.2%) had extensively drug-resistant tuberculosis and 196 (16.9%) had multidrug-resistant but non-extensively drug-resistant tuberculosis. Previous antituberculosis treatment (adjusted odds ratio [OR], 10.54 [95% CI, 5.97 to 18.62]), HIV infection (OR, 3.12 [CI, 1.31 to 7.41]), homelessness (OR, 2.73 [CI, 1.15 to 6.48]), and alcohol abuse (OR, 1.98 [CI, 1.08 to 3.64]) increased risk for extensive drug resistance. Previous treatment (OR, 4.11 [CI, 2.77 to 6.08]) and age 24 years or younger (OR, 2.57 [CI, 1.09 to 6.06]), 25 to 44 years (OR, 2.64 [CI, 1.35 to 5.16]), and 45 to 64 years (OR, 2.06 [CI, 1.06 to 3.99]) were determinants of multidrug resistance. In patients age 24 years or younger, female sex (OR, 6.23 [CI, 1.02 to 37.99]) and birth outside of Estonia (OR, 82.04 [CI, 3.46 to 1945.47]) increased risk for multidrug resistance. Limitation: Patients' comorbid conditions and drug abuse history were not incorporated into analyses because of inconsistent source data. Conclusion: Previous treatment is a common risk factor for extensively drug-resistant and multidrug-resistant tuberculosis. Reducing relapses; screening persons younger than 65 years and immigrants; and combating against HIV infection, alcoholism, and homelessness are key issues for decreasing the spread of highly drug-resistant tuberculosis.	[Kliiman, Kai] Univ Tartu, Dept Pulm Med, EE-51014 Tartu, Estonia	University of Tartu	Kliiman, K (corresponding author), Univ Tartu, Dept Pulm Med, Riia 167, EE-51014 Tartu, Estonia.	kai.kliiman@kliinikum.ee			Estonian Health Insurance Fund	Estonian Health Insurance Fund	By the Estonian Health Insurance Fund.	[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P387; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Clark CM, 2005, INT J TUBERC LUNG D, V9, P964; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Falzon D, 2006, INT J TUBERC LUNG D, V10, P954; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Granich RM, 2005, JAMA-J AM MED ASSOC, V293, P2732, DOI 10.1001/jama.293.22.2732; HARO S, 1994, TUBERCLE LUNG DIS, V75, P271, DOI 10.1016/0962-8479(94)90132-5; HOLLO V, 2007, TUBERCULOSIS INCIDEN; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748; Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489; Mdivani N, 2008, INT J INFECT DIS, V12, P635, DOI 10.1016/j.ijid.2008.03.012; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Migliori GB, 2007, EUR RESPIR J, V29, P423, DOI 10.1183/09031936.00001307; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Tekkel M, 2002, INT J TUBERC LUNG D, V6, P887; *UNAIDS WHO, 2006, AIDS DEP UPD; *WHO, 2006, ALC CONTR SER WHO, V4; *WHO, GLOB MAP INF XDR TB; World Health Organization (WHO), 2008, 4 WHOIUATLD; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301	30	43	47	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					766	W137		10.7326/0003-4819-150-11-200906020-00004	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487711				2022-12-28	WOS:000266530000003
J	Beroza, GC; Ide, S				Beroza, Gregory C.; Ide, Satoshi			Deep Tremors and Slow Quakes	SCIENCE			English	Editorial Material							SILENT SLIP EVENTS; SUBDUCTION ZONE; SOUTHWEST JAPAN; EARTHQUAKES; TRANSITION		[Beroza, Gregory C.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Ide, Satoshi] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	Stanford University; University of Tokyo	Beroza, GC (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	beroza@stanford.edu	IDE, SATOSHI/G-4887-2014	IDE, SATOSHI/0000-0003-0063-548X				Brodsky EE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030917; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Gomberg J, 2008, SCIENCE, V319, P173, DOI 10.1126/science.1149164; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Ito Y, 2007, SCIENCE, V315, P503, DOI 10.1126/science.1134454; Katsumata A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015981; Liu Y, 2007, EARTH PLANET SC LETT, V262, P493, DOI 10.1016/j.epsl.2007.08.018; McCaffrey R, 2008, NAT GEOSCI, V1, P316, DOI 10.1038/ngeo178; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Payero JS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032877; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Segall P, 2006, NATURE, V442, P71, DOI 10.1038/nature04938; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036367; Shibazaki B, 2007, GEOPHYS J INT, V171, P191, DOI 10.1111/j.1365-246X.2007.03434.x	17	31	33	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1025	1026		10.1126/science.1171231	http://dx.doi.org/10.1126/science.1171231			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460995				2022-12-28	WOS:000266246700028
J	Fazel, S; Langstrom, N; Hjern, A; Grann, M; Lichtenstein, P				Fazel, Seena; Langstrom, Niklas; Hjern, Anders; Grann, Martin; Lichtenstein, Paul			Schizophrenia, Substance Abuse, and Violent Crime	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAJOR MENTAL-DISORDERS; BIRTH COHORT; FOLLOW-UP; ILLNESS; BEHAVIOR; COMMUNITY; HEALTH; MULTICENTER; MEDICATION; REGISTER	Context Persons with schizophrenia are thought to be at increased risk of committing violent crime 4 to 6 times the level of general population individuals without this disorder. However, risk estimates vary substantially across studies, and considerable uncertainty exists as to what mediates this elevated risk. Despite this uncertainty, current guidelines recommend that violence risk assessment should be conducted for all patients with schizophrenia. Objective To determine the risk of violent crime among patients diagnosed as having schizophrenia and the role of substance abuse in mediating this risk. Design, Setting, and Participants Longitudinal designs were used to link data from nationwide Swedish registers of hospital admissions and criminal convictions in 1973-2006. Risk of violent crime in patients after diagnosis of schizophrenia (n = 8003) was compared with that among general population controls (n = 80 025). Potential confounders (age, sex, income, and marital and immigrant status) and mediators (substance abuse comorbidity) were measured at baseline. To study familial confounding, we also investigated risk of violence among unaffected siblings (n = 8123) of patients with schizophrenia. Information on treatment was not available. Main Outcome Measure Violent crime (any criminal conviction for homicide, assault, robbery, arson, any sexual offense, illegal threats, or intimidation). Results In patients with schizophrenia, 1054 (13.2%) had at least 1 violent offense compared with 4276 (5.3%) of general population controls (adjusted odds ratio [OR], 2.0; 95% confidence interval [CI], 1.8-2.2). The risk was mostly confined to patients with substance abuse comorbidity (of whom 27.6% committed an offense), yielding an increased risk of violent crime among such patients (adjusted OR, 4.4; 95% CI, 3.9-5.0), whereas the risk increase was small in schizophrenia patients without substance abuse comorbidity (8.5% of whom had at least 1 violent offense; adjusted OR, 1.2; 95% CI, 1.1-1.4; P<.001 for interaction). The risk increase among those with substance abuse comorbidity was significantly less pronounced when unaffected siblings were used as controls (28.3% of those with schizophrenia had a violent offense compared with 17.9% of their unaffected siblings; adjusted OR, 1.8; 95% CI, 1.4-2.4; P<.001 for interaction), suggesting significant familial (genetic or early environmental) confounding of the association between schizophrenia and violence. Conclusions Schizophrenia was associated with an increased risk of violent crime in this longitudinal study. This association was attenuated by adjustment for substance abuse, suggesting a mediating effect. The role of risk assessment, management, and treatment in individuals with comorbidity needs further examination.	[Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Grann, Martin] Univ Stockholm, Dept Psychol, S-10691 Stockholm, Sweden; [Fazel, Seena; Langstrom, Niklas; Grann, Martin] Univ Stockholm, Ctr Violence Prevent, Stockholm, Sweden; [Langstrom, Niklas; Lichtenstein, Paul] Univ Stockholm, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hjern, Anders] Univ Stockholm, Karolinska Inst, Ctr Epidemiol, Natl Board Hlth & Welf, Stockholm, Sweden; [Hjern, Anders] Uppsala Univ, Dept Childrens & Womens Hlth, Uppsala, Sweden	University of Oxford; Stockholm University; Stockholm University; Stockholm University; Karolinska Institutet; National Board of Health & Welfare; Stockholm University; Uppsala University	Fazel, S (corresponding author), Warneford Hosp, Univ Dept Psychiat, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Langstrom, Niklas/C-5615-2009; Fazel, Seena/B-5307-2008	Langstrom, Niklas/0000-0002-2686-6799; Fazel, Seena/0000-0002-5383-5365; lichtenstein, paul/0000-0003-3037-5287; Hjern, Anders/0000-0002-1645-2058	Swedish Research Council Medicine; Swedish Council for Working Life and Social Research	Swedish Research Council Medicine(Swedish Research Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The Swedish Research Council Medicine and the Swedish Council for Working Life and Social Research funded the study.	American Psychiatric Association, 2004, PRACT GUID TREATM PA; Angermeyer MC, 1996, SOC SCI MED, V43, P1721, DOI 10.1016/S0277-9536(96)00065-2; Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Arseneault L, 2003, BRIT J PSYCHIAT, V183, P520, DOI 10.1192/bjp.183.6.520; Bergman B, 1999, AM J FORENSIC PSYCH, V20, P27; Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Brewer RD, 2005, JAMA-J AM MED ASSOC, V294, P616, DOI 10.1001/jama.294.5.616; Chen Xiao, 2003, REGRESSION STATA; Cole TB, 2005, JAMA-J AM MED ASSOC, V294, P623, DOI 10.1001/jama.294.5.623; Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3; DOLMEN L, 2001, BROTTSLIGHETEN OLIKA; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Farnham FR, 2001, LANCET, V358, P1926, DOI 10.1016/S0140-6736(01)06977-X; FARRINGTON D, 2004, CROSS NATL STUDIES C; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Gosden NP, 2005, SCHIZOPHRENIA BULL, V31, P759, DOI 10.1093/schbul/sbi015; Grann M, 2004, BRIT MED J, V328, P1233, DOI 10.1136/bmj.328.7450.1233; GRANN M, 1998, SCANDINAVIAN J FOREN, V3, P78; Gunnell D, 2003, BRIT J PSYCHIAT, V182, P164, DOI 10.1192/bjp.182.2.164; Hansson L, 2001, ACTA PSYCHIAT SCAND, V103, P45, DOI 10.1034/j.1600-0447.2001.00083.x; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; Hodgins S, 2001, INT J LAW PSYCHIAT, V24, P427, DOI 10.1016/S0160-2527(01)00077-2; James A, 1998, LANCET, V352, P1048; Johnson JG, 2000, AM J PSYCHIAT, V157, P1406, DOI 10.1176/appi.ajp.157.9.1406; Joyal CC, 2007, CURR PSYCHIATRY REV, V3, P33, DOI 10.2174/157340007779815628; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Klein-Geltink JE, 2007, J CLIN EPIDEMIOL, V60, P766, DOI 10.1016/j.jclinepi.2006.11.008; LANDIS JR, 1977, BIOMETRICS, V33, P174; Langstrom N, 1999, NORD J PSYCHIAT, V53, P61; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Mullen P. E., 2006, ADV PSYCHIAT TREATME, V12, P239, DOI DOI 10.1192/APT.12.4.239; Mullen PE, 2000, LANCET, V355, P614, DOI 10.1016/S0140-6736(99)05082-5; Rasanen P, 1998, SCHIZOPHRENIA BULL, V24, P437, DOI 10.1093/oxfordjournals.schbul.a033338; Satcher D, 2001, JAMA-J AM MED ASSOC, V285, P1697, DOI 10.1001/jama.285.13.1697; Statistics Sweden, 2005, FLERG 2004 BESKR INN; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Svensson AC, 2007, SCHIZOPHR RES, V91, P238, DOI 10.1016/j.schres.2006.12.002; Swanson JW, 2008, BRIT J PSYCHIAT, V193, P37, DOI 10.1192/bjp.bp.107.042630; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490; Swartz MS, 1998, AM J PSYCHIAT, V155, P226; Tiihonen J, 1997, AM J PSYCHIAT, V154, P840; Walsh E, 2004, SCHIZOPHR RES, V67, P247, DOI 10.1016/S0920-9964(03)00091-4; Walsh E, 2002, BRIT J PSYCHIAT, V180, P490, DOI 10.1192/bjp.180.6.490; Williams J, 1996, PSYCHOL MED, V26, P775, DOI 10.1017/S003329170003779X	49	400	417	7	105	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					2016	2023		10.1001/jama.2009.675	http://dx.doi.org/10.1001/jama.2009.675			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	446YU	19454640	Green Accepted, Bronze			2022-12-28	WOS:000266159600026
J	Niinuma, H				Niinuma, Hiroyuki			Computed tomography angiography is highly accurate for diagnosing significant stenosis in peripheral arterial disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Iwate Med Univ, Morioka, Iwate 020, Japan	Iwate Medical University	Niinuma, H (corresponding author), Iwate Med Univ, Morioka, Iwate 020, Japan.							Met R, 2009, JAMA-J AM MED ASSOC, V301, P415, DOI 10.1001/jama.301.4.415	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-12	10.7326/0003-4819-150-10-200905190-02012	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451568				2022-12-28	WOS:000266285300032
J	Tareen, M; Grossman, ME				Tareen, Mohiba; Grossman, Marc E.			White Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tareen, Mohiba; Grossman, Marc E.] Columbia Univ, New York, NY 10032 USA	Columbia University	Tareen, M (corresponding author), Columbia Univ, New York, NY 10032 USA.	mk2750@columbia.edu							0	0	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					E26	E26		10.1056/NEJMicm0807237	http://dx.doi.org/10.1056/NEJMicm0807237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439737				2022-12-28	WOS:000266011200011
J	Trabucchi, M; Briata, P; Garcia-Mayoral, M; Haase, AD; Filipowicz, W; Ramos, A; Gherzi, R; Rosenfeld, MG				Trabucchi, Michele; Briata, Paola; Garcia-Mayoral, MariaFlor; Haase, Astrid D.; Filipowicz, Witold; Ramos, Andres; Gherzi, Roberto; Rosenfeld, Michael G.			The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs	NATURE			English	Article							POSTTRANSCRIPTIONAL REGULATION; DICER; EXPRESSION; MIRNAS; LIN-28; TRBP	Consistent with the role of microRNAs (miRNAs) in down-regulating gene expression by reducing the translation and/or stability of target messenger RNAs1, the levels of specific miRNAs are important for correct embryonic development and have been linked to several forms of cancer(2-4). However, the regulatory mechanisms by which primary miRNAs (pri-miRNAs) are processed first to precursor miRNAs (pre-miRNAs) and then to mature miRNAs by the multiprotein Drosha and Dicer complexes(5-8), respectively, remain largely unknown. The KH-type splicing regulatory protein (KSRP, also known as KHSRP) interacts with single-strand AU-rich-element-containing mRNAs and is a key mediator of mRNA decay(9,10). Here we show in mammalian cells that KSRP also serves as a component of both Drosha and Dicer complexes and regulates the biogenesis of a subset of miRNAs. KSRP binds with high affinity to the terminal loop of the target miRNA precursors and promotes their maturation. This mechanism is required for specific changes in target mRNA expression that affect specific biological programs, including proliferation, apoptosis and differentiation. These findings reveal an unexpected mechanism that links KSRP to the machinery regulating maturation of a cohort of miRNAs that, in addition to its role in promoting mRNA decay, independently serves to integrate specific regulatory programs of protein expression.	[Trabucchi, Michele; Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept & Sch Med, La Jolla, CA 92093 USA; [Briata, Paola; Gherzi, Roberto] Ist Nazl Ric Canc IST, I-16132 Genoa, Italy; [Garcia-Mayoral, MariaFlor; Ramos, Andres] Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Haase, Astrid D.; Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Genoa; IRCCS AOU San Martino IST; MRC National Institute for Medical Research; Friedrich Miescher Institute for Biomedical Research	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept & Sch Med, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	aramos@nimr.mrc.ac.uk; rgherzi@ucsd.edu; mrosenfeld@ucsd.edu	Briata, Paola/AAC-6039-2020; Trabucchi, Michele/O-1755-2018; @haase_astrid, Astrid D/HHS-1635-2022; Gherzi, Roberto/AAA-7256-2020	Briata, Paola/0000-0003-3470-0454; @haase_astrid, Astrid D/0000-0003-1120-9013; Gherzi, Roberto/0000-0001-8654-0611; Trabucchi, Michele/0000-0001-6885-5628	Italian ISS [527B/2B/6]; AIRC; CIPE; ISS [526D/39]; EC; NIH [DK018477, DK39949, HL065445]; AICF; Wellcome Trust [WT022088MA]; Novartis Research Foundation; MRC [MC_U117574558, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117574558] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R01DK018477, R37DK039949] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	Italian ISS; AIRC(Fondazione AIRC per la ricerca sul cancro); CIPE; ISS; EC(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AICF; Wellcome Trust(Wellcome TrustEuropean Commission); Novartis Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fondazione Telethon(Fondazione Telethon)	We thank V. Narry Kim, T. C. Hobman, I. G. Macara, D. Srivastava and J. G. Belasco for reagents, G. Corte for sharing laboratory facilities and critical reading, Y. T. Liu for use of the microarray facility, M. Ponassi and C. Nelson for technical assistance, I. Diaz-Moreno, M. Doyle, S. Martin and D. Hollingworth for discussions and reagents, and A. Pasquinelli and A. De Flora for comments and discussions. Part of the studies has been conducted in the laboratories and facilities of the Centro Biotecnologie Avanzate (CBA, Genova, Italy). M. G. R. is an investigator with the Howard Hughes Medical Institute. M. T. is supported by a post-doctoral fellowship from the Italian Telethon Foundation. This work has been partly supported by grants from Italian ISS (527B/2B/6), AIRC and CIPE 2007 to R. G., ISS (526D/39) to P. B., the EC FP6 Program Sirocco to W. F. and NIH grants DK018477, DK39949 and HL065445 to M. G. R. P. B. is recipient of a Senior Scholar Consultancy grant from AICF. Structural work on KSRP-RNA interaction is supported by grant WT022088MA from the Wellcome Trust. NMR spectra were recorded at the MRC Biomedical NMR Centre, London. The Friedrich Miescher Institute is supported by the Novartis Research Foundation.	Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 2000, GENE DEV, V14, P1236; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dorin D, 2003, J BIOL CHEM, V278, P4440, DOI 10.1074/jbc.M208954200; Garcia-Mayoral MF, 2008, NUCLEIC ACIDS RES, V36, P5290, DOI 10.1093/nar/gkn509; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Martin SR, 2004, FEBS LETT, V577, P284, DOI 10.1016/j.febslet.2004.10.023; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruggiero T, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-28; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schrimpf SP, 2001, ELECTROPHORESIS, V22, P1224, DOI 10.1002/1522-2683()22:6&lt;1224::AID-ELPS1224&gt;3.0.CO;2-I; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	40	489	498	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					1010	U144		10.1038/nature08025	http://dx.doi.org/10.1038/nature08025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19458619	Green Accepted			2022-12-28	WOS:000267063500048
J	Asthagiri, AR; Parry, DM; Butman, JA; Kim, HJ; Tsilou, ET; Zhuang, ZP; Lonser, RR				Asthagiri, Ashok R.; Parry, Dilys M.; Butman, John A.; Kim, H. Jeffrey; Tsilou, Ekaterini T.; Zhuang, Zhengping; Lonser, Russell R.			Neurofibromatosis type 2	LANCET			English	Review							SPINAL-CORD EPENDYMOMAS; NF2 TUMOR-SUPPRESSOR; BILATERAL ACOUSTIC NEUROFIBROMATOSIS; GENOTYPE-PHENOTYPE CORRELATIONS; VESTIBULAR SCHWANNOMA GROWTH; STEREOTACTIC RADIOSURGERY; HEARING PRESERVATION; DIAGNOSTIC-CRITERIA; DISEASE SEVERITY; NATURAL-HISTORY	Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that results from mutations in the NF2 tumour suppressor gene located on chromosome 22q. It has a frequency of one in 25 000 livebirths and nearly 100% penetrance by 60 years of age. Half of patients inherit a germline mutation from an affected parent and the remainder acquire a de novo mutation for neurofibromatosis type 2. Patients develop nervous system tumours (schwannomas, meningiomas, ependymomas, astrocytomas, and neurofibromas), peripheral neuropathy, ophthalmological lesions (cataracts, epiretinal membranes, and retinal hamartomas), and cutaneous lesions (skin tumours). Optimum treatment is multidisciplinary because of the complexities associated with management of the multiple, progressive, and protean lesions associated with the disorder. We review the molecular pathogenesis, genetics, clinical findings, and management strategies for neurofibromatosis type 2.	[Asthagiri, Ashok R.; Zhuang, Zhengping; Lonser, Russell R.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Parry, Dilys M.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Butman, John A.] NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA; [Kim, H. Jeffrey] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, Bethesda, MD USA; [Tsilou, Ekaterini T.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Asthagiri, AR (corresponding author), NINDS, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	asthagiria@ninds.nih.gov	Butman, John A/A-2694-2008; Butman, John/J-2780-2013	Butman, John/0000-0002-1547-9195	Intramural Research Program of the National Institute of Neurological Disorders; Stroke at the National Institutes of Health; NATIONAL EYE INSTITUTE [ZIEEY000477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003053] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders; Stroke at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health for their support of this Seminar.	Ahronowitz I, 2007, HUM MUTAT, V28, P1, DOI 10.1002/humu.20393; Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Antinheimo J, 1997, J NEUROSURG, V87, P610, DOI 10.3171/jns.1997.87.4.0610; Baser ME, 2006, NEUROLOGY, V66, P730, DOI 10.1212/01.wnl.0000201190.89751.41; Baser ME, 2005, J MED GENET, V42, P903, DOI 10.1136/jmg.2005.031302; Baser ME, 2005, J MED GENET, V42, P540, DOI 10.1136/jmg.2004.029504; Baser ME, 2004, AM J HUM GENET, V75, P231, DOI 10.1086/422700; Baser ME, 2003, J MED GENET, V40, P758, DOI 10.1136/jmg.40.10.758; Baser ME, 2002, NEUROLOGY, V59, P1759, DOI 10.1212/01.WNL.0000035638.74084.F4; Baser ME, 2002, J NEUROSURG, V96, P217, DOI 10.3171/jns.2002.96.2.0217; Baser ME, 2000, BRIT J CANCER, V82, P998; Baser ME, 1999, AM J HUM GENET, V64, P1230, DOI 10.1086/302338; Baser ME, 2002, AM J HUM GENET, V71, P715, DOI 10.1086/342716; BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; Bosch MM, 2006, AM J OPHTHALMOL, V141, P1068, DOI 10.1016/j.ajo.2005.12.042; BOUZAS EA, 1992, RETINA-J RET VIT DIS, V12, P103, DOI 10.1097/00006982-199212020-00005; BOUZAS EA, 1993, BRIT J OPHTHALMOL, V77, P354, DOI 10.1136/bjo.77.6.354; BOUZAS EA, 1993, NEUROLOGY, V43, P622, DOI 10.1212/WNL.43.3_Part_1.622; Brackmann DE, 2001, NEUROSURGERY, V49, P274, DOI 10.1097/00006123-200108000-00007; Buchman CA, 1996, LARYNGOSCOPE, V106, P1406, DOI 10.1097/00005537-199611000-00019; Chang UK, 2002, J NEURO-ONCOL, V57, P133; CHARABI S, 1992, ACTA OTO-LARYNGOL, V112, P810, DOI 10.3109/00016489209137478; Colosimo C, 2003, J NEUROSURG, V99, P114, DOI 10.3171/spi.2003.99.1.0114; Couldwell WT, 2006, J NEUROSURG, V105, P148, DOI 10.3171/jns.2006.105.1.148; Couldwell WT, 1996, J NEUROSURG, V84, P20, DOI 10.3171/jns.1996.84.1.0020; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Cushing H., 1917, TUMORS NERVUS ACUSTI; Dow G, 2005, J NEUROSURG-SPINE, V2, P574, DOI 10.3171/spi.2005.2.5.0574; DUMANSKI JP, 1987, P NATL ACAD SCI USA, V84, P9275, DOI 10.1073/pnas.84.24.9275; EGELHOFF JC, 1992, AM J NEURORADIOL, V13, P1071; ELDRIDGE R, 1991, AM J HUM GENET, V49, P133; EPSTEIN FJ, 1992, J NEUROSURG, V77, P355, DOI 10.3171/jns.1992.77.3.0355; EPSTEIN FJ, 1993, J NEUROSURG, V79, P204, DOI 10.3171/jns.1993.79.2.0204; Evans DGR, 2008, J NEUROSURG, V108, P92, DOI 10.3171/JNS/2008/108/01/0092; Evans DGR, 2006, J MED GENET, V43, P289, DOI 10.1136/jmg.2005.036319; Evans DGR, 2005, OTOL NEUROTOL, V26, P93, DOI 10.1097/00129492-200501000-00016; Evans DGR, 2005, J MED GENET, V42, P45, DOI 10.1136/jmg.2004.023705; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; Evans DGR, 1998, J MED GENET, V35, P450, DOI 10.1136/jmg.35.6.450; EVANS DGR, 1992, Q J MED, V84, P603; Evans DGR, 1999, ARCH DIS CHILD, V81, P496, DOI 10.1136/adc.81.6.496; Evans DGR, 2005, BRIT J NEUROSURG, V19, P5, DOI 10.1080/02688690500081206; Evans DGR, 2000, J MED GENET, V37, P897, DOI 10.1136/jmg.37.12.897; Evans GR, 2007, J MED GENET, V44, P424, DOI 10.1136/jmg.2006.047753; Feiling A, 1920, BRIT MED J, V1920, P496, DOI 10.1136/bmj.1.3093.496; FERRANTE L, 1992, ACTA NEUROCHIR, V119, P74, DOI 10.1007/BF01541785; Filler AG, 2004, NEUROL CLIN, V22, P643, DOI 10.1016/j.ncl.2004.03.005; FINE MJ, 1995, RADIOLOGY, V197, P655, DOI 10.1148/radiology.197.3.7480734; Fisher LM, 2007, OTOL NEUROTOL, V28, P1083, DOI 10.1097/MAO.0b013e31815a8411; Gardner WJ, 1930, ARCH NEURO PSYCHIATR, V23, P266, DOI 10.1001/archneurpsyc.1930.02220080050005; Gijtenbeek JMM, 2001, NEUROLOGY, V56, P1766, DOI 10.1212/WNL.56.12.1766; Giovannini M, 1999, GENE DEV, V13, P978, DOI 10.1101/gad.13.8.978; Hagel C, 2002, ACTA NEUROPATHOL, V104, P179, DOI 10.1007/s00401-002-0535-7; Hanemann CO, 2007, BRAIN PATHOL, V17, P371, DOI 10.1111/j.1750-3639.2007.00086.x; HOFFMAN RA, 1992, AM J OTOL, V13, P525; Hoshimaru M, 1999, NEUROSURGERY, V44, P264, DOI 10.1097/00006123-199902000-00012; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Iwata A, 1998, J NEUROL SCI, V156, P201, DOI 10.1016/S0022-510X(98)00032-X; JAASKELAINEN J, 1994, J NEUROSURG, V80, P541, DOI 10.3171/jns.1994.80.3.0541; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kalamarides M, 2002, GENE DEV, V16, P1060, DOI 10.1101/gad.226302; KANTER WR, 1980, NEUROLOGY, V30, P851, DOI 10.1212/WNL.30.8.851; KAYE LD, 1992, OPHTHALMOLOGY, V99, P1424; Khrais T, 2008, J LARYNGOL OTOL, V122, P128, DOI 10.1017/S0022215107001028; Kida Y, 2000, SURG NEUROL, V53, P383, DOI 10.1016/S0090-3019(00)00174-9; KILPATRICK TJ, 1992, J NEUROL NEUROSUR PS, V55, P391, DOI 10.1136/jnnp.55.5.391; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Kluwe L, 1998, HUM MOL GENET, V7, P2051, DOI 10.1093/hmg/7.13.2051; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kondziolka D, 1999, J NEUROSURG, V91, P44, DOI 10.3171/jns.1999.91.1.0044; Kuo Hung-Chou, 2004, J Clin Neuromuscul Dis, V5, P195, DOI 10.1097/01.cnd.0000108899.38238.7a; LANDAU K, 1990, ARCH OPHTHALMOL-CHIC, V108, P328, DOI 10.1001/archopht.1990.01070050026011; LARSON JJ, 1995, J NEUROSURG, V83, P596, DOI 10.3171/jns.1995.83.4.0596; Lee JY, 2004, J BIOL CHEM, V279, P30265, DOI 10.1074/jbc.M312083200; Lee M, 1996, NEUROSURGERY, V38, P32, DOI 10.1097/00006123-199601000-00009; Lim HH, 2007, J NEUROSCI, V27, P13541, DOI 10.1523/JNEUROSCI.3123-07.2007; Lim JY, 2006, BIOCHEM BIOPH RES CO, V340, P1151, DOI 10.1016/j.bbrc.2005.12.122; Lowe GM, 2000, J NEURO-ONCOL, V47, P195, DOI 10.1023/A:1006462321234; MacCollin M, 1998, Semin Pediatr Neurol, V5, P243, DOI 10.1016/S1071-9091(98)80003-X; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; Masuda A, 2004, OTOL NEUROTOL, V25, P150, DOI 10.1097/00129492-200403000-00012; Mathieu D, 2007, NEUROSURGERY, V60, P460, DOI 10.1227/01.NEU.0000255340.26027.53; MAUTNER VF, 1995, AM J ROENTGENOL, V165, P951, DOI 10.2214/ajr.165.4.7676998; Mautner VF, 1996, NEUROSURGERY, V38, P880, DOI 10.1097/00006123-199605000-00004; Mautner VF, 1997, ARCH DERMATOL, V133, P1539, DOI 10.1001/archderm.133.12.1539; MAYFRANK L, 1990, NEURORADIOLOGY, V32, P33, DOI 10.1007/BF00593938; MCCORMICK PC, 1990, J NEUROSURG, V72, P523, DOI 10.3171/jns.1990.72.4.0523; Meyers S M, 1995, Trans Am Ophthalmol Soc, V93, P245; MINEHAN KJ, 1995, J NEUROSURG, V83, P590, DOI 10.3171/jns.1995.83.4.0590; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Moyhuddin A, 2003, J MED GENET, V40, P459, DOI 10.1136/jmg.40.6.459; *NAT I HLTH CONS D, 1987, NEUROFIBROMATOSIS RE, V3, P3; Neff BA, 2007, LARYNGOSCOPE, V117, P1069, DOI 10.1097/MLG.0b013e31804b1ae7; Nunes F, 2003, J CHILD NEUROL, V18, P718, DOI 10.1177/08830738030180101301; Omeis I, 2006, SURG NEUROL, V65, P595, DOI 10.1016/j.surneu.2005.09.034; Otsuka G, 2003, J NEUROSURG, V99, P480, DOI 10.3171/jns.2003.99.3.0480; Otto SR, 2002, J NEUROSURG, V96, P1063, DOI 10.3171/jns.2002.96.6.1063; OverwegPlandsoen WCG, 1996, J NEUROL, V243, P724, DOI 10.1007/BF00873979; PARRY DM, 1994, AM J MED GENET, V52, P450, DOI 10.1002/ajmg.1320520411; Parry DM, 1996, AM J HUM GENET, V59, P529; Patronas NJ, 2001, RADIOLOGY, V218, P434, DOI 10.1148/radiology.218.2.r01fe40434; PEARSONWEBB MA, 1986, NEW ENGL J MED, V315, P1553; Perry A, 2001, J NEUROPATH EXP NEUR, V60, P994, DOI 10.1093/jnen/60.10.994; PYKETT MJ, 1994, HUM MOL GENET, V3, P559, DOI 10.1093/hmg/3.4.559; Ragge NK, 1997, EYE, V11, P12, DOI 10.1038/eye.1997.3; RAGGE NK, 1995, AM J OPHTHALMOL, V120, P634, DOI 10.1016/S0002-9394(14)72210-X; Rennie ATM, 2008, CLIN RADIOL, V63, P193, DOI 10.1016/j.crad.2007.08.003; Roche PH, 2000, NEUROCHIRURGIE, V46, P339; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; Rowe J, 2007, NEUROSURGERY, V60, P860, DOI 10.1227/01.NEU.0000255426.08926.95; Rowe JG, 2003, J NEUROL NEUROSUR PS, V74, P1288, DOI 10.1136/jnnp.74.9.1288; Ruggieri M, 2005, NEUROPEDIATRICS, V36, P21, DOI 10.1055/s-2005-837581; Ryu CH, 2005, ONCOGENE, V24, P5355, DOI 10.1038/sj.onc.1208633; Samii M, 1997, NEUROSURGERY, V40, P696, DOI 10.1097/00006123-199704000-00007; Scherer SS, 1996, J NEUROSCI RES, V46, P595, DOI 10.1002/(SICI)1097-4547(19961201)46:5<595::AID-JNR8>3.3.CO;2-2; Schwartz MS, 2008, NEUROTHERAPEUTICS, V5, P128, DOI 10.1016/j.nurt.2007.10.068; Scoles DR, 2006, HUM MOL GENET, V15, P1059, DOI 10.1093/hmg/ddl021; SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Siddiqui AA, 2004, BRIT J NEUROSURG, V18, P193, DOI 10.1080/02688690410001681109; Slattery WH, 1998, AM J OTOL, V19, P638; SOBEL RA, 1993, J NEUROPATH EXP NEUR, V52, P106, DOI 10.1097/00005072-199303000-00002; Sperfeld AD, 2002, BRAIN, V125, P996, DOI 10.1093/brain/awf115; THOMAS PK, 1990, MUSCLE NERVE, V13, P93, DOI 10.1002/mus.880130202; Trivedi R, 2000, J NEUROL NEUROSUR PS, V69, P257, DOI 10.1136/jnnp.69.2.257; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Twomey John G, 2008, J Pediatr Nurs, V23, P183, DOI 10.1016/j.pedn.2006.11.002; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wentworth S, 2009, INT J RADIAT ONCOL, V73, P208, DOI 10.1016/j.ijrobp.2008.03.073; Wiederhold T, 2004, ONCOGENE, V23, P8815, DOI 10.1038/sj.onc.1208110; WIESTLER OD, 1989, ACTA NEUROPATHOL, V79, P137, DOI 10.1007/BF00294370; Wishart J H, 1822, Edinb Med Surg J, V18, P393; 1991, NIH CONSEN STATEMENT, V9, P1	139	321	338	0	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1974	1986		10.1016/S0140-6736(09)60259-2	http://dx.doi.org/10.1016/S0140-6736(09)60259-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19476995	Green Accepted			2022-12-28	WOS:000266832500033
J	Bo, S; Siegert, MJ; Mudd, SM; Sugden, D; Fujita, S; Cui, XB; Jiang, YY; Tang, XY; Li, YS				Bo, Sun; Siegert, Martin J.; Mudd, Simon M.; Sugden, David; Fujita, Shuji; Cui Xiangbin; Jiang Yunyun; Tang Xueyuan; Li Yuansheng			The Gamburtsev mountains and the origin and early evolution of the Antarctic Ice Sheet	NATURE			English	Article							EAST ANTARCTICA; MIOCENE; VALLEY; EXPANSION; HISTORY	Ice-sheet development in Antarctica was a result of significant and rapid global climate change about 34 million years ago(1). Ice-sheet and climate modelling suggest reductions in atmospheric carbon dioxide ( less than three times the pre-industrial level of 280 parts per million by volume) that, in conjunction with the development of the Antarctic Circumpolar Current, led to cooling and glaciation paced by changes in Earth's orbit(2). Based on the present subglacial topography, numerical models point to ice-sheet genesis on mountain massifs of Antarctica, including the Gamburtsev mountains at Dome A, the centre of the present ice sheet(2,3). Our lack of knowledge of the present-day topography of the Gamburtsev mountains(4) means, however, that the nature of early glaciation and subsequent development of a continental-sized ice sheet are uncertain. Here we present radar information about the base of the ice at Dome A, revealing classic Alpine topography with pre-existing river valleys overdeepened by valley glaciers formed when the mean summer surface temperature was around 3 degrees C. This landscape is likely to have developed during the initial phases of Antarctic glaciation. According to Antarctic climate history (estimated from offshore sediment records) the Gamburtsev mountains are probably older than 34 million years and were the main centre for ice-sheet growth. Moreover, the landscape has most probably been preserved beneath the present ice sheet for around 14 million years.	[Bo, Sun; Cui Xiangbin; Jiang Yunyun; Tang Xueyuan; Li Yuansheng] Polar Res Inst China, Shanghai 200136, Peoples R China; [Siegert, Martin J.; Mudd, Simon M.; Sugden, David] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Fujita, Shuji] Natl Inst Polar Res, Res Org Informat & Syst, Itabashi Ku, Tokyo 1738515, Japan	Polar Research Institute of China; University of Edinburgh; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Bo, S (corresponding author), Polar Res Inst China, 451 Jinqiao Rd, Shanghai 200136, Peoples R China.	sunbo@pric.gov.cn; m.j.siegert@ed.ac.uk	Fujita, Shuji/A-7884-2016; Siegert, Martin J/A-3826-2008; Cui, Xiangbin/Y-1551-2019; Mudd, Simon M/F-8521-2010; Siegert, Martin/M-9939-2019	Fujita, Shuji/0000-0003-0127-0777; Siegert, Martin J/0000-0002-0090-4806; Mudd, Simon M/0000-0002-1357-8501; Siegert, Martin/0000-0002-0090-4806	National Natural Science Foundation of China [40476005]; Ministry of Science and Technology of China [2006BAB18B03]; UK Natural Environment Research Council [NE/D003733/1]; NERC [NE/F016646/1, NE/E018254/1] Funding Source: UKRI; Natural Environment Research Council [NE/E018254/1, NE/F016646/1] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is based upon work supported by the National Natural Science Foundation of China ( 40476005), the International Polar Year programme CHINARE ( Ministry of Science and Technology of China 2006BAB18B03) and the UK Natural Environment Research Council (NE/D003733/1). We thank A. Wright for drawing Fig. 1c.	Abramov O, 2004, INT J REMOTE SENS, V25, P669, DOI 10.1080/01431160310001599006; Amerson BE, 2008, GEOMORPHOLOGY, V93, P537, DOI 10.1016/j.geomorph.2007.04.001; Anderson RS, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000344; Barrett PJ, 2007, SPEC PUBL INT ASS SE, V39, P259; DeConto RM, 2003, PALAEOGEOGR PALAEOCL, V198, P39, DOI 10.1016/S0031-0182(03)00393-6; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Drewry DJ., 1983, ANTARCTICA GLACIOLOG; Ehrmann W, 2005, PALAEOGEOGR PALAEOCL, V229, P187, DOI 10.1016/j.palaeo.2005.06.022; Harwood DM, 2000, ANTARCT SCI, V12, P443; Holbourn A, 2005, NATURE, V438, P483, DOI 10.1038/nature04123; Huybrechts P., 1993, GEOGR ANN A, V75, P221, DOI [10.2307/521202, DOI 10.1080/04353676.1993.11880395, DOI 10.2307/521202]; Jamieson S. S. R., 2007, ANTARCTICA KEYSTONE, P39; Jamieson SSR, 2008, GEOMORPHOLOGY, V97, P91, DOI 10.1016/j.geomorph.2007.02.047; Lewis AR, 2007, GEOL SOC AM BULL, V119, P1449, DOI 10.1130/B26134; Lewis AR, 2008, P NATL ACAD SCI USA, V105, P10676, DOI 10.1073/pnas.0802501105; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; MacGregor KR, 2000, GEOLOGY, V28, P1031, DOI 10.1130/0091-7613(2000)28<1031:NSOGLP>2.0.CO;2; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; Montgomery DR, 2002, GEOLOGY, V30, P1047, DOI 10.1130/0091-7613(2002)030<1047:VFBFAG>2.0.CO;2; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Paterson WSB, 1994, PHYS GLACIERS, P1; Pekar SF, 2006, PALAEOGEOGR PALAEOCL, V231, P101, DOI 10.1016/j.palaeo.2005.07.027; PERKINS D, 1984, SUBGLACIAL LANDSCAPE; Raine JI., 2001, TERRA ANTARCT, V8, P389; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Sieger MJ, 2005, GLOBAL PLANET CHANGE, V45, P249, DOI 10.1016/j.gloplacha.2004.09.008; Summerfield MA, 1999, GEOL SOC SPEC PUBL, V162, P255, DOI 10.1144/GSL.SP.1999.162.01.20; TARBOTON DG, 1991, HYDROL PROCESS, V5, P81, DOI 10.1002/hyp.3360050107; WATSON D, 1992, CONTOURING GUIDE ANA, P1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	118	141	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					690	693		10.1038/nature08024	http://dx.doi.org/10.1038/nature08024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494912				2022-12-28	WOS:000266608600041
J	Diacon, AH; Pym, A; Grobusch, M; Patientia, R; Rustomjee, R; Page-Shipp, L; Pistorius, C; Krause, R; Bogoshi, M; Churchyard, G; Venter, A; Allen, J; Palomino, JC; De Marez, T; van Heeswijk, RPG; Lounis, N; Meyvisch, P; Verbeeck, J; Parys, W; de Beule, K; Andries, K; Mc Neeley, DF				Diacon, Andreas H.; Pym, Alexander; Grobusch, Martin; Patientia, Ramonde; Rustomjee, Roxana; Page-Shipp, Liesl; Pistorius, Christoffel; Krause, Rene; Bogoshi, Mampedi; Churchyard, Gavin; Venter, Amour; Allen, Jenny; Palomino, Juan Carlos; De Marez, Tine; van Heeswijk, Rolf P. G.; Lounis, Nacer; Meyvisch, Paul; Verbeeck, Johan; Parys, Wim; de Beule, Karel; Andries, Koen; Mc Neeley, David F.			The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY BACTERICIDAL ACTIVITY; ATP SYNTHASE; DRUGS; EPIDEMIOLOGY; R207910	BACKGROUND The diarylquinoline TMC207 offers a new mechanism of antituberculosis action by inhibiting mycobacterial ATP synthase. TMC207 potently inhibits drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro and shows bactericidal activity in patients who have drug-susceptible pulmonary tuberculosis. METHODS In the first stage of a two-stage, phase 2, randomized, controlled trial, we randomly assigned 47 patients who had newly diagnosed multidrug-resistant pulmonary tuberculosis to receive either TMC207 (400 mg daily for 2 weeks, followed by 200 mg three times a week for 6 weeks) (23 patients) or placebo (24 patients) in combination with a standard five-drug, second-line antituberculosis regimen. The primary efficacy end point was the conversion of sputum cultures, in liquid broth, from positive to negative. RESULTS The addition of TMC207 to standard therapy for multidrug-resistant tuberculosis reduced the time to conversion to a negative sputum culture, as compared with placebo (hazard ratio, 11.8; 95% confidence interval, 2.3 to 61.3; P = 0.003 by Cox regression analysis) and increased the proportion of patients with conversion of sputum culture (48% vs. 9%). The mean log(10) count of colony-forming units in the sputum declined more rapidly in the TMC207 group than in the placebo group. No significant differences in average plasma TMC207 concentrations were noted between patients with and those without culture conversion. Most adverse events were mild to moderate, and only nausea occurred significantly more frequently among patients in the TMC207 group than among patients in the placebo group (26% vs. 4%, P = 0.04). CONCLUSIONS The clinical activity of TMC207 validates ATP synthase as a viable target for the treatment of tuberculosis. (ClinicalTrials.gov number, NCT00449644.)	[Diacon, Andreas H.; Patientia, Ramonde; Venter, Amour] Univ Stellenbosch, Ctr Clin TB Res, Dept Sci & Technol, ZA-7505 Tygerberg, South Africa; [Diacon, Andreas H.; Patientia, Ramonde; Venter, Amour] Univ Stellenbosch, Natl Res Fdn, Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa; [Pym, Alexander; Rustomjee, Roxana; Allen, Jenny] MRC, Durban, South Africa; [Grobusch, Martin] Univ Witwatersrand, Div Clin Microbiol & Infect Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Grobusch, Martin] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Page-Shipp, Liesl] Right Care, Johannesburg, South Africa; [Pistorius, Christoffel] Jose Pearson Hosp, Port Elizabeth, South Africa; [Krause, Rene] Harry Comay Hosp, George, South Africa; [Bogoshi, Mampedi; Churchyard, Gavin] Aurum Hlth Inst, Johannesburg, South Africa; [Palomino, Juan Carlos] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [De Marez, Tine; Mc Neeley, David F.] Tibotec, Yardley, PA 19067 USA; [van Heeswijk, Rolf P. G.; Lounis, Nacer; Meyvisch, Paul; Verbeeck, Johan; Parys, Wim; de Beule, Karel; Andries, Koen] Tibotec BVBA, Mechelen, Belgium	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; Institute of Tropical Medicine (ITM); Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson	Mc Neeley, DF (corresponding author), Tibotec, 1020 Stoney Hill Rd,Suite 300, Yardley, PA 19067 USA.	dmcneele@its.jnj.com	Krause, Rene/AAS-5381-2021; Trajman, Anete/C-7679-2016	Krause, Rene/0000-0003-2394-500X; Trajman, Anete/0000-0002-4000-4984; Pym, Alexander/0000-0002-6260-8180; Churchyard, Gavin/0000-0002-4269-3699				Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 2007, GLOB TUB CONTR SURV; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bastian I, 2000, RESURG EMERGING INFE, V1, P1; CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DEBEENHOUWER H, 1995, TUBERCLE LUNG DIS, V76, P425, DOI 10.1016/0962-8479(95)90009-8; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Huitric E, 2007, ANTIMICROB AGENTS CH, V51, P4202, DOI 10.1128/AAC.00181-07; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139; Kent PT., 1985, PUBLIC HLTH MICROBIO; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Lounis N, 2008, J CLIN MICROBIOL, V46, P2212, DOI 10.1128/JCM.00177-08; Lounis N, 2006, ANTIMICROB AGENTS CH, V50, P3543, DOI 10.1128/AAC.00766-06; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Mitnick CD, 2007, PLOS MED, V4, P1730, DOI 10.1371/journal.pmed.0040292; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Sacks LV, 2008, TUBERCULOSIS, V88, pS93, DOI 10.1016/S1472-9792(08)70040-4; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	25	614	652	0	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2397	2405		10.1056/NEJMoa0808427	http://dx.doi.org/10.1056/NEJMoa0808427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494215				2022-12-28	WOS:000266590500005
J	Reddy, S; Jia, S; Geoffrey, R; Lorier, R; Suchi, M; Broeckel, U; Hessner, MJ; Verbsky, J				Reddy, Sreelatha; Jia, Shuang; Geoffrey, Rhonda; Lorier, Rachel; Suchi, Mariko; Broeckel, Ulrich; Hessner, Martin J.; Verbsky, James			BRIEF REPORT An Autoinflammatory Disease Due to Homozygous Deletion of the IL1RN Locus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; MUCKLE-WELLS-SYNDROME; NF-KAPPA-B; CIAS1 MUTATIONS; MICE LACKING; INFLAMMATION; FAMILY; ARTHROPATHY; ACTIVATION; SPECTRUM	We describe a patient with an autoinflammatory disease in which the main clinical features are pustular rash, marked osteopenia, lytic bone lesions, respiratory insufficiency, and thrombosis. Genetic studies revealed a 175-kb homozygous deletion at chromosome 2q13, which encompasses several interleukin-1 family members, including the gene encoding the interleukin-1-receptor antagonist (IL1RN). Mononuclear cells, obtained from the patient and cultured, produced large amounts of inflammatory cytokines, with increasing amounts secreted after stimulation with lipopolysaccharide. A similar increase was not observed in peripheral-blood mononuclear cells from a patient with neonatal-onset multisystem inflammatory disorder (NOMID). Treatment with anakinra completely resolved the symptoms and lesions.	[Reddy, Sreelatha; Jia, Shuang; Geoffrey, Rhonda; Lorier, Rachel; Broeckel, Ulrich; Hessner, Martin J.; Verbsky, James] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53201 USA; Childrens Res Inst, Milwaukee, WI USA	Medical College of Wisconsin	Verbsky, J (corresponding author), Med Coll Wisconsin, Dept Pediat, 9000 W Wisconsin Ave,Suite C465, Milwaukee, WI 53201 USA.	jverbsky@mcw.edu			National Institute of Allergy and Infectious Diseases [RO1AI078713, U19AI062627]; Research and Education Foundation of the American College of Rheumatology; Children's Hospital of Wisconsin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062627, R01AI078713, R56AI078713] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research and Education Foundation of the American College of Rheumatology; Children's Hospital of Wisconsin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institute of Allergy and Infectious Diseases (RO1AI078713 and U19AI062627), the Research and Education Foundation of the American College of Rheumatology, and the Children's Hospital of Wisconsin Foundation.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Hull KM, 2003, CURR OPIN RHEUMATOL, V15, P61, DOI 10.1097/00002281-200301000-00011; Nicklin MJH, 2002, GENOMICS, V79, P718, DOI 10.1006/geno.2002.6751; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Prieur A M, 1987, Scand J Rheumatol Suppl, V66, P57; PRIEUR AM, 1981, J PEDIATR-US, V99, P79, DOI 10.1016/S0022-3476(81)80961-4; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Shepherd J, 2004, J INVEST DERMATOL, V122, P665, DOI 10.1111/j.0022-202X.2004.22305.x; Strand V, 2004, RHEUMATOLOGY, V43, P10, DOI 10.1093/rheumatology/keh202; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Taylor SL, 2002, GENOMICS, V79, P726, DOI 10.1006/geno.2002.6752; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200	21	274	279	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2438	2444		10.1056/NEJMoa0809568	http://dx.doi.org/10.1056/NEJMoa0809568			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494219	Bronze, Green Accepted			2022-12-28	WOS:000266590500009
J	Wilck, MB; Hamel, MB; Baden, LR				Wilck, Marissa B.; Hamel, Mary Beth; Baden, Lindsey R.			Management of Incidental Hepatitis C Virus Infection - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PEGINTERFERON; RIBAVIRIN; TELAPREVIR		[Wilck, Marissa B.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Wilck, MB (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Afdhal NH, 2009, NEW ENGL J MED, V360, P1902, DOI 10.1056/NEJMclde0900131; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Pradat P, 2002, HEPATOLOGY, V36, P973, DOI 10.1053/jhep.2002.35530	6	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					E30	E31		10.1056/NEJMclde0902765	http://dx.doi.org/10.1056/NEJMclde0902765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453DN	19494211				2022-12-28	WOS:000266590500016
J	Leunissen, RWJ; Kerkhof, GF; Stijnen, T; Hokken-Koelega, A				Leunissen, Ralph W. J.; Kerkhof, Gerthe F.; Stijnen, Theo; Hokken-Koelega, Anita			Timing and Tempo of First-Year Rapid Growth in Relation to Cardiovascular and Metabolic Risk Profile in Early Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; FOR-GESTATIONAL-AGE; BODY-MASS INDEX; CATCH-UP GROWTH; GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; BLOOD-PRESSURE; INTRAVENOUS GLUCOSE; EARLY-CHILDHOOD; INFANT GROWTH	Context Growth during infancy appears to be an important determinant of cardiovascular disease and type 2 diabetes later in life. Objectives To specify which period in the first year of life is related to determinants of cardiovascular disease and type 2 diabetes in early adulthood and to investigate the association between tempo of first-year weight gain (>0.67 SDs) and these determinants. Design, Setting, and Participants Observational study using longitudinal data collected in the Programming Factors for Growth and Metabolism (PROGRAM) study of 217 healthy participants, aged 18 to 24 years, including a relatively large sample of participants born small for gestational age and participants with short stature, performed at a medical center in the Netherlands between August 2004 and September 2007. The association of cardiovascular disease and type 2 diabetes with tempo of weight gain was assessed in a subgroup of 87 participants. Main Outcome Measures Associations between periods of first-year growth and tempo of weight gain and determinants of cardiovascular disease and type 2 diabetes in early adulthood. Results Weight gain in the first 3 months of life was inversely associated with insulin sensitivity (beta, -0.223; 95% confidence interval [CI], -0.386 to -0.060) and serum high-density lipoprotein cholesterol level (beta, -0.053; 95% CI, -0.090 to -0.016) and positively associated with waist circumference (beta, 1.437; 95% CI, 0.066 to 2.808), acute insulin response (beta, 0.210; 95% CI, 0.024 to 0.395), ratio of total cholesterol to high-density lipoprotein cholesterol (beta, 0.052; 95% CI, 0.010 to 0.094), and level of triglycerides (beta, 0.066; 95% CI, 0.003 to 0.129) in early adulthood. Rapid weight gain during the first 3 months of life resulted in a higher percentage of body fat, more central adiposity, and reduced insulin sensitivity in early adulthood than when slower weight gain occurred during the entire first year. Conclusion Rapid weight gain in the first 3 months of life is associated with several determinants of cardiovascular disease and type 2 diabetes in early adulthood. JAMA. 2009;301(21):2234-2242 www.jama.com	[Leunissen, Ralph W. J.; Kerkhof, Gerthe F.; Hokken-Koelega, Anita] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Subdiv Endocrinol, NL-3015 GJ Rotterdam, Netherlands; [Stijnen, Theo] Leids Univ, Med Ctr, Dept Epidemiol & Biostat, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Leunissen, RWJ (corresponding author), Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Subdiv Endocrinol, Room Sb 2670,60 Molewaterpl Dr, NL-3015 GJ Rotterdam, Netherlands.	r.leunissen@erasmusmc.nl			Netherlands Organization for Scientific Research [015 000 088]; Revolving Fund 2001; Vereniging Trustfonds; Jan Dekkerstichting/Dr Ludgardine Bouwmanstiching; Stichting De Drie Lichten, the Netherlands	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Revolving Fund 2001; Vereniging Trustfonds; Jan Dekkerstichting/Dr Ludgardine Bouwmanstiching; Stichting De Drie Lichten, the Netherlands(Netherlands Government)	The Programming Factors for Growth and Metabolism (PROGRAM) study was financially supported by Netherlands Organization for Scientific Research grant 015 000 088, by grants from Revolving Fund 2001 and Vereniging Trustfonds awarded to Erasmus University, Rotterdam, the Netherlands, and by a grant from the Jan Dekkerstichting/Dr Ludgardine Bouwmanstiching and the Stichting De Drie Lichten, the Netherlands.	Armstrong J, 2002, LANCET, V359, P2003, DOI 10.1016/S0140-6736(02)08837-2; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Belfort MB, 2007, J PEDIATR-US, V151, P670, DOI 10.1016/j.jpeds.2007.05.010; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Fewtrell MS, 2001, AM J CLIN NUTR, V74, P516; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P445, DOI 10.1210/jc.2007-1543; LEUNISSEN RW, 2008, J CLIN ENDOCRINO AUG, P26; LEUNISSEN RW, 2008, CLIN ENDOCRINOL  JUN, P23; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; Singhal A, 2004, LANCET, V363, P1571, DOI 10.1016/S0140-6736(04)16198-9; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6	31	368	383	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2234	2242		10.1001/jama.2009.761	http://dx.doi.org/10.1001/jama.2009.761			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491185	Bronze			2022-12-28	WOS:000266554100021
J	Wignall, PB; Sun, YD; Bond, DPG; Izon, G; Newton, RJ; Vedrine, S; Widdowson, M; Ali, JR; Lai, XL; Jiang, HS; Cope, H; Bottrell, SH				Wignall, Paul B.; Sun, Yadong; Bond, David P. G.; Izon, Gareth; Newton, Robert J.; Vedrine, Stephanie; Widdowson, Mike; Ali, Jason R.; Lai, Xulong; Jiang, Haishui; Cope, Helen; Bottrell, Simon H.			Volcanism, Mass Extinction, and Carbon Isotope Fluctuations in the Middle Permian of China	SCIENCE			English	Article							LARGE IGNEOUS PROVINCE; SW CHINA; BOUNDARY; RELEASE; SECTION; OXYGEN; GSSP	The 260-million-year-old Emeishan volcanic province of southwest China overlies and is interbedded with Middle Permian carbonates that contain a record of the Guadalupian mass extinction. Sections in the region thus provide an opportunity to directly monitor the relative timing of extinction and volcanism within the same locations. These show that the onset of volcanism was marked by both large phreatomagmatic eruptions and extinctions amongst fusulinacean foraminifers and calcareous algae. The temporal coincidence of these two phenomena supports the idea of a cause-and-effect relationship. The crisis predates the onset of a major negative carbon isotope excursion that points to subsequent severe disturbance of the ocean-atmosphere carbon cycle.	[Wignall, Paul B.; Bond, David P. G.; Newton, Robert J.; Vedrine, Stephanie; Bottrell, Simon H.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Sun, Yadong; Lai, Xulong; Jiang, Haishui] China Univ Geosci, Fac Earth Sci, Wuhan 430074, Hubei, Peoples R China; [Izon, Gareth; Widdowson, Mike] Open Univ, Dept Earth & Environm Sci, Milton Keynes MK7 6AA, Bucks, England; [Ali, Jason R.] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Cope, Helen] Univ Strathclyde, Dept Bioengn, Glasgow G4 0NW, Lanark, Scotland	University of Leeds; China University of Geosciences; Open University - UK; University of Hong Kong; University of Strathclyde	Wignall, PB (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	p.wignall@see.leeds.ac.uk	Izon, Gareth/G-6004-2011; Sun, Yadong/N-6907-2013; Izon, Gareth/AAQ-4033-2020; Bond, David/I-6737-2012; Sun, Yadong/AAG-8781-2019; Newton, Robert/B-2599-2009; Ali, Jason/A-2738-2010	Sun, Yadong/0000-0003-4032-2082; Izon, Gareth/0000-0003-2742-4922; Sun, Yadong/0000-0003-4032-2082; Newton, Robert/0000-0003-0144-6867; Ali, Jason Richard/0000-0002-5214-620X; Lai, Xulong/0000-0002-2837-0885	Natural Environment Research Council [NE/D011558/1]; Natural Science Foundation of China [40872002, 406210022, 40232025]; Chinese State Administration of Foreign Experts Affairs [B08030]; Hong Kong Research Grant Council [HKU700204]; NERC [NE/D011558/1, NE/D011094/1] Funding Source: UKRI; Natural Environment Research Council [NE/D011094/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese State Administration of Foreign Experts Affairs; Hong Kong Research Grant Council(Hong Kong Research Grants Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank for funding the Natural Environment Research Council (grant no. NE/D011558/1), Natural Science Foundation of China (grants nos. 40872002, 406210022, and 40232025), Chinese State Administration of Foreign Experts Affairs (grant B08030), and Hong Kong Research Grant Council (grant no. HKU700204).	Ali JR, 2005, LITHOS, V79, P475, DOI 10.1016/j.lithos.2004.09.013; Courtillot V, 1999, EVOLUTIONARY CATASTR; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; He B, 2006, J GEOL, V114, P117, DOI 10.1086/498103; Jin YG, 2006, EPISODES, V29, P253, DOI 10.18814/epiiugs/2006/v29i4/003; Kaiho K, 2005, PALAEOGEOGR PALAEOCL, V223, P172, DOI 10.1016/j.palaeo.2005.04.013; Keller G, 2008, EARTH PLANET SC LETT, V268, P293, DOI 10.1016/j.epsl.2008.01.015; Lai XL, 2008, PALAEOGEOGR PALAEOCL, V269, P78, DOI 10.1016/j.palaeo.2008.08.005; MCCREA JM, 1950, J CHEM PHYS, V18, P849, DOI 10.1063/1.1747785; Peate IU, 2008, NAT GEOSCI, V1, P625, DOI 10.1038/ngeo281; Retallack GJ, 2008, J GEOL, V116, P1, DOI 10.1086/524120; Self S, 2008, SCIENCE, V319, P1654, DOI 10.1126/science.1152830; Self S, 2006, EARTH PLANET SC LETT, V248, P518, DOI 10.1016/j.epsl.2006.05.041; Wang W, 2004, EARTH PLANET SC LETT, V220, P57, DOI 10.1016/S0012-821X(04)00033-0; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Wignall PB, 1998, AM J SCI, V298, P537, DOI 10.2475/ajs.298.7.537; Zhou MF, 2002, EARTH PLANET SC LETT, V196, P113, DOI 10.1016/S0012-821X(01)00608-2	17	248	285	14	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1179	1182		10.1126/science.1171956	http://dx.doi.org/10.1126/science.1171956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478179				2022-12-28	WOS:000266410100040
J	Lubenov, EV; Siapas, AG				Lubenov, Evgueniy V.; Siapas, Athanassios G.			Hippocampal theta oscillations are travelling waves	NATURE			English	Article							MEDIAL ENTORHINAL CORTEX; FREELY-MOVING RAT; SYNAPTIC PLASTICITY; FIELD POTENTIALS; PYRAMIDAL CELLS; STELLATE CELLS; BEHAVING RAT; CA1 NEURONS; LAYER-II; RHYTHM	Theta oscillations clock hippocampal activity during awake behaviour and rapid eye movement (REM) sleep. These oscillations are prominent in the local field potential, and they also reflect the subthreshold membrane potential and strongly modulate the spiking of hippocampal neurons. The prevailing view is that theta oscillations are synchronized throughout the hippocampus, despite the lack of conclusive experimental evidence. In contrast, here we show that in freely behaving rats, theta oscillations in area CA1 are travelling waves that propagate roughly along the septotemporal axis of the hippocampus. Furthermore, we find that spiking in the CA1 pyramidal cell layer is modulated in a consistent travelling wave pattern. Our results demonstrate that theta oscillations pattern hippocampal activity not only in time, but also across anatomical space. The presence of travelling waves indicates that the instantaneous output of the hippocampus is topographically organized and represents a segment, rather than a point, of physical space.	[Lubenov, Evgueniy V.; Siapas, Athanassios G.] CALTECH, Div Engn & Appl Sci, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Siapas, AG (corresponding author), CALTECH, Div Engn & Appl Sci, Div Biol, Pasadena, CA 91125 USA.	lubenov@caltech.edu; thanos@caltech.edu			Caltech Information Science and Technology Center for Biological Circuit Design; 21st Century McDonnell Foundation Award; Bren Foundation; McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082942] Funding Source: NIH RePORTER	Caltech Information Science and Technology Center for Biological Circuit Design; 21st Century McDonnell Foundation Award; Bren Foundation; McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Wierzynski, M. Gu, G. Laurent, E. Schuman and A. Tolias for critical discussions and comments on the manuscript. We also thank the Caltech Brain Imaging Center and D. Procissi for the MRI brain scans. This work was supported by the Caltech Information Science and Technology Center for Biological Circuit Design, a 21st Century McDonnell Foundation Award, the Bren Foundation, and the McKnight Foundation.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1987, EXP BRAIN RES, V67, P502, DOI 10.1007/BF00247283; AMARAL DG, 2004, RAT NERVOUS SYSTEM, P443; ARNOLDS DEAT, 1980, ELECTROEN CLIN NEURO, V50, P324, DOI 10.1016/0013-4694(80)90160-1; BLAND BH, 1975, BRAIN RES, V94, P199, DOI 10.1016/0006-8993(75)90057-8; BRAGIN A, 1995, J NEUROSCI, V15, P47; BULLOCK TH, 1990, NEUROSCIENCE, V38, P609, DOI 10.1016/0306-4522(90)90055-9; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FOX SE, 1986, EXP BRAIN RES, V62, P495; FUJITA Y, 1964, J NEUROPHYSIOL, V27, P1011, DOI 10.1152/jn.1964.27.6.1011; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GREEN JD, 1960, J NEUROPHYSIOL, V23, P403, DOI 10.1152/jn.1960.23.4.403; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LEUNG LWS, 1986, BRAIN RES, V367, P323, DOI 10.1016/0006-8993(86)91611-2; LEUNG LWS, 1984, J NEUROPHYSIOL, V52, P1051, DOI 10.1152/jn.1984.52.6.1051; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; MILLER R, 1991, CORTICO HIPPOCAMPAL, P159; MITCHELL SJ, 1982, J NEUROSCI, V2, P292; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pedemonte M, 1996, EXP BRAIN RES, V112, P41; PETSCHE H, 1960, ELECTROEN CLIN NEURO, V12, P589, DOI 10.1016/0013-4694(60)90101-2; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TRAUB RD, 1991, NEURONAL NETWORKS HI, P119; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Vertes RP, 1997, NEUROSCIENCE, V81, P893; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; WINSON J, 1972, BEHAV BIOL, V7, P479, DOI 10.1016/S0091-6773(72)80210-4; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0	50	263	265	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					534	539		10.1038/nature08010	http://dx.doi.org/10.1038/nature08010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19489117	Green Accepted			2022-12-28	WOS:000266370500031
J	Raju, S; Neglen, P				Raju, Seshadri; Neglen, Peter			Chronic Venous Insufficiency and Varicose Veins	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELASTIC COMPRESSION STOCKINGS; VALVE RECONSTRUCTION; ILIAC VEIN; PATIENT COMPLIANCE; FOLLOW-UP; ENDOVENOUS TREATMENT; OUTFLOW OBSTRUCTION; DISEASE; ULCERS; SURGERY	A 52-year-old receptionist presents with an ulcer on her ankle that has persisted for a year. The use of narcotic analgesics once or twice a day and elevation of the leg reduce the pain. She does not have a history of diabetes and does not smoke. Physical examination reveals an ulcer, approximately 5 cm in diameter, above the medial malleolus. The ulcer has a clean bed of granulation and is surrounded by hyperpigmented skin. Pedal pulses are easily palpable. How should she be evaluated and treated?	[Raju, Seshadri] Univ Mississippi, Med Ctr, Jackson, MS USA	University of Mississippi; University of Mississippi Medical Center	Raju, S (corresponding author), 1020 River Oaks Dr,420, Flowood, MS 39232 USA.	rajumd@earthlink.net						Barron GS, 2007, ANN VASC SURG, V21, P652, DOI 10.1016/j.avsg.2007.07.002; Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; CLARKE H, 1989, BRIT J SURG, V76, P577, DOI 10.1002/bjs.1800760617; COCKETT FB, 1967, BRIT MED J, V2, P14, DOI 10.1136/bmj.2.5543.14; Cullum N, 2000, COCHRANE DB SYST REV, V2, pCD000265; Delis KT, 1998, J VASC SURG, V28, P815, DOI 10.1016/S0741-5214(98)70056-4; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; ERICKSON CA, 1995, J VASC SURG, V22, P629, DOI 10.1016/S0741-5214(95)70051-X; FRANKS PJ, 1995, AGE AGEING, V24, P490, DOI 10.1093/ageing/24.6.490; Hartung O, 2008, J VASC SURG, V47, P381, DOI 10.1016/j.jvs.2007.10.007; Hurst DR, 2001, J VASC SURG, V34, P106, DOI 10.1067/mva.2001.114213; Ibegbuna V, 2003, J VASC SURG, V37, P420, DOI 10.1067/mva.2003.104; JOHNSON BF, 1995, J VASC SURG, V21, P307, DOI 10.1016/S0741-5214(95)70271-7; Jull A, 2002, LANCET, V359, P1550, DOI 10.1016/S0140-6736(02)08513-6; Jull A B, 2004, J Wound Care, V13, P90; Kalra M, 2003, SURG CLIN N AM, V83, P671, DOI 10.1016/S0039-6109(02)00198-6; Kalra Manju, 2002, Vasc Endovascular Surg, V36, P41, DOI 10.1177/153857440203600108; KATZ ML, 1994, J VASC SURG, V19, P361, DOI 10.1016/S0741-5214(94)70111-3; Kibbe MR, 2004, J VASC SURG, V39, P937, DOI 10.1016/j.jvs.2003.12.032; KIEV J, 1990, ARCH PHYS MED REHAB, V71, P376; Labropoulos N, 1997, ARCH SURG-CHICAGO, V132, P46; MASUDA EM, 1994, J VASC SURG, V19, P391, DOI 10.1016/S0741-5214(94)70066-4; MAYBERRY JC, 1991, SURGERY, V109, P575; MAYBERRY JC, 1991, J VASC SURG, V13, P91; Meissner MH, 2007, J VASC SURG, V46, p54S, DOI 10.1016/j.jvs.2007.08.038; Morrison N, 2006, J VASC SURG, V44, P224, DOI 10.1016/j.jvs.2006.02.062; NEGLEN P, 1993, J VASC SURG, V17, P590, DOI 10.1016/0741-5214(93)90160-N; Neglen P, 2003, J VASC SURG, V38, P879, DOI 10.1016/S0741-5214(03)01020-6; Neglen P, 2002, J VASC SURG, V35, P694, DOI 10.1067/mva.2002.121127; Neglen P, 2007, J VASC SURG, V46, P979, DOI 10.1016/j.jvs.2007.06.046; Neglen P, 2006, J VASC SURG, V44, P828, DOI 10.1016/j.jvs.2006.06.026; NEGUS D, 1968, BRIT J SURG, V55, P369, DOI 10.1002/bjs.1800550510; Nelson EA, 2000, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002303; O'Donnell TF, 2008, J VASC SURG, V48, P1044, DOI 10.1016/j.jvs.2008.06.017; Pascarella L, 2005, ANN VASC SURG, V19, P921, DOI 10.1007/s10016-005-7661-3; Perrin M, 2000, CARDIOVASC SURG, V8, P246, DOI 10.1016/S0967-2109(00)00019-3; Raju S, 2008, J CARDIOVASC SURG, V49, P27; Raju S, 1999, J VASC SURG, V29, P1050, DOI 10.1016/S0741-5214(99)70246-6; Raju S, 1997, AM J SURG, V173, P301, DOI 10.1016/S0002-9610(96)00394-7; RAJU S, 1991, J VASC SURG, V14, P305, DOI 10.1016/0741-5214(91)90081-5; Raju S, 2002, J VASC SURG, V35, P8, DOI 10.1067/mva.2002.121054; RAJU S, 1988, J VASC SURG, V7, P301, DOI 10.1067/mva.1988.avs0070301; Raju S, 2001, J VASC SURG, V34, P779, DOI 10.1067/mva.2001.119396; Raju S, 1996, J VASC SURG, V23, P357, DOI 10.1016/S0741-5214(96)70281-1; Raju S, 1998, J VASC SURG, V27, P651, DOI 10.1016/S0741-5214(98)70230-7; Raju S, 2007, ANN VASC SURG, V21, P790, DOI 10.1016/j.avsg.2007.07.014; Raju S, 2006, J VASC SURG, V44, P820, DOI 10.1016/j.jvs.2006.05.054; Raju S, 2006, J VASC SURG, V44, P136, DOI 10.1016/j.jvs.2006.02.065; Rutherford RB, 2000, J VASC SURG, V31, P1307, DOI 10.1016/S0741-5214(00)90143-5; SCOTT J, 1976, PAIN, V2, P175, DOI 10.1016/0304-3959(76)90113-5; TenBrook JA, 2004, J VASC SURG, V39, P583, DOI 10.1016/j.jvs.2003.09.017; van den Bos R, 2009, J VASC SURG, V49, P230, DOI 10.1016/j.jvs.2008.06.030	53	95	110	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2319	2327		10.1056/NEJMcp0802444	http://dx.doi.org/10.1056/NEJMcp0802444			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474429				2022-12-28	WOS:000266367300008
J	White, SA; Shaw, JA; Sutherland, DER				White, Steve A.; Shaw, James A.; Sutherland, David E. R.			Pancreas transplantation	LANCET			English	Review							QUALITY-OF-LIFE; FREE MAINTENANCE IMMUNOTHERAPY; SIMULTANEOUS CADAVER PANCREAS; DONOR KIDNEY-TRANSPLANTATION; DEPENDENT DIABETES-MELLITUS; CORONARY-ARTERY-DISEASE; LIVING-RELATED DONOR; LONG-TERM; SINGLE-CENTER; RENAL-TRANSPLANTATION	Since the introduction of pancreas transplantation more than 40 years ago, efforts to develop more minimally invasive techniques for endocrine replacement therapy have been in progress, yet this surgical procedure still remains the treatment of choice for diabetic patients with end-stage renal failure. Many improvements have been made in the surgical techniques and immunosuppressive regimens, both of which have contributed to an increasing number of indications for pancreas transplantation. This operation can be justified on the basis that patients replace daily injections of insulin with an improved quality of life but at the expense of a major surgical procedure and lifelong immunosuppression. The various indications, categories, and outcomes of patients having a pancreas transplant are discussed, particularly with reference to the effect on long-term diabetic complications.	[White, Steve A.] Freeman Rd Hosp, Dept Hepatopancreatobiliary & Transplantat Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Shaw, James A.] Univ Newcastle, Ctr Diabet, Newcastle Upon Tyne, Tyne & Wear, England; [Sutherland, David E. R.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK; University of Minnesota System; University of Minnesota Twin Cities	White, SA (corresponding author), Freeman Rd Hosp, Dept Hepatobiliary & Organ Transplant Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	steve.white@nuth.nhs.uk						Adang EMM, 1996, TRANSPLANTATION, V62, P754, DOI 10.1097/00007890-199609270-00009; Allen RDM, 1997, TRANSPLANTATION, V63, P830, DOI 10.1097/00007890-199703270-00007; Arbogast H, 2005, AM J TRANSPLANT, V5, P267; BARROU Z, 1994, DIABETES, V43, P661, DOI 10.2337/diabetes.43.5.661; Battezzati A, 1998, DIABETIC MED, V15, P991, DOI 10.1002/(SICI)1096-9136(1998120)15:12<991::AID-DIA717>3.0.CO;2-Q; Bechstein WO, 2004, TRANSPLANTATION, V77, P1221, DOI 10.1097/01.TP.0000120865.96360.DF; Biesenbach G, 2005, TRANSPL INT, V18, P1054, DOI 10.1111/j.1432-2277.2005.00182.x; BILOUS RW, 1989, NEW ENGL J MED, V321, P80, DOI 10.1056/NEJM198907133210204; Boggi U, 2005, TRANSPL P, V37, P2641, DOI 10.1016/j.transproceed.2005.06.086; BOHMAN SO, 1985, DIABETES, V34, P306, DOI 10.2337/diabetes.34.3.306; Brook NR, 2003, BRIT J SURG, V90, P1009, DOI 10.1002/bjs.4133; Bruce DS, 1996, TRANSPLANTATION, V62, P451, DOI 10.1097/00007890-199608270-00005; Bunnapradist S, 2003, J AM SOC NEPHROL, V14, P1031, DOI 10.1097/01.ASN.0000054494.85680.1C; Burke GW, 2004, TRANSPLANTATION, V77, P1269, DOI 10.1097/01.TP.0000123903.12311.36; Cantarovich D, 2009, TRANSPL INT, V22, P61, DOI 10.1111/j.1432-2277.2008.00738.x; Cashion AK, 1999, TRANSPLANTATION, V68, P1846, DOI 10.1097/00007890-199912270-00005; Chow VCC, 1999, CLIN TRANSPLANT, V13, P356, DOI 10.1034/j.1399-0012.1999.130413.x; Coppelli A, 2005, DIABETES CARE, V28, P1366, DOI 10.2337/diacare.28.6.1366; DIEM P, 1990, J CLIN INVEST, V86, P2008, DOI 10.1172/JCI114936; Douzdjian V, 1999, CLIN TRANSPLANT, V13, P51, DOI 10.1034/j.1399-0012.1999.t01-1-130108.x; Drachenberg CB, 2001, TRANSPLANTATION, V71, P1784, DOI 10.1097/00007890-200106270-00014; Farney AC, 2000, ANN SURG, V232, P696, DOI 10.1097/00000658-200011000-00012; Fernandez LA, 2005, ANN SURG, V242, P716, DOI 10.1097/01.sla.0000186175.84788.50; FIORETTO P, 1993, LANCET, V342, P1193, DOI 10.1016/0140-6736(93)92183-T; Fioretto P, 2006, KIDNEY INT, V69, P907, DOI 10.1038/sj.ki.5000153; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; FONTBONNE A, 1991, DIABETOLOGIA, V34, P356, DOI 10.1007/BF00405009; Gaber AO, 2000, CELL TRANSPLANT, V9, P913, DOI 10.1177/096368970000900619; Gallon LG, 2007, TRANSPLANTATION, V83, P1324, DOI 10.1097/01.tp.0000264189.58324.91; Gliedman M L, 1978, Diabetes Care, V1, P1, DOI 10.2337/diacare.1.1.1; GORES PF, 1992, ANN SURG, V215, P217, DOI 10.1097/00000658-199203000-00005; Gross CR, 1998, CLIN TRANSPLANT, V12, P351; Gruessner AC, 2005, CLIN TRANSPLANT, V19, P433, DOI 10.1111/j.1399-0012.2005.00378.x; Gruessner AC, 2001, J AM SOC NEPHROL, V12, P2490, DOI 10.1681/ASN.V12112490; Gruessner RW, 2008, J AM COLL SURGEONS, V206, P458, DOI 10.1016/j.jamcollsurg.2007.09.004; Gruessner RWG, 1997, TRANSPLANTATION, V64, P1572, DOI 10.1097/00007890-199712150-00011; Gruessner RWG, 2005, TRANSPLANTATION, V79, P1184, DOI 10.1097/01.TP.0000161221.17627.8A; Gruessner RWG, 2005, JAMA-J AM MED ASSOC, V293, P675, DOI 10.1001/jama.293.6.675-a; Gruessner RWG, 2004, AM J TRANSPLANT, V4, P2018, DOI 10.1111/j.1600-6143.2004.00667.x; Gruessner RWG, 2003, TRANSPLANTATION OF THE PANCREAS, P398; Gruessner RWG, 1997, ANN SURG, V226, P471, DOI 10.1097/00000658-199710000-00008; Gruessner RWG, 1996, TRANSPLANTATION, V61, P1265, DOI 10.1097/00007890-199604270-00025; HESSE UJ, 1989, DIABETES, V38, P1; Hickey DP, 1997, J UROLOGY, V157, P2042, DOI 10.1016/S0022-5347(01)64670-6; Hughes TA, 1995, TRANSPLANTATION, V60, P1406, DOI 10.1097/00007890-199560120-00006; HUGHES TA, 1994, METABOLISM, V43, P333, DOI 10.1016/0026-0495(94)90102-3; Humar A, 2000, TRANSPLANTATION, V70, P1247, DOI 10.1097/00007890-200010270-00022; Humar A, 2003, TRANSPLANTATION, V76, P918, DOI 10.1097/01.TP.0000079457.43199.76; Humar A, 2001, AM J SURG, V182, P155, DOI 10.1016/S0002-9610(01)00676-6; Jukema JW, 2002, DIABETES CARE, V25, P906, DOI 10.2337/diacare.25.5.906; KATZ H, 1991, NEW ENGL J MED, V325, P1278, DOI 10.1056/NEJM199110313251804; Kaufman DB, 2006, AM J TRANSPLANT, V6, P331, DOI 10.1111/j.1600-6143.2005.01166.x; Kaufman DB, 2003, AM J TRANSPLANT, V3, P855, DOI 10.1034/j.1600-6143.2003.00160.x; Kaufman DB, 2005, AM J TRANSPLANT, V5, P2539, DOI 10.1111/j.1600-6143.2005.01067.x; Kaufman DB, 2000, SURGERY, V128, P726, DOI 10.1067/msy.2000.108424; KELLY WD, 1967, SURGERY, V61, P827; Kendall DM, 1997, DIABETES, V46, P249, DOI 10.2337/diabetes.46.2.249; Kendall DM, 1997, DIABETES, V46, P23, DOI 10.2337/diabetes.46.1.23; KENNEDY WR, 1990, NEW ENGL J MED, V322, P1031, DOI 10.1056/NEJM199004123221503; Khwaja K, 2003, CLIN TRANSPLANT, V17, P242, DOI 10.1034/j.1399-0012.2003.00042.x; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEINCLAUSS F, CLIN TRANSP IN PRESS; Knight RJ, 2008, CLIN TRANSPLANT, V22, P645, DOI 10.1111/j.1399-0012.2008.00839.x; Kuo PC, 1997, TRANSPLANTATION, V63, P238, DOI 10.1097/00007890-199701270-00011; La Rocca E, 2000, CELL TRANSPLANT, V9, P929, DOI 10.1177/096368970000900621; La Rocca E, 2001, KIDNEY INT, V60, P1964, DOI 10.1046/j.1523-1755.2001.00008.x; Larsen JL, 2004, DIABETES CARE, V27, P1706, DOI 10.2337/diacare.27.7.1706; Larson TS, 2004, TRANSPLANTATION, V77, P838, DOI 10.1097/01.TP.0000114611.73689.3B; LILLEHEI RC, 1970, ANN SURG, V172, P405, DOI 10.1097/00000658-197009000-00010; Lo A, 2001, TRANSPL INT, V14, P396, DOI 10.1111/j.1432-2277.2001.tb00078.x; LUZI L, 1994, J CLIN INVEST, V93, P1948, DOI 10.1172/JCI117186; Malaise J, 2007, XENOTRANSPLANTATION, V14, P380; MANSKE CL, 1993, KIDNEY INT, V44, P617, DOI 10.1038/ki.1993.289; Martinenghi S, 1997, DIABETOLOGIA, V40, P1110, DOI 10.1007/s001250050795; Mazur MJ, 2004, TRANSPLANTATION, V77, P844, DOI 10.1097/01.TP.0000114607.62534.C9; Mekeel KL, 2007, LIVER TRANSPLANT, V13, P406, DOI 10.1002/lt.21070; MILDE FK, 1995, DIABETES CARE, V18, P93, DOI 10.2337/diacare.18.1.93; Morath C, 2008, J AM SOC NEPHROL, V19, P1557, DOI 10.1681/ASN.2007070804; Nankivell BJ, 2000, TRANSPLANTATION, V69, P574, DOI 10.1097/00007890-200002270-00019; Nankivell BJ, 2004, TRANSPLANTATION, V78, P461, DOI 10.1097/01.TP.0000128612.75163.26; Nath DS, 2005, CLIN TRANSPLANT, V19, P792, DOI 10.1111/j.1399-0012.2005.00423.x; NATHAN DM, 1991, TRANSPLANTATION, V52, P85, DOI 10.1097/00007890-199107000-00018; NAVARRO X, 1990, DIABETES, V39, P802, DOI 10.2337/diabetes.39.7.802; NGHIEM DD, 1987, AM J SURG, V153, P405, DOI 10.1016/0002-9610(87)90588-5; Odorico JS, 2008, TRANSPL P, V40, P513, DOI 10.1016/j.transproceed.2008.01.038; Ojo AO, 2001, TRANSPLANTATION, V71, P82, DOI 10.1097/00007890-200101150-00014; Pai RP, 2000, TRANSPLANTATION, V69, P1108, DOI 10.1097/00007890-200003270-00015; Perosa M, 2007, XENOTRANSPLANTATION, V14, P522; PRIETO M, 1986, J SURG RES, V40, P597, DOI 10.1016/0022-4804(86)90103-4; Pruijm MT, 2006, TRANSPLANTATION, V81, P1119, DOI 10.1097/01.tp.0000208574.48230.fd; Ramanathan V, 2005, TRANSPLANTATION, V79, P1453, DOI 10.1097/01.TP.0000164147.60036.67; RAMSAY RC, 1988, NEW ENGL J MED, V318, P208, DOI 10.1056/NEJM198801283180403; Rayhill SC, 2000, ANN SURG, V231, P417, DOI 10.1097/00000658-200003000-00015; Reddy KS, 2003, AM J KIDNEY DIS, V41, P464, DOI 10.1053/ajkd.2003.50057; Ridgway DM, 2005, TRANSPLANT INT, V18, P828, DOI 10.1111/j.1432-2277.2005.00144.x; Robertson R P, 1999, Endocr Pract, V5, P24; Robertson RP, 1996, J INVEST MED, V44, P549; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Salvalaggio PR, 2007, AM J TRANSPLANT, V7, P1561, DOI 10.1111/j.1600-6143.2007.01818.x; Saudek F, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1076; Scalea JR, 2008, TRANSPLANTATION, V86, P1789, DOI 10.1097/TP.0b013e3181913fbf; Schulz T, 2005, TRANSPLANT P, V37, P1268, DOI 10.1016/j.transproceed.2004.12.252; SEE WA, 1991, TRANSPLANTATION, V52, P630, DOI 10.1097/00007890-199110000-00010; Senior PA, 2007, AM J TRANSPLANT, V7, P91, DOI 10.1111/j.1600-6143.2006.01573.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SOLLINGER HW, 1984, TRANSPLANT P, V16, P749; Sollinger HW, 1998, ANN SURG, V228, P284, DOI 10.1097/00000658-199809000-00002; SOLLINGER HW, 1992, SURGERY, V112, P842; Stegall MD, 1997, TRANSPLANTATION, V64, P1695, DOI 10.1097/00007890-199712270-00011; Stegalll MD, 2007, TRANSPLANTATION, V83, P1156, DOI 10.1097/01.tp.0000261104.27113.05; STOUT RW, 1990, DIABETES CARE, V13, P631, DOI 10.2337/diacare.13.6.631; Stratta RJ, 1997, TRANSPLANT P, V29, P3309, DOI 10.1016/S0041-1345(97)00923-8; Stratta RJ, 2003, TRANSPLANTATION, V75, P1260, DOI 10.1097/01.TP.0000062838.38351.2A; STRATTA RJ, 1993, TRANSPLANTATION, V55, P1097, DOI 10.1097/00007890-199305000-00031; Stratta RJ, 1998, SURGERY, V124, P823, DOI 10.1067/msy.1998.91366; Stratta RJ, 2000, SURGERY, V127, P217, DOI 10.1067/msy.2000.103160; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003; SUTHERLAND DER, 1984, T ASSOC AM PHYSICIAN, V97, P80; Tan M, 2005, AM J TRANSPLANT, V5, P1966, DOI 10.1111/j.1600-6143.2005.00950.x; TAYLOR RJ, 1993, J UROLOGY, V150, P1185, DOI 10.1016/S0022-5347(17)35721-X; Thai NL, 2006, TRANSPLANTATION, V82, P1621, DOI 10.1097/01.tp.0000250712.12389.3d; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tyden G, 1999, TRANSPLANTATION, V67, P645; Tyden G, 1996, NEW ENGL J MED, V335, P860, DOI 10.1056/NEJM199609193351205; Venstrom JM, 2003, JAMA-J AM MED ASSOC, V290, P2817, DOI 10.1001/jama.290.21.2817; WANG Q, 1994, OPHTHALMOLOGY, V101, P1071; Watson CJE, 2005, AM J TRANSPLANT, V5, P1347, DOI 10.1111/j.1600-6143.2005.00822.x; Woeste G, 2003, TRANSPL INT, V16, P128, DOI 10.1111/j.1432-2277.2003.tb00274.x; Zielinski A, 2003, TRANSPLANTATION, V76, P547, DOI 10.1097/01.TP.0000076624.79720.14	129	223	232	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1808	1817		10.1016/S0140-6736(09)60609-7	http://dx.doi.org/10.1016/S0140-6736(09)60609-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465236				2022-12-28	WOS:000266337300036
J	Wellen, KE; Hatzivassiliou, G; Sachdeva, UM; Bui, TV; Cross, JR; Thompson, CB				Wellen, Kathryn E.; Hatzivassiliou, Georgia; Sachdeva, Uma M.; Bui, Thi V.; Cross, Justin R.; Thompson, Craig B.			ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation	SCIENCE			English	Article							TRANSCRIPTION; H4; DEACETYLATION; ACETYLTRANSFERASE; SYNTHETASE; ACTIVATION; EXPRESSION; COMPLEXES; DYNAMICS; SIRTUINS	Histone acetylation in single-cell eukaryotes relies on acetyl coenzyme A (acetyl-CoA) synthetase enzymes that use acetate to produce acetyl-CoA. Metazoans, however, use glucose as their main carbon source and have exposure only to low concentrations of extracellular acetate. We have shown that histone acetylation in mammalian cells is dependent on adenosine triphosphate (ATP)-citrate lyase (ACL), the enzyme that converts glucose-derived citrate into acetyl-CoA. We found that ACL is required for increases in histone acetylation in response to growth factor stimulation and during differentiation, and that glucose availability can affect histone acetylation in an ACL-dependent manner. Together, these findings suggest that ACL activity is required to link growth factor-induced increases in nutrient metabolism to the regulation of histone acetylation and gene expression.	[Wellen, Kathryn E.; Hatzivassiliou, Georgia; Sachdeva, Uma M.; Bui, Thi V.; Cross, Justin R.; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu		Cross, Justin/0000-0002-6356-057X	NIH [T32-HL07439-27]; National Cancer Institute; Damon Runyon Cancer Research Foundation [DRG-1955-07]; NATIONAL CANCER INSTITUTE [R01CA092660, R01CA105463] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Thompson laboratory for helpful comments and discussion and A. Stout for assistance with the deconvolution microscopy. Supported by grants to C.B.T. from NIH and the National Cancer Institute. K.E.W. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation, DRG-1955-07. U.M.S. is supported in part by a training grant from NIH, T32-HL07439-27.	Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Johnsson A, 2006, EUKARYOT CELL, V5, P1337, DOI 10.1128/EC.00101-06; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; KNOSP O, 1991, MOL CELL BIOCHEM, V101, P51; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sun JM, 2001, J BIOL CHEM, V276, P49435, DOI 10.1074/jbc.M108364200; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	31	1373	1408	11	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1076	1080		10.1126/science.1164097	http://dx.doi.org/10.1126/science.1164097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461003	Green Accepted			2022-12-28	WOS:000266246700043
J	De Ridder, J; Barban, C; Baudin, F; Carrier, F; Hatzes, AP; Hekker, S; Kallinger, T; Weiss, WW; Baglin, A; Auvergne, M; Samadi, R; Barge, P; Deleuil, M				De Ridder, Joris; Barban, Caroline; Baudin, Frederic; Carrier, Fabien; Hatzes, Artie P.; Hekker, Saskia; Kallinger, Thomas; Weiss, Werner W.; Baglin, Annie; Auvergne, Michel; Samadi, Reza; Barge, Pierre; Deleuil, Magali			Non-radial oscillation modes with long lifetimes in giant stars	NATURE			English	Article							SOLAR-LIKE OSCILLATIONS; STELLAR OSCILLATIONS; EPSILON-OPHIUCHI; RED GIANTS; K-GIANTS; ASTEROSEISMOLOGY; DISCOVERY; ARCTURUS	Towards the end of their lives, stars like the Sun greatly expand to become red giant stars. Such evolved stars could provide stringent tests of stellar theory, as many uncertainties of the internal stellar structure accumulate with age. Important examples are convective overshooting and rotational mixing during the central hydrogen-burning phase, which determine the mass of the helium core, but which are not well understood(1). In principle, analysis of radial and non-radial stellar oscillations can be used to constrain the mass of the helium core. Although all giants are expected to oscillate(2), it has hitherto been unclear whether non-radial modes are observable at all in red giants, or whether the oscillation modes have a short or a long mode lifetime(3-7), which determines the observational precision of the frequencies. Here we report the presence of radial and non-radial oscillations in more than 300 giant stars. For at least some of the giants, the mode lifetimes are of the order of a month. We observe giant stars with equally spaced frequency peaks in the Fourier spectrum of the time series, as well as giants for which the spectrum seems to be more complex. No satisfactory theoretical explanation currently exists for our observations.	[De Ridder, Joris; Carrier, Fabien; Hekker, Saskia] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Barban, Caroline; Baglin, Annie; Auvergne, Michel; Samadi, Reza] Univ Paris 07, Univ Paris 06, UMR8109, LESIA,Observ Paris, F-92195 Meudon, France; [Baudin, Frederic] Univ Paris 11, CNRS, UMR 8617, Inst Astrophys Spatiale, F-91405 Orsay, France; [Hatzes, Artie P.] Thuringer Landessternwarte, D-07778 Tautenburg, Germany; [Hekker, Saskia] Observ Royal Belgique, B-1180 Brussels, Belgium; [Kallinger, Thomas; Weiss, Werner W.] Univ Vienna, Inst Astron, A-1180 Vienna, Austria; [Barge, Pierre; Deleuil, Magali] Univ Aix Marseille, OAMP, Lab Astrophys Marseille, F-13388 Marseille 13, France; [Barge, Pierre; Deleuil, Magali] CNRS, F-13388 Marseille 13, France	KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Vienna; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	De Ridder, J (corresponding author), Katholieke Univ Leuven, Inst Sterrenkunde, Celestijnenlaan 200D, B-3001 Louvain, Belgium.	joris@ster.kuleuven.ac.be	Kallinger, Thomas/N-7501-2019	Kallinger, Thomas/0000-0003-3627-2561; Baudin, Frederic/0000-0001-6213-6382; Hekker, Saskia/0000-0002-1463-726X; Weiss, Werner/0000-0003-3977-4436; Deleuil, Magali/0000-0001-6036-0225	Fund for Scientific Research, Flanders; research council of K. U. Leuven; Belgian Federal Science Policy; Deutsches Zentrum fur Luft-und Raumfahrt; Austrian Research Promotion Agency	Fund for Scientific Research, Flanders(FWO); research council of K. U. Leuven(KU Leuven); Belgian Federal Science Policy(Belgian Federal Science Policy Office); Deutsches Zentrum fur Luft-und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)); Austrian Research Promotion Agency	J. D. R., F. C. and S. H. acknowledge support from the Fund for Scientific Research, Flanders, from the research council of K. U. Leuven, and from the Belgian Federal Science Policy. A. P. H. acknowledges the support of the Deutsches Zentrum fur Luft-und Raumfahrt. T. K. and W. W. W. acknowledge support by the Austrian Research Promotion Agency (FFG-ARL). J. D. R. thanks A. Miglio, M.-A. Dupret and C. Aerts for discussions.	Aerts C, 2008, SOL PHYS, V251, P3, DOI 10.1007/s11207-008-9182-z; Baglin A, 2007, AIP CONF PROC, V895, P201, DOI 10.1063/1.2720423; Barban C, 2007, ASTRON ASTROPHYS, V468, P1033, DOI 10.1051/0004-6361:20066716; Buzasi D, 2000, ASTROPHYS J, V532, pL133, DOI 10.1086/312573; De Ridder J, 2006, ASTRON ASTROPHYS, V448, P689, DOI 10.1051/0004-6361:20053331; Dziembowski WA, 2001, MON NOT R ASTRON SOC, V328, P601, DOI 10.1046/j.1365-8711.2001.04894.x; Edmonds PD, 1996, ASTROPHYS J, V464, pL157, DOI 10.1086/310108; Frandsen S, 2002, ASTRON ASTROPHYS, V394, pL5, DOI 10.1051/0004-6361:20021281; Gilliland RL, 2008, ASTRON J, V136, P566, DOI 10.1088/0004-6256/136/2/566; Guenther DB, 2000, ASTROPHYS J, V530, pL45, DOI 10.1086/312473; Hatzes AP, 2007, ASTROPHYS J, V670, pL37, DOI 10.1086/523300; Hekker S, 2006, ASTRON ASTROPHYS, V458, P931, DOI 10.1051/0004-6361:20065755; Kallinger T, 2008, ASTRON ASTROPHYS, V478, P497, DOI 10.1051/0004-6361:20078171; KJELDSEN H, 1995, ASTRON ASTROPHYS, V293, P87; PALLE PL, 1995, ASTROPHYS J, V441, P952, DOI 10.1086/175414; Retter A, 2003, ASTROPHYS J, V591, pL151, DOI 10.1086/377211; Stello D, 2008, ASTROPHYS J LETT, V674, pL53, DOI 10.1086/528936; Stello D, 2007, MON NOT R ASTRON SOC, V377, P584, DOI 10.1111/j.1365-2966.2007.11585.x; Stello D, 2006, ASTRON ASTROPHYS, V448, P709, DOI 10.1051/0004-6361:20054016; Tarrant NJ, 2007, MON NOT R ASTRON SOC, V382, pL48, DOI 10.1111/j.1745-3933.2007.00387.x; TASSOUL M, 1980, ASTROPHYS J SUPPL S, V43, P469, DOI 10.1086/190678	21	226	226	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					398	400		10.1038/nature08022	http://dx.doi.org/10.1038/nature08022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458716				2022-12-28	WOS:000266243700039
J	Douglas, SM; Dietz, H; Liedl, T; Hogberg, B; Graf, F; Shih, WM				Douglas, Shawn M.; Dietz, Hendrik; Liedl, Tim; Hoegberg, Bjoern; Graf, Franziska; Shih, William M.			Self-assembly of DNA into nanoscale three-dimensional shapes	NATURE			English	Article							DOUBLE-CROSSOVER MOLECULES; CONDUCTIVE NANOWIRES; NANOSTRUCTURES; OCTAHEDRON; NANOTUBES; COMPLEXES; LATTICES; DESIGN	Molecular self-assembly offers a 'bottom-up' route to fabrication with subnanometre precision of complex structures from simple components(1). DNA has proved to be a versatile building block(2-5) for programmable construction of such objects, including two-dimensional crystals(6), nanotubes(7-11), and three-dimensional wire-frame nanopolyhedra(12-17). Templated self-assembly of DNA(18) into custom two-dimensional shapes on the megadalton scale has been demonstrated previously with a multiple-kilobase 'scaffold strand' that is folded into a flat array of antiparallel helices by interactions with hundreds of oligonucleotide 'staple strands'(19,20). Here we extend this method to building custom three-dimensional shapes formed as pleated layers of helices constrained to a honeycomb lattice. We demonstrate the design and assembly of nanostructures approximating six shapes-monolith, square nut, railed bridge, genie bottle, stacked cross, slotted cross-with precisely controlled dimensions ranging from 10 to 100 nm. We also show hierarchical assembly of structures such as homomultimeric linear tracks and heterotrimeric wireframe icosahedra. Proper assembly requires week-long folding times and calibrated monovalent and divalent cation concentrations. We anticipate that our strategy for self-assembling custom three-dimensional shapes will provide a general route to the manufacture of sophisticated devices bearing features on the nanometre scale.	[Douglas, Shawn M.; Dietz, Hendrik; Liedl, Tim; Hoegberg, Bjoern; Graf, Franziska; Shih, William M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Douglas, Shawn M.; Dietz, Hendrik; Liedl, Tim; Hoegberg, Bjoern; Graf, Franziska; Shih, William M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Douglas, Shawn M.; Graf, Franziska; Shih, William M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Shih, WM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	william_shih@dfci.harvard.edu	CHEN, Jin-dong/F-3610-2011; Liedl, Tim/O-7539-2014; Douglas, Shawn/GVU-2004-2022	Liedl, Tim/0000-0002-0040-0173; Douglas, Shawn/0000-0001-5398-9041; Dietz, Hendrik/0000-0003-1270-3662; Hogberg, Bjorn/0000-0003-2715-7887	Claudia Adams Barr Program Investigator grant; Wyss Institute for Biologically Inspired Engineering; NIH [1DP2OD004641-01]; Humboldt Fellowship; Deutscher Akademischer Austauschdienst (DAAD); Swedish Science Council (Vetenskapsra det); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641] Funding Source: NIH RePORTER	Claudia Adams Barr Program Investigator grant; Wyss Institute for Biologically Inspired Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Humboldt Fellowship(Alexander von Humboldt Foundation); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Swedish Science Council (Vetenskapsra det)(Swedish Research Council); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Su for assistance in cloning M13-based scaffold sequences and G. Hess for pilot studies on the railed-bridge design. This work was supported by a Claudia Adams Barr Program Investigator grant, a Wyss Institute for Biologically Inspired Engineering at Harvard grant, and an NIH New Investigator grant (1DP2OD004641-01) to W. M. S., a Humboldt Fellowship to H. D., Deutscher Akademischer Austauschdienst (DAAD) Fellowship to T. L., and Swedish Science Council (Vetenskapsra det) Fellowship to B. H.	Budker V, 2006, BIOPOLYMERS, V83, P646, DOI 10.1002/bip.20602; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; DIEKMANN S, 1987, NUCLEIC ACIDS RES, V15, P5765, DOI 10.1093/nar/15.14.5765; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; DOUGLAS SM, NUCL ACIDS IN PRESS; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Harris JR, 1996, MICROSC MICROANAL, V2, P43, DOI [10.1017/S1431927696210438, DOI 10.1017/S1431927696210438]; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hibino K, 2006, CHEM PHYS LETT, V426, P405, DOI 10.1016/j.cplett.2006.05.120; Jungmann R, 2008, J AM CHEM SOC, V130, P10062, DOI 10.1021/ja8030196; Li XJ, 1996, J AM CHEM SOC, V118, P6131, DOI 10.1021/ja960162o; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; MANDELKERN M, 1981, J MOL BIOL, V152, P153, DOI 10.1016/0022-2836(81)90099-1; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	29	1730	1824	28	946	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					414	418		10.1038/nature08016	http://dx.doi.org/10.1038/nature08016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458720	Green Accepted, Green Submitted			2022-12-28	WOS:000266243700043
J	Dressler, DD; Jaffer, AK				Dressler, Daniel D.; Jaffer, Amir K.			Selective decontamination of the digestive tract and selective oropharyngeal decontamination reduced mortality in the ICU	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dressler, Daniel D.] Emory Univ, Atlanta, GA 30322 USA; [Jaffer, Amir K.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Emory University; University of Miami	Dressler, DD (corresponding author), Emory Univ, Atlanta, GA 30322 USA.							Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; Nathens AB, 1999, ARCH SURG-CHICAGO, V134, P170, DOI 10.1001/archsurg.134.2.170	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-5	10.7326/0003-4819-150-10-200905190-02005	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451561				2022-12-28	WOS:000266285300025
J	Law, MR; Morris, JK; Wald, NJ				Law, M. R.; Morris, J. K.; Wald, N. J.			Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CONVERTING-ENZYME-INHIBITION; CORONARY-ARTERY-DISEASE; CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; PLACEBO-CONTROLLED TRIAL; CALCIUM-CHANNEL BLOCKER; ASYMPTOMATIC CAROTID ATHEROSCLEROSIS; INTERNATIONAL-NIFEDIPINE-TRIAL; LOW-DOSE HYDROCHLOROTHIAZIDE	Objectives To determine the quantitative efficacy of different classes of blood pressure lowering drugs in preventing coronary heart disease (CHD) and stroke, and who should receive treatment. Design Meta-analysis. Data source Medline (1966-2007). Study selection Randomised trials of blood pressure lowering drugs recording CHD events and strokes. 108 trials studied differences in blood pressure between study drug and placebo (or control group not receiving the study drug) ("blood pressure difference trials"), and 46 trials compared drugs ("drug comparison trials"). Seven trials with three randomised groups fell into both categories. The results were interpreted in the context of those expected from the largest published meta-analysis of cohort studies, totalling 958 000 people. Participants 464 000 people defined into three mutually exclusive categories: participants with no history of vascular disease, a history of CHD, or a history of stroke. Results In the blood pressure difference trials beta blockers had a special effect over and above that due to blood pressure reduction in preventing recurrent CHD events in people with a history of CHD: risk reduction 29% (95% confidence interval 22% to 34%) compared with 15% (11% to 19%) in trials of other drugs. The extra effect was limited to a few years after myocardial infarction, with a risk reduction of 31% compared with 13% in people with CHD with no recent infarct (P = 0.04). In the other blood pressure difference trials (excluding CHD events in trials of beta blockers in people with CHD), there was a 22% reduction in CHD events (17% to 27%) and a 41% (33% to 48%) reduction in stroke for a blood pressure reduction of 10 mm Hg systolic or 5 mm Hg diastolic, similar to the reductions of 25% (CHD) and 36% (stroke) expected for the same difference in blood pressure from the cohort study meta-analysis, indicating that the benefit is explained by blood pressure reduction itself. The five main classes of blood pressure lowering drugs (thiazides, beta blockers, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and calcium channel blockers) were similarly effective (within a few percentage points) in preventing CHD events and strokes, with the exception that calcium channel blockers had a greater preventive effect on stroke (relative risk 0.92, 95% confidence interval 0.85 to 0.98). The percentage reductions in CHD events and stroke were similar in people with and without cardiovascular disease and regardless of blood pressure before treatment (down to 110 mm Hg systolic and 70 mm Hg diastolic). Combining our results with those from two other studies (the meta-analyses of blood pressure cohort studies and of trials determining the blood pressure lowering effects of drugs according to dose) showed that in people aged 60-69 with a diastolic blood pressure before treatment of 90 mm Hg, three drugs at half standard dose in combination reduced the risk of CHD by an estimated 46% and of stroke by 62%; one drug at standard dose had about half this effect. The present meta-analysis also showed that drugs other than calcium channel blockers (with the exception of non-cardioselective beta blockers) reduced the incidence of heart failure by 24%(19% to 28%) and calcium channel blockers by 19% (6% to 31%). Conclusions With the exception of the extra protective effect of beta blockers given shortly after a myocardial infarction and the minor additional effect of calcium channel blockers in preventing stroke, all the classes of blood pressure lowering drugs have a similar effect in reducing CHD events and stroke for a given reduction in blood pressure so excluding material pleiotropic effects. The proportional reduction in cardiovascular disease events was the same or similar regardless of pretreatment blood pressure and the presence or absence of existing cardiovascular disease. Guidelines on the use of blood pressure lowering drugs can be simplified so that drugs are offered to people with all levels of blood pressure. Our results indicate the importance of lowering blood pressure in everyone over a certain age, rather than measuring it in everyone and treating it in some.	[Law, M. R.; Morris, J. K.; Wald, N. J.] Queen Mary Univ London, Barts & London Sch Med, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Law, MR (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London EC1M 6BQ, England.	m.r.law@qmul.ac.uk	Morris, Joan/AAT-9211-2020; Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021	Morris, Joan/0000-0002-7164-612X; 				Agodoa L, 2007, J HYPERTENS, V25, P951; AHLMARK G, 1974, LANCET, V2, P1563; AMERY A, 1985, LANCET, V1, P1349; ANDERSEN MP, 1979, LANCET, V2, P865; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1974, JAMA-J AM MED ASSOC, V229, P409; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1979, PREV MED, V8, P2; [Anonymous], 1980, LANCET, V1, P1261; [Anonymous], 1993, Stroke, V24, P543; [Anonymous], EUR HEART J, DOI DOI 10.1093/EURHEARTJ/EHY339; [Anonymous], 1982, JAMA-J AM MED ASSOC, V247, P633; *ANZHFRCG, 1997, LANCET, V349, P375; Aronow WS, 1997, AM J CARDIOL, V80, P207, DOI 10.1016/S0002-9149(97)00320-2; Asmar RG, 2001, HYPERTENSION, V38, P922, DOI 10.1161/hy1001.095774; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Baba S, 2001, DIABETES RES CLIN PR, V54, P191, DOI 10.1016/S0168-8227(01)00288-1; BABER NS, 1980, BRIT HEART J, V44, P96; BALCON R, 1992, CIRCULATION, V86, P100; BALL SG, 1993, LANCET, V342, P821; BARBER JM, 1976, ACTA MED SCAND, P213; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Basu S, 1997, CIRCULATION, V96, P183; Berl T, 2003, ANN INTERN MED, V138, P542, DOI 10.7326/0003-4819-138-7-200304010-00010; Bestehorn HP, 2004, J AM COLL CARDIOL, V43, P2160, DOI 10.1016/j.jacc.2004.02.047; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Boden WE, 2000, LANCET, V355, P1751, DOI 10.1016/S0140-6736(00)02262-5; BOISSEL JP, 1990, AM J CARDIOL, V66, P251, DOI 10.1016/0002-9149(90)90831-K; BORGHI L, 1993, J CARDIOVASC PHARM, V22, pS78; Borhani NO, 1996, JAMA-J AM MED ASSOC, V276, P785, DOI 10.1001/jama.276.10.785; Bosch J, 2006, NEW ENGL J MED, V355, P1551; Boutitie F, 1998, STAT MED, V17, P2883, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2883::AID-SIM900>3.0.CO;2-L; Bradley HA, 2006, J HYPERTENS, V24, P2131, DOI 10.1097/01.hjh.0000249685.58370.28; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; BRENNAN PJ, 1988, BRIT HEART J, V59, P364; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; BUHLER FR, 1985, J HYPERTENS, V3, P379; Bulpitt CJ, 2003, J HYPERTENS, V21, P2409, DOI 10.1097/00004872-200312000-00030; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; CARTER AB, 1970, LANCET, V1, P485; CATS VM, 1985, DRUGS, V29, P8, DOI 10.2165/00003495-198500291-00010; Chaturvedi V, 2003, EUR HEART J, V24, P475, DOI 10.1016/S0195-668X(02)00804-7; Chrysant Steven G, 2006, J Clin Hypertens (Greenwich), V8, P261, DOI 10.1111/j.1524-6175.2005.05264.x; Cleland JGF, 1997, EUR HEART J, V18, P41; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COOPE J, 1986, BRIT MED J, V293, P1145, DOI 10.1136/bmj.293.6555.1145; Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; CURB JD, 1983, JAMA-J AM MED ASSOC, V250, P2814; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dargie HJ, 1996, EUR HEART J, V17, P104; DARGIE HJ, 1987, CIRCULATION, V75, P98; Deary AJ, 2002, CLIN SCI, V103, P493; Dens JA, 2003, HEART, V89, P887, DOI 10.1136/heart.89.8.887; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; DUKE M, 1978, JAMA-J AM MED ASSOC, V239, P43, DOI 10.1001/jama.239.1.43; Effects of treatment on morbidity in hypertension, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.213.7.1143; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Elliott William J, 2005, J Clin Hypertens (Greenwich), V7, P5, DOI 10.1111/j.1524-6175.2005.04446.x; ERIKSSON S, 1995, CEREBROVASC DIS, V5, P21, DOI 10.1159/000107813; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; FAXON DP, 1995, J AM COLL CARDIOL, V25, P362, DOI 10.1016/0735-1097(94)00368-Z; Feskanich D, 1997, OSTEOPOROSIS INT, V7, P79, DOI 10.1007/BF01623465; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fox KM, 2003, LANCET, V362, P782; FREIS ED, 1982, JAMA-J AM MED ASSOC, V248, P2004; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; GOLDBOURT U, 1993, ARCH INTERN MED, V153, P345, DOI 10.1001/archinte.153.3.345; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Grimm RH, 1997, HYPERTENSION, V29, P8, DOI 10.1161/01.HYP.29.1.8; Gueyffier F, 1997, STROKE, V28, P2557, DOI 10.1161/01.STR.28.12.2557; Hannson L, 1994, Blood Press, V3, P248, DOI 10.3109/08037059409102265; HANSEN DA, 1984, ACTA MED SCAND, P50; HANSEN JF, 1990, AM J CARDIOL, V66, P779; HANSEN JF, 1984, EUR HEART J, V5, P516; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HANSTEEN V, 1982, BRIT MED J, V284, P155, DOI 10.1136/bmj.284.6310.155; Hedblad B, 2001, CIRCULATION, V103, P1721, DOI 10.1161/01.CIR.103.13.1721; HELGELAND A, 1980, AM J MED, V69, P725, DOI 10.1016/0002-9343(80)90438-6; Herlitz J, 1995, EUR HEART J, V16, P1825; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; HOES AW, 1995, ANN INTERN MED, V123, P481, DOI 10.7326/0003-4819-123-7-199510010-00001; Hypertension Detection and Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.242.23.2562; *IS SPRINT STUD GR, 1988, EUR HEART J, V9, P354; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; *JOINT NAT COMM PR, 2007, NIH PUBL; Jorgensen B, 2000, J AM COLL CARDIOL, V35, P592, DOI 10.1016/S0735-1097(99)00599-9; JULIAN DG, 1982, LANCET, V1, P1142; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; KAUL UA, 1988, INT J CARDIOL; KENDALL MJ, 1995, ANN INTERN MED, V123, P358, DOI 10.7326/0003-4819-123-5-199509010-00007; KHAN N, 2006, CMAJ, V12, P1737; Kjoller-Hansen L, 2000, J AM COLL CARDIOL, V35, P881, DOI 10.1016/S0735-1097(99)00634-8; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Kochar M, 1999, AM J HYPERTENS, V12, P797, DOI 10.1016/S0895-7061(99)00053-9; Kondo J, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00443-5; LaCroix AZ, 2000, ANN INTERN MED, V133, P516, DOI 10.7326/0003-4819-133-7-200010030-00010; Law M, 2005, CIRCULATION, V112, P2301, DOI 10.1161/CIRCULATIONAHA.104.529628; Law MR, 2007, BRIT J CLIN PHARMACO, V63, P157, DOI 10.1111/j.1365-2125.2006.02751.x; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lechat P, 1999, LANCET, V353, P9; Levine TB, 2000, CIRCULATION, V101, P758, DOI 10.1161/01.CIR.101.7.758; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LICHTLEN PR, 1990, CARDIOVASC DRUG THER, V4, P1047, DOI 10.1007/BF02018315; LICHTLEN PR, 1990, LANCET, V335, P1109, DOI 10.1016/0140-6736(90)91121-P; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; LIU LS, 1995, CHINESE MED J-PEKING, V108, P710; MacKay JH, 1996, ARCH INTERN MED, V156, P278, DOI 10.1001/archinte.156.3.278; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MacMahon S, 2000, J AM COLL CARDIOL, V36, P438, DOI 10.1016/S0735-1097(00)00736-1; Malacco E, 2003, BLOOD PRESSURE, V12, P160, DOI 10.1080/08037050310009545; Mann JFE, 2005, CLIN NEPHROL, V63, P181; Marre M, 2004, J HYPERTENS, V22, P1613, DOI 10.1097/01.hjh.0000133733.32125.09; MAZUR NA, 1984, COR VASA, V26, P241; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; MING S, 1997, CHINESE J INTERN MED, V36, P312; MOSS AJ, 1988, NEW ENGL J MED, V319, P385; *MULT INT STUD, 1975, BMJ-BRIT MED J, V3, P735; Nakamura T, 2005, HYPERTENS RES, V28, P415, DOI 10.1291/hypres.28.415; NAVARROLOPEZ F, 1993, AM J CARDIOL, V72, P1243, DOI 10.1016/0002-9149(93)90291-J; Neal B, 2000, LANCET, V356, P1955; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; *NICH EH STUD GROU, 1999, HYPERTENSION, V34, P1129; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; *NIH CLIN EXC, 2006, MAN HYP AD PRIM CAR; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Ogihara T, 2000, AM J HYPERTENS, V13, P461, DOI 10.1016/S0895-7061(99)00215-0; OLSSON G, 1985, J AM COLL CARDIOL, V5, P1428, DOI 10.1016/S0735-1097(85)80360-0; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; Pantoni L, 2000, J NEUROL SCI, V175, P116, DOI 10.1016/S0022-510X(00)00301-4; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; PEDERSEN TR, 1983, ACTA MED SCAND, P1; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; PEPINE CJ, 1994, CIRCULATION, V90, P762, DOI 10.1161/01.CIR.90.2.762; PERRY HM, 1989, STROKE, V20, P4, DOI 10.1161/01.STR.20.1.4; PERRY HM, 1978, ANN NY ACAD SCI, V304, P267; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; PIPER JM, 1992, OBSTET GYNECOL, V80, P429; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Pitt B, 2001, AM J CARDIOL, V87, P1058, DOI 10.1016/S0002-9149(01)01461-8; Poldermans D, 2001, EUR HEART J, V22, P1353, DOI 10.1053/euhj.2000.2555; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; PooleWilson PA, 1997, EUR HEART J, V18, P31; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rehnqvist N, 1996, EUR HEART J, V17, P76; Rengo F, 1996, AM J CARDIOL, V77, P365, DOI 10.1016/S0002-9149(97)89365-4; REYNOLDS JL, 1972, BRIT HEART J, V34, P252; Rosei EA, 1997, J HYPERTENS, V15, P1337, DOI 10.1097/00004872-199715110-00019; RUDER MA, 1985, AM HEART J, V110, P490, DOI 10.1016/0002-8703(85)90177-2; SALATHIA KS, 1985, EUR HEART J, V6, P190, DOI 10.1093/oxfordjournals.eurheartj.a061844; Salpeter S, 2002, COCHRANE DATABASE SY, DOI [DOI 10.1002/14651858.CD002992, 10.1002/14651858.CD002992]; SCHOLZE J, 1993, J HYPERTENS, V11, P217; Schoofs MWCJ, 2003, ANN INTERN MED, V139, P476, DOI 10.7326/0003-4819-139-6-200309160-00010; Schrader H, 2001, BMJ-BRIT MED J, V322, P19, DOI 10.1136/bmj.322.7277.19; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; SCHRODER R, 1984, EUR HEART J, V5, P189; SCHUTZ W, 1983, EUR HEART J, V4, P367; SCHWARTZ PJ, 1992, J CARDIOVASC ELECTR, V3, P2, DOI 10.1111/j.1540-8167.1992.tb01090.x; SINGH BN, 1992, J HYPERTENS, V10, P301, DOI 10.1097/00004872-199204000-00001; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; SMITH WM, 1977, CIRC RES, V40, P98; SOLOMON RJ, 1984, DRUGS, V28, P66, DOI 10.2165/00003495-198400281-00007; SONNENBLICK EH, 1987, EUR HEART J, V8, P1056; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Staessen JA, 2005, HYPERTENS RES, V28, P385, DOI 10.1291/hypres.28.385; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Staessen JA, 2003, J HYPERTENS, V21, P1055, DOI 10.1097/00004872-200306000-00002; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Suzuki H, 2005, HYPERTENS RES, V28, P307, DOI 10.1291/hypres.28.307; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; TAYLOR SH, 1982, NEW ENGL J MED, V307, P1293, DOI 10.1056/NEJM198211183072101; Teo KK, 2000, CIRCULATION, V102, P1748; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; The GLANT (Study Group on Long Term Antihypertensive Therapy) Study Group, 1995, HYPERTENS RES, V18, P235; Torp-Pedersen C, 2002, EUR J HEART FAIL, V4, P495, DOI 10.1016/S1388-9842(02)00032-6; Tronvik E, 2003, JAMA-J AM MED ASSOC, V289, P65, DOI 10.1001/jama.289.1.65; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Turnbull F, 2003, LANCET, V362, P1527; Ueshima K, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.03.035; *UK PROSP DIAB STU, 1998, JAMA-J AM MED ASSOC, V317, P713; vanGilst WH, 1996, J AM COLL CARDIOL, V28, P114, DOI 10.1016/0735-1097(96)00113-1; Verdecchia P, 2005, HYPERTENSION, V46, P386, DOI 10.1161/01.HYP.0000174591.42889.a2; Verma S, 2004, BMJ-BRIT MED J, V329, P1248, DOI 10.1136/bmj.329.7477.1248; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; WIKSTRAND J, 1991, HYPERTENSION, V17, P579, DOI 10.1161/01.HYP.17.4.579; WILHELMSEN L, 1987, J HYPERTENS, V5, P561, DOI 10.1097/00004872-198710000-00009; WILHELMSSON C, 1974, LANCET, V2, P1157; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Witt BJ, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.058; Witt BJ, 2007, J CARD FAIL, V13, P489, DOI 10.1016/j.cardfail.2007.01.009; Wiysonge CS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002003.pub2; Yasue H, 2004, AM J CARDIOL, V93, P969, DOI 10.1016/j.amjcard.2004.01.006; Yui Y, 2004, HYPERTENS RES, V27, P181, DOI 10.1291/hypres.27.181; YURENEV AP, 1992, AM J HYPERTENS, V5, pS182, DOI 10.1093/ajh/5.6.182S; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zanchetti A, 2004, STROKE, V35, P2807, DOI 10.1161/01.STR.0000147041.00840.59; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD; Zhang HF, 2006, HYPERTENSION, V48, P187, DOI 10.1161/01.HYP.0000231939.40959.60; [No title captured]; [No title captured]	226	1873	1985	4	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2009	338								b1665	10.1136/bmj.b1665	http://dx.doi.org/10.1136/bmj.b1665			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NR	19454737	Green Published, hybrid			2022-12-28	WOS:000266269800001
J	O'Hare, AM; Kaufman, JS; Covinsky, KE; Landefeld, CS; McFarland, LV; Larson, EB				O'Hare, Ann M.; Kaufman, James S.; Covinsky, Kenneth E.; Landefeld, C. Seth; McFarland, Lynne V.; Larson, Eric B.			Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II-Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; GLOMERULAR-FILTRATION-RATE; LEFT-VENTRICULAR HYPERTROPHY; DEPENDENT DIABETES-MELLITUS; NONDIABETIC RENAL-DISEASE; URINARY ALBUMIN EXCRETION; CARDIOVASCULAR OUTCOMES; HYPERTENSIVE PATIENTS; SERUM CREATININE; DOUBLE-BLIND	Angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists are recommended for patients with chronic kidney disease because these drugs can slow disease progression. Older adults account for a large and growing number of patients with chronic kidney disease. The authors evaluated the relevance to adults older than 70 years of the evidence base for major U. S. practice guidelines for the use of these agents in chronic kidney disease. The authors first examined the representation of older adults in randomized trials that underpin these guidelines, then compared the characteristics of participants in these trials with those of a representative sample of older adults with chronic kidney disease in the general population. The authors found that current guidelines for the use of angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease are based on evidence with limited relevance to most persons older than 70 years with this condition.	[O'Hare, Ann M.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98108 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Grp Hlth Ctr Hlth Studies, Seattle, WA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	O'Hare, AM (corresponding author), Univ Washington, Dept Med, Div Nephrol, Bldg 100,Room 5B113,1660 S Columbian Way, Seattle, WA 98108 USA.	ann.ohare@va.gov			National Institute on Aging [K 1K23AG28980]; NATIONAL INSTITUTE ON AGING [K23AG028980] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By a Beeson Career Development Award from the National Institute on Aging to Dr. O'Hare (K 1K23AG28980).	Agardh CD, 1996, J HUM HYPERTENS, V10, P185; Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; Bakris GL, 1996, KIDNEY INT, V50, P1641, DOI 10.1038/ki.1996.480; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chan JCN, 2000, KIDNEY INT, V57, P590, DOI 10.1046/j.1523-1755.2000.t01-1-00879.x; CHAN JCN, 1992, BRIT MED J, V305, P981, DOI 10.1136/bmj.305.6860.981; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cinotti GA, 2001, NEPHROL DIAL TRANSPL, V16, P961, DOI 10.1093/ndt/16.5.961; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dagenais GR, 2008, DIABETES CARE, V31, P1007, DOI 10.2337/dc07-1868; DeCesaris R, 1996, CLIN PHARMACOL THER, V60, P472, DOI 10.1016/S0009-9236(96)90204-0; Dyadyk AI, 1997, NEPHROL DIAL TRANSPL, V12, P945, DOI 10.1093/ndt/12.5.945; Esnault VLM, 2008, CLIN THER, V30, P482, DOI 10.1016/j.clinthera.2008.03.006; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gullion CM, 2006, AM J KIDNEY DIS, V48, P212, DOI 10.1053/j.ajkd.2006.04.083; HANNEDOUCHE T, 1994, BRIT MED J, V309, P833, DOI 10.1136/bmj.309.6958.833; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; *K DOQI, 2004, AM J KIDNEY DIS S, V43, pS1; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2006, ANN INTERN MED, V144, P213, DOI 10.7326/0003-4819-144-3-200602070-00011; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Makino H, 2007, DIABETES CARE, V30, P1577, DOI 10.2337/dc06-1998; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; MATHIESEN ER, 1991, BMJ-BRIT MED J, V303, P81, DOI 10.1136/bmj.303.6794.81; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Nakao N, 2003, LANCET, V361, P117, DOI 10.1016/S0140-6736(03)12229-5; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Remuzzi G, 2002, ANN INTERN MED, V136, P604, DOI 10.7326/0003-4819-136-8-200204160-00010; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Sarnak MJ, 2008, ARCH INTERN MED, V168, P147, DOI 10.1001/archinternmed.2007.40; Sawicki PT, 1997, NEPHROL DIAL TRANSPL, V12, P1890, DOI 10.1093/ndt/12.9.1890; Schnack C, 1996, DIABETOLOGIA, V39, P1611, DOI 10.1007/s001250050623; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Suzuki H, 2001, HYPERTENS RES, V24, P153, DOI 10.1291/hypres.24.153; Tarnow L, 2000, DIABETES CARE, V23, P1725, DOI 10.2337/diacare.23.12.1725; TREVISAN R, 1995, AM J HYPERTENS, V8, P876, DOI 10.1016/0895-7061(95)00162-I; vanEssen GG, 1997, KIDNEY INT, pS58; Velussi M, 1996, DIABETES, V45, P216, DOI 10.2337/diabetes.45.2.216; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Vogt L, 2005, J HYPERTENS, V23, P2055, DOI 10.1097/01.hjh.0000186829.56372.04; Winkelmayer WC, 2006, DIABETES CARE, V29, P2210, DOI 10.2337/dc06-0570; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wolf G, 2008, FRONT BIOSCI-LANDMRK, V13, P4993, DOI 10.2741/3058; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zhang ZX, 2005, J AM SOC NEPHROL, V16, P1775, DOI 10.1681/ASN.2004080632; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	72	92	101	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					717	U12		10.7326/0003-4819-150-10-200905190-00010	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451579				2022-12-28	WOS:000266285300008
J	Reineke, S; Lindner, F; Schwartz, G; Seidler, N; Walzer, K; Lussem, B; Leo, K				Reineke, Sebastian; Lindner, Frank; Schwartz, Gregor; Seidler, Nico; Walzer, Karsten; Luessem, Bjoern; Leo, Karl			White organic light-emitting diodes with fluorescent tube efficiency	NATURE			English	Article							TRIPLET EXCITONS; DEVICES; EMISSION; CARRIER; LAYERS	The development of white organic light-emitting diodes(1) (OLEDs) holds great promise for the production of highly efficient large-area light sources. High internal quantum efficiencies for the conversion of electrical energy to light have been realized(2-4). Nevertheless, the overall device power efficiencies are still considerably below the 60-70 lumens per watt of fluorescent tubes, which is the current benchmark for novel light sources. Although some reports about highly power-efficient white OLEDs exist(5,6), details about structure and the measurement conditions of these structures have not been fully disclosed: the highest power efficiency reported in the scientific literature is 44 lm W-1 (ref. 7). Here we report an improved OLED structure which reaches fluorescent tube efficiency. By combining a carefully chosen emitter layer with high-refractive-index substrates(8,9), and using a periodic outcoupling structure, we achieve a device power efficiency of 90 lm W-1 at 1,000 candelas per square metre. This efficiency has the potential to be raised to 124 lm W-1 if the light outcoupling can be further improved. Besides approaching internal quantum efficiency values of one, we have also focused on reducing energetic and ohmic losses that occur during electron-photon conversion. We anticipate that our results will be a starting point for further research, leading to white OLEDs having efficiencies beyond 100 lm W-1. This could make white-light OLEDs, with their soft area light and high colour-rendering qualities, the light sources of choice for the future.	[Reineke, Sebastian; Lindner, Frank; Schwartz, Gregor; Seidler, Nico; Walzer, Karsten; Luessem, Bjoern; Leo, Karl] Inst Angew Photophys, D-01062 Dresden, Germany	Technische Universitat Dresden	Leo, K (corresponding author), Inst Angew Photophys, George Bahr Str 1, D-01062 Dresden, Germany.	leo@iapp.de	Seidler, Nico/G-8616-2011; Leo, Karl/L-1125-2013; Reineke, Sebastian/AAE-2691-2020; Schwartz, Gregor/I-7531-2012; Lüssem, Björn/B-6776-2013; Reineke, Sebastian/G-9894-2014; Reineke, Sebastian/F-9693-2010	Seidler, Nico/0000-0003-2787-9732; Reineke, Sebastian/0000-0002-4112-6991; Schwartz, Gregor/0000-0003-0061-6959; Lüssem, Björn/0000-0001-5029-3356; Reineke, Sebastian/0000-0002-4112-6991; 	European Commission [IST-2002-004607]; Leibniz Prize of the Deutsche Forschungsgemeinschaft	European Commission(European CommissionEuropean Commission Joint Research Centre); Leibniz Prize of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the European Commission within the sixth framework IST programme under contract IST-2002-004607 ( project OLLA), for funding. We received further support via the Leibniz Prize of the Deutsche Forschungsgemeinschaft. We also thank Novaled AG, Dresden, for providing the hole-transport layer dopant NDP-2 as well as J. Forster and T. Gunther for technical assistance throughout sample preparation.	Adamovich VI, 2003, ORG ELECTRON, V4, P77, DOI 10.1016/j.orgel.2003.08.003; Baldo MA, 2000, PHYS REV B, V62, P10967, DOI 10.1103/PhysRevB.62.10967; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; D'Andrade B. W., 2008, P SPIE, V7051; D'Andrade BW, 2004, ADV MATER, V16, P624, DOI 10.1002/adma.200306670; GARTNER G, 2008, P SPIE, V6999; Goushi K, 2004, J APPL PHYS, V95, P7798, DOI 10.1063/1.1751232; GREENHAM NC, 1994, ADV MATER, V6, P491, DOI 10.1002/adma.19940060612; GREENHAM NC, 1995, CHEM PHYS LETT, V241, P89, DOI 10.1016/0009-2614(95)00584-Q; He GF, 2004, APPL PHYS LETT, V85, P3911, DOI 10.1063/1.1812378; Huang Q, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2425014; Kawamura Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017404; Kawamura Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862777; KIDO J, 1995, SCIENCE, V267, P1332, DOI 10.1126/science.267.5202.1332; Lin CL, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2178485; MADIGAN CF, 2006, APPL PHYS LETT, V76; Meerheim R, 2008, J APPL PHYS, V104, DOI 10.1063/1.2951960; Moller S, 2002, J APPL PHYS, V91, P3324, DOI 10.1063/1.1435422; NAKAMURA T, 2005, APPL PHYS LETT, V97; NAKAYAMA T, 2006, SID07, P1018; Qin DS, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1879108; Reineke S, 2008, PHYS STATUS SOLIDI B, V245, P804, DOI 10.1002/pssb.200743447; Reineke S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2786840; Schwartz G, 2007, ADV MATER, V19, P3672, DOI 10.1002/adma.200700641; Schwartz G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2338588; Su SJ, 2008, ADV MATER, V20, P4189, DOI 10.1002/adma.200801375; Sun Yr, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2827178; Sun YR, 2006, NATURE, V440, P908, DOI 10.1038/nature04645; Williams EL, 2007, ADV MATER, V19, P197, DOI 10.1002/adma.200602174	29	2890	2990	42	2463	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					234	U116		10.1038/nature08003	http://dx.doi.org/10.1038/nature08003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444212				2022-12-28	WOS:000266036100037
J	Freed, GL; Stockman, JA				Freed, Gary L.; Stockman, James A.			Oversimplifying Primary Care Supply and Shortages	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FUTURE; PEDIATRICIAN; WORKFORCE		[Freed, Gary L.] Univ Michigan, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Freed, Gary L.] Univ Michigan Hlth Syst, Dept Pediat & Communicable Dis, Div Gen Pediat, Ann Arbor, MI USA; [Freed, Gary L.] Univ Michigan, Dept Hlth Management & Policy, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Stockman, James A.] Amer Board Pediat Inc, Chapel Hill, NC USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Freed, GL (corresponding author), Univ Michigan, Child Hlth Evaluat & Res Unit, 300 N Ingalls Bldg,6E08, Ann Arbor, MI 48109 USA.	gfreed@med.umich.edu	Stockman, James/ABG-6085-2021					*AM MED ASS, 2007, AMA PHYS CHAR DISTR; Bodenheimer T, 2008, NEW ENGL J MED, V359, P2086, DOI 10.1056/NEJMp0805631; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Ebell MH, 2008, JAMA-J AM MED ASSOC, V300, P1131, DOI 10.1001/jama.300.10.1131; Federal Interagency Forum on Child and Family Statistics website, CHILD POP NUMB CHILD; Freed GL, 2009, PEDIATRICS, V123, pS26, DOI 10.1542/peds.2008-1578H; Goodman DC, 2005, PEDIATRICS, V116, pE156, DOI 10.1542/peds.2005-0874; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; Kuehn BM., 2008, JAMA-J AM MED ASSOC, V300, P1874; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P1872, DOI 10.1001/jama.300.16.1872; Shipman SA, 2004, PEDIATRICS, V113, P435, DOI 10.1542/peds.113.3.435; Steinwald A., 2008, PRIMARY CARE PROFESS; Zuckerman S., 2004, HLTH AFF MILLWOOD S	13	36	36	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1920	1922		10.1001/jama.2009.619	http://dx.doi.org/10.1001/jama.2009.619			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444JX	19436019				2022-12-28	WOS:000265978400030
J	Gluckman, PD; Hanson, MA; Bateson, P; Beedle, AS; Law, CM; Bhutta, ZA; Anokhin, KV; Bougneres, P; Chandak, GR; Dasgupta, P; Smith, GD; Ellison, PT; Forrester, TE; Gilbert, SF; Jablonka, E; Kaplan, H; Prentice, AM; Simpson, SJ; Uauy, R; West-Eberhard, MJ				Gluckman, Peter D.; Hanson, Mark A.; Bateson, Patrick; Beedle, Alan S.; Law, Catherine M.; Bhutta, Zulfiqar A.; Anokhin, Konstantin V.; Bougneres, Pierre; Chandak, Giriraj Ratan; Dasgupta, Partha; Smith, George Davey; Ellison, Peter T.; Forrester, Terrence E.; Gilbert, Scott F.; Jablonka, Eva; Kaplan, Hillard; Prentice, Andrew M.; Simpson, Stephen J.; Uauy, Ricardo; West-Eberhard, Mary Jane			Towards a new developmental synthesis: adaptive developmental plasticity and human disease	LANCET			English	Editorial Material							CHILD UNDERNUTRITION; DIABETES-MELLITUS; HEALTH; NUTRITION; CONSEQUENCES; FETAL; OBESITY; PREVENTION; ORIGINS; HISTORY		[Gluckman, Peter D.; Beedle, Alan S.] Univ Auckland, Liggins Inst, Auckland 1023, New Zealand; [Hanson, Mark A.] Univ Southampton, Inst Dev Sci, Southampton, Hants, England; [Bateson, Patrick] Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England; [Law, Catherine M.] UCL, Inst Child Hlth, London, England; [Bhutta, Zulfiqar A.] Aga Khan Univ, Dept Paediat, Karachi, Pakistan; [Anokhin, Konstantin V.] Russian Acad Med Sci, PK Anokhin Inst Normal Physiol, Dept Systemogenesis, Moscow, Russia; [Bougneres, Pierre] Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France; [Bougneres, Pierre] Hop St Vincent de Paul, INSERM, U561, F-75674 Paris, France; [Chandak, Giriraj Ratan] Ctr Cellular & Mol Biol, Genome Res Grp, Hyderabad 500007, Andhra Pradesh, India; [Dasgupta, Partha] Univ Cambridge, Fac Econ, Cambridge, England; [Smith, George Davey] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Ellison, Peter T.] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Forrester, Terrence E.] Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica; [Gilbert, Scott F.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Jablonka, Eva] Tel Aviv Univ, Cohn Inst Hist & Philosophy Sci & Ideas, IL-69978 Tel Aviv, Israel; [Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Prentice, Andrew M.] London Sch Hyg & Trop Med, Int Nutr Grp, London WC1, England; [Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Uauy, Ricardo] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile; [West-Eberhard, Mary Jane] Univ Costa Rica, Smithsonian Trop Res Inst, Sch Biol, San Pedro, Costa Rica	University of Auckland; University of Southampton; University of Cambridge; University of London; University College London; Aga Khan University; Russian Academy of Medical Sciences; Anokhin Institute of Normal Physiology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Cambridge; University of Bristol; Harvard University; University West Indies Mona Jamaica; Swarthmore College; Tel Aviv University; University of New Mexico; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; Universidad de Chile; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Costa Rica	Gluckman, PD (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019, Auckland 1023, New Zealand.	pd.gluckman@auckland.ac.nz	Hanson, Mark/AAE-8236-2019; Prentice, Andrew/AAG-1961-2019; Davey Smith, George/A-7407-2013; Anokhin, Konstantin V./K-7983-2014	Hanson, Mark/0000-0002-6907-613X; Davey Smith, George/0000-0002-1407-8314; Anokhin, Konstantin V./0000-0003-4437-6002; Law, Catherine/0000-0002-1777-9386; Simpson, Stephen J./0000-0003-0256-7687; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Kaplan, Hillard/0000-0002-7398-7358; Chandak, Giriraj Ratan/0000-0002-3095-9453; s, hema/0000-0002-3440-9475	Medical Research Council [G0600705] Funding Source: Medline; MRC [G0600705] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams J, 2005, INT J EPIDEMIOL, V34, P40, DOI 10.1093/ije/dyh232; ALDERMAN H, 2004, ESTIMATED EC BENEFIT; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bateson P, 2001, INT J EPIDEMIOL, V30, P928, DOI 10.1093/ije/30.5.928; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Burdge GC, 2007, BRIT J NUTR, V97, P1036, DOI 10.1017/S0007114507682920; Dasgupta P., 1993, INQUIRY WELL BEING D; Dasgupta P, 1999, DISCOUNTING INTERGEN; de Onis Mercedes, 2003, Forum Nutr, V56, P238; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Fall CHD, 2001, BRIT MED BULL, V60, P33, DOI 10.1093/bmb/60.1.33; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2008, FRONT HORM RES, V36, P61, DOI 10.1159/000115337; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Haider BA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Horton R, 2008, LANCET, V371, P179, DOI 10.1016/S0140-6736(07)61869-8; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Kaplan HS, 2002, P NATL ACAD SCI USA, V99, P10221, DOI 10.1073/pnas.152502899; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kuzawa CW, 2005, AM J HUM BIOL, V17, P5, DOI 10.1002/ajhb.20091; McKeigue PM, 1996, CIBA F SYMP, V201, P54; NEEL JV, 1962, AM J HUM GENET, V14, P353; Reaven Gerald, 2005, Diab Vasc Dis Res, V2, P105, DOI 10.3132/dvdr.2005.017; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; Singhal A, 2006, NUTR REV, V64, pS44, DOI 10.1301/nr.2006.may.S44-S49; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Stein AD, 2006, AM J EPIDEMIOL, V164, P1160, DOI 10.1093/aje/kwj328; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Uauy R, 2002, PUBLIC HEALTH NUTR, V5, P223, DOI 10.1079/PHN2001297; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Walker R, 2006, AM J HUM BIOL, V18, P295, DOI 10.1002/ajhb.20510; West-Eberhard Mary Jane, 2003, pi	43	281	288	1	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2009	373	9675					1654	1657		10.1016/S0140-6736(09)60234-8	http://dx.doi.org/10.1016/S0140-6736(09)60234-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19427960	Green Submitted			2022-12-28	WOS:000266066300036
J	Pagnussat, GC; Alandete-Saez, M; Bowman, JL; Sundaresan, V				Pagnussat, Gabriela C.; Alandete-Saez, Monica; Bowman, John L.; Sundaresan, Venkatesan			Auxin-Dependent Patterning and Gamete Specification in the Arabidopsis Female Gametophyte	SCIENCE			English	Article							YUCCA FLAVIN MONOOXYGENASES; IDENTIFICATION; EXPRESSION; GRADIENTS; ENDOSPERM; PROTEINS; ORIGIN; GENES	The female reproductive unit of flowering plants, the haploid female gametophyte, is highly reduced relative to other land plants. We show that patterning of the Arabidopsis female gametophyte depends on an asymmetric distribution of the hormone auxin during its syncitial development. Furthermore, this auxin gradient is correlated with location-specific auxin biosynthesis, rather than auxin efflux that directs patterning in the diploid sporophytic tissues comprising the rest of the plant. Manipulation of auxin responses or synthesis induces switching of gametic and nongametic cell identities and specialized nonreproductive cells to exhibit attributes presumptively lost during angiosperm evolution. These findings may account for the unique egg cell specification characteristic of angiosperms and the formation of seeds with single diploid embryos while containing endosperm that can have variable numbers of parental haploid genomes.	[Pagnussat, Gabriela C.; Alandete-Saez, Monica; Bowman, John L.; Sundaresan, Venkatesan] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Sundaresan, Venkatesan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; Monash University; University of California System; University of California Davis	Sundaresan, V (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	sundar@ucdavis.edu	Bowman, John P./ABF-5108-2020	Bowman, John P./0000-0002-4528-9333; Bowman, John/0000-0001-7347-3691; Sundaresan, Venkatesan/0000-0002-4670-0630; Pagnussat, Gabriela/0000-0002-6836-3495	NSF [IOS-0313501, IOS-0745167, IOB-0515435]	NSF(National Science Foundation (NSF))	We thank U. Grossniklaus for providing the cell-specific marker lines used in this study; B. Sheres, J. Friml, and M. Tasaka for providing plants carrying PIN::GFP fusions; Y. Zhao for providing YUC::GUS reporter lines and YUC1 cDNA; N. Dharmasiri for seeds of the tir1afb quadruple mutant; M. Yu and A. Krishnan for technical assistance; and G. Ruvkun, D. Hanahan, members of the Gasser, Bowman, and Sundaresan labs, and three anonymous reviewers for valuable suggestions. Funded by NSF grants IOS-0313501 (V.S.), IOS-0745167 (V.S.), and IOB-0515435 (J.L.B.).	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Brown R. C., 1992, EMSA B, V22, P48; BROWN RC, 1991, PROTOPLASMA, V165, P155, DOI 10.1007/BF01322286; Brukhin V, 2005, CURR SCI INDIA, V89, P1844; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Christensen CA, 1998, DEV BIOL, V202, P136, DOI 10.1006/dbio.1998.8980; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Cooke TJ, 2002, PLANT MOL BIOL, V49, P319, DOI 10.1023/A:1015242627321; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; Friedman WE, 2004, PLANT CELL, V16, pS119, DOI 10.1105/tpc.017277; Friedman WE, 2003, EVOLUTION, V57, P216, DOI 10.1111/j.0014-3820.2003.tb00257.x; Friedman WE, 2008, INT J PLANT SCI, V169, P79, DOI 10.1086/523354; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Frohlich MW, 2007, NATURE, V450, P1184, DOI 10.1038/nature06393; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Leyser O, 2005, CELL, V121, P819, DOI 10.1016/j.cell.2005.06.005; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Moore JM, 1997, COLD SPRING HARB SYM, V62, P35, DOI 10.1101/SQB.1997.062.01.007; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Umulis D, 2008, CURR TOP DEV BIOL, V81, P65, DOI 10.1016/S0070-2153(07)81002-7; Yu HJ, 2005, PLANT PHYSIOL, V139, P1853, DOI 10.1104/pp.105.067314; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	30	206	226	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1684	1689		10.1126/science.1167324	http://dx.doi.org/10.1126/science.1167324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19498110				2022-12-28	WOS:000267338200032
J	Maisel, WH				Maisel, William H.			Left Atrial Appendage Occlusion - Closure or Just the Beginning?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Med Device Safety Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Maisel, WH (corresponding author), Beth Israel Deaconess Med Ctr, Med Device Safety Inst, Boston, MA 02215 USA.							Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; *FOOD DRUG ADM, 2009, CIRC DEV PAN M APR 2; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Halperin JL, 2003, J AM COLL CARDIOL, V42, P1259, DOI 10.1016/S0735-1097(03)00958-6; NIH, CLINICALTRIALS GOV	5	47	54	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2601	2603		10.1056/NEJMp0903763	http://dx.doi.org/10.1056/NEJMp0903763			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19474420				2022-12-28	WOS:000267060000004
J	Wild, G; Gardner, A; West, SA				Wild, Geoff; Gardner, Andy; West, Stuart A.			Adaptation and the evolution of parasite virulence in a connected world	NATURE			English	Article							INCLUSIVE FITNESS; GROUP SELECTION; SOCIAL SEMANTICS; MODELS; COOPERATION; BEHAVIOUR; ALTRUISM	Adaptation is conventionally regarded as occurring at the level of the individual organism, where it functions to maximize the individual's inclusive fitness(1-3). However, it has recently been argued that empirical studies on the evolution of parasite virulence in spatial populations show otherwise(4-7). In particular, it has been claimed that the evolution of lower virulence in response to limited parasite dispersal(8,9) provides proof of Wynne-Edwards's(10) idea of adaptation at the group level. Although previous theoretical work has shown that limited dispersal can favour lower virulence, it has not clarified why, with five different suggestions having been given(6,8,11-15). Here we show that the effect of dispersal on parasite virulence can be understood entirely within the framework of inclusive fitness theory. Limited parasite dispersal favours lower parasite growth rates and, hence, reduced virulence because it (1) decreases the direct benefit of producing offspring(dispersers are worth more than non-dispersers, because they can go to patches with no or fewer parasites), and (2) increases the competition for hosts experienced by both the focal individual ('self-shading') and their relatives ('kin shading'). This demonstrates that reduced virulence can be understood as an individual-level adaptation by the parasite to maximize its inclusive fitness, and clarifies the links with virulence theory more generally(16).	[Wild, Geoff] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B7, Canada; [Gardner, Andy] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Western University (University of Western Ontario); University of Edinburgh; University of Oxford	Wild, G (corresponding author), Univ Western Ontario, Dept Appl Math, London, ON N6A 5B7, Canada.	gwild@uwo.ca	West, Stuart A/M-3608-2014; Wild, Geoff/AAG-1232-2019; Gardner, Andy/K-5353-2013	West, Stuart A/0000-0003-2152-3153; Wild, Geoff/0000-0001-7821-7304; Gardner, Andy/0000-0002-1304-3734	Natural Sciences and Engineering Research Council of Canada; UK Natural Environmental Research Council; Royal Society; Leverhulme Trust; European Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission)	We thank M. Boots, S. Brown, A. Buckling, A. Fernandes, S. Gandon, A. Griffin and S. Lion for discussions, and the Natural Sciences and Engineering Research Council of Canada, the UK Natural Environmental Research Council, the Royal Society, the Leverhulme Trust, and the European Research Council for funding.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; Day T, 2007, ECOL LETT, V10, P876, DOI 10.1111/j.1461-0248.2007.01091.x; Fisher Ronald A., 1930, GENETICAL THEORY NAT, DOI [10.5962/bhl.title.27468, DOI 10.5962/BHL.TITLE.27468]; FRANK SA, 1986, THEOR POPUL BIOL, V29, P312, DOI 10.1016/0040-5809(86)90013-4; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Goodnight C, 2008, COMPLEXITY, V13, P23, DOI 10.1002/cplx.20209; Grafen A, 2007, J EVOLUTION BIOL, V20, P1243, DOI 10.1111/j.1420-9101.2007.01321.x; Grafen A, 2006, J THEOR BIOL, V238, P541, DOI 10.1016/j.jtbi.2005.06.009; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Haraguchi Y, 1996, J THEOR BIOL, V183, P121, DOI 10.1006/jtbi.1996.9999; Holldobler B., 2008, SUPERORGANISM BEAUTY; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lion S, 2008, ECOL LETT, V11, P277, DOI 10.1111/j.1461-0248.2007.01132.x; O'Keefe KJ, 2002, AM NAT, V159, P597, DOI 10.1086/339990; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; Rousset F, 2004, THEOR POPUL BIOL, V65, P127, DOI 10.1016/j.tpb.2003.09.003; Rousset F., 2004, GENETIC STRUCTURE SE; Sober Elliott, 1998, OTHERS EVOLUTION PSY; Stearns S.C., 1992, pi; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Wilson DS, 2008, J EVOLUTION BIOL, V21, P368, DOI 10.1111/j.1420-9101.2007.01396.x; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wynne-Edwards V. C., 1962, pUnpaginated	30	100	101	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					983	986		10.1038/nature08071	http://dx.doi.org/10.1038/nature08071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19474791	Green Submitted			2022-12-28	WOS:000267063500042
J	Guo, P; Hirano, M; Herrin, BR; Li, JX; Yu, CL; Sadlonova, A; Cooper, MD				Guo, Peng; Hirano, Masayuki; Herrin, Brantley R.; Li, Jianxu; Yu, Cuiling; Sadlonova, Andrea; Cooper, Max D.			Dual nature of the adaptive immune system in lampreys	NATURE			English	Article							VARIABLE LYMPHOCYTE RECEPTORS; MIGRATION-INHIBITORY FACTOR; T-CELL REPERTOIRE; DIFFERENTIATION; EVOLUTION; RESPONSES; DIVERSITY; THYMUS; GENES; DIVERSIFICATION	Jawless vertebrates use variable lymphocyte receptors (VLR) comprised of leucine-rich-repeat (LRR) segments as counterparts of the immunoglobulin-based receptors that jawed vertebrates use for antigen recognition. Highly diverse VLR genes are somatically assembled by the insertion of variable LRR sequences into incomplete germline VLRA and VLRB genes. Here we show that in sea lampreys (Petromyzon marinus) VLRA and VLRB anticipatory receptors are expressed by separate lymphocyte populations by monoallelic VLRA or VLRB assembly, together with expression of cytosine deaminase 1 (CDA1) or 2 (CDA2), respectively. Distinctive gene expression profiles for VLRA(+) and VLRB+ lymphocytes resemble those of mammalian T and B cells. Although both the VLRA and the VLRB cells proliferate in response to antigenic stimulation, only the VLRB lymphocytes bind native antigens and differentiate into VLR antibody-secreting cells. Conversely, VLRA lymphocytes respond preferentially to a classical T-cell mitogen and upregulate the expression of the pro-inflammatory cytokine genes interleukin-17 (IL-17) and macrophage migration inhibitory factor (MIF). The finding of T-like and B-like lymphocytes in lampreys offers new insight into the evolution of adaptive immunity.	[Guo, Peng; Hirano, Masayuki; Herrin, Brantley R.; Li, Jianxu; Yu, Cuiling; Sadlonova, Andrea; Cooper, Max D.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Guo, Peng; Hirano, Masayuki; Herrin, Brantley R.; Li, Jianxu; Yu, Cuiling; Sadlonova, Andrea; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University	Cooper, MD (corresponding author), Emory Univ, Emory Vaccine Ctr, 1462 Clifton Rd NE, Atlanta, GA 30322 USA.	max.cooper@emory.edu	Li, Jianxu/I-5723-2013; Yu, Cuiling/E-6254-2011	Herrin, Brantley/0000-0002-1842-6806	National Institutes of Health; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, R01AI072435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. N. Alder and G. R. A. Ehrhardt for suggestions and discussion; C. L. Turnbough, Jr for providing B. anthracis spores and exosporium; D. E. Briles and W. H. Benjamin, Jr for E. coli, S. pneumoniae and S. typhimurium; H. Yi for help with electron microscopy; S. A. Durham and R. E. Karaffa, II for help with cell sorting; M. Flurry for help with preparation of figures. This work is supported by the National Institutes of Health and the Georgia Research Alliance.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; ARDAVIN CF, 1988, THYMUS, V11, P59; Banerjee D, 2005, IMMUNITY, V23, P445, DOI 10.1016/j.immuni.2005.09.012; BLOOM BR, 1975, J EXP MED, V142, P1306, DOI 10.1084/jem.142.5.1306; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; FINSTAD J, 1964, J EXP MED, V120, P1151, DOI 10.1084/jem.120.6.1151; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Lippert U, 2004, EXP DERMATOL, V13, P520, DOI 10.1111/j.0906-6705.2004.00182.x; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Paul W.E, 2008, FUNDAMENTAL IMMUNOLO; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; ROITT IM, 1969, LANCET, V2, P367; Sims-Mourtada JC, 2003, IMMUNOLOGY, V110, P296, DOI 10.1046/j.1365-2567.2003.01745.x; Suzuki T, 2004, DEV COMP IMMUNOL, V28, P993, DOI 10.1016/j.dci.2004.04.005; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsutsui S, 2007, IMMUNOGENETICS, V59, P873, DOI 10.1007/s00251-007-0254-2; Uinuk-ool T, 2002, P NATL ACAD SCI USA, V99, P14356, DOI 10.1073/pnas.212527699; Unanue ER, 2002, IMMUNOL REV, V185, P86, DOI 10.1034/j.1600-065X.2002.18510.x; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; Yu CL, 2009, EUR J IMMUNOL, V39, P571, DOI 10.1002/eji.200838846; ZINKERNA.RM, 1973, J EXP MED, V138, P1266, DOI 10.1084/jem.138.5.1266	50	254	276	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					796	U1		10.1038/nature08068	http://dx.doi.org/10.1038/nature08068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19474790	Green Accepted			2022-12-28	WOS:000267084500029
J	Kosten, S; Lacerot, G				Kosten, Sarian; Lacerot, Gissell			LIFE IN SCIENCE It Takes a Village	SCIENCE			English	Letter									[Kosten, Sarian] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, NL-6708 PG Wageningen, Netherlands; [Lacerot, Gissell] Univ Republica, Fac Ciencias, Montevideo, Uruguay	Wageningen University & Research; Universidad de la Republica, Uruguay	Kosten, S (corresponding author), Wageningen Univ, Aquat Ecol & Water Qual Management Grp, Droevendaalsesteeg 3A, NL-6708 PG Wageningen, Netherlands.	sarian.kosten@wur.nl	Kosten, Sarian/D-7550-2011	Kosten, Sarian/0000-0003-2031-0965; Lacerot, Gissell/0000-0002-9705-5715					0	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 5	2009	324	5932					1265	1265		10.1126/science.324_1265b	http://dx.doi.org/10.1126/science.324_1265b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498151				2022-12-28	WOS:000266635100018
J	Inouye, SK; Brown, CJ; Tinetti, ME				Inouye, Sharon K.; Brown, Cynthia J.; Tinetti, Mary E.			Medicare Nonpayment, Hospital Falls, and Unintended Consequences	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Inouye, Sharon K.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Inouye, Sharon K.] Harvard Univ, Sch Med, Boston, MA USA; [Inouye, Sharon K.] Hebrew SeniorLife, Inst Aging Res, Aging Brain Ctr, Boston, MA USA; [Brown, Cynthia J.] Univ Alabama, Dept Med, Birmingham, AL USA; [Tinetti, Mary E.] Yale Univ, Sch Med, New Haven, CT USA; [Tinetti, Mary E.] Yale Program Aging, New Haven, CT USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Hebrew SeniorLife; University of Alabama System; University of Alabama Birmingham; Yale University; Yale University	Inouye, SK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.		Inouye, Sharon/R-7216-2019	Brown, Cynthia J/0000-0002-1629-5507				Bradley EH, 2006, QUAL SAF HEALTH CARE, V15, P334, DOI 10.1136/qshc.2006.018820; FRANK C, 1996, CAN FAM PHYSICIAN, V42, P2404; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Oliver D, 2007, BRIT MED J, V334, P82, DOI 10.1136/bmj.39049.706493.55; Park M, 2007, J GERONTOL NURS, V33, P9, DOI 10.3928/00989134-20070201-04	5	158	163	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2390	2393		10.1056/NEJMp0900963	http://dx.doi.org/10.1056/NEJMp0900963			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453DN	19494213				2022-12-28	WOS:000266590500003
J	Tokuriki, N; Tawfik, DS				Tokuriki, Nobuhiko; Tawfik, Dan S.			Chaperonin overexpression promotes genetic variation and enzyme evolution	NATURE			English	Article							CARBONIC-ANHYDRASE-II; ESCHERICHIA-COLI; DIRECTED EVOLUTION; DELETERIOUS MUTATIONS; PROTEIN MUTATIONS; GROEL; STABILITY; HSP90; EVOLVABILITY; EXPRESSION	Most protein mutations, and mutations that alter protein functions in particular, undermine stability and are therefore deleterious. Chaperones, or heat-shock proteins, are often implicated in buffering mutations, and could thus facilitate the acquisition of neutral genetic diversity and the rate of adaptation. We examined the ability of the Escherichia coli GroEL/GroES chaperonins to buffer destabilizing and adaptive mutations. Here we show that mutational drifts performed in vitro with four different enzymes indicated that GroEL/GroES overexpression doubled the number of accumulating mutations, and promoted the folding of enzyme variants carrying mutations in the protein core and/or mutations with higher destabilizing effects (destabilization energies of >3.5 kcal mol(-1), on average, versus, similar to 1 kcal mol(-1) in the absence of GroEL/GroES). The divergence of modified enzymatic specificity occurred much faster under GroEL/GroES overexpression, in terms of the number of adapted variants (>= 2-fold) and their improved specificity and activity (>= 10-fold). These results indicate that protein stability is a major constraint in protein evolution, and buffering mechanisms such as chaperonins are key in alleviating this constraint.	[Tokuriki, Nobuhiko; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	TOKURIKI, NOBUHIKO/A-2968-2010		NIH [W81XWH-07-2-0020]; Israel Science Foundation; EU	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); EU(European Commission)	Financial support by the EU via the MiFEM consortium, NIH grant number W81XWH-07-2-0020, and Israel Science Foundation are gratefully acknowledged. We are thankful to P. Goloubinoff for his advice, V. Kolotonouv for technical assistance, L. Serrano for the use of FoldX, and A. Horovitz and S. Rutherford for their help in refining this manuscript.	Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bobula J, 2006, GENETICS, V174, P937, DOI 10.1534/genetics.106.061564; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Fares MA, 2004, TRENDS GENET, V20, P413, DOI 10.1016/j.tig.2004.07.001; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Gould SM, 2005, BIOCHEMISTRY-US, V44, P5444, DOI 10.1021/bi0475471; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; McLoughlin SY, 2008, P NATL ACAD SCI USA, V105, P13497, DOI 10.1073/pnas.0804804105; MISSET O, 1984, EUR J BIOCHEM, V144, P475, DOI 10.1111/j.1432-1033.1984.tb08490.x; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Noivirt-Brik O, 2007, BIOINFORMATICS, V23, P3276, DOI 10.1093/bioinformatics/btm513; Persson M, 1996, BBA-PROTEIN STRUCT M, V1298, P191, DOI 10.1016/S0167-4838(96)00125-2; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Radman M, 1999, ANN NY ACAD SCI, V870, P146, DOI 10.1111/j.1749-6632.1999.tb08874.x; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Roodveldt C, 2005, PROTEIN ENG DES SEL, V18, P51, DOI 10.1093/protein/gzi005; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Sasidharan R, 2007, P NATL ACAD SCI USA, V104, P10080, DOI 10.1073/pnas.0703737104; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wilke CO, 2005, BIOPHYS J, V89, P3714, DOI 10.1529/biophysj.105.062125; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	45	254	259	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					668	U71		10.1038/nature08009	http://dx.doi.org/10.1038/nature08009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494908				2022-12-28	WOS:000266608600036
J	Comi, RJ				Comi, Richard J.			Glucose Control in the Intensive Care Unit: A Roller Coaster Ride or a Swinging Pendulum?	ANNALS OF INTERNAL MEDICINE			English	Article							DIABETIC-PATIENTS; MYOCARDIAL-INFARCTION; STRESS HYPERGLYCEMIA; INSULIN THERAPY; INFECTION; MORTALITY; TIGHT	Many studies of tight control of blood glucose in critically ill patients are associated with poor outcomes. However, randomized studies of tight glucose control in patients admitted to coronary care or surgical intensive care units showed a reduction in mortality rates; supported by recommendations from professional organizations, many intensive care units implemented protocols for tight glucose control. More recent studies in medical intensive care units did not confirm the benefits of tight control, however, and the most recent study suggests that tight control increases mortality rates. Furthermore, tight control significantly increases episodes of hypoglycemia. The sum of the recent literature suggests that a degree of glucose control lies between the extremes of the adverse outcomes related to poor glucose control and those related to overly aggressive glucose control.	Dartmouth Hitchcock Med Ctr, Hitchcock Clin, Lebanon, NH 03756 USA	Dartmouth College	Comi, RJ (corresponding author), Dartmouth Hitchcock Med Ctr, Hitchcock Clin, 1 Med Ctr Dr, Lebanon, NH 03756 USA.							Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; CERRA FB, 1987, SURGERY, V101, P1; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Inzucchi SE, 2009, NEW ENGL J MED, V360, P1346, DOI 10.1056/NEJMe0901507; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Pomposelli JJ, 1998, JPEN-PARENTER ENTER, V22, P77, DOI 10.1177/014860719802200277; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Solomon CG, 2003, NEW ENGL J MED, V348, P579, DOI 10.1056/NEJMp030006; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	17	6	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					809	811		10.7326/0003-4819-150-11-200906020-00009	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487715				2022-12-28	WOS:000266530000008
J	McAlister, FA; Wiebe, N; Ezekowitz, JA; Leung, AA; Armstrong, PW				McAlister, Finlay A.; Wiebe, Natasha; Ezekowitz, Justin A.; Leung, Alexander A.; Armstrong, Paul W.			Meta-analysis: beta-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED INTERVENTION TRIAL; LEFT-VENTRICULAR FUNCTION; CORONARY-ARTERY-DISEASE; CARDIAC-INSUFFICIENCY BISOPROLOL; SYSTOLIC DYSFUNCTION BEAUTIFUL; EJECTION FRACTION; ELDERLY-PATIENTS; DOUBLE-BLIND; CLINICAL-OUTCOMES; METOPROLOL CR/XL	Background: Guidelines recommend that patients with heart failure receive beta-blockers in doses used in the trials that have proven their efficacy. Although the adverse effects of beta-blockade are dose-related, it is unclear whether the benefits are. Purpose: To determine whether the survival benefits of beta-blockade in heart failure are associated with the magnitude of heart rate reduction or the beta-blocker dose. Data Sources: MEDLINE, EMBASE, CINAHL, SIGLE, Web of Science, and the Cochrane Central Register of Controlled Trials, supplemented by hand-searches of bibliographies. Study Selection: Randomized, placebo-controlled heart failure trials that reported all-cause mortality. Data Extraction: Two reviewers independently extracted data on study characteristics, beta-blocker dosing and heart rate reduction, and death. Data Synthesis: The mean left ventricular ejection fraction in the 23 beta-blocker trials ranged from 0.17 to 0.36, and more than 95% of the 19 209 patients had systolic dysfunction. The overall risk ratio for death was 0.76 (95% CI, 0.68 to 0.84); however, heterogeneity testing revealed moderate heterogeneity among trials (I-2 = 30%), which was associated with the magnitude of heart rate reduction achieved within each trial (P for meta-regression = 0.006). For every heart rate reduction of 5 beats/min with beta-blocker treatment, a commensurate 18% reduction (CI, 6% to 29%) in the risk for death occurred. No significant relationship between all-cause mortality and beta-blocker dosing was observed (risk ratio for death, 0.74 [CI, 0.64 to 0.86]) in high-dose beta-blocker trials vs. 0.78 [CI, 0.63 to 0.96] in low-dose beta-blocker trials; P for meta-regression = 0.69). Limitations: The analysis is based on aggregate data and resting heart rates. Few patients in these trials had bradycardia or diastolic dysfunction at baseline. Conclusion: The magnitude of heart rate reduction is statistically significantly associated with the survival benefit of beta-blockers in heart failure, whereas the dose of beta-blocker is not.	[McAlister, Finlay A.; Wiebe, Natasha; Ezekowitz, Justin A.; Leung, Alexander A.; Armstrong, Paul W.] Univ Alberta, Edmonton, AB, Canada	University of Alberta	McAlister, FA (corresponding author), Univ Alberta Hosp, 2F1-21 Walter Mackenzie Hlth Sci Ctr,8440 112 St, Edmonton, AB T6G 2R7, Canada.	finlay.mcalister@ualberta.ca	Leung, Alexander/L-9856-2018; Wiebe, Natasha/V-7803-2019; Ezekowitz, Justin A/C-4579-2013; McAlister, Finlay/C-4151-2013	Leung, Alexander/0000-0002-7536-8497; Wiebe, Natasha/0000-0002-5613-1582; Ezekowitz, Justin A/0000-0002-2724-4086; McAlister, Finlay/0000-0001-7435-3341; Armstrong, Paul/0000-0002-0460-3445	Alberta Heritage Foundation; Canadian Institutes of Health Research	Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	No external funding was received for the study. Dr. McAlister is supported by an Alberta Heritage Foundation for Medical Research Health Scholar Award and holds the Merck Frosst/Aventis Patient Health Management Chair at the University of Alberta. Dr. Ezekowitz is supported by the Canadian Institutes of Health Research.	Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; ANDERSON JL, 1985, AM J CARDIOL, V55, P471, DOI 10.1016/0002-9149(85)90396-0; Arnold RH, 2003, HEART, V89, P293, DOI 10.1136/heart.89.3.293; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; BRISTOW MR, 1994, CIRCULATION, V89, P1632, DOI 10.1161/01.CIR.89.4.1632; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Cirillo W, 2000, CIRCULATION, V101, P378, DOI 10.1161/01.CIR.101.4.378; Cleland JGF, 2003, LANCET, V362, P14, DOI 10.1016/S0140-6736(03)13801-9; Cohn J N, 1997, J Card Fail, V3, P173, DOI 10.1016/S1071-9164(97)90013-0; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; Cucherat M, 2007, EUR HEART J, V28, P3012, DOI 10.1093/eurheartj/ehm489; de Groote P, 2007, AM HEART J, V154, P589, DOI 10.1016/j.ahj.2007.05.013; Edes I, 2005, EUR J HEART FAIL, V7, P631, DOI 10.1016/j.ejheart.2004.10.015; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; EICHHORN EJ, 1995, J AM COLL CARDIOL, V25, P154, DOI 10.1016/0735-1097(94)00340-V; FISHER ML, 1994, J AM COLL CARDIOL, V23, P943, DOI 10.1016/0735-1097(94)90641-6; Flannery G, 2008, AM J CARDIOL, V101, P865, DOI 10.1016/j.amjcard.2007.11.023; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Foody JM, 2002, JAMA-J AM MED ASSOC, V287, P883, DOI 10.1001/jama.287.7.883; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Gullestad L, 2005, J AM COLL CARDIOL, V45, P252, DOI 10.1016/j.jacc.2004.10.032; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Ko DT, 2004, ARCH INTERN MED, V164, P1389, DOI 10.1001/archinte.164.13.1389; Komajda M, 2004, EUR J HEART FAIL, V6, P467, DOI 10.1016/j.ejheart.2003.12.019; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Lechat P, 1997, CIRCULATION, V96, P2197; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lechat P, 2001, CIRCULATION, V103, P1428, DOI 10.1161/01.CIR.103.10.1428; MacMahon S, 1997, LANCET, V349, P375; Mehta PA, 2004, QJM-INT J MED, V97, P133, DOI 10.1093/qjmed/hch023; Metra M, 2003, AM HEART J, V145, P292, DOI 10.1067/mhj.2003.105; Metra M, 2005, EUR HEART J, V26, P2259, DOI 10.1093/eurheartj/ehi386; OLSEN SL, 1995, J AM COLL CARDIOL, V25, P1225, DOI 10.1016/0735-1097(95)00012-S; Packer M, 1996, CIRCULATION, V94, P2793, DOI 10.1161/01.CIR.94.11.2793; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Poole-Wilson PA, 2003, HEART, V89, P42, DOI 10.1136/heart.89.1.42; RAESIDE DE, 1976, PHYS MED BIOL, V21, P181, DOI 10.1088/0031-9155/21/2/001; Remme WJ, 2007, EUR J HEART FAIL, V9, P1128, DOI 10.1016/j.ejheart.2007.07.014; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Schleman KA, 2001, J CARD FAIL, V7, P4, DOI 10.1054/jcaf.2001.22491; Sin DD, 2002, AM J MED, V113, P650, DOI 10.1016/S0002-9343(02)01346-3; Sturm B, 2000, EUR J HEART FAIL, V2, P407, DOI 10.1016/S1388-9842(00)00120-3; Swedberg K, 2007, EUR HEART J SUPPL, V9, pF20, DOI 10.1093/eurheartj/sum031; Tandon P, 2004, ARCH INTERN MED, V164, P769, DOI 10.1001/archinte.164.7.769; Thackray SDR, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.07.007; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; Wikstrand J, 2002, J AM COLL CARDIOL, V40, P491, DOI 10.1016/S0735-1097(02)01970-8; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; WOODLEY SL, 1991, CIRCULATION, V84, P2426, DOI 10.1161/01.CIR.84.6.2426	54	382	401	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					784	W141		10.7326/0003-4819-150-11-200906020-00006	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487713				2022-12-28	WOS:000266530000005
J	Gautier, DL; Bird, KJ; Charpentier, RR; Grantz, A; Houseknecht, DW; Klett, TR; Moore, TE; Pitman, JK; Schenk, CJ; Schuenemeyer, JH; Sorensen, K; Tennyson, ME; Valin, ZC; Wandrey, CJ				Gautier, Donald L.; Bird, Kenneth J.; Charpentier, Ronald R.; Grantz, Arthur; Houseknecht, David W.; Klett, Timothy R.; Moore, Thomas E.; Pitman, Janet K.; Schenk, Christopher J.; Schuenemeyer, John H.; Sorensen, Kai; Tennyson, Marilyn E.; Valin, Zenon C.; Wandrey, Craig J.			Assessment of Undiscovered Oil and Gas in the Arctic	SCIENCE			English	Article								Among the greatest uncertainties in future energy supply and a subject of considerable environmental concern is the amount of oil and gas yet to be found in the Arctic. By using a probabilistic geology-based methodology, the United States Geological Survey has assessed the area north of the Arctic Circle and concluded that about 30% of the world's undiscovered gas and 13% of the world's undiscovered oil may be found there, mostly offshore under less than 500 meters of water. Undiscovered natural gas is three times more abundant than oil in the Arctic and is largely concentrated in Russia. Oil resources, although important to the interests of Arctic countries, are probably not sufficient to substantially shift the current geographic pattern of world oil production.	[Gautier, Donald L.; Bird, Kenneth J.; Moore, Thomas E.; Valin, Zenon C.] US Geol Survey, Menlo Pk, CA 94025 USA; [Charpentier, Ronald R.; Klett, Timothy R.; Pitman, Janet K.; Schenk, Christopher J.; Tennyson, Marilyn E.; Wandrey, Craig J.] US Geol Survey, Denver, CO 80225 USA; [Houseknecht, David W.] US Geol Survey, Reston, VA 20192 USA; [Schuenemeyer, John H.] SW Stat Consulting, Cortez, CO 81321 USA; [Sorensen, Kai] Geol Survey Denmark & Greenland, DK-1350 Copenhagen K, Denmark	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Geological Survey Of Denmark & Greenland	Gautier, DL (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	gautier@usgs.gov						*BP PUBL LTD CO, 2008, BP STAT REV WORLD EN; CHARPENTIER R. R., 2008, 20071404 US GEOL SUR; CHARPENTIER RR, 2008, 2008 AM ASS PETR GEO; GRANTZ A., 2009, MAPS SHOWING SEDIMEN; IHS Incorporated, 2007, INT PETR EXPL PROD D; SCHUENEMEYER JH, PROCEDURES IN PRESS; US GEOLOGICAL SURVEY, 2009, CIRC ARCT RES APPR N; *USGS WORLD ASS TE, 2000, TS GEOL SURV WORLD P	8	387	413	3	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1175	1179		10.1126/science.1169467	http://dx.doi.org/10.1126/science.1169467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478178				2022-12-28	WOS:000266410100039
J	Bornstein, SR				Bornstein, Stefan R.			CURRENT CONCEPTS Predisposing Factors for Adrenal Insufficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WATERHOUSE-FRIDERICHSEN-SYNDROME; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; DEHYDROEPIANDROSTERONE-SULFATE; CORTICOSTEROID INSUFFICIENCY; SEVERE SEPSIS; HYDROCORTISONE; MUTATIONS; CORTISOL; DISEASE		Tech Univ Dresden, Dept Med, D-01307 Dresden, Germany	Technische Universitat Dresden	Bornstein, SR (corresponding author), Tech Univ Dresden, Dept Med, Fetscherstr 74, D-01307 Dresden, Germany.	stefan.bornstein@uniklinikum-dresden.de			Deutsche Forschungsgemeinschaft [BO 1141/8-1, SFB 655-TP A6]; Sander Foundation; Center for Regenerative Therapies Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sander Foundation; Center for Regenerative Therapies Dresden	Supported by grants from Deutsche Forschungsgemeinschaft (BO 1141/8-1 and SFB 655-TP A6), from the Sander Foundation, and from the Center for Regenerative Therapies Dresden. No potential conflict of interest relevant to this article was reported.	Addison T., 1855, CONSTITUTIONAL LOCAL; Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Arlt W, 2006, J CLIN ENDOCR METAB, V91, P2548, DOI 10.1210/jc.2005-2258; Betterle C, 2004, CLIN EXP IMMUNOL, V137, P225, DOI 10.1111/j.1365-2249.2004.02561.x; Bornstein SR, 2004, P NATL ACAD SCI USA, V101, P16695, DOI 10.1073/pnas.0407550101; BORNSTEIN SR, 1992, ANAT RECORD, V234, P255, DOI 10.1002/ar.1092340212; Bornstein SR, 2003, AM J RESP CRIT CARE, V167, P485, DOI 10.1164/rccm.2211010; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P5256, DOI 10.1210/jc.2004-0661; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Charmandari E, 2008, J CLIN ENDOCR METAB, V93, P1563, DOI 10.1210/jc.2008-0040; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Dellinger RP, 2008, CRIT CARE MED, V36, P1394; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; den Brinker M, 2005, J CLIN ENDOCR METAB, V90, P5110, DOI 10.1210/jc.2005-1107; Diederich S, 2003, EUR J ENDOCRINOL, V148, P609, DOI 10.1530/eje.0.1480609; Eklund A, 2005, ACTA ANAESTH SCAND, V49, P379, DOI 10.1111/j.1399-6576.2004.00585.x; Fernandez J, 2006, HEPATOLOGY, V44, P1288, DOI 10.1002/hep.21352; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; Halonen J, 2007, JAMA-J AM MED ASSOC, V297, P1562, DOI 10.1001/jama.297.14.1562; Hamilton D, 2004, J CLIN PATHOL, V57, P208, DOI 10.1136/jcp.2003.9936; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Harvey PW, 2007, J APPL TOXICOL, V27, P103, DOI 10.1002/jat.1221; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Huang CJ, 2006, AM J RESP CRIT CARE, V173, P276, DOI 10.1164/rccm.200504-545OC; Kempna P, 2008, BEST PRACT RES CL EN, V22, P77, DOI 10.1016/j.beem.2007.07.008; Kim CJ, 2008, J CLIN ENDOCR METAB, V93, P696, DOI 10.1210/jc.2007-2330; Lee YW, 2008, J INT MED RES, V36, P357, DOI 10.1177/147323000803600220; Lin L, 2007, ENDOCR DEV, V11, P36, DOI 10.1159/000111056; Magnotti Michael, 2008, Endocr Pract, V14, P233; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marik PE, 2002, CRIT CARE MED, V30, P1267, DOI 10.1097/00003246-200206000-00018; Marx C, 2003, CRIT CARE MED, V31, P1382, DOI 10.1097/01.CCM.0000063282.83188.3D; Meduri GU, 2007, CHEST, V132, P1093, DOI 10.1378/chest.07-0714; Merke DP, 2000, NEW ENGL J MED, V343, P1362, DOI 10.1056/NEJM200011093431903; Merke DP, 2005, LANCET, V365, P2125, DOI 10.1016/S0140-6736(05)66736-0; O'Beirne J, 2007, J HEPATOL, V47, P418, DOI 10.1016/j.jhep.2007.06.008; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; Perry R, 2005, J CLIN ENDOCR METAB, V90, P3243, DOI 10.1210/jc.2004-0016; Rajab A, 2008, HUM MOL GENET, V17, P2150, DOI 10.1093/hmg/ddn114; Rock EP, 2007, ONCOLOGIST, V12, P107, DOI 10.1634/theoncologist.12-1-107; SADEGHINEJAD A, 1990, NEW ENGL J MED, V322, P13, DOI 10.1056/NEJM199001043220103; Sandrini F, 2001, J CLIN ENDOCR METAB, V86, P5433, DOI 10.1210/jc.86.11.5433; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Shibata S, 2001, AM J HEMATOL, V66, P303, DOI 10.1002/ajh.1063; Sivabalan Shanmugam, 2008, Int Arch Med, V1, P7, DOI 10.1186/1755-7682-1-7; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; van Staa TP, 2000, QJM-MON J ASSOC PHYS, V93, P105, DOI 10.1093/qjmed/93.2.105; van Wijngaarden RFAD, 2008, J CLIN ENDOCR METAB, V93, P1649, DOI 10.1210/jc.2007-2294; Varis T, 2000, CLIN PHARMACOL THER, V68, P487, DOI 10.1067/mcp.2000.110772; Vogeser M, 2001, CLIN CHEM LAB MED, V39, P944, DOI 10.1515/CCLM.2001.151	56	217	221	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2328	2339		10.1056/NEJMra0804635	http://dx.doi.org/10.1056/NEJMra0804635			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474430				2022-12-28	WOS:000266367300009
J	Hall, WJ				Hall, William J.			The Intervention of Saint George	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												william_hall@urmc.rochester.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2076	2077		10.1001/jama.2009.676	http://dx.doi.org/10.1001/jama.2009.676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19470977				2022-12-28	WOS:000266328800001
J	Dungan, KM; Braithwaite, SS; Preiser, JC				Dungan, Kathleen M.; Braithwaite, Susan S.; Preiser, Jean-Charles			Stress hyperglycaemia	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; INTENSIVE INSULIN THERAPY; BLOOD-GLUCOSE CONTROL; TRANSPORTER MESSENGER-RNA; CRITICALLY-ILL PATIENTS; LONG-TERM MORTALITY; PROTEIN-KINASE-C; OXIDATIVE STRESS; GLYCEMIC CONTROL; ADMISSION HYPERGLYCEMIA	Results of randomised controlled trials of tight glycaemic control in hospital inpatients might vary with population and disease state. Individualised therapy for different hospital inpatient populations and identification of patients at risk of hyperglycaemia might be needed. One risk factor that has received much attention is the presence of pre-existing diabetes. So-called stress hyperglycaemia, is usually defined as hyperglycaemia resolving spontaneously after dissipation of acute illness. The term generally refers to patients without known diabetes, although patients with diabetes might also develop stress hyperglycaemia-a fact overlooked in many studies comparing hospital inpatients with or without diabetes. investigators of several studies have suggested that patients with stress hyperglycaemia are at higher risk of adverse consequences than are those with pre-existing diabetes. We describe classification of stress hyperglycaemia, mechanisms of harm, and management strategies.	[Dungan, Kathleen M.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Braithwaite, Susan S.] Univ N Carolina, Chapel Hill, NC USA; [Preiser, Jean-Charles] Ctr Hosp Univ Liege, Liege, Belgium	University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of Liege	Dungan, KM (corresponding author), Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA.	kathleen.dungan@osumc.edu	Preiser, Jean-Charles/AAL-2355-2021; Dungan, Kathleen/E-2999-2011	Preiser, Jean-Charles/0000-0003-3163-0390; 	NIDDK NIH HHS [K23 DK080891-02, K23 DK080891] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK080891] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AACE DIAB MELL CL, 2007, ENDOCR PRACT S1, V13, P1; Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Ainla T, 2005, DIABETIC MED, V22, P1321, DOI 10.1111/j.1464-5491.2005.01625.x; Ali NA, 2008, CRIT CARE MED, V36, P2316, DOI 10.1097/CCM.0b013e3181810378; *AM DIAB ASS, JOINT STAT ADA AACE; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Ariza-Andraca C R, 1991, Arch Invest Med (Mex), V22, P229; Aronson D, 2007, DIABETES CARE, V30, P960, DOI 10.2337/dc06-1735; Barth E, 2007, CRIT CARE MED, V35, pS508, DOI 10.1097/01.CCM.0000278047.06965.20; Bartnik M, 2004, EUR HEART J, V25, P1880, DOI 10.1016/j.ehj.2004.07.027; BLUMBERG D, 1995, J SURG ONCOL, V59, P220, DOI 10.1002/jso.2930590404; Cao JJ, 2005, AM J CARDIOL, V96, P183, DOI 10.1016/j.amjcard.2005.03.040; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; *CDCP, 2005, NAT DIAB FACT SHEET; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Cohen G., 2007, Archives of Physiology and Biochemistry, V113, P259, DOI 10.1080/13813450701783513; Davidson PC, 2005, DIABETES CARE, V28, P2418, DOI 10.2337/diacare.28.10.2418; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Devos P, 2007, INTENS CARE MED, V33, P189; Dimitriadis G, 1997, BIOCHEM J, V321, P707, DOI 10.1042/bj3210707; Dossett LA, 2008, AM SURGEON, V74, P679; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Dronge AS, 2006, ARCH SURG-CHICAGO, V141, P375, DOI 10.1001/archsurg.141.4.375; Dungan K, 2007, DIABETES CARE, V30, P403, DOI 10.2337/dc06-1679; Egi M, 2008, CRIT CARE MED, V36, P2249, DOI 10.1097/CCM.0b013e318181039a; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; *END SOC, END SOC STAT PROV NI; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Fan J, 1996, SHOCK, V6, P164, DOI 10.1097/00024382-199609010-00002; Farrokhnia N, 2005, ACTA NEUROL SCAND, V112, P81, DOI 10.1111/j.1600-0404.2005.00440.x; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819; Freire AX, 2005, CHEST, V128, P3109, DOI 10.1378/chest.128.5.3109; Fujiwara T, 1996, METABOLISM, V45, P571, DOI 10.1016/S0026-0495(96)90026-8; Furnary AP, 2006, SEMIN THORAC CARDIOV, V18, P302, DOI 10.1053/j.semtcvs.2006.04.005; Furnary Anthony P, 2006, Endocr Pract, V12 Suppl 3, P22; GAMELLI RL, 1994, SHOCK, V1, P395, DOI 10.1097/00024382-199406000-00001; Gamelli RL, 1996, J LEUKOCYTE BIOL, V59, P639, DOI 10.1002/jlb.59.5.639; Gandhi GY, 2008, MAYO CLIN PROC, V83, P418, DOI 10.4065/83.4.418; Gray CS, 2004, AGE AGEING, V33, P71, DOI 10.1093/ageing/afh026; Greci LS, 2003, DIABETES CARE, V26, P1064, DOI 10.2337/diacare.26.4.1064; GREEN CJ, 1995, CLIN SCI, V89, P601, DOI 10.1042/cs0890601; Hadjadj S, 2004, DIABETIC MED, V21, P305, DOI 10.1111/j.1464-5491.2004.01112.x; Hashimoto K, 2005, DIABETES CARE, V28, P1182, DOI 10.2337/diacare.28.5.1182; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Ishihara M, 2005, AM HEART J, V150, P814, DOI 10.1016/j.ahj.2004.12.020; Ishihara M, 2007, AM J CARDIOL, V99, P1674, DOI 10.1016/j.amjcard.2007.01.044; Ishihara M, 2006, EUR HEART J, V27, P2413, DOI 10.1093/eurheartj/ehl271; Ishizuka K, 2007, ENDOCRINOLOGY, V148, P2994, DOI 10.1210/en.2006-1702; JEEVANANDAM M, 1990, J TRAUMA, V30, P582, DOI 10.1097/00005373-199005000-00010; Jones KW, 2008, J DIABETES COMPLICAT, V22, P365, DOI 10.1016/j.jdiacomp.2007.05.006; Kanji S, 2004, INTENS CARE MED, V30, P804, DOI 10.1007/s00134-004-2252-2; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; Kes VB, 2007, ANN SAUDI MED, V27, P352; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kitabchi AE, 2008, METABOLISM, V57, P116, DOI 10.1016/j.metabol.2007.08.014; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.517839; Kosuge M, 2005, CIRC J, V69, P375, DOI 10.1253/circj.69.375; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Krinsley JS, 2006, SEMIN THORAC CARDIOV, V18, P317, DOI 10.1053/j.semtcvs.2006.12.003; Krogh-Madsen R, 2008, AM J PHYSIOL-ENDOC M, V294, pE371, DOI 10.1152/ajpendo.00507.2007; Kudva Yogish C, 2007, Endocr Pract, V13, P244; LANG CH, 1992, AM J PHYSIOL, V263, pE703, DOI 10.1152/ajpendo.1992.263.4.E703; LANG CH, 1989, CIRC SHOCK, V29, P181; LANG CH, 1991, ENDOCRINOLOGY, V128, P645, DOI 10.1210/endo-128-2-645; LANG CH, 1990, METABOLISM, V39, P1096, DOI 10.1016/0026-0495(90)90172-9; Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385; Leonidou L, 2007, J INFECTION, V55, P340, DOI 10.1016/j.jinf.2007.05.177; Ling PR, 2005, CRIT CARE MED, V33, P1084, DOI 10.1097/01.CCM.0000163225.88827.63; MCGUINNESS OP, 1993, AM J PHYSIOL, V265, pE314, DOI 10.1152/ajpendo.1993.265.2.E314; McGuinness OP, 1997, AM J PHYSIOL-ENDOC M, V273, pE674, DOI 10.1152/ajpendo.1997.273.4.E674; Meier JJ, 2005, DIABETES CARE, V28, P2551, DOI 10.2337/diacare.28.10.2551; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Mudespacher Damaris, 2007, Diab Vasc Dis Res, V4, P346, DOI 10.3132/dvdr.2007.063; Noordzij PG, 2007, EUR J ENDOCRINOL, V156, P137, DOI 10.1530/eje.1.02321; Nordin Charles, 2005, Cardiol Rev, V13, P223, DOI 10.1097/01.crd.0000137251.77175.6a; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pasternak JJ, 2008, MAYO CLIN PROC, V83, P406, DOI 10.4065/83.4.406; Petursson P, 2007, INT J CARDIOL, V116, P315, DOI 10.1016/j.ijcard.2006.04.043; Price Grant C, 2008, Crit Care Resusc, V10, P209; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Rady MY, 2005, MAYO CLIN PROC, V80, P1558, DOI 10.4065/80.12.1558; Reed CC, 2007, J AM COLL SURGEONS, V204, P1048, DOI 10.1016/j.jamcollsurg.2006.12.047; Saudek CD, 1996, JAMA-J AM MED ASSOC, V276, P1322, DOI 10.1001/jama.276.16.1322; Schetz M, 2008, J AM SOC NEPHROL, V19, P571, DOI 10.1681/ASN.2006101091; Schiele F, 2006, DIABETIC MED, V23, P1370, DOI 10.1111/j.1464-5491.2006.02000.x; Schmeltz LR, 2007, DIABETES CARE, V30, P823, DOI 10.2337/dc06-2184; Shangraw RE, 1996, CRIT CARE MED, V24, P566, DOI 10.1097/00003246-199604000-00004; Soop M, 2002, AM J PHYSIOL-ENDOC M, V282, pE1276, DOI 10.1152/ajpendo.00535.2001; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Stegenga ME, 2008, BLOOD, V112, P82, DOI 10.1182/blood-2007-11-121723; Stentz FB, 2004, DIABETES, V53, P2079, DOI 10.2337/diabetes.53.8.2079; Stollberger C, 2005, ANN MED, V37, P357, DOI 10.1080/07853890510037356; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Szczudlik A, 2001, J NEUROL SCI, V189, P105, DOI 10.1016/S0022-510X(01)00566-4; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Umpierrez GE, 2009, J CLIN ENDOCR METAB, V94, P564, DOI 10.1210/jc.2008-1441; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Vancheri F, 2005, QJM-INT J MED, V98, P871, DOI 10.1093/qjmed/hci134; Vanhorebeek I, 2006, ENDOCRIN METAB CLIN, V35, P859, DOI 10.1016/j.ecl.2006.09.002; Vibo R, 2007, EUR J NEUROL, V14, P435, DOI 10.1111/j.1468-1331.2007.01704.x; Vogelzang M, 2008, INTENS CARE MED, V34, P1421, DOI 10.1007/s00134-008-1091-y; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; Waeschle RM, 2008, CRIT CARE, V12, DOI 10.1186/cc7097; Wallander M, 2008, DIABETES CARE, V31, P36, DOI 10.2337/dc07-1552; Wexler DJ, 2008, J CLIN ENDOCR METAB, V93, P4238, DOI 10.1210/jc.2008-1090; Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25; Worthley MI, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.06.043; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865; Yu WK, 2003, WORLD J GASTROENTERO, V9, P1824, DOI 10.3748/wjg.v9.i8.1824; Zauner A, 2007, METABOLISM, V56, P1, DOI 10.1016/j.metabol.2006.08.014; ZELLER WP, 1991, BIOCHEM BIOPH RES CO, V176, P535, DOI 10.1016/0006-291X(91)90958-A	123	715	767	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1798	1807		10.1016/S0140-6736(09)60553-5	http://dx.doi.org/10.1016/S0140-6736(09)60553-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465235	Green Accepted			2022-12-28	WOS:000266337300035
J	MacDonald, R; Horton, R; Buhmann, C				MacDonald, Rhona; Horton, Richard; Buhmann, Caecilie			Violent conflict and health: a call for papers	LANCET			English	Editorial Material									[MacDonald, Rhona; Horton, Richard] The Lancet, London NW1 7BY, England; [Buhmann, Caecilie] Global Doctors, DK-1353 Copenhagen, Denmark		MacDonald, R (corresponding author), The Lancet, London NW1 7BY, England.			Buhmann, Caecilie Bock/0000-0002-2926-9754				[Anonymous], MED SANS FRONTIERES; *GLOB DOCT, VIOL CONFL GLOB WORL; 2009, LANCET, V373, P1399; 2009, LANCET, V373, P95	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1747	1748		10.1016/S0140-6736(09)60964-8	http://dx.doi.org/10.1016/S0140-6736(09)60964-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19465219				2022-12-28	WOS:000266337300011
J	Tamborlane, WV; Beck, RW				Tamborlane, William V.; Beck, Roy W.			Continuous glucose monitoring in type 1 diabetes mellitus	LANCET			English	Editorial Material							PEDIATRIC-PATIENTS		[Tamborlane, William V.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Beck, Roy W.] Jaeb Ctr Hlth Res, Tampa, FL USA	Yale University; JAEB Center For Health Research	Tamborlane, WV (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	william.tamborlane@yale.edu						Diabetes Research in Children Network (DIRECNET) Study Group, 2003, Diabetes Technol Ther, V5, P781; Diabetes Research in Children Network (DIRECNET) Study Group, 2003, Diabetes Technol Ther, V5, P791; Hirsch IB, 2008, DIABETES TECHNOL THE, V10, P377, DOI 10.1089/dia.2008.0068; *JUV DIAB RES FDN, DIABETES CA IN PRESS; *JUV DIAB RES FDN, DIABETES IN PRESS; Kaufman FR, 2002, J PEDIATR-US, V141, P625, DOI 10.1067/mpd.2002.129175; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967	9	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1744	1746		10.1016/S0140-6736(09)60962-4	http://dx.doi.org/10.1016/S0140-6736(09)60962-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465217				2022-12-28	WOS:000266337300009
J	Mehta, SR; Granger, CB; Boden, WE; Steg, PG; Bassand, JP; Faxon, DP; Afzal, R; Chrolavicius, S; Jolly, SS; Widimsky, P; Avezum, A; Rupprecht, HJ; Zhu, J; Col, J; Natarajan, MK; Horsman, C; Fox, KAA; Yusuf, S				Mehta, Shamir R.; Granger, Christopher B.; Boden, William E.; Steg, Philippe Gabriel; Bassand, Jean-Pierre; Faxon, David P.; Afzal, Rizwan; Chrolavicius, Susan; Jolly, Sanjit S.; Widimsky, Petr; Avezum, Alvaro; Rupprecht, Hans-Jurgen; Zhu, Jun; Col, Jacques; Natarajan, Madhu K.; Horsman, Craig; Fox, Keith A. A.; Yusuf, Salim		TIMACS Investigators	Early versus Delayed Invasive Intervention in Acute Coronary Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; THROMBOLYTIC THERAPY; AMERICAN-COLLEGE; RANDOMIZED-TRIAL; UNSTABLE ANGINA; HIGH-RISK; OUTCOMES; ANGIOGRAPHY; GUIDELINES	BACKGROUND Earlier trials have shown that a routine invasive strategy improves outcomes in patients with acute coronary syndromes without ST-segment elevation. However, the optimal timing of such intervention remains uncertain. METHODS We randomly assigned 3031 patients with acute coronary syndromes to undergo either routine early intervention (coronary angiography <= 24 hours after randomization) or delayed intervention (coronary angiography >= 36 hours after randomization). The primary outcome was a composite of death, myocardial infarction, or stroke at 6 months. A prespecified secondary outcome was death, myocardial infarction, or refractory ischemia at 6 months. RESULTS Coronary angiography was performed in 97.6% of patients in the early-intervention group (median time, 14 hours) and in 95.7% of patients in the delayed-intervention group (median time, 50 hours). At 6 months, the primary outcome occurred in 9.6% of patients in the early-intervention group, as compared with 11.3% in the delayed-intervention group (hazard ratio in the early-intervention group, 0.85; 95% confidence interval [CI], 0.68 to 1.06; P = 0.15). There was a relative reduction of 28% in the secondary outcome of death, myocardial infarction, or refractory ischemia in the early-intervention group (9.5%), as compared with the delayed-intervention group (12.9%) (hazard ratio, 0.72; 95% CI, 0.58 to 0.89; P = 0.003). Prespecified analyses showed that early intervention improved the primary outcome in the third of patients who were at highest risk (hazard ratio, 0.65; 95% CI, 0.48 to 0.89) but not in the two thirds at low-to-intermediate risk (hazard ratio, 1.12; 95% CI, 0.81 to 1.56; P = 0.01 for heterogeneity). CONCLUSIONS Early intervention did not differ greatly from delayed intervention in preventing the primary outcome, but it did reduce the rate of the composite secondary outcome of death, myocardial infarction, or refractory ischemia and was superior to delayed intervention in high-risk patients. (ClinicalTrials.gov number, NCT00552513.)	[Mehta, Shamir R.; Afzal, Rizwan; Chrolavicius, Susan; Jolly, Sanjit S.; Natarajan, Madhu K.; Horsman, Craig; Yusuf, Salim] McMaster Univ & Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Granger, Christopher B.] Duke Clin Res Inst, Durham, NC USA; [Boden, William E.] SUNY Buffalo, Sch Med, Buffalo, NY 14260 USA; [Boden, William E.] SUNY Buffalo, Sch Publ Hlth, Buffalo, NY 14260 USA; [Steg, Philippe Gabriel] Univ Paris 07, INSERM, U698, APHP, Paris, France; [Bassand, Jean-Pierre] Univ Hosp Jean Minjoz, Besancon, France; [Faxon, David P.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Widimsky, Petr] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Rupprecht, Hans-Jurgen] Second Med Clin, Russelsheim, Germany; [Zhu, Jun] Fu Wai Hosp, Beijing, Peoples R China; [Col, Jacques] St Luc Univ, Leuven, Belgium; [Fox, Keith A. A.] Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland	McMaster University; Population Health Research Institute; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon; Harvard University; Brigham & Women's Hospital; University Hospital Vinohrady; Instituto Dante Pazzanese de Cardiologia; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Royal Infirmary of Edinburgh; University of Edinburgh	Mehta, SR (corresponding author), Hamilton Gen Hosp, McMaster Clin, Rm 508,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	smehta@mcmaster.ca	Widimsky, Petr/P-8088-2016; Avezum, Alvaro AA/K-6137-2016; Granger, Christopher B/D-3458-2014; Turazza, Fabio/AAB-8736-2020; Jolly, Sanjit/O-2534-2015; STEG, Philippe Gabriel/Z-1567-2019; Avezum, Alvaro/AAP-7687-2020; Benedek, Imre/E-7052-2017; Malik, Jan/C-4826-2008; Malik, Jan/K-8681-2019; LEYS, Didier/G-2955-2016; Benedek, Theodora/F-6353-2016; Fox, keith A A/I-3742-2013	Widimsky, Petr/0000-0001-5686-7752; Avezum, Alvaro AA/0000-0002-3073-6890; Granger, Christopher B/0000-0002-0045-3291; Turazza, Fabio/0000-0002-2348-5309; Benedek, Imre/0000-0003-0051-4047; Malik, Jan/0000-0002-2386-3293; Malik, Jan/0000-0002-2386-3293; LEYS, Didier/0000-0003-4408-4392; Benedek, Theodora/0000-0001-8326-1537; Moulin, thierry/0000-0002-6639-8117; Lanas, Fernando/0000-0003-3595-9759; Yusuf, Salim/0000-0003-4776-5601; Fox, Keith/0000-0002-0140-2752; STEG, Philippe Gabriel/0000-0001-6896-2941; Held, Claes/0000-0001-9402-7404	Canadian Institutes of Health Research; GlaxoSmithKline; Sanofi-Aventis; Organon NV; Heart and Stroke Foundation of Ontario; Bristol-Myers Squibb	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); Organon NV; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Bristol-Myers Squibb(Bristol-Myers Squibb)	Supported by the Canadian Institutes of Health Research; by the sponsors of the OASIS-5 study, which included GlaxoSmithKline, Sanofi-Aventis, and Organon NV; by a New Investigator Award from the Canadian Institutes of Health Research (to Dr. Mehta); and by the Heart and Stroke Foundation of Ontario (an endowed chair held by Dr. Yusuf).; Dr. Mehta reports receiving grant support from Bristol-Myers Squibb, GlaxoSmithKline, and Sanofi-Aventis and consulting or lecture fees from Abbott Vascular, Astellas, AstraZeneca, Boston Scientific, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Pfizer, and Sanofi-Aventis; Dr. Granger, receiving grant support from Sanofi-Aventis, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, the Medicines Company, Novartis, and Merck, and consulting or speaking fees from Sanofi-Aventis, GlaxoSmithKline, the Medicines Company, Novartis, Fibrex, and AstraZeneca; Dr. Boden, receiving consulting fees from CV Therapeutics and Sanofi-Aventis and lecture fees from CV Therapeutics, Sanofi-Aventis, and Abbott; Dr. Steg, receiving grant support from Sanofi-Aventis and consulting or lecture fees from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Endotis, GlaxoSmithKline, Merck, Nycomed, SanofiAventis, Servier, Takeda, and the Medicines Company; Dr. Bassand, receiving consulting and lecture fees and having an equity interest in GlaxoSmithKline and Sanofi-Aventis; Dr. Faxon, receiving consulting fees from Johnson & Johnson and grant support from Boston Scientific; Dr. Jolly, receiving lecture fees from GlaxoSmithKline; Dr. Rupprecht, receiving consulting and lecture fees from CV Therapeutics, Bristol-Myers Squibb, SanofiAventis, Eli Lilly, and GlaxoSmithKline; Dr. Natarajan, receiving lecture fees from Abbott Vascular, Boston Scientific, and Eli Lilly; Dr. Fox, receiving consulting and lecture fees from SanofiAventis, lecture fees from Bristol-Myers Squibb and GlaxoSmithKline, and grant support from Sanofi-Aventis and GlaxoSmithKline; and Dr. Yusuf, receiving grant support from Bristol-Myers Squibb, Sanofi-Aventis, and GlaxoSmithKline and consulting and lecture fees from AstraZeneca, Boehringer Ingelheim, BristolMyers Squibb, GlaxoSmithKline, Sanofi-Aventis, and Servier. No other potential conflict of interest relevant to this article was reported.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; ANDERSON JL, 2008, J AM COLL CARDIOL, V51, P974; [Anonymous], 1994, Circulation, V89, P1545; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; ANTMAN EM, 2008, CIRCULATION, V117, pE162; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Boden WE, 1998, NEW ENGL J MED, V339, P1397; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Clayton TC, 2004, EUR HEART J, V25, P1641, DOI 10.1016/j.ehj.2004.07.032; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; McCullough PA, 1998, J AM COLL CARDIOL, V32, P596, DOI 10.1016/S0735-1097(98)00284-8; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; MEHTA SR, 2005, AM HEART J, V150; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; RIEZEBOS RK, 2008, HEART           1222; Ryan JW, 2005, CIRCULATION, V112, P3049, DOI 10.1161/CIRCULATIONAHA.105.582346; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Spacek R, 2002, EUR HEART J, V23, P230, DOI 10.1053/euhj.2001.2735; SWAHN E, 2009, EUR HEART J     0207; Swanson N, 2009, HEART, V95, P211, DOI 10.1136/hrt.2008.149922; Tricoci P, 2007, CIRCULATION, V116, P2669, DOI 10.1161/CIRCULATIONAHA.107.690081; Wallentin L, 1999, LANCET, V354, P708; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	30	584	614	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2165	2175		10.1056/NEJMoa0807986	http://dx.doi.org/10.1056/NEJMoa0807986			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458363				2022-12-28	WOS:000266206000004
J	Dean, S; Marchetti, R; Kirk, K; Matthews, KR				Dean, Samuel; Marchetti, Rosa; Kirk, Kiaran; Matthews, Keith R.			A surface transporter family conveys the trypanosome differentiation signal	NATURE			English	Article							BLOOD-STREAM; LIFE-CYCLE; AFRICAN TRYPANOSOMES; PROCYCLIC FORMS; BRUCEI; TRANSFORMATION; MALARIA; ACID; TEMPERATURE; PROGRESSION	Microbial pathogens use environmental cues to trigger the developmental events needed to infect mammalian hosts or transmit to disease vectors. The parasites causing African sleeping sickness respond to citrate or cis-aconitate (CCA) to initiate life-cycle development when transmitted to their tsetse fly vector. This requires hypersensitization of the parasites to CCA by exposure to low temperature, conditions encountered after tsetse fly feeding at dusk or dawn. Here we identify a carboxylate-transporter family, PAD (proteins associated with differentiation), required for perception of this differentiation signal. Consistent with predictions for the response of trypanosomes to CCA, PAD proteins are expressed on the surface of the transmission-competent 'stumpy-form' parasites in the bloodstream, and at least one member is thermoregulated, showing elevated expression and surface access at low temperature. Moreover, RNA-interference-mediated ablation of PAD expression diminishes CCA-induced differentiation and eliminates CCA hypersensitivity under cold-shock conditions. As well as being molecular transducers of the differentiation signal in these parasites, PAD proteins provide the first example of a surface marker able to discriminate the transmission stage of trypanosomes in their mammalian host.	[Dean, Samuel; Matthews, Keith R.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Marchetti, Rosa; Kirk, Kiaran] Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia	University of Edinburgh; Australian National University	Matthews, KR (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	keith.matthews@ed.ac.uk	Kirk, Kiaran/C-8299-2009	Kirk, Kiaran/0000-0002-5613-2622; Dean, Samuel/0000-0002-4792-2198; Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184	Wellcome Trust; BBSRC studentship; Wellcome Trust Programme; Centre for Immunity, Infection and Evolution; BBSRC REI; BBSRC [BB/E012442/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012442/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Programme(Wellcome Trust); Centre for Immunity, Infection and Evolution; BBSRC REI(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Ullu for the gift of genomic macroarrays, M. Engstler and M. Boshart for the gift of the AnTat1.1 90: 13 line, and A. Schneider for pALC14. We thank D. Hall, P. Davies and D. Levin for technical assistance, P. MacGregor for statistical analysis and A. Paterou and D. Murray for Image analysis. This work was supported by a Wellcome Trust project grant and programme grant to K. R. M. S. D. was supported by a BBSRC studentship, a Wellcome Trust Programme Grant to K. R. M. and by a Journal of Cell Science Travelling fellowship for a visit to the laboratory of K. K. Support was also provided through a Wellcome Trust strategic award for the Centre for Immunity, Infection and Evolution and a BBSRC REI award for confocal facilities.	Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BASS KE, 1991, MOL BIOCHEM PARASIT, V44, P261, DOI 10.1016/0166-6851(91)90012-U; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bruce D, 1912, P R SOC LOND B-CONTA, V85, P423, DOI 10.1098/rspb.1912.0068; CZICHOS J, 1986, EXP PARASITOL, V62, P283, DOI 10.1016/0014-4894(86)90033-0; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Fang J, 2002, NATURE, V418, P742, DOI 10.1038/418742a; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; HUNT M, 1994, PARASITOL RES, V80, P600, DOI 10.1007/BF00933009; JACOBS SL, 1964, J NUCL MED, V5, P297; Kamsteeg EJ, 2007, P NATL ACAD SCI USA, V104, P16696, DOI 10.1073/pnas.0708023104; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; MATTHEWS KR, 1994, J CELL BIOL, V125, P1147, DOI 10.1083/jcb.125.5.1147; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Robertson M, 1912, P R SOC LOND B-CONTA, V85, P241, DOI 10.1098/rspb.1912.0048; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; SHAPIRO SZ, 1984, ACTA TROP, V41, P313; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Tasker M, 2000, MOL BIOL CELL, V11, P1905, DOI 10.1091/mbc.11.5.1905; TURNER CMR, 1988, PARASITOL RES, V74, P507, DOI 10.1007/BF00531626; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vassella E, 1997, J CELL SCI, V110, P2661; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	32	155	155	3	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					213	U93		10.1038/nature07997	http://dx.doi.org/10.1038/nature07997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444208	Green Accepted			2022-12-28	WOS:000266036100032
J	Fuhrman, JA				Fuhrman, Jed A.			Microbial community structure and its functional implications	NATURE			English	Review							BACTERIAL DIVERSITY; NORTHWEST ATLANTIC; BIOMASS PRODUCTION; MARINE VIRUSES; PATTERNS; OCEAN; BIOGEOGRAPHY; SEA; MICRODIVERSITY; MICROORGANISMS	Marine microbial communities are engines of globally important processes, such as the marine carbon, nitrogen and sulphur cycles. Recent data on the structures of these communities show that they adhere to universal biological rules. Co-occurrence patterns can help define species identities, and systems-biology tools are revealing networks of interacting microorganisms. Some microbial systems are found to change predictably, helping us to anticipate how microbial communities and their activities will shift in a changing world.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Fuhrman, JA (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	fuhrman@usc.edu	Fuhrman, Jed A/C-6461-2013	Fuhrman, Jed A/0000-0002-2361-1985	US National Science Foundation Microbial Observatories Program [0527034, 0623575, 0648581, 0703159]; University of Southern California Wrigley Institute for Environmental Studies	US National Science Foundation Microbial Observatories Program(National Science Foundation (NSF)); University of Southern California Wrigley Institute for Environmental Studies	I thank A. Hagstrom, F. Sun, J. Steele, I. Hewson, S. Naeem, J. Green and J. Brown for helping develop ideas presented here, and C. Chow, C. Horner-Devine and J. Cram for comments. Work in my laboratory was supported by the US National Science Foundation Microbial Observatories Program and grants 0527034, 0623575, 0648581, and 0703159, and by the University of Southern California Wrigley Institute for Environmental Studies.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Brown MV, 2005, AQUAT MICROB ECOL, V41, P15, DOI 10.3354/ame041015; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; Countway PD, 2007, ENVIRON MICROBIOL, V9, P1219, DOI 10.1111/j.1462-2920.2007.01243.x; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P1667, DOI 10.1111/j.1462-2920.2006.01052.x; Degnan PH, 2004, SYST BIOL, V53, P95, DOI 10.1080/10635150490264842; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; FIERER N, 2008, ACCESSING UNCULTIVAT, P95; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Franklin MP, 2005, ENVIRON MICROBIOL, V7, P723, DOI 10.1111/j.1462-2920.2004.00736.x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; FUHRMAN JA, 2007, MANUAL ENV MICROBIOL, pCH35; FUHRMAN JA, 1993, OCEANOGRAPHY, V6, P51; Fuhrman JA., 2008, MICROBIAL ECOLOGY OC, P45, DOI 10.1002/9780470281840.ch3; Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Garcia-Martinez J, 2000, MOL ECOL, V9, P935, DOI 10.1046/j.1365-294x.2000.00953.x; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hewson I, 2004, APPL ENVIRON MICROB, V70, P3425, DOI 10.1128/AEM.70.6.3425-3433.2004; Hewson I, 2006, LIMNOL OCEANOGR, V51, P1274, DOI 10.4319/lo.2006.51.3.1274; Hewson I, 2006, MAR ECOL PROG SER, V311, P67, DOI 10.3354/meps311067; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Malmstrom RR, 2005, APPL ENVIRON MICROB, V71, P2979, DOI 10.1128/AEM.71.6.2979-2986.2005; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; PACE NR, 1986, ADV MICROB ECOL, V9, P1; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rosenweig ML, 1995, SPECIES DIVERSITY SP; Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Staley JT, 1997, CURR OPIN BIOTECH, V8, P340, DOI 10.1016/S0958-1669(97)80014-6; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Woodcock S, 2007, FEMS MICROBIOL ECOL, V62, P171, DOI 10.1111/j.1574-6941.2007.00379.x; Woodcock S, 2006, ECOL LETT, V9, P805, DOI 10.1111/j.1461-0248.2006.00929.x; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002	78	742	801	54	718	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					193	199		10.1038/nature08058	http://dx.doi.org/10.1038/nature08058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444205				2022-12-28	WOS:000266036100029
J	Hawkes, N				Hawkes, Nigel			Health Policy Integrated care	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	5	5	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 8	2009	338								b1484	10.1136/bmj.b1484	http://dx.doi.org/10.1136/bmj.b1484			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GY	19429651				2022-12-28	WOS:000265969900001
J	Whitley, RJ				Whitley, Richard J.			A 70-Year-Old Woman With Shingles Review of Herpes Zoster	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENUATED VARICELLA VACCINE; POSTHERPETIC NEURALGIA; ORAL ACYCLOVIR; UNITED-STATES; DOUBLE-BLIND; IMMUNE-RESPONSES; NEUROPATHIC PAIN; RANDOMIZED-TRIAL; RISK-FACTORS; VIRUS	Herpes zoster is a common late complication of varicella-zoster virus exposure and can be further complicated by postherpetic neuralgia. Ms A is a 70-year-old woman with shingles and Ramsay-Hunt syndrome who presented to the emergency department with a few days of earache followed by pain in the back of her head. Using her case as a springboard, the diagnosis, natural history, and treatment of herpes zoster and postherpetic neuralgia in immunocompetent older adults are reviewed, in addition to the effectiveness of the herpes zoster vaccine. JAMA. 2009;302(1):73-80	Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Whitley, RJ (corresponding author), Univ Alabama Birmingham, Dept Pediat, CHB 303,1600 7th Ave S, Birmingham, AL 35294 USA.	rwhitley@peds.uab.edu			National Institutes of Health;  [N0-1AI30025]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	Dr Whitley reports that he received support from the National Institutes of Health for the conduct of studies on herpes zoster between 1973 and 1996. Clinical trial data on the natural history of herpes zoster since the completion of controlled trials were analyzed through the support of contract N0-1AI30025. He serves on the board of directors of Gilead Sciences and is a consultant to Chimerix; neither company is involved in the development of therapeutics for VZV infections.	[Anonymous], 2006, ZOST PACK INS; Arani RB, 2001, STAT MED, V20, P2429, DOI 10.1002/sim.851; Arvin AM, 2008, J INFECT DIS, V197, pS58, DOI 10.1086/522123; BERNSTEIN JE, 1989, J AM ACAD DERMATOL, V21, P265, DOI 10.1016/S0190-9622(89)70171-7; BEUTNER KR, 1995, ANTIMICROB AGENTS CH, V39, P1546, DOI 10.1128/AAC.39.7.1546; Bowsher D, 1997, J PAIN SYMPTOM MANAG, V13, P327, DOI 10.1016/S0885-3924(97)00077-8; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; BROWN GR, 1976, SOUTHERN MED J, V69, P576, DOI 10.1097/00007611-197605000-00028; BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; Centers for Disease Control and Prevention, 2008, PREV HERP ZOST REC A; Chaves SS, 2007, NEW ENGL J MED, V356, P1121, DOI 10.1056/NEJMoa064040; Choo PW, 1997, ARCH INTERN MED, V157, P1217, DOI 10.1001/archinte.157.11.1217; CHOO PW, 1995, J INFECT DIS, V172, P706, DOI 10.1093/infdis/172.3.706; Dahl H, 1997, J CLIN MICROBIOL, V35, P347, DOI 10.1128/JCM.35.2.347-349.1997; DEGREEF H, 1994, INT J ANTIMICROB AG, V4, P241, DOI 10.1016/0924-8579(94)90024-8; Desmond RA, 2002, J PAIN SYMPTOM MANAG, V23, P510, DOI 10.1016/S0885-3924(02)00393-7; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; *DRUGS COM, GAB; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Dworkin RH, 2003, NEUROLOGY, V60, P1274, DOI 10.1212/01.WNL.0000055433.55136.55; Dworkin RH, 1996, PAIN, V67, P241, DOI 10.1016/0304-3959(96)03122-3; Dworkin RH, 2008, J PAIN, V9, pS37, DOI 10.1016/j.jpain.2007.10.008; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Dworkin RH, 2009, PAIN, V142, P209, DOI 10.1016/j.pain.2008.12.022; Galer BS, 1999, PAIN, V80, P533, DOI 10.1016/S0304-3959(98)00244-9; GERSHON AA, 1992, J INFECT DIS, V166, pS63, DOI 10.1093/infdis/166.Supplement_1.S63; Gershon AA, 2000, NEW ENGL J MED, V343, P222; Gershon AA, 2007, NEW ENGL J MED, V356, P2648; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Gnann JW, 1998, ANTIMICROB AGENTS CH, V42, P1139, DOI 10.1128/AAC.42.5.1139; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Guris D, 2008, J INFECT DIS, V197, pS71, DOI 10.1086/522156; Haanpaa M, 2000, J PAIN SYMPTOM MANAG, V20, P50, DOI 10.1016/S0885-3924(00)00149-4; HARDY I, 1991, NEW ENGL J MED, V325, P1545, DOI 10.1056/NEJM199111283252204; HARPAZ JTR, CONSIDERATIONS SHING; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; HUFF JC, 1988, AM J MED, V85, P84; Jung BF, 2004, NEUROLOGY, V62, P1545, DOI 10.1212/01.WNL.0000123261.00004.29; KISHOREKUMAR R, 1990, CLIN PHARMACOL THER, V47, P305, DOI 10.1038/clpt.1990.33; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Kotani N, 2000, NEW ENGL J MED, V343, P1514, DOI 10.1056/NEJM200011233432102; Levin MJ, 1998, J INFECT DIS, V178, pS109, DOI 10.1086/514264; LEVIN MJ, 1994, J INFECT DIS, V170, P522, DOI 10.1093/infdis/170.3.522; *LEX COMP CLIN ON, GAB; Li QF, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006866.pub2; LIESEGANG TJ, 1991, OPHTHALMOLOGY, V98, P1216; MAX MB, 1988, NEUROLOGY, V38, P1427, DOI 10.1212/WNL.38.9.1427; MCKENDRICK MW, 1986, BRIT MED J, V293, P1529, DOI 10.1136/bmj.293.6561.1529; MCKENDRICK MW, 1989, BRIT MED J, V298, P431, DOI 10.1136/bmj.298.6671.431; *MERCK CO, 2005, PROQUAD PACK INS; *MERCK CO, 2005, VAR PACK INS; Michalik DE, 2008, J INFECT DIS, V197, P944, DOI 10.1086/529043; MORTON P, 1989, NEW ZEAL MED J, V102, P93; Ormerod LD, 1998, CLIN INFECT DIS, V26, P34, DOI 10.1086/516285; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Oxman MN, 1995, NEUROLOGY, V45, pS41, DOI 10.1212/WNL.45.12_Suppl_8.S41; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Reynolds MA, 2008, J INFECT DIS, V197, pS224, DOI 10.1086/522162; Reynolds MA, 2008, J INFECT DIS, V197, pS120, DOI 10.1086/522146; ROGERS RS, 1971, J AM GERIATR SOC, V19, P495, DOI 10.1111/j.1532-5415.1971.tb01208.x; Rowbotham M, 1998, JAMA-J AM MED ASSOC, V280, P1837, DOI 10.1001/jama.280.21.1837; Rowbotham MC, 1996, PAIN, V65, P39, DOI 10.1016/0304-3959(95)00146-8; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Scott FT, 2006, VACCINE, V24, P1308, DOI 10.1016/j.vaccine.2005.09.026; Seward JF, 2008, J INFECT DIS, V197, pS82, DOI 10.1086/522145; STRAUS SE, 1984, NEW ENGL J MED, V311, P1362, DOI 10.1056/NEJM198411223112107; *THOMS, 2008, REDB PHARM FUND REF; Trannoy E, 2000, VACCINE, V18, P1700, DOI 10.1016/S0264-410X(99)00510-1; TYRING S, 1995, ANN INTERN MED, V123, P89, DOI 10.7326/0003-4819-123-2-199507150-00002; Tyring SK, 2000, ARCH FAM MED, V9, P863, DOI 10.1001/archfami.9.9.863; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Volmink J, 1996, FAM PRACT, V13, P84, DOI 10.1093/fampra/13.1.84; Watson CPN, 1998, NEUROLOGY, V50, P1837; WELLER TH, 1983, NEW ENGL J MED, V309, P1362, DOI 10.1056/NEJM198312013092205; WHITLEY R, 2004, HARRISONS PRINCIPLES; WHITLEY R, 2005, PRINCIPLES PRACTICE, P1780; Whitley RJ, 2005, J INFECT DIS, V191, P1999, DOI 10.1086/430328; Whitley RJ, 1996, ANN INTERN MED, V125, P376, DOI 10.7326/0003-4819-125-5-199609010-00004; Wiffen PJ, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005452, 10.1002/14651858.CD005451]; WOOD MJ, 1994, NEW ENGL J MED, V330, P896, DOI 10.1056/NEJM199403313301304; Wood MJ, 1996, CLIN INFECT DIS, V22, P341, DOI 10.1093/clinids/22.2.341; WORTHINGTON M, 2009, COSTS TREAT ZOSTER; Zhou FJ, 2005, JAMA-J AM MED ASSOC, V294, P797, DOI 10.1001/jama.294.7.797	83	36	37	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					73	80		10.1001/jama.2009.822	http://dx.doi.org/10.1001/jama.2009.822			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19491172				2022-12-28	WOS:000267492800024
J	Toledo-Arana, A; Dussurget, O; Nikitas, G; Sesto, N; Guet-Revillet, H; Balestrino, D; Loh, E; Gripenland, J; Tiensuu, T; Vaitkevicius, K; Barthelemy, M; Vergassola, M; Nahori, MA; Soubigou, G; Regnault, B; Coppee, JY; Lecuit, M; Johansson, J; Cossart, P				Toledo-Arana, Alejandro; Dussurget, Olivier; Nikitas, Georgios; Sesto, Nina; Guet-Revillet, Helene; Balestrino, Damien; Loh, Edmund; Gripenland, Jonas; Tiensuu, Teresa; Vaitkevicius, Karolis; Barthelemy, Mathieu; Vergassola, Massimo; Nahori, Marie-Anne; Soubigou, Guillaume; Regnault, Beatrice; Coppee, Jean-Yves; Lecuit, Marc; Johansson, Joergen; Cossart, Pascale			The Listeria transcriptional landscape from saprophytism to virulence	NATURE			English	Article							SMALL NONCODING RNAS; MONOCYTOGENES VIRULENCE; IDENTIFICATION; GENOME; EXPRESSION; GENE; INFECTION; MODEL; RIBOSWITCHES; TARGETS	The bacterium Listeria monocytogenes is ubiquitous in the environment and can lead to severe food-borne infections. It has recently emerged as a multifaceted model in pathogenesis. However, how this bacterium switches from a saprophyte to a pathogen is largely unknown. Here, using tiling arrays and RNAs from wild-type and mutant bacteria grown in vitro, ex vivo and in vivo, we have analysed the transcription of its entire genome. We provide the complete Listeria operon map and have uncovered far more diverse types of RNAs than expected: in addition to 50 small RNAs (<500 nucleotides), at least two of which are involved in virulence in mice, we have identified antisense RNAs covering several open-reading frames and long overlapping 59 and 39 untranslated regions. We discovered that riboswitches can act as terminators for upstream genes. When Listeria reaches the host intestinal lumen, an extensive transcriptional reshaping occurs with a SigB-mediated activation of virulence genes. In contrast, in the blood, PrfA controls transcription of virulence genes. Remarkably, several non-coding RNAs absent in the non-pathogenic species Listeria innocua exhibit the same expression patterns as the virulence genes. Together, our data unravel successive and coordinated global transcriptional changes during infection and point to previously unknown regulatory mechanisms in bacteria.	[Toledo-Arana, Alejandro; Dussurget, Olivier; Sesto, Nina; Guet-Revillet, Helene; Balestrino, Damien; Nahori, Marie-Anne; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Toledo-Arana, Alejandro; Dussurget, Olivier; Nikitas, Georgios; Sesto, Nina; Guet-Revillet, Helene; Balestrino, Damien; Nahori, Marie-Anne; Lecuit, Marc; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Toledo-Arana, Alejandro; Dussurget, Olivier; Sesto, Nina; Guet-Revillet, Helene; Balestrino, Damien; Nahori, Marie-Anne; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Nikitas, Georgios; Lecuit, Marc] Inst Pasteur, Microorganismes & Barrieres Hote G5, F-75015 Paris, France; [Nikitas, Georgios; Lecuit, Marc] INSERM, U604, F-75015 Paris, France; [Loh, Edmund; Gripenland, Jonas; Tiensuu, Teresa; Vaitkevicius, Karolis; Johansson, Joergen] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Loh, Edmund; Gripenland, Jonas; Tiensuu, Teresa; Vaitkevicius, Karolis; Johansson, Joergen] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Barthelemy, Mathieu; Soubigou, Guillaume; Regnault, Beatrice; Coppee, Jean-Yves] Inst Pasteur, F-75015 Paris, France; [Vergassola, Massimo] Inst Pasteur, UP Genet Sil, F-75015 Paris, France; [Vergassola, Massimo] CNRS, URA2171, F-75015 Paris, France; [Lecuit, Marc] Univ Paris 05, Hop Necker Enfants Malad, AP HP, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Umea University; Umea University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pascale.cossart@pasteur.fr	Vaitkevicius, Karolis/R-9714-2016; Lecuit, Marc/J-4073-2013; Lecuit, Marc/M-4126-2019; Toledo-Arana, Alejandro/F-9624-2011	Vaitkevicius, Karolis/0000-0001-9309-3653; Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Toledo-Arana, Alejandro/0000-0001-8148-6281; Loh, Edmund/0000-0001-7050-566X; Vergassola, Massimo/0000-0002-7212-8244; gripenland, jonas/0000-0002-9445-8586; BALESTRINO, Damien/0000-0001-5378-0379; REGNAULT, Beatrice/0000-0002-3914-1914; Marie-Anne, Nahori/0000-0002-4066-4528; Johansson, Jorgen/0000-0002-0904-497X; Dussurget, Olivier/0000-0001-9924-0837	Swedish Research Council [K2008-58X-15144-05-3, 621-2006-4450]; EU [Nu 018618, 2005-018618]; Institut Pasteur [GPH 9]; Inserm; INRA; ANR [ANR-05-MIIM-026-01]; ERC [233348]; Howard Hughes Medical Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We are grateful to E. Charpentier and the members of her group for providing the RACE protocol. We thank L. Frangeul for helping with L. monocytogenes annotation files. J. J. is supported by the Swedish Research Council grants K2008-58X-15144-05-3 and 621-2006-4450 and EU (BacRNA 2005 Contract Nu 018618). Work in the laboratory of P. C. received financial support from Institut Pasteur (GPH 9), Inserm, INRA, EU (BacRNA 2005-018618), ANR (ANR-05-MIIM-026-01) and ERC (Advanced Grant 233348). A. T.-A. was an EMBO long-term fellow. P. C. is an international research scholar of the Howard Hughes Medical Institute.	Barry T, 1999, FEMS MICROBIOL LETT, V173, P47, DOI 10.1111/j.1574-6968.1999.tb13483.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Chakraborty T, 2000, INT J MED MICROBIOL, V290, P167; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; Garner MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006; Glaser P, 2001, SCIENCE, V294, P849; Gregory BD, 2008, PLANT J, V53, P636, DOI 10.1111/j.1365-313X.2007.03320.x; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; Loh E, 2006, TRENDS MICROBIOL, V14, P294, DOI 10.1016/j.tim.2006.05.001; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Nielsen JS, 2008, J BACTERIOL, V190, P6264, DOI 10.1128/JB.00740-08; Raengpradub S, 2008, APPL ENVIRON MICROB, V74, P158, DOI 10.1128/AEM.00951-07; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Winkler WC, 2005, CURR OPIN CHEM BIOL, V9, P594, DOI 10.1016/j.cbpa.2005.09.016; Yazaki J, 2007, CURR OPIN PLANT BIOL, V10, P534, DOI 10.1016/j.pbi.2007.07.006	37	661	683	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					950	956		10.1038/nature08080	http://dx.doi.org/10.1038/nature08080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19448609				2022-12-28	WOS:000267063500035
J	Goldston, D				Goldston, David			Climate future	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com						2009, NATURE, V459, P493	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					628	628		10.1038/459628a	http://dx.doi.org/10.1038/459628a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494887	Bronze			2022-12-28	WOS:000266608600011
J	Lieberman, P				Lieberman, Philip			FOXP2 and Human Cognition	CELL			English	Editorial Material							HUMAN-BEHAVIOR; CIRCUITS		Brown Univ, Providence, RI 02912 USA	Brown University	Lieberman, P (corresponding author), Brown Univ, Providence, RI 02912 USA.	philip_lieberman@brown.edu						CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Fitch WT., 2006, ENCY LANGUAGE LINGUI, V2, P115, DOI DOI 10.1016/B0-08-044854-2/00821-X; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Klein R.G., 1999, HUMAN CAREER; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lieberman P., 2007, EXPEDITION, V49, P15; LIEBERMAN P, 2006, EVOLUTIONARY BIOL OG; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Ullman MT, 2006, CORTEX, V42, P480, DOI 10.1016/S0010-9452(08)70382-4	9	29	30	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 29	2009	137	5					800	802		10.1016/j.cell.2009.05.013	http://dx.doi.org/10.1016/j.cell.2009.05.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490887	Bronze			2022-12-28	WOS:000266454800009
J	Spoel, SH; Mou, ZL; Tada, Y; Spivey, NW; Genschik, P; Dong, XNA				Spoel, Steven H.; Mou, Zhonglin; Tada, Yasuomi; Spivey, Natalie W.; Genschik, Pascal; Dong, Xinnian			Proteasome-Mediated Turnover of the Transcription Coactivator NPR1 Plays Dual Roles in Regulating Plant Immunity	CELL			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DNA-BINDING ACTIVITY; NF-KAPPA-B; SALICYLIC-ACID; GENE-EXPRESSION; PR-1 GENE; DISEASE RESISTANCE; UBIQUITIN-LIGASE; 26S PROTEASOME; IN-VIVO	Systemic acquired resistance (SAR) is a broad-spectrum plant immune response involving profound transcriptional changes that are regulated by the coactivator NPR1. Nuclear translocation of NPR1 is a critical regulatory step, but how the protein is regulated in the nucleus is unknown. Here, we show that turnover of nuclear NPR1 protein plays an important role in modulating transcription of its target genes. In the absence of pathogen challenge, NPR1 is continuously cleared from the nucleus by the proteasome, which restricts its coactivator activity to prevent untimely activation of SAR. Surprisingly, inducers of SAR promote NPR1 phosphorylation at residues Ser11/Ser15, and then facilitate its recruitment to a Cullin3-based ubiquitin ligase. Turnover of phosphorylated NPR1 is required for full induction of target genes and establishment of SAR. These in vivo data demonstrate dual roles for coactivator turnover in both preventing and stimulating gene transcription to regulate plant immunity.	[Spoel, Steven H.; Mou, Zhonglin; Tada, Yasuomi; Spivey, Natalie W.; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Genschik, Pascal] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France	Duke University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dong, XNA (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	xdong@duke.edu	Tada, Yasuomi/M-5041-2014	Spoel, Steven/0000-0003-4340-7591; Tada, Yasuomi/0000-0001-9900-069X; GENSCHIK, Pascal/0000-0002-4107-5071	National Institutes of Health (NIH) [1R01-GM69594]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069594] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Zhen- Ming Pei for providing the anti-CAS antibodies, Xudong Zhang and Dr. Karolina Pajerowska-Mukhtar for technical assistance, Dr. Yue Xiong for helpful discussions, and Drs. Meng Chen, James Siedow, Tai- ping Sun, and Tso-Pang Yao for critically reading the manuscript. This work was supported by a grant from the National Institutes of Health (NIH) (1R01-GM69594) to X. D.	Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Dieterle M, 2005, PLANT J, V41, P386, DOI 10.1111/j.1365-313X.2004.02302.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; Johnson C, 2003, PLANT CELL, V15, P1846, DOI 10.1105/tpc.012211; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Ryals J, 1997, PLANT CELL, V9, P425, DOI 10.1105/tpc.9.3.425; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Thomann A, 2005, PLANT J, V43, P437, DOI 10.1111/j.1365-313X.2005.02467.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	42	383	405	4	96	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					860	872		10.1016/j.cell.2009.03.038	http://dx.doi.org/10.1016/j.cell.2009.03.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490895	Green Accepted, Bronze			2022-12-28	WOS:000266454800017
J	Tucker, AM; Vogel, RA; Lincoln, AE; Dunn, RE; Ahrensfield, DC; Allen, TW; Castle, LW; Heyer, RA; Pellman, EJ; Strollo, PJ; Wilson, PWF; Yates, AP				Tucker, Andrew M.; Vogel, Robert A.; Lincoln, Andrew E.; Dunn, Reginald E.; Ahrensfield, Debra C.; Allen, Thomas W.; Castle, Lon W.; Heyer, Robert A.; Pellman, Elliot J.; Strollo, Patrick J., Jr.; Wilson, Peter W. F.; Yates, Anthony P.			Prevalence of Cardiovascular Disease Risk Factors Among National Football League Players	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE SLEEP-APNEA; ARTERIAL COMPLIANCE; BLOOD-PRESSURE; HYPERTENSION; MECHANISMS; MORTALITY; OBESITY; UPDATE; SODIUM	Context Concern exists about the cardiovascular health implications of large size among professional football players and those players who aspire to professional status. Objectives To assess cardiovascular disease (CVD) risk factors in active National Football League (NFL) players and to compare these findings with data from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Design, Setting, and Participants A cross-sectional study of 504 active, veteran football players from a convenience sample of 12 NFL teams at professional athletic training facilities between April and July 2007. Data were compared with men of the same age in the general US population (CARDIA study, a population-based observational study of 1959 participants aged 23 to 35 years recruited in 1985-1986). Main Outcome Measures Prevalence of CVD risk factors (hypertension, dyslipidemia, glucose intolerance, and smoking). Results The NFL players were less likely to smoke when compared with the CARDIA group (0.1% [n=1]; 95% confidence interval [CI], 0%-1.4%; vs 30.5% [n=597]; 95% CI, 28.5%-32.5%; P<.001). Despite being taller and heavier, NFL players had significantly lower prevalence of impaired fasting glucose (6.7% [n=24]; 95% CI, 4.6%-8.7%; vs 15.5% [n=267]; 95% CI, 13.8%-17.3%; P < .001). The groups did not differ in prevalence of high total cholesterol and low-density lipoprotein cholesterol (LDL-C), low high-density lipoprotein cholesterol (HDL-C), or high triglycerides. Hypertension (13.8% [n=67]; 95% CI, 11.0%-16.7%; vs 5.5% [n=108]; 95% CI, 4.6%-6.6%) and prehypertension (64.5% [n=310]; 95% CI, 58.3%-70.7%; vs 24.2% [n=473]; 95% CI, 22.3%-26.1%) were significantly more common in NFL players than in the CARDIA group ( both P<.001). Large size measured by body mass index (BMI) was associated with increased blood pressure, LDL-C, triglycerides, and fasting glucose, and decreased HDL-C. Conclusions Compared with a sample of healthy young-adult men, a sample of substantially larger NFL players had a lower prevalence of impaired fasting glucose, less reported smoking, a similar prevalence of dyslipidemia, and a higher prevalence of hypertension. Increased size measured by BMI was associated with increased CVD risk factors in this combined population. JAMA. 2009; 301(20):2111-2119 www.jama.com	[Pellman, Elliot J.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Pellman, Elliot J.] Mt Sinai Sch Med, Dept Orthopaed, New York, NY USA; [Strollo, Patrick J., Jr.] Univ Pittsburgh, Sch Med, Dept Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Yates, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA USA; [Wilson, Peter W. F.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Vogel, Robert A.] Univ Maryland, Sch Med, Dept Cardiol, Baltimore, MD 21201 USA; [Lincoln, Andrew E.; Dunn, Reginald E.] MedStar Res Inst, Sports Med Res Ctr, Baltimore, MD USA; [Ahrensfield, Debra C.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19122 USA; [Allen, Thomas W.] Univ Oklahoma, Coll Med, Dept Family Sports Med, Tulsa, OK USA; [Castle, Lon W.] Cleveland Clin, Westlake, OH USA; [Heyer, Robert A.] Carolinas Med Ctr, Dept Internal Med, Charlotte, NC 28203 USA; [Tucker, Andrew M.] Union Mem Hosp, Union Mem Sports Med, Baltimore, MD USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa; Cleveland Clinic Foundation; Carolinas Medical Center; Union Memorial Hospital	Tucker, AM (corresponding author), Care of Camire L, Union Mem Hosp, ELS, Union Mem Sports Med, 3333 N Calvert St,Ste 400, Baltimore, MD 21218 USA.	andrew.tucker@medstar.net	Strollo, Patrick J/L-7062-2016; Wilson, Peter W.F./J-2455-2016		National Football League (NFL)	National Football League (NFL)	This study was funded by the National Football League (NFL).	Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Ballard TP, 2004, MED SCI SPORT EXER, V36, P731, DOI 10.1249/01.MSS.0000121943.02489.2B; Baron SRR, 1994, 88085 HETA CDCP NAT; Bertovic DA, 1999, HYPERTENSION, V33, P1385, DOI 10.1161/01.HYP.33.6.1385; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Eichner ER, 2007, SPORTS MED, V37, P368, DOI 10.2165/00007256-200737040-00024; Elliott WJ, 2007, BLOOD PRESS MONIT, V12, P23, DOI 10.1097/MBP.0b013e3280858dcf; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Garry J P, 2001, Prev Cardiol, V4, P103, DOI 10.1111/j.1520-037X.2001.00534.x; George CFP, 2003, NEW ENGL J MED, V348, P367, DOI 10.1056/NEJM200301233480422; Gillis J, HIGH SCH SPORTS PART; Harp JB, 2005, JAMA-J AM MED ASSOC, V293, P1061, DOI 10.1001/jama.293.9.1061-b; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; Laurson KR, 2007, JAMA-J AM MED ASSOC, V297, P363, DOI 10.1001/jama.297.4.363; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Lesser GT, 2005, JAMA-J AM MED ASSOC, V293, P2999, DOI 10.1001/jama.293.24.2999-a; Magalski A, 2008, J AM COLL CARDIOL, V51, P2250, DOI 10.1016/j.jacc.2008.01.065; MALINA RM, 2009, SCI FOOTBALL, V5, P434; Miyachi M, 2004, CIRCULATION, V110, P2858, DOI 10.1161/01.CIR.0000146380.08401.99; Modesti PA, 2006, HYPERTENSION, V47, P155, DOI 10.1161/01.HYP.0000199192.17126.d4; *NAT FED STAT HIGH, 2005, 2005 06 HIGH SCH ATH; Orr JS, 2008, HYPERTENSION, V51, P1519, DOI 10.1161/HYPERTENSIONAHA.108.112946; Sega R, 1998, J HYPERTENS, V16, P1585, DOI 10.1097/00004872-199816110-00004; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Valentine Verle, 2007, Curr Sports Med Rep, V6, P237, DOI 10.1007/s11932-007-0038-3; *WHO, 1989, MEAS OB CLASS DISTR; Wise M, 2005, WASHINGTON POST, V2005, pE1; Wolf J, 2007, NUTR METAB CARDIOVAS, V17, P233, DOI 10.1016/j.numecd.2006.12.005	30	105	106	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2111	2119		10.1001/jama.2009.716	http://dx.doi.org/10.1001/jama.2009.716			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19470988	Bronze			2022-12-28	WOS:000266328800023
J	Weigensberg, MJ; Goran, MI				Weigensberg, Marc J.; Goran, Michael I.			Type 2 diabetes in children and adolescents	LANCET			English	Editorial Material							BETA-CELL FUNCTION; INSULIN-RESISTANCE; PREVENTION		[Weigensberg, Marc J.; Goran, Michael I.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Goran, Michael I.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Goran, Michael I.] Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Goran, MI (corresponding author), Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA.	Goran@usc.edu						August GP, 2008, J CLIN ENDOCR METAB, V93, P4576, DOI 10.1210/jc.2007-2458; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Goran MI, 2002, DIABETES CARE, V25, P2184, DOI 10.2337/diacare.25.12.2184; Goran MI, 2001, DIABETES, V50, P2444, DOI 10.2337/diabetes.50.11.2444; Goran MI, 2008, DIABETES, V57, P3007, DOI 10.2337/db08-0445; Goran MI, 2008, J PEDIATR-US, V152, P753, DOI 10.1016/j.jpeds.2008.02.004; Haymond M, 2007, PEDIATR DIABETES, V8, P74; Jones KL, 2002, DIABETES CARE, V25, P89, DOI 10.2337/diacare.25.1.89; Rosenbloom AL, 2008, PEDIATR DIABETES, V9, P512, DOI 10.1111/j.1399-5448.2008.00429.x; Weiss R, 2005, DIABETES CARE, V28, P902, DOI 10.2337/diacare.28.4.902; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X	12	30	39	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1743	1744		10.1016/S0140-6736(09)60961-2	http://dx.doi.org/10.1016/S0140-6736(09)60961-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19465216				2022-12-28	WOS:000266337300008
J	Poland, GA; Barry, MA				Poland, Gregory A.; Barry, Michael A.			Common Cold, Uncommon Variation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN RHINOVIRUSES		[Poland, Gregory A.; Barry, Michael A.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Poland, Gregory A.; Barry, Michael A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Dept Med, Rochester, MN 55905 USA.							Kirchberger S, 2007, INT ARCH ALLERGY IMM, V142, P1, DOI 10.1159/000095993; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; PALMENBERG AC, 2009, SCIENCE         0212; Stone JK, 2008, ANTIMICROB AGENTS CH, V52, P1970, DOI 10.1128/AAC.00011-08; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080	5	5	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2245	2246		10.1056/NEJMcibr0902053	http://dx.doi.org/10.1056/NEJMcibr0902053			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458372				2022-12-28	WOS:000266206000015
J	Riccio, A; Li, Y; Moon, J; Kim, KS; Smith, KS; Rudolph, U; Gapon, S; Yao, GL; Tsvetkov, E; Rodig, SJ; Van't Veer, A; Meloni, EG; Carlezon, WA; Bolshakov, VY; Clapham, DE				Riccio, Antonio; Li, Yan; Moon, Jisook; Kim, Kwang-Soo; Smith, Kiersten S.; Rudolph, Uwe; Gapon, Svetlana; Yao, Gui Lan; Tsvetkov, Evgeny; Rodig, Scott J.; Van't Veer, Ashlee; Meloni, Edward G.; Carlezon, William A., Jr.; Bolshakov, Vadim Y.; Clapham, David E.			Essential Role for TRPC5 in Amygdala Function and Fear-Related Behavior	CELL			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; SYNAPTIC PLASTICITY; CONDITIONING PATHWAYS; GROWTH CONES; MEMORY; CHANNELS; RATS; ANXIETY; BRAIN	The transient receptor potential channel 5 (TRPC5) is predominantly expressed in the brain where it can form heterotetrameric complexes with TRPC1 and TRPC4 channel subunits. These excitatory, nonselective cationic channels are regulated by G protein, phospholipase C-coupled receptors. Here, we show that TRPC5(-/-) mice exhibit diminished innate fear levels in response to innately aversive stimuli. Moreover, mutant mice exhibited significant reductions in responses mediated by synaptic activation of Group I metabotropic glutamate and cholecystokinin 2 receptors in neurons of the amygdala. Synaptic strength at afferent inputs to the amygdala was diminished in P10-P13 null mice. In contrast, baseline synaptic transmission, membrane excitability, and spike timing-dependent long-term potentiation at cortical and thalamic inputs to the amygdala were largely normal in older null mice. These experiments provide genetic evidence that TRPC5, activated via G protein-coupled neuronal receptors, has an essential function in innate fear.	[Li, Yan; Moon, Jisook; Kim, Kwang-Soo; Smith, Kiersten S.; Rudolph, Uwe; Tsvetkov, Evgeny; Van't Veer, Ashlee; Meloni, Edward G.; Carlezon, William A., Jr.; Bolshakov, Vadim Y.] Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; [Riccio, Antonio; Gapon, Svetlana; Clapham, David E.] Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Manton Ctr Orphan Dis, Boston, MA 02115 USA; [Riccio, Antonio; Yao, Gui Lan; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Bolshakov, VY (corresponding author), Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu; dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Tsvetkov, Evgeny/C-1085-2016; Van't Veer, Ashlee/GOV-5648-2022; Tsvetkov, Evgeny A/B-6573-2016; Clapham, David/R-5974-2019; Rodig, Scott/Y-3889-2019	Clapham, David/0000-0002-4459-9428; Tsvetkov, Evgeny/0000-0001-9339-1677; Van't Veer, Ashlee/0000-0003-4920-447X; Tsvetkov, Evgeny A/0000-0002-6784-0907; /0000-0002-4162-3947	National Institutes of Health [P30-HD18655]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Whitehall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Whitehall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Lin Lin Zhao for her help with maintaining the TRPC5 mouse colony and Kenneth Law for help with immunostaining. We also thank the Gene Manipulation Facility of the Children's Hospital Mental Retardation and Developmental Disabilities Research Center (National Institutes of Health grant P30-HD18655). This work was supported by grants from the National Institutes of Health (NIH), the National Alliance for Research on Schizophrenia and Depression (NARSAD), and the Whitehall Foundation (to V. Y. B.).	Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Faber ESL, 2006, NEUROSCIENCE, V137, P781, DOI 10.1016/j.neuroscience.2005.09.027; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Frankland PW, 1997, J NEUROSCI, V17, P1838; Gordon JA, 2004, ANNU REV NEUROSCI, V27, P193, DOI 10.1146/annurev.neuro.27.070203.144212; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Meis S, 2007, MOL CELL NEUROSCI, V35, P356, DOI 10.1016/j.mcn.2007.03.012; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; de la Mora MP, 2006, EUR J NEUROSCI, V23, P2749, DOI 10.1111/j.1460-9568.2006.04798.x; Pietraszek M, 2005, EUR J PHARMACOL, V514, P25, DOI 10.1016/j.ejphar.2005.03.028; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2002, J BIOL CHEM, V277, P12302, DOI 10.1074/jbc.M112313200; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Royer S, 2000, J NEUROPHYSIOL, V83, P3509, DOI 10.1152/jn.2000.83.6.3509; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	45	202	204	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					761	772		10.1016/j.cell.2009.03.039	http://dx.doi.org/10.1016/j.cell.2009.03.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450521	Bronze, Green Accepted			2022-12-28	WOS:000266114100023
J	Steltzer, H; Post, E				Steltzer, Heidi; Post, Eric			Seasons and Life Cycles	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; PHENOLOGICAL RESPONSE; VEGETATION INDEX; LEAF PHENOLOGY; PLANT-GROWTH; METAANALYSIS; LATITUDES; GRASSLAND; ECOSYSTEM; IMPACTS		[Steltzer, Heidi] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Post, Eric] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Post, Eric] Aarhus Univ, Natl Environm Res Inst, Dept Arctic Environm, DK-4000 Roskilde, Denmark	Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Aarhus University	Steltzer, H (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	steltzer@nrel.colostate.edu; esp10@psu.edu						Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Delbart N, 2008, GLOBAL CHANGE BIOL, V14, P603, DOI 10.1111/j.1365-2486.2007.01505.x; DOUGHTY CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI DOI 10.1029/2007JG000590; Gazal R, 2008, GLOBAL CHANGE BIOL, V14, P1568, DOI 10.1111/j.1365-2486.2008.01602.x; Heumann BW, 2007, REMOTE SENS ENVIRON, V108, P385, DOI 10.1016/j.rse.2006.11.025; Hollister RD, 2005, ECOLOGY, V86, P1562, DOI 10.1890/04-0520; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Jarrad FC, 2008, AUST J BOT, V56, P617, DOI 10.1071/BT08018; Jentsch A, 2009, GLOBAL CHANGE BIOL, V15, P837, DOI 10.1111/j.1365-2486.2008.01690.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; Petrie PR, 2008, AUST J GRAPE WINE R, V14, P33, DOI 10.1111/j.1755-0238.2008.00005.x; Post ES, 2008, ECOLOGY, V89, P363, DOI 10.1890/06-2138.1; Richardson AD, 2007, OECOLOGIA, V152, P323, DOI 10.1007/s00442-006-0657-z; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Wittich KP, 2008, INT J BIOMETEOROL, V52, P167, DOI 10.1007/s00484-007-0108-5	24	96	110	6	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					886	887		10.1126/science.1171542	http://dx.doi.org/10.1126/science.1171542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443769				2022-12-28	WOS:000266048800019
J	Wan, XH; O'Quinn, RP; Pierce, HL; Joglekar, AP; Gall, WE; DeLuca, JG; Carroll, CW; Liu, ST; Yen, TJ; McEwen, BF; Stukenberg, T; Desai, A; Salmon, ED				Wan, Xiaohu; O'Quinn, Ryan P.; Pierce, Heather L.; Joglekar, Ajit P.; Gall, Walt E.; DeLuca, Jennifer G.; Carroll, Christopher W.; Liu, Song-Tao; Yen, Tim J.; McEwen, Bruce F.; Stukenberg, Todd; Desai, Arshad; Salmon, E. D.			Protein Architecture of the Human Kinetochore Microtubule Attachment Site	CELL			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CENP-E; OUTER PLATE; MOLECULAR ARCHITECTURE; CHROMOSOME CONGRESSION; HIGH-RESOLUTION; NDC80 COMPLEX; LIVING CELLS; LOCALIZATION; SEGREGATION	Chromosome segregation requires assembly of kinetochores on centromeric chromatin to mediate interactions with spindle microtubules and control cell-cycle progression. To elucidate the protein architecture of human kinetochores, we developed a two-color fluorescence light microscopy method that measures average label separation, Delta, at < 5 nm accuracy. Delta analysis of 16 proteins representing core structural complexes spanning the centromeric chromatin-microtubule interface, when correlated with mechanical states of spindle-attached kinetochores, provided a nanometer-scale map of protein position and mechanical properties of protein linkages. Treatment with taxol, which suppresses microtubule dynamics and activates the spindle checkpoint, revealed a specific switch in kinetochore architecture. Cumulatively, Delta analysis revealed that compliant linkages are restricted to the proximity of chromatin, suggested a model for how the KMN (KNL1/Mis12 complex/Ndc80 complex) network provides microtubule attachment and generates pulling forces from depolymerization, and identified an intrakinetochore molecular switch that may function in controlling checkpoint activity.	[Wan, Xiaohu; O'Quinn, Ryan P.; Pierce, Heather L.; Joglekar, Ajit P.; Gall, Walt E.; Salmon, E. D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Wan, Xiaohu] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [O'Quinn, Ryan P.] NIH, NIH UNC Grad Partnerships Program Cytoskeleton &, Bethesda, MD 20892 USA; [DeLuca, Jennifer G.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Carroll, Christopher W.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Liu, Song-Tao; Yen, Tim J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [McEwen, Bruce F.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Stukenberg, Todd] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; Colorado State University; Stanford University; Fox Chase Cancer Center; State University of New York (SUNY) System; Wadsworth Center; University of Virginia; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Salmon, ED (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	tsalmon@email.unc.edu	Liu, Song-Tao/Y-4732-2019	Liu, Song-Tao/0000-0002-9623-8579; Joglekar, Ajit/0000-0002-0607-5332; Yen, Tim/0000-0003-2159-0997; Stukenberg, Todd/0000-0002-6788-2111	NIH [GM24364, GM60678, GM06627, GM86877, GM44762, GM074215]; Burroughs-Wellcome Fund; Leukemia and Lymphoma Society [CA06927]; PA Tobacco Fund; NATIONAL CANCER INSTITUTE [K01CA125051, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215, R01GM044762, R01GM086877, R37GM024364, R01GM060678, R01GM024364] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); PA Tobacco Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to a number of scientists who provided well-characterized reagents including Dr. Steve Taylor, Dr. Mitsuhiro Yanagida, Dr. Tomomi Kiyomitsu, Dr. Aaron Straight, and Dr. Jan Ellenberg. The authors would like to thank J. Hittle for expert technical assistance in generating antibodies. We also thank Dr. Kerry Bloom, Dr. Andrea Musacchio, and members of the Salmon and Desai labs for their critiques of early versions of this manuscript. Funded by NIH GM24364 and GM60678 (E. D. S.); GM06627 (B. F. M.); GM86877 and GM44762 (T. J. Y.); and GM074215 (A. D.). A. P. J. holds a Career Award at the Scientific Interface from the Burroughs-Wellcome Fund. T. J. Y. is also supported by the Leukemia and Lymphoma Society, a core grant (CA06927), the PA Tobacco Fund, and an appropriation from the Commonwealth of Pennsylvania.	Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Asbury CL, 2008, STRUCTURE, V16, P834, DOI 10.1016/j.str.2008.05.005; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Brinkley B R, 1992, Trends Cell Biol, V2, P15, DOI 10.1016/0962-8924(92)90139-E; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maddox PS, 2003, METHOD ENZYMOL, V360, P597; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maiato H, 2006, CHROMOSOMA, V115, P469, DOI 10.1007/s00412-006-0076-2; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; McIntosh JR, 2005, NAT STRUCT MOL BIOL, V12, P210, DOI 10.1038/nsmb0305-210; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Politi V, 2002, J CELL SCI, V115, P2317; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Schittenhelm RB, 2007, CHROMOSOMA, V116, P385, DOI 10.1007/s00412-007-0103-y; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; VandenBeldt KJ, 2006, CURR BIOL, V16, P1217, DOI 10.1016/j.cub.2006.04.046; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170	59	271	277	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 15	2009	137	4					672	684		10.1016/j.cell.2009.03.035	http://dx.doi.org/10.1016/j.cell.2009.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450515	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000266114100016
J	Radesky, JS; Sugar, NF				Radesky, Jenny S.; Sugar, Naomi F.			Case report Femur fracture in an infant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							YOUNG-CHILDREN; HEAD TRAUMA; PREMATURE-INFANTS; ABUSE; INJURY; RISK		Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Seattle Childrens Hosp, Seattle, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Sugar, NF (corresponding author), Harborview Med Ctr, MS 359 947, Seattle, WA 98108 USA.	nsugar@u.washington.edu						AMIR J, 1988, J PEDIATR ORTHOPED, V8, P41, DOI 10.1097/01241398-198801000-00010; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Belfer RA, 2001, AM J EMERG MED, V19, P122, DOI 10.1053/ajem.2001.21345; BRILL PW, 1998, DIAGNOSTIC IMAGING C, P178; Carroll DM, 2007, J PERINAT MED, V35, P366, DOI 10.1515/JPM.2007.067; Day Fiona, 2006, J Clin Forensic Med, V13, P55, DOI 10.1016/j.jcfm.2005.08.001; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Jaudes PK, 2008, CHILD ABUSE NEGLECT, V32, P671, DOI 10.1016/j.chiabu.2007.08.007; Jenny C, 2006, PEDIATRICS, V118, P1299, DOI 10.1542/peds.2006-1795; Kemp AM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1518; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Nimkin K, 2001, RADIOL CLIN N AM, V39, P843, DOI 10.1016/S0033-8389(05)70314-6; Peters ML, 2008, ARCH PEDIAT ADOL MED, V162, P877, DOI 10.1001/archpedi.162.9.877; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Scherl SA, 2000, CLIN ORTHOP RELAT R, P96; Schwend RM, 2000, J PEDIATR ORTHOPED, V20, P475, DOI 10.1097/00004694-200007000-00010; VALVANO TJ, 2008, CHILD MALTREAT  1110	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2009	338								b1583	10.1136/bmj.b1583	http://dx.doi.org/10.1136/bmj.b1583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	446IZ	19439767				2022-12-28	WOS:000266116600001
J	Anderson, T				Anderson, Tatum			Global Fund looks to boost private sector contributions	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1594	1594		10.1016/S0140-6736(09)60890-4	http://dx.doi.org/10.1016/S0140-6736(09)60890-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19437602				2022-12-28	WOS:000266066300014
J	Bonauer, A; Carmona, G; Iwasaki, M; Mione, M; Koyanagi, M; Fischer, A; Burchfield, J; Fox, H; Doebele, C; Ohtani, K; Chavakis, E; Potente, M; Tjwa, M; Urbich, C; Zeiher, AM; Dimmeler, S				Bonauer, Angelika; Carmona, Guillaume; Iwasaki, Masayoshi; Mione, Marina; Koyanagi, Masamichi; Fischer, Ariane; Burchfield, Jana; Fox, Henrik; Doebele, Carmen; Ohtani, Kisho; Chavakis, Emmanouil; Potente, Michael; Tjwa, Marc; Urbich, Carmen; Zeiher, Andreas M.; Dimmeler, Stefanie			MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice	SCIENCE			English	Article							ENDOTHELIAL-CELL MIGRATION; VASCULAR INTEGRITY; EXPRESSION; DICER; FIBRONECTIN; POLYCISTRON; ALPHA(5); GENE	MicroRNAs (miRs) are small noncoding RNAs that regulate gene expression by binding to target messenger RNAs (mRNAs), leading to translational repression or degradation. Here, we show that the miR-17 similar to 92 cluster is highly expressed in human endothelial cells and that miR-92a, a component of this cluster, controls the growth of new blood vessels (angiogenesis). Forced overexpression of miR-92a in endothelial cells blocked angiogenesis in vitro and in vivo. In mouse models of limb ischemia and myocardial infarction, systemic administration of an antagomir designed to inhibit miR-92a led to enhanced blood vessel growth and functional recovery of damaged tissue. MiR-92a appears to target mRNAs corresponding to several proangiogenic proteins, including the integrin subunit alpha5. Thus, miR-92a may serve as a valuable therapeutic target in the setting of ischemic disease.	[Bonauer, Angelika; Carmona, Guillaume; Iwasaki, Masayoshi; Koyanagi, Masamichi; Fischer, Ariane; Burchfield, Jana; Fox, Henrik; Doebele, Carmen; Ohtani, Kisho; Chavakis, Emmanouil; Potente, Michael; Urbich, Carmen; Dimmeler, Stefanie] Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Mione, Marina] Mol Oncol Fdn, Italian Fdn Canc Res Inst, I-02139 Milan, Italy; [Fox, Henrik; Chavakis, Emmanouil; Potente, Michael; Zeiher, Andreas M.] Univ Frankfurt, Dept Med 3, Div Cardiol, D-60590 Frankfurt, Germany; [Tjwa, Marc] Univ Frankfurt, Leibniz AG, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Dimmeler, S (corresponding author), Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de	Mione, Maria Caterina/ABG-9926-2021; Fox, Henrik/AAG-9968-2019; Mione, Maria Caterina/I-3073-2013	Fox, Henrik/0000-0002-2187-8715; Potente, Michael/0000-0002-5689-0036; Mione, Maria Caterina/0000-0002-9040-3705; Dimmeler, Stefanie/0000-0002-1045-2436	Deutsche Forschungsgemeinschaft [Di 600/6-3, Exc 147/1]; Alfried Krupp Foundation; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); European Research Council (Angiomir); Leducq Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alfried Krupp Foundation; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); European Research Council (Angiomir)(European Research Council (ERC)); Leducq Foundation(Leducq Foundation)	We thank M. Muhly-Reinholz, T. Roxe, N. Reinfeld, and F. Pezzimenti for expert technical assistance and W.-K. Hofmann for performing the mRNA array. This work is supported by the Deutsche Forschungsgemeinschaft (Di 600/6-3, Exc 147/1), the Alfried Krupp Foundation (A.B.), the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) (C.D.), the European Research Council (Angiomir), and the Leducq Foundation (J.B. and M.K.). A.B., C.U., A.M.Z., and S.D. have applied for a patent relating to this work.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Urbich C, 2002, ARTERIOSCL THROM VAS, V22, P69, DOI 10.1161/hq0102.101518; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	28	958	1062	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1710	1713		10.1126/science.1174381	http://dx.doi.org/10.1126/science.1174381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19460962				2022-12-28	WOS:000267338200040
J	Chen, L; Jiao, ZH; Zheng, LS; Zhang, YY; Xie, ST; Wang, ZX; Wu, JW				Chen, Lei; Jiao, Zhi-Hao; Zheng, Li-Sha; Zhang, Yuan-Yuan; Xie, Shu-Tao; Wang, Zhi-Xin; Wu, Jia-Wei			Structural insight into the autoinhibition mechanism of AMP-activated protein kinase	NATURE			English	Article							CRYSTAL-STRUCTURE; ALPHA-SUBUNITS; RAT-LIVER; ENERGY; PHOSPHORYLATION; DOMAIN; IDENTIFICATION; SEQUENCE; BINDING; BETA	The AMP-activated protein kinase (AMPK) is characterized by its ability to bind to AMP, which enables it to adjust enzymatic activity by sensing the cellular energy status and maintain the balance between ATP production and consumption in eukaryotic cells(1,2). It also has important roles in the regulation of cell growth and proliferation, and in the establishment and maintenance of cell polarity(3). These important functions have rendered AMPK an important drug target for obesity, type 2 diabetes and cancer treatments(4). However, the regulatory mechanism of AMPK activity by AMP binding remains unsolved. Here we report the crystal structures of an unphosphorylated fragment of the AMPK alpha-subunit (KD-AID) from Schizosaccharomyces pombe that contains both the catalytic kinase domain and an autoinhibitory domain (AID), and of a phosphorylated kinase domain from Saccharomyces cerevisiae (Snf1-pKD). The AID binds, from the 'backside', to the hinge region of its kinase domain, forming contacts with both amino-terminal and carboxy-terminal lobes. Structural analyses indicate that AID binding might constrain the mobility of helix alpha C, hence resulting in an autoinhibited KD-AID with much lower kinase activity than that of the kinase domain alone. AMP activates AMPK both allosterically and by inhibiting dephosphorylation(5,6). Further in vitro kinetic studies demonstrate that disruption of the KD-AID interface reverses the autoinhibition and these AMPK heterotrimeric mutants no longer respond to the change in AMP concentration. The structural and biochemical data have shown the primary mechanism of AMPK autoinhibition and suggest a conformational switch model for AMPK activation by AMP.	[Chen, Lei; Jiao, Zhi-Hao; Zhang, Yuan-Yuan; Xie, Shu-Tao; Wang, Zhi-Xin; Wu, Jia-Wei] Tsinghua Univ, Dept Biol Sci & Biotechnol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zheng, Li-Sha; Wang, Zhi-Xin] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Zheng, Li-Sha; Wang, Zhi-Xin] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, JW (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022	Chen, Lei/0000-0002-7619-8311	MOST [2006CB503900, 2007CB914400]; NSFC [30425005, 30770476]	MOST; NSFC(National Natural Science Foundation of China (NSFC))	We thank Y. Shi and S. C. Lin for critical discussions and reading of the manuscript; J. Chai and Y. Dong for help with data collection and processing; L. Gu and J. Wang for advice on structure determination. This work is supported in part by MOST grants 2006CB503900 and 2007CB914400, and by NSFC grants 30425005 and 30770476.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; YEH LA, 1980, J BIOL CHEM, V255, P2308	39	152	163	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1146	U139		10.1038/nature08075	http://dx.doi.org/10.1038/nature08075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19474788				2022-12-28	WOS:000267636700047
J	Gao, X; Lu, FR; Zhou, LJ; Dang, SY; Sun, LF; Li, XC; Wang, JW; Shi, YG				Gao, Xiang; Lu, Feiran; Zhou, Lijun; Dang, Shangyu; Sun, Linfeng; Li, Xiaochun; Wang, Jiawei; Shi, Yigong			Structure and Mechanism of an Amino Acid Antiporter	SCIENCE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSPORTER SUPERFAMILY; AGMATINE ANTIPORTER; RECOGNITION SITE; MOLECULAR-BASIS; RESISTANCE; PUTRESCINE; EXCRETION; ARGININE	Virulent enteric pathogens such as Escherichia coli strain O157:H7 rely on acid-resistance (AR) systems to survive the acidic environment in the stomach. A major component of AR is an arginine-dependent arginine: agmatine antiporter that expels intracellular protons. Here, we report the crystal structure of AdiC, the arginine: agmatine antiporter from E. coli O157:H7 and a member of the amino acid/polyamine/organocation (APC) superfamily of transporters at 3.6 angstrom resolution. The overall fold is similar to that of several Na+-coupled symporters. AdiC contains 12 transmembrane segments, forms a homodimer, and exists in an outward-facing, open conformation in the crystals. A conserved, acidic pocket opens to the periplasm. Structural and biochemical analysis reveals the essential ligand-binding residues, defines the transport route, and suggests a conserved mechanism for the antiporter activity.	[Gao, Xiang; Lu, Feiran; Zhou, Lijun; Dang, Shangyu; Sun, Linfeng; Li, Xiaochun; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Struct Biol Ctr, Dept Biol Sci & Biotechol, Beijing 100084, Peoples R China; [Gao, Xiang; Lu, Feiran; Zhou, Lijun; Dang, Shangyu; Sun, Linfeng; Li, Xiaochun; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Struct Biol Ctr, Dept Biol Sci & Biotechol, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Dang, Shangyu/0000-0001-9141-1865; gao, xiang/0000-0001-6397-5639; Zhou, Lijun/0000-0002-0393-4787; Shi, Yigong/0000-0003-2030-168X; Li, Xiaochun/0000-0002-0177-0803; Lu, Feiran/0000-0002-1757-2895	Ministry of Science and Technology [2009CB918801]; Tsinghua University 985 Phase II; National Natural Science Foundation; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University 985 Phase II; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	We thank N. Shimizu at the Spring-8 beamline BL41XU and T. Kumasaka and S. Baba at beamline BL38XU for on-site assistance, Q. Liu for screening crystals at MacCHESS (Macromolecular Diffraction at the Cornell High Energy Synchrotron Source), and N. Yan for discussion and comments on the manuscript. This work was supported by funds from the Ministry of Science and Technology (grant no. 2009CB918801), Tsinghua University 985 Phase II funds, National Natural Science Foundation, and Beijing Municipal Commissions of Education and Science and Technology. The atomic coordinates have been deposited in the Protein Data Bank with the accession codes 3H5M and 3H6B.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	28	187	189	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1565	1568		10.1126/science.1173654	http://dx.doi.org/10.1126/science.1173654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19478139				2022-12-28	WOS:000267130600045
J	Donald, PR; van Helden, PD				Donald, Peter R.; van Helden, Paul D.			The Global Burden of Tuberculosis - Combating Drug Resistance in Difficult Times	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Donald, Peter R.] Univ Stellenbosch, Dept Paediat & Child Hlth, ZA-7600 Stellenbosch, South Africa; [van Helden, Paul D.] Univ Stellenbosch, MRC,Ctr Mol & Cellular Biol, Div Human Genet & Mol Biol,Fac Hlth Sci, Natl Res Fdn,Ctr Excellence Biomed TB Res, ZA-7600 Stellenbosch, South Africa	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University	Donald, PR (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, ZA-7600 Stellenbosch, South Africa.							Global Initiative for Asthma, 2009, PUBL WHO, V02-3659; Millen SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001933; van Helden Paul D, 2006, Expert Rev Anti Infect Ther, V4, P759, DOI 10.1586/14787210.4.5.759; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; 2006, MMWR MORB MORTAL WKL, V55, P301	5	101	106	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2393	2395		10.1056/NEJMp0903806	http://dx.doi.org/10.1056/NEJMp0903806			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453DN	19494214	Bronze			2022-12-28	WOS:000266590500004
J	Grice, EA; Kong, HH; Conlan, S; Deming, CB; Davis, J; Young, AC; Bouffard, GG; Blakesley, RW; Murray, PR; Green, ED; Turner, ML; Segre, JA				Grice, Elizabeth A.; Kong, Heidi H.; Conlan, Sean; Deming, Clayton B.; Davis, Joie; Young, Alice C.; Bouffard, Gerard G.; Blakesley, Robert W.; Murray, Patrick R.; Green, Eric D.; Turner, Maria L.; Segre, Julia A.		NISC Comparative Sequencing Progra	Topographical and Temporal Diversity of the Human Skin Microbiome	SCIENCE			English	Article							BACTERIAL BIOTA	Human skin is a large, heterogeneous organ that protects the body from pathogens while sustaining microorganisms that influence human health and disease. Our analysis of 16S ribosomal RNA gene sequences obtained from 20 distinct skin sites of healthy humans revealed that physiologically comparable sites harbor similar bacterial communities. The complexity and stability of the microbial community are dependent on the specific characteristics of the skin site. This topographical and temporal survey provides a baseline for studies that examine the role of bacterial communities in disease states and the microbial interdependencies required to maintain healthy skin.	[Grice, Elizabeth A.; Conlan, Sean; Deming, Clayton B.; Segre, Julia A.] NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Kong, Heidi H.; Turner, Maria L.] NCI, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Davis, Joie] NHGRI, Off Translat Res, Bethesda, MD 20892 USA; [Young, Alice C.; Bouffard, Gerard G.; Blakesley, Robert W.; Green, Eric D.; NISC Comparative Sequencing Progra] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Bouffard, Gerard G.; Blakesley, Robert W.; Green, Eric D.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Murray, Patrick R.] NIH, Clin Microbiol Lab, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Segre, JA (corresponding author), NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA.	jsegre@nhgri.nih.gov	ravegnini, gloria/K-1330-2016; Kong, Heidi H/L-4856-2018; Conlan, Sean/B-4401-2008	ravegnini, gloria/0000-0002-7774-402X; Kong, Heidi H/0000-0003-4424-064X; Conlan, Sean/0000-0001-6848-3465; Grice, Elizabeth/0000-0003-3939-2200	NIGMS Pharmacology Research Associate Training Fellowship; NHGRI; NCI Center for Cancer Research Intramural Research Programs; NCBI Genome Project [30125]; NATIONAL CANCER INSTITUTE [ZIABC010938] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG000180] Funding Source: NIH RePORTER	NIGMS Pharmacology Research Associate Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI Center for Cancer Research Intramural Research Programs; NCBI Genome Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the volunteers who participated in this study; E. Bassett for assistance with sample collection; members of the Segre laboratory for their underlying contributions; M. Udey, N. Salafsky, and E. Lander for critical reading of the manuscript; and J. Fekecs and D. Leja for graphical assistance. Supported by a NIGMS Pharmacology Research Associate Training Fellowship (E.A.G.) and by the NHGRI and NCI Center for Cancer Research Intramural Research Programs. All sequences are deposited under NCBI Genome Project 30125, GenBank accession numbers GQ000001 to GQ116391.	Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Marples M. J., 1965, ECOLOGY HUMAN SKIN; SCHARSCHMIDT TC, 2009, J INVEST DERMATOL; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521	11	1661	1793	23	511	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1190	1192		10.1126/science.1171700	http://dx.doi.org/10.1126/science.1171700			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478181	Green Accepted			2022-12-28	WOS:000266410100043
J	Sawyers, CL				Sawyers, Charles L.			Finding and Drugging the Vulnerabilities of RAS-Dependent Cancers	CELL			English	Editorial Material							INHIBITORS		Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Human Oncol & Pathogenesis Program, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA.	sawyersc@mskcc.org	Sawyers, Charles/G-5327-2016					Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; McInnes C, 2005, CURR TOP MED CHEM, V5, P181, DOI 10.2174/1568026053507660; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	8	12	12	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 29	2009	137	5					796	798		10.1016/j.cell.2009.05.011	http://dx.doi.org/10.1016/j.cell.2009.05.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490885	Bronze			2022-12-28	WOS:000266454800007
J	Fernandez-Casado, A; Sanchez-Gonzalez, B				Fernandez-Casado, Alejandro; Sanchez-Gonzalez, Blanca			Tongue Necrosis in a Patient with Essential Thrombocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fernandez-Casado, Alejandro; Sanchez-Gonzalez, Blanca] Hosp del Mar, Barcelona 08003, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Fernandez-Casado, A (corresponding author), Hosp del Mar, Barcelona 08003, Spain.	96039@imas.imim.es							0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					E28	E28		10.1056/NEJMicm0807709	http://dx.doi.org/10.1056/NEJMicm0807709			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474421				2022-12-28	WOS:000266367300011
J	Sorefan, K; Girin, T; Liljegren, SJ; Ljung, K; Robles, P; Galvan-Ampudia, CS; Offringa, R; Friml, J; Yanofsky, MF; Ostergaard, L				Sorefan, Karim; Girin, Thomas; Liljegren, Sarah J.; Ljung, Karin; Robles, Pedro; Galvan-Ampudia, Carlos S.; Offringa, Remko; Friml, Jiri; Yanofsky, Martin F.; Ostergaard, Lars			A regulated auxin minimum is required for seed dispersal in Arabidopsis	NATURE			English	Article							DEHISCENCE ZONE; PROTEIN; EXPRESSION; INITIATION; FRUITFULL; GRADIENTS; SYSTEM; GENES	Local hormone maxima are essential for the development of multicellular structures and organs. For example, steroid hormones accumulate in specific cell types of the animal fetus to induce sexual differentiation(1) and concentration peaks of the plant hormone auxin direct organ initiation and mediate tissue patterning(2-4). Here we provide an example of a regulated local hormone minimum required during organogenesis. Our results demonstrate that formation of a local auxin minimum is necessary for specification of the valve margin separation layer where Arabidopsis fruit opening takes place. Consequently, ectopic production of auxin, specifically in valve margin cells, leads to a complete loss of proper cell fate determination. The valve margin identity factor INDEHISCENT (IND) is responsible for forming the auxin minimum by coordinating auxin efflux in separation-layer cells. We propose that the simplicity of formation and maintenance make local hormone minima particularly well suited to specify a small number of cells such as the stripes at the valve margins.	[Sorefan, Karim; Girin, Thomas; Ostergaard, Lars] John Innes Ctr Plant Sci Res, Crop Genet Dept, Norwich NR4 7UH, Norfolk, England; [Liljegren, Sarah J.; Robles, Pedro; Yanofsky, Martin F.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Liljegren, Sarah J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Ljung, Karin] Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Robles, Pedro] Univ Miguel Hernandez, Div Genet, Alicante 03202, Spain; [Robles, Pedro] Univ Miguel Hernandez, Inst Bioingn, Alicante 03202, Spain; [Galvan-Ampudia, Carlos S.; Offringa, Remko] Leiden State Univ, Inst Biol, Dept Mol & Dev Genet, NL-2333 AL Leiden, Netherlands; [Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, VIB, B-9052 Ghent, Belgium; [Friml, Jiri] Univ Ghent VIB, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; Umea University; Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; Leiden University; Leiden University - Excl LUMC; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Ostergaard, L (corresponding author), John Innes Ctr Plant Sci Res, Crop Genet Dept, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England.	lars.ostergaard@bbsrc.ac.uk	Ljung, Karin/AAE-8691-2019; Friml, Jiri/D-9511-2012; Robles, Pedro/L-5104-2014; Ostergaard, Lars/AAA-3020-2020	Ljung, Karin/0000-0003-2901-189X; Friml, Jiri/0000-0002-8302-7596; Robles, Pedro/0000-0002-4539-5435; Ostergaard, Lars/0000-0003-2459-0511; Girin, Thomas/0000-0002-5738-7731; Ostergaard, Lars/0000-0002-7619-605X	Spanish government; FWO; Netherlands Organisation for Scientific Research; National Science Foundation; Biotechnological and Biological Sciences Research Council; John Innes Centre; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000613] Funding Source: researchfish	Spanish government(Spanish GovernmentEuropean Commission); FWO(FWO); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Centre; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. York and K. Findlay for assistance on SEM analysis, G. Calder for assistance with confocal microscopy, P. Pople for graphics assistance, and H. F. Klee for the pMON518 plasmid containing the iaaM gene. We also wish to thank G. S. Ditta, L. Dolan, S. Fuentes, J. Kleine-Vehn, R. Sablowski, P. Stephenson and T. Wood for carefully reading the manuscript and constructive criticism. P. R was the recipient of a postdoctoral fellowship from the Spanish government. This work was supported by grants from FWO (Odysseus program) to J. F., from The Netherlands Organisation for Scientific Research (ALW-NWO) to R. O., from the National Science Foundation to M. F. Y., and from the Biotechnological and Biological Sciences Research Council as well as core strategic funds from the John Innes Centre to L. O.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Chauvaux N, 1997, J EXP BOT, V48, P1423, DOI 10.1093/jxb/48.7.1423; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; EDLUND A, 1995, PLANT PHYSIOL, V108, P1043, DOI 10.1104/pp.108.3.1043; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Gremski K, 2007, DEVELOPMENT, V134, P3593, DOI 10.1242/dev.011510; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; Ito T, 2007, PLANT CELL, V19, P3516, DOI 10.1105/tpc.107.055467; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Morohashi K, 2007, PLANT PHYSIOL, V145, P736, DOI 10.1104/pp.107.104521; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ostergaard L, 2006, PLANT BIOTECHNOL J, V4, P45, DOI 10.1111/j.1467-7652.2005.00156.x; Ostergaard L, 2009, CURR OPIN PLANT BIOL, V12, P36, DOI 10.1016/j.pbi.2008.09.011; Petersen M, 1996, PLANT MOL BIOL, V31, P517, DOI 10.1007/BF00042225; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Roeder AHK, 2003, CURR BIOL, V13, P1630, DOI 10.1016/j.cub.2003.08.027; ROMANO CP, 1995, PLANT MOL BIOL, V27, P1071, DOI 10.1007/BF00020881; ROMANO CP, 1991, GENE DEV, V5, P438, DOI 10.1101/gad.5.3.438; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; WU Z, 2007, J CELL PHYSL, V213, P429; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286	39	200	209	6	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					583	U114		10.1038/nature07875	http://dx.doi.org/10.1038/nature07875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478783				2022-12-28	WOS:000266370500042
J	Delamothe, T				Delamothe, Tony			On the Contrary Catholic priests: it is better to marry than to burn (and beat up)	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2009	338								b2142	10.1136/bmj.b2142	http://dx.doi.org/10.1136/bmj.b2142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	451WT	19474033				2022-12-28	WOS:000266502300020
J	Richey, R; Howdle, P; Shaw, E; Stokes, T				Richey, Roberta; Howdle, Peter; Shaw, Elizabeth; Stokes, Tim		Guideline Dev Grp	Guidelines Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Howdle, Peter] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Richey, Roberta; Shaw, Elizabeth; Stokes, Tim] Natl Inst Hlth & Clin Excellence, Ctr Clin Practice Short Clin Guidelines, Manchester M1 4BD, Lancs, England	Saint James's University Hospital; University of Leeds; National Institute for Health & Care Excellence	Howdle, P (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	p.d.howdle@leeds.ac.uk	Stokes, Tim/M-9420-2018; Burden, Sorrel/C-6101-2015	Stokes, Tim/0000-0002-1127-1952; Burden, Sorrel/0000-0002-4967-647X				Bottaro G, 1999, AM J GASTROENTEROL, V94, P691, DOI 10.1111/j.1572-0241.1999.00938.x; Hopper AD, 2007, BRIT MED J, V335, P558, DOI 10.1136/bmj.39316.442338.AD; *NAT I HLTH CLIN E, 2009, COELL DIS REC ASS CO; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119	4	21	21	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 27	2009	338								b1684	10.1136/bmj.b1684	http://dx.doi.org/10.1136/bmj.b1684			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WT	19474030				2022-12-28	WOS:000266502300002
J	Krishnamurthy, H; Piscitelli, CL; Gouaux, E				Krishnamurthy, Harini; Piscitelli, Chayne L.; Gouaux, Eric			Unlocking the molecular secrets of sodium-coupled transporters	NATURE			English	Review							SEROTONIN TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; CRYSTAL-STRUCTURE; MEMBRANE-TRANSPORT; ESCHERICHIA-COLI; BINDING-SITE; DIFFERENT STOICHIOMETRIES; GLYCINE TRANSPORTERS; LEUCINE TRANSPORTER; PERMEATION PATHWAY	Transmembrane sodium-ion gradients provide energy that can be harnessed by 'secondary transporters' to drive the translocation of solute molecules into a cell. Decades of study have shown that such sodium-coupled transporters are involved in many physiological processes, making them targets for the treatment of numerous diseases. Within the past year, crystal structures of several sodium-coupled transporters from different families have been reported, showing a remarkable structural conservation between functionally unrelated transporters. These atomic-resolution structures are revealing the mechanism of the sodium-coupled transport of solutes across cellular membranes.	[Krishnamurthy, Harini; Piscitelli, Chayne L.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; [Piscitelli, Chayne L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	US National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070039, R37MH070039] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institutes of Health. E. G. is an investigator with the Howard Hughes Medical Institute. We thank R. Hibbs, K. Hollenstein, H. Owen, S. Singh and A. Sobolevsky for helpful comments and L. Vaskalis for assistance with the figures.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; Barker EL, 1999, J NEUROSCI, V19, P4705; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; CHAKRABARTI AC, 1992, BIOCHIM BIOPHYS ACTA, V1111, P171, DOI 10.1016/0005-2736(92)90308-9; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Diez-Sampedro A, 2001, AM J PHYSIOL-RENAL, V280, pF278, DOI 10.1152/ajprenal.2001.280.2.F278; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Gu HH, 1996, J BIOL CHEM, V271, P6911, DOI 10.1074/jbc.271.12.6911; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYES SR, 1982, J BIOL CHEM, V257, P1172; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; MITCHELL P, 1967, ADV ENZYMOL RAMB, V29, P33; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; PATLAK CLIFFORD S., 1957, BULL MATH BIOPHYS, V19, P209, DOI 10.1007/BF02477764; QUICK M, 2002, TRANSMEMBRANE TRANSP; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Supplisson S, 2002, FEBS LETT, V529, P93, DOI 10.1016/S0014-5793(02)03251-9; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VIDAVER GA, 1966, J THEOR BIOL, V10, P301, DOI 10.1016/0022-5193(66)90128-7; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2004, PHYSIOLOGY, V19, P370, DOI 10.1152/physiol.00026.2004; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	67	256	259	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					347	355		10.1038/nature08143	http://dx.doi.org/10.1038/nature08143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458710	Green Accepted			2022-12-28	WOS:000266243700032
J	Rosenbaum, DM; Rasmussen, SGF; Kobilka, BK				Rosenbaum, Daniel M.; Rasmussen, Soren G. F.; Kobilka, Brian K.			The structure and function of G-protein-coupled receptors	NATURE			English	Review							BETA-ADRENERGIC-RECEPTOR; INTERNAL WATER-MOLECULES; CONSERVED ASPARTIC-ACID; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; BOVINE RHODOPSIN; DRUG DISCOVERY; HELIX MOVEMENT; BINDING-SITE; IONIC LOCK	G-protein-coupled receptors (GPCRs) mediate most of our physiological responses to hormones, neurotransmitters and environmental stimulants, and so have great potential as therapeutic targets for a broad spectrum of diseases. They are also fascinating molecules from the perspective of membrane-protein structure and biology. Great progress has been made over the past three decades in understanding diverse GPCRs, from pharmacology to functional characterization in vivo. Recent high-resolution structural studies have provided insights into the molecular mechanisms of GPCR activation and constitutive activity.	[Rosenbaum, Daniel M.; Rasmussen, Soren G. F.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Palo Alto, CA 94305 USA	Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, 279 Campus Dr, Palo Alto, CA 94305 USA.	kobilka@stanford.edu		Kobilka, Brian/0000-0001-5958-3990; Rasmussen, Soren/0000-0002-1853-1841	US National Institute of General Medical Sciences [F32 GM082028, RO1GM083118]; Lundbeck Foundation; National Institute of Neurological Disorders and Stroke [RO1-NS28471]; Mather Charitable Foundation; Lundbeck Foundation [R19-2008-2113] Funding Source: researchfish	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lundbeck Foundation(Lundbeckfonden); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mather Charitable Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the US National Institute of General Medical Sciences (grant F32 GM082028 to D. M. R. and grant RO1GM083118 to B. K.), the Lundbeck Foundation (to S. G. F. R.), the National Institute of Neurological Disorders and Stroke (grant RO1-NS28471 to B. K.) and the Mather Charitable Foundation (to B. K.).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; FREEDMAN NJ, 1996, RECENT PROG HORM RES, V51, P352; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HOFFMAN BB, 1982, ANNU REV PHYSIOL, V44, P475, DOI 10.1146/annurev.ph.44.030182.002355; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Krebs A, 1998, J MOL BIOL, V282, P991, DOI 10.1006/jmbi.1998.2070; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patny A, 2006, CURR MED CHEM, V13, P1667, DOI 10.2174/092986706777442002; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Sugimoto Y, 2002, J PHARMACOL EXP THER, V301, P51, DOI 10.1124/jpet.301.1.51; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Werner K, 2008, J BIOMOL NMR, V40, P49, DOI 10.1007/s10858-007-9205-3; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xiao RP, 1999, CIRC RES, V85, P1092; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	71	1534	1588	26	929	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					356	363		10.1038/nature08144	http://dx.doi.org/10.1038/nature08144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458711	Green Accepted			2022-12-28	WOS:000266243700033
J	Shinoda, T; Ogawa, H; Cornelius, F; Toyoshima, C				Shinoda, Takehiro; Ogawa, Haruo; Cornelius, Flemming; Toyoshima, Chikashi			Crystal structure of the sodium-potassium pump at 2.4 angstrom resolution	NATURE			English	Article							NA,K-ATPASE BETA-SUBUNIT; CALCIUM-PUMP; CATION-BINDING; RECTAL GLANDS; PROTEIN; DOMAIN; ATP; IDENTIFICATION; NA+,K+-ATPASE; CHOLESTEROL	Sodium-potassium ATPase is an ATP-powered ion pump that establishes concentration gradients for Na+ and K+ ions across the plasma membrane in all animal cells by pumping Na+ from the cytoplasm and K+ from the extracellular medium(1,2). Such gradients are used in many essential processes, notably for generating action potentials. Na+, K+-ATPase is a member of the P-type ATPases, which include sarcoplasmic reticulum Ca2+-ATPase and gastric H+, K+-ATPase, among others, and is the target of cardiac glycosides. Here we describe a crystal structure of this important ion pump, from shark rectal glands, consisting of alpha- and beta-subunits and a regulatory FXYD protein(3,4), all of which are highly homologous to human ones. The ATPase was fixed in a state analogous to E2 center dot 2K(+)center dot P-i, in which the ATPase has a high affinity for K+ and still binds P-i, as in the first crystal structure of pig kidney enzyme at 3.5 angstrom resolution(5). Clearly visualized now at 2.4 angstrom resolution are coordination of K+ and associated water molecules in the transmembrane binding sites and a phosphate analogue (MgF42-) in the phosphorylation site. The crystal structure shows that the beta-subunit has a critical role in K+ binding (although its involvement has previously been suggested(6-8)) and explains, at least partially, why the homologous Ca2+-ATPase counter-transports H+ rather than K+, despite the coordinating residues being almost identical.	[Shinoda, Takehiro; Ogawa, Haruo; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Cornelius, Flemming] Univ Aarhus, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark	University of Tokyo; Aarhus University	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Cornelius, Flemming/C-1912-2019; Toyoshima, Chikashi/R-4153-2019	Cornelius, Flemming/0000-0003-1566-0020; Shinoda, Takehiro/0000-0003-0297-2471; Toyoshima, Chikashi/0000-0001-9640-0778	Ministry of Education, Culture, Sports, Science and Technology of Japan; Danish Medical Research Council	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Kawamoto and N. Shimizu for their help in data collection at BL41XU, SPring-8, and T. Tsuda for many aspects of this work. We are grateful to D. B. McIntosh for his help in improving the manuscript and H. R. Z. Christensen for technical assistance. Thanks are also due to G. Cramb for sharing sequencing results of the beta-subunit with us before publication. This work was supported by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan, to C. T., and grants from the Danish Medical Research Council, to F. C.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROWN ID, 1976, ACTA CRYSTALLOGR B, V32, P1957, DOI 10.1107/S0567740876006869; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Jacobsen MD, 2002, BIOCHEMISTRY-US, V41, P1451, DOI 10.1021/bi015891h; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; JONES LR, 1988, METHOD ENZYMOL, V157, P85; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; POST RL, 1972, J BIOL CHEM, V247, P6530; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; SKOU JC, 1988, METHOD ENZYMOL, V156, P43; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sotomayor CP, 2000, BIOCHEMISTRY-US, V39, P10928, DOI 10.1021/bi000717z; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; UENO T, 1978, J BIOCHEM, V84, P787, DOI 10.1093/oxfordjournals.jbchem.a132190; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925	40	468	480	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					446	U167		10.1038/nature07939	http://dx.doi.org/10.1038/nature07939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458722				2022-12-28	WOS:000266243700050
J	Morin, CM; Vallieres, A; Guay, B; Ivers, H; Savard, J; Merette, C; Bastien, C; Baillargeon, L				Morin, Charles M.; Vallieres, Annie; Guay, Bernard; Ivers, Hans; Savard, Josee; Merette, Chantal; Bastien, Celyne; Baillargeon, Lucie			Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent Insomnia A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDIRECT COSTS; PREVALENCE; EPIDEMIOLOGY; METAANALYSIS; DEPRESSION; ZOLPIDEM; BURDEN; ADULTS	Context Cognitive behavioral therapy (CBT) and hypnotic medications are efficacious for short-term treatment of insomnia, but few patients achieve complete remission with any single treatment. It is unclear whether combined or maintenance therapies would enhance outcome. Objectives To evaluate the added value of medication over CBT alone for acute treatment of insomnia and the effects of maintenance therapies on long-term outcome. Design, Setting, and Patients Prospective, randomized controlled trial involving 2-stage therapy for 160 adults with persistent insomnia treated at a university hospital sleep center in Canada between January 2002 and April 2005. Interventions Participants received CBT alone or CBT plus 10 mg/d (taken at bedtime) of zolpidem for an initial 6-week therapy, followed by extended 6-month therapy. Patients initially treated with CBT attended monthly maintenance CBT for 6 months or received no additional treatment and those initially treated with combined therapy (CBT plus 10 mg/d of zolpidem) continued with CBT plus intermittent use of zolpidem or CBT only. Main Outcome Measures Sleep onset latency, time awake after sleep onset, total sleep time, and sleep efficiency derived from daily diaries (primary outcomes); treatment response and remission rates derived from the Insomnia Severity Index (secondary outcomes). Results Cognitive behavioral therapy used singly or in combination with zolpidem produced significant improvements in sleep latency, time awake after sleep onset, and sleep efficiency during initial therapy (all P<.001); a larger increase of sleep time was obtained with the combined approach (P=.04). Both CBT alone and CBT plus zolpidem produced similar rates of treatment responders (60% [45/75] vs 61% [45/74], respectively; P=.84) and treatment remissions (39% [29/75] vs 44% [33/74], respectively; P=.52) with the 6-week acute treatment, but combined therapy produced a higher remission rate compared with CBT alone during the 6- month extended therapy phase and the 6-month follow-up period (56% [43/74 and 32/59] vs 43% [34/75 and 28/68]; P=.05). The best long-term outcome was obtained with patients treated with combined therapy initially, followed by CBT alone, as evidenced by higher remission rates at the 6- month follow-up compared with patients who continued to take zolpidem during extended therapy (68% [20/30] vs 42% [12/29]; P=.04). Conclusion In patients with persistent insomnia, the addition of medication to CBT produced added benefits during acute therapy, but long-term outcome was optimized when medication is discontinued during maintenance CBT. Trial Registration clinicaltrials.gov Identifier: NCT00042146 JAMA. 2009;301(19):2005-2015 www.jama.com	[Morin, Charles M.] Univ Laval, Ecole Psychol, Pavillon FAS, Quebec City, PQ G1K 0A6, Canada; [Morin, Charles M.; Vallieres, Annie; Guay, Bernard; Merette, Chantal; Bastien, Celyne] Univ Laval, Ctr Rech, Univ Laval Robert Giffard, Quebec City, PQ G1K 0A6, Canada; [Baillargeon, Lucie] Univ Laval, Dept Med Familiale, Quebec City, PQ G1K 0A6, Canada; [Guay, Bernard] Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Savard, Josee] Hop Hotel Dieu, Ctr Rech Cancerol, Quebec City, PQ, Canada; [Baillargeon, Lucie] Pavillon CHUL, Unite Med Familiale, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Morin, CM (corresponding author), Univ Laval, Ecole Psychol, Pavillon FAS, Quebec City, PQ G1K 0A6, Canada.	cmorin@psy.ulaval.ca	Morin, Charles M./A-4700-2008; Morin, Charles/G-1021-2011	Morin, Charles M./0000-0002-8649-8895; Savard, Josee/0000-0002-8052-1046	National Institute of Mental Health [MH 60413]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060413] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research for this article was supported by grant MH 60413 from the National Institute of Mental Health.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; [Anonymous], 2005, SLEEP, V28, P1049; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bootzin R.R., 1991, STIMULUS CONTROL INS, P19, DOI [10.1007/978-1-4757-9586-8_2, DOI 10.1007/978-1-4757-9586-8_2]; Brown H., 1999, APPL MIXED MODELS ME; Buysse DJ, 2008, AM J PSYCHIAT, V165, P678, DOI 10.1176/appi.ajp.2008.08010129; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Curry DT, 2006, PSYCHIAT CLIN N AM, V29, P871, DOI 10.1016/j.psc.2006.09.006; DALEY M, SLEEP MED IN PRESS; Daley M, 2009, SLEEP, V32, P55; Edinger JD, 2007, SLEEP, V30, P203, DOI 10.1093/sleep/30.2.203; Espie CA, 2008, J CLIN ONCOL, V26, P4651, DOI 10.1200/JCO.2007.13.9006; First M.G., 1997, STRUCTURED CLIN INTE; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Hajak G, 2003, EUR PSYCHIAT, V18, P201, DOI 10.1016/S0924-9338(03)00089-0; Harvey AG, 2003, SLEEP MED REV, V7, P237, DOI 10.1053/smrv.2002.0266; Hauri PJ, 1997, SLEEP, V20, P1111, DOI 10.1093/sleep/20.12.1111; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; KIRK RE, 1995, EXPT DOSING PROCEDUR; Lichstein KL, 2000, PSYCHOL AGING, V15, P232, DOI 10.1037/0882-7974.15.2.232; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; MCCLUSKY HY, 1991, AM J PSYCHIAT, V148, P121; MILBY JB, 1993, AM J PSYCHIAT, V150, P1259; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Morin CM, 2006, SLEEP MED, V7, pS15, DOI 10.1016/j.sleep.2006.03.005; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM., 1993, INSOMNIA PSYCHOL ASS; Morin CM, 2003, INSOMNIA CLIN GUIDE; Nowell PD, 1997, JAMA-J AM MED ASSOC, V278, P2170; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ozminkowski RJ, 2007, SLEEP, V30, P263, DOI 10.1093/sleep/30.3.263; Perlis ML, 2004, J CLIN PSYCHIAT, V65, P1128; Rechtschaffen A, 1968, MANUAL STANDARIZED T; Roth T, 2007, AM J MANAG CARE, V13, pS117; SAS, 2004, SAS STAT 9 1 US GUID, V1-7; *SAS I INC, 2006, SAS STAT 9 1 3 GEN L; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; SPIELMAN AJ, 1987, SLEEP, V10, P45; Suka M, 2003, J OCCUP HEALTH, V45, P344, DOI 10.1539/joh.45.344; Vallieres A, 2005, BEHAV RES THER, V43, P1611, DOI 10.1016/j.brat.2004.11.011; Wu RG, 2006, PSYCHOTHER PSYCHOSOM, V75, P220, DOI 10.1159/000092892	48	440	467	2	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					2005	2015		10.1001/jama.2009.682	http://dx.doi.org/10.1001/jama.2009.682			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	446YU	19454639	Green Accepted, Bronze			2022-12-28	WOS:000266159600025
J	Carpenter, CR				Carpenter, Christopher R.			Adding dexamethasone to standard therapy reduces short-term relapse for acute migraine in the emergency department	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEADACHE; METAANALYSIS; MANAGEMENT		Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Carpenter, CR (corresponding author), Washington Univ, St Louis, MO 63130 USA.							Cole JC, 2007, QUAL LIFE RES, V16, P1231, DOI 10.1007/s11136-007-9217-1; Colman I, 2008, BMJ-BRIT MED J, V336, P1359, DOI 10.1136/bmj.39566.806725.BE; Ducharme J, 1998, ACAD EMERG MED, V5, P899; Edlow JA, 2008, ANN EMERG MED, V52, P407, DOI 10.1016/j.annemergmed.2008.07.001; Gallagher RM, 2004, CEPHALALGIA, V24, P8, DOI 10.1111/j.1468-2982.2004.00893.x; Goldberg LD, 2005, AM J MANAG CARE, V11, pS62; Maizels M, 2002, HEADACHE, V42, P747, DOI 10.1046/j.1526-4610.2002.02176.x; Singh A, 2008, ACAD EMERG MED, V15, P1223, DOI 10.1111/j.1553-2712.2008.00283.x; Vinson DR, 2002, ANN EMERG MED, V39, P215, DOI 10.1067/mem.2002.121400	9	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-11	10.7326/0003-4819-150-10-200905190-02011	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451567				2022-12-28	WOS:000266285300031
J	Ezekowitz, JA; McAlister, FA				Ezekowitz, Justin A.; McAlister, Finlay A.			Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ezekowitz, Justin A.; McAlister, Finlay A.] Univ Alberta, Edmonton, AB, Canada	University of Alberta	Ezekowitz, JA (corresponding author), Univ Alberta, Edmonton, AB, Canada.		McAlister, Finlay/C-4151-2013; Ezekowitz, Justin A/C-4579-2013	McAlister, Finlay/0000-0001-7435-3341; Ezekowitz, Justin A/0000-0002-2724-4086				Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Ezekowitz JA, 2008, AM J CARDIOL, V102, P79, DOI 10.1016/j.amjcard.2008.02.102; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McAlister FA, 1999, AM HEART J, V138, P87, DOI 10.1016/S0002-8703(99)70251-6; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	5	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-10	10.7326/0003-4819-150-10-200905190-02010	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451566				2022-12-28	WOS:000266285300030
J	Kruse, JP; Gu, W				Kruse, Jan-Philipp; Gu, Wei			Modes of p53 Regulation	CELL			English	Review							DNA-BINDING DOMAIN; UBIQUITIN LIGASE ACTIVITY; TUMOR-SUPPRESSOR P53; SMALL-MOLECULE INHIBITORS; RIBOSOMAL-PROTEIN L11; ACTIVITY IN-VIVO; EMBRYONIC LETHALITY; ACTIVATES P53; NEGATIVE REGULATOR; POSTTRANSLATIONAL MODIFICATIONS	The traditional view of p53 activation includes three steps-p53 stabilization, DNA binding, and transcriptional activation. However, recent studies indicate that each step of p53 activation is more complex than originally anticipated. Moreover, both genetic studies in mice and in vitro studies with purified components suggest that the classical model may not be sufficient to explain all aspects of p53 activation in vivo. To reconcile these differences, we propose that antirepression, the release of p53 from repression by factors such as Mdm2 and MdmX, is a key step in the physiological activation of p53.	[Kruse, Jan-Philipp; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Kruse, Jan-Philipp; Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu			NIH/NCI; Leukemia and Lymphoma Society; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA085533, R01CA131439, P01CA097403, R01CA098821, R01CA104843, R01CA129627, P01CA080058] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work in W. G.'s laboratory is supported by the NIH/NCI, the Leukemia and Lymphoma Society, and the Ellison Medical Foundation.	Abida WM, 2007, J BIOL CHEM, V282, P1797, DOI 10.1074/jbc.M609001200; Allison SJ, 2009, AGING-US, V1, P316, DOI 10.18632/aging.100028; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Cain C, 2000, J BIOL CHEM, V275, P39944, DOI 10.1074/jbc.M002509200; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwakuma T, 2007, ONCOGENE, V26, P2177, DOI 10.1038/sj.onc.1210278; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kim E, 1999, ONCOGENE, V18, P7310, DOI 10.1038/sj.onc.1203139; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu YG, 2004, CANCER BIOL THER, V3, P1102, DOI 10.4161/cbt.3.11.1189; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; LUNA RMD, 1995, NATURE, V378, P203; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Mellert H, 2007, CELL CYCLE, V6, P1304, DOI 10.4161/cc.6.11.4343; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wahl GM, 2006, CELL DEATH DIFFER, V13, P973, DOI 10.1038/sj.cdd.4401911; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	150	1231	1259	7	209	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					609	622		10.1016/j.cell.2009.04.050	http://dx.doi.org/10.1016/j.cell.2009.04.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450511	Green Accepted, Bronze			2022-12-28	WOS:000266114100011
J	Phelps, RA; Chidester, S; Dehghanizadeh, S; Phelps, J; Sandoval, IT; Rai, K; Broadbent, T; Sarkar, S; Burt, RW; Jones, DA				Phelps, Reid A.; Chidester, Stephanie; Dehghanizadeh, Somaye; Phelps, Jason; Sandoval, Imelda T.; Rai, Kunal; Broadbent, Talmage; Sarkar, Sharmistha; Burt, Randall W.; Jones, David A.			A Two-Step Model for Colon Adenoma Initiation and Progression Caused by APC Loss	CELL			English	Article							RETINOIC ACID BIOSYNTHESIS; TERMINAL-BINDING-PROTEIN; BETA-CATENIN; POLYPOSIS-COLI; COLORECTAL-CANCER; K-RAS; INTESTINAL DEVELOPMENT; REGULATES EXPRESSION; SPLICE VARIANT; IN-VIVO	Aberrant Wnt/beta-catenin signaling following loss of the tumor suppressor adenomatous polyposis coli (APC) is thought to initiate colon adenoma formation. Using zebrafish and human cells, we show that homozygous loss of APC causes failed intestinal cell differentiation but that this occurs in the absence of nuclear beta-catenin and increased intestinal cell proliferation. Therefore, loss of APC is insufficient for causing beta-catenin nuclear localization. APC mutation-induced intestinal differentiation defects instead depend on the transcriptional corepressor C-terminal binding protein-1 (CtBP1), whereas proliferation defects and nuclear accumulation of beta-catenin require the additional activation of KRAS. These findings suggest that, following APC loss, CtBP1 contributes to adenoma initiation as a first step, whereas KRAS activation and beta-catenin nuclear localization promote adenoma progression to carcinomas as a second step. Consistent with this model, human FAP adenomas showed robust upregulation of CtBP1 in the absence of detectable nuclear beta-catenin, whereas nuclear beta-catenin was detected in carcinomas.	[Phelps, Reid A.; Chidester, Stephanie; Dehghanizadeh, Somaye; Phelps, Jason; Sandoval, Imelda T.; Rai, Kunal; Broadbent, Talmage; Sarkar, Sharmistha; Burt, Randall W.; Jones, David A.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Phelps, Reid A.; Dehghanizadeh, Somaye; Rai, Kunal; Broadbent, Talmage; Sarkar, Sharmistha; Jones, David A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Sandoval, Imelda T.; Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Burt, Randall W.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jones, DA (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	david.jones@hci.utah.edu		Rai, Kunal/0000-0003-2321-6894; Chidester, Stephanie/0000-0003-4163-3480	National Cancer Institute [CA073992, CA96934]; Huntsman Cancer Foundation; Cancer Center Support [CA042014]; University of Utah MD/PHD program; NATIONAL CANCER INSTITUTE [R01CA116468, P01CA073992, P30CA042014] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Huntsman Cancer Foundation; Cancer Center Support; University of Utah MD/PHD program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Richard Dorsky (University of Utah) for providing the TOPGFP zebrafish. This work is supported by grants from the National Cancer Institute (CA073992 and CA96934) and the Huntsman Cancer Foundation awarded to D. A. J. The work was also supported by access to technical cores supported by a Cancer Center Support Grant (CA042014). We thank Dr. Diana Stafforini for helpful discussions. R. A. P. and T. B. are supported in part by the University of Utah MD/PHD program.	Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104; Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bienz M, 2004, CURR OPIN CELL BIOL, V16, P528, DOI 10.1016/j.ceb.2004.08.001; Blaker H, 2003, AM J CLIN PATHOL, V120, P418, DOI 10.1309/4E4WG3AYGJNCD11P; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Eisinger AL, 2007, J BIOL CHEM, V282, P29394, DOI 10.1074/jbc.M609768200; Esufali S, 2007, CANCER RES, V67, P2469, DOI 10.1158/0008-5472.CAN-06-2843; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Gripp KW, 2007, AM J MED GENET A, V143A, P1472, DOI 10.1002/ajmg.a.31815; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Haramis APG, 2006, EMBO REP, V7, P444, DOI 10.1038/sj.embor.7400638; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Iwao K, 1998, CANCER RES, V58, P1021; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kongkanuntn R, 1999, ONCOGENE, V18, P7219, DOI 10.1038/sj.onc.1203181; Moran AE, 2004, J BIOL CHEM, V279, P43261, DOI 10.1074/jbc.M404276200; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nadauld LD, 2005, J BIOL CHEM, V280, P30490, DOI 10.1074/jbc.M504973200; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Nadauld LD, 2006, P NATL ACAD SCI USA, V103, P13409, DOI 10.1073/pnas.0601634103; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2002, CURR BIOL, V12, pR499, DOI 10.1016/S0960-9822(02)00969-7; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Romagnolo B, 1999, CANCER RES, V59, P3875; Samowitz WS, 1999, CANCER RES, V59, P1442; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sparks AB, 1998, CANCER RES, V58, P1130; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052	48	220	226	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					623	634		10.1016/j.cell.2009.02.037	http://dx.doi.org/10.1016/j.cell.2009.02.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450512	Bronze, Green Accepted			2022-12-28	WOS:000266114100012
J	Pushp, A; Parker, CV; Pasupathy, AN; Gomes, KK; Ono, S; Wen, JS; Xu, ZJ; Gu, G; Yazdani, A				Pushp, Aakash; Parker, Colin V.; Pasupathy, Abhay N.; Gomes, Kenjiro K.; Ono, Shimpei; Wen, Jinsheng; Xu, Zhijun; Gu, Genda; Yazdani, Ali			Extending Universal Nodal Excitations Optimizes Superconductivity in Bi2Sr2CaCu2O8+delta	SCIENCE			English	Article							HIGH-T-C; HIGH-TEMPERATURE SUPERCONDUCTORS; UNDERDOPED BI2212; MOTT INSULATOR; ENERGY GAPS; PSEUDOGAP	Understanding the mechanism by which d wave superconductivity in the cuprates emerges and is optimized by doping the Mott insulator is one of the major outstanding problems in condensed-matter physics. Our high-resolution scanning tunneling microscopy measurements of the high-transition temperature (T-c) superconductor Bi2Sr2CaCu2O8+delta show that samples with different T-c values in the low doping regime follow a remarkably universal d wave low-energy excitation spectrum, indicating a doping-independent nodal gap. We demonstrate that T-c instead correlates with the fraction of the Fermi surface over which the samples exhibit the universal spectrum. Optimal T-c is achieved when all parts of the Fermi surface follow this universal behavior. Increasing the temperature above T-c turns the universal spectrum into an arc of gapless excitations, whereas overdoping breaks down the universal nodal behavior.	[Pushp, Aakash; Parker, Colin V.; Pasupathy, Abhay N.; Gomes, Kenjiro K.; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Pushp, Aakash; Parker, Colin V.; Pasupathy, Abhay N.; Gomes, Kenjiro K.; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Pushp, Aakash] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Ono, Shimpei] Cent Res Inst Elect Power Ind, Tokyo 2018511, Japan; [Wen, Jinsheng; Xu, Zhijun; Gu, Genda] Brookhaven Natl Lab, Upton, NY 11973 USA	Princeton University; Princeton University; University of Illinois System; University of Illinois Urbana-Champaign; Central Research Institute of Electric Power Industry - Japan; United States Department of Energy (DOE); Brookhaven National Laboratory	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	yazdani@princeton.edu	xu, zhijun/A-3264-2013; Parker, Colin/AAK-6766-2021; Ono, Shimpei/D-2918-2017; Wen, Jinsheng/F-4209-2010; Pushp, Aakash/G-6626-2011	xu, zhijun/0000-0001-7486-2015; Wen, Jinsheng/0000-0001-5864-1466; XU, ZHIJUN/0000-0002-4960-3801; Parker, Colin/0000-0001-6902-4471; Yazdani, Ali/0000-0003-4996-8904; Ono, Shimpei/0000-0003-1514-8879	U.S. Department of Energy (DOE) [DE-FG02-07ER46419, DE-AC02-98CH10886]; NSF through the Princeton Center for Complex Materials; NSF	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF through the Princeton Center for Complex Materials; NSF(National Science Foundation (NSF))	We gratefully acknowledge discussions with P. W. Anderson, N. P. Ong, M. R. Norman, and M. Randeria. The work at Princeton is supported by the U.S. Department of Energy (DOE) under contract DE-FG02-07ER46419 and NSF through the Princeton Center for Complex Materials and through an NSF-Instrumentation grant. The work in BNL is supported by DOE under contract DE-AC02-98CH10886.	Boyer MC, 2007, NAT PHYS, V3, P802, DOI 10.1038/nphys725; Campuzano JC, 2004, PHYSICS OF SUPERCONDUCTORS, VOL II, P167; CHIEN CC, PREPRINT; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Gomes KK, 2007, NATURE, V447, P569, DOI 10.1038/nature05881; He RH, 2009, NAT PHYS, V5, P119, DOI 10.1038/NPHYS1159; Honerkamp C, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.035109; Howald C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.100504; Kanigel A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157001; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kondo T, 2009, NATURE, V457, P296, DOI 10.1038/nature07644; Le Tacon M, 2006, NAT PHYS, V2, P537, DOI 10.1038/nphys362; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lee WS, 2007, NATURE, V450, P81, DOI 10.1038/nature06219; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; Norman MR, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174501; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Pasupathy AN, 2008, SCIENCE, V320, P196, DOI 10.1126/science.1154700; Sutherland M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174520; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Wang YY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247002; YOSHIDA T, PREPRINT; [No title captured]	29	102	104	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1689	1693		10.1126/science.1174338	http://dx.doi.org/10.1126/science.1174338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19498107				2022-12-28	WOS:000267338200033
J	Adamo, L; Naveiras, O; Wenzel, PL; McKinney-Freeman, S; Mack, PJ; Gracia-Sancho, J; Suchy-Dicey, A; Yoshimoto, M; Lensch, MW; Yoder, MC; Garcia-Cardena, G; Daley, GQ				Adamo, Luigi; Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Mack, Peter J.; Gracia-Sancho, Jorge; Suchy-Dicey, Astrid; Yoshimoto, Momoko; Lensch, M. William; Yoder, Mervin C.; Garcia-Cardena, Guillermo; Daley, George Q.			Biomechanical forces promote embryonic haematopoiesis	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; STEM-CELLS; MOUSE EMBRYO; DEFINITIVE HEMATOPOIESIS; IN-VITRO; YOLK-SAC; EXPRESSION DEFINES; ENDOTHELIAL-CELLS; PROGENITOR CELLS; FLOW	Biomechanical forces are emerging as critical regulators of embryogenesis, particularly in the developing cardiovascular system(1,2). After initiation of the heartbeat in vertebrates, cells lining the ventral aspect of the dorsal aorta, the placental vessels, and the umbilical and vitelline arteries initiate expression of the transcription factor Runx1 (refs 3-5), a master regulator of haematopoiesis, and give rise to haematopoietic cells(4). It remains unknown whether the biomechanical forces imposed on the vascular wall at this developmental stage act as a determinant of haematopoietic potential(6). Here, using mouse embryonic stem cells differentiated in vitro, we show that fluid shear stress increases the expression of Runx1 in CD41(+)c-Kit(+) haematopoietic progenitor cells(7), concomitantly augmenting their haematopoietic colony-forming potential. Moreover, we find that shear stress increases haematopoietic colony-forming potential and expression of haematopoietic markers in the para-aortic splanchnopleura/aorta-gonads-mesonephros of mouse embryos and that abrogation of nitric oxide, a mediator of shear-stress-induced signalling(8), compromises haematopoietic potential in vitro and in vivo. Collectively, these data reveal a critical role for biomechanical forces in haematopoietic development.	[Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Adamo, Luigi; Mack, Peter J.; Gracia-Sancho, Jorge; Suchy-Dicey, Astrid; Garcia-Cardena, Guillermo] Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Yoshimoto, Momoko; Yoder, Mervin C.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis	Daley, GQ (corresponding author), Childrens Hosp Boston, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	guillermo_garcia-cardena@hms.harvard.edu; george.daley@childrens.harvard.edu	Wenzel, Pamela/A-2992-2010; McKinney-Freeman, Shannon/N-8161-2018; Garcia-Cardena, Guillermo/Q-6649-2019; Yoshimoto, Momoko/AFP-3523-2022; Yoshimoto, Momoko/N-4238-2014; Gracia-Sancho, Jordi/C-8920-2014; Suchy-Dicey, Astrid/AAM-6640-2021; Wenzel, Pamela/AAJ-1944-2021	McKinney-Freeman, Shannon/0000-0001-8061-2557; Yoshimoto, Momoko/0000-0002-7272-6682; Yoshimoto, Momoko/0000-0002-7272-6682; Gracia-Sancho, Jordi/0000-0001-7736-4089; Suchy-Dicey, Astrid/0000-0002-5608-7817; Wenzel, Pamela/0000-0002-4530-015X; Yoder, Mervin/0000-0003-4354-7631; Naveiras, Olaia/0000-0003-3434-0022	Giovanni Armenise- Harvard Foundation; Barrie de la Maza Foundation; National Institutes of Health; NIH Director's Pioneer Award of the NIH Roadmap for Medical Research; Burroughs Wellcome Fund Clinical Scientist Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080759] Funding Source: NIH RePORTER	Giovanni Armenise- Harvard Foundation; Barrie de la Maza Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award of the NIH Roadmap for Medical Research; Burroughs Wellcome Fund Clinical Scientist Award(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Losyev for assistance with flow cytometry, S. Schmitt for critical help in optimizing AGM culture conditions, C. Lengerke and Y. Mukouyama for critical discussions. L. A. was partially funded by the Giovanni Armenise- Harvard Foundation. O. N. was partially funded by the Barrie de la Maza Foundation. G. G.-C. was supported by grants from the National Institutes of Health and G. Q. D was supported by grants from the National Institutes of Health ( NIH), and the NIH Director's Pioneer Award of the NIH Roadmap for Medical Research. G. Q. D. is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and is an Investigator of the Howard Hughes Medical Institute.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Blackman BR, 2002, J BIOMECH ENG-T ASME, V124, P397, DOI 10.1115/1.1486468; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Garin G, 2006, ENDOTHELIUM-J ENDOTH, V13, P375, DOI 10.1080/10623320601061599; HAAR JL, 1971, ANAT REC, V170, P199, DOI 10.1002/ar.1091700206; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Ji RP, 2003, CIRC RES, V92, P133, DOI 10.1161/01.RES.0000056532.18710.C0; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lensch MW, 2004, CURR TOP DEV BIOL, V60, P127; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; NOSEK TM, 2000, ESSENTIALS HUMAN PHY; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Phoon CKL, 2002, AM J PHYSIOL-HEART C, V283, pH908, DOI 10.1152/ajpheart.00869.2001; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; Tavian M, 2005, ANN NY ACAD SCI, V1044, P41, DOI 10.1196/annals.1349.006; Tiboni GM, 2007, BIRTH DEFECTS RES B, V80, P28, DOI 10.1002/bdrb.20100; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004	33	374	385	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1131	U120		10.1038/nature08073	http://dx.doi.org/10.1038/nature08073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19440194	Green Accepted, Green Published			2022-12-28	WOS:000267636700044
J	Munoz, N; Manalastas, R; Pitisuttithum, P; Tresukosol, D; Monsonego, J; Ault, K; Clavel, C; Luna, J; Myers, E; Hood, S; Bautista, O; Bryan, J; Taddeo, FJ; Esser, MT; Vuocolo, S; Haupt, RM; Barr, E; Saah, A				Munoz, Nubia; Manalastas, Ricardo, Jr.; Pitisuttithum, Punee; Tresukosol, Damrong; Monsonego, Joseph; Ault, Kevin; Clavel, Christine; Luna, Joaquin; Myers, Evan; Hood, Sara; Bautista, Oliver; Bryan, Janine; Taddeo, Frank J.; Esser, Mark T.; Vuocolo, Scott; Haupt, Richard M.; Barr, Eliav; Saah, Alfred			Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial	LANCET			English	Article; Proceedings Paper	24th International Papillomavirus Conference and Clinical Workshop	NOV 03-09, 2007	Beijing, PEOPLES R CHINA				YOUNG-WOMEN; INFECTION	Background Although the peak incidence of human papillomavirus (HPV) infection occurs in most populations within 5-10 years of first sexual experience, all women remain at risk for acquisition of HPV infections. We tested the safety, immunogenicity, and efficacy of the quadrivalent HPV (types 6, 11, 16, 18) L1 virus-like-particle vaccine in women aged 24-45 years. Methods Women aged 24-45 years with no history of genital warts or cervical disease were enrolled from community health centres, academic health centres, and primary health-care providers into an ongoing multicentre, parallel, randomised, placebo-controlled, double-blind study. Participants were allocated by computer-generated schedule to receive quadrivalent HPV vaccine (n=1911) or placebo (n=1908) at day 1, and months 2 and 6. All study site investigators and personnel, study participants, monitors, and central laboratory personnel were blinded to treatment allocation. Coprimary efficacy endpoints were 6 months' or more duration of infection and cervical and external genital disease due to HPV 6, 11, 16, 18; and due to HPV 16 and 18 alone. Primary efficacy analyses were done in a per-protocol population, but intention-to-treat analyses were also undertaken. This study is registered with ClinicalTrials.gov, number NCT00090220. Findings 1910 women received at least one dose of vaccine and 1907 at least one dose of placebo. In the per-protocol population, efficacy against the first coprimary endpoint (disease or infection related to HPV 6, 11, 16, and 18) was 90.5% (95% CI 73.7-97.5, four of 1615 cases in the vaccine group vs 41/1607 in the placebo group) and 83.1% (50.6-95.8, four of 1601 cases vs 23/1579 cases) against the second coprimary endpoint (disease or infection related to HPV 16 and 18 alone). in the intention-to-treat population, efficacy against the first coprimary endpoint was 30.9% (95% CI 11.1-46.5, 108/1886 cases vs 154/1883 cases) and against the second coprimary endpoint was 22.6% (-2.9 to 41.9, 90/1886 cases vs 115/1883 cases), since infection and disease were present at baseline. We recorded no vaccine-related serious adverse events. Interpretation The quadrivalent HPV vaccine is efficacious in women aged 24-45 years not infected with the relevant HPV types at enrolment.	[Manalastas, Ricardo, Jr.] Philippine Gen Hosp, Dept Obstet & Gynecol, Infect Dis Sect, Manila, Philippines; [Munoz, Nubia; Luna, Joaquin] Natl Canc Inst, Bogota, Colombia; [Pitisuttithum, Punee] Mahidol Univ, Fac Trop Med, Vaccine Trial Ctr, Bangkok, Thailand; [Tresukosol, Damrong] Chulalongkorn Hosp, Dept Obstet & Gynecol, Bangkok, Thailand; [Monsonego, Joseph] Federat Mutualiste Parisienne, Paris, France; [Ault, Kevin] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA; [Clavel, Christine] CHU Reims, Lab Pol Bouin, Reims, France; [Myers, Evan] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Hood, Sara; Bautista, Oliver; Bryan, Janine; Taddeo, Frank J.; Esser, Mark T.; Vuocolo, Scott; Haupt, Richard M.; Barr, Eliav; Saah, Alfred] Merck, N Wales, PA USA	University of the Philippines System; University of the Philippines Manila; Mahidol University; Chulalongkorn University; Emory University; CHU de Reims; Universite de Reims Champagne-Ardenne; Duke University	Munoz, N (corresponding author), 24 Quai Fulchiron, F-69005 Lyon, France.	nubia.munoz@free.fr		Bryan, Janine/0000-0002-4923-6247				Collins S, 2002, BJOG-INT J OBSTET GY, V109, P96, DOI 10.1111/j.1471-0528.2002.01053.x; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Insinga Ralph P, 2007, Infect Agent Cancer, V2, P15, DOI 10.1186/1750-9378-2-15; Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Opalka D, 2003, CLIN DIAGN LAB IMMUN, V10, P108, DOI 10.1128/CDLI.10.1.108-115.2003; Pagliusi SR, 2004, VACCINE, V23, P569, DOI 10.1016/j.vaccine.2004.07.046; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stevenson B, 2007, J ECON PERSPECT, V21, P27, DOI 10.1257/jep.21.2.27; Villa LL, 2007, J INFECT DIS, V196, P1438, DOI 10.1086/522864; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; World Health Organization, 2004, HUM PAP INF CERV CAN	18	339	374	1	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1949	1957		10.1016/S0140-6736(09)60691-7	http://dx.doi.org/10.1016/S0140-6736(09)60691-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	456GT	19493565				2022-12-28	WOS:000266832500029
J	Murray, CB				Murray, Christopher B.			Watching Nanocrystals Grow	SCIENCE			English	Editorial Material							ORIENTED ATTACHMENT; IN-SITU; NANOPARTICLES; NUCLEATION; MICROSCOPY; NANOCLUSTERS		[Murray, Christopher B.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Murray, Christopher B.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Murray, CB (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	cbmurray@sas.upenn.edu						Abecassis B, 2007, NANO LETT, V7, P1723, DOI 10.1021/nl0707149; Belloni J, 2006, CATAL TODAY, V113, P141, DOI 10.1016/j.cattod.2005.11.082; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; Ferreira PJ, 2008, MRS BULL, V33, P83, DOI 10.1557/mrs2008.20; Finney EE, 2008, J COLLOID INTERF SCI, V317, P351, DOI 10.1016/j.jcis.2007.05.092; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Linse P, 2002, J PHYS-CONDENS MAT, V14, P13449, DOI 10.1088/0953-8984/14/49/304; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Shestopalov I, 2004, LAB CHIP, V4, P316, DOI 10.1039/b403378g; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Yen BKH, 2003, ADV MATER, V15, P1858, DOI 10.1002/adma.200305162; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	14	34	34	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 5	2009	324	5932					1276	1277		10.1126/science.1174666	http://dx.doi.org/10.1126/science.1174666			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498154				2022-12-28	WOS:000266635100027
J	Cosio, MG; Saetta, M; Agusti, A				Cosio, Manuel G.; Saetta, Marina; Agusti, Alvar			MECHANISMS OF DISEASE Immunologic Aspects of Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TOLL-LIKE RECEPTORS; T-LYMPHOCYTE RESPONSE; AIR-FLOW OBSTRUCTION; DENDRITIC CELLS; AUTOIMMUNE-DISEASES; INCREASED EXPRESSION; PERIPHERAL AIRWAYS; BRONCHIAL BIOPSIES; TOBACCO SMOKING; LUNG-FUNCTION		[Cosio, Manuel G.] McGill Univ, Royal Victoria Hosp, Resp Div, Montreal, PQ H3A 1A1, Canada; [Cosio, Manuel G.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ H3A 1A1, Canada; [Saetta, Marina] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Sect Resp Dis, Padua, Italy; [Agusti, Alvar] Hosp Univ Son Dureta, Fdn Caubet Cimera, Mallorca, Balearic Isl, Spain; [Agusti, Alvar] CIBER Enfermedades Resp, Mallorca, Balearic Isl, Spain	McGill University; Royal Victoria Hospital; McGill University; University of Padua; Atencio Primaria de Menorca; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Cosio, MG (corresponding author), McGill Univ, Royal Victoria Hosp, Resp Div, 687 Pine Ave W,Rm L4-11, Montreal, PQ H3A 1A1, Canada.	manuel.cosio@mcgill.ca	Saetta, Marina/D-1924-2009; Agusti Garcia-Navarro, Alvar/F-4474-2015	Agusti Garcia-Navarro, Alvar/0000-0003-3271-3788; SAETTA, MARINA/0000-0002-1547-2102	Lloyd-Carr Harris Foundation; Italian Ministry of University and Research; CIBERES; Instituto de Salud Carlos III (Spanish government)	Lloyd-Carr Harris Foundation; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); CIBERES; Instituto de Salud Carlos III (Spanish government)(Instituto de Salud Carlos III)	Supported by the Lloyd-Carr Harris Foundation, the Italian Ministry of University and Research, and CIBERES, an initiative of Instituto de Salud Carlos III (Spanish government).	ABBAS AK, 2000, CELLULAR MOL IMMUNOL, P291; Agusti A, 2003, THORAX, V58, P832, DOI 10.1136/thorax.58.10.832; Baraldo S, 2008, EUR RESPIR J, V31, P486, DOI 10.1183/09031936.00000608; Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Barnes PJ, 2006, EUR RESPIR MONOGR, P130, DOI 10.1183/1025448x.00038008; Baron CL, 2001, J CELL SCI, V114, P999; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Bratke K, 2008, AM J RESP CELL MOL, V38, P655, DOI 10.1165/rcmb.2007-0400OC; Brent L, 2003, NEW ENGL J MED, V349, P1381, DOI 10.1056/NEJMon035589; Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Calabrese F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-14; Chapman HA, 2000, CHEST, V117, p295S, DOI 10.1378/chest.117.5_suppl_1.295S; Chrysofakis G, 2004, CHEST, V125, P71, DOI 10.1378/chest.125.1.71; Churg A, 2002, AM J RESP CELL MOL, V27, P368, DOI 10.1165/rcmb.4791; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Cosio MG, 2004, EUR RESPIR J, V24, P3, DOI 10.1183/09031936.04.00043104; COSIO MG, 2005, LUNG BIOL HLTH DIS S, V198, P205; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; DeMeo DL, 2004, THORAX, V59, P396, DOI 10.1136/thx.2003.012856; Di Stefano A, 2004, EUR RESPIR J, V24, P78, DOI 10.1183/09031936.04.00080303; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; ERIKSSON S, 1964, ACTA MED SCAND, V175, P197; Ermann J, 2001, NAT IMMUNOL, V2, P759, DOI 10.1038/ni0901-759; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Harel-Meir M, 2007, NAT CLIN PRACT RHEUM, V3, P707, DOI 10.1038/ncprheum0655; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P499; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; HUNNINGHAKE GW, 1983, AM REV RESPIR DIS, V128, P833; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; JANOFF A, 1968, SCIENCE, V161, P702, DOI 10.1126/science.161.3842.702; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Jiang H, 2004, J CLIN INVEST, V114, P1198, DOI 10.1172/JCI200423411; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Lambrecht BN, 2001, EUR RESPIR J, V18, P692; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Levkau B, 2002, CELL DEATH DIFFER, V9, P1360, DOI 10.1038/sj.cdd.4401106; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Majo J, 2001, EUR RESPIR J, V17, P946, DOI 10.1183/09031936.01.17509460; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Marsh H, 2006, STAND, V6, P35; MARTIN TR, 1985, AM REV RESPIR DIS, V132, P254; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McCloskey SC, 2001, AM J RESP CRIT CARE, V164, P1419, DOI 10.1164/ajrccm.164.8.2105002; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Mills PR, 1999, AM J RESP CRIT CARE, V160, pS38, DOI 10.1164/ajrccm.160.supplement_1.11; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Parker LC, 2007, CLIN EXP IMMUNOL, V147, P199, DOI 10.1111/j.1365-2249.2006.03203.x; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Pons J, 2005, EUR RESPIR J, V25, P441, DOI 10.1183/09031936.05.00069304; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rao T, 1999, ENVIRON HEALTH PERSP, V107, P737, DOI 10.2307/3434335; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; RICHARDS GA, 1989, AM REV RESPIR DIS, V139, P181, DOI 10.1164/ajrccm/139.1.181; Rivera RM, 2008, INT J TUBERC LUNG D, V12, P972; Rose N, 2003, NAT MED, V9, P641, DOI 10.1038/nm0603-641; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Rose NR, 1998, SEMIN IMMUNOL, V10, P5, DOI 10.1006/smim.1997.0100; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SAETTA M, 1993, AM REV RESPIR DIS, V147, P301, DOI 10.1164/ajrccm/147.2.301; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; SAETTA M, 1985, AM REV RESPIR DIS, V132, P894; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHRIVER EE, 1992, AM REV RESPIR DIS, V145, P762, DOI 10.1164/ajrccm/145.4_Pt_1.762; Shapiro SD, 2001, AM J RESP CRIT CARE, V164, P339, DOI 10.1164/ajrccm.164.3.2105072c; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Steinman Lawrence, 2006, Proc Am Thorac Soc, V3, P484, DOI 10.1513/pats.200603-061MS; STONE PJ, 1995, AM J RESP CRIT CARE, V151, P952; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; SUN WM, 1995, TOXICOLOGY, V100, P163, DOI 10.1016/0300-483X(95)03087-V; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Taraseviciene-Stewart L, 2005, AM J RESP CRIT CARE, V171, P734, DOI 10.1164/rccm.200409-1275OC; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Turato G, 2002, AM J RESP CRIT CARE, V166, P105, DOI 10.1164/rccm.2111084; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vernooy JHJ, 2007, AM J RESP CRIT CARE, V175, P464, DOI 10.1164/rccm.200602-169OC; WEBSTER PM, 1979, AM REV RESPIR DIS, V119, P223; Wickenden JA, 2003, AM J RESP CELL MOL, V29, P562, DOI 10.1165/rcmb.2002-0235OC; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Yung RL, 2008, AUTOIMMUNITY, V41, P329, DOI 10.1080/08916930802024889	101	559	600	0	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2445	2454		10.1056/NEJMra0804752	http://dx.doi.org/10.1056/NEJMra0804752			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494220	Green Published			2022-12-28	WOS:000266590500010
J	Thaver, D; Zaidi, AKM; Critchley, J; Azmatullah, A; Madni, SA; Bhutta, ZA				Thaver, Durrane; Zaidi, Anita K. M.; Critchley, Julia; Azmatullah, Asma; Madni, Syed Ali; Bhutta, Zulfiqar A.			A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNCOMPLICATED TYPHOID-FEVER; RANDOMIZED CONTROLLED-TRIAL; RESISTANT SALMONELLA-TYPHI; LEVEL CIPROFLOXACIN RESISTANCE; ANTIMICROBIAL DRUG-RESISTANCE; SEROVAR PARATYPHI-A; MULTIDRUG-RESISTANT; SEROTYPE TYPHI; DECREASED SUSCEPTIBILITY; TREATMENT FAILURE	Objectives To review evidence supporting use of fluoroquinolones as first line agents over other antibiotics for treating typhoid and paratyphoid fever (enteric fever). Design Meta-analysis of randomised controlled trials. Data sources Cochrane Infectious Diseases Group specialised register, CENTRAL (issue 4, 2007), Medline (1966-2007), Embase (1974-2007), LILACS (1982-2007), selected conferences, reference lists, and ongoing trial register (November 2007). Review methods Trials comparing fluoroquinolones with chloramphenicol, cephalosporins, or azithromycin in culture-proven enteric fever were included. Two reviewers extracted data and assessed methodological quality. Odds ratios with 95% confidence intervals were estimated. Trials recruiting over 60% children were analysed separately from trials on adults. Primary outcomes studied were clinical failure, microbiological failure, and relapse. Results Twenty trials were included. Trials were small and often of limited methodological quality. Only 10 trials concealed allocation and only three were blinded. In trials on adults, fluoroquinolones were not significantly different from chloramphenicol for clinical failure (594 participants) or microbiological failure (n=378), but reduced clinical relapse (odds ratio 0.14 (95% confidence interval 0.04 to 0.50), n=467, 6 trials). Azithromycin and fluoroquinolones were comparable (n=152, 2 trials). Compared with ceftriaxone, fluoroquinolones reduced clinical failure (0.08 (0.01 to 0.45), n=120, 3 trials) but not microbiological failure or relapse. Compared with cefixime, fluoroquinolones reduced clinical failure (0.05 (0.01 to 0.24), n=238, 2 trials) and relapse (0.18 (0.03 to 0.91), n=218, 2 trials). In trials on children infected with nalidixic acid resistant strains, older fluoroquinolones (ofloxacin) produced more clinical failures than azithromycin (2.67 (1.16 to 6.11), n=125, 1 trial), but there were no differences with newer fluoroquinolones (gatifloxacin, n= 285, 1 trial). Fluoroquinolones and cefixime were not significantly different (n=82, 1 trial). Conclusions In adults, fluoroquinolones may be better than chloramphenicol for preventing clinical relapse. Data were limited for other comparisons, particularly for children.	[Thaver, Durrane; Zaidi, Anita K. M.; Azmatullah, Asma; Madni, Syed Ali; Bhutta, Zulfiqar A.] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan; [Critchley, Julia] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE1 4HH, Tyne & Wear, England	Aga Khan University; Newcastle University - UK	Zaidi, AKM (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, POB 3500, Karachi 74800, Pakistan.	anita.zaidi@aku.edu		Critchley, Julia/0000-0002-5248-4188	Aga Khan University, Karachi, Pakistan; Cochrane Infectious Disease Group, UK; UK Department for International Development (DFID)	Aga Khan University, Karachi, Pakistan; Cochrane Infectious Disease Group, UK; UK Department for International Development (DFID)	The study was supported by the Aga Khan University, Karachi, Pakistan, and by the Cochrane Infectious Disease Group, UK, which is funded by the UK Department for International Development (DFID) for the benefit of developing countries.	ABEJAR NH, 1993, PHILIPP J INTERN MED, V31, P327; ACHARYA G, 1995, AM J TROP MED HYG, V52, P162, DOI 10.4269/ajtmh.1995.52.162; Ahmed D, 2006, ANTIMICROB AGENTS CH, V50, P3516, DOI 10.1128/AAC.00667-06; ALDERSON P, 2002, COCHRANE COLLABORATI; ARNOLD K, 1993, AM J MED, V94, P195; Asna SMZH, 2003, JPN J INFECT DIS, V56, P32; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; Bhutta ZA, 2000, ANTIMICROB AGENTS CH, V44, P450, DOI 10.1128/AAC.44.2.450-452.2000; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; BRAN JL, 1991, P 31 INT C ANT AG CH, P224; Brooks WA, 2005, EMERG INFECT DIS, V11, P326, DOI 10.3201/eid1102.040422; BROWN NM, 1994, J ANTIMICROB CHEMOTH, V33, P1258, DOI 10.1093/jac/33.6.1258; BUTLER T, 1991, REV INFECT DIS, V13, P85; Butt T., 2005, Eastern Mediterranean Health Journal, V11, P1038; Butt Tariq, 2006, J Coll Physicians Surg Pak, V16, P31; Cao X T, 1999, Pediatr Infect Dis J, V18, P245; Chandel DS, 2000, EMERG INFECT DIS, V6, P420, DOI 10.3201/eid0604.000420; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Chinh NT, 2000, ANTIMICROB AGENTS CH, V44, P1855, DOI 10.1128/AAC.44.7.1855-1859.2000; Cooke FJ, 2006, BRIT MED J, V333, P353, DOI 10.1136/bmj.333.7563.353-b; CRISTIANO P, 1995, INFECTION, V23, P103, DOI 10.1007/BF01833875; Crump JA, 2008, EPIDEMIOL INFECT, V136, P436, DOI 10.1017/S0950268807009338; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2008, ANTIMICROB AGENTS CH, V52, P1278, DOI 10.1128/AAC.01509-07; Dimitrov T, 2007, J MED MICROBIOL, V56, P277, DOI 10.1099/jmm.0.46773-0; Dolecek C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002188; Dutta S, 2005, ANTIMICROB AGENTS CH, V49, P1662, DOI 10.1128/AAC.49.4.1662-1663.2005; Gasem MH, 2003, ANTIMICROB AGENTS CH, V47, P1727, DOI 10.1128/AAC.47.5.1727-1731.2003; Gendrel D, 2003, LANCET INFECT DIS, V3, P537, DOI 10.1016/S1473-3099(03)00736-9; Girgis NI, 1999, ANTIMICROB AGENTS CH, V43, P1441, DOI 10.1128/AAC.43.6.1441; GOTTUZZO E, 1992, USE QUINOLONES TRAVE, P16; Harish BN, 2006, INDIAN J MED RES, V124, P585; Harish BN, 2004, J MED MICROBIOL, V53, P819, DOI 10.1099/jmm.0.05451-0; HIEN TT, 1994, T ROY SOC TROP MED H, V88, P464, DOI 10.1016/0035-9203(94)90435-9; Higgins JPT, COCHRANE HDB SYSTEMA, P4; HUAI Y, 2000, ZHONGUA ER KE ZHI, V38, P386; ISLAM A, 1988, J INFECT DIS, V158, P742, DOI 10.1093/infdis/158.4.742; Joshi S, 2007, T ROY SOC TROP MED H, V101, P308, DOI 10.1016/j.trstmh.2006.05.009; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; LASSERRE R, 1991, J ANTIMICROB CHEMOTH, V28, P765, DOI 10.1093/jac/28.5.765; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; MAHLE WT, 1993, PEDIATR INFECT DIS J, V12, P627, DOI 10.1097/00006454-199308000-00001; MAHMOOD A, 2000, JCPSP-J COLL PHYSICI, V10, P444; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Mohanty S, 2006, EPIDEMIOL INFECT, V134, P961, DOI 10.1017/S0950268805005844; MORELLI G, 1992, CURR THER RES CLIN E, V52, P532, DOI 10.1016/S0011-393X(05)80459-X; Murdoch DA, 1998, LANCET, V351, P339, DOI 10.1016/S0140-6736(05)78338-0; NALIN DR, 1987, PROGR ANTIMICROBIAL, P1174; *NORD COCHR CTR CO, 2008, REV MAN REVMAN COMP; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Pandit A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000542; Parry CM, 2007, ANTIMICROB AGENTS CH, V51, P819, DOI 10.1128/AAC.00447-06; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Parry CM, 2004, T ROY SOC TROP MED H, V98, P413, DOI 10.1016/j.trstmh.2003.10.014; Phongmany S, 2005, T ROY SOC TROP MED H, V99, P451, DOI 10.1016/j.trstmh.2004.08.007; Powell KR, 2006, PEDIATRICS, V118, P1287, DOI 10.1542/peds.2006-1722; QUINTEROPEREZ NP, 1988, 28 INT C ANT AG CHEM, P177; Renuka K, 2005, J MED MICROBIOL, V54, P999, DOI 10.1099/jmm.0.45966-0; Rodrigues C, 2003, CLIN INFECT DIS, V36, P535, DOI 10.1086/367644; ROWE B, 1995, LANCET, V346, P1302, DOI 10.1016/S0140-6736(95)91906-6; Rupali P, 2004, DIAGN MICR INFEC DIS, V49, P1, DOI 10.1016/j.diagmicrobio.2003.12.002; Saha MR, 2003, JPN J INFECT DIS, V56, P121; Saha SK, 2001, PEDIATR INFECT DIS J, V20, P521, DOI 10.1097/00006454-200105000-00010; SARMA PSA, 1991, T ROY SOC TROP MED H, V85, P670, DOI 10.1016/0035-9203(91)90390-K; Siddiqui FJ, 2006, INT J INFECT DIS, V10, P215, DOI 10.1016/j.ijid.2005.03.010; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Slinger R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-36; SMITH MD, 1994, ANTIMICROB AGENTS CH, V38, P1716, DOI 10.1128/AAC.38.8.1716; Sood S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(99)00637-6; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Sur D, 2006, T ROY SOC TROP MED H, V100, P725, DOI 10.1016/j.trstmh.2005.10.019; Takkar V P, 1995, Indian Pediatr, V32, P586; Thaver D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004530.pub3; Threlfall EJ, 2008, EMERG INFECT DIS, V14, P860, DOI 10.3201/eid1405.071184; Threlfall EJ, 2003, INT J ANTIMICROB AG, V22, P487, DOI 10.1016/S0924-8579(03)00262-0; Threlfall EJ, 2001, EMERG INFECT DIS, V7, P448, DOI 10.3201/eid0703.017315; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; van Doorn KJ, 2003, NEW ENGL J MED, V348, P1182; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Walia M, 2005, ANN TROP PAEDIATR, V25, P161, DOI 10.1179/146532805X58085; Walia M, 2006, T ROY SOC TROP MED H, V100, P942, DOI 10.1016/j.trstmh.2006.02.015; WALLACE MR, 1993, EUR J CLIN MICROBIOL, V12, P907, DOI 10.1007/BF01992163; Wasfy MO, 2002, CLIN INFECT DIS, V35, P1265, DOI 10.1086/343052; *WHO DEP VACC BIOL, 2003, TREATM TYPH FEV BACK, P19; YOUSAF MH, 1992, PAKISTAN J GASTROENT, V6, P46; YU YS, 1998, ZHONGGUO LIN CHUANG, V14, P70	87	31	33	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2009	338								b1865	10.1136/bmj.b1865	http://dx.doi.org/10.1136/bmj.b1865			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AG	19493939	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000266726300004
J	Tongren, JE; Sites, A; Zwicker, K; Pelletier, A				Tongren, Jon Eric; Sites, Anne; Zwicker, Katharyn; Pelletier, Andrew			Firearm Use in G- and PG-Rated Movies, 2003-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Tongren, Jon Eric] Ctr Dis Control & Prevent, Off Workforce & Career Dev, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Sites, Anne; Zwicker, Katharyn] Maine Dept Hlth & Human Serv, Augusta, GA USA; [Pelletier, Andrew] Ctr Dis Control & Prevent, Coordinating Off Terrorism Preparedness & Emergen, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Tongren, JE (corresponding author), Ctr Dis Control & Prevent, Off Workforce & Career Dev, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	jjt9@cdc.gov						[Anonymous], WEB BAS INJ STAT QUE; Bar-on ME, 2001, PEDIATRICS, V108, P1222; Pelletier AR, 2000, ARCH PEDIAT ADOL MED, V154, P283, DOI 10.1001/archpedi.154.3.283; Pelletier AR, 1999, JAMA-J AM MED ASSOC, V282, P428, DOI 10.1001/jama.282.5.428; Ramsey LT, 2004, JAMA-J AM MED ASSOC, V292, P2836, DOI 10.1001/jama.292.23.2836-c; VARIETY DOMESTIC TOP	6	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2213	2214		10.1001/jama.2009.746	http://dx.doi.org/10.1001/jama.2009.746			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	452PQ	19491182	Bronze			2022-12-28	WOS:000266554100018
J	Kuhn, JR; Emilio, M; Bush, R				Kuhn, J. R.; Emilio, M.; Bush, R.			Comment on "A Large Excess in Apparent Solar Oblateness Due to Surface Magnetism"	SCIENCE			English	Editorial Material								Fivian et al, (Reports, 24 October 2008, p. 560) analyzed data from the Reuven Ramaty High-Energy Solar Spectroscopic Imager satellite and reported that the Sun is more oblate than previous measurements have suggested. We argue that their threshold-based analysis yields a biased measure of the solar limb shape geometry.	[Kuhn, J. R.] Univ Hawaii, Inst Astron, Maui, HI 96760 USA; [Kuhn, J. R.] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Emilio, M.] Univ Estadual Ponta Grossa, Dept Geociencias, Astron Observ, Ponta Grossa, Parana, Brazil; [Bush, R.] Stanford Univ, Stanford, CA 94305 USA	University of Hawaii System; ETH Zurich; Universidade Estadual de Ponta Grossa; Stanford University	Kuhn, JR (corresponding author), Univ Hawaii, Inst Astron, Maui, HI 96760 USA.	kuhn@ifa.hawaii.edu	Emilio, Marcelo/C-4118-2011	Emilio, Marcelo/0000-0001-5589-9015; Kuhn, Jeff/0000-0003-1361-9104				Fivian MD, 2008, SCIENCE, V322, P560, DOI 10.1126/science.1160863; Kuhn JR, 1998, NATURE, V392, P155, DOI 10.1038/32361; *STANF U, NNX07AK36G STANF U; *STANF U SUBC U HA, NAS502139 STANF U SU	4	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931								10.1126/science.1170358	http://dx.doi.org/10.1126/science.1170358			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478167				2022-12-28	WOS:000266410100023
J	Shaheen, NJ; Sharma, P; Overholt, BF; Wolfsen, HC; Sampliner, RE; Wang, KK; Galanko, JA; Bronner, MP; Goldblum, JR; Bennett, AE; Jobe, BA; Eisen, GM; Fennerty, MB; Hunter, JG; Fleischer, DE; Sharma, VK; Hawes, RH; Hoffman, BJ; Rothstein, RI; Gordon, SR; Mashimo, H; Chang, KJ; Muthusamy, VR; Edmundowicz, SA; Spechler, SJ; Siddiqui, AA; Souza, RF; Infantolino, A; Falk, GW; Kimmey, MB; Madanick, RD; Chak, A; Lightdale, CJ				Shaheen, Nicholas J.; Sharma, Prateek; Overholt, Bergein F.; Wolfsen, Herbert C.; Sampliner, Richard E.; Wang, Kenneth K.; Galanko, Joseph A.; Bronner, Mary P.; Goldblum, John R.; Bennett, Ana E.; Jobe, Blair A.; Eisen, Glenn M.; Fennerty, M. Brian; Hunter, John G.; Fleischer, David E.; Sharma, Virender K.; Hawes, Robert H.; Hoffman, Brenda J.; Rothstein, Richard I.; Gordon, Stuart R.; Mashimo, Hiroshi; Chang, Kenneth J.; Muthusamy, V. Raman; Edmundowicz, Steven A.; Spechler, Stuart J.; Siddiqui, Ali A.; Souza, Rhonda F.; Infantolino, Anthony; Falk, Gary W.; Kimmey, Michael B.; Madanick, Ryan D.; Chak, Amitabh; Lightdale, Charles J.			Radiofrequency Ablation in Barrett's Esophagus with Dysplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-GRADE DYSPLASIA; PHOTODYNAMIC THERAPY; FOLLOW-UP; ADENOCARCINOMA; MULTICENTER; MANAGEMENT; DIAGNOSIS; RISK; PREVALENCE; GUIDELINES	BACKGROUND Barrett's esophagus, a condition of intestinal metaplasia of the esophagus, is associated with an increased risk of esophageal adenocarcinoma. We assessed whether endoscopic radiofrequency ablation could eradicate dysplastic Barrett's esophagus and decrease the rate of neoplastic progression. METHODS In a multicenter, sham-controlled trial, we randomly assigned 127 patients with dysplastic Barrett's esophagus in a 2: 1 ratio to receive either radiofrequency ablation (ablation group) or a sham procedure (control group). Randomization was stratified according to the grade of dysplasia and the length of Barrett's esophagus. Primary outcomes at 12 months included the complete eradication of dysplasia and intestinal metaplasia. RESULTS In the intention-to-treat analyses, among patients with low-grade dysplasia, complete eradication of dysplasia occurred in 90.5% of those in the ablation group, as compared with 22.7% of those in the control group (P<0.001). Among patients with high-grade dysplasia, complete eradication occurred in 81.0% of those in the ablation group, as compared with 19.0% of those in the control group (P<0.001). Overall, 77.4% of patients in the ablation group had complete eradication of intestinal metaplasia, as compared with 2.3% of those in the control group (P<0.001). Patients in the ablation group had less disease progression (3.6% vs. 16.3%, P = 0.03) and fewer cancers (1.2% vs. 9.3%, P = 0.045). Patients reported having more chest pain after the ablation procedure than after the sham procedure. In the ablation group, one patient had upper gastrointestinal hemorrhage, and five patients (6.0%) had esophageal stricture. CONCLUSIONS In patients with dysplastic Barrett's esophagus, radiofrequency ablation was associated with a high rate of complete eradication of both dysplasia and intestinal metaplasia and a reduced risk of disease progression. (ClinicalTrials.gov number, NCT00282672.)	[Shaheen, Nicholas J.] Univ N Carolina, Sch Med, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC 27599 USA; [Sharma, Prateek] Univ Kansas, Sch Med, Kansas City, KS USA; [Overholt, Bergein F.] Gastrointestinal Associates, Knoxville, TN USA; [Wolfsen, Herbert C.] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; [Sampliner, Richard E.] S Arizona Vet Affairs Hlth Care Syst, Tucson, AZ USA; [Wang, Kenneth K.] Mayo Clin, Rochester, MN USA; [Bronner, Mary P.; Goldblum, John R.; Bennett, Ana E.; Eisen, Glenn M.] Cleveland Clin, Cleveland, OH 44106 USA; [Jobe, Blair A.; Eisen, Glenn M.; Fennerty, M. Brian; Hunter, John G.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Fleischer, David E.; Sharma, Virender K.] Mayo Clin Arizona, Scottsdale, AZ USA; [Hawes, Robert H.; Hoffman, Brenda J.] Med Univ S Carolina, Charleston, SC USA; [Rothstein, Richard I.; Gordon, Stuart R.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Mashimo, Hiroshi] Vet Affairs Boston Healthcare Syst, W Roxbury, MA USA; [Chang, Kenneth J.; Muthusamy, V. Raman] Univ Calif Irvine, Irvine, CA USA; [Edmundowicz, Steven A.] Washington Univ, Med Ctr, St Louis, MO USA; [Spechler, Stuart J.; Siddiqui, Ali A.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Infantolino, Anthony] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Kimmey, Michael B.] Tacoma Digest Dis Res Ctr, Tacoma, WA USA; [Chak, Amitabh] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Lightdale, Charles J.] Columbia Univ, Med Ctr, New York, NY USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Kansas; University of Kansas Medical Center; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System; Mayo Clinic; Cleveland Clinic Foundation; Oregon Health & Science University; Mayo Clinic; Mayo Clinic Phoenix; Medical University of South Carolina; Dartmouth College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of California System; University of California Irvine; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Jefferson University; Case Western Reserve University; Case Western Reserve University Hospital; Columbia University	Shaheen, NJ (corresponding author), Univ N Carolina, Sch Med, Ctr Esophageal Dis & Swallowing, CB 7080, Chapel Hill, NC 27599 USA.	nshaheen@med.unc.edu	Shaheen, Nicholas J/A-1898-2013; Gordon, Stuart/AAD-8334-2021	Falk, Gary/0000-0002-7143-1436; Edmundowicz, Steven/0000-0002-6541-3485	National Institutes of Health [P30 DK034987]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by BARRX Medical. Study medication was provided by AstraZeneca. Statistical analysis and data management were supported by a grant (P30 DK034987) from the National Institutes of Health.	Abrams JA, 2008, CLIN GASTROENTEROL H, V6, P30, DOI 10.1016/j.cgh.2007.10.006; Buttar NS, 2001, GASTROENTEROLOGY, V120, P1630, DOI 10.1053/gast.2001.25111; Das D, 2008, AM J GASTROENTEROL, V103, P1079, DOI 10.1111/j.1572-0241.2008.01790.x; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; Eloubeidi MA, 2003, AM J GASTROENTEROL, V98, P1627, DOI 10.1016/S0002-9270(03)00228-4; Fleischer DE, 2008, GASTROINTEST ENDOSC, V68, P867, DOI 10.1016/j.gie.2008.03.008; Ganz RA, 2008, GASTROINTEST ENDOSC, V68, P35, DOI 10.1016/j.gie.2007.12.015; Gondrie JJ, 2008, ENDOSCOPY, V40, P359, DOI 10.1055/s-2007-995567; Hornick JL, 2005, AM J SURG PATHOL, V29, P372, DOI 10.1097/01.pas.0000147403.33509.de; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; Overholt BF, 2007, GASTROINTEST ENDOSC, V66, P460, DOI 10.1016/j.gie.2006.12.037; Overholt BF, 2006, GASTROINTEST ENDOSC, V63, P359; Overholt BF, 2005, GASTROINTEST ENDOSC, V62, P488, DOI 10.1016/j.gie.2005.06.047; Playford RJ, 2006, GUT, V55, P442, DOI 10.1136/gut.2005.083600; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Rastogi A, 2008, GASTROINTEST ENDOSC, V67, P394, DOI 10.1016/j.gie.2007.07.019; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Schnell TG, 2001, GASTROENTEROLOGY, V120, P1607, DOI 10.1053/gast.2001.25065; Sharma P, 2006, CLIN GASTROENTEROL H, V4, P566, DOI 10.1016/j.cgh.2006.03.001; Sharma VK, 2007, GASTROINTEST ENDOSC, V65, P185, DOI 10.1016/j.gie.2006.09.033; Spechler SJ, 2002, NEW ENGL J MED, V346, P836, DOI 10.1056/NEJMcp012118; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Westhoff B, 2005, GASTROINTEST ENDOSC, V61, P226, DOI 10.1016/S0016-5107(04)02589-1; Williams VA, 2007, J GASTROINTEST SURG, V11, P1589, DOI 10.1007/s11605-007-0330-9; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X	27	954	981	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2277	2288		10.1056/NEJMoa0808145	http://dx.doi.org/10.1056/NEJMoa0808145			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474425				2022-12-28	WOS:000266367300004
J	Snellen, IAG; de Mooij, EJW; Albrecht, S				Snellen, Ignas A. G.; de Mooij, Ernst J. W.; Albrecht, Simon			The changing phases of extrasolar planet CoRoT-1b	NATURE			English	Article							EMISSION-SPECTRUM; HD 209458B; TEMPERATURE INVERSION; THERMAL EMISSION; GIANT PLANETS; LIGHT CURVES; HOT JUPITERS; STARLIGHT; 189733B; SEARCH	Hot Jupiters are a class of extrasolar planet that orbit their parent stars at very short distances. They are expected to be tidally locked, which can lead to a large temperature difference between their daysides and nightsides. Infrared observations of eclipsing systems have yielded dayside temperatures for a number of transiting planets(1-5). The day-night contrast of the transiting extrasolar planet HD189733b was 'mapped' using infrared observations(6,7). It is expected that the contrast between the daysides and nightsides of hot Jupiters is much higher at visual wavelengths, shorter than that of the peak emission, and could be further enhanced by reflected stellar light. Here we report the analysis of optical photometric data(8) obtained over 36 planetary orbits of the transiting hot Jupiter CoRoT-1b. The data are consistent with the nightside hemisphere of the planet being entirely black, with the dayside flux dominating the optical phase curve. This means that at optical wavelengths the planet's phase variation is just as we see it for the interior planets in the Solar System. The data allow for only a small fraction of reflected light, corresponding to a geometric albedo of <0.20.	[Snellen, Ignas A. G.; de Mooij, Ernst J. W.; Albrecht, Simon] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Snellen, IAG (corresponding author), Leiden Univ, Leiden Observ, Postbus 9513, NL-2300 RA Leiden, Netherlands.	snellen@strw.leidenuniv.nl		de Mooij, Ernst/0000-0001-6391-9266; Snellen, Ignas/0000-0003-1624-3667				AUVERGNE M, 2009, ASTRON ASTR IN PRESS; Barge P, 2008, ASTRON ASTROPHYS, V482, pL17, DOI 10.1051/0004-6361:200809353; Burrows A, 2008, ASTROPHYS J, V678, P1436, DOI 10.1086/533518; Burrows A, 2007, ASTROPHYS J, V668, pL171, DOI 10.1086/522834; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Collier Cameron A, 2002, MON NOT R ASTRON SOC, V330, P187, DOI 10.1046/j.1365-8711.2002.05084.x; Cooper CS, 2005, ASTROPHYS J, V629, pL45, DOI 10.1086/444354; Cowan NB, 2007, MON NOT R ASTRON SOC, V379, P641, DOI 10.1111/j.1365-2966.2007.11897.x; COX AN, 2000, ALLENS ASTROPHYSICAL, pCH1; de Mooij EJW, 2009, ASTRON ASTROPHYS, V493, pL35, DOI 10.1051/0004-6361:20081239; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Green D, 2003, ASTROPHYS J, V597, P590, DOI 10.1086/378224; Grillmair CJ, 2008, NATURE, V456, P767, DOI 10.1038/nature07574; Harrington J, 2007, NATURE, V447, P691, DOI 10.1038/nature05863; Harrington J, 2006, SCIENCE, V314, P623, DOI 10.1126/science.1133904; Hood B, 2008, MON NOT R ASTRON SOC, V389, P257, DOI 10.1111/j.1365-2966.2008.13549.x; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2009, ASTROPHYS J, V690, P822, DOI 10.1088/0004-637X/690/1/822; Knutson HA, 2009, ASTROPHYS J, V691, P866, DOI 10.1088/0004-637X/691/1/866; Kurucz R., 1993, ATLAS9 ATMOSPHERE PR; Leigh C, 2003, MON NOT R ASTRON SOC, V346, pL16, DOI 10.1046/j.1365-2966.2003.07276.x; Leigh C, 2003, MON NOT R ASTRON SOC, V344, P1271, DOI 10.1046/j.1365-8711.2003.06901.x; Rowe JF, 2008, ASTROPHYS J, V689, P1345, DOI 10.1086/591835; SAMADI R, 2007, EXTRACTION PHOTOMETR; Seager S, 2000, ASTROPHYS J, V540, P504, DOI 10.1086/309292; SHOWMAN A, 2008, ASTROPHYS J UNPUB; Sing DK, 2009, ASTRON ASTROPHYS, V493, pL31, DOI 10.1051/0004-6361:200811268	29	109	110	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 28	2009	459	7246					543	545		10.1038/nature08045	http://dx.doi.org/10.1038/nature08045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478779	Green Submitted			2022-12-28	WOS:000266370500033
J	Clewley, JP; Kelly, CM; Andrews, N; Vogliqi, K; Mallinson, G; Kaisar, M; Hilton, DA; Ironside, JW; Edwards, P; McCardle, LM; Ritchie, DL; Dabaghian, R; Ambrose, HE; Gill, ON				Clewley, Jonathan P.; Kelly, Carole M.; Andrews, Nick; Vogliqi, Kelly; Mallinson, Gary; Kaisar, Maria; Hilton, David A.; Ironside, James W.; Edwards, Philip; McCardle, Linda M.; Ritchie, Diane L.; Dabaghian, Reza; Ambrose, Helen E.; Gill, O. Noel			Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey	BRITISH MEDICAL JOURNAL			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; BLOOD-TRANSFUSION; TISSUE SAMPLES; VARIANT; UK; CLASSIFICATION; DIAGNOSIS; APPENDIX; GENE	Objective To establish with improved accuracy the prevalence of disease related prion protein (PrP(CJD)) in the population of Britain and thereby guide a proportionate public health response to limit the threat of healthcare associated transmission of variant Creutzfeldt-Jakob disease (vCJD). Design Cross sectional opportunistic survey. Study samples Anonymised tonsil pairs removed at elective tonsillectomy throughout England and Scotland. Setting National anonymous tissue archive for England and Scotland. Main outcome measure Presence of PrP(CJD) determined by using two enzyme immunoassays based on different analytical principles, with further investigation by immunohistochemistry or immunoblotting of any samples reactive in either assay. Results Testing of 63 007 samples was completed by the end of September 2008. Of these, 12 753 were from the birth cohort in which most vCJD cases have arisen (1961-85) and 19 908 were from the 1986-95 cohort that would have been also exposed to bovine spongiform encephalopathy through infected meat or meat products. None of the samples tested was unequivocally reactive in both enzyme immunoassays. Only two samples were reactive in one or other enzyme immunoassay and equivocal in the other, and nine samples were equivocally reactive in both enzyme immunoassays. Two hundred and seventy six samples were initially reactive in one or other enzyme immunoassay; the repeat reactivity rate was 15% or less, depending on the enzyme immunoassay and cutoff definition. None of the samples (including all the 276 initially reactive in enzyme immunoassay) that were investigated by immunohistochemistry or immunoblotting was positive for the presence of PrP(CJD). Conclusions The observed prevalence of PrP(CJD) in tonsils from the 1961-95 combined birth cohort was 0/32 661 with a 95% confidence interval of 0 to 113 per million. In the 1961-85 cohort, the prevalence of zero with a 95% confidence interval of 0 to 289 per million was lower than, but still consistent with, a previous survey of appendix tissue that showed a prevalence of 292 per million with a 95% confidence interval of 60 to 853 per million. Continuing to archive and test tonsil specimens, especially in older birth cohorts, and other complementary large scale anonymous tissue surveys, particularly of post-mortem tissues, will further refine the calculated prevalence of PrP(CJD).	[Clewley, Jonathan P.; Kelly, Carole M.; Andrews, Nick; Vogliqi, Kelly; Dabaghian, Reza; Ambrose, Helen E.; Gill, O. Noel] Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England; [Mallinson, Gary; Kaisar, Maria] Natl Blood Serv, Bristol Inst Transfus Sci, Bristol BS10 5ND, Avon, England; [Hilton, David A.; Edwards, Philip] Derriford Hosp, Dept Histopathol, Plymouth PL6 8DH, Devon, England; [Ironside, James W.; McCardle, Linda M.; Ritchie, Diane L.] Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Health Protection Agency; Derriford Hospital; University of Edinburgh	Clewley, JP (corresponding author), Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England.	jonathan.clewley@hpa.org.uk		Kaisar, Maria/0000-0002-0712-9937; Ironside, James/0000-0001-5869-2108	Department of Health; MRC [G0600953, G0900580] Funding Source: UKRI; Medical Research Council [G0600953, G0900580] Funding Source: researchfish	Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Department of Health; the work was carried out independently of the funder.	Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bons N, 1999, P NATL ACAD SCI USA, V96, P4046, DOI 10.1073/pnas.96.7.4046; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Cali I, 2006, BRAIN, V129, P2266, DOI 10.1093/brain/awl224; Chazot G, 1996, LANCET, V347, P1181, DOI 10.1016/S0140-6736(96)90638-8; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Frosh A, 2004, LANCET, V364, P1260, DOI 10.1016/S0140-6736(04)17143-2; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Head MW, 2004, ANN NEUROL, V55, P851, DOI 10.1002/ana.20127; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Ironside JW, 2002, APMIS, V110, P79, DOI 10.1034/j.1600-0463.2002.100110.x; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; MONTGOMERY J, CHIEF MED OFF MAY 20; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; SchulzSchaeffer WJ, 1996, CLIN NEUROPATHOL, V15, P353; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zimmermann K, 1999, ACTA NEUROPATHOL, V97, P355, DOI 10.1007/s004010050998; 2007, HLTH PROT REP, P1	33	68	70	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2009	338								b1442	10.1136/bmj.b1442	http://dx.doi.org/10.1136/bmj.b1442			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NT	19460798	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000266270000001
J	Erez, E; Fass, D; Bibi, E				Erez, Elinor; Fass, Deborah; Bibi, Eitan			How intramembrane proteases bury hydrolytic reactions in the membrane	NATURE			English	Review							SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE; SUBSTRATE-SPECIFICITY; RHOMBOID PROTEASE; INTRACELLULAR DOMAIN; PROTEOLYTIC RELEASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CORE PROTEIN; TNF-ALPHA	Intramembrane proteolysis is increasingly seen as a regulatory step in a range of diverse processes, including development, organelle shaping, metabolism, pathogenicity and degenerative disease. Initial scepticism over the existence of intramembrane proteases was soon replaced by intense exploration of their catalytic mechanisms, substrate specificities, regulation and structures. Crystal structures of metal-dependent and serine intramembrane proteases have revealed active sites embedded in the plane of the membrane but accessible by water, a requirement for hydrolytic reactions. Efforts to understand how these membrane-bound proteases carry out their reactions have started to yield results.	[Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Erez, Elinor; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	deborah.fass@weizmann.ac.il; e.bibi@weizmann.ac.il		Bibi, Eitan/0000-0003-3700-2707	Israel Science Foundation; Yale-Weizmann Collaborative Program; Kimmelman Center for Macromolecular Assemblies	Israel Science Foundation(Israel Science Foundation); Yale-Weizmann Collaborative Program; Kimmelman Center for Macromolecular Assemblies	E. B. is supported by the Israel Science Foundation and the Yale-Weizmann Collaborative Program. D. F. acknowledges support from the Kimmelman Center for Macromolecular Assemblies.	Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Akiyama Y, 2007, MOL MICROBIOL, V64, P1028, DOI 10.1111/j.1365-2958.2007.05715.x; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; An FY, 1999, J BACTERIOL, V181, P5915, DOI 10.1128/JB.181.19.5915-5921.1999; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Carpenter EP, 2008, CURR OPIN STRUC BIOL, V18, P581, DOI 10.1016/j.sbi.2008.07.001; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; CHRISTIANSON DW, 1989, ACCOUNTS CHEM RES, V22, P62, DOI 10.1021/ar00158a003; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DE SB, 1999, NATURE, V398, P518; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DODSON G, 1984, NATURE, V309, P309, DOI 10.1038/309309a0; Dowse Timothy J., 2008, V47, P121; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Hausrath AC, 2002, ACTA CRYSTALLOGR D, V58, P1002, DOI 10.1107/S090744490200584X; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hulko M, 2007, PROTEIN SCI, V16, P644, DOI 10.1110/ps.062478607; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Lewis AP, 1999, PROTEIN SCI, V8, P439; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pascall JC, 2004, BIOCHEM BIOPH RES CO, V317, P244, DOI 10.1016/j.bbrc.2004.03.039; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Southan C, 2001, DRUG DISCOV TODAY, V6, P681, DOI 10.1016/S1359-6446(01)01793-7; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tsruya R, 2007, EMBO J, V26, P1211, DOI 10.1038/sj.emboj.7601581; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; 1974, PROTEIN DATA BANK NE	84	95	95	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					371	378		10.1038/nature08146	http://dx.doi.org/10.1038/nature08146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458713				2022-12-28	WOS:000266243700035
J	Kado, DM; Lui, LY; Ensrud, KE; Fink, HA; Karlamangla, AS; Cummings, SR				Kado, Deborah M.; Lui, Li-Yung; Ensrud, Kristine E.; Fink, Howard A.; Karlamangla, Arun S.; Cummings, Steven R.		Study Osteoporotic Fractures	Hyperkyphosis Predicts Mortality Independent of Vertebral Osteoporosis in Older Women	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-DWELLING MEN; RANCHO-BERNARDO; FRACTURES; POSTURE; PREVALENT; KYPHOSIS; RISK; AGE; DEFORMITIES; DENSITY	Background: Excessive kyphosis may be associated with earlier mortality, but previous studies have not controlled for clinically silent vertebral fractures, which are a known mortality risk factor. Objective: To determine whether hyperkyphosis predicts increased mortality independent of vertebral fractures. Design: Prospective cohort study. Setting: Four clinical centers in Baltimore County, Maryland; Portland, Oregon; Minneapolis, Minnesota; and the Monongahela Valley, Pennsylvania. Patients: 610 women, age 67 to 93 years, from a cohort of 9704 women recruited from community-based listings between 1986 and 1988. Measurements: Kyphosis was measured by using a flexicurve. Prevalent radiographic vertebral fractures at baseline were defined by morphometry, and mortality was assessed during an average follow-up of 13.5 years. Results: In age-adjusted models, each SD increase in kyphosis carried a 1.14-fold increased risk for death (95% CI, 1.02 to 1.27; P = 0.023). After adjustment for age and other predictors of mortality, including such osteoporosis-related factors as low bone density, moderate and severe prevalent vertebral fractures, and number of prevalent vertebral fractures, women with greater kyphosis were at increased risk for earlier death (relative hazard per SD increase, 1.15 [CI, 1.01 to 1.30]; P = 0.029). On stratification by prevalent vertebral fracture status, only women with prevalent fractures were at increased mortality risk from hyperkyphosis, independent of age, self-reported health, smoking, spine bone mineral density, number of vertebral fractures, and severe vertebral fractures (relative hazard per SD increase, 1.58 [CI, 1.06 to 2.35]; P = 0.024). Limitation: The study population included only white women. Conclusion: In older women with vertebral fractures, hyperkyphosis predicts an increased risk for death, independent of underlying spinal osteoporosis and the extent and severity of vertebral fractures. Primary Funding Source: National Institute of Arthritis and Musculoskeletal and Skin Diseases and National Institute on Aging.	Univ Calif Los Angeles, Los Angeles, CA USA; Calif Pacific Med Ctr, San Francisco, CA USA; Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA	University of California System; University of California Los Angeles; California Pacific Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Kado, DM (corresponding author), Mac Donald Res Lab, 675 Charles E Young Dr S,Room 2741, Los Angeles, CA 90095 USA.	dkado@mednet.ucla.edu	Fink, Howard/F-3933-2012	Kado, Deborah/0000-0002-2582-5573; Ensrud, Kristine/0000-0002-9069-3036	National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging [AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22,, 2 R01 AG00539422A1, 2 R01 AG027574-22A1, 1K12AG01004, 1 R01 AG024246]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582, R01AR035583, R01AR035584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005407, K12AG001004, R01AG024246, F32AG005407, R01AG027574, R01AG005394, R01AG027576] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute on Aging under the following grant numbers: AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576- 22, 2 R01 AG00539422A1, 2 R01 AG027574- 22A1, 1K12AG01004, and 1 R01 AG024246.	BLACK DM, 1995, J BONE MINER RES, V10, P890; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; ETTINGER B, 1994, OSTEOPOROSIS INT, V4, P55, DOI 10.1007/BF02352262; Genant HK, 1996, J BONE MINER RES, V11, P984; Genant HK, 1996, J BONE MINER RES, V11, P707; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; HARRELL FE, 2009, SAS MACRO PERCENTAGE; Huang MH, 2006, J BONE MINER RES, V21, P419, DOI 10.1359/JBMR.051201; Ismail AA, 1998, OSTEOPOROSIS INT, V8, P291, DOI 10.1007/s001980050067; Kado DM, 2008, J BONE MINER RES, V23, pS118; Kado DM, 2007, J GERONTOL A-BIOL, V62, P652, DOI 10.1093/gerona/62.6.652; Kado DM, 2007, ANN INTERN MED, V147, P330, DOI 10.7326/0003-4819-147-5-200709040-00008; Kado DM, 2005, J GERONTOL A-BIOL, V60, P633, DOI 10.1093/gerona/60.5.633; Kado DM, 2004, J AM GERIATR SOC, V52, P1662, DOI 10.1111/j.1532-5415.2004.52458.x; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Kado DM, 2003, OSTEOPOROSIS INT, V14, P589, DOI 10.1007/s00198-003-1412-5; KIEL DP, 1995, J BONE MINER RES, V10, pS189; MILNE JS, 1983, AGE AGEING, V12, P225, DOI 10.1093/ageing/12.3.225; Pongchaiyakul C, 2005, J BONE MINER RES, V20, P1349, DOI 10.1359/JBMR.050317; STEIGER P, 1992, J BONE MINER RES, V7, P625; Tinetti ME, 2000, ANN INTERN MED, V132, P337, DOI 10.7326/0003-4819-132-5-200003070-00002	23	84	92	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					681	U4		10.7326/0003-4819-150-10-200905190-00005	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	448TQ	19451575	Green Accepted			2022-12-28	WOS:000266285300003
J	Bekes, M; Salvesen, GS				Bekes, Miklos; Salvesen, Guy S.			The CULt of Caspase-8 Ubiquitination	CELL			English	Editorial Material							ACTIVATION; INSIGHTS		[Bekes, Miklos; Salvesen, Guy S.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Salvesen, GS (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@burnham.org						Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621	9	12	12	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					604	606		10.1016/j.cell.2009.04.052	http://dx.doi.org/10.1016/j.cell.2009.04.052			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450509	Bronze			2022-12-28	WOS:000266114100009
J	Ivins, ER				Ivins, Erik R.			Ice Sheet Stability and Sea Level	SCIENCE			English	Editorial Material							ANTARCTICA; RISE		CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Ivins, ER (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	eri@fryxell.jpl.nasa.gov						Bamber JL, 2007, EARTH PLANET SC LETT, V257, P1, DOI 10.1016/j.epsl.2007.03.005; Bamber JL, 2009, SCIENCE, V324, P901, DOI 10.1126/science.1169335; BINDSCHADLER RA, 1991, SCIENCE, V252, P242, DOI 10.1126/science.252.5003.242; FitzGerald DM, 2008, ANNU REV EARTH PL SC, V36, P601, DOI 10.1146/annurev.earth.35.031306.140139; HUGHES TJ, 1998, ICE SHEETS; James TS, 1997, J GEOPHYS RES-SOL EA, V102, P605, DOI 10.1029/96JB02855; Mitrovica JX, 2009, SCIENCE, V323, P753, DOI 10.1126/science.1166510; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Payne AJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003733; Ramillien G, 2006, GLOBAL PLANET CHANGE, V53, P198, DOI 10.1016/j.gloplacha.2006.06.003; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035417; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; VAUGHAN DG, 2007, EOS T AGU, V88, DOI DOI 10.1029/2007E0460001; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785	18	11	12	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					888	889		10.1126/science.1173958	http://dx.doi.org/10.1126/science.1173958			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443771				2022-12-28	WOS:000266048800021
J	Bower, AS; Lozier, MS; Gary, SF; Boning, CW				Bower, Amy S.; Lozier, M. Susan; Gary, Stefan F.; Boening, Claus W.			Interior pathways of the North Atlantic meridional overturning circulation	NATURE			English	Article							LABRADOR SEA-WATER; WESTERN BOUNDARY CURRENT	To understand how our global climate will change in response to natural and anthropogenic forcing, it is essential to determine how quickly and by what pathways climate change signals are transported throughout the global ocean, a vast reservoir for heat and carbon dioxide. Labrador Sea Water (LSW), formed by open ocean convection in the subpolar North Atlantic, is a particularly sensitive indicator of climate change on interannual to decadal timescales(1-3). Hydrographic observations made anywhere along the western boundary of the North Atlantic reveal a core of LSW at intermediate depths advected southward within the Deep Western Boundary Current (DWBC)(4-9). These observations have led to the widely held view that the DWBC is the dominant pathway for the export of LSW from its formation site in the northern North Atlantic towards the Equator(10,11). Here we show that most of the recently ventilated LSW entering the subtropics follows interior, not DWBC, pathways. The interior pathways are revealed by trajectories of subsurface RAFOS floats released during the period 2003-2005 that recorded once-daily temperature, pressure and acoustically determined position for two years, and by model-simulated 'e-floats' released in the subpolar DWBC. The evidence points to a few specific locations around the Grand Banks where LSW is most often injected into the interior. These results have implications for deep ocean ventilation and suggest that the interior subtropical gyre should not be ignored when considering the Atlantic meridional overturning circulation.	[Bower, Amy S.] Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02540 USA; [Lozier, M. Susan; Gary, Stefan F.] Duke Univ, Nicholas Sch Environm, Div Earth & Ocean Sci, Durham, NC 27708 USA; [Boening, Claus W.] IFM GEOMAR Leibniz Inst Meereswissensch, D-24105 Kiel, Germany	Woods Hole Oceanographic Institution; Duke University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Bower, AS (corresponding author), Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02540 USA.	abower@whoi.edu; mslozier@duke.edu	Boening, Claus/AAW-6387-2020; Boening, Claus W/B-1686-2012; Boening, Claus W/HIR-8996-2022; Kushnir, Yochanan/B-4472-2013	Boening, Claus/0000-0002-6251-5777; Boening, Claus W/0000-0002-6251-5777; Boening, Claus W/0000-0002-6251-5777; Bower, Amy/0000-0003-0902-4984	US National Science Foundation.; Division Of Ocean Sciences [0824652] Funding Source: National Science Foundation	US National Science Foundation.(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge the captains and crews of the R/V Oceanus and numerous Canadian fisheries research vessels, and scientists from the Northwest Atlantic Fisheries Centre in St. John's, Newfoundland, for their assistance in the deployment of the floats and sound sources used in this study. In particular, we thank E. Colbourne for his support of the float release programme. We also acknowledge J. Valdes and B. Guest for their expert technical support in the preparation of the floats, and H. Furey for providing float tracking. J. Fischer of IFM-GEOMAR provided several days of ship time to replace sound sources. We dedicate this work to the memory of F. Schott. The work was supported by the US National Science Foundation.	Boning CW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026906; Bryden HL, 2005, J MAR RES, V63, P35, DOI 10.1357/0022240053693806; DAVIS RE, 1992, J ATMOS OCEAN TECH, V9, P264, DOI 10.1175/1520-0426(1992)009<0264:TALCE>2.0.CO;2; Fischer J, 2002, J PHYS OCEANOGR, V32, P573, DOI 10.1175/1520-0485(2002)032<0573:LSWTBP>2.0.CO;2; Getzlaff K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026470; HOGG NG, 1986, DEEP-SEA RES, V33, P1139, DOI 10.1016/0198-0149(86)90017-8; Kearns EJ, 1998, J GEOPHYS RES-OCEANS, V103, P15509, DOI 10.1029/98JC00370; Kieke D, 2006, J PHYS OCEANOGR, V36, P64, DOI 10.1175/JPO2814.1; Lavender KL, 2000, NATURE, V407, P66, DOI 10.1038/35024048; Lavender KL, 2005, DEEP-SEA RES PT I, V52, P767, DOI 10.1016/j.dsr.2004.12.007; Lazier J, 2002, DEEP-SEA RES PT I, V49, P1819, DOI 10.1016/S0967-0637(02)00064-X; Lazier J.R.N., 1980, ATMOS OCEAN, V18, P227, DOI DOI 10.1080/07055900.1980.9649089; Lozier MS, 1997, SCIENCE, V277, P361, DOI 10.1126/science.277.5324.361; Lozier MS, 1999, GEOPHYS RES LETT, V26, P219, DOI 10.1029/1998GL900264; MOLINARI RL, 1992, DEEP-SEA RES, V39, P1967, DOI 10.1016/0198-0149(92)90008-H; Molinari RL, 1998, GEOPHYS RES LETT, V25, P2249, DOI 10.1029/98GL01853; PACANOWSKI RC, 1996, 31329 GFDL NOAA; PICKART RS, 1992, DEEP-SEA RES, V39, P1553, DOI 10.1016/0198-0149(92)90047-W; Rhein M, 2002, J PHYS OCEANOGR, V32, P648, DOI 10.1175/1520-0485(2002)032<0648:LSWPCI>2.0.CO;2; RHINES PB, 1995, ACCP PRINC INV M NOA; Rio MH, 2005, P GOCINA INT WORKSH; Rossby T, 1996, REV GEOPHYS, V34, P463, DOI 10.1029/96RG02214; Rossby T, 1986, J ATMOS OCEAN TECH, V3, P672, DOI 10.1175/1520-0426(1986)003<0672:TRS>2.0.CO;2; SCHMITZ WJ, 1993, REV GEOPHYS, V31, P29, DOI 10.1029/92RG02583; SCHOTT FA, 2007, OCEAN CIRCULATION ME, P95; Smethie WM, 2000, J GEOPHYS RES-OCEANS, V105, P14297, DOI 10.1029/1999JC900274; Stramma L, 2004, DEEP-SEA RES PT I, V51, P1033, DOI 10.1016/j.dsr.2004.04.001; TALLEY LD, 1982, J PHYS OCEANOGR, V12, P1189, DOI 10.1175/1520-0485(1982)012<1189:DACOLS>2.0.CO;2; Zenk W, 2000, J ATMOS OCEAN TECH, V17, P1439, DOI 10.1175/1520-0426(2000)017<1439:TFPANT>2.0.CO;2	29	184	189	0	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					243	U126		10.1038/nature07979	http://dx.doi.org/10.1038/nature07979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444214	Green Published			2022-12-28	WOS:000266036100039
J	West, JB				West, John B.			Arterial blood measurements in climbers on Mount Everest	LANCET			English	Editorial Material							EXTREME ALTITUDE; GAS-EXCHANGE		Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	West, JB (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jwest@ucsd.edu						Catron Thomas F, 2006, BMC Physiol, V6, P3, DOI 10.1186/1472-6793-6-3; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Peacock AJ, 1997, EUR RESPIR J, V10, P1439, DOI 10.1183/09031936.97.10071439; Richalet JP, 1999, ADV EXP MED BIOL, V474, P297; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; WEST JB, 1983, J APPL PHYSIOL, V55, P678, DOI 10.1152/jappl.1983.55.3.678; West John B., 1998, HIGH LIFE HIST HIGH; WINSLOW RM, 1984, J APPL PHYSIOL, V56, P109, DOI 10.1152/jappl.1984.56.1.109	8	4	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1589	1590		10.1016/S0140-6736(09)60888-6	http://dx.doi.org/10.1016/S0140-6736(09)60888-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19427943				2022-12-28	WOS:000266066300010
J	Rodriguez, S; Le Mouelic, S; Rannou, P; Tobie, G; Baines, KH; Barnes, JW; Griffith, CA; Hirtzig, M; Pitman, KM; Sotin, C; Brown, RH; Buratti, BJ; Clark, RN; Nicholson, PD				Rodriguez, Sebastien; Le Mouelic, Stephane; Rannou, Pascal; Tobie, Gabriel; Baines, Kevin H.; Barnes, Jason W.; Griffith, Caitlin A.; Hirtzig, Mathieu; Pitman, Karly M.; Sotin, Christophe; Brown, Robert H.; Buratti, Bonnie J.; Clark, Roger N.; Nicholson, Phil D.			Global circulation as the main source of cloud activity on Titan	NATURE			English	Article								Clouds on Titan result from the condensation of methane and ethane and, as on other planets, are primarily structured by circulation of the atmosphere(1-4). At present, cloud activity mainly occurs in the southern (summer) hemisphere, arising near the pole(5-12) and at mid-latitudes(7,8,13-15) from cumulus updrafts triggered by surface heating and/or local methane sources, and at the north (winter) pole(16,17), resulting from the subsidence and condensation of ethane-rich air into the colder troposphere. General circulation models(1-3) predict that this distribution should change with the seasons on a 15-year timescale, and that clouds should develop under certain circumstances at temperate latitudes (similar to 40 degrees) in the winter hemisphere(2). The models, however, have hitherto been poorly constrained and their long-term predictions have not yet been observationally verified. Here we report that the global spatial cloud coverage on Titan is in general agreement with the models, confirming that cloud activity is mainly controlled by the global circulation. The non-detection of clouds at latitude similar to 40 degrees N and the persistence of the southern clouds while the southern summer is ending are, however, both contrary to predictions. This suggests that Titan's equator-to-pole thermal contrast is overestimated in the models and that its atmosphere responds to the seasonal forcing with a greater inertia than expected.	[Rodriguez, Sebastien; Le Mouelic, Stephane; Tobie, Gabriel; Sotin, Christophe] Univ Nantes, CNRS, UMR 6112, Lab Planetol & Geodynam, F-44000 Nantes, France; [Rodriguez, Sebastien] Univ Paris 07, CNRS, CEA Saclay,DSM,IRFU,SAp, Lab AIM,UMR 7158, F-91191 Gif Sur Yvette, France; [Rannou, Pascal] Univ Reims, CNRS, Grp Spectrometrie Mol & Atmospher, UMR 6089, F-51687 Reims, France; [Rannou, Pascal] Univ Versailles St Quentin, CNRS, LATMOS, UMR 7620, F-91371 Verrieres Le Buisson, France; [Baines, Kevin H.; Pitman, Karly M.; Sotin, Christophe; Buratti, Bonnie J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Barnes, Jason W.] NASA, Ames Res Ctr MS 244 30, Moffett Field, CA 94035 USA; [Griffith, Caitlin A.; Brown, Robert H.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Hirtzig, Mathieu] Univ Michigan, PSL, AOSS, Ann Arbor, MI 48109 USA; [Clark, Roger N.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; [Nicholson, Phil D.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; CEA; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); University of Arizona; University of Michigan System; University of Michigan; United States Department of the Interior; United States Geological Survey; Cornell University	Rodriguez, S (corresponding author), Univ Nantes, CNRS, UMR 6112, Lab Planetol & Geodynam, 2 Rue Houssiniere, F-44000 Nantes, France.	sebastien.rodriguez@cea.fr	Rodriguez, Sebastien/H-5902-2016; Barnes, Jason W/B-1284-2009; RANNOU, Pascal/I-9059-2012	Rodriguez, Sebastien/0000-0003-1219-0641; Barnes, Jason W/0000-0002-7755-3530; RANNOU, pascal/0000-0003-0836-723X; Le Mouelic, Stephane/0000-0001-5260-1367	CNRS; CEA; CNES French; Universities of Paris Diderot and Nantes	CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); CNES French; Universities of Paris Diderot and Nantes	We thank M. E. Brown for discussions that allowed us greatly to improve the quality of this study. This work was performed partly at the Jet Propulsion Laboratory, California Institute of Technology, under contract to the National Aeronautics and Space Administration. K. M. P. and J. W. B. are supported by the NASA Postdoctoral Program, administered by Oak Ridge Associated Universities. Calibrated VIMS data appear courtesy of the VIMS team. We thank the CNRS, CEA and CNES French agencies, as well as the Universities of Paris Diderot and Nantes for their financial support.	Atreya SK, 2006, PLANET SPACE SCI, V54, P1177, DOI 10.1016/j.pss.2006.05.028; Baines KH, 2005, EARTH MOON PLANETS, V96, P119, DOI 10.1007/s11038-005-9058-2; Barnes JW, 2007, ICARUS, V186, P242, DOI 10.1016/j.icarus.2006.08.021; Barnes JW, 2005, SCIENCE, V310, P92, DOI 10.1126/science.1117075; Barth EL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028652; Bouchez AH, 2005, ASTROPHYS J, V618, pL53, DOI 10.1086/427693; Brown ME, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035964; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; de Pater I, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002620; Griffith CA, 2006, SCIENCE, V313, P1620, DOI 10.1126/science.1128245; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; GRIFFITH CA, SCIENCE UNPUB; Hirtzig M, 2006, ASTRON ASTROPHYS, V456, P761, DOI 10.1051/0004-6361:20053381; Hueso R, 2006, NATURE, V442, P428, DOI 10.1038/nature04933; Jennings DE, 2009, ASTROPHYS J LETT, V691, pL103, DOI 10.1088/0004-637X/691/2/L103; LEMOUELIC S, 2008, LUNAR PLANET SCI, V39, P1649; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; Mitchell JL, 2006, P NATL ACAD SCI USA, V103, P18421, DOI 10.1073/pnas.0605074103; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Roe HG, 2005, ASTROPHYS J, V618, pL49, DOI 10.1086/427499; Schaller EL, 2006, ICARUS, V182, P224, DOI 10.1016/j.icarus.2005.12.021; Schaller EL, 2006, ICARUS, V184, P517, DOI 10.1016/j.icarus.2006.05.025; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; Tokano T, 2001, ICARUS, V153, P130, DOI 10.1006/icar.2001.6659; Turtle EP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036186	28	68	68	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					678	682		10.1038/nature08014	http://dx.doi.org/10.1038/nature08014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494910	Green Submitted			2022-12-28	WOS:000266608600038
J	Banks, I				Banks, Ian			Personal View Improving healthcare services for men	BRITISH MEDICAL JOURNAL			English	Editorial Material												ian@medic40.freeserve.co.uk							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 3	2009	338								b2129	10.1136/bmj.b2129	http://dx.doi.org/10.1136/bmj.b2129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	455AG	19493922				2022-12-28	WOS:000266726300008
J	Garber, J; Clarke, GN; Weersing, VR; Beardslee, WR; Brent, DA; Gladstone, TRG; DeBar, LL; Lynch, FL; D'Angelo, E; Hollon, SD; Shamseddeen, W; Iyengar, S				Garber, Judy; Clarke, Gregory N.; Weersing, V. Robin; Beardslee, William R.; Brent, David A.; Gladstone, Tracy R. G.; DeBar, Lynn L.; Lynch, Frances L.; D'Angelo, Eugene; Hollon, Steven D.; Shamseddeen, Wael; Iyengar, Satish			Prevention of Depression in At-Risk Adolescents A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	54th Annual Meeting of the American-Academy-of-Child-and-Adolescent-Psychiatry	OCT 23-28, 2007	Boston, MA	Amer Acad Child & Adolescent Psychiat			CHILDREN; PSYCHOTHERAPY; RELIABILITY; PREDICTORS; CONTINUITY; SYMPTOMS; DISORDER; VALIDITY; PARENTS; BURDEN	Context Adolescent offspring of depressed parents are at markedly increased risk of developing depressive disorders. Although some smaller targeted prevention trials have found that depression risk can be reduced, these results have yet to be replicated and extended to large-scale, at-risk populations in different settings. Objective To determine the effects of a group cognitive behavioral (CB) prevention program compared with usual care in preventing the onset of depression. Design, Setting, and Participants A multicenter randomized controlled trial conducted in 4 US cities in which 316 adolescent (aged 13-17 years) offspring of parents with current or prior depressive disorders were recruited from August 2003 through February 2006. Adolescents had a past history of depression, current elevated but sub-diagnostic depressive symptoms, or both. Assessments were conducted at baseline, after the 8-week intervention, and after the 6-month continuation phase. Intervention Adolescents were randomly assigned to the CB prevention program consisting of 8 weekly, 90-minute group sessions followed by 6 monthly continuation sessions or assigned to receive usual care alone. Main Outcome Measure Rate and hazard ratio (HR) of a probable or definite depressive episode (ie, depressive symptom rating score of >= 4) for at least 2 weeks as diagnosed by clinical interviewers. Results Through the postcontinuation session follow-up, the rate and HR of incident depressive episodes were lower for those in the CB prevention program than for those in usual care (21.4% vs 32.7%; HR, 0.63; 95% confidence interval [CI], 0.40-0.98). Adolescents in the CB prevention program also showed significantly greater improvement in self-reported depressive symptoms than those in usual care (coefficient, -1.1; z=-2.2; P=.03). Current parental depression at baseline moderated intervention effects ( HR, 5.98; 95% CI, 2.29-15.58; P=.001). Among adolescents whose parents were not depressed at baseline, the CB prevention program was more effective in preventing onset of depression than usual care (11.7% vs 40.5%; HR, 0.24; 95% CI, 0.11-0.50), whereas for adolescents with a currently depressed parent, the CB prevention program was not more effective than usual care in preventing incident depression (31.2% vs 24.3%; HR, 1.43; 95% CI, 0.76-2.67). Conclusion The CB prevention program had a significant prevention effect through the 9-month follow-up period based on both clinical diagnoses and self-reported depressive symptoms, but this effect was not evident for adolescents with a currently depressed parent. Trial Registration clinicaltrials.gov Identifier: NCT00073671 JAMA. 2009;301(21):2215-2224 www.jama.com	[Garber, Judy; Hollon, Steven D.] Vanderbilt Univ, Dept Psychol & Human Dev, Nashville, TN 37203 USA; [Garber, Judy; Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; [Clarke, Gregory N.; DeBar, Lynn L.; Lynch, Frances L.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Weersing, V. Robin] San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92182 USA; [Weersing, V. Robin] Univ Calif San Diego, San Diego, CA 92103 USA; [Beardslee, William R.; Gladstone, Tracy R. G.; D'Angelo, Eugene] Childrens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Beardslee, William R.; Gladstone, Tracy R. G.; D'Angelo, Eugene] Judge Baker Childrens Ctr, Boston, MA 02115 USA; [Brent, David A.; Shamseddeen, Wael; Iyengar, Satish] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA USA; [Gladstone, Tracy R. G.] Wellesley Coll, Wellesley, MA 02181 USA	Vanderbilt University; Vanderbilt University; Kaiser Permanente; California State University System; San Diego State University; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard University; Judge Baker's Children's Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Wellesley College	Garber, J (corresponding author), Vanderbilt Univ, Dept Psychol & Human Dev, 552 Peabody,230 Appleton Pl, Nashville, TN 37203 USA.	judy.garber@vanderbilt.edu	D'Angelo, Eugene/W-9914-2019	Weersing, V. Robin/0000-0002-7904-4799; Shamseddeen, Wael/0000-0001-9717-4979	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064503, T32MH018951, R01MH064717, R01MH064541, K02MH001697, K02MH066249, R01MH064735] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andrade AR, 2000, J AM ACAD CHILD PSY, V39, P161, DOI 10.1097/00004583-200002000-00014; Angold A, 1998, AM J PUBLIC HEALTH, V88, P75, DOI 10.2105/AJPH.88.1.75; Ascher BH, 1996, J EMOT BEHAV DISORD, V4, P12, DOI 10.1177/106342669600400102; Beardslee WR, 1998, J AM ACAD CHILD PSY, V37, P1134, DOI 10.1097/00004583-199811000-00012; Beck A.T., 1979, COGNITIVE THERAPY EM; BEGG CB, 1980, BIOMETRICS, V36, P81, DOI 10.2307/2530497; Birmaher B, 2000, ARCH GEN PSYCHIAT, V57, P29, DOI 10.1001/archpsyc.57.1.29; Brent DA, 1998, J AM ACAD CHILD PSY, V37, P906, DOI 10.1097/00004583-199809000-00010; Brent DA, 1997, ARCH GEN PSYCHIAT, V54, P877; Brent DA, 2008, RUTTERS CHILD ADOLES, P587; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Clarke G, 1998, J PREV INTERVENTION, V17, P19; Clarke G. N., 1990, INSTRUCTORS MANUAL A; CLARKE GN, 1995, J AM ACAD CHILD PSY, V34, P312, DOI 10.1097/00004583-199503000-00016; Clarke GN, 2001, ARCH GEN PSYCHIAT, V58, P1127, DOI 10.1001/archpsyc.58.12.1127; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Curry J, 2006, J AM ACAD CHILD PSY, V45, P1427, DOI 10.1097/01.chi.0000240838.78984.e2; EFRON B, 1971, BIOMETRIKA, V58, P403, DOI 10.2307/2334377; First M.G., 1997, STRUCTURED CLIN INTE; Garber J, 2006, AM J PREV MED, V31, pS104, DOI 10.1016/j.amepre.2006.07.007; Gunlicks ML, 2008, J AM ACAD CHILD PSY, V47, P379, DOI 10.1097/CHI.0b013e3181640805; Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333; Hollingshead A., 1975, 4 FACTOR INDEX SOCIA; Horowitz JL, 2006, J CONSULT CLIN PSYCH, V74, P401, DOI 10.1037/0022-006X.74.3.401; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KELLER MB, 1987, ARCH GEN PSYCHIAT, V44, P540; Kennard B, 2006, J AM ACAD CHILD PSY, V45, P1404, DOI 10.1097/01.chi.0000242228.75516.21; Kraemer HC, 1987, MANY SUBJECTS STAT P; Lewinsohn P M, 1998, Depress Anxiety, V7, P47, DOI 10.1002/(SICI)1520-6394(1998)7:1<47::AID-DA6>3.0.CO;2-2; Lewinsohn PM, 1999, J AM ACAD CHILD PSY, V38, P56, DOI 10.1097/00004583-199901000-00020; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Merry S. N., 2006, COCHRANE DB SYST REV, V3, P1; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mrazek P., 1994, REDUCING RISKS MENTA; Podorefsky DL, 2001, J AM ACAD CHILD PSY, V40, P879, DOI 10.1097/00004583-200108000-00008; POZNANSKI EO, 1984, J AM ACAD CHILD PSY, V23, P191, DOI 10.1097/00004583-198403000-00011; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Rao U, 1999, J AM ACAD CHILD PSY, V38, P908, DOI 10.1097/00004583-199907000-00022; ROBERTS RE, 1991, J AM ACAD CHILD PSY, V30, P58, DOI 10.1097/00004583-199101000-00009; ROBERTS RE, 1990, J CONSULT CLIN PSYCH, V2, P122; Rohde P, 2004, J AM ACAD CHILD PSY, V43, P660, DOI 10.1097/01.chi.0000121067.29744.41; Seligman M.E.P., 2002, PREVENTION TREATMENT, V5, DOI [DOI 10.1037/1522-3736.5.1.58A, 10.1037/1522-3736.5.1.58a]; Shireman TI, 2002, PSYCHIAT SERV, V53, P1444, DOI 10.1176/appi.ps.53.11.1444; Southam-Gerow MA, 2001, J CLIN CHILD PSYCHOL, V30, P422, DOI 10.1207/S15374424JCCP3003_13; Weissman MM, 2006, AM J PSYCHIAT, V163, P1001, DOI 10.1176/appi.ajp.163.6.1001; Weissman MM, 1999, JAMA-J AM MED ASSOC, V281, P1707, DOI 10.1001/jama.281.18.1707; WILLETT JB, 1993, J CONSULT CLIN PSYCH, V61, P952, DOI 10.1037/0022-006X.61.6.952; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	49	338	340	2	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2215	2224		10.1001/jama.2009.788	http://dx.doi.org/10.1001/jama.2009.788			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	452PQ	19491183	Green Accepted, Bronze			2022-12-28	WOS:000266554100019
J	Patel, M; Pedreira, C; De Oliveira, LH; Tate, J; Orozco, M; Mercado, J; Gonzalez, A; Malespin, O; Amador, JJ; Umana, J; Balmaseda, A; Perez, MC; Gentsch, J; Kerin, T; Hull, J; Mijatovic, S; Andrus, J; Parashar, U				Patel, Manish; Pedreira, Cristina; De Oliveira, Lucia Helena; Tate, Jacqueline; Orozco, Maribel; Mercado, Juan; Gonzalez, Alcides; Malespin, Omar; Amador, Juan Jose; Umana, Jazmina; Balmaseda, Angel; Perez, Maria Celina; Gentsch, Jon; Kerin, Tara; Hull, Jennifer; Mijatovic, Slavica; Andrus, Jon; Parashar, Umesh			Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in Nicaragua	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL POLIOVIRUS VACCINE; CHOLERA VACCINE; NEW-DELHI; REASSORTANT; EFFICACY; IMMUNOGENICITY; INFECTION; SAFETY; PROTECTION; STRAINS	Context Pentavalent rotavirus vaccine (RV5), a live, oral attenuated vaccine, prevented 98% of severe rotavirus diarrhea in a trial conducted mainly in Finland and the United States. Nicaragua introduced RV5 in 2006, providing the first opportunity to assess the association between vaccination and rotavirus disease in a developing country. Objective To assess the association between RV5 vaccination and subsequent rotavirus diarrhea requiring overnight admission or intravenous hydration. Design, Setting, and Participants Case-control evaluation in 4 hospitals in Nicaragua from June 2007 to June 2008. Cases were children age-eligible to receive RV5 who were admitted or required intravenous hydration for laboratory-confirmed rotavirus diarrhea. For each case (n=285), 1 to 3 neighborhood (n=840) and hospital (n=690) controls were selected. Main Outcome Measures Primary outcome was the association of RV5 and rotavirus diarrhea requiring overnight admission or intravenous hydration in the emergency department. Secondary analysis further classified disease as severe and very severe. We computed the matched odds ratio of vaccination in cases vs controls. Vaccine effectiveness was estimated using the formula 1-matched odds ratio x 100%. Results Of the 285 rotavirus cases, 265 (93%) required hospitalization; 251 (88%) received intravenous hydration. A single rotavirus strain (G2P[ 4]) was identified in 88% of the cases. Among cases and controls, respectively, 18% and 12% were unvaccinated, 12% and 15% received 1 dose of RV5, 15% and 17% received 2 doses, and 55% and 57% received 3 doses. Vaccination with 3 doses was associated with a lower risk of rotavirus diarrhea requiring overnight admission or intravenous hydration (odds ratio [OR], 0.54; 95% confidence interval [CI], 0.36-0.82). Of the 285 rotavirus cases, 191 (67%) were severe and 54 (19%) were very severe. A progressively lower risk of severe (OR, 0.42; 95% CI, 0.26-0.70) and very severe rotavirus diarrhea (OR, 0.23; 95% CI, 0.08-0.61) was observed after RV5 vaccination. Thus, effectiveness of 3 doses of RV5 against rotavirus disease requiring admission or treatment with intravenous hydration was 46% (95% CI, 18%-64%); against severe rotavirus diarrhea, 58% ( 95% CI, 30%-74%); and against very severe rotavirus diarrhea, 77% (95% CI, 39%-92%). Conclusion Vaccination with RV5 was associated with a lower risk of severe rotavirus diarrhea in children younger than 2 years in Nicaragua but to a lesser extent than that seen in clinical trials in industrialized countries. JAMA. 2009;301(21):2243-2251 www.jama.com	[Patel, Manish] Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA; [Pedreira, Cristina] Pan Amer Hlth Org, Managua, Nicaragua; [De Oliveira, Lucia Helena; Andrus, Jon] Pan Amer Hlth Org, Washington, DC USA; [Orozco, Maribel; Mercado, Juan; Gonzalez, Alcides; Malespin, Omar; Umana, Jazmina; Balmaseda, Angel; Perez, Maria Celina] Minist Salud, Managua, Nicaragua; [Amador, Juan Jose] Program Appropriate Technol Hlth, Managua, Nicaragua	Centers for Disease Control & Prevention - USA; Pan American Health Organization; Pan American Health Organization	Patel, M (corresponding author), Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, MS A47,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	aul3@cdc.gov			Global Alliance for Vaccines and Immunization	Global Alliance for Vaccines and Immunization	This study was conducted under a collaborative arrangement with the Program for Appropriate Technology in Health and was funded in part by the Global Alliance for Vaccines and Immunization.	Amador JJ, 2008, REV PANAM SALUD PUBL, V23, P277, DOI 10.1590/S1020-49892008000400008; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203; BOOM J, 2008, 48 INT C ANT AG CHEM; Bresee JS, 2005, PEDIATR INFECT DIS J, V24, P947, DOI 10.1097/01.inf.0000186295.18969.e6; Bresee JS, 2005, J INFECT DIS, V192, pS1, DOI 10.1086/431515; Ciarlet M, 2008, PEDIATR INFECT DIS J, V27, P874, DOI 10.1097/INF.0b013e3181782780; Cunliffe NA, 2001, LANCET, V358, P550, DOI 10.1016/S0140-6736(01)05706-3; DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994; de Oliveira LH, 2008, EXPERT REV VACCINES, V7, P345, DOI 10.1586/14760584.7.3.345; ESTES MK, 1989, MICROBIOL REV, V53, P410, DOI 10.1128/MMBR.53.4.410-449.1989; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; GOTUZZO E, 1993, INFECT IMMUN, V61, P3994, DOI 10.1128/IAI.61.9.3994-3997.1993; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Griffin DD, 2002, VIROLOGY, V294, P256, DOI 10.1006/viro.2001.1333; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; Hallander HO, 2002, VACCINE, V21, P138, DOI 10.1016/S0264-410X(02)00348-1; HANLON P, 1987, LANCET, V1, P1342; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Lagos R, 1999, J INFECT DIS, V180, P1709, DOI 10.1086/315051; Lanata CF, 1996, J INFECT DIS, V174, P268, DOI 10.1093/infdis/174.2.268; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; Linhares AC, 1999, PEDIATR INFECT DIS J, V18, P1001, DOI 10.1097/00006454-199911000-00013; MIGASENA S, 1995, VACCINE, V13, P168, DOI 10.1016/0264-410X(95)93131-R; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; SATTEN GA, 1990, J CLIN EPIDEMIOL, V43, P55, DOI 10.1016/0895-4356(90)90056-U; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; VODOPIJA I, 1986, VACCINE, V4, P233, DOI 10.1016/0264-410X(86)90135-0; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285	40	210	215	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2243	2251		10.1001/jama.2009.756	http://dx.doi.org/10.1001/jama.2009.756			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491186	Bronze			2022-12-28	WOS:000266554100022
J	Hoff, G; Grotmol, T; Skovlund, E; Bretthauer, M				Hoff, Geir; Grotmol, Tom; Skovlund, Eva; Bretthauer, Michael		Norwegian Colorectal Canc Preventi	Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BASE-LINE FINDINGS; COLONOSCOPY; PREVENTION; SURVEILLANCE; POLYPECTOMY; NEOPLASIA; POLYP	Objective To determine the risk of colorectal cancer after screening with flexible sigmoidoscopy. Design Randomised controlled trial. Setting Population based screening in two areas in Norway-city of Oslo and Telemark county (urban and mixed urban and rural populations). Participants 55 736 men and women aged 55-64 years. Intervention Once only flexible sigmoidoscopy screening with or without a single round of faecal occult blood testing (n=13 823) compared with no screening (n=41 913). Main outcome measures Planned end points were cumulative incidence and mortality of colorectal cancer after 5, 10, and 15 years. This first report from the study presents cumulative incidence after 7 years of follow-up and hazard ratio for mortality after 6 years. Results No difference was found in the 7 year cumulative incidence of colorectal cancer between the screening and control groups (134.5 v 131.9 cases per 100 000 person years). In intention to screen analysis, a trend towards reduced colorectal cancer mortality was found (hazard ratio 0.73, 95% confidence interval 0.47 to 1.13, P=0.16). For attenders compared with controls, a statistically significant reduction in mortality was apparent for both total colorectal cancer (hazard ratio 0.41, 0.21 to 0.82, P=0.011) and rectosigmoidal cancer (0.24, 0.08 to 0.76, P=0.016). Conclusions A reduction in incidence of colorectal cancer with flexible sigmoidoscopy screening could not be shown after 7 years' follow-up. Mortality from colorectal cancer was not significantly reduced in the screening group but seemed to be lower for attenders, with a reduction of 59% for any location of colorectal cancer and 76% for rectosigmoidal cancer in per protocol analysis, an analysis prone to selection bias. Trial registration Clinical trials NCT00119912.	[Hoff, Geir; Grotmol, Tom; Bretthauer, Michael] Canc Registry Norway, Norwegian Colorectal Canc Prevent NORCCAP Ctr, NO-0310 Oslo, Norway; [Hoff, Geir] Telemark Hosp, Dept Med, NO-3710 Skien, Norway; [Skovlund, Eva] Univ Oslo, Sch Pharm, NO-0316 Oslo, Norway; [Bretthauer, Michael] Aker Univ Hosp, Rikshosp, Dept Gastroenterol, NO-0027 Oslo, Norway	University of Oslo; Telemark Hospital Trust; University of Oslo; University of Oslo; National Hospital Norway	Hoff, G (corresponding author), Canc Registry Norway, POB 5313, N-0304 Oslo, Norway.	hofg@online.no			Norwegian Cancer Society; Norwegian Ministry of Health	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Ministry of Health	NORCCAP trial 1 was funded by grants from the Norwegian Cancer Society and the Norwegian Ministry of Health. The authors are independent from the funders of the NORCCAP trial 1.	Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2001, J MED SCREEN, V8, P137, DOI 10.1136/jms.8.3.137; Bretthauer N, 2002, SCAND J GASTROENTERO, V37, P568, DOI 10.1080/00365520252903125; *CANC REG NORW, 2006, CANC NORW 2005; Cuzick J, 2007, J MED SCREEN, V14, P178, DOI 10.1258/096914107782912059; Gondal G, 2003, SCAND J GASTROENTERO, V38, P635, DOI 10.1080/00365520310003002; Hoff G, 1996, SCAND J GASTROENTERO, V31, P834, DOI 10.3109/00365529609051989; Larsen IK, 2006, EUR J CANCER PREV, V15, P10, DOI 10.1097/01.cej.0000186636.27496.bb; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Loeve F, 2004, INT J CANCER, V111, P633, DOI 10.1002/ijc.20277; Palitz A M, 1997, HMO Pract, V11, P5; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rasmussen M, 1999, SCAND J GASTROENTERO, V34, P73; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rozen P, 2004, EUR J CANCER PREV, V13, P71, DOI 10.1097/00008469-200402000-00011; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Segnan N, 2002, J NATL CANCER I, V94, P1763; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; UK National Screening Committee, CRIT APPR VIAB EFF A; Wilson JMG, 1968, PRINCIPLES PRACTICE; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	24	230	235	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2009	338								b1846	10.1136/bmj.b1846	http://dx.doi.org/10.1136/bmj.b1846			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WW	19483252	hybrid, Green Published			2022-12-28	WOS:000266502600001
J	Bernstein, KA; Rothstein, R				Bernstein, Kara A.; Rothstein, Rodney			At Loose Ends: Resecting a Double-Strand Break	CELL			English	Review							HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; DNA; HELICASE; REPLICATION; SGS1; COMPLEX; ENDONUCLEASE; STABILITY; REPAIR		[Bernstein, Kara A.; Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Rothstein, R (corresponding author), Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA.	rothstein@cancercenter.columbia.edu	Bernstein, Kara Anne/S-4943-2016	Bernstein, Kara Anne/0000-0003-2247-6459; Rothstein, Rodney/0000-0002-4107-9654	NIGMS NIH HHS [R01 GM067055, GM50237, R01 GM050237, GM078840, F32 GM078840, R37 GM050237, GM67055] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050237, F32GM078840, R37GM050237, R01GM067055] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bernstein KA, 2009, EMBO J, V28, P915, DOI 10.1038/emboj.2009.28; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Seki M, 2008, CELL CYCLE, V7, P2472, DOI 10.4161/cc.7.16.6462; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	18	79	81	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					807	810		10.1016/j.cell.2009.05.007	http://dx.doi.org/10.1016/j.cell.2009.05.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490890	Green Accepted, Bronze			2022-12-28	WOS:000266454800012
J	Morris, K				Morris, Kelly			World Bank health projects get mixed review	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1749	1749		10.1016/S0140-6736(09)60965-X	http://dx.doi.org/10.1016/S0140-6736(09)60965-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19480074				2022-12-28	WOS:000266337300012
J	Wade, N				Wade, Nicholas			John Maddox (1925-2009) RETROSPECTIVE	SCIENCE			English	Biographical-Item												nwade@nytimes.com						MADDOX J, PUBLICATION LIST	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1028	1028		10.1126/science.1175760	http://dx.doi.org/10.1126/science.1175760			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460997				2022-12-28	WOS:000266246700030
J	Brent, J				Brent, Jeffrey			Fomepizole for Ethylene Glycol and Methanol Poisoning	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXICOLOGY PRACTICE GUIDELINES; HEALTHY-HUMAN SUBJECTS; METABOLIC INTERACTIONS; VISUAL IMPAIRMENT; AMERICAN-ACADEMY; RETINAL TOXICITY; FORMATE KINETICS; 4-METHYLPYRAZOLE; HEMODIALYSIS; RATS	A 35-year-old man is brought to the emergency department by his wife after ingesting automobile antifreeze in an attempt at self-harm. On presentation, the patient is somnolent. He is afebrile and has a blood pressure of 126/72 mm Hg, a pulse rate of 102 beats per minute, and a respiratory rate of 24 breaths per minute. Pulse oximetry shows a hemoglobin saturation of 97% while the patient is breathing ambient air. His physical examination is normal except for tachypnea. His serum electrolyte profile and creatinine level are normal except for a serum carbon dioxide level of 17 mmol per liter. Arterial blood gas measurement reveals a pH of 7.30. Urinalysis shows microscopic hematuria and needle-shaped crystals typical of calcium oxalate. The patient's calculated serum osmolarity is 308 mOsm per liter, and his measured serum osmolality 395 mOsm per kilogram. A medical toxicologist recommends treatment with fomepizole. Subsequently, the patient's serum ethylene glycol concentration is determined to be 580 mg per deciliter (93.4 mmol per liter).	[Brent, Jeffrey] Toxicol Associates, Denver, CO USA		Brent, J (corresponding author), Univ Colorado, Hlth Sci Ctr, 2555 S Downing St,Suite 260, Denver, CO 80210 USA.	jeffrey.brent@ucdenver.edu						Anseeuw K, 2008, EUR J EMERG MED, V15, P107, DOI 10.1097/MEJ.0b013e3282f3c13b; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P537; Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415; BAUD FJ, 1986, J TOXICOL-CLIN TOXIC, V24, P463, DOI 10.3109/15563658608995388; Baum CR, 2000, PEDIATRICS, V106, P1489, DOI 10.1542/peds.106.6.1489; Benitez JG, 2000, J TOXICOL-CLIN TOXIC, V38, P795, DOI 10.1081/CLT-100102394; BENNETT IL, 1953, MEDICINE, V32, P431, DOI 10.1097/00005792-195312000-00002; BLACK KA, 1985, P NATL ACAD SCI USA, V82, P3854, DOI 10.1073/pnas.82.11.3854; BLOMSTRAND R, 1980, ARCH BIOCHEM BIOPHYS, V199, P591, DOI 10.1016/0003-9861(80)90317-3; Borron SW, 1999, LANCET, V354, P831; Boyer EW, 2001, PEDIATRICS, V107, P172, DOI 10.1542/peds.107.1.172; Brent J, 1999, NEW ENGL J MED, V340, P832, DOI 10.1056/NEJM199903183401102; Brent J, 2001, NEW ENGL J MED, V344, P424, DOI 10.1056/NEJM200102083440605; Bronstein AC, 2008, CLIN TOXICOL, V46, P927, DOI 10.1080/15563650802559632; Brown MJ, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.4.e77; Calello DP, 2007, PEDIATR EMERG CARE, V23, P82; Calello DP, 2006, PEDIATR EMERG CARE, V22, P523, DOI 10.1097/01.pec.0000227389.99508.a7; CHENG JT, 1987, J TOXICOL-CLIN TOXIC, V25, P95, DOI 10.3109/15563658708992616; CLAY KL, 1977, TOXICOL APPL PHARM, V39, P39, DOI 10.1016/0041-008X(77)90175-2; Corley RA, 2008, TOXICOL APPL PHARM, V228, P165, DOI 10.1016/j.taap.2007.11.024; Detaille Thierry, 2004, Pediatr Crit Care Med, V5, P490, DOI 10.1097/01.PCC.0000128600.17670.FF; Eells JT, 1996, TOXICOL APPL PHARM, V140, P58, DOI 10.1006/taap.1996.0197; Eells JT, 2000, NEUROTOXICOLOGY, V21, P321; GARNER CD, 1995, J TOXICOL ENV HEALTH, V44, P43, DOI 10.1080/15287399509531942; Guo CG, 2007, TOXICOL LETT, V173, P8, DOI 10.1016/j.toxlet.2007.06.010; Hantson P, 2002, Eur J Emerg Med, V9, P278, DOI 10.1097/00063110-200209000-00015; Harry P, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.3.e31; Hovda KE, 2008, HUM EXP TOXICOL, V27, P539, DOI 10.1177/0960327108095992; Hovda KE, 2005, CLIN NEPHROL, V64, P190; Hovda KE, 2005, CLIN TOXICOL, V43, P221, DOI 10.1081/CLT-200058936; INGEMANSSON SO, 1983, ACTA OPHTHALMOL, P1; JACOBSEN D, 1984, ACTA MED SCAND, V216, P409; JACOBSEN D, 1989, EUR J CLIN PHARMACOL, V37, P599; Jacobsen D, 1997, J TOXICOL-CLIN TOXIC, V35, P127, DOI 10.3109/15563659709001182; JACOBSEN D, 1990, Journal of Emergency Medicine, V8, P455, DOI 10.1016/0736-4679(90)90176-V; JACOBSEN D, 1988, ALCOHOL CLIN EXP RES, V12, P516, DOI 10.1111/j.1530-0277.1988.tb00235.x; JACOBSEN D, 2005, CRITICAL CARE TOXICO, P869; Jacobson D, 2005, CRITICAL CARE TOXICO, P895; Kerns W, 2002, J TOXICOL-CLIN TOXIC, V40, P137, DOI 10.1081/CLT-120004401; Lynd LD, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-5; Mbia JJE, 2002, AM J OPHTHALMOL, V134, P914, DOI 10.1016/S0002-9394(02)01798-1; MCMARTIN KE, 1984, J TOXICOL-CLIN TOXIC, V22, P133, DOI 10.3109/15563658408992549; MCMARTIN KE, 1980, ARCH BIOCHEM BIOPHYS, V199, P606, DOI 10.1016/0003-9861(80)90318-5; Megarbane B, 2001, INTENS CARE MED, V27, P1370, DOI 10.1007/s001340101011; Moreau CL, 1998, J TOXICOL-CLIN TOXIC, V36, P659, DOI 10.3109/15563659809162613; Poldelski V, 2001, AM J KIDNEY DIS, V38, P339, DOI 10.1053/ajkd.2001.26099; Sivilotti MLA, 2009, ANN EMERG MED, V53, P451, DOI 10.1016/j.annemergmed.2008.07.038; Sivilotti MLA, 2001, J TOXICOL-CLIN TOXIC, V39, P627, DOI 10.1081/CLT-100108496; WU DF, 1993, J PHARMACOL EXP THER, V264, P1468; ZITTOUN J, 1993, EUR J CLIN PHARMACOL, V44, P569, DOI 10.1007/BF02440861	50	118	126	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2216	2223		10.1056/NEJMct0806112	http://dx.doi.org/10.1056/NEJMct0806112			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458366				2022-12-28	WOS:000266206000008
J	Starzl, TE; Barker, C				Starzl, Thomas E.; Barker, Clyde			The Origin of Clinical Organ Transplantation Revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HUMAN-KIDNEY; SUCCESSFUL HOMOTRANSPLANTATION; SKIN HOMOGRAFTS; BONE-MARROW; TOLERANCE; EXPERIENCE; RADIATION; REJECTION; MIGRATION; CELLS		[Starzl, Thomas E.] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA; [Barker, Clyde] Univ Penn, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania	Starzl, TE (corresponding author), UPMC Montefiore, 7th Floor S,3459 5th Ave, Pittsburgh, PA 15213 USA.	mangantl@upmc.edu			NIDDK NIH HHS [R01 DK029961-19] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029961] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARKER CF, 1968, J EXP MED, V128, P197, DOI 10.1084/jem.128.1.197; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; CALNE R. Y., 1961, TRANSPLANTATION BULL, V28, P65; HAMBURGER J, 1962, AM J MED, V32, P854, DOI 10.1016/0002-9343(62)90032-3; KUSS R, 1962, POSTGRAD MED J, V38, P528, DOI 10.1136/pgmj.38.443.528; MAIN JM, 1955, J NATL CANCER I, V15, P1023; MERRILL JP, 1956, JAMA-J AM MED ASSOC, V160, P277, DOI 10.1001/jama.1956.02960390027008; MERRILL JP, 1960, NEW ENGL J MED, V262, P1251, DOI 10.1056/NEJM196006232622501; MURRAY JE, 1963, NEW ENGL J MED, V268, P1315, DOI 10.1056/NEJM196306132682401; PRZEPIORKA D, 1991, AM J CLIN PATHOL, V95, P201, DOI 10.1093/ajcp/95.2.201; SCHWARTZ R, 1959, NATURE, V183, P1682, DOI 10.1038/1831682a0; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P385; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; Starzl TE, 1998, NEW ENGL J MED, V339, P1905, DOI 10.1056/NEJM199812243392607; ZINKERNAGEL RM, 1993, IMMUNOL REV, V133, P199, DOI 10.1111/j.1600-065X.1993.tb01517.x	15	6	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					2041	2043		10.1001/jama.2009.644	http://dx.doi.org/10.1001/jama.2009.644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454644	Green Accepted			2022-12-28	WOS:000266159600030
J	Marengo, MS; Garcia-Blanco, MA				Marengo, Matthew S.; Garcia-Blanco, Mariano A.			Shedding UV Light on Alternative Splicing	CELL			English	Editorial Material							DNA-DAMAGE; MESSENGER-RNA; PHOSPHORYLATION; ATM		[Marengo, Matthew S.; Garcia-Blanco, Mariano A.] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA; [Marengo, Matthew S.; Garcia-Blanco, Mariano A.] Duke Univ, Ctr RNA Biol, Med Ctr, Durham, NC 27710 USA; [Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Marengo, MS (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA.	matt.marengo@duke.edu; garci001@mc.duke.edu						Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kim HS, 2006, CANCER RES, V66, P4561, DOI 10.1158/0008-5472.CAN-05-3629; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006	9	3	3	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					600	602		10.1016/j.cell.2009.04.054	http://dx.doi.org/10.1016/j.cell.2009.04.054			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450507	Bronze			2022-12-28	WOS:000266114100007
J	North, TE; Goessling, W; Peeters, M; Li, PL; Ceol, C; Lord, AM; Weber, GJ; Harris, J; Cutting, CC; Huang, P; Dzierzak, E; Zon, LI				North, Trista E.; Goessling, Wolfram; Peeters, Marian; Li, Pulin; Ceol, Craig; Lord, Allegra M.; Weber, Gerhard J.; Harris, James; Cutting, Claire C.; Huang, Paul; Dzierzak, Elaine; Zon, Leonard I.			Hematopoietic Stem Cell Development Is Dependent on Blood Flow	CELL			English	Article							NITRIC-OXIDE SYNTHASE; BETA-CATENIN; MOUSE; EXPRESSION; GENE; DISRUPTION; MIGRATION; EMBRYO; DIFFERENTIATION; ACTIVATION	During vertebrate embryogenesis, hematopoietic stem cells (HSCs) arise in the aorta-gonads-mesonephros (AGM) region. We report here that blood flow is a conserved regulator of HSC formation. In zebrafish, chemical blood flow modulators regulated HSC development, and silent heart (sih) embryos, lacking a heartbeat and blood circulation, exhibited severely reduced HSCs. Flow-modifying compounds primarily affected HSC induction after the onset of heartbeat; however, nitric oxide (NO) donors regulated HSC number even when treatment occurred before the initiation of circulation, and rescued HSCs in sih mutants. Morpholino knockdown of nos1 (nnos/enos) blocked HSC development, and its requirement was shown to be cell autonomous. In the mouse, Nos3 (eNos) was expressed in HSCs in the AGM. Intrauterine Nos inhibition or embryonic Nos3 deficiency resulted in a reduction of hematopoietic clusters and transplantable murine HSCs. This work links blood flow to AGM hematopoiesis and identifies NO as a conserved downstream regulator of HSC development.	[North, Trista E.; Goessling, Wolfram; Li, Pulin; Ceol, Craig; Lord, Allegra M.; Weber, Gerhard J.; Zon, Leonard I.] Harvard Univ, Sch Med, Stem Cell Program & Hematol Oncol, Childrens Hosp,Howard Hughes Med Inst,Harvard Ste, Boston, MA 02115 USA; [North, Trista E.; Harris, James] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Goessling, Wolfram; Cutting, Claire C.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Goessling, Wolfram] Dana Farber Canc Inst, Boston, MA 02115 USA; [Peeters, Marian; Dzierzak, Elaine] Erasmus MC, Erasmus Stem Cell Inst, NL-3000 DR Rotterdam, Netherlands; [Huang, Paul] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital	Zon, LI (corresponding author), Harvard Univ, Sch Med, Stem Cell Program & Hematol Oncol, Childrens Hosp,Howard Hughes Med Inst,Harvard Ste, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	North, Trista/ABG-4789-2020	North, Trista/0000-0003-1249-563X; Goessling, Wolfram/0000-0001-9972-1569; Li, Pulin/0000-0002-8525-4936; Huang, Paul/0000-0002-5436-8658; Harris, James/0000-0002-8995-8324	National Institutes of Health; Netherlands Besluit Subsidies Investeringen Kennisinfrastructuur; Howard Hughes Medical Institute investigator; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Besluit Subsidies Investeringen Kennisinfrastructuur; Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Lin and J. Loscalzo for helpful suggestions, D. Atochin for assistance with Nos knockout mice, and W. Davis for technical support with spinning- disk confocal microscopy. We thank K. R. Kopani, J. Ojeda, and A. Meyers for technical assistance with the zebrafish HSC screen. This work was supported by the National Institutes of Health (T. E. N., W. G., E. D., and L. I. Z) and a Netherlands Besluit Subsidies Investeringen Kennisinfrastructuur award (E. D.). L. I. Z. is a Howard Hughes Medical Institute investigator.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Burggren WW, 2004, PHYSIOL BIOCHEM ZOOL, V77, P333, DOI 10.1086/422230; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; DOWNING JR, 1993, BLOOD, V81, P2860; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Duran-Reyes G, 1999, LIFE SCI, V65, P2259, DOI 10.1016/S0024-3205(99)00491-9; Dzierzak E, 2008, DEVELOPMENT, V135, P2343, DOI 10.1242/dev.021279; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Eddy FB, 2005, COMP BIOCHEM PHYS A, V142, P221, DOI 10.1016/j.cbpb.2005.05.038; Epperly MW, 2007, EXP HEMATOL, V35, P137, DOI 10.1016/j.exphem.2006.09.009; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Holmqvist B, 2004, J EXP BIOL, V207, P923, DOI 10.1242/jeb.00845; Ishimura N, 2005, GASTROENTEROLOGY, V128, P1354, DOI 10.1053/j.gastro.2005.01.055; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jin H, 2009, DEVELOPMENT, V136, P647, DOI 10.1242/dev.029637; Krasnov P, 2008, MOL MED, V14, P141, DOI 10.2119/2007-00011.Krasnov; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Michurina T, 2004, MOL THER, V10, P241, DOI 10.1016/j.ymthe.2004.05.030; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nath AK, 2004, DEVELOPMENT, V131, P2485, DOI 10.1242/dev.01131; Noiri E, 1998, AM J PHYSIOL-CELL PH, V274, pC236, DOI 10.1152/ajpcell.1998.274.1.C236; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Pallares P, 2008, REPRODUCTION, V136, P573, DOI 10.1530/REP-08-0272; Pelster B, 2005, COMP BIOCHEM PHYS A, V142, P215, DOI 10.1016/j.cbpb.2005.05.036; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Poon KL, 2003, GENE EXPR PATTERNS, V3, P463, DOI 10.1016/S1567-133X(03)00063-2; Prevotat L, 2006, GASTROENTEROLOGY, V131, P1142, DOI 10.1053/j.gastro.2006.07.017; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Teichert AM, 2008, CIRC RES, V103, P24, DOI 10.1161/CIRCRESAHA.107.168567; van Haperen R, 2003, AM J PATHOL, V163, P1677, DOI 10.1016/S0002-9440(10)63524-9; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128	51	327	340	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					736	748		10.1016/j.cell.2009.04.023	http://dx.doi.org/10.1016/j.cell.2009.04.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450519	Green Accepted, Bronze			2022-12-28	WOS:000266114100021
J	Kotton, CN; Elias, N; Delmonico, FL; Kradin, RL				Kotton, Camille N.; Elias, Nahel; Delmonico, Francis L.; Kradin, Richard L.			A Man with Coma after Cardiac Arrest Intestinal schistosomiasis in a brain-dead organ donor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIVER-TRANSPLANTATION; TRANSMISSION; VIRUS; HISTORY; DISEASE; GRAFT		[Kotton, Camille N.] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; [Elias, Nahel] Massachusetts Gen Hosp, Dept Transplant Surg, Boston, MA 02114 USA; [Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Delmonico, Francis L.] New England Organ Bank Inc, Newton, MA USA; [Kotton, Camille N.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Elias, Nahel; Delmonico, Francis L.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kotton, CN (corresponding author), Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA.		Elias, Nahel/AAO-8344-2020	Elias, Nahel/0000-0001-6466-7347; Kotton, Camille/0000-0001-7320-2234				CDC-Centers for Disease Control and Prevention, 1994, MMWR RECOMM REP, V43, P1; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; HELLENBRAND W, 2005, EURO SURVEILL, V10; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Kauffman HM, 2001, TRANSPL P, V33, P1844, DOI 10.1016/S0041-1345(00)02703-2; Kayler LK, 2003, TRANSPLANT P, V35, P2974, DOI 10.1016/j.transproceed.2003.10.065; Lapierre V, 2005, NEW ENGL J MED, V352, P2552; Mahmoud KM, 2001, NEPHROL DIAL TRANSPL, V16, P2214, DOI 10.1093/ndt/16.11.2214; Mascola L., 2006, Morbidity and Mortality Weekly Report, V55, P798; Pannegeon V, 2005, TRANSPLANTATION, V80, P287, DOI 10.1097/01.TP.0000158429.94014.B5; Pungpapong S, 2006, LIVER TRANSPLANT, V12, P310, DOI 10.1002/lt.20641; SIMONDS RJ, 1992, NEW ENGL J MED, V326, P726, DOI 10.1056/NEJM199203123261102; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; 2002, MMWR MORB MORTAL WKL, V51, P210	15	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2118	2125		10.1056/NEJMcpc0806982	http://dx.doi.org/10.1056/NEJMcpc0806982			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439747				2022-12-28	WOS:000266011200012
J	Oberlander, J				Oberlander, Jonathan			Picking the Right Poison - Options for Funding Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TAXES		[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Russell Sage Fdn, New York, NY USA.							Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Congressional Budget Office, 2008, BUDG OPT, V1; Marmor T, 2009, ANN INTERN MED, V150, P485, DOI 10.7326/0003-4819-150-7-200904070-00114; Oberlander J, 2008, HEALTH AFFAIR, V27, pW544, DOI 10.1377/hlthaff.27.6.w544; [No title captured]	5	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2045	2048		10.1056/NEJMp0903282	http://dx.doi.org/10.1056/NEJMp0903282			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	444WN	19439738				2022-12-28	WOS:000266011200001
J	Zhang, ZX; Xu, N; Chen, DTN; Yunker, P; Alsayed, AM; Aptowicz, KB; Habdas, P; Liu, AJ; Nagel, SR; Yodh, AG				Zhang, Zexin; Xu, Ning; Chen, Daniel T. N.; Yunker, Peter; Alsayed, Ahmed M.; Aptowicz, Kevin B.; Habdas, Piotr; Liu, Andrea J.; Nagel, Sidney R.; Yodh, Arjun G.			Thermal vestige of the zero-temperature jamming transition	NATURE			English	Article							COLLOIDAL CRYSTALS; VIDEO MICROSCOPY; GLASS-TRANSITION; SUSPENSIONS; RELAXATION; PARTICLES; DYNAMICS; MIXTURE	When the packing fraction is increased sufficiently, loose particulates jam to form a rigid solid in which the constituents are no longer free to move. In typical granular materials and foams, the thermal energy is too small to produce structural rearrangements. In this zero-temperature (T = 0) limit, multiple diverging(1-8) and vanishing(2,9,10) length scales characterize the approach to a sharp jamming transition. However, because thermal motion becomes relevant when the particles are small enough, it is imperative to understand how these length scales evolve as the temperature is increased. Here we used both colloidal experiments and computer simulations to progress beyond the zero-temperature limit to track one of the key parameters-the overlap distance between neighbouring particles-which vanishes at the T = 0 jamming transition. We find that this structural feature retains a vestige of its T = 0 behaviour and evolves in an unusual manner, which has masked its appearance until now. It is evident as a function of packing fraction at fixed temperature, but not as a function of temperature at fixed packing fraction or pressure. Our results conclusively demonstrate that length scales associated with the T = 0 jamming transition persist in thermal systems, not only in simulations but also in laboratory experiments.	[Zhang, Zexin; Xu, Ning; Chen, Daniel T. N.; Yunker, Peter; Alsayed, Ahmed M.; Liu, Andrea J.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Xu, Ning; Nagel, Sidney R.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Aptowicz, Kevin B.] W Chester Univ, Dept Phys, W Chester, PA 19383 USA; [Habdas, Piotr] St Josephs Univ, Dept Phys, Philadelphia, PA 19131 USA	University of Pennsylvania; University of Chicago; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; Saint Joseph's University	Zhang, ZX (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	zexin@sas.upenn.edu; ningxu@sas.upenn.edu	Liu, Andrea/GYD-4759-2022; Zhang, Zexin/B-1005-2009; Xu, Ning/C-4264-2013; ZHANG, Zexin/AAU-2833-2021; Liu, Andrea J/K-3968-2017; Xu, Ning/F-8181-2014	Liu, Andrea/0000-0002-2295-2729; Zhang, Zexin/0000-0002-4963-5002; Xu, Ning/0000-0002-1905-8558; ZHANG, Zexin/0000-0002-4963-5002; Liu, Andrea J/0000-0002-2295-2729; Xu, Ning/0000-0002-1905-8558; Yunker, Peter/0000-0001-8471-4171	Department of Energy; National Science Foundation [DE-FG02-05ER46199, DE-FG02-03ER46088]; University of Chicago MRSEC [DMR-0820054, DMR-080488]; PENN MRSEC [DMR-0520020]; Rhodia; Teraport computer cluster at the University of Chicago	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); University of Chicago MRSEC(National Science Foundation (NSF)); PENN MRSEC(National Science Foundation (NSF)); Rhodia; Teraport computer cluster at the University of Chicago(University of Chicago)	We thank T. Lubensky, D. Durian and K. Chen for discussions and a critical reading of the manuscript. We acknowledge the financial support of the Department of Energy and the National Science Foundation: DE-FG02-05ER46199 (A.J.L.,N.X.), DE-FG02-03ER46088 (S.R.N.,N.X.), the University of Chicago MRSEC DMR-0820054 (S.R.N.,N.X.), DMR-080488 (A.G.Y.), and the PENN MRSEC DMR-0520020 ( A.G.Y.,A.J.L.,Z.Z.). Z.Z. gratefully acknowledges partial support from Rhodia. Finally, we acknowledge the support of the Teraport computer cluster at the University of Chicago.	Abate AR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031308; Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; BUSSE LE, 1981, PHYS REV LETT, V47, P1848, DOI 10.1103/PhysRevLett.47.1848; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Donev A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011105; Drocco JA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.088001; Durian DJ, 1995, PHYS REV LETT, V75, P4780, DOI 10.1103/PhysRevLett.75.4780; Ellenbroek WG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258001; Han Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041406; Han YL, 2008, NATURE, V456, P898, DOI 10.1038/nature07595; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; KOB W, 1995, PHYS REV E, V51, P4626, DOI 10.1103/PhysRevE.51.4626; Lacevic N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.030101; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Lyon LA, 2004, J PHYS CHEM B, V108, P19099, DOI 10.1021/jp048486j; Murray CA, 1996, ANNU REV PHYS CHEM, V47, P421, DOI 10.1146/annurev.physchem.47.1.421; O'Hern CS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011306; O'Hern CS, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.075507; Olsson P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.178001; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; Perera DN, 1999, J CHEM PHYS, V111, P5441, DOI 10.1063/1.479804; Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2; Senff H, 1999, J CHEM PHYS, V111, P1705, DOI 10.1063/1.479430; Silbert LE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098301; Silbert LE, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041304; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Wu JZ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.048304; Wyart M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051306; Xu N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.038001	30	215	221	1	96	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					230	233		10.1038/nature07998	http://dx.doi.org/10.1038/nature07998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444211				2022-12-28	WOS:000266036100036
J	Baron, RJ				Baron, Richard J.			The Chasm Between Intention and Achievement in Primary Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NATIONAL-SURVEY		[Baron, Richard J.] Greenhouse Internists, Philadelphia, PA USA		Baron, RJ (corresponding author), 345 E Mt Airy Ave, Philadelphia, PA 19119 USA.	rbaron@greenhouseinternists.com						[Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; Baron RJ, 2008, JAMA-J AM MED ASSOC, V299, P1595, DOI 10.1001/jama.299.13.1595; Baron RJ, 2007, ANN INTERN MED, V147, P549, DOI 10.7326/0003-4819-147-8-200710160-00007; Baron RJ, 2004, ANN INTERN MED, V140, P659, DOI 10.7326/0003-4819-140-8-200404200-00015; Berenson RA, 2008, HEALTH AFFAIR, V27, P1219, DOI 10.1377/hlthaff.27.5.1219; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; Lipner RS, 2006, ANN INTERN MED, V144, P29, DOI 10.7326/0003-4819-144-1-200601030-00007; PELLEGRINO ED, 1981, PHILOS BASIS MED PRA, P71; *R GRAH CTR, PAT CTR MED HOM HIST; Reuben DB, 2007, AM J MED, V120, P99, DOI 10.1016/j.amjmed.2006.10.019; Singer N., NY TIMES	13	15	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1922	1924		10.1001/jama.2009.558	http://dx.doi.org/10.1001/jama.2009.558			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444JX	19436020				2022-12-28	WOS:000265978400031
J	Saxton, JF; Johns, MME				Saxton, Jonathan F.; Johns, Michael M. E.			Grow the US National Health Service Corps	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Johns, Michael M. E.] Emory Univ, Dept Otolaryngol, Atlanta, GA 30308 USA; [Saxton, Jonathan F.] Isaacson Miller Inc, Boston, MA USA	Emory University	Johns, MME (corresponding author), Emory Univ, Dept Otolaryngol, 550 Peachtree St,9th Floor,Ste 4400, Atlanta, GA 30308 USA.	mmejohns@emory.edu						*ASS AM MED COLL, 2008, AAMC DAT BOOK MED SC; Baron RJ, 2008, JAMA-J AM MED ASSOC, V299, P1595, DOI 10.1001/jama.299.13.1595; *BLUE RIDG AC HLTH, PROM VAL EXP COV GOO; Fischer JE, 2007, JAMA-J AM MED ASSOC, V298, P2191, DOI 10.1001/jama.298.18.2191; JOHNS MME, 1993, JAMA-J AM MED ASSOC, V269, P3156, DOI 10.1001/jama.269.24.3156; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; *WHO, FACTS REL CHRON DIS	7	6	6	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1925	1926		10.1001/jama.2009.660	http://dx.doi.org/10.1001/jama.2009.660			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444JX	19436021				2022-12-28	WOS:000265978400032
J	Martin, SG; Berthelot-Grosjean, M				Martin, Sophie G.; Berthelot-Grosjean, Martine			Polar gradients of the DYRK-family kinase Pom1 couple cell length with the cell cycle	NATURE			English	Article							NIM1/CDR1 MITOTIC INDUCER; DUAL-SPECIFICITY KINASE; FISSION YEAST; PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; NEGATIVE REGULATION; DIVISION PLANE; GROWTH; WEE1; PHOSPHORYLATION	Cells normally grow to a certain size before they enter mitosis and divide. Entry into mitosis depends on the activity of Cdk1, which is inhibited by the Wee1 kinase and activated by the Cdc25 phosphatase(1). However, how cells sense their size for mitotic commitment remains unknown. Here we show that an intracellular gradient of the dual-specificity tyrosine-phosphorylation regulated kinase (DYRK) Pom1, which emanates from the ends of rod-shaped Schizosaccharomyces pombe cells, serves to measure cell length and control mitotic entry. Pom1 provides positional information both for polarized growth and to inhibit cell division at cell ends(2-5). We discovered that Pom1 is also a dose-dependent G2-M inhibitor. Genetic analyses indicate that Pom1 negatively regulates Cdr1 and Cdr2, two previously described Wee1 inhibitors of the SAD kinase family(6-10). This inhibition may be direct, because in vivo and in vitro evidence suggest that Pom1 phosphorylates Cdr2. Whereas Cdr1 and Cdr2 localize to a medial cortical region, Pom1 forms concentration gradients from cell tips that overlap with Cdr1 and Cdr2 in short cells, but not in long cells. Disturbing these Pom1 gradients leads to Cdr2 phosphorylation and imposes a G2 delay. In short cells, Pom1 prevents precocious M-phase entry, suggesting that the higher medial Pom1 levels inhibit Cdr2 and promote a G2 delay. Thus, gradients of Pom1 from cell ends provide a measure of cell length to regulate M-phase entry.	[Martin, Sophie G.; Berthelot-Grosjean, Martine] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Lausanne	Martin, SG (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Genopode Bldg, CH-1015 Lausanne, Switzerland.	Sophie.Martin@unil.ch	Martin, Sophie/AAE-3198-2019	Martin, Sophie/0000-0002-5317-2557; Berthelot-Grosjean, Martine/0000-0002-7168-2622	Swiss National Science Foundation Professorship [PP00A-114936]; Human Frontiers Science Program Career Development Award [CDA0016/2008]	Swiss National Science Foundation Professorship(Swiss National Science Foundation (SNSF)); Human Frontiers Science Program Career Development Award(Human Frontier Science Program)	We wish to thank J. Bahler, F. Chang, P. Cruz, K. Gull, I. Hagan, P. Russell, K. Shiozaki and V. Simanis for strains and reagents. We thank R. Benton, F. Chang, C. Fankhauser, N. Hernandez and F. Bendezu for critical reading of the manuscript. We also wish to thank J. Moseley and P. Nurse for open discussion before publication. Research in the laboratory of S. G. M. is supported by a Swiss National Science Foundation Professorship grant (PP00A-114936) and a Human Frontiers Science Program Career Development Award (CDA0016/2008).	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Souza GM, 1998, DEVELOPMENT, V125, P2291; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0; Wu L, 1997, EMBO J, V16, P1342, DOI 10.1093/emboj/16.6.1342	32	227	229	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 11	2009	459	7248					852	U7		10.1038/nature08054	http://dx.doi.org/10.1038/nature08054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19474792				2022-12-28	WOS:000267084500041
J	Renton, B				Renton, Bryan			Picture quiz The tired patient	BRITISH MEDICAL JOURNAL			English	Editorial Material									Warrington Hosp, Warrington WA5 1QG, Cheshire, England		Renton, B (corresponding author), Warrington Hosp, Lovely Lane, Warrington WA5 1QG, Cheshire, England.	bjrenton@doctors.net.uk						KLABLUNDE R, CARDIOVASCULAR PHARM; Slovis C, 2002, BRIT MED J, V324, P1320, DOI 10.1136/bmj.324.7349.1320; YASEEN S, EMEDICINE	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 3	2009	338								b1623	10.1136/bmj.b1623	http://dx.doi.org/10.1136/bmj.b1623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AG	19493949				2022-12-28	WOS:000266726300002
J	Clawson, D				Clawson, Dan			Tenure and the Future of the University	SCIENCE			English	Editorial Material									Univ Massachusetts, Dept Sociol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Clawson, D (corresponding author), Univ Massachusetts, Dept Sociol, Amherst, MA 01003 USA.	clawson@sadri.umass.edu						American Association of University Professors (AAUP), 1970, 1940 STAT PRINC AC F; Brint Steven, 1996, AGE EXPERTS CHANGING, DOI DOI 10.1515/9780691214535; CARLIN JF, 1999, CHRONICLE HIGHE 1105, pA76; Chait Richard, 2002, QUESTIONS TENURE; Clawson D, 2008, EQUITY EXCELL EDUC, V41, P12, DOI 10.1080/10665680701776241; CLOTFELTER CT, 2002, QUESTIONS TENURE; Eagan M. K., 2008, NEW DIRECTIONS TEACH, V115, P39, DOI DOI 10.1002/TL.324; Freidson E., 2001, PROFESSIONALISM 3 LO; GROSS B, 2008, COMMUNITY COLL TRANS; IMMERWAHR J, 1999, TAKING RESPONSIBILIT; Kennedy Donald, 1997, ACAD DUTY, P131; King J.E., 2008, PATHWAY PRESIDENCY C; KIRP D, 2003, SHAKESPEARE; *NAT ED ASS, 2007, UPDATE, V11, P1; National Center for Educational Statistics, 2007, DIGEST ED STAT; *NCES, 2004, 2004 NAT STUD POSTS; *NCES, 2007, EMPL POSTS I; Noble D., 2002, DIGITAL DIPLOMA MILL; Taylor Mark, 2009, NY TIMES        0427, pa23; United States Census Bureau, 2009, STAT ABSTR US 2009; *US BUR CENS, 1980, STAT ABSTR US 1981; *US DEP ED, 1972, DIG ED STAT	22	21	21	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1147	1148		10.1126/science.1172995	http://dx.doi.org/10.1126/science.1172995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	450OG	19478168	Green Submitted			2022-12-28	WOS:000266410100027
J	Arculus, R; Campbell, IH; McLennan, SM; Taylor, SR				Arculus, Richard; Campbell, Ian H.; McLennan, Scott M.; Taylor, Stuart Ross			Asteroids and andesites	NATURE			English	Letter									[Arculus, Richard; Campbell, Ian H.; Taylor, Stuart Ross] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [McLennan, Scott M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	Australian National University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Arculus, R (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	Ross.Taylor@anu.edu.au	McDonough, William F/I-7720-2012; Campbell, Ian/A-4941-2008	McDonough, William F/0000-0001-9154-3673; Campbell, Ian/0000-0001-8578-0154; McLennan, Scott/0000-0003-4259-7178; Arculus, Richard/0000-0002-3432-392X				Day JMD, 2009, NATURE, V457, P179, DOI 10.1038/nature07651; MITTLEFEHLDT DW, 1988, LUNAR PLANET SCI, V19; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1	3	6	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					E1	E1		10.1038/nature08077	http://dx.doi.org/10.1038/nature08077			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478728	Bronze			2022-12-28	WOS:000266370500027
J	Chan, JCN; Malik, V; Jia, WP; Kadowaki, T; Yajnik, CS; Yoon, KH; Hu, FB				Chan, Juliana C. N.; Malik, Vasanti; Jia, Weiping; Kadowaki, Takashi; Yajnik, Chittaranjan S.; Yoon, Kun-Ho; Hu, Frank B.			Diabetes in Asia Epidemiology, Risk Factors, and Pathophysiology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMPAIRED GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; HONG-KONG CHINESE; BODY-MASS INDEX; LIFE-STYLE INTERVENTION; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; BETA-CELL FUNCTION; METABOLIC-SYNDROME	Context With increasing globalization and East-West exchanges, the increasing epidemic of type 2 diabetes in Asia has far-reaching public health and socioeconomic implications. Objective To review recent data in epidemiologic trends, risk factors, and complications of type 2 diabetes in Asia. Evidence Acquisition Search of MEDLINE using the term diabetes and other relevant keywords to identify meta-analyses, systematic reviews, large surveys, and cohort studies. Separate searches were performed for specific Asian countries. The review was limited to English-language articles published between January 1980 and March 2009; publications on type 1 diabetes were excluded. Evidence Synthesis The prevalence of diabetes in Asian populations has increased rapidly in recent decades. In 2007, more than 110 million individuals in Asia were living with diabetes, with a disproportionate burden among the young and middle aged. Similarly, rates of overweight and obesity are increasing sharply, driven by economic development, nutrition transition, and increasingly sedentary lifestyles. The "metabolically obese" phenotype (ie, normal body weight with increased abdominal adiposity) is common in Asian populations. The increased risk of gestational diabetes, combined with exposure to poor nutrition in utero and overnutrition in later life in some populations, may contribute to the increasing diabetes epidemic through "diabetes begetting diabetes" in Asia. While young age of onset and long disease duration place Asian patients with diabetes at high risk for cardiorenal complications, cancer is emerging as an important cause of morbidity and mortality. Conclusions Type 2 diabetes is an increasing epidemic in Asia, characterized by rapid rates of increase over short periods and onset at a relatively young age and low body mass index. Prevention and control of diabetes should be a top public health priority in Asian populations. JAMA. 2009;301(20):2129-2140 www.jama.com	[Chan, Juliana C. N.] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Dept Med, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Malik, Vasanti; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Malik, Vasanti; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Malik, Vasanti; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Malik, Vasanti; Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo, Japan; [Yajnik, Chittaranjan S.] KEM Hosp Res Ctr, Diabet Unit, Pune, Maharashtra, India; [Yoon, Kun-Ho] Catholic Univ Korea, Seoul St Marys Hosp, Dept Endocrinol & Metab, Seoul, South Korea	Chinese University of Hong Kong; Chinese University of Hong Kong; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Shanghai Jiao Tong University; University of Tokyo; Catholic University of Korea; Seoul St. Mary's Hospital	Chan, JCN (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	jchan@cuhk.edu.hk; frank.hu@channing.harvard.edu	Kumar, Vivek/H-8538-2013; Sharma, Vishal/B-9729-2011; Chan, Juliana/B-7918-2016	Sharma, Vishal/0000-0003-2472-3409; Chan, Juliana/0000-0003-1325-1194	AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi-Sankyo; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp Dohme; Novo Nordisk; Pfizer; Roche; sanofiaventis	AstraZeneca(AstraZeneca); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi-Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Merck Serono(Merck & Company); Merck Sharp Dohme(Merck & Company); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); sanofiaventis(Sanofi-Aventis)	Dr Chan reported receiving research funding or speakers' honoraria from AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Lilly, Merck Serono, Merck Sharp & Dohme, Novo Nordisk, Pfizer, Roche, and sanofiaventis; serving as a member of the advisory boards, and/or speaker forums, and/or steering committees of international projects sponsored by AstraZeneca, Bayer, Lilly, and Merck Sharp & Dohme; with her group and on behalf of the Chinese University of Hong Kong, filing a patent application to use genetic markers to predict risk of diabetes and diabetic kidney disease in Chinese populations; and, in a technology transfer project, establishing a university-affiliated diabetes center (Qualigenics) to deliver a multidisciplinary chronic care program in the community ( all related revenues and proceeds go to the Chinese University of Hong Kong to support ongoing research and development in diabetes). Dr Kadowaki reported receiving research funding or speakers' honoraria from Takeda, Daiichi-Sankyo, Astellas, Ono, Dainippon Sumitomo, sanofi-aventis, Novo Nordisk, Novartis, and Lilly and serving as a member of the advisory board of Daiichi-Sankyo, Ono, Merck, Lilly, sanofi-aventis, Novo Nordisk, and Novartis ( all funds go to the University of Tokyo to support ongoing research and development in diabetes). Dr Yoon reported serving as a member of the steering committees, and/or advisory boards, and/or speaker forums of Merck Sharp & Dohme, GlaxoSmithKline, Lilly, Merck Serono, Novartis, and Choongwae Korea on diabetes- related subjects; serving as an investigator on clinical trials supported by AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Merck Sharp & Dohme, Lilly, sanofi-aventis, GlaxoSmithKline, Roche, CJ Pharmaceutical, and CW Korea; with his team and on behalf of the Catholic University of Korea, filing a patent application to use various Web-based diabetes management programs and intracellular miRNA targets to improve beta cell function in patients with diabetes; and, in a technology project, working with his team to establish a university-affiliated institute for ubiquitous health care and a joint venture company called C & I Healthcare to use protocol-driven care delivered through Internet and mobile communications to improve diabetes care in the community. Dr Hu reported receiving research funding from Merck, Unilever, and the California Walnut Commission and receiving payment or honoraria for presentations at academic conferences supported by Novartis and Novo Nordisk. Mr Malik, Dr Jia, and Dr Yajnik reported no financial disclosures.	AbuSayeed M, 1997, DIABETES RES CLIN PR, V34, P149, DOI 10.1016/S0168-8227(96)01337-X; Aekplakorn W, 2003, DIABETES CARE, V26, P2758, DOI 10.2337/diacare.26.10.2758; Aekplakorn W, 2007, DIABETES CARE, V30, P2007, DOI 10.2337/dc06-2319; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Alberti K. G., 1999, DEFINITION DIAGNOSIS; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Baltazar JC, 2004, DIABETES RES CLIN PR, V64, P107, DOI 10.1016/j.diabres.2003.10.013; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bonovas S, 2004, DIABETOLOGIA, V47, P1071, DOI 10.1007/s00125-004-1415-6; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; CHAN JC, DIABETES CA IN PRESS; CHAN JCN, 1995, DIABETES CARE, V18, P1013, DOI 10.2337/diacare.18.7.1013; Chan Juliana C N, 2003, Curr Diab Rep, V3, P101, DOI 10.1007/s11892-003-0032-y; Chan WB, 2004, DIABETIC MED, V21, P349, DOI 10.1111/j.1464-5491.2004.01158.x; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Chen CJ, 2007, TOXICOL APPL PHARM, V222, P298, DOI 10.1016/j.taap.2006.12.032; Chen CC, 2008, METABOLISM, V57, P544, DOI 10.1016/j.metabol.2007.11.018; Chen FE, 2000, NEW ENGL J MED, V343, P544, DOI 10.1056/NEJM200008243430804; Cheng AYS, 2006, DIABETOLOGIA, V49, P1777, DOI 10.1007/s00125-006-0294-4; CHENG TO, 1995, BRIT MED J, V310, P61, DOI 10.1136/bmj.310.6971.61a; Chern JPS, 2001, DIABETES CARE, V24, P850, DOI 10.2337/diacare.24.5.850; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Cho NH, 2007, DIABETES CARE, V30, P2566, DOI 10.2337/dc07-0106; Choi YJ, 2006, DIABETES RES CLIN PR, V74, P295, DOI 10.1016/j.diabres.2006.03.029; CHOU P, 1992, DIABETES CARE, V15, P81, DOI 10.2337/diacare.15.1.81; COCKRAM CS, 1993, DIABETES RES CLIN PR, V21, P67, DOI 10.1016/0168-8227(93)90099-Q; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Dandona Paresh, 2008, Curr Mol Med, V8, P816, DOI 10.2174/156652408786733658; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dickinson S, 2002, J NUTR, V132, P2574, DOI 10.1093/jn/132.9.2574; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; FERNANDO DJS, 1994, POSTGRAD MED J, V70, P347, DOI 10.1136/pgmj.70.823.347; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Fujiyoshi PT, 2006, ENVIRON HEALTH PERSP, V114, P1677, DOI 10.1289/ehp.9262; Fukushima M, 2004, METABOLISM, V53, P831, DOI 10.1016/j.metabol.2004.02.012; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Grossmann M, 2009, CLIN ENDOCRINOL, V70, P547, DOI 10.1111/j.1365-2265.2008.03357.x; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Haag M, 2005, MED SCI MONITOR, V11, pRA359; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; *INT DIAB FED, 2006, DIAB ATL; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kabir Z, 2007, LANCET, V370, P134, DOI 10.1016/S0140-6736(07)61085-X; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Kim DM, 2005, OBES REV, V6, P117, DOI 10.1111/j.1467-789X.2005.00173.x; Kim Do-Hyoung, 2007, Korean Journal of Internal Medicine, V22, P186; Kim HM, 2006, AM J EPIDEMIOL, V164, P787, DOI 10.1093/aje/kwj251; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; KITAZAWA Y, 1983, Tohoku Journal of Experimental Medicine, V141, P229; Kleinman A, 2004, NEW ENGL J MED, V351, P951, DOI 10.1056/NEJMp048078; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ko GTC, 2007, INT J OBESITY, V31, P254, DOI 10.1038/sj.ijo.0803389; Ko GTC, 2001, EUR J EPIDEMIOL, V17, P289, DOI 10.1023/A:1017935707807; Ko GTC, 2001, POSTGRAD MED J, V77, P240, DOI 10.1136/pmj.77.906.240; Kong APS, 2007, DIABETES CARE, V30, P953, DOI 10.2337/dc06-2443; Kong APS, 2006, CURR DIABETES REV, V2, P397, DOI 10.2174/1573399810602040397; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Kosulwat V, 2002, PUBLIC HEALTH NUTR, V5, P183, DOI 10.1079/PHN2001292; Kuroe A, 2003, DIABETES RES CLIN PR, V59, P71, DOI 10.1016/S0168-8227(02)00177-8; Lao TT, 2007, J HEPATOL, V47, P46, DOI 10.1016/j.jhep.2007.02.014; Lao TT, 2001, DIABETOLOGIA, V44, P966, DOI 10.1007/s001250100594; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Lau YL, 1997, NEW ENGL J MED, V336, P1298, DOI 10.1056/NEJM199705013361805; Le DSNT, 2006, J ATHEROSCLER THROMB, V13, P16; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lee DH, 2008, DIABETOLOGIA, V51, P402, DOI 10.1007/s00125-007-0896-5; Lee R, 2009, INT J CARDIOL, V134, P422, DOI 10.1016/j.ijcard.2007.12.107; Lee WRW, 2000, DIABETES RES CLIN PR, V50, pS35, DOI 10.1016/S0168-8227(00)00184-4; Lee ZSK, 1999, DIABETES CARE, V22, P1450, DOI 10.2337/diacare.22.9.1450; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Likitmasku S, 2003, J PEDIATR ENDOCR MET, V16, P71; Liu KH, 2006, DIABETES CARE, V29, P379, DOI 10.2337/diacare.29.02.06.dc05-1578; Liu W J, 2007, Med J Malaysia, V62, P197; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Lu FH, 1998, DIABETIC MED, V15, P564, DOI 10.1002/(SICI)1096-9136(199807)15:7<564::AID-DIA615>3.0.CO;2-H; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Luk A, 2008, DIABETES RES CLIN PR, V82, pS15, DOI 10.1016/j.diabres.2008.09.033; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; MA RC, 2009, OBESITY SCI PRACTICE, P237; MA RCW, 2009, OBESITY SCI PRACTICE, P215; Ma RCW, 2009, INT J GYNECOL OBSTET, V104, pS42, DOI 10.1016/j.ijgo.2008.11.032; Mafauzy M, 1999, Asia Pac J Public Health, V11, P16, DOI 10.1177/101053959901100104; Mak KH, 2007, AM J CARDIOL, V100, P227, DOI 10.1016/j.amjcard.2007.02.090; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Matsumura Y, 2001, ASIA PAC J CLIN NUTR, V10, pS40, DOI 10.1046/j.1440-6047.2001.0100s1S40.x; Mehta SH, 2003, HEPATOLOGY, V38, P50, DOI 10.1053/jhep.2003.50291; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; *MIN HLTH MAL DIS, NCD RISK FACT MAL; Ministry of Health, WHO GLOB INF NAT HLT; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Mohan V, 2007, PEDIATR DIABETES, V8, P28, DOI 10.1111/j.1399-5448.2007.00328.x; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Murakami K, 2006, AM J CLIN NUTR, V83, P1161, DOI 10.1093/ajcn/83.5.1161; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; *NAT CTR HLTH SAT, NAT HLTH NUTR EX SUR; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2004, GENOMICS, V83, P559, DOI 10.1016/j.ygeno.2003.09.008; Ng MCY, 2001, DIABETES CARE, V24, P663, DOI 10.2337/diacare.24.4.663; Oh K, 2005, AM J EPIDEMIOL, V161, P672, DOI 10.1093/aje/kwi085; OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066; Ono Kazuo, 2007, Nepal Med Coll J, V9, P154; Ozaki R, 2007, ARCH DIS CHILD, V92, P224, DOI 10.1136/adc.2006.100453; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PARK YS, 1995, DIABETES CARE, V18, P545, DOI 10.2337/diacare.18.4.545; Parving HH, 2006, KIDNEY INT, V69, P2057, DOI 10.1038/sj.ki.5000377; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; QUOC PS, 1994, AM J EPIDEMIOL, V139, P713, DOI 10.1093/oxfordjournals.aje.a117061; Rahim MA, 2007, DIABETES RES CLIN PR, V77, P300, DOI 10.1016/j.diabres.2006.11.010; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2005, J Assoc Physicians India, V53, P34; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Ren Q, 2008, DIABETOLOGIA, V51, P1146, DOI 10.1007/s00125-008-1039-3; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P293, DOI 10.1016/j.diabres.2004.04.007; Sasaki H, 2005, DIABETES RES CLIN PR, V67, P167, DOI 10.1016/j.diabres.2004.06.012; Scharoun-Lee M, 2009, J EPIDEMIOL COMMUN H, V63, P133, DOI 10.1136/jech.2008.075721; Sekikawa A, 2000, J DIABETES COMPLICAT, V14, P78, DOI 10.1016/S1056-8727(00)00074-X; Seow A, 2006, JNCI-J NATL CANCER I, V98, P135, DOI 10.1093/jnci/djj015; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Shera AS, 2007, DIABETES RES CLIN PR, V76, P219, DOI 10.1016/j.diabres.2006.08.011; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Siegel K, 2008, HEALTH AFFAIR, V27, P1077, DOI 10.1377/hlthaff.27.4.1077; Singh DL, 2003, DIABETIC MED, V20, P170, DOI 10.1046/j.1464-5491.2003.00829_4.x; So WY, 2006, DIABETES CARE, V29, P2046, DOI 10.2337/dc06-0248; Son LENTD, 2004, DIABETIC MED, V21, P371, DOI 10.1111/j.1464-5491.2004.01159.x; Song KH, 2007, DIABETES RES CLIN PR, V78, P378, DOI 10.1016/j.diabres.2007.04.011; Stolk RP, 2005, DIABETOLOGIA, V48, P657, DOI 10.1007/s00125-005-1677-7; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Sutanegara D, 2000, DIABETES RES CLIN PR, V50, pS9, DOI 10.1016/S0168-8227(00)00173-X; Takeuchi T, 2009, DIABETES METAB, V35, P32, DOI 10.1016/j.diabet.2008.06.006; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; Tatsanavivat P, 1998, INT J EPIDEMIOL, V27, P405, DOI 10.1093/ije/27.3.405; THAI A C, 1990, Annals Academy of Medicine Singapore, V19, P517; Thomas GN, 2007, CLIN ENDOCRINOL, V66, P666, DOI 10.1111/j.1365-2265.2007.02798.x; Tong PCY, 2005, J CLIN ENDOCR METAB, V90, P6418, DOI 10.1210/jc.2005-0228; Tong PCY, 2002, DIABETES CARE, V25, P1480, DOI 10.2337/diacare.25.8.1480; Tong PCY, 2006, DIABETES CARE, V29, P2439, DOI 10.2337/dc06-0887; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Veena SR, 2007, DIABETOLOGIA, V50, P43, DOI 10.1007/s00125-006-0516-9; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; *W PAC DECL DIAB S, 2008, PLAN ACT W PAC DECL; Wang C, 2010, INT J CARDIOL, V139, P159, DOI 10.1016/j.ijcard.2008.10.012; Wang XL, 2005, DIABETIC MED, V22, P332, DOI 10.1111/j.1464-5491.2004.01408.x; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wei JN, 2003, DIABETES CARE, V26, P343, DOI 10.2337/diacare.26.2.343; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; *WHO, 1985, TECHN REP SER WHO, V727, P11; WHO Expert Committee on Diabetes Mellitus, 1980, TECHN REP SER WHO; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wong KC, 2006, DIABETES RES CLIN PR, V73, P126, DOI 10.1016/j.diabres.2006.01.007; Woodward M, 2003, DIABETES CARE, V26, P360; *WORLD EC FOR, 2009, GLOB RISK 2009 GLOB; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yajnik CS, 2009, INT J GYNECOL OBSTET, V104, pS27, DOI 10.1016/j.ijgo.2008.11.034; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Yang XL, 2008, ARCH INTERN MED, V168, P451, DOI 10.1001/archinte.168.5.451; Yang X, 2008, AM J CARDIOL, V101, P596, DOI 10.1016/j.amjcard.2007.10.019; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yeo KK, 2006, DIABETOLOGIA, V49, P2866, DOI 10.1007/s00125-006-0469-z; Yokoi N, 2006, DIABETES, V55, P2379, DOI 10.2337/db05-1203; Yokoyama H, 1998, DIABETES CARE, V21, P1080, DOI 10.2337/diacare.21.7.1080; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zaini A, 2000, DIABETES RES CLIN PR, V50, pS23, DOI 10.1016/S0168-8227(00)00175-3; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886; ZHONG XL, 1982, CHINESE MED J-PEKING, V95, P423; Zhou Huan, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P41, DOI 10.2114/jpa2.25.41	194	1436	1496	12	322	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2129	2140		10.1001/jama.2009.726	http://dx.doi.org/10.1001/jama.2009.726			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19470990				2022-12-28	WOS:000266328800025
J	Falcini, F; Vitale, A; La Torre, F; Conti, G; Fede, C; Calcagno, G				Falcini, Fernanda; Vitale, Agata; La Torre, Francesco; Conti, Giovanni; Fede, Carmelo; Calcagno, Giuseppina			Refractory pneumonia and high fever	LANCET			English	Editorial Material							KAWASAKI-DISEASE; DIAGNOSIS; YOUNG		[Vitale, Agata; La Torre, Francesco; Conti, Giovanni; Fede, Carmelo; Calcagno, Giuseppina] Univ Messina, Rheumatol Unit, Dept Paediat, I-98100 Messina, Italy; [Falcini, Fernanda] Univ Florence, Transit Unit, Div Rheumatol, Dept Biomed, I-50139 Florence, Italy	University of Messina; University of Florence	Falcini, F (corresponding author), Univ Florence, Dept BioMed, Rheumatol Unit, Viale Pieraccini 18, I-50139 Florence, Italy.	falcini@unifi.it	Conti, Giovanni/AAF-1059-2020; La Torre, Francesco/AAW-9779-2021	La Torre, Francesco/0000-0002-5235-2900				de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X; Kim T, 2007, EUR J PEDIATR, V166, P421, DOI 10.1007/s00431-006-0251-8; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Saint-Faust M, 2007, ARCH PEDIATRIE, V14, P1427, DOI 10.1016/j.arcped.2007.08.018; UMEZAWA T, 1989, PEDIATR RADIOL, V20, P48, DOI 10.1007/BF02010633	5	6	6	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1818	1818		10.1016/S0140-6736(09)60694-2	http://dx.doi.org/10.1016/S0140-6736(09)60694-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465237				2022-12-28	WOS:000266337300037
J	Hyde, R				Hyde, Rob			European children still at high risk of injury	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1752	1752		10.1016/S0140-6736(09)60967-3	http://dx.doi.org/10.1016/S0140-6736(09)60967-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19480075				2022-12-28	WOS:000266337300014
J	Lancaster, T				Lancaster, Tim			Absolute CVD risk, stratified by risk score, was 20% higher in primary care patients with CVD than in those without CVD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Oxford, UK Natl Sch Primary Care Res, Oxford, England	University of Oxford	Lancaster, T (corresponding author), Univ Oxford, UK Natl Sch Primary Care Res, Oxford, England.							Kerr AJ, 2009, HEART, V95, P125, DOI 10.1136/hrt.2007.140905	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-15	10.7326/0003-4819-150-10-200905190-02015	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451571				2022-12-28	WOS:000266285300035
J	Hayden, BY; Pearson, JM; Platt, ML				Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.			Fictive Reward Signals in the Anterior Cingulate Cortex	SCIENCE			English	Article							SEQUENTIAL INVESTMENT TASK; DECISION-MAKING; COUNTERFACTUAL THINKING; ORBITOFRONTAL CORTEX; INCENTIVE SALIENCE; VALUATION; UNCERTAINTY; REGRET; CHOICE	The neural mechanisms supporting the ability to recognize and respond to fictive outcomes, outcomes of actions that one has not taken, remain obscure. We hypothesized that neurons in the anterior cingulate cortex (ACC), which monitors the consequences of actions and mediates subsequent changes in behavior, would respond to fictive reward information. We recorded responses of single neurons during performance of a choice task that provided information about the reward values of options that were not chosen. We found that ACC neurons signal fictive reward information and use a coding scheme similar to that used to signal experienced outcomes. Thus, individual ACC neurons process both experienced and fictive rewards.	[Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.] Duke Univ, Sch Med, Ctr Neuroecon Studies, Ctr Cognit Neurosci,Dept Neurobiol, Durham, NC 27701 USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27701 USA	Duke University; Duke University	Hayden, BY (corresponding author), Duke Univ, Sch Med, Ctr Neuroecon Studies, Ctr Cognit Neurosci,Dept Neurobiol, Durham, NC 27701 USA.	hayden@neuro.duke.edu	Hayden, Benjamin/J-7994-2013	Hayden, Benjamin/0000-0002-7678-4281; Pearson, John/0000-0002-9876-7837	National Institute on Drug Abuse postdoctoral fellowship [023338]; National Eye Institute [013496]; Duke Institute for Brain Studies; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA023338, K99DA027718] Funding Source: NIH RePORTER	National Institute on Drug Abuse postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Duke Institute for Brain Studies; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a postdoctoral fellowship to B.Y.H. National Institute on Drug Abuse (023338) a R01 to M.L.P., (National Eye Institute 013496), and the Duke Institute for Brain Studies (M.L.P.). We thank K. Watson for help in training the animals and S. Heilbronner for useful discussions on the tasks. The authors declare no conflicts of interest.	Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Byrne RMJ, 2002, TRENDS COGN SCI, V6, P426, DOI 10.1016/S1364-6613(02)01974-5; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Chiu PH, 2008, NAT NEUROSCI, V11, P514, DOI 10.1038/nn2067; Epstude K, 2008, PERS SOC PSYCHOL REV, V12, P168, DOI 10.1177/1088868308316091; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lee D, 2005, COGNITIVE BRAIN RES, V25, P416, DOI 10.1016/j.cogbrainres.2005.07.003; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Reid R. L, 1986, J GAMBLING BEHAV, V2, P32, DOI [DOI 10.1007/BF01019932, 10.1007/BF01019932]; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Roese NJ, 1997, PSYCHOL BULL, V121, P133, DOI 10.1037/0033-2909.121.1.133; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004	27	154	159	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					948	950		10.1126/science.1168488	http://dx.doi.org/10.1126/science.1168488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443783	Green Accepted			2022-12-28	WOS:000266048800042
J	Jack, A				Jack, Andrew			Governments must be pulled up for failings over flu	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 15	2009	338								b2019	10.1136/bmj.b2019	http://dx.doi.org/10.1136/bmj.b2019			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	446JB	19447826				2022-12-28	WOS:000266116800004
J	Moloney, A				Moloney, Anastasia			Questions raised over response to influenza A outbreak	LANCET			English	Editorial Material																			0	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1591	1592		10.1016/S0140-6736(09)60868-0	http://dx.doi.org/10.1016/S0140-6736(09)60868-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19437600	Green Published, Bronze			2022-12-28	WOS:000266066300012
J	Garten, RJ; Davis, CT; Russell, CA; Shu, B; Lindstrom, S; Balish, A; Sessions, WM; Xu, XY; Skepner, E; Deyde, V; Okomo-Adhiambo, M; Gubareva, L; Barnes, J; Smith, CB; Emery, SL; Hillman, MJ; Rivailler, P; Smagala, J; de Graaf, M; Burke, DF; Fouchier, RAM; Pappas, C; Alpuche-Aranda, CM; Lopez-Gatell, H; Olivera, H; Lopez, I; Myers, CA; Faix, D; Blair, PJ; Yu, C; Keene, KM; Dotson, PD; Boxrud, D; Sambol, AR; Abid, SH; George, KS; Bannerman, T; Moore, AL; Stringer, DJ; Blevins, P; Demmler-Harrison, GJ; Ginsberg, M; Kriner, P; Waterman, S; Smole, S; Guevara, HF; Belongia, EA; Clark, PA; Beatrice, ST; Donis, R; Katz, J; Finelli, L; Bridges, CB; Shaw, M; Jernigan, DB; Uyeki, TM; Smith, DJ; Klimov, AI; Cox, NJ				Garten, Rebecca J.; Davis, C. Todd; Russell, Colin A.; Shu, Bo; Lindstrom, Stephen; Balish, Amanda; Sessions, Wendy M.; Xu, Xiyan; Skepner, Eugene; Deyde, Varough; Okomo-Adhiambo, Margaret; Gubareva, Larisa; Barnes, John; Smith, Catherine B.; Emery, Shannon L.; Hillman, Michael J.; Rivailler, Pierre; Smagala, James; de Graaf, Miranda; Burke, David F.; Fouchier, Ron A. M.; Pappas, Claudia; Alpuche-Aranda, Celia M.; Lopez-Gatell, Hugo; Olivera, Hiram; Lopez, Irma; Myers, Christopher A.; Faix, Dennis; Blair, Patrick J.; Yu, Cindy; Keene, Kimberly M.; Dotson, P. David, Jr.; Boxrud, David; Sambol, Anthony R.; Abid, Syed H.; George, Kirsten St.; Bannerman, Tammy; Moore, Amanda L.; Stringer, David J.; Blevins, Patricia; Demmler-Harrison, Gail J.; Ginsberg, Michele; Kriner, Paula; Waterman, Steve; Smole, Sandra; Guevara, Hugo F.; Belongia, Edward A.; Clark, Patricia A.; Beatrice, Sara T.; Donis, Ruben; Katz, Jacqueline; Finelli, Lyn; Bridges, Carolyn B.; Shaw, Michael; Jernigan, Daniel B.; Uyeki, Timothy M.; Smith, Derek J.; Klimov, Alexander I.; Cox, Nancy J.			Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans	SCIENCE			English	Article							A VIRUS; PHYLOGENETIC ANALYSIS; UNITED-STATES; NORTH-AMERICA; EVOLUTION; PIGS; PATHOGENICITY; TRANSMISSION; EMERGENCE; INFECTION	Since its identification in April 2009, an A(H1N1) virus containing a unique combination of gene segments from both North American and Eurasian swine lineages has continued to circulate in humans. The lack of similarity between the 2009 A(H1N1) virus and its nearest relatives indicates that its gene segments have been circulating undetected for an extended period. Its low genetic diversity suggests that the introduction into humans was a single event or multiple events of similar viruses. Molecular markers predictive of adaptation to humans are not currently present in 2009 A(H1N1) viruses, suggesting that previously unrecognized molecular determinants could be responsible for the transmission among humans. Antigenically the viruses are homogeneous and similar to North American swine A(H1N1) viruses but distinct from seasonal human A(H1N1).	[Russell, Colin A.; Skepner, Eugene; de Graaf, Miranda; Burke, David F.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Garten, Rebecca J.; Davis, C. Todd; Shu, Bo; Lindstrom, Stephen; Balish, Amanda; Sessions, Wendy M.; Xu, Xiyan; Skepner, Eugene; Deyde, Varough; Okomo-Adhiambo, Margaret; Gubareva, Larisa; Barnes, John; Smith, Catherine B.; Emery, Shannon L.; Hillman, Michael J.; Rivailler, Pierre; Smagala, James; Pappas, Claudia; Guevara, Hugo F.; Belongia, Edward A.; Clark, Patricia A.; Beatrice, Sara T.; Donis, Ruben; Katz, Jacqueline; Finelli, Lyn; Bridges, Carolyn B.; Shaw, Michael; Jernigan, Daniel B.; Uyeki, Timothy M.; Klimov, Alexander I.; Cox, Nancy J.] Ctr Dis Control & Prevent CDC, WHO, Collaborating Ctr Influenza, Atlanta, GA 30333 USA; [Russell, Colin A.; Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [de Graaf, Miranda; Fouchier, Ron A. M.; Smith, Derek J.] Erasmus MC, Dept Virol, NL-3000 CA Rotterdam, Netherlands; [Alpuche-Aranda, Celia M.; Lopez-Gatell, Hugo; Olivera, Hiram; Lopez, Irma] InDRE Prolongac Carpio, Mexico City 11340, DF, Mexico; [Myers, Christopher A.; Faix, Dennis; Blair, Patrick J.] USN, Hlth Res Ctr, San Diego, CA 92152 USA; [Yu, Cindy] Arizona State Publ Hlth Lab, Phoenix, AZ 85007 USA; [Keene, Kimberly M.] Colorado Dept Publ Hlth & Environm, Denver, CO 80230 USA; [Dotson, P. David, Jr.] Indiana State Dept Hlth Labs, Indianapolis, IN 46202 USA; [Boxrud, David] Minnesota Dept Hlth, Publ Hlth Lab, St Paul, MN 55164 USA; [Sambol, Anthony R.] Nebraska Publ Hlth Lab, Omaha, NE 68198 USA; [Abid, Syed H.] Westchester Cty Dept Labs & Res Publ Hlth Labs, Valhalla, NY 10595 USA; [George, Kirsten St.] New York State Dept Hlth, Wadsworth Ctr, Slingerlands, NY USA; [Bannerman, Tammy] Ohio Dept Hlth Lab, Reynoldsburg, OH USA; [Moore, Amanda L.] S Carolina Dept Hlth & Environm Control, Columbia, SC 29223 USA; [Stringer, David J.] Dallas Cty Hlth & Human Serv, Dallas, TX 75207 USA; [Blevins, Patricia] San Antonio Metro Hlth Dist, Brooks City Base, TX 78235 USA; [Demmler-Harrison, Gail J.] Texas Childrens Hosp, Diagnost Virol Lab, Houston, TX 77030 USA; [Ginsberg, Michele] San Diego Publ Hlth Lab, San Diego, CA 92186 USA; [Kriner, Paula] Imperial Cty Publ Hlth Dept, El Centro, CA 92243 USA; [Waterman, Steve] CDC, Border Infect Dis Surveillance Project, Atlanta, GA 30333 USA; [Smole, Sandra] Massachusetts Dept Publ Hlth, William A Hinton State Lab Inst, Jamaica Plain, MA 02130 USA; [Guevara, Hugo F.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA 94804 USA; [Belongia, Edward A.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Clark, Patricia A.] Michigan Dept Community Hlth, Lansing, MI 48906 USA; [Beatrice, Sara T.] NYU, Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY 10016 USA	University of Cambridge; Centers for Disease Control & Prevention - USA; World Health Organization; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Erasmus University Rotterdam; Erasmus MC; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Colorado Department of Public Health & Environment; Minnesota Department of Health (MHD); Wadsworth Center; Baylor College of Medicine; Centers for Disease Control & Prevention - USA; Massachusetts Department of Public Health; California Department of Public Health; Marshfield Clinic; MDHHS - Michigan Department of Health & Human Services; New York University	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk; njc1@cdc.gov	de Graaf, Miranda/AFM-6878-2022; Bannerman, Tammy/E-2694-2011; Burke, David F/C-2091-2013; Russell, Colin/ABE-7106-2020; Fouchier, Ron A/A-1911-2014; Finelli, Lyn/AAK-2360-2020; Smith, Derek/Z-3075-2019; de Graaf, Miranda/K-1262-2018	de Graaf, Miranda/0000-0002-7831-0098; Burke, David F/0000-0001-8830-3951; Fouchier, Ron A/0000-0001-8095-2869; Smith, Derek/0000-0002-2393-1890; de Graaf, Miranda/0000-0002-7831-0098; Russell, Colin/0000-0002-2113-162X; Okomo-Adhiambo, Margaret/0000-0003-0415-8916; Belongia, Edward/0000-0001-7478-0415; Barnes, John/0000-0002-5874-4411	National Institute of Allergy and Infectious Diseases [HHSN266200700010C]; International Federation of Pharmaceutical Manufacturers and Associations [RG51953]; Research Fellowship from Clare College, Cambridge; NIH [DP1-OD000490-01]; European Union [223498 EMPERIE]; Human Frontier Science Program [RG P0050/2008]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Federation of Pharmaceutical Manufacturers and Associations; Research Fellowship from Clare College, Cambridge; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Human Frontier Science Program(Human Frontier Science Program); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the many individuals at the local, state, and national levels for their enormous contributions to the surveillance of the 2009 A(H1N1) virus; the entire CDC Influenza Division staff and emergency staff; the maintainers of the GISAID EpiFluDB and NCBI GenBank/IVR, and the members of the WHO Global Influenza Surveillance Network. The findings and conclusions of this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. R.A.M.F. was supported by National Institute of Allergy and Infectious Diseases under NIH contract HHSN266200700010C. E.S. was supported in part by the International Federation of Pharmaceutical Manufacturers and Associations through grant RG51953. C.A.R. was supported in part by a Research Fellowship from Clare College, Cambridge. D.J.S., C.A.R., E.S., and D.F.B. were supported by an NIH Directors Pioneer Award, part of the NIH roadmap for medical research, through grant DP1-OD000490-01, an FP7 grant, 223498 EMPERIE, from the European Union, and program grant RG P0050/2008 from the Human Frontier Science Program. GenBank accession numbers are listed in the Supporting Online Material	[Anonymous], MMWR MORB MORTAL WKL; *CDC, H1N1 FLU SWIN FLU; Chen Yixiang, 2008, Weishengwu Xuebao, V48, P466; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; Gregory V, 2001, J GEN VIROL, V82, P1397, DOI 10.1099/0022-1317-82-6-1397; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; KENDAL AP, 1977, J INFECT DIS, V136, pS381, DOI 10.1093/infdis/136.Supplement_3.S381; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Komadina N, 2007, VIRUS GENES, V35, P161, DOI 10.1007/s11262-007-0097-9; Lee CS, 2008, VIRUS GENES, V37, P168, DOI 10.1007/s11262-008-0251-z; Maldonado J, 2006, VET J, V172, P377, DOI 10.1016/j.tvjl.2005.04.014; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SHEERAR MG, 1989, J GEN VIROL, V70, P3297, DOI 10.1099/0022-1317-70-12-3297; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope R E, 1931, J Exp Med, V54, P373, DOI 10.1084/jem.54.3.373; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Song DS, 2007, VIRUS RES, V125, P98, DOI 10.1016/j.virusres.2006.11.008; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Swofford D. L., 2003, PAUP; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Vincent AL, 2006, VET MICROBIOL, V118, P212, DOI 10.1016/j.vetmic.2006.07.017; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, INFL H1N1; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999; 2009, MMWR MORB MORTAL WKL, V58, P453; 2009, MMWR MORB MORTAL WKL, V58, P433	38	1824	1980	15	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					197	201		10.1126/science.1176225	http://dx.doi.org/10.1126/science.1176225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19465683	Green Accepted			2022-12-28	WOS:000267802000046
J	Mann, JFE; Schmieder, RE; Dyal, L; McQueen, MJ; Schumacher, H; Pogue, J; Wang, XY; Probstfield, JL; Avezum, A; Cardona-Munoz, E; Dagenais, GR; Diaz, R; Fodor, G; Maillon, JM; Ryden, L; Yu, CM; Teo, KK; Yusuf, S				Mann, Johannes F. E.; Schmieder, Roland E.; Dyal, Leanne; McQueen, Matthew J.; Schumacher, Helmut; Pogue, Janice; Wang, Xingyu; Probstfield, Jeffrey L.; Avezum, Alvaro; Cardona-Munoz, Ernesto; Dagenais, Gilles R.; Diaz, Rafael; Fodor, George; Maillon, Jean M.; Ryden, Lars; Yu, Cheuk M.; Teo, Koon K.; Yusuf, Salim		TRANSCEND Telmisartan Randomised	Effect of Telmisartan on Renal Outcomes A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING ENZYME-INHIBITORS; GLOMERULAR-FILTRATION-RATE; II RECEPTOR BLOCKERS; KIDNEY-DISEASE; RISK; PROTEINURIA; COMBINATION; PROGRESSION; MICROALBUMINURIA; NEPHROPATHIES	Background: Angiotensin-receptor blockers (ARBs) blunt progression of advanced diabetic nephropathy, but their long-term renal effects in other patients are not clear. Objective: To examine the long-term renal effects of telmisartan versus placebo in adults at high vascular risk. Design: Randomized trial. Patients were randomly assigned by a central automated system between November 2001 and May 2004 and were followed until March 2008. Participants and investigators were blinded to intervention status. Setting: Multicenter, multinational study. Patients: 5927 adults with known cardiovascular disease or diabetes with end-organ damage but without macroalbuminuria or heart failure who cannot tolerate angiotensin-converting enzyme inhibitors. Intervention: Telmisartan, 80 mg/d (n = 2954), or matching placebo (n = 2972) plus standard treatment for a mean of 56 months. Measurements: Composite renal outcome of dialysis or doubling of serum creatinine, changes in estimated glomerular filtration rate (GFR), and changes in albuminuria. Results: No important difference was found in the composite renal outcome with telmisartan (58 patients [1.96%]) versus placebo (46 patients [1.55%]) (hazard ratio, 1.29 [95% Cl, 0.87 to 1.89]; P = 0.20). Among the telmisartan and placebo groups, 7 and 10 patients had dialysis and 56 and 36 patients had doubling of serum creatinine, respectively (hazard ratio, 1.59 [Cl, 1.04 to 2.41]; P = 0.031). Albuminuria increased less with telmisartan than with placebo (32% [Cl, 23% to 41%] vs. 63% [Cl, 52% to 76%]; P < 0.001). Decreases in estimated GFR were greater with telmisartan than with placebo (mean change in estimated GFR, -3.2 mL/min per 1.73 m(2) [SD, 18.3] vs. -0.26 mL/min per 1.73 m(2) [SD, 18.0]; P < 0.001). Limitation: Only 17 participants had dialysis. Conclusion: In adults with vascular disease but without macroalbuminuria, the effects of telmisartan on major renal outcomes were similar to those of placebo. Primary Funding Source: Boehringer Ingelheim.	Univ Munich, Schwabing Gen Hosp, Munich, Germany; Univ Munich, KfH Kidney Ctr, Munich, Germany; Univ Erlangen Nurnberg, Erlangen, Germany; McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; Boehringer Ingelheim KG, D-6507 Ingelheim, Germany; Beijing Hypertens League Inst, Beijing, Peoples R China; Univ Washington, Seattle, WA 98195 USA; Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico; Laval Univ & Hosp, Inst Cardiol & Pneumol, Quebec City, PQ, Canada; Univ Buenos Aires, Buenos Aires, DF, Argentina; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; Univ Grenoble, Grenoble, France; Karolinska Inst, Stockholm, Sweden; Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China	University of Munich; University of Munich; University of Erlangen Nuremberg; McMaster University; Population Health Research Institute; Boehringer Ingelheim; Chinese Hypertension League; University of Washington; University of Washington Seattle; Instituto Dante Pazzanese de Cardiologia; Universidad de Guadalajara; Laval University; University of Buenos Aires; University of Ottawa; University of Ottawa Heart Institute; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Karolinska Institutet; Chinese University of Hong Kong; Prince of Wales Hospital	Mann, JFE (corresponding author), McMaster Univ, Hamilton Gen Hosp, ONTARGET Off, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	ontarget@phri.ca	Avezum, Alvaro/AAP-7687-2020; Yu, Cheuk-man/P-3747-2015; Mann, Johannes/AAI-8803-2020; Avezum, Alvaro AA/K-6137-2016	Avezum, Alvaro AA/0000-0002-3073-6890; CARDONA MUNOZ, ERNESTO GERMAN/0000-0001-7868-667X; Yusuf, Salim/0000-0003-4776-5601; da Silva Franco, Roberto Jorge/0000-0001-9787-4393				Apperloo AJ, 1997, KIDNEY INT, V51, P793, DOI 10.1038/ki.1997.111; Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Caskey FJ, 2006, AM J KIDNEY DIS, V47, P445, DOI 10.1053/j.ajkd.2005.12.026; Frei U, 1999, NEPHROL DIAL TRANSPL, V14, P1085, DOI 10.1093/ndt/14.5.1085; Gerstein HC, 2000, LANCET, V355, P253; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mann JFE, 2003, AM J KIDNEY DIS, V42, P936, DOI 10.1016/j.ajkd.2003.07.015; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Phillips CO, 2007, ARCH INTERN MED, V167, P1930, DOI 10.1001/archinte.167.18.1930; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 2000, AM J KIDNEY DIS, V35, P1155, DOI 10.1016/S0272-6386(00)70054-0; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	22	116	121	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2009	151	1					1	U15		10.7326/0003-4819-151-1-200907070-00122	http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00122			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BF	19451556				2022-12-28	WOS:000267946100001
J	Gambetta, MC; Oktaba, K; Muller, J				Gambetta, Maria Cristina; Oktaba, Katarzyna; Mueller, Juerg			Essential Role of the Glycosyltransferase Sxc/Ogt in Polycomb Repression	SCIENCE			English	Article							LINKED N-ACETYLGLUCOSAMINE; X-CHROMOSOME; GENE; GLYCOSYLATION; LOCALIZATION; PROTEINS; NUCLEAR; PATTERN	Polycomb group proteins are conserved transcriptional repressors that control animal and plant development. Here, we found that the Drosophila Polycomb group gene super sex combs (sxc) encodes Ogt, the highly conserved glycosyltransferase that catalyzes the addition of N-acetylglucosamine (GlcNAc) to proteins in animals and plants. Genome-wide profiling in Drosophila revealed that GlcNAc-modified proteins are highly enriched at Polycomb response elements. Among different Polycomb group proteins, Polyhomeotic is glycosylated by Sxc/Ogt in vivo. sxc/Ogt-null mutants lacked O-linked GlcNAcylation and failed to maintain Polycomb transcriptional repression even though Polycomb group protein complexes were bound at their target sites. Polycomb repression appears to be a critical function of Sxc/Ogt in Drosophila and may be mediated by the glycosylation of Polyhomeotic.	[Gambetta, Maria Cristina; Oktaba, Katarzyna; Mueller, Juerg] EMBL, Gene Express Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Muller, J (corresponding author), EMBL, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	juerg.mueller@embl.de	Oktaba, Katarzyna/A-7737-2018; Gambetta, Maria Cristina/P-8511-2016; Müller, Jürg/ABB-3007-2020	Oktaba, Katarzyna/0000-0002-3950-5626; Gambetta, Maria Cristina/0000-0002-9450-3551; Müller, Jürg/0000-0003-2391-4641	EMBL; Deutsche Forschungsgemeinschaft	EMBL; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors are supported by EMBL and by grants from the Deutsche Forschungsgemeinschaft. The microarray data have been deposited in the ArrayExpress database under the accession number E-TABM-697.	Beuchle D, 2001, DEVELOPMENT, V128, P993; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DURA JM, 1987, CELL, V51, P829, DOI 10.1016/0092-8674(87)90106-1; FAUVARQUE MO, 1995, MECH DEVELOP, V52, P343, DOI 10.1016/0925-4773(95)00412-T; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HOLT GD, 1986, J BIOL CHEM, V261, P8049; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; INGHAM PW, 1985, COLD SPRING HARB SYM, V50, P201, DOI 10.1101/SQB.1985.050.01.026; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; TURNER JR, 1990, P NATL ACAD SCI USA, V87, P5608, DOI 10.1073/pnas.87.15.5608	22	241	245	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					93	96		10.1126/science.1169727	http://dx.doi.org/10.1126/science.1169727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19478141				2022-12-28	WOS:000267594000043
J	Wheeler, MJ; de Graaf, BHJ; Hadjiosif, N; Perry, RM; Poulter, NS; Osman, K; Vatovec, S; Harper, A; Franklin, FCH; Franklin-Tong, VE				Wheeler, Michael J.; de Graaf, Barend H. J.; Hadjiosif, Natalie; Perry, Ruth M.; Poulter, Natalie S.; Osman, Kim; Vatovec, Sabina; Harper, Andrea; Franklin, F. Christopher H.; Franklin-Tong, Vernonica E.			Identification of the pollen self-incompatibility determinant in Papaver rhoeas	NATURE			English	Article							PROGRAMMED CELL-DEATH; GENE; CLONING; ACTIN; DEPOLYMERIZATION; POLYMORPHISM; LOCUS	Higher plants produce seed through pollination, using specific interactions between pollen and pistil. Self-incompatibility is an important mechanism used in many species to prevent inbreeding; it is controlled by a multi-allelic S locus(1,2). 'Self' (incompatible) pollen is discriminated from 'non-self' (compatible) pollen by interaction of pollen and pistil S locus components, and is subsequently inhibited. In Papaver rhoeas, the pistil S locus product is a small protein that interacts with incompatible pollen, triggering a Ca2+-dependent signalling network, resulting in pollen inhibition and programmed cell death(3-7). Here we have cloned three alleles of a highly polymorphic pollen-expressed gene, PrpS (Papaver rhoeas pollen S), from Papaver and provide evidence that this encodes the pollen S locus determinant. PrpS is a single-copy gene linked to the pistil S gene (currently called S, but referred to hereafter as PrsS for Papaver rhoeas stigma S determinant). Sequence analysis indicates that PrsS and PrpS are equally ancient and probably co-evolved. PrpS encodes a novel similar to 20-kDa protein. Consistent with predictions that it is a transmembrane protein, PrpS is associated with the plasma membrane. We show that a predicted extracellular loop segment of PrpS interacts with PrsS and, using PrpS antisense oligonucleotides, we demonstrate that PrpS is involved in S-specific inhibition of incompatible pollen. Identification of PrpS represents a major advance in our understanding of the Papaver self-incompatibility system. As a novel cell-cell recognition determinant it contributes to the available information concerning the origins and evolution of cell-cell recognition systems involved in discrimination between self and non-self, which also include histocompatibility systems in primitive chordates and vertebrates.	[Wheeler, Michael J.; de Graaf, Barend H. J.; Hadjiosif, Natalie; Perry, Ruth M.; Poulter, Natalie S.; Osman, Kim; Vatovec, Sabina; Harper, Andrea; Franklin, F. Christopher H.; Franklin-Tong, Vernonica E.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Franklin-Tong, VE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	V.E.Franklin-Tong@bham.ac.uk	Franklin-Tong, Vernonica E/D-1287-2012; De Graaf, Barend HJ/A-5880-2010	de Graaf, Barend H J/0000-0003-0542-5510; Poulter, Natalie/0000-0002-3187-2130; Franklin-Tong, Noni/0000-0003-1782-8413; Vatovec, Sabina/0000-0002-7991-2840; Franklin, F. Chris H./0000-0003-3507-722X; Harper, Andrea/0000-0003-3859-1152	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C501325/1]; Biotechnology and Biological Sciences Research Council [BB/C501325/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Chen-Ying for contributing preliminary data and horticultural staff for growing and collecting plant material. We also thank J. Kohn for help and advice on sequence analysis, and A. Lovering and T. Hakoshima for advice regarding structural predictions. We wish to acknowledge the long-term contribution from M. Lawrence, who initiated studies on Papaver self-incompatibility. Work in the laboratories of F. C. H. F. and V. E. F.-T. is funded by the Biotechnology and Biological Sciences Research Council (BBSRC); this work was supported by grant BB/C501325/1.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bailey N.T.J., 1959, STAT METHODS BIOL, P33; Biris N, 2003, EUR J BIOCHEM, V270, P3760, DOI 10.1046/j.1432-1033.2003.03762.x; Bosch M, 2007, P NATL ACAD SCI USA, V104, P18327, DOI 10.1073/pnas.0705826104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; CHARLESWORTH D, 1995, BIOESSAYS, V17, P31, DOI 10.1002/bies.950170108; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Graaf BHJ, 2006, NATURE, V444, P490, DOI 10.1038/nature05311; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Fisher R.A., 1956, STAT METHODS SCI INF; FOOTE HCC, 1994, P NATL ACAD SCI USA, V91, P2265, DOI 10.1073/pnas.91.6.2265; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; FRANKLINTONG VE, 1988, HEREDITY, V61, P286; FRANKLINTONG VE, 1993, PLANT J, V4, P163, DOI 10.1046/j.1365-313X.1993.04010163.x; Geitmann A, 2000, PLANT CELL, V12, P1239, DOI 10.1105/tpc.12.7.1239; Hearn MJ, 1996, PLANT J, V9, P467, DOI 10.1046/j.1365-313X.1996.09040467.x; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Jordan ND, 2000, PLANT J, V23, P471, DOI 10.1046/j.1365-313x.2000.00811.x; Kohn J. R., 2008, P103, DOI 10.1007/978-3-540-68486-2_5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurup S, 1998, SEX PLANT REPROD, V11, P192, DOI 10.1007/s004970050141; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moutinho A, 2001, SEX PLANT REPROD, V14, P101, DOI 10.1007/s004970100086; Newbigin E, 2008, PLANT CELL, V20, P2286, DOI 10.1105/tpc.108.060327; Poulter NS, 2008, PLANT PHYSIOL, V146, P1358, DOI 10.1104/pp.107.107052; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Walker EA, 1996, PLANT MOL BIOL, V30, P983, DOI 10.1007/BF00020809; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173	39	142	160	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					992	U118		10.1038/nature08027	http://dx.doi.org/10.1038/nature08027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19483678	Green Accepted			2022-12-28	WOS:000267063500044
J	Chen, K; Baran, PS				Chen, Ke; Baran, Phil S.			Total synthesis of eudesmane terpenes by site-selective C-H oxidations	NATURE			English	Article							ENZYMES; OXYFUNCTIONALIZATION; FUNCTIONALIZATION; SESQUITERPENOIDS; BIOSYNTHESIS; HYDROCARBONS; ACTIVATION; EFFICIENT; TAXOL	From menthol to cholesterol to Taxol, terpenes are a ubiquitous group of molecules (over 55,000 members isolated so far) that have long provided humans with flavours, fragrances, hormones, medicines and even commercial products such as rubber(1). Although they possess a seemingly endless variety of architectural complexities, the biosynthesis of terpenes often occurs in a unified fashion as a 'two-phase' process(2,3). In the first phase (the cyclase phase), simple linear hydrocarbon phosphate building blocks are stitched together by means of 'prenyl coupling', followed by enzymatically controlled molecular cyclizations and rearrangements. In the second phase (the oxidase phase), oxidation of alkenes and carbon-hydrogen bonds results in a large array of structural diversity. Although organic chemists have made great progress in developing the logic(3-5) needed for the cyclase phase of terpene synthesis, particularly in the area of polyene cyclizations(6), much remains to be learned if the oxidase phase is to be mimicked in the laboratory. Here we show how the logic of terpene biosynthesis has inspired the highly efficient and stereocontrolled syntheses of five oxidized members of the eudesmane family of terpenes in a modicum of steps by a series of simple carbocycle-forming reactions followed by multiple site-selective inter-and intramolecular carbon-hydrogen oxidations. This work establishes an intellectual framework in which to conceive the laboratory synthesis of other complex terpenes using a 'two-phase' approach.	[Chen, Ke; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	We are grateful to A. Eschenmoser for discussions and to Bristol-Myers Squibb for financial support. M. Moron Galan and Y. Ishihara are acknowledged for technical contributions to the early stages of this project. We are grateful to B. Shi and A. Reingold for assistance with high-performance liquid chromatography and X-ray crystallographic analyses, respectively.	Betancort JM, 2001, ORG LETT, V3, P3737, DOI 10.1021/ol0167006; Brodsky BH, 2005, J AM CHEM SOC, V127, P15391, DOI 10.1021/ja055549i; CARDONA L, 1992, TETRAHEDRON, V48, P851, DOI 10.1016/S0040-4020(01)88189-8; Chen K, 2008, J AM CHEM SOC, V130, P7247, DOI 10.1021/ja802491q; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chi YG, 2005, ORG LETT, V7, P4253, DOI 10.1021/ol0517729; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davis EM, 2000, TOP CURR CHEM, V209, P53; De Marino S, 2005, PLANTA MED, V71, P706, DOI 10.1055/s-2005-864191; DENIS JN, 1988, J AM CHEM SOC, V110, P5917, DOI 10.1021/ja00225a063; Eschenmoser A, 2005, HELV CHIM ACTA, V88, P3011, DOI 10.1002/hlca.200590245; Fraunhoffer KJ, 2005, ORG LETT, V7, P223, DOI 10.1021/ol047800p; Groves JT, 1996, J AM CHEM SOC, V118, P8961, DOI 10.1021/ja9542092; IRWIN MA, 1973, PHYTOCHEMISTRY, V12, P849, DOI 10.1016/0031-9422(73)80689-2; Jennewein S, 2001, P NATL ACAD SCI USA, V98, P13595, DOI 10.1073/pnas.251539398; Levine SR, 2009, ORG LETT, V11, P289, DOI 10.1021/ol802409h; Maimone TJ, 2007, NAT CHEM BIOL, V3, P396, DOI 10.1038/nchembio.2007.1; MELLO R, 1989, J AM CHEM SOC, V111, P6749, DOI 10.1021/ja00199a039; Nicolaou K.C., 2008, MOL CHANGED WORLD; PAKNIKAR SK, 1977, INDIAN J CHEM B, V15, P86; RUZICKA L, 1953, EXPERIENTIA, V9, P357, DOI 10.1007/BF02167631; SCHREIBER J, 1955, HELV CHIM ACTA, V38, P1529, DOI 10.1002/hlca.19550380627; Wender PA, 2005, ORG LETT, V7, P79, DOI 10.1021/ol047859w; Wilson RM, 2007, J ORG CHEM, V72, P4293, DOI 10.1021/jo070871s; Wu QX, 2006, NAT PROD REP, V23, P699, DOI 10.1039/b606168k; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l; Zhao PJ, 2006, CHEM BIODIVERS, V3, P337, DOI 10.1002/cbdv.200690036	30	306	307	2	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					824	828		10.1038/nature08043	http://dx.doi.org/10.1038/nature08043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	459EV	19440196				2022-12-28	WOS:000267084500035
J	Murray, L; Burnham, G				Murray, Laura; Burnham, Gilbert			Understanding childhood sexual abuse in Africa	LANCET			English	Editorial Material									[Murray, Laura; Burnham, Gilbert] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Burnham, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Baltimore, MD 21205 USA.	gburnham@jhsph.edu						Bass JK, 2007, LANCET, V370, P918, DOI 10.1016/S0140-6736(07)61426-3; Donenberg Geri R, 2004, Contemp Psychiatry (Hagerstown Md), V2, P1; Donenberg Geri R, 2003, Contemp Psychiatry (Hagerstown Md), V2, P1; KIWAWULO C, 2008, NEW VISION      0801; Lalor K, 2004, CHILD ABUSE NEGLECT, V28, P833, DOI 10.1016/j.chiabu.2003.11.022; Lalor K, 2004, CHILD ABUSE NEGLECT, V28, P439, DOI 10.1016/j.chiabu.2003.07.005; ODOKORACH SF, 2008, ABUSED CHILD SEXUAL; Putnam FW, 2003, J AM ACAD CHILD PSY, V42, P269, DOI 10.1097/00004583-200303000-00006; Reza A, 2009, LANCET, V373, P1966, DOI 10.1016/S0140-6736(09)60247-6	9	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1924	1926		10.1016/S0140-6736(09)60344-5	http://dx.doi.org/10.1016/S0140-6736(09)60344-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456GT	19428099				2022-12-28	WOS:000266832500006
J	Fischer, J; Loss, D				Fischer, Jan; Loss, Daniel			Dealing with Decoherence	SCIENCE			English	Editorial Material							QUANTUM DOTS; SPIN		[Fischer, Jan; Loss, Daniel] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland	University of Basel	Fischer, J (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	jan.fischer@unibas.ch; daniel.loss@unibas.ch	Loss, Daniel/A-3721-2008	Loss, Daniel/0000-0001-5176-3073				Amasha S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046803; Braunecker B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.116403; Coish WA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195340; Fischer J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155329; Gerardot BD, 2008, NATURE, V451, P441, DOI 10.1038/nature06472; Greilich A, 2007, SCIENCE, V317, P1896, DOI 10.1126/science.1146850; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Heiss D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.241306; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Koppens FHL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236802; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Ono K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.256803; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955	15	40	40	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 5	2009	324	5932					1277	1278		10.1126/science.1169554	http://dx.doi.org/10.1126/science.1169554			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498155				2022-12-28	WOS:000266635100028
J	Gotoh, S; Chohnabayash, N				Gotoh, Shimpei; Chohnabayash, Naohiko			Infection 57 Years after Plombage	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gotoh, Shimpei; Chohnabayash, Naohiko] St Lukes Int Hosp, Tokyo 1048560, Japan	St. Luke's International Hospital	Gotoh, S (corresponding author), St Lukes Int Hosp, Tokyo 1048560, Japan.		Gotoh, Shimpei/AAD-9100-2021	Gotoh, Shimpei/0000-0002-8563-8200					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					E29	E29		10.1056/NEJMicm0707466	http://dx.doi.org/10.1056/NEJMicm0707466			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494210				2022-12-28	WOS:000266590500012
J	Buist, DSM; Anderson, ML; Reed, SD; Bowles, EJA; Fitzgibbons, ED; Gandara, JC; Seger, D; Newton, KM				Buist, Diana S. M.; Anderson, Melissa L.; Reed, Susan D.; Bowles, Erin J. Aiello; Fitzgibbons, E. Dawn; Gandara, Juleann C.; Seger, Deborah; Newton, Katherine M.			Short-Term Hormone Therapy Suspension and Mammography Recall A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ESTROGEN REPLACEMENT THERAPY; BREAST-CANCER RISK; QUALITY-OF-LIFE; SCREENING MAMMOGRAPHY; MENSTRUAL-CYCLE; DENSITY CHANGES; UNITED-STATES; FOLLOW-UP; AGE; WOMEN	Background: Without population-based evidence, some clinicians recommend short-term suspension of hormone therapy to improve the performance of mammography. Hormone therapy increases breast density, and abnormal screening mammograms are more common among women with denser breasts and among women using hormone therapy. Objective: To test whether 1 to 2 months of hormone therapy suspension before screening mammography decreases additional mammographic imaging (recall) in women age 45 to 80 years. Design: 3-group randomized, controlled trial. Setting: Integrated health plan in western Washington from 2004 to 2007. Patients: 1704 women age 45 to 80 years who used hormone therapy at their most recent screening (index) mammography, were due for screening (study) mammography, and were still using hormone therapy. Intervention: Block random assignment (by breast density and hormone therapy type) to no hormone therapy suspension (n = 567) or suspension for 1 month (n = 570) or 2 months (n = 567) before study mammography. One blinded expert radiologist interpreted all mammograms. Measurements: Recall was the primary outcome, and change in mammographic breast density (percentage and dense area) between the index and study mammograms was the secondary outcome. Results: Mammography recall rates were 11.3% (61 of 542 women in the no-suspension group), 12.3% (50 of 478 women in the 1-month suspension group), and 9.8% (44 of 451 women in the 2-month suspension group). No subgroups were identified in which brief suspension of hormone therapy resulted in decreased mammography recall. With suspension, decreases in percentage of breast density were orderly and statistically significant: 0.1% (no-suspension group), -0.9% (1-month suspension group), and -1.5% (2-month suspension group). Similar ordered decreases were observed for dense area. Women in the suspension groups experienced increased menopause symptoms. Limitations: Results can only be generalized to women age 45 to 80 years who have used hormone therapy for at least 1 year and will consider short-term suspension; most eligible women (61%) declined participation. Mammography recall was determined by 1 expert radiologist. Conclusion: Brief hormone therapy suspension was associated with small changes in breast density and did not affect recall rates. No evidence supports short-term hormone therapy suspension before mammography.	[Buist, Diana S. M.] Univ Washington, Grp Hlth Ctr Hlth Studies, Seattle, WA 98101 USA; Grp Hlth Permanente, Seattle, WA USA	University of Washington; University of Washington Seattle	Buist, DSM (corresponding author), Univ Washington, Grp Hlth Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	buist.d@ghc.org		Reed, Susan/0000-0001-7532-3785	Department of Defense [DAMD17-03-1-0447]; National Cancer Institute [U01CA63731]; NATIONAL CANCER INSTITUTE [U01CA063731] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The READ Trial was funded by the Department of Defense (DAMD17-03-1-0447). Study participants were recruited from the Group Health Breast Cancer Screening Program, which is funded by the National Cancer Institute (U01CA63731).	American Cancer Society, 2008, CANC FACTS FIG; American College of Radiology, 1998, BREAST IM REP DAT SY, V3rd; Baines CJ, 1997, CANCER-AM CANCER SOC, V80, P720; Barton MB, 2001, J GEN INTERN MED, V16, P150, DOI 10.1111/j.1525-1497.2001.00329.x; Beam CA, 1996, ARCH INTERN MED, V156, P209, DOI 10.1001/archinte.156.2.209; Beam CA, 1999, ACAD RADIOL, V6, P216, DOI 10.1016/S1076-6332(99)80208-6; Boudreau DM, 2006, MED CARE, V44, P62, DOI 10.1097/01.mlr.0000188969.83608.92; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BROWN ML, 1995, AM J ROENTGENOL, V165, P1373, DOI 10.2214/ajr.165.6.7484568; Buist DSM, 2006, CANCER EPIDEM BIOMAR, V15, P2303, DOI 10.1158/1055-9965.EPI-06-0475; Buist DSM, 2004, OBSTET GYNECOL, V104, P1042, DOI 10.1097/01.AOG.0000143826.38439.af; Burnside Elizabeth S, 2006, Radiol Case Rep, V1, P27, DOI 10.2484/rcr.v1i2.4; Byng JW, 1996, PHYS MED BIOL, V41, P909, DOI 10.1088/0031-9155/41/5/007; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Byrne C, 2008, AM J EPIDEMIOL, V167, P1037, DOI 10.1093/aje/kwn062; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Christodoulakos GE, 2006, MATURITAS, V54, P78, DOI 10.1016/j.maturitas.2005.08.012; *CTR MED MED SERV, 2005, MED POP YEAR 2005 11, V2008; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P1384, DOI 10.1093/jnci/djg048; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; Erel CT, 2001, MATURITAS, V40, P151, DOI 10.1016/S0378-5122(01)00236-5; Greendale GA, 2003, J NATL CANCER I, V95, P30, DOI 10.1093/jnci/95.1.30; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Harvey J, 2005, CLIMACTERIC, V8, P185, DOI 10.1080/13697130500103458; Harvey JA, 1997, J NATL CANCER I, V89, P1623, DOI 10.1093/jnci/89.21.1623; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Institute of Medicine, 2005, IMPR BREAST IM QUAL; Junkermann H, 2005, MATURITAS, V50, P105, DOI 10.1016/j.maturitas.2004.04.008; Kelemen LE, 2008, AM J EPIDEMIOL, V167, P1027, DOI 10.1093/aje/kwn063; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Lange CA, 1999, MOL ENDOCRINOL, V13, P829, DOI 10.1210/me.13.6.829; Laya MB, 1996, J NATL CANCER I, V88, P643, DOI 10.1093/jnci/88.10.643; LAYA MB, 1995, RADIOLOGY, V196, P433, DOI 10.1148/radiology.196.2.7617857; LEE HP, 1992, CANCER CAUSE CONTROL, V3, P313, DOI 10.1007/BF00146884; Lundstrom E, 1999, AM J OBSTET GYNECOL, V181, P348, DOI 10.1016/S0002-9378(99)70560-0; MA L, 1992, J NATL CANCER I, V84, P781, DOI 10.1093/jnci/84.10.781; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Marchesoni D, 2006, MATURITAS, V53, P59, DOI 10.1016/j.maturitas.2005.02.010; *N AM MEN SOC, 1999, MED LETT DRUGS THER, V41, P67; *NAT CANC I BCSC, ABN INT 4032556 SCRE; Randal J, 2004, J NATL CANCER I, V96, P1200, DOI 10.1093/jnci/96.16.1200; Reed SD, 2007, AM J OBSTET GYNECOL, V196, P593, DOI 10.1016/j.ajog.2007.03.008; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; Rutter CM, 2001, JAMA-J AM MED ASSOC, V285, P171, DOI 10.1001/jama.285.2.171; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Speroff L, 2002, J SOC GYNECOL INVEST, V9, P251, DOI 10.1016/S1071-5576(02)00189-2; TAPLIN SH, 1990, CANCER, V66, P812, DOI 10.1002/1097-0142(19900815)66:4<812::AID-CNCR2820660436>3.0.CO;2-1; Taplin SH, 2004, JNCI-J NATL CANCER I, V96, P1518, DOI 10.1093/jnci/djh284; Taplin SH, 2004, CANCER EPIDEM BIOMAR, V13, P225, DOI 10.1158/1055-9965.EPI-03-0206; Taplin SH, 2006, AM J ROENTGENOL, V187, P1475, DOI 10.2214/AJR.05.0940; Ursin G, 2001, CANCER EPIDEM BIOMAR, V10, P141; White E, 1998, J NATL CANCER I, V90, P906, DOI 10.1093/jnci/90.12.906; WIKLUND I, 1991, CONTROL CLIN TRIALS, V12, pS204, DOI 10.1016/S0197-2456(05)80024-8; WIKLUND I, 1992, MATURITAS, V14, P211, DOI 10.1016/0378-5122(92)90116-L	57	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					752	W135		10.7326/0003-4819-150-11-200906020-00003	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00003			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19487710	Green Accepted			2022-12-28	WOS:000266530000002
J	Fuchs, E				Fuchs, Elaine			The Tortoise and the Hair: Slow-Cycling Cells in the Stem Cell Race	CELL			English	Review							LABEL-RETAINING CELLS; HEMATOPOIETIC STEM; SELF-RENEWAL; PROLIFERATIVE CAPACITY; SMALL-INTESTINE; IN-VIVO; FOLLICLE; DIFFERENTIATION; SKIN; TRANSPLANTATION		Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR050452-05, R01 AR050452, R01 AR050452-04] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alonso L, 2005, J CELL BIOL, V170, P559, DOI 10.1083/jcb.200504131; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BJERKNES M, 1981, AM J ANAT, V160, P93, DOI 10.1002/aja.1001600108; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; NOWAK JA, 2009, THESIS ROCKEFELLER U; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 2003, J INVEST DERMATOL, V121, P13, DOI 10.1046/j.1523-1747.2003.12319.x; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Punzel M, 2001, ANN NY ACAD SCI, V938, P72; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sotiropoulou PA, 2008, STEM CELLS, V26, P2964, DOI 10.1634/stemcells.2008-0634; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	61	273	280	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					811	819		10.1016/j.cell.2009.05.002	http://dx.doi.org/10.1016/j.cell.2009.05.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490891	Bronze, Green Accepted			2022-12-28	WOS:000266454800013
J	Eichenfield, M; Camacho, R; Chan, J; Vahala, KJ; Painter, O				Eichenfield, Matt; Camacho, Ryan; Chan, Jasper; Vahala, Kerry J.; Painter, Oskar			A picogram- and nanometre-scale photonic-crystal optomechanical cavity	NATURE			English	Article							NANOCAVITY; DESIGN	The dynamic back-action caused by electromagnetic forces (radiation pressure) in optical(1-6) and microwave(7) cavities is of growing interest(8). Back-action cooling, for example, is being pursued as a means of achieving the quantum ground state of macroscopic mechanical oscillators. Work in the optical domain has revolved around millimetre-or micrometre-scale structures using the radiation pressure force. By comparison, in microwave devices, low-loss superconducting structures have been used for gradient-force-mediated coupling to a nanomechanical oscillator of picogram mass(7). Here we describe measurements of an optical system consisting of a pair of specially patterned nanoscale beams in which optical and mechanical energies are simultaneously localized to a cubic-micron-scale volume, and for which large perphoton optical gradient forces are realized. The resulting scale of the per-photon force and the mass of the structure enable the exploration of cavity optomechanical regimes in which, for example, the mechanical rigidity of the structure is dominantly provided by the internal light field itself. In addition to precision measurement and sensitive force detection(9), nano-optomechanics may find application in reconfigurable and tunable photonic systems(10), light-based radio-frequency communication(11) and the generation of giant optical nonlinearities for wavelength conversion and optical buffering(12).	[Eichenfield, Matt; Camacho, Ryan; Chan, Jasper; Vahala, Kerry J.; Painter, Oskar] CALTECH, Sr Lab Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology	Painter, O (corresponding author), CALTECH, Sr Lab Appl Phys, Pasadena, CA 91125 USA.	opainter@caltech.edu	Chan, Jasper/E-6801-2011; Camacho, Ryan M/B-1841-2010	Camacho, Ryan M/0000-0001-9644-1422; Painter, Oskar/0000-0002-1581-9209	US Defense Advanced Research Projects Agency; US National Science Foundation	US Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Science Foundation(National Science Foundation (NSF))	The authors would like to thank Q. Lin for extensive discussions regarding this work, and for pointing out the origin of the mechanical resonance interference. Funding for this work was provided by a US Defense Advanced Research Projects Agency seedling effort managed by H. Temkin, and through an Emerging Models and Technologies grant from the US National Science Foundation.	Arcizet O, 2006, NATURE, V444, P71, DOI 10.1038/nature05244; Ashkin A, 2000, IEEE J SEL TOP QUANT, V6, P841, DOI 10.1109/2944.902132; Chan J, 2009, OPT EXPRESS, V17, P3802, DOI 10.1364/OE.17.003802; Corbitt T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.160801; Eichenfield M, 2007, NAT PHOTONICS, V1, P416, DOI 10.1038/nphoton.2007.96; Gigan S, 2006, NATURE, V444, P67, DOI 10.1038/nature05273; Hossein-Zadeh M, 2008, IEEE PHOTONIC TECH L, V20, P234, DOI 10.1109/LPT.2007.912991; Ilic B, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1919395; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Kippenberg TJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033901; Kippenberg TJ, 2007, OPT EXPRESS, V15, P17172, DOI 10.1364/OE.15.017172; Li M, 2008, NATURE, V456, P480, DOI 10.1038/nature07545; Marquardt F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.103901; McCutcheon MW, 2008, OPT EXPRESS, V16, P19136, DOI 10.1364/OE.16.019136; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; Notomi M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.023903; Olsson RH, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/1/012002; Povinelli ML, 2005, OPT LETT, V30, P3042, DOI 10.1364/OL.30.003042; Rakich PT, 2007, NAT PHOTONICS, V1, P658, DOI 10.1038/nphoton.2007.203; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Schliesser A, 2008, NAT PHYS, V4, P415, DOI 10.1038/nphys939; Schliesser A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243905; Song BS, 2005, NAT MATER, V4, P207, DOI 10.1038/nmat1320; Srinivasan K, 2005, IEEE J SEL AREA COMM, V23, P1321, DOI 10.1109/JSAC.2005.851212; Stowe TD, 1997, APPL PHYS LETT, V71, P288, DOI 10.1063/1.119522; Takahashi Y, 2007, OPT EXPRESS, V15, P17206, DOI 10.1364/OE.15.017206; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Tittonen I, 1999, PHYS REV A, V59, P1038, DOI 10.1103/PhysRevA.59.1038; Verbridge SS, 2006, J APPL PHYS, V99, DOI 10.1063/1.2204829; Verbridge SS, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2952762	30	539	550	6	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					550	U79		10.1038/nature08061	http://dx.doi.org/10.1038/nature08061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19489118	Green Accepted, Green Submitted			2022-12-28	WOS:000266370500035
J	Greer, DM; Friday, RP; Romero, J; Auluck, PK				Greer, David M.; Friday, Robert P.; Romero, Javier; Auluck, Pavan K.			A Man with Progressive Neurologic Deficits Neuro-Behcet's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; CNS INVOLVEMENT; MANIFESTATIONS; MRI		[Greer, David M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Friday, Robert P.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Romero, Javier] Massachusetts Gen Hosp, Div Neuroradiol, Boston, MA 02114 USA; [Auluck, Pavan K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Greer, David M.] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Friday, Robert P.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Romero, Javier] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Auluck, Pavan K.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Greer, DM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Auluck, Pavan K/A-1160-2010	Greer, David/0000-0002-2026-8333				Akman-Demir G, 2003, NEURORADIOLOGY, V45, P851, DOI 10.1007/s00234-003-1102-1; Akman-Demir G, 1999, BRAIN, V122, P2171, DOI 10.1093/brain/122.11.2171; Al-Araji A, 2009, LANCET NEUROL, V8, P192, DOI 10.1016/S1474-4422(09)70015-8; Arai Y, 2006, NEUROPATHOLOGY, V26, P579, DOI 10.1111/j.1440-1789.2006.00734.x; Bang D, 2003, J KOREAN MED SCI, V18, P231, DOI 10.3346/jkms.2003.18.2.231; Bihan H, 2007, MEDICINE, V86, P259, DOI 10.1097/MD.0b013e31815585aa; CALABRESE LH, 1988, MEDICINE, V67, P20, DOI 10.1097/00005792-198801000-00002; CARR J, 1993, BRIT J RHEUMATOL, V32, P644; Chin RL, 2005, CURR OPIN RHEUMATOL, V17, P91; Deuter CME, 2008, PROG RETIN EYE RES, V27, P111, DOI 10.1016/j.preteyeres.2007.09.002; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Hadfield MG, 1997, CLIN NEUROPATHOL, V16, P55; Haghighi AB, 2009, EXPERT REV NEUROTHER, V9, P565, DOI [10.1586/ern.09.11, 10.1586/ERN.09.11]; Hamuryudan V, 1997, ARTHRITIS RHEUM, V40, P769, DOI 10.1002/art.1780400425; HATEMI G, 2008, ANN RHEUM DIS   0417; Hindmarsh T, 1986, Acta Radiol Suppl, V369, P192; Hirohata S, 2008, J NEUROL SCI, V267, P41, DOI 10.1016/j.jns.2007.09.041; Kidd D, 1999, BRAIN, V122, P2183, DOI 10.1093/brain/122.11.2183; Kocer N, 1999, AM J NEURORADIOL, V20, P1015; Koch M, 2008, EPILEPSIA, V49, P948, DOI 10.1111/j.1528-1167.2008.01565.x; Kotter I, 2006, CLIN RHEUMATOL, V25, P482, DOI 10.1007/s10067-005-0070-8; LUXON L, 1979, LANCET, V1, P90; Naranjo A, 2004, CLIN EXP RHEUMATOL, V22, P427; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Pipitone N, 2008, ARTHRIT RHEUM-ARTHR, V59, P285, DOI 10.1002/art.23345; Rosenblatt BJ, 2003, OPHTHALMOLOGY, V110, P1650, DOI 10.1016/S0161-6420(03)00491-3; Serdaroglu P, 1998, J NEUROL, V245, P197, DOI 10.1007/s004150050205; SERDAROGLU P, 1989, ARCH NEUROL-CHICAGO, V46, P265, DOI 10.1001/archneur.1989.00520390031011; Sfikakis PP, 2007, RHEUMATOLOGY, V46, P736, DOI 10.1093/rheumatology/kem034; SILMAN AJ, 1990, LANCET, V335, P1078; Siva A, 2004, CURR OPIN NEUROL, V17, P347, DOI 10.1097/00019052-200406000-00017; Spranger M, 1997, NEUROLOGY, V48, P263, DOI 10.1212/WNL.48.1.263; Tirilomis T, 2001, CHEST, V120, P2116, DOI 10.1378/chest.120.6.2116; Tsai Julie H., 2007, International Ophthalmology, V27, P189, DOI 10.1007/s10792-007-9044-y; YOUNG AW, 1970, MOD TREAT, V7, P973	35	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2341	2351		10.1056/NEJMcpc0810842	http://dx.doi.org/10.1056/NEJMcpc0810842			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474432				2022-12-28	WOS:000266367300012
J	Jacobson, AM				Jacobson, Alan M.			Diabetes: finding "a clean well-lighted place"	LANCET			English	Editorial Material							COGNITIVE-BEHAVIOR THERAPY; DEPRESSION; PATIENT; CARE; MELLITUS; TRIAL		Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.	Jacobson, AM (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.	Alan.jacobson@joslin.harvard.edu						Back AL, 2009, ARCH INTERN MED, V169, P474, DOI 10.1001/archinternmed.2008.583; Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; HEMINGWAY E, 1987, SHORT STORIES E HEMI, P379; Ismail K, 2008, ANN INTERN MED, V149, P708, DOI 10.7326/0003-4819-149-10-200811180-00005; Jacobson AM, 1996, NEW ENGL J MED, V334, P1249, DOI 10.1056/NEJM199605093341907; JACOBSON AM, 1991, DIABETES CARE, V14, P599, DOI 10.2337/diacare.14.7.599; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Laffel L M, 1998, Qual Manag Health Care, V6, P53; Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005; ROST KM, 1991, DIABETES CARE, V14, P881, DOI 10.2337/diacare.14.10.881	12	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1746	1747		10.1016/S0140-6736(09)60963-6	http://dx.doi.org/10.1016/S0140-6736(09)60963-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19465218				2022-12-28	WOS:000266337300010
J	Lockwood, CJ; Nadel, AS; King, ME; Roberts, DJ				Lockwood, Charles J.; Nadel, Allan S.; King, Mary Etta; Roberts, Drucilla J.			A Pregnant Woman with an Abnormal Fetal Ultrasound Study Hydrops fetalis and hydrops placentalis due to fetal (congenital) pulmonary lymphangiectasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONIMMUNE HYDROPS; NOONAN-SYNDROME; DIAGNOSIS; IDENTIFICATION; CHYLOTHORAX; SEQUENCE		[Lockwood, Charles J.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Nadel, Allan S.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [King, Mary Etta] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Nadel, Allan S.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [King, Mary Etta] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Roberts, Drucilla J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lockwood, CJ (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.		Roberts, Drucilla/AAB-6379-2022					Abrams ME, 2007, PEDIATRICS, V120, P84, DOI 10.1542/peds.2006-3680; Bellini C, 2005, LYMPHOLOGY, V38, P111; BENACERRAF BR, 1987, NEW ENGL J MED, V317, P1371, DOI 10.1056/NEJM198711263172203; Bieber F R, 1979, Birth Defects Orig Artic Ser, V15, P51; Buchner M, 2007, PRENATAL DIAG, V27, P1069, DOI 10.1002/pd.1832; Burin MG, 2004, PRENATAL DIAG, V24, P653, DOI 10.1002/pd.967; Colmant C, 2006, PRENATAL DIAG, V26, P750, DOI 10.1002/pd.1467; Den Hollander NS, 2000, ULTRASOUND OBST GYN, V16, P87, DOI 10.1046/j.1469-0705.2000.00148.x; Eccles Diane, 2003, J Obstet Gynaecol, V23, P666; Ferrero GB, 2008, EUR J MED GENET, V51, P566, DOI 10.1016/j.ejmg.2008.06.011; Grethel EJ, 2007, FETAL DIAGN THER, V22, P269, DOI 10.1159/000100788; Gundogan M, 2006, FETAL DIAGN THER, V21, P466, DOI 10.1159/000093890; Hoehn T, 2006, EUR RESPIR J, V27, P1311, DOI 10.1183/09031936.06.00082705; Jongmans M, 2005, AM J MED GENET A, V134A, P165, DOI 10.1002/ajmg.a.30598; Laje P, 2008, FETAL DIAGN THER, V24, P225, DOI 10.1159/000151343; Loren David J, 2005, J Perinatol, V25, P491, DOI 10.1038/sj.jp.7211335; MACHIN GA, 1989, AM J MED GENET, V34, P366, DOI 10.1002/ajmg.1320340313; Manning MA, 2004, AM J MED GENET A, V125A, P240, DOI 10.1002/ajmg.a.20467; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; MOERMAN P, 1993, AM J MED GENET, V47, P54, DOI 10.1002/ajmg.1320470112; Nicolaides KH, 2004, ULTRASOUND EXAMINATI; NOONAN JA, 1970, AM J DIS CHILD, V120, P314, DOI 10.1001/archpedi.1970.02100090088006; Stevenson DA, 2006, AM J MED GENET A, V140A, P368, DOI 10.1002/ajmg.a.31093; Thornton CM, 1997, AM J MED GENET, V69, P406, DOI 10.1002/(SICI)1096-8628(19970414)69:4<406::AID-AJMG13>3.0.CO;2-R; Tongsong T, 2000, ULTRASOUND OBST GYN, V15, P428, DOI 10.1046/j.1469-0705.2000.00126.x; TORIELLO HV, 1985, AM J MED GENET, V21, P271, DOI 10.1002/ajmg.1320210208; WARSOF SL, 1986, CLIN OBSTET GYNECOL, V29, P533, DOI 10.1097/00003081-198609000-00009; Wieacker P, 2005, AM J MED GENET A, V132A, P318, DOI 10.1002/ajmg.a.30392; Wilson RD, 2006, PRENATAL DIAG, V26, P1058, DOI 10.1002/pd.1555; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Xiao ZY, 2009, WORLD J PEDIATR, V5, P68, DOI 10.1007/s12519-009-0014-5; Zaki M, 2007, ULTRASOUND OBST GYN, V29, P284, DOI 10.1002/uog.3859	32	7	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2225	2235		10.1056/NEJMcpc0809064	http://dx.doi.org/10.1056/NEJMcpc0809064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458368				2022-12-28	WOS:000266206000011
J	Auerbach, AD; Hilton, JF; Maselli, J; Pekow, PS; Rothberg, MB; Lindenauer, PK				Auerbach, Andrew D.; Hilton, Joan F.; Maselli, Judith; Pekow, Penelope S.; Rothberg, Michael B.; Lindenauer, Peter K.			Shop for Quality or Volume? Volume, Quality, and Outcomes of Coronary Artery Bypass Surgery	ANNALS OF INTERNAL MEDICINE			English	Article							OPERATIVE MORTALITY; HOSPITAL VOLUME; THERAPY; CARE; PAY	Background: Care from high-volume centers or surgeons has been associated with lower mortality rates in coronary artery bypass surgery, but how volume and quality of care relate to each other is not well understood. Objective: To determine how volume and differences in quality of care influence outcomes after coronary artery bypass surgery. Design: Observational cohort. Setting: 164 hospitals in the United States. Patients: 81 289 patients 18 years or older who had coronary artery bypass grafting from 1 October 2003 to 1 September 2005. Measurements: Hospital and surgeon case volumes were estimated by using a data set. Quality measures were defined by whether patients received specific medications and by counting the number of measures missed. Hierarchical models were used to estimate effects of volume and quality on death and readmission up to 30 days. Results: After adjustment for clinical factors, lowest surgeon volume and highest hospital volume were associated with higher mortality rates and lower readmission risk, respectively. Patients who did not receive aspirin (odds ratio, 1.89 [95% CI, 1.65 to 2.16) or beta-blockers (odds ratio, 1.29 [CI, 1.12 to 1.49]) had higher odds for death, after adjustment for clinical risk factors and case volume. Adjustment for individual quality measures did not alter associations between volume and readmission or death. However, if no quality measures were missed, mortality rates at the lowest-volume centers (adjusted mortality rate, 1.05% [CI, 0.81% to 1.29%]) and highest-volume centers (adjusted mortality rate, 0.98% [CI, 0.72% to 1.25%]) were similar. Limitation: Because administrative data were used, the quality measures may not replicate measures collected through chart abstraction. Conclusion: Maximizing adherence to quality measures is associated with improved mortality rates, independent of hospital or surgeon volume. Primary Funding Source: California HealthCare Foundation.	[Auerbach, Andrew D.] Univ Calif San Francisco, Div Hosp Med, Dept Med, San Francisco, CA 94143 USA; Tufts Univ, Sch Med, Baystate Med Ctr, Springfield, MA 01199 USA	University of California System; University of California San Francisco; Baystate Medical Center; Tufts University	Auerbach, AD (corresponding author), Univ Calif San Francisco, Div Hosp Med, Dept Med, 505 Parnassus Ave,Box 0131, San Francisco, CA 94143 USA.	ada@medicine.ucsf.edu	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Auerbach, Andrew/0000-0001-8440-0527	California HealthCare Foundation [05-1755]; Agency for Healthcare Research and Quality; Patient Safety Research and Training Grant [K08 HS11416-02]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS011416] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL098372] Funding Source: NIH RePORTER	California HealthCare Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Patient Safety Research and Training Grant; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the California HealthCare Foundation (grant number 05-1755) and Agency for Healthcare Research and Quality (Patient Safety Research and Training Grant K08 HS11416-02; Dr. Auerbach).	*AM COLL CARD, 2004, CIRCULATION, V110, pE340; Birkmeyer JD, 2006, ANN SURG, V243, P411, DOI 10.1097/01.sla.0000201800.45264.51; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2004, SURGERY, V135, P569, DOI 10.1016/j.surg.2004.03.004; Birkmeyer JD, 2000, JAMA-J AM MED ASSOC, V283, P1191, DOI 10.1001/jama.283.9.1191; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birkmeyer JD, 2006, CANCER-AM CANCER SOC, V106, P2476, DOI 10.1002/cncr.21888; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Carey JS, 2005, J THORAC CARDIOV SUR, V129, P1276, DOI 10.1016/j.jtcvs.2004.12.043; Casale AS, 2007, ANN SURG, V246, P613, DOI 10.1097/SLA.0b013e318155a996; Christian CK, 2003, ANN SURG, V238, P447, DOI 10.1097/01.sla.0000089850.27592.eb; Dimick J, 2004, HLTH AFF MILLWOOD S; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Glance LG, 2006, HEALTH SERV RES, V41, P1413, DOI 10.1111/j.1475-6773.2006.00554.x; Glance LG, 2006, HEALTH SERV RES, V41, P231, DOI 10.1111/j.1475-6773.2005.00419.x; Greenfield LJ, 2003, ANN SURG, V238, P455; Ho V, 2006, ANN SURG ONCOL, V13, P851, DOI 10.1245/ASO.2006.07.021; Iezzoni LI, 2007, MED CARE, V45, P280, DOI 10.1097/01.mlr.0000259078.54902.fe; Khuri SF, 2005, WORLD J SURG, V29, P1222, DOI 10.1007/s00268-005-7987-6; Lin HC, 2008, J THORAC CARDIOV SUR, V135, P923, DOI 10.1016/j.jtcvs.2007.10.005; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; MARCIN J, 1998, HEALTH SERV RES, V174, P2004; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195; RICCIARDI R, 2008, ARCH SURG-CHICAGO, V143, P344; Ricciardi R, 2008, ARCH SURG-CHICAGO, V143, P338, DOI 10.1001/archsurg.143.4.338; Shahian DM, 2008, J THORAC CARDIOV SUR, V135, P1202, DOI 10.1016/j.jtcvs.2007.12.037; Shahian DM, 2007, ANN THORAC SURG, V83, pS3, DOI 10.1016/j.athoracsur.2007.01.053; The Joint Commission, SURG CARE IMPROVEMEN; Ward MM, 2004, J RURAL HEALTH, V20, P344, DOI 10.1111/j.1748-0361.2004.tb00048.x; Wen HC, 2006, ANN THORAC SURG, V81, P835, DOI 10.1016/j.athoracsur.2005.09.031; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	36	57	58	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					696	U6		10.7326/0003-4819-150-10-200905190-00007	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	448TQ	19451576	Green Accepted			2022-12-28	WOS:000266285300005
J	Norenberg, DD				Norenberg, David D.			The Demise of Primary Care: A Diatribe From the Trenches	ANNALS OF INTERNAL MEDICINE			English	Article								Medical school graduates are avoiding primary care. The very aspects that once attracted students have been subverted. The breadth of practice that was once appealing has become the breadth of heavy-handed scrutiny, as politicians and business leaders have demanded quality-simplistically defined as dogmatic adherence to a standard. Individualized clinical judgment has been devalued; thinking has been replaced by algorithms. Practice guidelines have been usurped by pay-for-performance police, on patrol for deviations-not understanding that knowing and allowing for exceptions is the heart and soul of primary care. The coercive surveillance of "Quality Improvement" has become oppressive, making single organ-system specialties increasingly attractive (or at least more tolerable). Generalists are spending so much time proving they are good doctors, they don't have time to be good doctors. A remedy is suggested: a pilot project of volunteer salaried internists (more trusted, less audited) commissioned to our expandable national health care program, Medicare.	Gundersen Lutheran Med Ctr, La Crosse, WI 54601 USA	Gundersen Lutheran Medical Center	Norenberg, DD (corresponding author), Gundersen Lutheran Med Ctr, 1900 South Ave, La Crosse, WI 54601 USA.								0	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					725	726		10.7326/0003-4819-150-10-200905190-00011	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451580				2022-12-28	WOS:000266285300009
J	Kidd, T				Kidd, Thomas			Crossing the Line	SCIENCE			English	Editorial Material							AXON GUIDANCE; DROSOPHILA-MIDLINE; COMMISSURAL AXONS; ROBO; TRANSCRIPTION; RECEPTORS; NETRINS; PROTEIN; DSCAM; SLIT		Univ Nevada, Dept Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Kidd, T (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	tkidd@unr.edu	Wadham, Ben/I-7166-2015; Kidd, Thomas/AAT-9993-2020	Wadham, Ben/0000-0003-1340-3485; Kidd, Thomas/0000-0001-7190-4208				Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Garbe DS, 2007, DEVELOPMENT, V134, P4325, DOI 10.1242/dev.012872; GHYSEN A, 1992, INT J DEV BIOL, V36, P47; Gilestro GF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003798; Goldschneider D, 2008, MOL CELL BIOL, V28, P4068, DOI 10.1128/MCB.02114-07; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320	15	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					893	894		10.1126/science.1174216	http://dx.doi.org/10.1126/science.1174216			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443775				2022-12-28	WOS:000266048800025
J	Simonetta, KR; Kazmirski, SL; Goedken, ER; Cantor, AJ; Kelch, BA; McNally, R; Seyedin, SN; Makino, DL; O'Donnell, M; Kuriyan, J				Simonetta, Kyle R.; Kazmirski, Steven L.; Goedken, Eric R.; Cantor, Aaron J.; Kelch, Brian A.; McNally, Randall; Seyedin, Steven N.; Makino, Debora L.; O'Donnell, Mike; Kuriyan, John			The Mechanism of ATP-Dependent Primer-Template Recognition by a Clamp Loader Complex	CELL			English	Article							DNA-POLYMERASE-III; REPLICATION FACTOR-C; CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI SSB; CRYSTAL-STRUCTURE; SLIDING CLAMP; GAMMA-COMPLEX; DELTA-SUBUNIT; STRUCTURAL-ANALYSIS; ACCESSORY PROTEINS	Clamp loaders load sliding clamps onto primer-template DNA. The structure of the E. coli clamp loader bound to DNA reveals the formation of an ATP-dependent spiral of ATPase domains that tracks only the template strand, allowing recognition of both RNA and DNA primers. Unlike hexameric helicases, in which DNA translocation requires distinct conformations of the ATPase domains, the clamp loader spiral is symmetric and is set up to trigger release upon DNA recognition. Specificity for primed DNA arises from blockage of the end of the primer and accommodation of the emerging template along a surface groove. A related structure reveals how the c protein, essential for coupling the clamp loader to single-stranded DNA-binding protein (SSB), binds to the clamp loader. By stabilizing a conformation of the clamp loader that is consistent with the ATPase spiral observed upon DNA binding, c binding promotes the clamp-loading activity of the complex.	[Simonetta, Kyle R.; Kazmirski, Steven L.; Goedken, Eric R.; Cantor, Aaron J.; Kelch, Brian A.; McNally, Randall; Seyedin, Steven N.; Makino, Debora L.; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu		McNally, Randall/0000-0002-1919-2466; O'Donnell, Michael/0000-0001-9002-4214; Cantor, Aaron/0000-0002-2158-6253; Seyedin, Steven/0000-0002-6841-968X	NIH [GM45547, GM38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839, R01GM045547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Berger and members of the Kuriyan Lab, in particular Meindert Lamers, for helpful discussions. We are also thankful to David King for synthesis of the c peptide and to the staff at beamlines 8.2.1, 8.2.2, and 5.0.1 of the Advanced Light Source (Berkeley, CA) for their help and technical support. This work was supported in part by grants from the NIH to J. K. (GM45547) and M. O. (GM38839).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson SG, 2007, J BIOL CHEM, V282, P7035, DOI 10.1074/jbc.M610136200; Ason B, 2003, J BIOL CHEM, V278, P10033, DOI 10.1074/jbc.M211741200; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Chen S, 2008, NUCLEIC ACIDS RES, V36, P3274, DOI 10.1093/nar/gkn157; Coman MM, 2004, J MOL BIOL, V342, P1457, DOI 10.1016/j.jmb.2004.07.097; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DONG ZM, 1993, J BIOL CHEM, V268, P11758; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Gao DX, 2001, J BIOL CHEM, V276, P4447, DOI 10.1074/jbc.M009827200; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Goedken ER, 2004, J MOL BIOL, V336, P1047, DOI 10.1016/j.jmb.2003.12.074; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 2004, EUR J BIOCHEM, V271, P439, DOI 10.1046/j.1432-1033.2003.03944.x; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Jarvis TC, 2005, J BIOL CHEM, V280, P40465, DOI 10.1074/jbc.M508310200; Jarvis TC, 2005, J BIOL CHEM, V280, P7890, DOI 10.1074/jbc.M412263200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Neuwald AF, 1999, GENOME RES, V9, P27; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; Ozawa K, 2005, J BIOMOL NMR, V32, P235, DOI 10.1007/s10858-005-7946-4; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	56	100	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					659	671		10.1016/j.cell.2009.03.044	http://dx.doi.org/10.1016/j.cell.2009.03.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450514	Green Accepted, Bronze			2022-12-28	WOS:000266114100015
J	Abraham, P; Juhasz, A; Dullemond, CP; Kospal, A; Van Boekel, R; Bouwman, J; Henning, T; Moor, A; Mosoni, L; Sicilia-Aguilar, A; Sipos, N				Abraham, P.; Juhasz, A.; Dullemond, C. P.; Kospal, A.; Van Boekel, R.; Bouwman, J.; Henning, Th.; Moor, A.; Mosoni, L.; Sicilia-Aguilar, A.; Sipos, N.			Episodic formation of cometary material in the outburst of a young Sun-like star	NATURE			English	Article							CRYSTALLINE SILICATES; DUST; EVOLUTION; SPECTRA; GRAINS; DISKS	The Solar System originated in a cloud of interstellar gas and dust. The dust is in the form of amorphous silicate particles(1,2) and carbonaceous dust. The composition of cometary material, however, shows that a significant fraction of the amorphous silicate dust was transformed into crystalline form during the early evolution of the protosolar nebula(3). How and when this transformation happened has been a question of debate, with the main options being heating by the young Sun(4,5) and shock heating(6). Here we report mid-infrared features in the outburst spectrum of the young Sun-like star EX Lupi that were not present in quiescence. We attribute them to crystalline forsterite. We conclude that the crystals were produced through thermal annealing in the surface layer of the inner disk by heat from the outburst, a process that has hitherto not been considered. The observed lack of cold crystals excludes shock heating at larger radii.	[Abraham, P.; Moor, A.; Mosoni, L.; Sipos, N.] Hungarian Acad Sci, Konkoly Observ Budapest, H-1525 Budapest, Hungary; [Juhasz, A.; Dullemond, C. P.; Van Boekel, R.; Bouwman, J.; Henning, Th.; Mosoni, L.; Sicilia-Aguilar, A.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Kospal, A.] Leiden Univ, Leiden Observ, NL-2333 CA Leiden, Netherlands	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; Max Planck Society; Leiden University; Leiden University - Excl LUMC	Abraham, P (corresponding author), Hungarian Acad Sci, Konkoly Observ Budapest, POB 67, H-1525 Budapest, Hungary.	abraham@konkoly.hu	Henning, Thomas K/O-4372-2018	Henning, Thomas K/0000-0002-1493-300X; Juhasz, Attila/0000-0002-5552-1618; Dullemond, Cornelis/0000-0002-7078-5910; Bouwman, Jeroen/0000-0003-4757-2500; Kospal, Agnes/0000-0001-7157-6275; Mosoni, Laurent/0000-0002-5409-6760; Sicilia-Aguilar, Aurora/0000-0002-8421-0851	Hungarian Research Fund; Netherlands Organization for Scientific Research	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Acknowledgements We are grateful to A. F. Jones for providing us with timely visual observations of EX Lupi during the preparation of our infrared measurements. The presented work was partly supported by the Hungarian Research Fund. The research of A . K. is supported by the Netherlands Organization for Scientific Research.	Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bouwman J, 2001, ASTRON ASTROPHYS, V375, P950, DOI 10.1051/0004-6361:20010878; Bringa EM, 2007, ASTROPHYS J, V662, P372, DOI 10.1086/517865; Ciesla FJ, 2009, ICARUS, V200, P655, DOI 10.1016/j.icarus.2008.12.009; Colangeli L, 2003, ASTRON ASTROPHYS REV, V11, P97, DOI 10.1007/s00159-002-0017-x; DORSCHNER J, 1995, ASTRON ASTROPHYS, V300, P503; Gail HP, 2001, ASTRON ASTROPHYS, V378, P192, DOI 10.1051/0004-6361:20011130; GLAUSER AM, 2008, P 5 SPITZ C NEW LIGH; Hallenbeck SL, 1998, ICARUS, V131, P198, DOI 10.1006/icar.1997.5854; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; Harker DE, 2002, ASTROPHYS J, V565, pL109, DOI 10.1086/339363; Hartmann L, 1996, ANNU REV ASTRON ASTR, V34, P207, DOI 10.1146/annurev.astro.34.1.207; HERBIG GH, 1977, ASTROPHYS J, V217, P693, DOI 10.1086/155615; HERBST W, 1994, ASTRON J, V108, P1906, DOI 10.1086/117204; Jager C, 1998, ASTRON ASTROPHYS, V339, P904; JONES AFA, 2008, 1217 CENTR BUR EL TE; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Koike C, 2003, ASTRON ASTROPHYS, V399, P1101, DOI 10.1051/0004-6361:20021831; Kospal A., 2008, INFORM B VARIABLE ST, V5819, P1; Li MP, 2007, MON NOT R ASTRON SOC, V382, pL26, DOI 10.1111/j.1745-3933.2007.00382.x; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; Quanz SP, 2007, ASTROPHYS J, V668, P359, DOI 10.1086/521219; Sicilia-Aguilar A, 2008, ASTROPHYS J, V673, P382, DOI 10.1086/524055; SIPOS N, ASTRON ASTROPH UNPUB; Watson DM, 2009, ASTROPHYS J SUPPL S, V180, P84, DOI 10.1088/0067-0049/180/1/84	26	114	114	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					224	226		10.1038/nature08004	http://dx.doi.org/10.1038/nature08004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444209	Green Submitted			2022-12-28	WOS:000266036100034
J	Jankowska, EA; Rozentryt, P; Ponikowska, B; Hartmann, O; Kustrzycka-Kratochwil, D; Reczuch, K; Nowak, J; Borodulin-Nadzieja, L; Polonski, L; Banasiak, W; Poole-Wilson, PA; Anker, SD; Ponikowski, P				Jankowska, Ewa A.; Rozentryt, Piotr; Ponikowska, Beata; Hartmann, Oliver; Kustrzycka-Kratochwil, Dorota; Reczuch, Krzysztof; Nowak, Jolanta; Borodulin-Nadzieja, Ludmila; Polonski, Lech; Banasiak, Waldemar; Poole-Wilson, Philip A.; Anker, Stefan D.; Ponikowski, Piotr			Circulating Estradiol and Mortality in Men With Systolic Chronic Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN-RECEPTOR-ALPHA; ENDOGENOUS SEX-HORMONES; ENDOTHELIAL PROGENITOR CELLS; TUMOR-NECROSIS-FACTOR; CARDIOVASCULAR-DISEASE; GENE VARIATION; BLOOD-FLOW; RISK; ASSOCIATION; DEFICIENCY	Context Androgen deficiency is common in men with chronic heart failure (HF) and is associated with increased morbidity and mortality. Estrogens are formed by the aromatization of androgens; therefore, abnormal estrogen metabolism would be anticipated in HF. Objective To examine the relationship between serum concentration of estradiol and mortality in men with chronic HF and reduced left ventricular ejection fraction (LVEF). Design, Setting, and Participants A prospective observational study at 2 tertiary cardiology centers (Wroclaw and Zabrze, Poland) of 501 men (mean [SD] age, 58 [ 12] years) with chronic HF, LVEF of 28% (SD, 8%), and New York Heart Association [NYHA] classes 1, 2, 3, and 4 of 52, 231, 181, and 37, respectively, who were recruited between January 1, 2002, and May 31, 2006. Cohort was divided into quintiles of serum estradiol (quintile 1, < 12.90 pg/mL; quintile 2, 12.90-21.79 pg/mL; quintile 3, 21.80-30.11 pg/mL; quintile 4, 30.12-37.39 pg/mL; and quintile 5, >= 37.40 pg/mL). Quintile 3 was considered prospectively as the reference group. Main Outcome Measures Serum concentrations of estradiol and androgens (total testosterone and dehydroepiandrosterone sulfate [DHEA-S]) were measured using immunoassays. Results Among 501 men with chronic HF, 171 deaths (34%) occurred during the 3-year follow-up. Compared with quintile 3, men in the lowest and highest estradiol quintiles had increased mortality (adjusted hazard ratio [HR], 4.17; 95% confidence interval [CI], 2.33-7.45 and HR, 2.33; 95% CI, 1.30-4.18; respectively; P < .001). These 2 quintiles had different clinical characteristics (quintile 1: increased serum total testosterone, decreased serum DHEA- S, advanced NYHA class, impaired renal function, and decreased total fat tissue mass; and quintile 5: increased serum bilirubin and liver enzymes, and decreased serum sodium; all P < .05 vs quintile 3). For increasing estradiol quintiles, 3-year survival rates adjusted for clinical variables and androgens were 44.6% ( 95% CI, 24.4%-63.0%), 65.8% (95% CI, 47.3%-79.2%), 82.4% (95% CI, 69.4%-90.2%), 79.0% ( 95% CI, 65.5%-87.6%), and 63.6% (95% CI, 46.6%-76.5%); respectively (P < .001). Conclusion Among men with chronic HF and reduced LVEF, high and low concentrations of estradiol compared with the middle quintile of estradiol are related to an increased mortality. JAMA. 2009;301(18):1892-1901 www.jama.com	[Jankowska, Ewa A.; Kustrzycka-Kratochwil, Dorota; Reczuch, Krzysztof; Banasiak, Waldemar; Ponikowski, Piotr] Mil Hosp, Dept Cardiol, Ctr Heart Dis, PL-50981 Wroclaw, Poland; [Jankowska, Ewa A.] Polish Acad Sci, Inst Anthropol, Wroclaw, Poland; [Jankowska, Ewa A.; Reczuch, Krzysztof; Ponikowski, Piotr] Wroclaw Med Univ, Dept Heart Dis, Wroclaw, Poland; [Ponikowska, Beata; Borodulin-Nadzieja, Ludmila] Wroclaw Med Univ, Dept Physiol, Wroclaw, Poland; [Rozentryt, Piotr; Nowak, Jolanta; Polonski, Lech] Silesian Ctr Heart Dis, Dept Cardiol 2, Zabrze, Poland; [Hartmann, Oliver; Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany; [Anker, Stefan D.] Ist Ricovero & Cura Carattere Sci, Ctr Clin & Basic Res, Rome, Italy; [Poole-Wilson, Philip A.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England	Polish Academy of Sciences; Wroclaw Medical University; Wroclaw Medical University; Silesian Center for Heart Diseases; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Center Clinical & Basic Research; Imperial College London; Royal Brompton Hospital	Jankowska, EA (corresponding author), Mil Hosp, Dept Cardiol, Ctr Heart Dis, Ul Weigla 5, PL-50981 Wroclaw, Poland.	jankowska@antro.pan.wroc.pl	Ponikowski, Piotr/O-6454-2015; Jankowska, Ewa A/AAY-3040-2020; Reczuch, Krzysztof/ABI-1216-2020; Jankowska, Ewa A/G-7960-2011; Jankowska, Ewa A/O-6358-2015; Jankowska, Ewa/ABD-4073-2021	Ponikowski, Piotr/0000-0002-3391-7064; Jankowska, Ewa A/0000-0002-9202-432X; Reczuch, Krzysztof/0000-0002-1699-739X; Jankowska, Ewa A/0000-0002-9202-432X; Nowak, Jolanta/0000-0003-0462-0154; Rozentryt, Piotr/0000-0002-8979-2205	Polish Ministry of Science and Higher Education [3 T11F 008 30]; Polish Science Foundation	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish Science Foundation(Foundation for Polish Science)	This research was supported by grant 3 T11F 008 30 from the Polish Ministry of Science and Higher Education (costs of the laboratory assessments). Dr Jankowska was supported by a Postdoctoral Research Fellowship from the Polish Science Foundation.	Abbott RD, 2007, NEUROLOGY, V68, P563, DOI 10.1212/01.wnl.0000254473.88647.ca; Adamopoulos S, 2002, EUR J HEART FAIL, V4, P719, DOI 10.1016/S1388-9842(02)00170-8; Angstwurm MWA, 2005, CRIT CARE MED, V33, P2786, DOI 10.1097/01.CCM.0000190242.24410.17; Anker SD, 1997, EUR HEART J, V18, P259; Anker SD, 1997, J AM COLL CARDIOL, V30, P997, DOI 10.1016/S0735-1097(97)00262-3; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Anker SD, 1997, CIRCULATION, V96, P526; Arnlov J, 2006, ANN INTERN MED, V145, P176, DOI 10.7326/0003-4819-145-3-200608010-00005; Babiker FA, 2002, CARDIOVASC RES, V53, P709, DOI 10.1016/S0008-6363(01)00526-0; BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539; Cavasin MA, 2003, AM J PHYSIOL-HEART C, V284, pH1560, DOI 10.1152/ajpheart.01087.2002; Forster C, 2004, P NATL ACAD SCI USA, V101, P14234, DOI 10.1073/pnas.0405571101; FRIEDMAN HS, 1995, ALCOHOL CLIN EXP RES, V19, P123, DOI 10.1111/j.1530-0277.1995.tb01479.x; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Jankowska EA, 2006, CIRCULATION, V114, P1829, DOI 10.1161/CIRCULATIONAHA.106.649426; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Kadokami T, 2005, J INTERF CYTOK RES, V25, P254, DOI 10.1089/jir.2005.25.254; Kim Jin Kyung, 2006, Nucl Recept Signal, V4, pe013; Kjaergaard AD, 2007, CIRCULATION, V115, P861, DOI 10.1161/CIRCULATIONAHA.106.615567; Komesaroff PA, 2001, HYPERTENSION, V38, P1011, DOI 10.1161/hy1101.095006; Kunnas TA, 2000, BRIT MED J, V321, P273, DOI 10.1136/bmj.321.7256.273; Lee TM, 2004, CARDIOVASC RES, V63, P109, DOI 10.1016/j.cardiores.2004.03.009; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li J, 2008, STEROIDS, V73, P720, DOI 10.1016/j.steroids.2008.02.011; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; Mahmoodzadeh S, 2006, FASEB J, V20, P926, DOI 10.1096/fj.05-5148com; Muller M, 2003, J CLIN ENDOCR METAB, V88, P5076, DOI 10.1210/jc.2003-030611; Murata Y, 2002, MOL CELL ENDOCRINOL, V193, P7, DOI 10.1016/S0303-7207(02)00090-4; Nakamura S, 2004, CIRCULATION, V110, P1787, DOI 10.1161/01.CIR.0000143072.36782.51; Rochira V, 2002, MOL CELL ENDOCRINOL, V193, P19, DOI 10.1016/S0303-7207(02)00092-8; Satoh M, 2007, CIRCULATION, V115, P3197, DOI 10.1161/CIRCULATIONAHA.106.657981; Shearman AM, 2005, STROKE, V36, P2281, DOI 10.1161/01.STR.0000181088.76518.ec; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Song WC, 1998, J PHARMACOL EXP THER, V284, P1197; Spratt DI, 2006, AM J PHYSIOL-ENDOC M, V291, pE631, DOI 10.1152/ajpendo.00467.2005; Sudhir K, 1999, J CLIN ENDOCR METAB, V84, P3411, DOI 10.1210/jc.84.10.3411; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yoshioka J, 2004, NUCL MED COMMUN, V25, P557, DOI 10.1097/01.mnm.0000126624.79048.70; Yu AM, 2005, ENDOCRINOLOGY, V146, P2911, DOI 10.1210/en.2004-1248; Zhou L, 2007, EUR J PHARMACOL, V567, P186, DOI 10.1016/j.ejphar.2007.03.047	43	69	73	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1892	1901		10.1001/jama.2009.639	http://dx.doi.org/10.1001/jama.2009.639			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444JX	19436016				2022-12-28	WOS:000265978400027
J	Chew, SK; Chen, P; Link, N; Galindo, KA; Pogue, K; Abrams, JM				Chew, Su Kit; Chen, Po; Link, Nichole; Galindo, Kathleen A.; Pogue, Kristi; Abrams, John M.			Genome-wide silencing in Drosophila captures conserved apoptotic effectors	NATURE			English	Article							APICAL CASPASE DRONC; CELL-DEATH; CYTOCHROME-C; RNA INTERFERENCE; ACTIVATION; PROTEIN; PATHWAYS; GROWTH; ASSAYS; DIAP1	Apoptosis is a conserved form of programmed cell death firmly established in the aetiology, pathogenesis and treatment of many human diseases. Central to the core machinery of apoptosis are the caspases and their proximal regulators. Current models for caspase control involve a balance of opposing elements, with variable contributions from positive and negative regulators among different cell types and species(1). To advance a comprehensive view of components that support caspase-dependent cell death, we conducted a genome-wide silencing screen in the Drosophila model. Our strategy used a library of double-stranded RNAs together with a chemical antagonist of Inhibitor of apoptosis proteins (IAPs) that simulates the action of native regulators in the Reaper and Smac (also known as Diablo) families(2). Here we present a highly validated set of targets that is necessary for death provoked by several stimuli. Among these, Tango7 is identified as a new effector. Cells depleted for this gene resisted apoptosis at a step before the induction of effector caspase activity, and the directed silencing of Tango7 in Drosophila prevented caspase-dependent programmed cell death. Unlike known apoptosis regulators in this model system(3), Tango7 activity did not influence stimulus-dependent loss of Drosophila DIAP1 (also known as th and IAP1), but instead regulated levels of the apical caspase Dronc (Nc). Similarly, the human Tango7 counterpart, PCID1 (also known as EIF3M), impinged on caspase 9, revealing a new regulatory axis affecting the apoptosome.	[Chew, Su Kit; Chen, Po; Link, Nichole; Galindo, Kathleen A.; Pogue, Kristi; Abrams, John M.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Abrams, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	john.abrams@utsouthwestern.edu			National Institute of General Medical Sciences; National Institute on Alcohol Abuse and Alcoholism; UTSW High Impact/High Risk Grant Program; National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072124, R56GM072124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017328] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); UTSW High Impact/High Risk Grant Program; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank X. Tu, L. Durham, L. Lum, P. Beachy, M. Roth, X. Wang, P. Harran, Y. Lazebnik, D. Dorris, the University of Texas Southwestern Medical Center (UTSW) High Throughput Screening laboratory and the Live Cell Imaging facility for technical and material support; Bloomington Stock Center, K. Basler, National Institute of Genetics (NIG) stock center (Japan) for fly lines; K. White, B. Hay and the Hybridoma Bank for antibodies; V. Malhotra for the pMT-Tango7 plasmid; J. Seeman and the Wang laboratory for discussions; and M. Allen for administrative support. This work was supported by grants from the National Institute of General Medical Sciences, the National Institute on Alcohol Abuse and Alcoholism and the UTSW High Impact/High Risk Grant Program. N. L. is supported by a National Research Service Award.	Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Link N, 2007, J CELL BIOL, V178, P567, DOI 10.1083/jcb.200702125; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matapurkar A, 2006, CELL DEATH DIFFER, V13, P2062, DOI 10.1038/sj.cdd.4401968; Mendes CS, 2006, EMBO REP, V7, P933, DOI 10.1038/sj.embor.7400773; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Perez A, 2005, J VIROL, V79, P7419, DOI 10.1128/JVI.79.12.7419-7430.2005; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Verhagen AM, 2002, APOPTOSIS, V7, P163, DOI 10.1023/A:1014318615955; Weinmann L, 2008, CELL DEATH DIFFER, V15, P718, DOI 10.1038/sj.cdd.4402301; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068	29	27	30	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					123	U141		10.1038/nature08087	http://dx.doi.org/10.1038/nature08087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19483676	Green Accepted			2022-12-28	WOS:000267545200042
J	Niethammer, P; Grabher, C; Look, AT; Mitchison, TJ				Niethammer, Philipp; Grabher, Clemens; Look, A. Thomas; Mitchison, Timothy J.			A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish	NATURE			English	Article							TUMOR-SUPPRESSOR PTEN; ENDOTHELIAL-CELLS; NOX INHIBITOR; DUAL OXIDASES; INFLAMMATION; CHEMOTAXIS; MIGRATION; GROWTH; NEUTROPHILS; EXPRESSION	Barrier structures (for example, epithelia around tissues and plasma membranes around cells) are required for internal homeostasis and protection from pathogens. Wound detection and healing represent a dormant morphogenetic program that can be rapidly executed to restore barrier integrity and tissue homeostasis. In animals, initial steps include recruitment of leukocytes to the site of injury across distances of hundreds of micrometres within minutes of wounding. The spatial signals that direct this immediate tissue response are unknown. Owing to their fast diffusion and versatile biological activities, reactive oxygen species, including hydrogen peroxide (H2O2), are interesting candidates for wound-to-leukocyte signalling. Here we probe the role of H2O2 during the early events of wound responses in zebrafish larvae expressing a genetically encoded H2O2 sensor(1). This reporter revealed a sustained rise in H2O2 concentration at the wound margin, starting similar to 3 min after wounding and peaking at similar to 20 min, which extended similar to 100-200 mu m into the tail-fin epithelium as a decreasing concentration gradient. Using pharmacological and genetic inhibition, we show that this gradient is created by dual oxidase (Duox), and that it is required for rapid recruitment of leukocytes to the wound. This is the first observation, to our knowledge, of a tissue-scale H2O2 pattern, and the first evidence that H2O2 signals to leukocytes in tissues, in addition to its known antiseptic role.	[Niethammer, Philipp; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Grabher, Clemens; Look, A. Thomas] Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Look, A. Thomas] Harvard Univ, Sch Med, Dept Pediat,Childrens Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Niethammer, P (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Philipp_Niethammer@hms.harvard.edu	Grabher, Clemens/H-2064-2013		National Institutes of Health [GM023928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	P. N. was supported by a Human Frontiers Science Program long-term fellowship. This work was supported by the National Institutes of Health grant GM023928. We would like to thank A. Huttenlocher and P. Crosier for providing us with the mpo::GFP and lysC::DsRED2 transgenic zebrafish lines, respectively.	Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Huttenlocher A, 2008, TRENDS CELL BIOL, V18, P298, DOI 10.1016/j.tcb.2008.04.001; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Klyubin IV, 1996, EUR J CELL BIOL, V70, P347; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lange S, 2009, CARDIOVASC RES, V81, P159, DOI 10.1093/cvr/cvn258; Li WD, 2000, J CELL BIOCHEM, V78, P550, DOI 10.1002/1097-4644(20000915)78:4<550::AID-JCB4>3.3.CO;2-#; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Nusslein-Volhard C, 2002, ZEBRAFISH; Oktyabrsky ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P132, DOI 10.1134/S0006297907020022; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Renshaw SA, 2007, EXP LUNG RES, V33, P549, DOI 10.1080/01902140701756778; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Stielow C, 2006, BIOCHEM BIOPH RES CO, V344, P200, DOI 10.1016/j.bbrc.2006.03.114; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; TEGTMEIER F, 2005, Patent No. 2005111041; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	33	1075	1111	15	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					996	U123		10.1038/nature08119	http://dx.doi.org/10.1038/nature08119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19494811	Green Accepted			2022-12-28	WOS:000267063500045
J	Mace, R				Mace, Ruth			On Becoming Modern	SCIENCE			English	Editorial Material									UCL, Dept Anthropol, London WC1H 0BW, England	University of London; University College London	Mace, R (corresponding author), UCL, Dept Anthropol, Taviton St, London WC1H 0BW, England.	r.mace@ucl.ac.uk		Mace, Ruth/0000-0002-6137-7739				Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Chagnon N.A., 1983, YANOMAMO FIERCE PEOP; Dawkins Richard, 1976, SELFISH GENE; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Richerson P. J., 2005, NOT GENES ALONE CULT; West SA, 2008, J EVOLUTION BIOL, V21, P374, DOI 10.1111/j.1420-9101.2007.01458.x	9	8	8	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 5	2009	324	5932					1280	1281		10.1126/science.1175383	http://dx.doi.org/10.1126/science.1175383			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453TF	19498157				2022-12-28	WOS:000266635100030
J	Shonkoff, JP; Boyce, WT; McEwen, BS				Shonkoff, Jack P.; Boyce, W. Thomas; McEwen, Bruce S.			Neuroscience, Molecular Biology, and the Childhood Roots of Health Disparities Building a New Framework for Health Promotion and Disease Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; EVOLUTIONARY-DEVELOPMENTAL THEORY; ADULT MENTAL-HEALTH; EARLY-LIFE STRESS; SOCIOECONOMIC-STATUS; BIRTH-WEIGHT; CARDIOVASCULAR-DISEASE; MALTREATED CHILDREN; SOCIAL DETERMINANTS; PRENATAL EXPOSURE	A scientific consensus is emerging that the origins of adult disease are often found among developmental and biological disruptions occurring during the early years of life. These early experiences can affect adult health in 2 ways-either by cumulative damage over time or by the biological embedding of adversities during sensitive developmental periods. In both cases, there can be a lag of many years, even decades, before early adverse experiences are expressed in the form of disease. From both basic research and policy perspectives, confronting the origins of disparities in physical and mental health early in life may produce greater effects than attempting to modify health-related behaviors or improve access to health care in adulthood. JAMA. 2009;301(21):2252-2259 www.jama.com	[Shonkoff, Jack P.] Harvard Univ, Ctr Dev Child, Cambridge, MA 02138 USA; [Boyce, W. Thomas] Univ British Columbia, Coll Interdisciplinary Studies, Vancouver, BC V5Z 1M9, Canada; [Boyce, W. Thomas] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada; [McEwen, Bruce S.] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10021 USA	Harvard University; University of British Columbia; University of British Columbia; Rockefeller University	Shonkoff, JP (corresponding author), Harvard Univ, Ctr Dev Child, 50 Church St,4th Floor, Cambridge, MA 02138 USA.	jack_shonkoff@harvard.edu	McEwen, Bruce/Z-1630-2019		Division of Violence Prevention; National Center for Injury Control and Prevention; US Centers for Disease Control and Prevention (CDC); National Scientific Council; Birth to Five Policy Alliance; Buffett Early Childhood Fund; Pierre and Pamela Omidyar Fund; John D. and Catherine T. MacArthur Foundation	Division of Violence Prevention; National Center for Injury Control and Prevention; US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Scientific Council; Birth to Five Policy Alliance; Buffett Early Childhood Fund; Pierre and Pamela Omidyar Fund; John D. and Catherine T. MacArthur Foundation	Primary funding for this article was received from the Division of Violence Prevention, National Center for Injury Control and Prevention, US Centers for Disease Control and Prevention (CDC), which reviewed previous versions of the manuscript. No substantive changes were made to the manuscript as a result of these comments, nor was approval of the manuscript offered to or given by the funders. Additional funding, without manuscript review, for the work of the authors as members of the National Scientific Council on the Developing Child has been provided by the Birth to Five Policy Alliance, the Buffett Early Childhood Fund, the Pierre and Pamela Omidyar Fund, and the John D. and Catherine T. MacArthur Foundation.	Alastalo H, 2009, ANN MED, V41, P66, DOI 10.1080/07853890802301983; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, BRIT MED J, V306, P422, DOI 10.1136/bmj.306.6875.422; Barker DJP, 1997, ACTA PAEDIATR, V86, P78; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Berkman L, 2000, SOCIAL EPIDEMIOLOGY, P391; Berkman L, 2008, NEW ENGL J MED, V358, P2509, DOI 10.1056/NEJMe0802773; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Brena RM, 2006, NAT GENET, V38, P1359, DOI 10.1038/ng1206-1359; CAMPBELL FA, 1994, CHILD DEV, V65, P684, DOI 10.1111/j.1467-8624.1994.tb00777.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, ARCH PEDIAT ADOL MED, V160, P805, DOI 10.1001/archpedi.160.8.805; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Cirulli F, 2009, NEUROSCI BIOBEHAV R, V33, P573, DOI 10.1016/j.neubiorev.2008.09.001; Colborn T, 2004, ENVIRON HEALTH PERSP, V112, P944, DOI 10.1289/ehp.6601; Colcombe SJ, 2004, J MOL NEUROSCI, V24, P9, DOI 10.1385/JMN:24:1:009; COLLEY JRT, 1973, BRIT MED J, V3, P195, DOI 10.1136/bmj.3.5873.195; Danese A, 2008, ARCH GEN PSYCHIAT, V65, P409, DOI 10.1001/archpsyc.65.4.409; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; De Rooij SR, 2006, DIABETES CARE, V29, P1052, DOI 10.2337/dc05-1993; DODGE KA, 1994, CHILD DEV, V65, P649, DOI 10.2307/1131407; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Ellis BJ, 2005, DEV PSYCHOPATHOL, V17, P303, DOI 10.1017/S0954579405050157; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Evans GW, 2007, PSYCHOL SCI, V18, P953, DOI 10.1111/j.1467-9280.2007.02008.x; Evans GW, 2005, PSYCHOL SCI, V16, P560, DOI 10.1111/j.0956-7976.2005.01575.x; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2005, CHILD MALTREATMENT, V10, P5, DOI 10.1177/1077559504271287; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Geronimus Arline T., 1992, Ethnicity and Disease, V2, P207; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Geronimus AT, 1996, SOC SCI MED, V42, P589, DOI 10.1016/0277-9536(95)00159-X; Gianaros PJ, 2007, SOC COGN AFFECT NEUR, V2, P161, DOI 10.1093/scan/nsm013; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Gilliam WS, 2006, INFANT YOUNG CHILD, V19, P228, DOI 10.1097/00001163-200607000-00007; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Gunnar MR, 2006, DEV PSYCHOPATHOL, V18, P651, DOI 10.1017/S0954579406060330; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hanson MA, 2008, BASIC CLIN PHARMACOL, V102, P90, DOI 10.1111/j.1742-7843.2007.00186.x; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; HART B, 1995, MEANINGFUL DIFFERENC, P268; Hatch EE, 1998, JAMA-J AM MED ASSOC, V280, P630, DOI 10.1001/jama.280.7.630; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Hillis SD, 2004, PEDIATRICS, V113, P320, DOI 10.1542/peds.113.2.320; Horwitz AV, 2001, J HEALTH SOC BEHAV, V42, P184, DOI 10.2307/3090177; Isgor C, 2004, HIPPOCAMPUS, V14, P636, DOI 10.1002/hipo.10207; Johnson MH, 2005, DEV PSYCHOBIOL, V46, P287, DOI 10.1002/dev.20057; Kaufman D, 2007, DIABETES, V56, P1382, DOI 10.2337/db06-1409; Keating D. P., 1999, DEV HLTH WEALTH NATI, P406; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Kuh D, 2004, LIFE COURSE APPROACH, P473; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; Lupien SJ, 2000, BIOL PSYCHIAT, V48, P976, DOI 10.1016/S0006-3223(00)00965-3; Lustig RH, 2006, NAT CLIN PRACT ENDOC, V2, P447, DOI 10.1038/ncpendmet0220; Luthar SS, 2006, ANN NY ACAD SCI, V1094, P105, DOI 10.1196/annals.1376.009; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Massin MM, 2001, CARDIOLOGY, V95, P80, DOI 10.1159/000047350; Masten AS, 2007, DEV PSYCHOPATHOL, V19, P921, DOI 10.1017/S0954579407000442; Horwitz SM, 2007, PEDIATRICS, V119, pE208, DOI 10.1542/peds.2005-1997; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Menard C, 2004, SOC PSYCH PSYCH EPID, V39, P857, DOI 10.1007/s00127-004-0868-8; Middlebrooks JS., 2008, EFFECTS CHILDHOOD ST; National Scientific Council on the Developing Child, 2005, EXCESSIVE STRESS DIS; Nomura Y, 2007, COMPR PSYCHIAT, V48, P470, DOI 10.1016/j.comppsych.2007.04.005; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Opler MGA, 2005, ENVIRON HEALTH PERSP, V113, P1239, DOI 10.1289/ehp.7572; Pesonen AK, 2007, AM J EPIDEMIOL, V166, P1126, DOI 10.1093/aje/kwm254; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Schilling EA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-30; Schreuder MF, 2006, PEDIATR RES, V59, P126, DOI 10.1203/01.pdr.0000190576.08501.df; SCHULMAN K, 1999, SEEDS SUCCESS STATE; Schweinhart LJ, 2005, LIFETIME EFFECTS HIG, pxvii; Shankaran S, 2006, ARCH PEDIAT ADOL MED, V160, P977, DOI 10.1001/archpedi.160.9.977; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shonkoff JP, 2000, NEURONS NEIGHBORHOOD, P588; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Worthman CM, 2005, AM J HUM BIOL, V17, P95, DOI 10.1002/ajhb.20096; Yliharsila H, 2004, J HYPERTENS, V22, P1283, DOI 10.1097/01.hjh.0000125438.28861.a4; YOSHIKAWA H, 1994, PSYCHOL BULL, V115, P28, DOI 10.1037/0033-2909.115.1.28; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	114	1449	1466	4	234	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2252	2259		10.1001/jama.2009.754	http://dx.doi.org/10.1001/jama.2009.754			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	452PQ	19491187				2022-12-28	WOS:000266554100023
J	Desai, M; Nolte, E; Mays, N; Nikolentzos, A				Desai, Monica; Nolte, Ellen; Mays, Nicholas; Nikolentzos, Athanasios			International experience of paying for expensive medicines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CELL LUNG-CANCER; CHEMOTHERAPY		[Nolte, Ellen; Mays, Nicholas] Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Nolte, E (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.	enolte@rand.org		Nolte, Ellen/0000-0002-2289-117X	National Institute for Health Research [ACF-2008-20-002] Funding Source: researchfish; Department of Health [0510002] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		APPLEBY J, 2008, BMJ-BRIT MED J, V337, P1122; Chu DT, 2007, LUNG CANCER, V56, P433, DOI 10.1016/j.lungcan.2007.01.028; Clarke R, 2008, CLIN ONCOL-UK, V20, P771, DOI 10.1016/j.clon.2008.09.005; Department of Health, 2009, GUID NHS PAT WHO WIS; Department of Health, 2004, COD COND PRIV PRACT; DoHSC (Department of Health & Social Care), 2021, NHS CONST ENGL; FLOOD C, 2007, MCGILL HLTH LAW PUBL, V1, P7; Gubb J, 2008, BMJ-BRIT MED J, V336, P1104, DOI [10.1136/bmj.39563.453183.AD, 10.1136/bmj.39563.493218.AD]; KHOO K, 2007, REPORT CARD CANC CAN, V10, P40; *NAT I HLTH CLIN E, APPR LIF EXT END LIF; NIKOLENTZOS A, PAYING EXPENSIVE DRU; *PROV WORK GROUP, 2006, REP PROV WORK GROUP; *RAR CANC FOR, 2008, TAK EXC AUD POL PROC; Richards M, 2008, IMPROVING ACCESS MED; SATCHELL G, 2008, BBC NEWS        1223; Silvestri G, 1998, BRIT MED J, V317, P771, DOI 10.1136/bmj.317.7161.771; TEMPLETON S, 2008, SUNDAY TIMES    0601; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	18	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2009	338								b1993	10.1136/bmj.b1993	http://dx.doi.org/10.1136/bmj.b1993			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WV	19482871	Green Accepted			2022-12-28	WOS:000266502500003
J	Gregoriou, GG; Gotts, SJ; Zhou, HH; Desimone, R				Gregoriou, Georgia G.; Gotts, Stephen J.; Zhou, Huihui; Desimone, Robert			High-Frequency, Long-Range Coupling Between Prefrontal and Visual Cortex During Attention	SCIENCE			English	Article							MACAQUE AREA V4; NEURONAL SYNCHRONIZATION; NEURAL MECHANISMS; TOP-DOWN; GAMMA OSCILLATIONS; CORTICAL NETWORK; CONNECTIONS; ENTRAINMENT; TOPOGRAPHY; SELECTION	Electrical recordings in humans and monkeys show attentional enhancement of evoked responses and gamma synchrony in ventral stream cortical areas. Does this synchrony result from intrinsic activity in visual cortex or from inputs from other structures? Using paired recordings in the frontal eye field (FEF) and area V4, we found that attention to a stimulus in their joint receptive field leads to enhanced oscillatory coupling between the two areas, particularly at gamma frequencies. This coupling appeared to be initiated by FEF and was time-shifted by about 8 to 13 milliseconds across a range of frequencies. Considering the expected conduction and synaptic delays between the areas, this time-shifted coupling at gamma frequencies may optimize the postsynaptic impact of spikes from one area upon the other, improving cross-area communication with attention.	[Gregoriou, Georgia G.; Zhou, Huihui; Desimone, Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Gotts, Stephen J.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Desimone, R (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	desimone@mit.edu	Gotts, Stephen/J-4842-2012; Desimone, Robert/G-1121-2018; Gregoriou, Georgia/AAD-3925-2019; Gregoriou, Georgia/F-7759-2011	Gregoriou, Georgia/0000-0002-4002-6657; Gregoriou, Georgia/0000-0002-4002-6657	NIH [MH64445];  [EY017292];  [EY017921]; NATIONAL EYE INSTITUTE [R01EY017921, R01EY017292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036, P50MH064445] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank G. Pielli, D. Stock, and C. Alfes for help with the animal training and Z.-X. Liu for help with the Granger causality analysis. We also thank N. Bichot, R. Landman, G. Mulliken, and A. Mitz for helpful discussions. Supported by grants EY017292 and EY017921 to R.D. S.J.G. was supported in part by grant MH64445 from NIH (USA).	Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nowak LG, 1997, CEREBR CORT, V12, P205; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Ungerleider LG, 2008, CEREB CORTEX, V18, P477, DOI 10.1093/cercor/bhm061; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256	27	812	825	2	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1207	1210		10.1126/science.1171402	http://dx.doi.org/10.1126/science.1171402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478185	Green Submitted, Green Accepted			2022-12-28	WOS:000266410100048
J	Hacker, JS				Hacker, Jacob S.			HEALTH CARE 2009 Healthy Competition - The Why and How of "Public-Plan Choice"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hacker, Jacob S.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Hacker, Jacob S.] Berkeley Law Sch Ctr Hlth Econ & Family Secur, Berkeley, CA USA	University of California System; University of California Berkeley	Hacker, JS (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.							Hacker Jacob S., 2008, CASE PUBLIC PLAN CHO; *LAK RES PARTN, 2008, TEL SURV 800 LIK VOT; Lewin Group, 2008, COST IMP AN HLTH CAR; Nichols L.M., 2009, MODEST PROPOSAL COMP; PARK CAM, 2009, KAISER HLTH TRACKING	5	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2269	2271		10.1056/NEJMp0903210	http://dx.doi.org/10.1056/NEJMp0903210			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449YO	19474422				2022-12-28	WOS:000266367300001
J	Savva, GM; Wharton, SB; Ince, PG; Forster, G; Matthews, FE; Brayne, C				Savva, George M.; Wharton, Stephen B.; Ince, Paul G.; Forster, Gillian; Matthews, Fiona E.; Brayne, Carol		Med Res Council Cognitive Function	Age, Neuropathology, and Dementia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COUNCIL COGNITIVE FUNCTION; ALZHEIMERS-DISEASE; SENILE DEMENTIA; OLDER PERSONS; POPULATION; IMPAIRMENT; EPIDEMIOLOGY; PREVALENCE; DISORDERS; DIAGNOSIS	BACKGROUND Research in Alzheimer's disease is focused mainly on younger old persons, whereas studies involving very old persons report attenuated relationships between the pathological features of Alzheimer's disease and dementia. METHODS We assessed 456 brains donated to the population-based Medical Research Council Cognitive Function and Ageing Study from persons 69 to 103 years of age at death. We used a standard neuropathological protocol that included measures of the pathological features of Alzheimer's disease, cerebral atrophy, and cerebrovascular disease. Neuropathological variables were dichotomized to represent no burden or a mild burden of pathological lesions as compared with a moderate or severe burden. Logistic regression was used to estimate the effect of age on the relationship between neuropathological features and dementia. RESULTS The difference in the prevalence of moderate and severe Alzheimer's-type pathological changes between persons with and those without dementia decreased with increasing age. The association between neocortical neuritic plaques and dementia was strong at 75 years of age (odds ratio, 8.63; 95% confidence interval [CI], 3.81 to 19.60) and reduced at 95 years of age (odds ratio, 2.48; 95% CI, 0.92 to 4.14), and similar attenuations with advancing age were observed in the association between other pathological changes related to Alzheimer's disease and dementia in all brain areas. In contrast, neocortical cerebral atrophy maintained a relationship with age in persons with dementia at both 75 years of age (odds ratio, 5.11; 95% CI, 1.94 to 13.46) and 95 years of age (odds ratio, 6.10; 95% CI, 2.80 to 13.28) and thus distinguished the cohort with dementia from the cohort without dementia. CONCLUSIONS The association between the pathological features of Alzheimer's disease and dementia is stronger in younger old persons than in older old persons. Age must be taken into account when assessing the likely effect of interventions against dementia on the population.	[Wharton, Stephen B.] Univ Sheffield, Sch Med, Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England; [Savva, George M.; Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge, England; [Matthews, Fiona E.] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2BW, England	University of Sheffield; University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Wharton, SB (corresponding author), Univ Sheffield, Sch Med, Acad Unit Pathol, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	s.wharton@sheffield.ac.uk	Savva, George M/E-9670-2011; Ince, Paul G/A-5064-2009; Matthews, Fiona/O-6932-2015; Brayne, Carol/AAA-4285-2020	Savva, George M/0000-0001-9190-124X; Ince, Paul G/0000-0001-6677-8753; Matthews, Fiona/0000-0002-1728-2388; Brayne, Carol/0000-0001-5307-663X; Wharton, Stephen B/0000-0003-2785-333X	Medical Research Council, United Kingdom [G9901400]; Medical Research Council [G0400074, G0502157, G0300126, MC_U105292687, G9901400] Funding Source: researchfish; MRC [G0300126, MC_U105292687, G9901400, G0502157, G0400074] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a grant (G9901400) from the Medical Research Council, United Kingdom.	Alzheimer & Society, 2007, DEMENTIA UK 2 EDITIO; AMADUCCI LA, 1986, NEUROLOGY, V36, P1497, DOI 10.1212/WNL.36.11.1497; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Brayne C, 2006, INT J EPIDEMIOL, V35, P1140, DOI 10.1093/ije/dyl199; COPELAND JRM, 1991, EUR ARCH PSY CLIN N, V240, P212, DOI 10.1007/BF02189529; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Esiri MM, 2001, LANCET, V357, P169; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Green MS, 2000, NEUROLOGY, V54, P105, DOI 10.1212/WNL.54.1.105; HACHINSKI VC, 1974, LANCET, V2, P207; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Halliday G, 2002, ACTA NEUROPATHOL, V104, P72, DOI 10.1007/s00401-002-0529-5; Haroutunian V, 2008, ARCH NEUROL-CHICAGO, V65, P1211, DOI 10.1001/archneur.65.9.1211; HUBBARD BM, 1981, J NEUROL SCI, V50, P135, DOI 10.1016/0022-510X(81)90048-4; JELLINGER K, 1990, J NEUROL SCI, V95, P239, DOI 10.1016/0022-510X(90)90072-U; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; MANN DMA, 1985, J NEUROL SCI, V69, P139, DOI 10.1016/0022-510X(85)90129-7; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; Matthews FE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-185; PERRY EK, 1992, NEUROBIOL AGING, V13, P393, DOI 10.1016/0197-4580(92)90113-C; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prohovnik I, 2006, NEUROLOGY, V66, P49, DOI 10.1212/01.wnl.0000191298.68045.50; ROSSOR MN, 1984, BRIT MED J, V288, P961, DOI 10.1136/bmj.288.6422.961; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schoenmaker N, 2004, LANCET NEUROL, V3, P627, DOI 10.1016/S1474-4422(04)00884-1; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terry RD, 2001, NEUROBIOL AGING, V22, P347, DOI 10.1016/S0197-4580(00)00250-5; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; Zaccai J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-2	35	636	643	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2302	2309		10.1056/NEJMoa0806142	http://dx.doi.org/10.1056/NEJMoa0806142			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474427				2022-12-28	WOS:000266367300006
J	Herzig, SJ; Howell, MD; Ngo, LH; Marcantonio, ER				Herzig, Shoshana J.; Howell, Michael D.; Ngo, Long H.; Marcantonio, Edward R.			Acid-Suppressive Medication Use and the Risk for Hospital-Acquired Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STRESS-ULCER PROPHYLAXIS; CRITICALLY-ILL PATIENTS; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; GASTRIC COLONIZATION; NOSOCOMIAL PNEUMONIA; ADMINISTRATIVE DATA; GENERAL-PRACTICE; CARE PATIENTS; OMEPRAZOLE	Context The use of acid-suppressive medication has been steadily increasing, particularly in the inpatient setting, despite lack of an accepted indication in the majority of these patients. Objective To examine the association between acid-suppressive medication and hospital-acquired pneumonia. Design, Setting, and Patients Prospective pharmacoepidemiologic cohort study. All patients who were admitted to a large, urban, academic medical center in Boston, Massachusetts, from January 2004 through December 2007; at least 18 years of age; and hospitalized for 3 or more days were eligible for inclusion. Admissions with time spent in the intensive care unit were excluded. Acid-suppressive medication use was defined as any order for a proton-pump inhibitor or histamine(2) receptor antagonist. Traditional and propensity-matched multivariable logistic regression were used to control for confounders. Main Outcome Measure Incidence of hospital-acquired pneumonia, defined via codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (JCD-9-CM), in patients exposed and unexposed to acid-suppressive medication. Results The final cohort comprised 63 878 admissions. Acid-suppressive medication was ordered in 52% of admissions and hospital-acquired pneumonia occurred in 2219 admissions (3.5%). The unadjusted incidence of hospital-acquired pneumonia was higher in the group exposed to acid-suppressive medication than in the unexposed group (4.9% vs 2.0%; odds ratio [OR], 2.6; 95% confidence interval [CI], 2.3-2.8). Using multivariable logistic regression, the adjusted OR of hospital-acquired pneumonia in the group exposed to acid-suppressive medication was 1.3 (95% CI, 1.1-1.4). The matched propensity-score analyses yielded identical results. The association was significant for proton-pump inhibitors (OR, 1.3; 95% CI, 1.1-1.4) but not for histamine2 receptor antagonists (OR, 1.2;95% CI, 0.98-1.4). Conclusions In this large, hospital-based pharmacoepidemiologic cohort, acid-suppressive medication use was associated with 30% increased odds of hospital-acquired pneumonia. In subset analyses, statistically significant risk was demonstrated only for proton-pump inhibitor use. JAMA. 2009;301(20):2120-2128 www.jama.com	[Herzig, Shoshana J.; Ngo, Long H.; Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA; [Herzig, Shoshana J.; Ngo, Long H.; Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Div Primary Care, Boston, MA 02215 USA; [Howell, Michael D.] Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care, Boston, MA 02215 USA; [Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; [Herzig, Shoshana J.; Howell, Michael D.; Ngo, Long H.; Marcantonio, Edward R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Herzig, SJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med, 330 Brookline Ave,DEC311, Boston, MA 02215 USA.	sherzig@bidmc.harvard.edu	Marcantonio, Edward R/U-3929-2017; Howell, Michael/B-8065-2009	Marcantonio, Edward R/0000-0002-2911-4250; Howell, Michael/0000-0001-7003-6971	Health Resources and Services Administration of the Department of Health and Human Services [T32HP11001]	Health Resources and Services Administration of the Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Dr Herzig was funded by grant T32HP11001 from the Health Resources and Services Administration of the Department of Health and Human Services to support the Harvard Medical School Fellowship in General Medicine and Primary Care.	Adams K., 2003, PRIORITY AREAS NATL; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; APTE NM, 1992, CRIT CARE MED, V20, P590, DOI 10.1097/00003246-199205000-00008; Aseeri M, 2008, AM J GASTROENTEROL, V103, P2308, DOI 10.1111/j.1572-0241.2008.01975.x; AYBAY C, 1995, GEN PHARMACOL-VASC S, V26, P1413, DOI 10.1016/0306-3623(94)00301-3; Capodicasa E, 1999, IMMUNOPHARM IMMUNOT, V21, P357, DOI 10.3109/08923979909052768; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook Deborah J., 1996, JAMA (Journal of the American Medical Association), V275, P308, DOI 10.1001/jama.275.4.308; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; DONOWITZ LG, 1986, INFECT CONT HOSP EP, V7, P23, DOI 10.1017/S0195941700063748; DRIKS MR, 1987, NEW ENGL J MED, V317, P1376, DOI 10.1056/NEJM198711263172204; DUMOULIN GC, 1982, LANCET, V1, P242; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Erstad BL, 1999, AM J HEALTH-SYST PH, V56, P347; GARVEY BM, 1989, CRIT CARE MED, V17, P211, DOI 10.1097/00003246-198903000-00002; Grube RRA, 2007, AM J HEALTH-SYST PH, V64, P1396, DOI 10.2146/ajhp060393; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Hartmann M, 1996, ALIMENT PHARM THERAP, V10, P359, DOI 10.1111/j.0953-0673.1996.00359.x; *HCUP, HCUP FACTS FIG 2006; Heidelbaugh JJ, 2006, AM J GASTROENTEROL, V101, P2200, DOI 10.1111/j.1572-0241.2006.00839.x; Janicki T, 2007, J HOSP MED, V2, P86, DOI 10.1002/jhm.177; Kantorova I, 2004, HEPATO-GASTROENTEROL, V51, P757; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lowe DO, 2006, CLIN INFECT DIS, V43, P1272, DOI 10.1086/508453; Mallow Stephanie, 2004, Curr Surg, V61, P452, DOI 10.1016/j.cursur.2004.03.014; Messori A, 2000, BMJ-BRIT MED J, V321, P1103, DOI 10.1136/bmj.321.7269.1103; Mikawa K, 1999, ANESTH ANALG, V89, P218, DOI 10.1097/00000539-199907000-00040; Nardino RJ, 2000, AM J GASTROENTEROL, V95, P3118; Parente F, 2003, ALIMENT PHARM THER, V17, P1503, DOI 10.1046/j.1365-2036.2003.01600.x; Parsons LS, P 26 ANN SAS US GROU, DOI www2. sas. com/ proceedings/ sugi26/ p214- 26. pdf.; Pham CQD, 2006, ANN PHARMACOTHER, V40, P1261, DOI 10.1345/aph.1G703; PRODHOM G, 1994, ANN INTERN MED, V120, P653, DOI 10.7326/0003-4819-120-8-199404150-00005; Qadeer MA, 2006, J HOSP MED, V1, P13, DOI 10.1002/jhm.10; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Scagliarini R, 2005, DIGEST DIS SCI, V50, P2307, DOI 10.1007/s10620-005-3052-4; Scaringi L, 1996, SCAND J IMMUNOL, V44, P204, DOI 10.1046/j.1365-3083.1996.d01-300.x; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	42	298	321	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2120	2128		10.1001/jama.2009.722	http://dx.doi.org/10.1001/jama.2009.722			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19470989	Bronze			2022-12-28	WOS:000266328800024
J	de Groot, K; Harper, L; Jayne, DRW; Suarez, LFF; Gregorini, G; Gross, WL; Luqmani, R; Pusey, CD; Rasmussen, N; Sinico, RA; Tesar, V; Vanhille, P; Westman, K; Savage, COS				de Groot, Kirsten; Harper, Lorraine; Jayne, David R. W.; Suarez, Luis Felipe Flores; Gregorini, Gina; Gross, Wolfgang L.; Luqmani, Rashid; Pusey, Charles D.; Rasmussen, Niels; Sinico, Renato A.; Tesar, Vladimir; Vanhille, Philippe; Westman, Kerstin; Savage, Caroline O. S.		European Vasculitis Study Grp	Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ANCA-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; PREDICTORS; METHOTREXATE; MAINTENANCE; THERAPY; RELAPSE; DAMAGE	Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily oral cyclophosphamide for induction of remission. Design: Randomized, controlled trial. Random assignments were computer-generated; allocation was concealed by faxing centralized treatment assignment to providers at the time of enrollment. Patients, investigators, and assessors of outcomes were not blinded to assignment. Setting: 42 centers in 12 European countries. Patients: 149 patients who had newly diagnosed generalized ANCA-associated vasculitis with renal involvement but not immediately life-threatening disease. Intervention: Pulse cyclophosphamide, 15 mg/kg every 2 to 3 weeks (76 patients), or daily oral cyclophosphamide, 2 mg/kg per day (73 patients), plus prednisolone. Measurement: Time to remission (primary outcome); change in renal function, adverse events, and cumulative dose of cyclophosphamide (secondary outcomes). Results: Groups did not differ in time to remission (hazard ratio, 1.098 [95% CI, 0.78 to 1.55]; P = 0.59) or proportion of patients who achieved remission at 9 months (88.1% vs. 87.7%). Thirteen patients in the pulse group and 6 in the daily oral group achieved remission by 9 months and subsequently had relapse. Absolute cumulative cyclophosphamide dose in the daily oral group was greater than that in the pulse group (15.9 g [interquartile range, 11 to 22.5 g] vs. 8.2 g [interquartile range, 5.95 to 10.55 g]; P < 0.001). The pulse group had a lower rate of leukopenia (hazard ratio, 0.41 [CI, 0.23 to 0.71]). Limitations: The study was not powered to detect a difference in relapse rates between the 2 groups. Duration of follow-up was limited. Conclusion: The pulse cyclophosphamide regimen induced remission of ANCA-associated vasculitis as well as the daily oral regimen at a reduced cumulative cyclophosphamide dose and caused fewer cases of leukopenia. Primary Funding Source: The European Union.	[Harper, Lorraine] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; Klinikum Offenbach, Offenbach, Germany; Addenbrookes Hosp, Cambridge, England; Inst Natl Ciencias Med & Nutr, Mexico City, DF, Mexico; Spedali Civil Brescia, I-25125 Brescia, Italy; Univ Brescia, Brescia, Italy; Univ Schleswig Holstein, Lubeck, Germany; Univ Oxford, Oxford, England; Univ London Imperial Coll Sci Technol & Med, London, England; Rigshosp, DK-2100 Copenhagen, Denmark; Osped San Carlo Borromeo Milano, Milan, Italy; Charles Univ Prague, Prague, Czech Republic; Ctr Hosp, Valenciennes, France; Malmo Univ Hosp, Malmo, Sweden	University of Birmingham; Sana Klinikum Offenbach; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Hospital Spedali Civili Brescia; University of Brescia; University of Kiel; Schleswig Holstein University Hospital; University of Oxford; Imperial College London; Rigshospitalet; University of Copenhagen; San Carlo Borromeo Hospital; Charles University Prague; CH de Valenciennes; Lund University; Skane University Hospital	Harper, L (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England.	L.harper@bham.ac.uk	Garibotto, Giacomo/AAB-1190-2019; Tesar, Vladimir/O-2312-2017; Gross, Wolfgang Ludwig WG/C-8733-2011; sinico, renato alberto/I-6777-2012; Puéchal, Xavier/P-1555-2017	Garibotto, Giacomo/0000-0001-6432-2429; Tesar, Vladimir/0000-0001-6982-0689; sinico, renato alberto/0000-0002-9470-218X; Puéchal, Xavier/0000-0003-3573-9203; Jayne, David/0000-0002-1712-0637; Svenungsson, Elisabet/0000-0003-3396-3244; Westman, Kerstin/0000-0002-2930-998X; Lundberg, Ingrid/0000-0002-6068-9212; Bruchfeld, Annette/0000-0002-9752-9941; Specker, Christof/0000-0003-2504-3229	European Union [BMH1-CT93-1078, CIPD-CT94-0307, BMH4-CT97-2328, IC20-CT97-0019]; Medical Research Council [G9818340B] Funding Source: researchfish	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	By the European Union (European Community Systemic Vasculitis Trial project, contract nos. BMH1-CT93-1078 and CIPD-CT94-0307, and Associated Vasculitis European Randomised Trial project, contract nos. BMH4-CT97-2328 and IC20-CT97-0019).	de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; de Groot K, 2001, NEPHROL DIAL TRANSPL, V16, P2018, DOI 10.1093/ndt/16.10.2018; Exley AR, 1997, ARTHRITIS RHEUM, V40, P371, DOI 10.1002/art.1780400222; FAUCI AS, 1983, ANN INTERN MED, V98, P76, DOI 10.7326/0003-4819-98-1-76; Guillevin L, 2003, ARTHRIT RHEUM-ARTHR, V49, P93, DOI 10.1002/art.10922; Harper L, 2005, RHEUMATOLOGY, V44, P495, DOI 10.1093/rheumatology/keh522; Hauer HA, 2002, KIDNEY INT, V61, P80, DOI 10.1046/j.1523-1755.2002.00089.x; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hogan SL, 2005, ANN INTERN MED, V143, P621, DOI 10.7326/0003-4819-143-9-200511010-00005; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jayne DRW, 2007, J AM SOC NEPHROL, V18, P2180, DOI 10.1681/ASN.2007010090; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Koldingsnes W, 2002, RHEUMATOLOGY, V41, P572, DOI 10.1093/rheumatology/41.5.572; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LUQMANI RA, 1994, Q J MED, V87, P671; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P310, DOI 10.1136/ard.2008.088096; Neumann I, 2005, NEPHROL DIAL TRANSPL, V20, P96, DOI 10.1093/ndt/gfh563; Reinhold-Keller E, 2000, ARTHRITIS RHEUM, V43, P1021, DOI 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J; Reinhold-Keller E, 2002, ARTHRIT RHEUM-ARTHR, V47, P326, DOI 10.1002/art.10459; Stone JH, 2005, NEW ENGL J MED, V352, P351; TalarWilliams C, 1996, ANN INTERN MED, V124, P477, DOI 10.7326/0003-4819-124-5-199603010-00003; Villa-Forte A, 2007, MEDICINE, V86, P269, DOI 10.1097/MD.0b013e3181568ec0	23	587	611	2	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					670	U3		10.7326/0003-4819-150-10-200905190-00004	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451574				2022-12-28	WOS:000266285300002
J	Okada, D; Ozawa, F; Inokuchi, K				Okada, Daisuke; Ozawa, Fumiko; Inokuchi, Kaoru			Input-Specific Spine Entry of Soma-Derived Vesl-1S Protein Conforms to Synaptic Tagging	SCIENCE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; AMPA RECEPTORS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; LATE MAINTENANCE; PLASTICITY; LTP; STIMULATION; EXPRESSION	Late-phase synaptic plasticity depends on the synthesis of new proteins that must function only in the activated synapses. The synaptic tag hypothesis requires input-specific functioning of these proteins after undirected transport. Confirmation of this hypothesis requires specification of a biochemical tagging activity and an example protein that behaves as the hypothesis predicts. We found that in rat neurons, soma-derived Vesl-1S (Homer-1a) protein, a late-phase plasticity-related synaptic protein, prevailed in every dendrite and did not enter spines. N-methyl-D-aspartate receptor activation triggered input-specific spine entry of Vesl-1S proteins, which met many criteria for synaptic tagging. These results suggest that Vesl-1S supports the hypothesis and that the activity-dependent regulation of spine entry functions as a synaptic tag.	[Okada, Daisuke] Mitsubishi Kagaku Inst Life Sci MITILS, Tokyo 1948511, Japan; Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Japan Science & Technology Agency (JST)	Okada, D (corresponding author), Mitsubishi Kagaku Inst Life Sci MITILS, 11 Minamiooya, Tokyo 1948511, Japan.	kaoru@mitils.jp; dada@mitils.jp	Inokuchi, Kaoru/AAI-9693-2020	Inokuchi, Kaoru/0000-0002-5393-3133	Ministry of Education, Technology and Culture; MEXT of the Japanese Government; JST-CREST	Ministry of Education, Technology and Culture; MEXT of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We thank A. Miyawaki (RIKEN, Japan) for the gift of PAGFP. Supported partly by grants from the Ministry of Education, Technology and Culture (K.I.), the Special Coordinate Funds for Promoting Science and Technology from MEXT of the Japanese Government (K.I.), and JST-CREST (K.I.).	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Ageta H, 2001, J BIOL CHEM, V276, P15893, DOI 10.1074/jbc.M011097200; Ango F, 2000, J NEUROSCI, V20, P8710; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Inoue N, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-7; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Mackenzie PJ, 1998, J NEUROPHYSIOL, V80, P2089, DOI 10.1152/jn.1998.80.4.2089; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Niibori Y, 2007, NEUROSCI RES, V57, P399, DOI 10.1016/j.neures.2006.11.014; Okubo-Suzuki R, 2008, MOL CELL NEUROSCI, V38, P266, DOI 10.1016/j.mcn.2008.03.001; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	33	82	83	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					904	909		10.1126/science.1171498	http://dx.doi.org/10.1126/science.1171498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443779				2022-12-28	WOS:000266048800029
J	DeLong, EF				DeLong, Edward F.			The microbial ocean from genomes to biomes	NATURE			English	Review							MARINE-BACTERIA; COMMUNITY STRUCTURE; GENE-EXPRESSION; PROTEORHODOPSIN; BACTERIOPLANKTON; METAGENOMICS; ABUNDANT; DIVERSE; MICROORGANISMS; PHOTOTROPHY	Numerically, microbial species dominate the oceans, yet their population dynamics, metabolic complexity and synergistic interactions remain largely uncharted. A full understanding of life in the ocean requires more than knowledge of marine microbial taxa and their genome sequences. The latest experimental techniques and analytical approaches can provide a fresh perspective on the biological interactions within marine ecosystems, aiding in the construction of predictive models that can interrelate microbial dynamics with the biogeochemical matter and energy fluxes that make up the ocean ecosystem.	[DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Biol Engn, Cambridge, MA 02139 USA.	delong@mit.edu			US National Science Foundation; US Department of Energy; Gordon and Betty Moore Foundation; Agouron Institute	US National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Agouron Institute(Pfizer)	I thank my current and former students, colleagues and co-workers for sharing their ideas, insights, enthusiasm and inspiration. Work in my laboratory is supported by grants from the US National Science Foundation, the US Department of Energy, the Gordon and Betty Moore Foundation and the Agouron Institute. This article is a contribution from the NSF Science and Technology Center, and the Center for Microbial Oceanography: Research and Education.	Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; Cho JC, 2007, ENVIRON MICROBIOL, V9, P1456, DOI 10.1111/j.1462-2920.2007.01264.x; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Dalevi D, 2008, BIOINFORMATICS, V24, pI7, DOI 10.1093/bioinformatics/btn276; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; DeLong E, 2006, PLOS BIOL, V4, P2412, DOI 10.1371/journal.pbio.0040437; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeLong EF, 2002, ENVIRON MICROBIOL, V4, P9, DOI 10.1046/j.1462-2920.2002.t01-12-00257.x; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Doney SC, 2004, FRONT ECOL ENVIRON, V2, P457, DOI 10.2307/3868334; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fasham MJR, 2001, AMBIO, P4; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Fuchs BM, 2007, P NATL ACAD SCI USA, V104, P2891, DOI 10.1073/pnas.0608046104; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Giovannoni S, 2007, NAT REV MICROBIOL, V5, P820, DOI 10.1038/nrmicro1752; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Harrington ED, 2007, P NATL ACAD SCI USA, V104, P13913, DOI 10.1073/pnas.0702636104; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Krause L, 2006, BIOINFORMATICS, V22, pE281, DOI 10.1093/bioinformatics/btl247; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mou XZ, 2007, ENVIRON MICROBIOL, V9, P2025, DOI 10.1111/j.1462-2920.2007.01318.x; Neufeld JD, 2007, ISME J, V1, P103, DOI 10.1038/ismej.2007.30; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pham VD, 2008, ENVIRON MICROBIOL, V10, P2313, DOI 10.1111/j.1462-2920.2008.01657.x; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Stingl U, 2007, APPL ENVIRON MICROB, V73, P2290, DOI 10.1128/AEM.02559-06; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340	78	154	164	3	115	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					200	206		10.1038/nature08059	http://dx.doi.org/10.1038/nature08059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444206	Green Submitted			2022-12-28	WOS:000266036100030
J	Schipper, K; Abma, TA; Hene, RJ; Widdershoven, GAM				Schipper, K.; Abma, Tineke A.; Hene, Ronald J.; Widdershoven, Guy A. M.			A Patient's Journey Polycystic kidney disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Schipper, K.; Abma, Tineke A.; Widdershoven, Guy A. M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Humanities, NL-1007 MB Amsterdam, Netherlands; [Hene, Ronald J.] Univ Med Ctr Utrecht, NL-3508 GA Utrecht, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center	Abma, TA (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Humanities, Postbox 7057, NL-1007 MB Amsterdam, Netherlands.	T.Abma@HES.unimaas.nl	Abma, Tineke/AER-4580-2022	Abma, Tineke/0000-0002-8902-322X					0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2009	338								b1595	10.1136/bmj.b1595	http://dx.doi.org/10.1136/bmj.b1595			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446IW	19433503				2022-12-28	WOS:000266116300001
J	Qureshi, AI; Mendelow, AD; Hanley, DF				Qureshi, Adnan I.; Mendelow, A. David; Hanley, Daniel F.			Intracerebral haemorrhage	LANCET			English	Review							NEUROCRITICAL CARE PATIENTS; ORAL ANTICOAGULANT-THERAPY; ELEVATED BLOOD-PRESSURE; WHITE-MATTER LESIONS; ACTIVATED FACTOR-VII; FRESH-FROZEN PLASMA; INTRAVENTRICULAR HEMORRHAGE; NEUROLOGIC DETERIORATION; INTRACRANIAL HEMORRHAGE; PERIHEMATOMAL EDEMA	Intracerebral. haemorrhage is an important public health problem leading to high rates of death and disability in adults. Although the number of hospital admissions for intracerebral haemorrhage has increased worldwide in the past 10 years, mortality has not fallen. Results of clinical trials and observational studies suggest that coordinated primary and specialty care is associated with lower mortality than is typical community practice. Development of treatment goals for critical care, and new sequences of care and specialty practice can improve outcome after intracerebral haemorrhage. Specific treatment approaches include early diagnosis and haemostasis, aggressive management of blood pressure, open surgical and minimally invasive surgical techniques to remove clot, techniques to remove intraventricular blood, and management of intracranial pressure. These approaches improve clinical management of patients with intracerebral haemorrhage and promise to reduce mortality and increase functional survival.	[Qureshi, Adnan I.] Univ Minnesota, Dept Neurol & Neurosurg, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN 55455 USA; [Mendelow, A. David] Univ Newcastle, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Hanley, Daniel F.] Johns Hopkins Med Inst, Div Brain Injury Outcomes, Baltimore, MD 21205 USA	University of Minnesota System; University of Minnesota Twin Cities; Newcastle University - UK; Johns Hopkins University; Johns Hopkins Medicine	Qureshi, AI (corresponding author), Univ Minnesota, Dept Neurol, 12-100 PWB,516 Delaware St SE, Minneapolis, MN 55455 USA.	qureshi@umn.edu	Mendelow, Alexander/AAW-2878-2021	Qureshi, Adnan/0000-0003-4962-540X; Hanley, Daniel/0000-0002-9536-4258	National Institutes of Health [RO-1-NS44976-01A2]; American Heart Association [0840053N]; Minnesota Medical Foundation; US Food and Drug Administration [5RO1-FD 001693]; National Institute of Neurological Disorders and Stroke (NINDS) [IR34-NS056638, 1R01-NS 046309]; MRC [G0501444] Funding Source: UKRI; Medical Research Council [G0501444] Funding Source: researchfish; FOOD AND DRUG ADMINISTRATION [R01FD001693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R34NS056638, R01NS044976, R01NS046309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Minnesota Medical Foundation; US Food and Drug Administration; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	AIQ has received funding from National Institutes of Health RO-1-NS44976-01A2 (medication provided by ESP Pharma), American Heart Association Established Investigator Award 0840053N, and Minnesota Medical Foundation (Minneapolis, MN, USA). ADM is the director of the Newcastle Neurosurgery Foundation, and has received honoraria for attending Advisory Committee Meetings for Codman and for Novo Nordisk. DFH receives funding through the US Food and Drug Administration orphan-drugs programme grant 5RO1-FD 001693, National Institute of Neurological Disorders and Stroke (NINDS) planning grant, IR34-NS056638, MISITIE: NINDS, 1R01-NS 046309, Jeffrey and Harriet Legum professorship, Genentech, sponsored research agreement; he also has disavowed interest in this patent (Johns Hopkins University use patent application #10/509,694) and has received an honorarium from Novo Nordisk.	Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; *AM HEART ORG, INT CARD DIS STAT CA; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Andrews CO, 2001, ANN PHARMACOTHER, V35, P1435; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530; Bailey RD, 2001, NEUROLOGY, V56, P773, DOI 10.1212/WNL.56.6.773; Becker KJ, 1999, STROKE, V30, P2025, DOI 10.1161/01.STR.30.10.2025; Bhattathiri PS, 2006, ACTA NEUROCHIR SUPPL, V96, P65; BOEER A, 1991, J NEUROL NEUROSUR PS, V54, P466, DOI 10.1136/jnnp.54.5.466; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Broderick JP, 2005, STROKE, V36, P1619, DOI 10.1161/01.STR.0000170714.43167.34; Brody DL, 2005, NEUROCRIT CARE, V2, P263, DOI 10.1385/NCC:2:3:263; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Butler AC, 1998, BRIT J HAEMATOL, V103, P1064; Carhuapoma JR, 2000, STROKE, V31, P726, DOI 10.1161/01.STR.31.3.726; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Christensen MC, 2008, ADV THER, V25, P831, DOI 10.1007/s12325-008-0092-0; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Dziedzic T, 2003, CLIN NEUROL NEUROSUR, V105, P87, DOI 10.1016/S0303-8467(02)00106-3; Eckman MH, 2003, STROKE, V34, P1710, DOI 10.1161/01.STR.0000078311.18928.16; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fernandes HM, 2000, ACT NEUR S, V76, P463; Fiebach JB, 2004, STROKE, V35, P502, DOI 10.1161/01.STR.0000114203.75678.88; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145; Fujii Y, 2001, STROKE, V32, P883, DOI 10.1161/01.STR.32.4.883; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Goldstein JN, 2007, NEUROLOGY, V68, P889, DOI 10.1212/01.wnl.0000257087.22852.21; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gujjar AR, 1998, NEUROLOGY, V51, P447, DOI 10.1212/WNL.51.2.447; Hachinski V, 2003, STROKE, V34, P2775, DOI 10.1161/01.STR.0000107480.16433.4C; Hanley DF, 2009, STROKE, V40, P1533, DOI 10.1161/STROKEAHA.108.535419; Hart RG, 2000, NEUROLOGY, V55, P907, DOI 10.1212/WNL.55.7.907; Hattori N, 2004, J NEUROSURG, V101, P417, DOI 10.3171/jns.2004.101.3.0417; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Huttner HB, 2008, EUR J NEUROL, V15, P342, DOI 10.1111/j.1468-1331.2008.02077.x; Huttner HB, 2007, STROKE, V38, P183, DOI 10.1161/01.STR.0000251795.02560.62; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Huttner HB, 2006, CEREBROVASC DIS, V21, P159, DOI 10.1159/000090527; Inaji M, 2003, ACTA NEUROCHIR SUPPL, V86, P445; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Kalita J, 2004, J NEUROL SCI, V224, P19, DOI 10.1016/j.jns.2004.05.019; Kazui S, 1997, STROKE, V28, P2370, DOI 10.1161/01.STR.28.12.2370; Keir SL, 2002, CEREBROVASC DIS, V14, P197, DOI 10.1159/000065661; Kelly J, 2003, STROKE, V34, P2999, DOI 10.1161/01.STR.0000102561.86835.17; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Labovitz DL, 2005, NEUROLOGY, V65, P518, DOI 10.1212/01.wnl.0000172915.71933.00; Lacut K, 2005, NEUROLOGY, V65, P865, DOI 10.1212/01.wnl.0000176073.80532.a2; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Longatti PL, 2004, STROKE, V35, pE35, DOI 10.1161/01.STR.0000113736.73632.F6; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Lyden PD, 2007, STROKE, V38, P2262, DOI 10.1161/STROKEAHA.106.472746; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Matz PG, 2001, J CEREBR BLOOD F MET, V21, P921, DOI 10.1097/00004647-200108000-00004; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; MAYER SA, 1994, NEUROLOGY, V44, P1379, DOI 10.1212/WNL.44.8.1379; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mayer SA, 2008, STROKE, V39, P528; Mendelow AD, 2007, CURR OPIN CRIT CARE, V13, P169, DOI 10.1097/MCC.0b013e3280a9e5c2; Mendelow AD, 2005, LANCET, V365, P387; Misra UK, 2005, J NEUROL SCI, V239, P5, DOI 10.1016/j.jns.2005.07.011; Misra UK, 2005, J NEUROL SCI, V234, P41, DOI 10.1016/j.jns.2005.03.038; Mizutani T, 2000, J NEUROSURG, V93, P859, DOI 10.3171/jns.2000.93.5.0859; Moon JS, 2008, CRIT CARE MED, V36, P172, DOI 10.1097/01.CCM.0000297876.62464.6B; Morgenstern LB, 2005, STROKE, V36, pE23, DOI 10.1161/01.STR.0000155685.77775.4c; Morgenstern LB, 2001, NEUROLOGY, V56, P1294, DOI 10.1212/WNL.56.10.1294; Morgenstern LB, 1997, ANN NEUROL, V42, P919, DOI 10.1002/ana.410420614; Morioka J, 2006, SURG NEUROL, V65, P67, DOI 10.1016/j.surneu.2005.03.023; Naff N J, 1997, New Horiz, V5, P359; Naff NJ, 2004, NEUROSURGERY, V54, P577, DOI 10.1227/01.NEU.0000108422.10842.60; Naff NJ, 2000, STROKE, V31, P841, DOI 10.1161/01.STR.31.4.841; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P194; Nakamura T, 2005, STROKE, V36, P348, DOI 10.1161/01.STR.0000153044.60858.1b; Nieuwkamp DJ, 2000, J NEUROL, V247, P117, DOI 10.1007/PL00007792; Nyquist P, 2007, J NEUROL SCI, V261, P84, DOI 10.1016/j.jns.2007.04.039; Ogata T, 2008, J NEUROL SCI, V272, P83, DOI 10.1016/j.jns.2008.04.032; Ohwaki K, 2004, STROKE, V35, P1364, DOI 10.1161/01.STR.0000128795.38283.4b; Ohwaki K, 2006, NEUROCRIT CARE, V5, P15, DOI 10.1385/NCC:5:1:15; Orakcioglu B, 2005, EXP NEUROL, V193, P369, DOI 10.1016/j.expneurol.2005.01.017; Palareti G., 1996, LANCET, V48, P23; Pantazis G, 2006, SURG NEUROL, V66, P492, DOI 10.1016/j.surneu.2006.05.054; Passero S, 2002, EPILEPSIA, V43, P1175, DOI 10.1046/j.1528-1157.2002.00302.x; Phan TG, 2000, ARCH NEUROL-CHICAGO, V57, P1710, DOI 10.1001/archneur.57.12.1710; Qureshi AI, 2008, CIRCULATION, V118, P176, DOI 10.1161/CIRCULATIONAHA.107.723874; Qureshi AI, 2007, STROKE, V38, P2180, DOI 10.1161/STROKEAHA.106.467506; Qureshi AI, 2007, NEUROCRIT CARE, V6, P56, DOI 10.1385/NCC:6:1:56; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Qureshi AI, 2006, CRIT CARE MED, V34, P1975, DOI 10.1097/01.CCM.0000220763.85974.E8; Qureshi Adnan I, 2005, J Intensive Care Med, V20, P34, DOI 10.1177/0885066604271619; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; Qureshi AI, 2002, NEUROSURG CLIN N AM, V13, P355, DOI 10.1016/S1042-3680(02)00012-8; QURESHI AI, 1995, STROKE, V26, P1764, DOI 10.1161/01.STR.26.10.1764; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; QURESHI AI, 2008, INT STROK C NEW ORL; Rabinstein AA, 2002, NEUROLOGY, V58, P1367, DOI 10.1212/WNL.58.9.1367; Rabinstein AA, 2007, ARCH NEUROL-CHICAGO, V64, P203, DOI 10.1001/archneur.64.2.noc60131; Roitberg B, 2005, NEUROSURGERY, V57, P832, DOI 10.1227/01.NEU.0000180816.80626.C2; Rosand J, 2000, NEUROLOGY, V55, P947, DOI 10.1212/WNL.55.7.947; Rost NS, 2008, STROKE, V39, P2166, DOI 10.1161/STROKEAHA.107.501650; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sansing LH, 2003, J NEUROSURG, V98, P985, DOI 10.3171/jns.2003.98.5.0985; Schellinger PD, 2003, STROKE, V34, P1674, DOI 10.1161/01.STR.0000076010.10696.55; Siddique MS, 2002, J NEUROSURG, V96, P736, DOI 10.3171/jns.2002.96.4.0736; Sjoblom L, 2001, STROKE, V32, P2567, DOI 10.1161/hs1101.098523; Smith EE, 2004, NEUROLOGY, V63, P1606, DOI 10.1212/01.WNL.0000142966.22886.20; St Louis EK, 1998, NEUROLOGY, V51, P1364, DOI 10.1212/WNL.51.5.1364; Steiner T, 2006, STROKE, V37, P256, DOI 10.1161/01.STR.0000196989.09900.f8; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Steiner T, 2006, NEUROSURGERY, V59, P767, DOI 10.1227/01.NEU.0000232837.34992.32; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Sumer MM, 2002, NEUROL SCI, V23, P29, DOI 10.1007/s100720200020; TAKEBAYASHI S, 1983, STROKE, V14, P28, DOI 10.1161/01.STR.14.1.28; Teernstra OPM, 2003, STROKE, V34, P968, DOI 10.1161/01.STR.0000063367.52044.40; Tuhrim S, 2008, NEW ENGL J MED, V358, P2174, DOI 10.1056/NEJMe0801856; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wagner KR, 2002, DEV NEUROSCI-BASEL, V24, P154, DOI 10.1159/000065703; Wang CX, 2007, DRUG AGING, V24, P537, DOI 10.2165/00002512-200724070-00002; Wang J, 2005, STROKE, V36, P613, DOI 10.1161/01.STR.0000155729.12931.8f; Weimar C, 2003, CEREBROVASC DIS, V15, P29, DOI 10.1159/000067119; Wijdicks EFM, 2000, CEREBROVASC DIS, V10, P93, DOI 10.1159/000016036; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yadav YR, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-1; Yamamoto T, 2006, MINIM INVAS NEUROSUR, V49, P173, DOI 10.1055/s-2006-944242; Yang SX, 2006, J CEREBR BLOOD F MET, V26, P1490, DOI 10.1038/sj.jcbfm.9600305; Yasaka M, 2003, THROMB HAEMOSTASIS, V89, P278; Yilmazlar S, 2005, NEUROL RES, V27, P653, DOI 10.1179/016164105X35657; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zhang ZQ, 2007, CEREBROVASC DIS, V24, P91, DOI 10.1159/000103122; Zurasky JA, 2005, NEUROLOGY, V64, P725, DOI 10.1212/01.WNL.0000152045.56837.58	148	1046	1096	2	101	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2009	373	9675					1632	1644		10.1016/S0140-6736(09)60371-8	http://dx.doi.org/10.1016/S0140-6736(09)60371-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445QJ	19427958	Green Accepted			2022-12-28	WOS:000266066300034
J	Darzi, A; Kibasi, T				Darzi, Ara; Kibasi, Tom			Could the UK lead the world in medical education and training?	LANCET			English	Editorial Material									[Darzi, Ara; Kibasi, Tom] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept BioSurg & Surg Technol, London W2 1NY, England	Imperial College London	Darzi, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept BioSurg & Surg Technol, London W2 1NY, England.	a.darzi@imperial.ac.uk						Department of Health, 2008, HIGH QUAL WORKF NHS; *HM TREAS DEP INN, 2007, SCI INN INV FRAM 200; Minshall T., 2005, U SPIN OUT COMPANIES; Nye J., 2004, SOFT POWER MEANS SUC; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; Times Higher Education, 2008, TIMES HIGHER ED 1009; Universities UK, 2006, EC IMP UK HIGH ED I	7	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2095	2096		10.1016/S0140-6736(09)60733-9	http://dx.doi.org/10.1016/S0140-6736(09)60733-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19446325				2022-12-28	WOS:000267229700010
J	Fara, P				Fara, Patricia			A microscopic reality tale	NATURE			English	Editorial Material									Univ Cambridge Clare Coll, Cambridge CB2 1TL, England	University of Cambridge	Fara, P (corresponding author), Univ Cambridge Clare Coll, Cambridge CB2 1TL, England.	pf10006@cam.ac.uk						Hooke Robert, 2007, MICROGRAPHIA SOME PH, pa3r; JONES C, 1998, PICTURING SCI REPROD; McDougall Warren, 2009, LONDONS LEONARDO LIF, V5, P353; Tucker Jennifer, 2005, NATURE EXPOSED PHOTO	4	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					642	644		10.1038/459642a	http://dx.doi.org/10.1038/459642a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494897				2022-12-28	WOS:000266608600020
J	Delhommeau, F; Dupont, S; Della Valle, V; James, C; Trannoy, S; Masse, A; Kosmider, O; Le Couedic, JP; Robert, F; Alberdi, A; Lecluse, Y; Plo, I; Dreyfus, FJ; Marzac, C; Casadevall, N; Lacombe, C; Romana, SP; Dessen, P; Soulier, J; Viguie, F; Fontenay, M; Vainchenker, W; Bernard, OA				Delhommeau, Francois; Dupont, Sabrina; Della Valle, Veronique; James, Chloe; Trannoy, Severine; Masse, Aline; Kosmider, Olivier; Le Couedic, Jean-Pierre; Robert, Fabienne; Alberdi, Antonio; Lecluse, Yann; Plo, Isabelle; Dreyfus, Francois J.; Marzac, Christophe; Casadevall, Nicole; Lacombe, Catherine; Romana, Serge P.; Dessen, Philippe; Soulier, Jean; Viguie, Franck; Fontenay, Michaela; Vainchenker, William; Bernard, Olivier A.			Mutation in TET2 in Myeloid Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL COMPARTMENT; UNIPARENTAL DISOMY; MYELOPROLIFERATIVE DISORDERS; MYELODYSPLASTIC SYNDROMES; POLYCYTHEMIA-VERA; V617F MUTATION; GENETIC EVENT; JAK2; LEUKEMIA; CLASSIFICATION	BACKGROUND The myelodysplastic syndromes and myeloproliferative disorders are associated with deregulated production of myeloid cells. The mechanisms underlying these disorders are not well defined. METHODS We conducted a combination of molecular, cytogenetic, comparative-genomic-hybridization, and single-nucleotide-polymorphism analyses to identify a candidate tumor-suppressor gene common to patients with myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia (AML). The coding sequence of this gene, TET2, was determined in 320 patients. We analyzed the consequences of deletions or mutations in TET2 with the use of in vitro clonal assays and transplantation of human tumor cells into mice. RESULTS We initially identified deletions or mutations in TET2 in three patients with myelodysplastic syndromes, in three of five patients with myeloproliferative disorders, in two patients with primary AML, and in one patient with secondary AML. We selected the six patients with myelodysplastic syndromes or AML because they carried acquired rearrangements on chromosome 4q24; we selected the five patients with myeloproliferative disorders because they carried a dominant clone in hematopoietic progenitor cells that was positive for the V617F mutation in the Janus kinase 2 (JAK2) gene. TET2 defects were observed in 15 of 81 patients with myelodysplastic syndromes (19%), in 24 of 198 patients with myeloproliferative disorders (12%) (with or without the JAK2 V617F mutation), in 5 of 21 patients with secondary AML (24%), and in 2 of 9 patients with chronic myelomonocytic leukemia (22%). TET2 defects were present in hematopoietic stem cells and preceded the JAK2 V617F mutation in the five samples from patients with myeloproliferative disorders that we analyzed. CONCLUSIONS Somatic mutations in TET2 occur in about 15% of patients with various myeloid cancers.	[Della Valle, Veronique; Trannoy, Severine; Robert, Fabienne; Romana, Serge P.; Bernard, Olivier A.] Hop Necker Enfants Malad, INSERM, E0210, F-75015 Paris, France; [Delhommeau, Francois; Dupont, Sabrina; James, Chloe; Masse, Aline; Le Couedic, Jean-Pierre; Lecluse, Yann; Plo, Isabelle; Casadevall, Nicole; Dessen, Philippe; Vainchenker, William] Inst Gustave Roussy, INSERM, U790, F-94805 Villejuif, France; [Delhommeau, Francois; Dupont, Sabrina; Masse, Aline; Le Couedic, Jean-Pierre; Casadevall, Nicole; Dessen, Philippe; Vainchenker, William] Univ Paris 11, Villejuif, France; [Delhommeau, Francois; Marzac, Christophe; Casadevall, Nicole] Hop St Antoine, F-75571 Paris, France; [Delhommeau, Francois; Casadevall, Nicole] Univ Paris 06, Paris, France; [Della Valle, Veronique; Kosmider, Olivier; Dreyfus, Francois J.; Lacombe, Catherine; Romana, Serge P.; Viguie, Franck; Fontenay, Michaela; Bernard, Olivier A.] Univ Paris 05, Paris, France; [Kosmider, Olivier; Dreyfus, Francois J.; Lacombe, Catherine; Fontenay, Michaela] Hop Cochin, Inst Cochin, INSERM, CNRS UMR8104,U567, F-75674 Paris, France; [Kosmider, Olivier; Lacombe, Catherine; Fontenay, Michaela; Bernard, Olivier A.] Hop Cochin, Hematol Lab, AP HP, F-75674 Paris, France; [Dreyfus, Francois J.] Hop Cochin, Unite Fonct Hematol, F-75674 Paris, France; [James, Chloe] Univ Bordeaux 2, INSERM, U876, F-33076 Bordeaux, France; [Alberdi, Antonio; Soulier, Jean] Univ Paris Diderot, INSERM, Unite MR944, Hop St Louis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bernard, OA (corresponding author), Hop Necker Enfants Malad, INSERM, E0210, 149 Rue Vaugirard, F-75015 Paris, France.	olivier.bernard@inserm.fr	Plo, Isabelle/C-9056-2017; Trannoy, Severine/D-1530-2015; Bernard, Olivier A./E-5721-2016; james, chloe/A-2015-2012; Plo, Isabelle/AAT-6742-2021	Plo, Isabelle/0000-0002-5915-6910; Trannoy, Severine/0000-0002-5059-9846; James, Chloe/0000-0001-9553-2701; KOSMIDER, olivier/0000-0002-6021-4057; Vainchenker, William/0000-0003-4705-202X; Fontenay, Michaela/0000-0002-5492-6349; Bernard, Olivier/0000-0002-0463-9747; Romana, Serge Pierrick/0000-0003-3435-239X; Delhommeau, Francois/0000-0002-4915-0734	INSERM; La Ligue Nationale contre le Cancer; La Fondation de France; Institut National du Cancer; Canceropole Ile de France; L'association Francaise contre les Myopathies; GIS-Institut des Maladies Rares; la Direction Regionale de la Recherche Clinique AP-HP; Ministere de la Recherche et de la Technologie; European Hematology Association	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); La Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Ile de France(Region Ile-de-France); L'association Francaise contre les Myopathies(Association Francaise contre les Myopathies); GIS-Institut des Maladies Rares; la Direction Regionale de la Recherche Clinique AP-HP; Ministere de la Recherche et de la Technologie; European Hematology Association	Supported by grants from INSERM, La Ligue Nationale contre le Cancer, La Fondation de France, Institut National du Cancer, Canceropole Ile de France (Cellules Souches Cancereuses and Apoptosis 2007), L'association Francaise contre les Myopathies, GIS-Institut des Maladies Rares, la Direction Regionale de la Recherche Clinique AP-HP, Ministere de la Recherche et de la Technologie (to Dr. Dupont), and the European Hematology Association (to Dr. Delhommeau).	Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Braun T, 2006, BLOOD, V107, P1156; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Delhommeau F, 2006, CELL MOL LIFE SCI, V63, P2939, DOI 10.1007/s00018-006-6272-7; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Gondek LP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001225; Greenberg, 1998, BLOOD, V91, P1100; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; James C, 2008, BLOOD, V112, P2429, DOI 10.1182/blood-2008-02-137877; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Morgani KJ, 2008, ANNU REV MED, V59, P213, DOI 10.1146/annurev.med.59.061506.154159; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Ono R, 2002, CANCER RES, V62, P4075; Raghavan M, 2008, BLOOD, V112, P814, DOI 10.1182/blood-2008-01-132431; Robert-Richard E, 2006, HAEMATOLOGICA, V91, P1384; Tiu R, 2007, LEUKEMIA, V21, P1648, DOI 10.1038/sj.leu.2404757; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; Villeval JL, 2006, SEMIN THROMB HEMOST, V32, P341, DOI 10.1055/s-2006-942755	29	1309	1370	4	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2289	2301		10.1056/NEJMoa0810069	http://dx.doi.org/10.1056/NEJMoa0810069			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474426	Bronze			2022-12-28	WOS:000266367300005
J	Lemyze, M; Salomon, S; Brown, D; Detouche, P; Collet, F				Lemyze, M.; Salomon, S.; Brown, D.; Detouche, P.; Collet, F.			Picture quiz What is the target?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE LUNG INJURY; MYCOPLASMA-PNEUMONIAE; DIAGNOSIS; CARE		[Lemyze, M.; Salomon, S.; Detouche, P.; Collet, F.] Hop Broussais, Dept Crit Care Med, F-35400 St Malo, France; [Brown, D.] Hop Broussais, Dept Emergency Med, F-35400 St Malo, France		Lemyze, M (corresponding author), Hop Broussais, Dept Crit Care Med, F-35400 St Malo, France.	malcolmlemyze@yahoo.fr						Braun GS, 2006, J EMERG MED, V30, P371, DOI 10.1016/j.jemermed.2005.07.015; CHAN ED, 1995, WESTERN J MED, V162, P133; Foy HM, 1999, CLIN INFECT DIS, V28, P237, DOI 10.1086/515118; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Lamoreux MR, 2006, AM FAM PHYSICIAN, V74, P1883; LIAPIKOU A, CLIN INFECT DIS; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; LYELL A, 1967, LANCET, V2, P1116; Macfarlane JT, 2004, THORAX, V59, P364, DOI 10.1136/thx.2004.024992; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Miyashita N, 2007, J MED MICROBIOL, V56, P1625, DOI 10.1099/jmm.0.47119-0; Murdoch DR, 2003, CLIN INFECT DIS, V36, P1162, DOI 10.1086/374559; Radisic M, 2000, CLIN INFECT DIS, V31, P1507, DOI 10.1086/317498; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2009	338								b1604	10.1136/bmj.b1604	http://dx.doi.org/10.1136/bmj.b1604			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WT	19474026				2022-12-28	WOS:000266502300001
J	Ray, KK; Seshasai, SRK; Wijesuriya, S; Sivakumaran, R; Nethercott, S; Preiss, D; Erqou, S; Sattar, N				Ray, Kausik K.; Seshasai, Sreenivasa Rao Kondapally; Wijesuriya, Shanelle; Sivakumaran, Rupa; Nethercott, Sarah; Preiss, David; Erqou, Sebhat; Sattar, Naveed			Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials	LANCET			English	Article							PIOGLITAZONE CLINICAL-TRIAL; GLYCEMIC CONTROL; BLOOD-GLUCOSE; TYPE-2; EVENTS; COMPLICATIONS; MORTALITY; ROSIGLITAZONE; VETERANS; ASSOCIATION	Background Whether intensive control of glucose reduces macrovascular events and all-cause mortality in individuals with type 2 diabetes mellitus is unclear. We undertook a meta-analysis of randomised controlled trials to determine whether intensive treatment is beneficial. Methods We selected five prospective randomised controlled trials of 33 040 participants to assess the effect of an intensive glucose-lowering regimen on death and cardiovascular outcomes compared with a standard regimen. We gathered information about events of non-fatal myocardial infarction, coronary heart disease (fatal and non-fatal myocardial infarction), stroke, and all-cause mortality and did a random-effects meta-analysis to obtain summary effect estimates for the clinical outcomes with use of odds ratios calculated from the raw data of every trial. Statistical heterogeneity across trials was assessed with the chi(2) and 12 statistics. Findings The five trials provided information on 1497 events of non-fatal myocardial infarction, 2318 of coronary heart disease, 1127 of stroke, and 2892 of all-cause mortality during about 163 000 person-years of follow-up. The mean haemoglobin A(1c) concentration (HbA(1c)) was 0.9% lower for participants given intensive treatment than for those given standard treatment. Intensive glycaemic control resulted in a 17% reduction in events of non-fatal myocardial infarction (odds ratio 0.83, 95% CI 0.75-0.93), and a 15% reduction in events of coronary heart disease (0.85 0.77-0.93). Intensive glycaemic control had no significant effect on events of stroke (0.93, 0.81-1.06) or all-cause mortality (1.02, 0.87-1.19). Interpretation Overall, intensive compared with standard glycaemic control significantly reduces coronary events without an increased risk of death. However, the optimum mechanism, speed, and extent of HbA(1c) reduction might be different in differing populations. Funding None.	[Ray, Kausik K.; Seshasai, Sreenivasa Rao Kondapally; Wijesuriya, Shanelle; Sivakumaran, Rupa; Nethercott, Sarah; Erqou, Sebhat] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Ray, Kausik K.] Addenbrookes Hosp, Dept Cardiol, Cambridge, England; [Preiss, David; Sattar, Naveed] Univ Glasgow, Dept Med, Glasgow, Lanark, Scotland	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Glasgow	Ray, KK (corresponding author), Strangeways Res Lab, Dept Publ Hlth & Primary Care, Worts Causeway, Cambridge CB1 8RN, England.	kkr25@medschl.cam.ac.uk	Ray, Kausik/Z-2055-2019	Preiss, David/0000-0003-3139-1836; s, hema/0000-0002-3440-9475	Cates Cambridge Trust scholarship; Overseas Research Studentship; British Heart Foundation	Cates Cambridge Trust scholarship; Overseas Research Studentship; British Heart Foundation(British Heart Foundation)	SRKS and SE are supported by the Cates Cambridge Trust scholarship and Overseas Research Studentship Award Scheme. KKR is funded by a British Heart Foundation intermediate fellowship.	Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; Abraira C, 2003, J DIABETES COMPLICAT, V17, P314, DOI 10.1016/S1056-8727(02)00277-5; [Anonymous], 1982, Diabetes, V31 Suppl 5, P1; Charbonnel B, 2004, DIABETES CARE, V27, P1647, DOI 10.2337/diacare.27.7.1647; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; KILO C, 1980, JAMA-J AM MED ASSOC, V243, P450, DOI 10.1001/jama.243.5.450; Lehman R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b800; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; SCHOR S, 1971, J AMER MED ASSOC, V217, P1671, DOI 10.1001/jama.217.12.1671; Shichiri M, 2000, DIABETES CARE, V23, pB21; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; The University Group Diabetes Program, 1975, DIABETES, V24, P65; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wilcox R, 2008, AM HEART J, V155, P712, DOI 10.1016/j.ahj.2007.11.029	31	980	1052	0	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1765	1772		10.1016/S0140-6736(09)60697-8	http://dx.doi.org/10.1016/S0140-6736(09)60697-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465231				2022-12-28	WOS:000266337300031
J	Abramov, O; Mojzsis, SJ				Abramov, Oleg; Mojzsis, Stephen J.			Microbial habitability of the Hadean Earth during the late heavy bombardment	NATURE			English	Article							SUPRACRUSTAL ROCKS; LUNAR CATACLYSM; WEST GREENLAND; ORIGIN; LIFE; METEORITE; ZIRCONS; AGE; EVOLUTION; HISTORY	Lunar rocks(1,2) and impact melts(3), lunar(4) and asteroidal meteorites(5), and an ancient martian meteorite(6) record thermal metamorphic events with ages that group around and/or do not exceed 3.9 Gyr. That such a diverse suite of solar system materials share this feature is interpreted to be the result of a post-primary-accretion cataclysmic spike in the number of impacts commonly referred to as the late heavy bombardment (LHB)(1-7). Despite its obvious significance to the preservation of crust and the survivability of an emergent biosphere, the thermal effects of this bombardment on the young Earth remain poorly constrained. Here we report numerical models constructed to probe the degree of thermal metamorphism in the crust in the effort to recreate the effect of the LHB on the Earth as a whole; outputs were used to assess habitable volumes of crust for a possible near-surface and subsurface primordial microbial biosphere. Our analysis shows that there is no plausible situation in which the habitable zone was fully sterilized on Earth, at least since the termination of primary accretion of the planets and the postulated impact origin of the Moon. Our results explain the root location of hyperthermophilic bacteria in the phylogenetic tree for 16S small-subunit ribosomal RNA(8), and bode well for the persistence of microbial biospheres even on planetary bodies strongly reworked by impacts.	[Abramov, Oleg; Mojzsis, Stephen J.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Abramov, O (corresponding author), Univ Colorado, Dept Geol Sci, 2200 Colorado Ave,UCB 399, Boulder, CO 80309 USA.	oleg.abramov@colorado.edu	MOJZSIS, STEPHEN/AAU-9527-2020	MOJZSIS, STEPHEN/0000-0003-0000-125X; Abramov, Oleg/0000-0002-2884-2299	NASA Astrobiology Institute; NASA Exobiology program	NASA Astrobiology Institute; NASA Exobiology program(National Aeronautics & Space Administration (NASA))	This work is funded by the NASA Astrobiology Institute (through the NASA Postdoctoral Program) and the NASA Exobiology program. Office space and computer resources provided by the Department of Space Studies of the Southwest Research Institute in the early stages of this project are greatly appreciated. Reviews by E. Asphaug, as well as comments by D. Trail and T. M. Harrison, are gratefully acknowledged.	Abramov O, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002213; Abramov O, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002453; Ash RD, 1996, NATURE, V380, P57, DOI 10.1038/380057a0; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Bottke WF, 2005, ICARUS, V175, P111, DOI 10.1016/j.icarus.2004.10.026; Bowring SA, 1999, CONTRIB MINERAL PETR, V134, P3, DOI 10.1007/s004100050465; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; DALRYMPLE GB, 1993, J GEOPHYS RES-PLANET, V98, P13085, DOI 10.1029/93JE01222; Dauphas N, 2004, SCIENCE, V306, P2077, DOI 10.1126/science.1104639; GOGARTENBOEKELS M, 1995, ORIGINS LIFE EVOL B, V25, P251, DOI 10.1007/BF01581588; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; HARMILTON WB, 1993, GEOL N AM, V2, P597; Hartmann W. K., 2000, ORIGIN EARTH MOON, P493; Hopkins M, 2008, NATURE, V456, P493, DOI 10.1038/nature07465; Kring DA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001529; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; Manning CE, 2006, AM J SCI, V306, P303, DOI 10.2475/05.2006.02; McKeegan KD, 2007, GEOLOGY, V35, P591, DOI 10.1130/G23465A.1; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Ryder G, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001583; Ryder G., 2000, ORIGIN EARTH MOON, P475; Ryder G., 1990, EOS T AM GEOPHYS UN, VAGU71, P313, DOI [10.1029/90EO00086, DOI 10.1029/90EO00086, 10.1029/ 90EO00086]; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Trail D, 2007, GEOCHIM COSMOCHIM AC, V71, P4044, DOI 10.1016/j.gca.2007.06.003; TURNER G, 1973, P LUNAR PLANET SCI C, P1889; Zahnle KJ, 1997, COMETS ORIGIN EVOLUT, P175	30	150	155	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					419	422		10.1038/nature08015	http://dx.doi.org/10.1038/nature08015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458721				2022-12-28	WOS:000266243700044
J	Armbrust, EV				Armbrust, E. Virginia			The life of diatoms in the world's oceans	NATURE			English	Review							PSEUDO-NITZSCHIA; PHAEODACTYLUM-TRICORNUTUM; THALASSIOSIRA-PSEUDONANA; PHYTOPLANKTON BLOOMS; EVOLUTION; GENOME; BACILLARIOPHYCEAE; BACTERIA; WATERS; SILICA	Marine diatoms rose to prominence about 100 million years ago and today generate most of the organic matter that serves as food for life in the sea. They exist in a dilute world where compounds essential for growth are recycled and shared, and they greatly influence global climate, atmospheric carbon dioxide concentration and marine ecosystem function. How these essential organisms will respond to the rapidly changing conditions in today's oceans is critical for the health of the environment and is being uncovered by studies of their genomes.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	armbrust@ocean.washington.edu			Gordon and Betty Moore Foundation Marine Microbiology Initiative; US National Science Foundation; National Institute of Environmental Health Sciences	Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); US National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	I am grateful to members of my laboratory and to G. Rocap and S. Francis for discussion and edits of the manuscript. Support was provided by funding from the Gordon and Betty Moore Foundation Marine Microbiology Initiative, the US National Science Foundation and the National Institute of Environmental Health Sciences.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BATES SS, 2006, ECOLOGY HARMFUL ALGA, pCH7; Becker B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-203; Bidle KD, 2002, SCIENCE, V298, P1980, DOI 10.1126/science.1076076; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; Cloern JE, 2007, P NATL ACAD SCI USA, V104, P18561, DOI 10.1073/pnas.0706151104; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Denman KL, 2008, MAR ECOL PROG SER, V364, P219, DOI 10.3354/meps07542; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; Droop MR, 2007, J PLANKTON RES, V29, P107, DOI 10.1093/plankt/fbm009; Drum RW, 2003, TRENDS BIOTECHNOL, V21, P325, DOI 10.1016/S0167-7799(03)00169-0; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foster RA, 2006, ENVIRON MICROBIOL, V8, P1913, DOI 10.1111/j.1462-2920.2006.01068.x; Goldstein T, 2008, P ROY SOC B-BIOL SCI, V275, P267, DOI 10.1098/rspb.2007.1221; Guidry Michael W., 2007, P377; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kaczmarska I, 2005, HARMFUL ALGAE, V4, P725, DOI 10.1016/j.hal.2004.10.001; Katz ME, 2005, MAR GEOL, V217, P323, DOI 10.1016/j.margeo.2004.08.005; Kooistra Wiebe H. C. F., 2007, P207; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; Lau WWY, 2007, APPL ENVIRON MICROB, V73, P2440, DOI 10.1128/AEM.01965-06; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Marchetti A, 2008, J PHYCOL, V44, P650, DOI 10.1111/j.1529-8817.2008.00526.x; Marchetti A, 2006, LIMNOL OCEANOGR, V51, P2092, DOI 10.4319/lo.2006.51.5.2092; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; Matsumoto K, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001515; McDougald D, 2007, ANAL BIOANAL CHEM, V387, P445, DOI 10.1007/s00216-006-0761-2; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Montsant A, 2007, J PHYCOL, V43, P585, DOI 10.1111/j.1529-8817.2007.00342.x; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Peers G, 2006, NATURE, V441, P341, DOI 10.1038/nature04630; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Rabosky DL, 2009, NATURE, V457, P183, DOI 10.1038/nature07435; Reyes-Prieto A, 2006, CURR BIOL, V16, P2320, DOI 10.1016/j.cub.2006.09.063; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Schmid AMM, 2003, J PHYCOL, V39, P122, DOI 10.1046/j.1529-8817.2003.02084.x; Sedwick PN, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001586; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Smetacek V, 2008, SCIENCE, V319, P1346, DOI 10.1126/science.1151330; Sorhannus U, 2007, MAR MICROPALEONTOL, V65, P1, DOI 10.1016/j.marmicro.2007.05.002; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Vardi A, 2008, CURR BIOL, V18, P895, DOI 10.1016/j.cub.2008.05.037; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; Vrieling EG, 2007, P NATL ACAD SCI USA, V104, P10441, DOI 10.1073/pnas.0608980104; Wenzl S, 2008, ANGEW CHEM INT EDIT, V120, P1753; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Zielinski U, 1997, PALAEOGEOGR PALAEOCL, V129, P213, DOI 10.1016/S0031-0182(96)00130-7	73	568	590	20	416	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					185	192		10.1038/nature08057	http://dx.doi.org/10.1038/nature08057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444204				2022-12-28	WOS:000266036100028
J	Morey, MC; Snyder, DC; Sloane, R; Cohen, HJ; Peterson, B; Hartman, TJ; Miller, P; Mitchell, DC; Demark-Wahnefried, W				Morey, Miriam C.; Snyder, Denise C.; Sloane, Richard; Cohen, Harvey Jay; Peterson, Bercedis; Hartman, Terryl J.; Miller, Paige; Mitchell, Diane C.; Demark-Wahnefried, Wendy			Effects of Home-Based Diet and Exercise on Functional Outcomes Among Older, Overweight Long-term Cancer Survivors RENEW: A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; LOWER-EXTREMITY FUNCTION; PHYSICAL-ACTIVITY; DISABILITY INSTRUMENT; HEALTH; INTERVENTIONS; ASSOCIATIONS; MODELS; ADULTS; AGE	Context Five-year survival rates for early stage colorectal, breast, and prostate cancer currently exceed 90% and are increasing. Cancer survivors are at greater risk for second malignancies, other comorbidities, and accelerated functional decline. Lifestyle interventions may provide benefit, but it is unknown whether long-term cancer survivors can modify their lifestyle behaviors sufficiently to improve functional status. Objective To determine whether a telephone counseling and mailed print material-based diet and exercise intervention is effective in reorienting functional decline in older, overweight cancer survivors. Design, Setting, and Participants Randomized controlled trial of 641 overweight (body mass index >= 25 and <40), long-term (>= 5 years) survivors (aged 65-91 years) of colorectal, breast, and prostate cancer, who were randomly assigned to an intervention group (n=319) or delayed intervention (control) group (n=322) in Canada, the United Kingdom, and 21 US states. Individuals were recruited for the Reach out to Enhance Wellness (RENEW) trial from July 1, 2005, through May 17, 2007. Intervention A 12-month, home-based tailored program of telephone counseling and mailed materials promoting exercise, improved diet quality, and modest weight loss. The control group was wait-listed for 12 months. Main Outcome Measures Change in self-reported physical function on the Short-Form 36 physical function subscale (score range, 0-100; a high score indicates better functioning) from baseline to 12 months was the primary end point. Secondary outcomes included changes in function on the basic and advanced lower extremity function subscales of the Late Life Function and Disability Index (score range, 0-100), physical activity, body mass index, and overall health-related quality of life. Results The mean baseline Short-Form 36 physical function score was 75.7. At the 12-month follow-up, the mean function scores declined less rapidly in the intervention group (-2.15; 95% confidence interval [CI], -0.36 to -3.93) compared with the control group (-4.84; 95% CI, -3.04 to -6.63) (P=.03). The mean baseline basic lower extremity function score was 78.2. The mean changes in basic lower extremity function were 0.34 (95% CI, -0.84 to 1.52) in the intervention group compared with -1.89 ( 95% CI, -0.70 to -3.09) in the control group (P=.005). Physical activity, dietary behaviors, and overall quality of life increased significantly in the intervention group compared with the control group, and weight loss also was greater (2.06 kg [ 95% CI, 1.69 to 2.43 kg] vs 0.92 kg [95% CI, 0.51 to 1.33 kg], respectively; P < .001). Conclusion Among older, long-term survivors of colorectal, breast, and prostate cancer, a diet and exercise intervention reduced the rate of self-reported functional decline compared with no intervention. Trial Registration clinicaltrials.gov Identifier: NCT00303875 JAMA. 2009; 301(18):1883-1891 www.jama.com	[Morey, Miriam C.; Sloane, Richard; Cohen, Harvey Jay] Duke Univ, Older Amer Independence Ctr, Ctr Study Aging & Human Dev, Durham, NC 27705 USA; [Morey, Miriam C.; Cohen, Harvey Jay] Duke Univ, Dept Med, Durham, NC 27705 USA; [Peterson, Bercedis] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27705 USA; [Snyder, Denise C.; Sloane, Richard; Cohen, Harvey Jay; Demark-Wahnefried, Wendy] Duke Univ, Sch Med, Durham, NC 27705 USA; [Snyder, Denise C.; Sloane, Richard; Cohen, Harvey Jay; Demark-Wahnefried, Wendy] Duke Univ, Sch Nursing, Durham, NC 27705 USA; [Morey, Miriam C.; Cohen, Harvey Jay] Durham VA Med Ctr Geriatr Res, Educ & Clin Ctr, Durham, NC USA; [Hartman, Terryl J.; Miller, Paige; Mitchell, Diane C.] Penn State Univ, University Pk, PA 16802 USA; [Demark-Wahnefried, Wendy] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; UTMD Anderson Cancer Center	Morey, MC (corresponding author), Duke Univ, Older Amer Independence Ctr, Ctr Study Aging & Human Dev, 508 Fulton St,GRECC 182, Durham, NC 27705 USA.	morey@geri.duke.edu			National Institutes of Health [CA106919, P30AG028716]; Veterans Affairs Research and Development [E3386R]; NATIONAL CANCER INSTITUTE [R01CA106919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Research and Development(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants CA106919 and P30AG028716 and grant E3386R from the Veterans Affairs Research and Development.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Baker F, 2003, CANCER, V97, P674, DOI 10.1002/cncr.11085; Bales CW, 2008, J AM MED DIR ASSOC, V9, P302, DOI 10.1016/j.jamda.2008.01.006; Bellizzi KM, 2005, J CLIN ONCOL, V23, P8884, DOI 10.1200/JCO.2005.02.2343; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P526; *COMM CANC SURV, CANC PAT CANC SURV L; Courneya KS, 2007, APPL PHYSIOL NUTR ME, V32, P1001, DOI 10.1139/H07-074; Courneya Kerry S, 2007, Semin Oncol Nurs, V23, P242, DOI 10.1016/j.soncn.2007.08.002; *CTR MED MED SERV, MED EV PRIOR 2008; Deimling GT, 2007, CANCER INVEST, V25, P106, DOI 10.1080/07357900701224813; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Demark-Wahnefried W, 2003, CONTROL CLIN TRIALS, V24, P206, DOI 10.1016/S0197-2456(02)00266-0; Demark-Wahnefried W, 2006, J CLIN ONCOL, V24, P3465, DOI 10.1200/JCO.2006.05.7224; Department of Health and Human Services, 2008 PHYS ACT GUID A; Federal Interagency Foram on Aging-Related Statistics, 2006, OLD AM UPD 2006 KEY; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; HOLM S, 1979, SCAND J STAT, V6, P65; Jette AM, 2002, J GERONTOL A-BIOL, V57, pM209, DOI 10.1093/gerona/57.4.M209; Kolt GS, 2007, J AM GERIATR SOC, V55, P986, DOI 10.1111/j.1532-5415.2007.01203.x; Madsen SM, 2002, J INTERN MED, V251, P156, DOI 10.1046/j.1365-2796.2002.00949.x; Marcus BH, 1996, SPORTS MED, V22, P321, DOI 10.2165/00007256-199622050-00005; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Ouellette MM, 2004, STROKE, V35, P1404, DOI 10.1161/01.STR.0000127785.73065.34; Peddle CJ, 2008, DIS COLON RECTUM, V51, P1242, DOI 10.1007/s10350-008-9324-2; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; Stewart AL, 2001, J GERONTOL A-BIOL, V56, pM465, DOI 10.1093/gerona/56.8.M465; Stull VB, 2007, J NUTR, V137, p243S, DOI 10.1093/jn/137.1.243S; Synder DC, 2009, PSYCHO-ONCOLOGY, V18, P429, DOI 10.1002/pon.1491; *US DEP AGR, DIET GUID AM 2005; Vandelanotte C, 2008, PREV MED, V46, P232, DOI 10.1016/j.ypmed.2007.07.008; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255	39	377	378	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1883	1891		10.1001/jama.2009.643	http://dx.doi.org/10.1001/jama.2009.643			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	444JX	19436015	Green Accepted, Bronze			2022-12-28	WOS:000265978400026
J	Collins, R; Peto, R; Hennekens, C; Doll, R; Bubes, V; Buring, J; Dushkesas, R; Gaziano, M; Brennam, P; Meade, T; Rudnicka, A; Hansson, L; Warnold, I; Zanchetti, A; Avanzini, F; Roncaglioni, MC; Tognoni, G; Chown, M; Gaziano, M; Hennekens, C; Baigent, C; Barton, I; Baxter, A; Bhala, N; Blackwell, L; Boreham, J; Bowman, L; Buck, G; Collins, R; Emberson, J; Godwin, J; Halls, H; Holland, L; Kearney, P; Peto, R; Reith, C; Wilson, K; Baigent, C; Blackwell, L; Patrono, C				Collins, Rory; Peto, Richard; Hennekens, Charles; Doll, Richard; Bubes, Vadim; Buring, Julie; Dushkesas, Rimma; Gaziano, Michael; Brennam, Patrick; Meade, Tom; Rudnicka, Alicja; Hansson, Lennart; Warnold, Ingrid; Zanchetti, Alberto; Avanzini, Fausto; Roncaglioni, Maria Carla; Tognoni, Gianni; Chown, Marilyn; Gaziano, Michael; Hennekens, Charles; Baigent, Colin; Barton, Ian; Baxter, Alex; Bhala, Neeraj; Blackwell, Lisa; Boreham, Jill; Bowman, Louise; Buck, Georgina; Collins, Rory; Emberson, Jonathan; Godwin, Jon; Halls, Heather; Holland, Lisa; Kearney, Patricia; Peto, Richard; Reith, Christina; Wilson, Kate; Baigent, Colin; Blackwell, Lisa; Patrono, Carlo		Antithrombotic Trialists Collabora	Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials	LANCET			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; EVENTS; CANCER; WOMEN; RISK; MEN; AGE	Background Low-dose aspirin is of definite and substantial net benefit for many people who already have occlusive vascular disease. We have assessed the benefits and risks in primary prevention. Methods We undertook meta-analyses of serious vascular events (myocardial infarction, stroke, or vascular death) and major bleeds in six primary prevention trials (95000 individuals at low average risk, 660000 person-years, 3554 serious vascular events) and 16 secondary prevention trials (17000 individuals at high average risk, 43 000 person-years, 3306 serious vascular events) that compared long-term aspirin versus control. We report intention-to-treat analyses of first events during the scheduled treatment period. Findings in the primary prevention trials, aspirin allocation yielded a 12% proportional reduction in serious vascular events (0.51% aspirin vs 0.57% control per year, p=0.0001), due mainly to a reduction of about a fifth in non-fatal myocardial infarction (0.18% vs 0.23% per year, p<0.0001). The net effect on stroke was not significant (0.20% vs 0.21% per year, p=0.4: haernorrhagic stroke 0.04% vs 0.03%, p=0.05; other stroke 0.16% vs 0.18% per year, p=0.08). Vascular mortality did not differ significantly (0.19% vs 0.19% per year, p=0.7). Aspirin allocation increased major gastrointestinal and extracranial bleeds (0.10% vs 0.07% per year, p<0.0001), and the main risk factors for coronary disease were also risk factors for bleeding. In the secondary prevention trials, aspirin allocation yielded a greater absolute reduction in serious vascular events (6.7% vs 8.2% per year, p<0.0001), with a non-significant increase in haernorrhagic stroke but reductions of about a fifth in total stroke (2.08% vs 2.54% per year, p=0.002) and in coronary events (4.3% vs 5.3% per year, p<0.0001). In both primary and secondary prevention trials, the proportional reductions in the aggregate of all serious vascular events seemed similar for men and women. Interpretation In primary prevention without previous disease, aspirin is of uncertain net value as the reduction in occlusive events needs to be weighed against any increase in major bleeds. Further trials are in progress. Funding UK Medical Research Council, British Heart Foundation, Cancer Research UK, and the European Community Biomed Programme.	[Buring, Julie] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [Peto, Richard; Godwin, Jon] Univ Oxford, CTSU, Oxford, England; [Hennekens, Charles] Florida Atlantic Univ, Charles Schmidt Coll Biomed Sci, Boca Raton, FL 33431 USA; [Hennekens, Charles] Florida Atlantic Univ, Ctr Excellence, Boca Raton, FL 33431 USA; [Kearney, Patricia] Univ Dublin Trinity Coll, Dept Med Gerontol, Dublin 2, Ireland; [Meade, Tom] Univ London, London Sch Hyg & Trop Med, London, England; [Patrono, Carlo] Catholic Univ, Sch Med, Rome, Italy; [Roncaglioni, Maria Carla] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; [Zanchetti, Alberto] Univ Milan, Ist Auxol Italiano, Milan, Italy	Harvard University; Brigham & Women's Hospital; University of Oxford; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; Trinity College Dublin; University of London; London School of Hygiene & Tropical Medicine; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Auxologico Italiano; University of Milan	Collins, R (corresponding author), Univ Oxford, Clin Trial Serv Unit, ATT Collaborat, Richard Doll Bldg, Oxford OX3 7LF, England.	colin.baigent@ctsu.ox.ac.uk	Kearney, Patricia M/AAE-8501-2020; Collins, Rory/ABA-8487-2020; roncaglioni, maria carla/AAB-1875-2020	roncaglioni, maria carla/0000-0002-2029-7847; Kearney, Patricia/0000-0001-9599-3540; Buck, Georgina/0000-0001-5909-4265; Avanzini, Fausto/0000-0002-4029-2891; Patrono, Carlo/0000-0002-6447-2424; Emberson, Jonathan/0000-0001-7792-9422; Bhala, Neeraj/0000-0003-2502-1177	UK MRC; BHF; Cancer Research UK; European Community Biomed Programme; B H F Intermediate Research Fellowship; Medical Research Council [G9534799, G0701113, MC_U137686849, MC_U137686861] Funding Source: researchfish; MRC [G9534799, MC_U137686849, MC_U137686861, G0701113] Funding Source: UKRI	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BHF(British Heart Foundation); Cancer Research UK(Cancer Research UK); European Community Biomed Programme; B H F Intermediate Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the trial participants and investigators. Sources of funding of each individual trial are described in its publications. The CTSU is supported by a core grant from the UK MRC, the BHF, and Cancer Research UK, and has previously received funding from the European Community Biomed Programme. C Baigent is supported by the MRC, R Collins by a B H F Personal Chair, and J Emberson by a B H F Intermediate Research Fellowship. This paper is dedicated to the memory of Richard Doll (1912-2005), in collaboration with whom the first primary prevention trial<SUP>10</SUP> was undertaken.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bulugahapitiya U, 2008, HEART, V94, P1429, DOI 10.1136/hrt.2008.150698; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Calonge N, 2009, ANN INTERN MED, V150, P396; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; Elwood P, 2005, BMJ-BRIT MED J, V330, P1440, DOI 10.1136/bmj.330.7505.1440; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Meade TW, 1998, LANCET, V351, P233; Nelson MR, 2003, DRUG AGING, V20, P897, DOI 10.2165/00002512-200320120-00004; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	27	2458	2578	7	179	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2009	373	9678					1849	1860						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19482214	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000266616400028
J	Mumoli, N; Busoni, A; Cei, M				Mumoli, Nicola; Busoni, Alberto; Cei, Marco			A swallowed denture	LANCET			English	Editorial Material									[Mumoli, Nicola; Busoni, Alberto; Cei, Marco] Livorno Hosp, Dept Internal Med, I-57100 Livorno, Italy		Mumoli, N (corresponding author), Livorno Hosp, Dept Internal Med, Viale Alfieri 36, I-57100 Livorno, Italy.	nimumoli@tiscali.it	Mumoli, Nicola/J-4652-2019	Mumoli, Nicola/0000-0001-7166-5630					0	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1890	1890		10.1016/S0140-6736(09)60307-X	http://dx.doi.org/10.1016/S0140-6736(09)60307-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19482215				2022-12-28	WOS:000266616400032
J	Trifonov, V; Khiabanian, H; Rabadan, R				Trifonov, Vladimir; Khiabanian, Hossein; Rabadan, Raul			Geographic Dependence, Surveillance, and Origins of the 2009 Influenza A (H1N1) Virus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMANS		[Trifonov, Vladimir; Khiabanian, Hossein; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Ctr Computat Biol & Bioinformat, Dept Biomed Informat, New York, NY 10032 USA	Columbia University	Trifonov, V (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Computat Biol & Bioinformat, Dept Biomed Informat, 630 W 168th St, New York, NY 10032 USA.		Simonsen, Lone/K-4531-2014; Rabadan, Raul/AAZ-7367-2020; Khiabanian, Hossein/N-7207-2019	Simonsen, Lone/0000-0003-1535-8526; Khiabanian, Hossein/0000-0003-1446-4394; Rabadan, Raul/0000-0001-7946-9255				Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FRASER C, 2009, SCIENCE         0514; GARTEN RJ, 2009, SCIENCE         0522; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Trifonov V, 2009, EURO SURVEILL, V14	5	201	218	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					115	119		10.1056/NEJMp0904572	http://dx.doi.org/10.1056/NEJMp0904572			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467OS	19474418				2022-12-28	WOS:000267748900003
J	Dimarakis, I; Anderson, J				Dimarakis, Ioannis; Anderson, Jonathan			Plombage Cavities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dimarakis, Ioannis; Anderson, Jonathan] Hammersmith Hosp, London W12 OHS, England	Imperial College London	Dimarakis, I (corresponding author), Hammersmith Hosp, London W12 OHS, England.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2455	2455		10.1056/NEJMicm0802723	http://dx.doi.org/10.1056/NEJMicm0802723			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494221				2022-12-28	WOS:000266590500011
J	Liu, YC; Weinberg, MS; Ortega, LS; Painter, JA; Maloney, SA				Liu, Yecai; Weinberg, Michelle S.; Ortega, Luis S.; Painter, John A.; Maloney, Susan A.			Overseas Screening for Tuberculosis in US-Bound Immigrants and Refugees	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOREIGN-BORN PERSONS; UNITED-STATES; INFECTIOUS TUBERCULOSIS; CONTACT INVESTIGATIONS; CALIFORNIA; COUNTY; OUTCOMES; TRENDS	BACKGROUND In 2007, a total of 57.8% of the 13,293 new cases of tuberculosis in the United States were diagnosed in foreign-born persons, and the tuberculosis rate among foreign-born persons was 9.8 times as high as that among U.S.-born persons (20.6 vs. 2.1 cases per 100,000 population). Annual arrivals of approximately 400,000 immigrants and 50,000 to 70,000 refugees from overseas are likely to contribute substantially to the tuberculosis burden among foreign-born persons in the United States. METHODS The Centers for Disease Control and Prevention (CDC) collects information on overseas screening for tuberculosis among U. S.- bound immigrants and refugees, along with follow-up evaluation after their arrival in the United States. We analyzed screening and follow-up data from the CDC to study the epidemiology of tuberculosis in these populations. RESULTS From 1999 through 2005, a total of 26,075 smear-negative cases of tuberculosis (i.e., cases in which a chest radiograph was suggestive of active tuberculosis but sputum smears were negative for acid-fast bacilli on 3 consecutive days) and 22,716 cases of inactive tuberculosis (i.e., cases in which a chest radiograph was suggestive of tuberculosis that was no longer clinically active) were diagnosed by overseas medical screening of 2,714,223 U. S.- bound immigrants, representing prevalences of 961 cases per 100,000 persons (95% confidence interval [CI], 949 to 973) and 837 cases per 100,000 persons (95% CI, 826 to 848), respectively. Among 378,506 U.S.bound refugees, smear-negative tuberculosis was diagnosed in 3923 and inactive tuberculosis in 10,743, representing prevalences of 1036 cases per 100,000 persons (95% CI, 1004 to 1068) and 2838 cases per 100,000 persons (95% CI, 2785 to 2891), respectively. Active pulmonary tuberculosis was diagnosed in the United States in 7.0% of immigrants and refugees with an overseas diagnosis of smear-negative tuberculosis and in 1.6% of those with an overseas diagnosis of inactive tuberculosis. CONCLUSIONS Overseas screening for tuberculosis with follow-up evaluation after arrival in the United States is a high-yield intervention for identifying tuberculosis in U. S.- bound immigrants and refugees and could reduce the number of tuberculosis cases among foreign-born persons in the United States.	[Liu, Yecai; Weinberg, Michelle S.; Ortega, Luis S.; Painter, John A.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; [Maloney, Susan A.] CDC Collaborat, Thailand Minist Publ Hlth US, Int Emerging Infect Program, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Liu, YC (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, 1600 Clifton Rd,MS E03, Atlanta, GA 30333 USA.	yliu@cdc.gov						[Anonymous], 2007, TECHN INSTR TUB SCRE; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Binkin NJ, 1996, CLIN INFECT DIS, V23, P1226, DOI 10.1093/clinids/23.6.1226; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Catlos EK, 1998, AM J RESP CRIT CARE, V158, P1037, DOI 10.1164/ajrccm.158.4.9801024; Centers for Disease Control and Prevention, 1991, TECHN INSTR PAN PHYS; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DeRiemer K, 1998, ARCH INTERN MED, V158, P753, DOI 10.1001/archinte.158.7.753; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; LoBue PA, 2004, CHEST, V126, P1777, DOI 10.1378/chest.126.6.1777; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; *OFF IMM SERV, 2007, YB IMM STAT 2006; Pratt R., 2008, Morbidity and Mortality Weekly Report, V57, P281; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Sciortino S, 1999, INT J TUBERC LUNG D, V3, P778; Sprinson JE, 2003, INT J TUBERC LUNG D, V7, pS363; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; Thorpe LE, 2004, NEW ENGL J MED, V350, P2105, DOI 10.1056/NEJM200405133502023; Wells CD, 1997, AM J RESP CRIT CARE, V156, P573, DOI 10.1164/ajrccm.156.2.9611101; WHO, 2007, WHOHTMTB2007376; Zuber PLF, 1996, TUBERCLE LUNG DIS, V77, P524, DOI 10.1016/S0962-8479(96)90050-7; Zuber PLF, 1996, AM J RESP CRIT CARE, V154, P151, DOI 10.1164/ajrccm.154.1.8680671; 2008, MMWR MORB MORTAL WKL, V57, P292; 1995, MMWR MORB MORTAL WKL, V44, P703	28	94	94	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2406	2415		10.1056/NEJMoa0809497	http://dx.doi.org/10.1056/NEJMoa0809497			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453DN	19494216	Bronze			2022-12-28	WOS:000266590500006
J	Bignami, GF				Bignami, Giovanni F.			Celebrating the 400th Anniversary of Telescope Astronomy	SCIENCE			English	Editorial Material									[Bignami, Giovanni F.] Accademia Lincei, I-00165 Rome, Italy; [Bignami, Giovanni F.] Inst Univ Super, I-27100 Pavia, Italy		Bignami, GF (corresponding author), Accademia Lincei, Palazzo Corsini,Via Lungara, I-00165 Rome, Italy.	giovanni.bignami@gmail.com		Bignami, Giovanni/0000-0001-9582-2450				*GAL, GAL IM UN ANT TEL PA; ASTRONOMY NEUTRINO T	2	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1149	1150		10.1126/science.1172000	http://dx.doi.org/10.1126/science.1172000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478169				2022-12-28	WOS:000266410100028
J	Carvalho, A; Desai, A; Oegema, K				Carvalho, Ana; Desai, Arshad; Oegema, Karen			Structural Memory in the Contractile Ring Makes the Duration of Cytokinesis Independent of Cell Size	CELL			English	Article							ACTIN-FILAMENTS; CLEAVAGE FURROW; C-ELEGANS; CAENORHABDITIS-ELEGANS; FORCE GENERATION; FISSION YEAST; HELA-CELLS; MYOSIN-II; DYNAMICS; EGGS	Cytokinesis is accomplished by constriction of a cortical contractile ring. We show that during the early embryonic divisions in C. elegans, ring constriction occurs in two phases-an initial phase at a constant rate followed by a second phase during which the constriction rate decreases in proportion to ring perimeter. Cytokinesis completes in the same amount of time, despite the reduction in cell size during successive divisions, due to a strict proportionality between initial ring size and the constant constriction rate. During closure, the myosin motor in the ring decreases in proportion to perimeter without turning over. We propose a "contractile unit'' model to explain how the ring retains a structural memory of its initial size as it disassembles. The scalability of constriction may facilitate coordination of mitotic events and cytokinesis when cell size, and hence the distance traversed by the ring, varies during embryogenesis and in other contexts.	[Carvalho, Ana; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Carvalho, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, CMM E 3080,9500 Gilman Dr, La Jolla, CA 92093 USA.	ancarvalho@ucsd.edu; koegema@ucsd.edu	Carvalho, Ana/J-4788-2013	Carvalho, Ana/0000-0002-2256-7134	Fundacao para a Ciencia e Tecnologia, Portugal; European Social Fund [SFRH/BPD/26519/2006]; Ludwig Institute for Cancer Research	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); Ludwig Institute for Cancer Research	We thank our reviewers for providing challenging feedback that greatly improved the manuscript; Craig Mello and Ji Liu for the unpublished strain WM179; Chris Campbell and Reto Gassmann for critical reading of the manuscript; and members of the Oegema and Desai labs for support. A. C. was funded by the Fundacao para a Ciencia e Tecnologia, Portugal, and the European Social Fund (SFRH/BPD/26519/2006). K. O. is a Pew Scholar in the Biomedical Sciences. K. O. and A. D. receive salary and additional support from the Ludwig Institute for Cancer Research.	ARNOLD JM, 1969, J CELL BIOL, V41, P894, DOI 10.1083/jcb.41.3.894; Biron D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098102; Biron D, 2004, NATO SCI SER II-MATH, V160, P217; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Field C.M., 2008, SEPTINS, P147; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; He XY, 1997, EXP CELL RES, V233, P252, DOI 10.1006/excr.1997.3585; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; KAMASAKI T, 2007, PHYS REV LETT, V85, P1778; Kruse K, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051913; Kruse K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.138101; MABUCHI I, 1994, J CELL SCI, V107, P1853; MABUCHI I, 1988, P NATL ACAD SCI USA, V85, P5966, DOI 10.1073/pnas.85.16.5966; Maddox AS, 2007, DEV CELL, V12, P827, DOI 10.1016/j.devcel.2007.02.018; Maddox AS, 2005, DEVELOPMENT, V132, P2837, DOI 10.1242/dev.01828; MAUPIN P, 1986, J ULTRA MOL STRUCT R, V94, P92, DOI 10.1016/0889-1605(86)90055-8; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; SANGER JM, 1980, J CELL BIOL, V86, P568, DOI 10.1083/jcb.86.2.568; SCHROEDE.TE, 1970, Z ZELLFORSCH MIK ANA, V109, P431, DOI 10.1007/BF00343960; Schroeder T. E., 1968, Experimental Cell Research, V53, P272, DOI 10.1016/0014-4827(68)90373-X; SCHROEDER TE, 1972, J CELL BIOL, V53, P419, DOI 10.1083/jcb.53.2.419; SCHROEDER TE, 1975, MOL CELL MOVEMENT, P305; SELMAN GG, 1970, J CELL SCI, V6, P207; TAKIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P520, DOI 10.1093/oxfordjournals.jbchem.a123414; Tanaka-Takiguchi Y, 2004, J MOL BIOL, V341, P467, DOI 10.1016/j.jmb.2004.06.019; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; TUCKER JB, 1971, J CELL SCI, V8, P557; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zumdieck A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000696	38	158	157	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 29	2009	137	5					926	937		10.1016/j.cell.2009.03.021	http://dx.doi.org/10.1016/j.cell.2009.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490897	Bronze			2022-12-28	WOS:000266454800022
J	Obayashi, M; Yoshimitsu, J; Fukao, Y				Obayashi, Masayuki; Yoshimitsu, Junko; Fukao, Yoshio			Tearing of Stagnant Slab	SCIENCE			English	Article							KANTO DISTRICT; IZU-BONIN; PACIFIC; MANTLE; LITHOSPHERE; SEISMICITY; SUBDUCTION; BOUNDARY; BENEATH; MOTION	Subducted slabs of oceanic lithosphere below the western Pacific tend to be stagnant in the transition zone with poorly known mechanical properties. Typical examples are the Izu-Bonin and Japan slabs that meet each other to form a cusplike junction beneath southwest Japan. Here, we show that these two slabs are torn apart at their junction when they bend to flatten over the 660-kilometer discontinuity, as is expected from a simple geometric argument. We present three lines of evidence for this ongoing slab tear.	[Obayashi, Masayuki; Yoshimitsu, Junko; Fukao, Yoshio] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Obayashi, M (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	obayashi@jamstec.go.jp		Obayashi, Masayuki/0000-0003-4026-2649	Grants-in-Aid for Science Research [16075208]	Grants-in-Aid for Science Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the National Research Institute for Earth Science and Disaster Prevention for providing Japan-Indonesia Seismic Network, South Pacific Broadband Seismic Network, and Hi-net data. We are grateful to B. L. N. Kennett for use of SKIPPY data and to Incorporated Research Institutions for Seismology for use of their broadband network data. This study was supported by Grants-in-Aid for Science Research in the Priority Areas of "Stagnant Slab: A New Keyword for Mantle Dynamics" (16075208).	BURBACH GV, 1986, REV GEOPHYS, V24, P833, DOI 10.1029/RG024i004p00833; Castle JC, 1998, EARTH PLANETS SPACE, V50, P977, DOI 10.1186/BF03352192; DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; Fukao Y, 2001, REV GEOPHYS, V39, P291, DOI 10.1029/1999RG000068; FUKAO Y, 2001, WORKSH REP OHP ION J, P13; Hafkenscheid E, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003791; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; HORI S, 1990, TECTONOPHYSICS, V176, P355, DOI 10.1016/0040-1951(90)90078-M; ISACKS B, 1971, REV GEOPHYS SPACE GE, V9, P103, DOI 10.1029/RG009i001p00103; Ishida M, 1999, EARTH PLANETS SPACE, V51, pI, DOI 10.1186/BF03352201; Kirby SH, 1996, REV GEOPHYS, V34, P261, DOI 10.1029/96RG01050; MATSUZAWA T, 1990, TECTONOPHYSICS, V181, P123, DOI 10.1016/0040-1951(90)90012-W; Miller MS, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001110; Miller MS, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003705; Nakamura M, 1998, PHYS EARTH PLANET IN, V106, P63, DOI 10.1016/S0031-9201(97)00109-X; Obayashi M, 2006, EARTH PLANET SC LETT, V243, P149, DOI 10.1016/j.epsl.2005.12.032; Obayashi M, 2004, GEOPHYS J INT, V157, P1152, DOI 10.1111/j.1365-246X.2004.02233.X; Ohmi S, 2000, GEOPHYS J INT, V141, P136, DOI 10.1046/j.1365-246X.2000.00086.x; OHTAKI T, 1998, EOS T AGU S, V79, pW80; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV, DOI 10.1186/BF03353076; SENO T, 1993, J GEOPHYS RES-SOL EA, V98, P17941, DOI 10.1029/93JB00782; Sigloch K, 2008, NAT GEOSCI, V1, P458, DOI 10.1038/ngeo231; van der Hilst R.D., 1994, EOS T AM GEOPHYS UN, V75, P177, DOI DOI 10.1029/94EO00857; VANDERHILST R, 1993, EARTH PLANET SC LETT, V120, P395, DOI 10.1016/0012-821X(93)90253-6; Wortel MJR, 2000, SCIENCE, V290, P1910, DOI 10.1126/science.290.5498.1910; YAMAOKA K, 1986, REV GEOPHYS, V24, P27, DOI 10.1029/RG024i001p00027	27	66	68	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1173	1175		10.1126/science.1172496	http://dx.doi.org/10.1126/science.1172496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478177				2022-12-28	WOS:000266410100038
J	Adler, AI; Shaw, EJ; Stokes, T; Ruiz, F				Adler, Amanda I.; Shaw, Elizabeth J.; Stokes, Tim; Ruiz, Francis		Guideline Dev Grp	Guidelines Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adler, Amanda I.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England; [Shaw, Elizabeth J.; Stokes, Tim] Natl Inst Hlth & Clin Excellence, Manchester M1 4BD, Lancs, England; [Ruiz, Francis] Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England	University of Cambridge; National Institute for Health & Care Excellence; National Institute for Health & Care Excellence	Adler, AI (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England.	aia31@medschl.cam.ac.uk	Stokes, Tim/M-9420-2018	Stokes, Tim/0000-0002-1127-1952				National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB NEW AG BL; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; *NIH CLIN EXC, 2007, GUID SHORT CLIN GUID	3	32	35	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2009	338								b1668	10.1136/bmj.b1668	http://dx.doi.org/10.1136/bmj.b1668			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NU	19465464				2022-12-28	WOS:000266270100002
J	Ohlrogge, J; Allen, D; Berguson, B; DellaPenna, D; Shachar-Hill, Y; Stymne, S				Ohlrogge, John; Allen, Doug; Berguson, Bill; DellaPenna, Dean; Shachar-Hill, Yair; Stymne, Sten			Driving on Biomass	SCIENCE			English	Editorial Material							BIOFUELS		[Ohlrogge, John; Allen, Doug; Shachar-Hill, Yair] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Ohlrogge, John; Allen, Doug; Shachar-Hill, Yair] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Berguson, Bill] Univ Minnesota, Nat Resources Res Inst, Forestry Program, Duluth, MN 55811 USA; [DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Stymne, Sten] Swedish Univ Agr Sci, Dept Plant Breeding & Biotechnol, Alnarp, Sweden	Michigan State University; Michigan State University; United States Department of Energy (DOE); University of Minnesota System; University of Minnesota Duluth; Michigan State University; Swedish University of Agricultural Sciences	Ohlrogge, J (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	ohlrogge@msu.edu	Allen, Doug K/M-2836-2013; Shachar-Hill, Yair/B-6165-2013	Allen, Doug K/0000-0001-8599-8946; Shachar-Hill, Yair/0000-0001-8793-5084				Campbell JE, 2009, SCIENCE, V324, P1055, DOI 10.1126/science.1168885; *DOE, DIES VEH; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Franco A, 2005, INT J THERM SCI, V44, P163, DOI 10.1016/j.ijthermalsci.2004.07.005; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Koplow D., 2007, BIOFUELS WHAT COST G; *NAT RES DEF COUNC, 2007, ENV ASS PLUG IN HYBR, V1; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Towler GP, 2004, ENVIRON PROG, V23, P334, DOI 10.1002/ep.10052; COMP VEHICLE ENERGY	11	124	129	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1019	1020		10.1126/science.1171740	http://dx.doi.org/10.1126/science.1171740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460990				2022-12-28	WOS:000266246700023
J	Thibault-Starzyk, F; Seguin, E; Thomas, S; Daturi, M; Arnolds, H; King, DA				Thibault-Starzyk, Frederic; Seguin, Etienne; Thomas, Sebastien; Daturi, Marco; Arnolds, Heike; King, David A.			Real-Time Infrared Detection of Cyanide Flip on Silver-Alumina NOx Removal Catalyst	SCIENCE			English	Article							SITU FTIR SPECTROSCOPY; METAL-SURFACES; SELECTIVE REDUCTION; ELECTRON DYNAMICS; STEP-SCAN; AG/AL2O3; NANOPARTICLES; ACTIVATION; COMPLEXES; MECHANISM	Spectroscopic studies of the mechanistic steps that occur on supported precious metal catalysts used in industrial and automotive applications are hampered by a dearth of suitable experimental methods. We used femtosecond laser excitation followed by nanosecond time-resolved in situ Fourier-transform infrared spectroscopy to initiate a catalytic reaction on alumina-supported silver catalysts, which are of interest in minimizing nitrogen oxide emissions from fuel-efficient lean-burn engines. We found that the key intermediate step in the reaction between carbon monoxide and nitric oxide is the flip of a cyanide group from a silver nanoparticle to the alumina support (with a lifetime of 2 microseconds), which indicates the central role played by the interface between the metal particle and the oxide support.	[Thibault-Starzyk, Frederic; Seguin, Etienne; Thomas, Sebastien; Daturi, Marco] Univ Caen, CNRS, ENSICAEN, Catalyse & Spectrochim Lab, F-14050 Caen, France; [Arnolds, Heike] Univ Liverpool, Dept Chem, Surface Sci Res Ctr, Liverpool L69 3BX, Merseyside, England; [King, David A.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; University of Liverpool; University of Cambridge	Thibault-Starzyk, F (corresponding author), Univ Caen, CNRS, ENSICAEN, Catalyse & Spectrochim Lab, Blvd Marechal Juin, F-14050 Caen, France.	fts@ensicaen.fr	Daturi, Marco/GZA-5408-2022; Thibault-Starzyk, Frederic/B-5606-2008; Arnolds, Heike/Q-9526-2017	Daturi, Marco/0000-0001-5147-3260; Thibault-Starzyk, Frederic/0000-0002-8095-0860; Arnolds, Heike/0000-0002-5723-9309; Thomas, Sebastien/0000-0002-7290-5883	fellowship from Churchill College, Cambridge; Engineering and Physical Sciences Research Council Advanced Research Fellowship; EPSRC [EP/C01197X/1, EP/C01197X/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C011988/1, EP/C01197X/1, EP/C011988/2, EP/C01197X/2] Funding Source: researchfish	fellowship from Churchill College, Cambridge; Engineering and Physical Sciences Research Council Advanced Research Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank K. Jewkes and P. Turner from Bruker Optics for their technical help. Supported by a fellowship from Churchill College, Cambridge (F.T.S.) and an Engineering and Physical Sciences Research Council Advanced Research Fellowship (H.A.).	Arnolds H, 2008, CHEM PHYS, V350, P94, DOI 10.1016/j.chemphys.2008.01.007; Bera P, 2000, PHYS CHEM CHEM PHYS, V2, P3715, DOI 10.1039/b003908j; Bigot JY, 2000, CHEM PHYS, V251, P181, DOI 10.1016/S0301-0104(99)00298-0; Bion N, 2003, J CATAL, V217, P47, DOI 10.1016/S0021-9517(03)00035-6; Bion N, 2001, PHYS CHEM CHEM PHYS, V3, P4811, DOI 10.1039/b107523n; Bonn M, 2000, PHYS REV B, V61, P1101, DOI 10.1103/PhysRevB.61.1101; Bromberg SE, 1997, SCIENCE, V278, P260, DOI 10.1126/science.278.5336.260; Burch R, 2002, APPL CATAL B-ENVIRON, V39, P283, DOI 10.1016/S0926-3373(02)00118-2; Carpene E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024301; Frischkorn C, 2006, CHEM REV, V106, P4207, DOI 10.1021/cr050161r; He H, 2005, CATAL TODAY, V100, P37, DOI 10.1016/j.cattod.2004.11.006; HOOGERS G, 1994, SURF SCI, V310, P147, DOI 10.1016/0039-6028(94)91380-3; JOHNSON TJ, 1993, APPL SPECTROSC, V47, P1376, DOI 10.1366/0003702934067397; Lane IM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.186105; Lisowski M, 2004, APPL PHYS A-MATER, V78, P165, DOI 10.1007/s00339-003-2301-7; Liu ZP, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156102; Ouyang F, 2008, KINET CATAL+, V49, P236, DOI 10.1134/S0023158408020110; Palazzi A, 2004, J ORGANOMET CHEM, V689, P2324, DOI 10.1016/j.jorganchem.2004.04.021; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Perrie W, 2005, APPL SURF SCI, V248, P213, DOI 10.1016/j.apsusc.2005.03.005; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Sato K, 2003, APPL CATAL B-ENVIRON, V44, P67, DOI 10.1016/S0926-3373(03)00020-1; SHRIVER DF, 1962, J AM CHEM SOC, V84, P4610, DOI 10.1021/ja00882a061; Sung J, 2008, J PHYS CHEM C, V112, P5707, DOI 10.1021/jp0774140; THIBAULTSTARZYK F, 2007, NANOPARTICLES CATALY, P508; Voisin C, 2000, PHYS REV LETT, V85, P2200, DOI 10.1103/PhysRevLett.85.2200; Wang ZM, 2000, PHYS CHEM CHEM PHYS, V2, P3007, DOI 10.1039/b000226g; Wille A, 2007, APPL CATAL B-ENVIRON, V70, P294, DOI 10.1016/j.apcatb.2005.10.031; YEOM YH, 2004, IN SITU SPECTROSCOPY, P33; SUMMARY WORLDWIDE DI	30	82	83	4	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1048	1051		10.1126/science.1169041	http://dx.doi.org/10.1126/science.1169041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461000				2022-12-28	WOS:000266246700035
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, A; Gregory, KD; Grossman, D; Isham, G; LeFevre, ML; Leipzig, R; Marion, LN; Melnyk, B; Moyer, VA; Ockene, JK; Sawaya, GF; Schwartz, JS; Wilt, T				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen; Gregory, Kimberly D.; Grossman, David; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne; Marion, Lucy N.; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Schwartz, J. Sanford; Wilt, Timothy		US Preventive Serv Task Force	Screening for Syphilis Infection in Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Update of the 2004 U. S. Preventive Services Task Force statement about screening for syphilis in pregnancy. Methods: The U. S. Preventive Services Task Force did a targeted literature search for evidence on the benefits of screening, the harms of screening, and the harms of treatment of syphilis with penicillin during pregnancy. Recommendation: Screen all pregnant women for syphilis infection. (Grade A recommendation.)	[Calonge, Ned; US Preventive Serv Task Force] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA; [Calonge, Ned] Colorado Dept Publ Hlth, Denver, CO USA; [Melnyk, Bernadette] Arizona State Univ, Coll Nursing & Healthcare Innovat, Phoenix, AZ USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen] Dartmouth Med Sch, Lebanon, NH USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Grossman, David] Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; [Isham, George] Hlth Partners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne] Mt Sinai Sch Med, New York, NY USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Moyer, Virginia A.] Baylor Coll Med, Houston, TX 77030 USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Wilt, Timothy] Minneapolis Vet Affairs Med Ctr Chron Dis Outcome, Minneapolis, MN USA	Agency for Healthcare Research & Quality; Arizona State University; Arizona State University-Downtown Phoenix; Cincinnati Children's Hospital Medical Center; Dartmouth College; Cedars Sinai Medical Center; Group Health Cooperative; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University System of Georgia; Augusta University; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania	Calonge, N (corresponding author), US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA.		Melnyk, Bernadette J/E-9868-2013					*AM AC FAM PHYS, 2008, SUMM REC CLIN PREV S; *CDCP, 2006, SEX TRANSM DIS TREAT; Edozien A. O., 2004, Morbidity and Mortality Weekly Report, V53, P716; *M AC PED AM COLL, 2007, GUID PER CAR; Wolff T, 2009, ANN INTERN MED, V150, P710, DOI 10.7326/0003-4819-150-10-200905190-00009	5	38	40	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					705	U7						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451577				2022-12-28	WOS:000266285300006
J	Hammell, CL; Henning, JD				Hammell, Clare L.; Henning, J. D.			Prehospital management of severe traumatic brain injury	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ENDOTRACHEAL INTUBATION; VENTILATION; IMPACT		[Hammell, Clare L.] Royal Liverpool Univ Hosp, Liverpool L7 8XP, Merseyside, England; [Henning, J. D.] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Hammell, Clare L.; Henning, J. D.] Great N Air Ambulance Serv, Darlington DL1 5NQ, Durham, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; James Cook University Hospital	Hammell, CL (corresponding author), Royal Liverpool Univ Hosp, Liverpool L7 8XP, Merseyside, England.	cham37uk@yahoo.com						Alderson P, 2004, COCHRANE DB SYST REV, V18, P1048; *ASS AN GREAT BRIT, 2006, TRANSF PAT BRAIN INJ; *BRAIN TRAUM FDN, GUID PREH MAN TRAUM; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Deitch Sean, 2003, Prehosp Emerg Care, V7, P380, DOI 10.1080/10903120390936617; FINDLAY G, 2007, TRAUMA WHO CARES NAT; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hoyle JD, 2007, PREHOSP EMERG CARE, V11, P330, DOI 10.1080/10903120701205083; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; *NIH CLIN EXC, 2004, CLIN COST EFF PREH I; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; *ROY COLL SURG ENG, 1999, REP WORK PART MAN PA; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Wang H E, 2001, Prehosp Emerg Care, V5, P134, DOI 10.1080/10903120190939995; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032	25	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2009	338								b1683	10.1136/bmj.b1683	http://dx.doi.org/10.1136/bmj.b1683			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NR	19454738				2022-12-28	WOS:000266269800002
J	Rathore, SS; Curtis, JP; Chen, J; Wang, YF; Nallamothu, BK; Epstein, AJ; Krumholz, HM; Hines, HH				Rathore, Saif S.; Curtis, Jeptha P.; Chen, Jersey; Wang, Yongfei; Nallamothu, Brahmajee K.; Epstein, Andrew J.; Krumholz, Harlan M.; Hines, Harold H., Jr.		Natl Cardiovasc Data Registry	Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PRIMARY ANGIOPLASTY; LATE REPERFUSION; TREATMENT DELAYS; SIZE; ONSET; DURATION; OUTCOMES; REGISTRY; THERAPY	Objective To evaluate the association between door-to-balloon time and mortality in hospital in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction to assess the incremental mortality benefit of reductions in door-to-balloon times of less than 90 minutes. Design Prospective cohort study of patients enrolled in the American College of Cardiology National Cardiovascular Data Registry, 2005-6. Setting Acute care hospitals. Participants 43 801 patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Main outcome measure Mortality in hospital. Results Median door-to-balloon time was 83 minutes (interquartile range 6-109, 57.9% treated within 90 minutes). Overall mortality in hospital was 4.6%. Multivariable logistic regression models with fractional polynomial models indicated that longer door-to-balloon times were associated with a higher adjusted risk of mortality in hospital in a continuous non-linear fashion (30 minutes = 3.0%, 60 minutes = 3.5%, 90 minutes = 4.3%, 120 minutes = 5.6%, 150 minutes = 7.0%, 180 minutes = 8.4%, P<0.001). A reduction in door-to-balloon time from 90 minutes to 60 minutes was associated with 0.8% lower mortality, and a reduction from 60 minutes to 30 minutes with a 0.5% lower mortality. Conclusion Any delay in primary percutaneous coronary intervention after a patient arrives at hospital is associated with higher mortality in hospital in those admitted with ST elevation myocardial infarction. Time to treatment should be as short as possible, even in centres currently providing primary percutaneous coronary intervention within 90 minutes.	[Rathore, Saif S.] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Curtis, Jeptha P.; Chen, Jersey; Hines, Harold H., Jr.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Wang, Yongfei; Hines, Harold H., Jr.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, CVC Cardiovasc Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Epstein, Andrew J.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; [Hines, Harold H., Jr.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; University of Michigan System; University of Michigan; Yale University; Yale University	Rathore, SS (corresponding author), Yale Univ, Sch Med, 367 Cedar St,316 FSH, New Haven, CT 06510 USA.	saif.rathore@yale.edu	, Harlan/AAI-2875-2020	Epstein, Andrew/0000-0001-5078-6564	National Institutes of Health's Center for Research Resources [UL1 RR024139]; National Institute of General Medical Sciences Medical Scientist Training [5T32GM07205]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health's Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences Medical Scientist Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding and statement of independence from funding sources: This manuscript is the result of an unfunded analysis of the American College of Cardiology National Cardiovascular Data Registry. Although the sponsor was responsible for data collection, data management, and review of the manuscript before submission, they had no role in the design or conduct of this study, data analysis, interpretation of the data, manuscript preparation, or approval of the manuscript. SSR and JPC are supported, in part, by CTSA Grant Number UL1 RR024139 from the National Institutes of Health's Center for Research Resources. SSR is also supported by the National Institute of General Medical Sciences Medical Scientist Training Program grant 5T32GM07205.	[Anonymous], J AM COLL CARDIOL, DOI DOI 10.1016/J.JACC.2007.10.001; Antoniucci D, 2002, AM J CARDIOL, V89, P1248, DOI 10.1016/S0002-9149(02)02320-2; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Brodie BR, 2006, AM HEART J, V151, P1231, DOI 10.1016/j.ahj.2005.07.016; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2003, AM HEART J, V145, P708, DOI 10.1067/mhj.2003.9; Brodie BR, 2001, AM J CARDIOL, V88, P1085, DOI 10.1016/S0002-9149(01)02039-2; Brodie BR, 2007, AM J CARDIOL, V99, P1680, DOI 10.1016/j.amjcard.2007.01.047; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; De Luca G, 2004, EUR HEART J, V25, P1009, DOI 10.1016/j.ehj.2004.03.021; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; FLAMENG W, 1990, BASIC RES CARDIOL, V85, P392, DOI 10.1007/BF01907131; GARCIADORADO D, 1987, CARDIOVASC RES, V21, P537, DOI 10.1093/cvr/21.7.537; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Gibson CM, 2004, EUR HEART J, V25, P1001, DOI 10.1016/j.ehj.2004.04.029; Hudson MP, 2007, J AM COLL CARDIOL, V49, p42B; Juliard JM, 2003, AM J CARDIOL, V91, P1401, DOI 10.1016/S0002-9149(03)00388-6; KIM CB, 1993, CIRCULATION, V88, P2426, DOI 10.1161/01.CIR.88.5.2426; Krone RJ, 2000, AM J CARDIOL, V85, P1179, DOI 10.1016/S0002-9149(00)00724-4; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Liem AL, 1998, J AM COLL CARDIOL, V32, P629, DOI 10.1016/S0735-1097(98)00280-0; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Nallamothu BK, 2007, HEART, V93, P1552, DOI 10.1136/hrt.2006.112847; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; Rokos IC, 2008, J AM COLL CARDIOL, V51, pA379; Schomig A, 2003, CIRCULATION, V108, P1084, DOI 10.1161/01.CIR.0000086346.32856.9C; Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X; Song YB, 2008, J AM COLL CARDIOL, V51, pA164; Stone GW, 2007, AM J CARDIOL, V100, P1370, DOI 10.1016/j.amjcard.2007.06.027; Stone GW, 1998, J AM COLL CARDIOL, V31, p271A, DOI 10.1016/S0735-1097(97)84885-1; van't Hof AWJ, 1998, EUR HEART J, V19, P118, DOI 10.1053/euhj.1997.0746; Williams DO, 2004, CIRCULATION, V109, P1806, DOI 10.1161/01.CIR.0000126892.17646.83	34	293	307	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2009	338								b1807	10.1136/bmj.b1807	http://dx.doi.org/10.1136/bmj.b1807			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NR	19454739	Green Published, hybrid			2022-12-28	WOS:000266269800003
J	Vinkovic, D				Vinkovic, Dejan			Radiation-pressure mixing of large dust grains in protoplanetary disks	NATURE			English	Article							SOLAR NEBULA; EVOLUTION; TAURI; TRANSPORT; SURFACE; STARS	Dusty disks around young stars are formed out of interstellar dust that consists of amorphous, submicrometre grains. Yet the grains found in comets(1) and meteorites(2), and traced in the spectra of young stars(3), include large crystalline grains that must have undergone annealing or condensation at temperatures in excess of 1,000 K, even though they are mixed with surrounding material that never experienced temperatures as high as that(4). This prompted theories of large-scale mixing capable of transporting thermally altered grains from the inner, hot part of accretion disks to outer, colder disk regions(5-7), but all have assumptions that may be problematic(8-12). Here I report that infrared radiation arising from the dusty disk can loft grains bigger than one micrometre out of the inner disk, whereupon they are pushed outwards by stellar radiation pressure while gliding above the disk. Grains re-enter the disk at radii where it is too cold to produce sufficient infrared radiation-pressure support for a given grain size and solid density. Properties of the observed disks suggest that this process might be active in almost all young stellar objects and young brown dwarfs.	Univ Split, Dept Phys, Split 21000, Croatia	University of Split	Vinkovic, D (corresponding author), Univ Split, Dept Phys, Nikole Tesle 12, Split 21000, Croatia.	vinkovic@pmfst.hr		Vinkovic, Dejan/0000-0001-9082-3921				Alexander R, 2008, NEW ASTRON REV, V52, P60, DOI 10.1016/j.newar.2008.04.004; Boss AP, 2008, EARTH PLANET SC LETT, V268, P102, DOI 10.1016/j.epsl.2008.01.008; Boss AP, 2005, ASTROPHYS J, V629, P535, DOI 10.1086/431457; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; DORSCHNER J, 1995, ASTRON ASTROPHYS, V300, P503; FUJIWARA D, 2005, PROTOSTARS PLANETS, V5; Hill HGM, 2001, P NATL ACAD SCI USA, V98, P2182, DOI 10.1073/pnas.051530998; Hubickyj O, 2006, PLANET FORMATION, P479; Isella A, 2005, ASTRON ASTROPHYS, V438, P899, DOI 10.1051/0004-6361:20052773; Jager C, 1998, ASTRON ASTROPHYS, V339, P904; Jones R. H., 2000, Protostars and planets 4, P927; Klahr H, 2006, PLANET FORMATION, P457; Matsumura S, 2006, MON NOT R ASTRON SOC, V365, P572, DOI 10.1111/j.1365-2966.2005.09737.x; Millan-Gabet R, 2007, PROTOSTARS PLANETS, P539; Pinte C, 2008, ASTRON ASTROPHYS, V489, P633, DOI 10.1051/0004-6361:200810121; Sargent B, 2006, ASTROPHYS J, V645, P395, DOI 10.1086/504283; Schegerer AA, 2008, ASTRON ASTROPHYS, V478, P779, DOI 10.1051/0004-6361:20077049; Shang H., 2007, PROTOSTARS PLANETS; Takeuchi T, 2003, ASTROPHYS J, V593, P524, DOI 10.1086/376496; van Boekel R, 2005, ASTRON ASTROPHYS, V437, P189, DOI 10.1051/0004-6361:20042339; Vinkovic D, 2007, ASTROPHYS J, V658, P462, DOI 10.1086/511327; Vinkovic D, 2006, ASTROPHYS J, V651, P906, DOI 10.1086/507762; Voshchinnikov NV, 2008, ASTRON ASTROPHYS, V483, pL9, DOI 10.1051/0004-6361:200809697; Watson DM, 2009, ASTROPHYS J SUPPL S, V180, P84, DOI 10.1088/0067-0049/180/1/84; Wooden DH, 2005, ASP C SER, V341, P774; Wuchterl G, 2003, ASTRON ASTROPHYS, V398, P1081, DOI 10.1051/0004-6361:20021707	30	37	37	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					227	229		10.1038/nature08032	http://dx.doi.org/10.1038/nature08032			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444210	Green Submitted			2022-12-28	WOS:000266036100035
J	Berger, JS; Krantz, MJ; Kittelson, JM; Hiatt, WR				Berger, Jeffrey S.; Krantz, Mori J.; Kittelson, John M.; Hiatt, William R.			Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease A Meta-analysis of Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LOW-DOSE ASPIRIN; ANTIPLATELET THERAPY; LOWER-EXTREMITY; INFLAMMATORY MARKERS; D-DIMER; DIPYRIDAMOLE; PATENCY; ASSOCIATION; PROGRESSION; INHIBITION	Context Randomized trials have shown that aspirin decreases the risk of cardiovascular events in patients with symptomatic coronary and cerebrovascular disease. Despite guideline recommendations for secondary prevention in peripheral artery disease (PAD), the effect of aspirin in this population is not well established. Objective To investigate the effect of aspirin on cardiovascular event rates in patients with PAD. Data Sources and Study Selection MEDLINE, the Cochrane Central Register of Controlled Trials, EMBASE, Science Citation Index (1966 to December 2008), and unpublished studies from the supplemental index of the Antithrombotic Trialists' Collaboration. Eligible studies were prospective, randomized controlled trials of aspirin therapy, with or without dipyridamole that reported cardiovascular event rates. Eighteen trials involving 5269 individuals were identified. Data Extraction Studies were reviewed to determine the number of participants, mean follow-up, and the primary end point of cardiovascular events (nonfatal myocardial infarction [MI], nonfatal stroke, and cardiovascular death). Data on the secondary end points of all-cause mortality, major bleeding, and the individual components of the primary outcome measure were also abstracted. For the primary end point, the analysis had 88% power to detect a 25% reduction and 70% power to detect a 20% reduction in cardiovascular events in the aspirin group compared with the control group. Data Synthesis Among 5269 participants, cardiovascular events were experienced by 251 (8.9%) of 2823 patients taking aspirin (alone or with dipyridamole) and by 269 (11.0%) of 2446 in the control group (pooled relative risk [RR], 0.88; 95% confidence interval [CI], 0.76-1.04). Aspirin therapy was associated with a reduction in the secondary outcome of nonfatal stroke (52 of 2823 vs 76 of 2446; RR, 0.66; 95% CI, 0.47-0.94) but was not associated with significant reductions in all-cause or cardiovascular mortality, MI, or major bleeding. In the subset of 3019 participants taking aspirin alone vs control, aspirin was associated with a nonsignificant reduction in cardiovascular events (125 of 1516 vs 144 of 1503; RR, 0.75; 95% CI, 0.48-1.18), a significant reduction in nonfatal stroke ( 32 of 1516 vs 51 of 1503; RR, 0.64; 95% CI, 0.42-0.99), but no statistically significant reductions in all-cause or cardiovascular mortality, MI, or major bleeding. Conclusions In patients with PAD, treatment with aspirin alone or with dipyridamole resulted in a statistically nonsignificant decrease in the primary end point of cardiovascular events and a significant reduction in nonfatal stroke. Results for the primary end point may reflect limited statistical power. Additional randomized controlled trials of aspirin therapy are needed to establish the net benefit and bleeding risks in PAD. JAMA. 2009;301(18):1909-1919 www.jama.com	[Hiatt, William R.] Univ Colorado, Sch Med, Dept Med, Sect Vasc Med,Div Geriatr,Colorado Prevent Ctr, Denver, CO 80203 USA; [Krantz, Mori J.; Hiatt, William R.] Univ Colorado, Sch Med, Dept Med, Sect Vasc Med,Div Cardiol, Denver, CO 80203 USA; [Berger, Jeffrey S.] Univ Penn, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA; [Berger, Jeffrey S.] Duke Clin Res Inst, Durham, NC USA; [Kittelson, John M.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Pennsylvania; Duke University; Colorado School of Public Health	Hiatt, WR (corresponding author), Univ Colorado, Sch Med, Dept Med, Sect Vasc Med,Div Geriatr,Colorado Prevent Ctr, 789 Sherman St,Ste 200, Denver, CO 80203 USA.	will.hiatt@UCDenver.edu		Berger, Jeffrey/0000-0001-8216-4647	National Heart, Lung, and Blood Institute; American Heart Association Fellow [0775074N]; National Heart, Lung, and Blood Institute [U01 HL079160];  [5K12HL83772-2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL079160, K12HL083772] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Fellow(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Berger was partially funded by grants 5K12HL83772-2, a Research Career Development Award from the National Heart, Lung, and Blood Institute and 0775074N an American Heart Association Fellow to Faculty Award. Dr Krantz was partially funded by grant U01 HL079160 from National Heart, Lung, and Blood Institute.	Anand S, 2007, NEW ENGL J MED, V357, P217; Andreotti F, 2006, EUR HEART J, V27, P519, DOI 10.1093/eurheartj/ehi485; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; BERGQVIST D, 1994, EUR J VASCULAR SURG, V8, P83; Brevetti G, 2008, ATHEROSCLEROSIS, V197, P1, DOI 10.1016/j.atherosclerosis.2007.11.002; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cassar K, 2003, J VASC SURG, V38, P99, DOI 10.1016/S0741-5214(03)00129-0; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Colwell J A, 1989, J Diabet Complications, V3, P191, DOI 10.1016/0891-6632(89)90029-9; Department of Health and Human Services (HHS) Public Health Service (PHS) Food and Drug Administration (FDA), 1999, FED REGISTER, V64, P49652; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DONALDSON DR, 1985, VASCULAR SURG, V19, P224, DOI 10.1177/153857448501900405; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EHRESMANN U, 1977, MED WELT, V28, P1157; GOLDHABER SZ, 1992, LANCET, V340, P143, DOI 10.1016/0140-6736(92)93216-A; GOLDMAN M, 1984, VASCULAR SURG, V18, P217, DOI 10.1177/153857448401800404; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; GREEN RM, 1982, SURGERY, V92, P1016; Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547; HARJOLA P, 1981, J CARDIOVASC SURG, V22, P141; HEISS HW, 1990, ANGIOLOGY, V41, P263, DOI 10.1177/000331979004100402; HESS H, 1985, LANCET, V1, P415; HESS H, 1975, P COLFARIT S, V3, P80; Hiatt WR, 2007, J MAL VASCUL, V32, P71, DOI 10.1016/j.jmv.2007.01.110; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Iwashima Y, 2006, ATHEROSCLEROSIS, V188, P384, DOI 10.1016/j.atherosclerosis.2005.10.039; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; KOHLER TR, 1984, SURGERY, V96, P462; Kudoh T, 2006, THROMB RES, V117, P263, DOI 10.1016/j.thromres.2005.03.011; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lechat P, 2006, J MAL VASCUL, V31, P129; Lee WJ, 2006, THROMB RES, V118, P619, DOI 10.1016/j.thromres.2005.10.012; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; MCCOLLUM C, 1991, J VASC SURG, V13, P150, DOI 10.1016/0741-5214(91)90022-M; McDermott MM, 2003, CIRCULATION, V107, P3191, DOI 10.1161/01.CIR.0000074227.53616.CC; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; O'Donnell MJ, 2008, STROKE, V39, P1638, DOI 10.1161/STROKEAHA.107.497271; Pande RL, 2008, CIRCULATION, V118, P33, DOI 10.1161/CIRCULATIONAHA.107.721878; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Poole C, 1999, AM J EPIDEMIOL, V150, P469, DOI 10.1093/oxfordjournals.aje.a010035; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; SCHOOP W, 1984, INTERNIST, V25, P429; SCHOOP W, 1983, THROMB HAEMOSTASIS, V50, P137; Serneri GGN, 2004, EUR HEART J, V25, P1845, DOI 10.1016/j.ehj.2004.07.013; Sobel M, 2008, CHEST, V133, p815S, DOI 10.1378/chest.08-0686; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; Zekert F., 1975, THROMBOSEN EMBOLIEN, P68	55	240	248	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1909	1919		10.1001/jama.2009.623	http://dx.doi.org/10.1001/jama.2009.623			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444JX	19436018	Bronze			2022-12-28	WOS:000265978400029
J	Bockarie, MJ; Molyneux, DH				Bockarie, Moses J.; Molyneux, David H.			Tropical Diseases The end of lymphatic filariasis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOBAL PROGRAM; MALARIA		[Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Bockarie, MJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	moses.bockarie@liv.ac.uk	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021					[Anonymous], 2004, Wkly Epidemiol Rec, V79, P417; BRENGUES J., 1969, Cahiers ORSTOM, Serie Entomologie Medicale et Parasiiologie, V7, P279; Durrheim DN, 2004, TROP MED INT HEALTH, V9, P843, DOI 10.1111/j.1365-3156.2004.01287.x; Gyapong JO, 2005, EXPERT OPIN PHARMACO, V6, P179, DOI 10.1517/14656566.6.2.179; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Kere NK, 1996, MED VET ENTOMOL, V10, P145, DOI 10.1111/j.1365-2915.1996.tb00720.x; Molyneux DH, 2009, LANCET, V373, P529, DOI 10.1016/S0140-6736(09)60181-1; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; WEBBER RH, 1979, T ROY SOC TROP MED H, V73, P722, DOI 10.1016/0035-9203(79)90031-2; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333; 1870, BRIT MED J, V2, P559, DOI DOI 10.1136/BMJ.2.516.555	13	29	30	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2009	338								b1686	10.1136/bmj.b1686	http://dx.doi.org/10.1136/bmj.b1686			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446IZ	19439451	Green Accepted			2022-12-28	WOS:000266116600003
J	Ionescu-Ittu, R; Marelli, AJ; Mackie, AS; Pilote, L				Ionescu-Ittu, Raluca; Marelli, Ariane J.; Mackie, Andrew S.; Pilote, Louise			Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEURAL-TUBE DEFECTS; BIRTH-DEFECTS; MULTIVITAMIN SUPPLEMENTATION; 1ST-TRIMESTER EXPOSURE; PERICONCEPTIONAL USE; PRENATAL-DIAGNOSIS; FOOD FORTIFICATION; FOLATE INTAKE; RISK-FACTORS; MALFORMATIONS	Objective To investigate whether the 1998 government policy for mandatory fortification of flour and pasta products with folate was followed by a reduction in the prevalence of severe congenital heart defects. Design Time trend analysis. Setting Province of Quebec, Canada. Participants Infants born in 1990-2005 identified with severe congenital heart defects (tetralogy of Fallot, endocardial cushion defects, univentricular hearts, truncus arteriosus, or transposition complexes) in Quebec administrative databases. Methods Data analysed in two time periods (before and after fortification). Birth prevalence measured annually as infants (live and stillbirths) with severe congenital heart defects per 1000 births in Quebec. Changes in the birth prevalence from the period before to the period after fortification were estimated with Poisson regression. Results Among the 1 324 440 births in Quebec in 19902005 there were 2083 infants born with severe congenital heart defects, corresponding to an average birth prevalence of 1.57/1000 births. Time trend analysis showed no change in the birth prevalence of severe birth defects in the nine years before fortification (rate ratio 1.01, 95% confidence interval 0.99 to 1.03), while in the seven years after fortification there was a significant 6% decrease per year (0.94, 0.90 to 0.97). Conclusions Public health measures to increase folic acid intake were followed by a decrease in the birth prevalence of severe congenital heart defects. These findings support the hypothesis that folic acid has a preventive effect on heart defects.	[Ionescu-Ittu, Raluca] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Marelli, Ariane J.] McGill Univ, Ctr Hlth, McGill Adult Unit Congenital Heart Dis Excellence, Montreal, PQ, Canada; [Mackie, Andrew S.] Univ Alberta, Stollery Childrens Hosp, Div Cardiol, Edmonton, AB, Canada; [Pilote, Louise] McGill Univ, Ctr Hlth, Div Gen Internal Med, Montreal, PQ, Canada	McGill University; McGill University; Stollery Children's Hospital; University of Alberta; McGill University	Pilote, L (corresponding author), Royal Victoria Hosp, V Bldg,687 Pine Ave W,Room V2-17, Montreal, PQ H3A 1A1, Canada.	louise.pilote@mcgill.ca		Pilote, Louise/0000-0002-6159-0628; Mackie, Andrew/0000-0001-6126-1130	Heart and Stroke Foundation of Canada; Fonds de Recherche en Sante du Quebec (FRSQ)	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	AJM was funded by the Heart and Stroke Foundation of Canada. ASM is funded by the Fonds de Recherche en Sante du Quebec (FRSQ). LP is a senior investigator funded by the FRSQ and James McGill professor of Medicine. The study was funded in part by the Heart and Stroke foundation of Canada and by the FRSQ.	ACUNA J, 1999, PREVENTION NEURAL TU; ADAMS MM, 1989, J AM COLL CARDIOL, V14, P432, DOI 10.1016/0735-1097(89)90199-X; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Bakker MK, 2007, BIRTH DEFECTS RES A, V79, P652, DOI 10.1002/bdra.20388; BECERRA JE, 1990, PEDIATRICS, V85, P1; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Blackburn S., 2007, MATERNAL FETAL NEONA, V3rd; Blomberg M, 2000, ACTA PAEDIATR, V89, P1238, DOI 10.1080/080352500750027637; Boneva RS, 2001, CIRCULATION, V103, P2376; Bottega NA, 2008, CIRCULATION, V118, pS929; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Botto LD, 2000, AM J EPIDEMIOL, V151, P878, DOI 10.1093/oxfordjournals.aje.a010291; Botto LD, 2004, AM J MED GENET C, V125C, P12, DOI 10.1002/ajmg.c.30004; Botto LD, 2003, AM J MED GENET A, V121A, P95, DOI 10.1002/ajmg.a.20132; *BUR FOOD REG INT, 1998, CANADA GAZETTE 2, V132, P3029; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; *CAN S, 2007, CAN S CANSIM TABL 05; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Czeizel AE, 2004, BIRTH DEFECTS RES A, V70, P853, DOI 10.1002/bdra.20086; Czeizel AE, 2001, REPROD TOXICOL, V15, P637, DOI 10.1016/S0890-6238(01)00178-2; Czeizel AE, 1998, LANCET, V352, P1225, DOI 10.1016/S0140-6736(05)60567-3; de Jong-van den Berg LTW, 2005, AM J OBSTET GYNECOL, V192, P121, DOI 10.1016/j.ajog.2004.05.085; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Dietrich M, 2005, J AM COLL NUTR, V24, P266, DOI 10.1080/07315724.2005.10719474; DUCHESNE L, 2006, SITUATION DEMOGRAPHI, P69; Garne E, 2005, ULTRASOUND OBST GYN, V25, P6, DOI 10.1002/uog.1784; Girard C., 2007, BILAN DEMOGRAPHIQUE; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Health Canada, 2002, CONG AN CAN PER HLTH; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Huhta JC, 2006, CURR OPIN PEDIATR, V18, P484, DOI 10.1097/01.mop.0000245347.45336.d7; Huhta JC, 2005, FETAL PEDIATR PATHOL, V24, P71, DOI 10.1080/15227950591008240; *I SATT QUEB, 2007, NAISS SEL DUR GROSS; *I STAT QUEB, 2001, PORTR SOC QUEB DONN; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; LIU S, EVALUATION FOOD FORT; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Mills JL, 2004, BIRTH DEFECTS RES A, V70, P844, DOI 10.1002/bdra.20075; *MIN PUBL WORKS GO, 2002, CONG AN CAN PER HLTH, P15; MONGEAU L, 2005, EXCES POIDS POPULATI; NORA JJ, 1987, AM J CARDIOL, V59, P459, DOI 10.1016/0002-9149(87)90956-8; Peller AJ, 2004, OBSTET GYNECOL, V104, P957, DOI 10.1097/01.AOG.0000142718.53380.8f; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Ramos E, 2007, BJOG-INT J OBSTET GY, V114, P1055, DOI 10.1111/j.1471-0528.2007.01387.x; Ray JG, 2004, NUTR REV, V62, pS35, DOI 10.1111/j.1753-4887.2004.tb00072.x; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; RIEDER MJ, 1994, CLIN PERINATOL, V21, P483, DOI 10.1016/S0095-5108(18)30328-2; Scanlon KS, 1998, EPIDEMIOLOGY, V9, P95, DOI 10.1097/00001648-199801000-00019; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Talner NS, 1998, PEDIATRICS, V102, P258; Tam LE, 2005, J OBSTET GYNAECOL CA, V27, P232, DOI 10.1016/S1701-2163(16)30515-1; Tang LS, 2004, BIRTH DEFECTS RES A, V70, P449, DOI 10.1002/bdra.20043; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815; Wacholder S, 1995, Stat Methods Med Res, V4, P293, DOI 10.1177/096228029500400403; WALLER DK, 1994, AM J OBSTET GYNECOL, V170, P541, DOI 10.1016/S0002-9378(94)70224-1; Watkins ML, 2001, EPIDEMIOLOGY, V12, P439, DOI 10.1097/00001648-200107000-00014; Wen SW, 2000, TERATOLOGY, V61, P342, DOI 10.1002/(SICI)1096-9926(200005)61:5<342::AID-TERA5>3.0.CO;2-7; Werler MM, 1999, AM J EPIDEMIOL, V150, P675, DOI 10.1093/oxfordjournals.aje.a010070; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; 1993, J SOGC S, P41; 1996, FED REG, V61, P8781	63	142	150	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2009	338								b1673	10.1136/bmj.b1673	http://dx.doi.org/10.1136/bmj.b1673			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446IX	19436079	Green Published			2022-12-28	WOS:000266116400003
J	McConnell, J				McConnell, John			Influenza begs many questions	LANCET			English	Editorial Material									The Lancet, Infect Dis, London NW1 7BY, England		McConnell, J (corresponding author), The Lancet, Infect Dis, London NW1 7BY, England.			McConnell, John/0000-0002-9928-6568					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1590	1590		10.1016/S0140-6736(09)60880-1	http://dx.doi.org/10.1016/S0140-6736(09)60880-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19427944				2022-12-28	WOS:000266066300011
J	Bath, PMW; England, TJ				Bath, Philip M. W.; England, Timothy J.			Thigh-length compression stockings and DVT after stroke	LANCET			English	Editorial Material							ACUTE ISCHEMIC-STROKE; PREVENTION		[Bath, Philip M. W.; England, Timothy J.] Univ Nottingham, Inst Neurosci, Stroke Trials Unit, Nottingham NG5 1PB, England	University of Nottingham	Bath, PMW (corresponding author), Univ Nottingham, Inst Neurosci, Stroke Trials Unit, City Hosp Campus, Nottingham NG5 1PB, England.	Philip.bath@nottingham.ac.uk	England, Timothy J/AAD-3100-2021; Bath, Philip/F-9020-2011	England, Timothy J/0000-0001-5330-8584; Bath, Philip/0000-0003-2734-5132				Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Amaragiri SV, 2000, COCHRANE DB SYST REV, V1; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bath PM, 2000, STROKE, V31, P311; Bath PMW, 2001, LANCET, V358, P702, DOI 10.1016/S0140-6736(01)05837-8; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Kamphuisen PW, 2005, J THROMB HAEMOST, V3, P1187, DOI 10.1111/j.1538-7836.2005.01443.x; Lacut K, 2005, NEUROLOGY, V65, P865, DOI 10.1212/01.wnl.0000176073.80532.a2; Langhorne P, 1999, CEREBROVASC DIS, V9, P2, DOI 10.1159/000047570; MAZZONE C, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001922.PUB2; Sandercock P, 1997, LANCET, V349, P1569; Sandercock PA, 2008, COCHRANE DB SYST REV, V3; Sprigg Nikola, 2005, J Stroke Cerebrovasc Dis, V14, P203, DOI 10.1016/j.jstrokecerebrovasdis.2005.06.001	14	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1923	1924		10.1016/S0140-6736(09)60990-9	http://dx.doi.org/10.1016/S0140-6736(09)60990-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19477504	Green Accepted			2022-12-28	WOS:000266832500005
J	Lane, J				Lane, Julia			Assessing the Impact of Science Funding	SCIENCE			English	Editorial Material									Natl Sci Fdn, Arlington, VA 22230 USA	National Science Foundation (NSF)	Lane, J (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	jlane@nsf.gov		Lane, Julia/0000-0002-8139-2960				BOZEMAN B, 2007, 0738203 NSF; BRANSCOMB L, 2009, SCISIP LISTSERV; BRANSTETTER L, 2008, 0830233 NSF; DAVIS SJ, 2006, W12768 NBER; *DIR SCI TECHN IND, 2009, FORW LOOK RESP CRIS; *DIUS, 2008, INN NAT WHIT PAP; Ehrenberg R, 2005, MODERN LABOR EC THEO; FUCHS E, 2008, 0830354 NSF; FUGLIE K, 1996, AER735 USDA EC RES S; Goldston D, 2009, NATURE, V458, P21, DOI 10.1038/458021a; Hage J., 2007, SCI PUBL POLICY, V34, P731, DOI DOI 10.3152/030234207X265385; HAND E, NATURE, DOI DOI 10.1038/NEWS.2009.126; HECKMAN JJ, 1999, 7288 NBER; Jorgenson DW, 2008, J ECON PERSPECT, V22, P3, DOI 10.1257/jep.22.1.3; KIESLER S, 2008, 0830306 NSF; Leshner AI, 2009, SCIENCE, V324, P313, DOI 10.1126/science.1174215; LINK A, 2008, 0827976 NSF; Mervis J, 2009, SCIENCE, V323, P1274, DOI 10.1126/science.323.5919.1274; OBAMA BH, 2008, B OBAMA CONNECTING E; *OECD, 2009, OECD INN STRAT; SCHUNN C, 2008, 0830210 NSF; SCOTCHMER S, 2008, 0830186 NSF; Tassey G, 2008, ECON INNOV NEW TECH, V17, P615, DOI 10.1080/10438590701785439	23	52	53	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1273	1275		10.1126/science.1175335	http://dx.doi.org/10.1126/science.1175335			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453TF	19498153				2022-12-28	WOS:000266635100026
J	Taylor, KS; Lambert, TW; Goldacre, MJ				Taylor, Kathryn S.; Lambert, Trevor W.; Goldacre, Michael J.			Career progression and destinations, comparing men and women in the NHS: postal questionnaire surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-HOSPITAL MEDICINE; ACADEMIC MEDICINE; UNITED-KINGDOM; DOCTORS; DISCRIMINATION; ADVANCEMENT; OBSTACLES; SURGERY; SUCCESS; SEX	Objective To study the career progression of NHS doctors, comparing men and women. Design Postal questionnaire surveys. Participants and setting Graduates of 1977, 1988, and 1993 from all UK medical schools. Results The response rate was 68% (7012/10 344). Within general practice, 97% (1208/1243) of men, 99% (264/267) of women who had always worked full time throughout their career, and 87% (1083/1248) of all women were principals. Median times from qualification to principal status were 5.8 (95% confidence interval 5.6 to 6.0) years for men, 5.6 (5.4 to 5.8) years for women who had worked full time during training, and 6.8 (6.5 to 7.0) years for all women. Of the 1977 and 1988 graduates in hospital practice, 96% (1293/1347) of men were consultants, compared with 92% (276/299) of women who had always worked full time throughout their career and 67% (277/416) of women who had not. Median time to first consultant post was 11.7 (11.5 to 11.9) years for men, 11.3 (11.0 to 11.6) years for women who worked full time during training, and 12.3 (12.0 to 12.6) years for all women. Women who had not always worked full time throughout their career were over-represented in general practice and under-represented in most hospital specialties, substantially so in the surgical specialties and anaesthetics. Women who had always worked full time were under-represented not only in the surgical specialties but also in general practice. Conclusions Women not progressing as far and as fast as men was, generally, a reflection of not having always worked full time rather than their sex. The findings suggest that women do not generally encounter direct discrimination; however, the possibility that indirect discrimination, such as lack of opportunities for part time work, has influenced choice of specialty cannot be ruled out.	[Taylor, Kathryn S.; Lambert, Trevor W.; Goldacre, Michael J.] Univ Oxford, UK Med Careers Res Grp, Unit Hlth Care Epidemiol, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, UK Med Careers Res Grp, Unit Hlth Care Epidemiol, Dept Publ Hlth, Oxford OX3 7LF, England.	michael.goldacre@dphpc.ox.ac.uk	Taylor, Kathryn/ABG-1422-2020	Lambert, Trevor/0000-0001-9688-3036	policy research programme, Department of Health; NIHR Co-ordinating Centre for Research Capacity Development	policy research programme, Department of Health; NIHR Co-ordinating Centre for Research Capacity Development	The UK Medical Careers Research Group is funded by the policy research programme, Department of Health. The Unit of Health Care Epidemiology is funded by the NIHR Co-ordinating Centre for Research Capacity Development. The study sponsors did not have a role in the design, conduct, analysis, or reporting of the study. The views and opinions expressed in the paper do not necessarily reflect those of the sponsors.	Allen I, 2005, BRIT MED J, V331, P569, DOI 10.1136/bmj.331.7516.569; Altman DG, 1998, BRIT MED J, V317, P468; Ash AS, 2004, ANN INTERN MED, V141, P205, DOI 10.7326/0003-4819-141-3-200408030-00009; BEBBINGTON D, 1990, HIGH ED Q, V56, P360; Calman KC, 1999, MED EDUC, V33, P28; Carr PL, 2003, J WOMENS HEALTH, V12, P1009, DOI 10.1089/154099903322643938; *CHIEF MED OFF, 2007, STAT PUBL HLTH ANN R; Colletti LM, 2000, ARCH SURG-CHICAGO, V135, P972, DOI 10.1001/archsurg.135.8.972; CURRIE C, 1993, BRIT MED J, V306, P735, DOI 10.1136/bmj.306.6880.735; *DEP HLTH, 2001, IMPR WORK LIV DOCT; *DEP HLTH, 1993, HOSP DOCT TRAIN FUT; Dex S., 1987, WOMENS OCCUPATIONAL; *ED TOM DOCT WORK, 2008, ED TOM DOCT FUT MOD; *EQ OPP COMM, 2004, CAR BARR MED DOCT EX; Fitzgerald RC, 2001, HOSP MED, V62, P778, DOI 10.12968/hosp.2001.62.12.1708; Goldacre MJ, 2008, ANN R COLL SURG EN S, V90, P134; Hamel MB, 2006, NEW ENGL J MED, V355, P310, DOI 10.1056/NEJMe068143; JACKSON C, 2002, INFORM CHOICES NEED; Kaplan SH, 1996, NEW ENGL J MED, V335, P1282, DOI 10.1056/NEJM199610243351706; Killaspy H., 2003, PSYCHIATR BULL, V27, P323; Lambert TW, 1996, BRIT MED J, V313, P19, DOI 10.1136/bmj.313.7048.19; Mavromaras K, 2006, BRIT MED J, V332, P148, DOI 10.1136/bmj.38628.738935.3A; MCKEIGUE PM, 1990, BRIT MED J, V301, P961, DOI 10.1136/bmj.301.6758.961; McKinstry B, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-56; McKinstry B, 2008, BRIT MED J, V336, P748, DOI 10.1136/bmj.39505.491065.94; McManus IC, 2000, J EPIDEMIOL COMMUN H, V54, P10, DOI 10.1136/jech.54.1.10; *MED MANP ED DIV, 1988, HLTH TRENDS, V4, P101; *NHS EMPL, 2007, FUT MED WORKF; Reed V, 2001, MED EDUC, V35, P139, DOI 10.1046/j.1365-2923.2001.00837.x; Sandhu B, 2007, MED EDUC, V41, P909, DOI 10.1111/j.1365-2923.2007.02825.x; Sonnad SS, 2002, SURGERY, V132, P415, DOI 10.1067/msy.2002.127694; *STAT OFF, 1998, 1833 STAT OFF; *STAT OFF, 2003, 1684 STAT OFF; Timmis AD, 2005, HEART, V91, P273, DOI 10.1136/hrt.2004.047852; Tooke J., 2007, ASPIRING EXCELLENCE; Valian V, 1999, WHY SO SLOW ADVANCEM; Williams C, 2000, MED EDUC, V34, P602, DOI 10.1046/j.1365-2923.2000.00666.x	37	53	53	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2009	338								b1735	10.1136/bmj.b1735	http://dx.doi.org/10.1136/bmj.b1735			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AG	19493938	Green Published, hybrid			2022-12-28	WOS:000266726300003
J	Corl, AB; Berger, KH; Ophir-Shohat, G; Gesch, J; Simms, JA; Bartlett, SE; Heberlein, U				Corl, Ammon B.; Berger, Karen H.; Ophir-Shohat, Galit; Gesch, Julie; Simms, Jeffrey A.; Bartlett, Selena E.; Heberlein, Ulrike			Happyhour, a Ste20 Family Kinase, Implicates EGFR Signaling in Ethanol-Induced Behaviors	CELL			English	Article							TARGETED GENE-EXPRESSION; GROWTH-FACTOR RECEPTOR; GERMINAL CENTER KINASE; N-TERMINAL KINASE; PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; ALCOHOL DEPENDENCE; BINDING PROTEIN; LOW-LEVEL; PATHWAY	The consequences of alcohol use disorders (AUDs) are devastating to individuals and society, yet few treatments are currently available. To identify genes regulating the behavioral effects of ethanol, we conducted a genetic screen in Drosophila and identified amutant, happyhour (hppy), dueto its increased-resistance to the sedative effects of ethanol. Hppy protein shows strong homology to mammalian Ste20 family kinases of the GCK-1 subfamily. Genetic and biochemical experiments revealed that the epidermal growth factor (EGF)-signaling pathway regulates ethanol sensitivity in Drosophila and that Hppy functions as an inhibitor of the pathway. Acute pharmacological inhibition of the EGF receptor (EGFR) in adult animals altered acute ethanol sensitivity in both flies and mice and reduced ethanol consumption in a preclinical rat model of alcoholism. Inhibitors of the EGFR or components of its signaling pathway are thus potential pharmacotherapies for AUDs.	[Corl, Ammon B.; Heberlein, Ulrike] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; [Ophir-Shohat, Galit; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Berger, Karen H.; Gesch, Julie; Simms, Jeffrey A.; Bartlett, Selena E.; Heberlein, Ulrike] Ernest Gallo Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Heberlein, U (corresponding author), Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA.	ulrike.heberlein@ucsf.edu	Bartlett, Selena/J-1345-2012	Bartlett, Selena/0000-0002-1741-3958	NIH/NIAAA; Department of Defense; State of California for Medical Research; UCSF Neuroscience Training Grant; ARCS Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER	NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Defense(United States Department of Defense); State of California for Medical Research; UCSF Neuroscience Training Grant; ARCS Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We are grateful to Aylin Rodan for initiating this project, Linus Tsai and Ian King for outcrossing many of the lines used in this study, Amy Lasek for designing the primer/probe sets used for hppy QPCR, Melissa Sniffen for assistance with Drosophila CNS dissections, and all other members of the Heberlein lab for thoughtful discussions regarding this project. We thank Kevin Moses, Marek Mlodzik, Tim Tully, Mariann Bienz, Celeste Berg, Kunihiro Matsumoto, Barry Dickson, and the Bloomington Stock Center for providing fly lines. Scanning electron microscopy was performed at the Cornell Integrated Microscopy Center at Cornell University in Ithaca, NY. We gratefully acknowledge the gift of Tarceva from OSI Pharmaceuticals. We also thank Joan Holgate and Carsten Nielsen, in the preclinical development group, for assistance with the rodent experiments. This research was supported by grants from the NIH/NIAAA ( U. H.), the Department of Defense ( U. H. and S. E. B.), the State of California for Medical Research through UCSF ( U. H. and S. E. B.), and the UCSF Neuroscience Training Grant and the ARCS Foundation ( A. B. C.).	Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Arlinde C, 2004, PHARMACOGENOMICS J, V4, P208, DOI 10.1038/sj.tpj.6500243; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chandler LJ, 2005, ALCOHOL CLIN EXP RES, V29, P672, DOI 10.1097/01.ALC.0000158935.53360.5F; Chen Y. R., 1999, GENE THER MOL BIOL, V4, P83; Ciardiello F, 2004, CURR OPIN ONCOL, V16, P130, DOI 10.1097/00001622-200403000-00008; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; Dick DM, 2004, ALCOHOL CLIN EXP RES, V28, P4, DOI 10.1097/01.ALC.0000108645.54345.98; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lovinger DM, 1997, N-S ARCH PHARMACOL, V356, P267, DOI 10.1007/PL00005051; Ma CL, 2005, BIOCHEM PHARMACOL, V69, P1785, DOI 10.1016/j.bcp.2005.03.029; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Ranson M, 2004, J CLIN PHARM THER, V29, P95, DOI 10.1111/j.1365-2710.2004.00543.x; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; REICH T, 1999, J NEUROSCI, V22, P9490; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Thiele TE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0006.2002; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; Urizar NL, 2007, J NEUROSCI, V27, P4541, DOI 10.1523/JNEUROSCI.0305-07.2007; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wolf FW, 2002, J NEUROSCI, V22, P11035	50	81	81	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					949	960		10.1016/j.cell.2009.03.020	http://dx.doi.org/10.1016/j.cell.2009.03.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19464045	Bronze			2022-12-28	WOS:000266454800024
J	Peterson, TR; Laplante, M; Thoreen, CC; Sancak, Y; Kang, SA; Kuehl, WM; Gray, NS; Sabatini, DM				Peterson, Timothy R.; Laplante, Mathieu; Thoreen, Carson C.; Sancak, Yasemin; Kang, Seong A.; Kuehl, W. Michael; Gray, Nathanael S.; Sabatini, David M.			DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival	CELL			English	Article							C-MAF; PROTEIN; PHOSPHORYLATION; KINASE; COMPLEX; DYSREGULATION; PROLIFERATION; ACTIVATION; DOMAINS; TARGET	The mTORC1 and mTORC2 pathways regulate cell growth, proliferation, and survival. We identify DEPTOR as an mTOR-interacting protein whose expression is negatively regulated by mTORC1 and mTORC2. Loss of DEPTOR activates S6K1, Akt, and SGK1, promotes cell growth and survival, and activates mTORC1 and mTORC2 kinase activities. DEPTOR overexpression suppresses S6K1 but, by relieving feedback inhibition from mTORC1 to PI3K signaling, activates Akt. Consistent with many human cancers having activated mTORC1 and mTORC2 pathways, DEPTOR expression is low in most cancers. Surprisingly, DEPTOR is highly overexpressed in a subset of multiple myelomas harboring cyclin D1/D3 or c-MAF/MAFB translocations. In these cells, high DEPTOR expression is necessary to maintain PI3K and Akt activation and a reduction in DEPTOR levels leads to apoptosis. Thus, we identify a novel MTOR-interacting protein whose deregulated overexpression in multiple myeloma cells represents a mechanism for activating PI3K/Akt signaling and promoting cell survival.	[Peterson, Timothy R.; Laplante, Mathieu; Thoreen, Carson C.; Sancak, Yasemin; Kang, Seong A.; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Peterson, Timothy R.; Laplante, Mathieu; Thoreen, Carson C.; Sancak, Yasemin; Kang, Seong A.; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA; [Kuehl, W. Michael] NCI, Bethesda, MD 20814 USA; [Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	National Institutes of Health [R01 AI47389, R01 CA103866]; Keck Foundation; LAM Foundation; American Diabetes Association; Canadian Institutes of Health Research; American Cancer Society; Intramural Research Program; National Cancer Institute; Center for Cancer Research; Dana Farber Cancer Institute High-Tech Research Fund; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [ZIASC006581, R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); LAM Foundation; American Diabetes Association(American Diabetes Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Cancer Society(American Cancer Society); Intramural Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Farber Cancer Institute High-Tech Research Fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Thijn Brummelkamp for reviewing the manuscript and the following for technical assistance: Leslie Brents, Stephen Carr, Jake Jaffe, Xana Frias, Heather Keys, Stephanie Kinkel, Doug McMillin, Jan Reiling, Eric Spooner, Ed Van Veen, and Marcel Van Vugt. We thank members of the Sabatini lab for helpful discussions. This work was supported by grants from the National Institutes of Health ( NIH; R01 AI47389 and R01 CA103866) to D. M. S.; awards from the Keck Foundation and LAM Foundation to D. M. S.; a fellowship from the American Diabetes Association to T. R. P.; a fellowship from the Canadian Institutes of Health Research to M. L.; and a fellowship from the American Cancer Society to S. A. K. W. M. K was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. N. S. G. is funded in part by the Dana Farber Cancer Institute High-Tech Research Fund. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Alessi DR, 2001, BIOCHEM SOC T, V29, P1, DOI 10.1042/bst029a059; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Bliskovsky V, 2003, P NATL ACAD SCI USA, V100, P14982, DOI 10.1073/pnas.2431627100; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chang H, 2006, LEUKEMIA RES, V30, P262, DOI 10.1016/j.leukres.2005.07.008; Chen SH, 2006, DEV CELL, V11, P436, DOI 10.1016/j.devcel.2006.09.011; Chesi M, 1998, BLOOD, V91, P4457, DOI 10.1182/blood.V91.12.4457.412k48_4457_4463; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shapiro-Shelef M, 2004, CURR OPIN IMMUNOL, V16, P226, DOI 10.1016/j.coi.2004.02.001; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; TSUBUKI S, 1993, BIOCHEM BIOPH RES CO, V196, P1195, DOI 10.1006/bbrc.1993.2378; van Stralen E, 2009, EXP HEMATOL, V37, P78, DOI 10.1016/j.exphem.2008.08.006; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	47	883	908	4	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					873	886		10.1016/j.cell.2009.03.046	http://dx.doi.org/10.1016/j.cell.2009.03.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19446321	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000266454800018
J	Wise, M; Calvin, K; Thomson, A; Clarke, L; Bond-Lamberty, B; Sands, R; Smith, SJ; Janetos, A; Edmonds, J				Wise, Marshall; Calvin, Katherine; Thomson, Allison; Clarke, Leon; Bond-Lamberty, Benjamin; Sands, Ronald; Smith, Steven J.; Janetos, Anthony; Edmonds, James			Implications of Limiting CO2 Concentrations for Land Use and Energy	SCIENCE			English	Article							INTEGRATED ASSESSMENT; AGRICULTURE; REDUCTION	Limiting atmospheric carbon dioxide (CO2) concentrations to low levels requires strategies to manage anthropogenic carbon emissions from terrestrial systems as well as fossil fuel and industrial sources. We explore the implications of fully integrating terrestrial systems and the energy system into a comprehensive mitigation regime that limits atmospheric CO2 concentrations. We find that this comprehensive approach lowers the cost of meeting environmental goals but also carries with it profound implications for agriculture: Unmanaged ecosystems and forests expand, and food crop and livestock prices rise. Finally, we find that future improvement in food crop productivity directly affects land-use change emissions, making the technology for growing crops potentially important for limiting atmospheric CO2 concentrations.	[Wise, Marshall; Calvin, Katherine; Thomson, Allison; Clarke, Leon; Bond-Lamberty, Benjamin; Sands, Ronald; Smith, Steven J.; Janetos, Anthony; Edmonds, James] Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park	Edmonds, J (corresponding author), Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, 5825 Univ Res Court,Suite 3500, College Pk, MD 20740 USA.	jae@pnl.gov	Smith, Steven/HDM-9496-2022; Thomson, Allison/GRO-3207-2022; Smith, Steven/F-4502-2010; Thomson, Allison M/B-1254-2010; Bond-Lamberty, Benjamin/C-6058-2008	Smith, Steven/0000-0003-3248-5607; Thomson, Allison M/0000-0001-5326-1755; Bond-Lamberty, Benjamin/0000-0001-9525-4633; Calvin, Katherine/0000-0003-2191-4189; Sands, Ronald/0000-0002-2864-0339	U.S. Department of Energys Office of Science; Electric Power Research Institute	U.S. Department of Energys Office of Science(United States Department of Energy (DOE)); Electric Power Research Institute	The authors are grateful to the U.S. Department of Energys Office of Science and to the Electric Power Research Institute for financial support for the research the results of which are reported here. The authors also thank E. Malone for helpful comments on an earlier draft. Of course, the opinions expressed here are the authors alone.	[Anonymous], 2007, J AGR FOOD IND ORG; Brenkert A., 2003, PNNL14337; Bruinsma J, 2003, WORLD AGR 2015 2030; Clarke L, 2007, CCSP SYNTHESIS ASS A; Clarke L., 2007, PNNL16735; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Edmonds J., 1985, GLOBAL ENERGY ASSESS; Edmonds JA, 2003, GREENHOUSE GAS CONTROL TECHNOLOGIES, VOLS I AND II, PROCEEDINGS, P1427; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Gillingham KT, 2008, MITIG ADAPT STRAT GL, V13, P675, DOI 10.1007/s11027-007-9122-5; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Kim SH, 2006, ENERG J, P63; Lucas PL, 2007, ENVIRON SCI POLICY, V10, P85, DOI 10.1016/j.envsci.2006.10.007; Metz ORDB, 2007, CLIMATE CHANGE 2007; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Rokityanskiy D, 2007, TECHNOL FORECAST SOC, V74, P1057, DOI 10.1016/j.techfore.2006.05.022; ROSE S, LAND CLIMATE STABILI; Sands RD, 2003, CLIMATIC CHANGE, V56, P185, DOI 10.1023/A:1021344614845; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Tavoni M, 2007, ENERG POLICY, V35, P5346, DOI 10.1016/j.enpol.2006.01.036; Wise M., 2009, PNNL18341	23	612	632	9	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1183	1186		10.1126/science.1168475	http://dx.doi.org/10.1126/science.1168475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478180				2022-12-28	WOS:000266410100041
J	Wolff, T; Shelton, E; Sessions, C; Miller, T				Wolff, Tracy; Shelton, Erica; Sessions, Cecili; Miller, Therese			Screening for Syphilis Infection in Pregnant Women: Evidence for the US Preventive Services Task Force Reaffirmation Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Background: In 2004, the U. S. Preventive Services Task Force strongly recommended that clinicians screen all pregnant women for syphilis infection. Purpose: To update the evidence on screening pregnant women for syphilis infection. Data Sources: MEDLINE searches from 1 January 2003 through 31 July 2008, recent systematic reviews, reference lists of retrieved articles, and expert suggestions. Study Selection: English-language studies were selected to answer the following 2 questions: Does screening for syphilis in pregnancy reduce the prevalence of congenital syphilis in neonates? Are there harms of screening for syphilis or harms of treatment with penicillin in pregnancy to women or neonates? Randomized, controlled trials; meta-analyses; systematic reviews; cohort studies; and ecologic studies were selected for the potential benefits question. Randomized, controlled trials; meta-analyses; systematic reviews; cohort studies; case-control studies; and large case series were selected for the potential harms question. Data Extraction: Information on the study design, selection criteria, demographic characteristics, and clinical outcomes was extracted from each study. Data Synthesis: One study on benefits evaluated the effect before and after the implementation of a universal syphilis screening program for pregnant women and found reductions in rates of congenital syphilis. Two studies on screening accuracy for syphilis reported false-positive rates of less than 1%. One study that used a large insurance claims database reported an incidence of anaphylaxis after oral penicillin of 0.1 per 10 000 dispensings. In a study from Hungary, oral penicillin in pregnancy was not associated with orofacial clefts. Limitations: This was a targeted literature search and could have missed small studies on the benefits and harms of screening for syphilis in pregnancy. We did not review evidence on interventions to improve rates of prenatal screening. Conclusion: New evidence from a study of universal screening supports previous evidence on the effectiveness of screening for syphilis in pregnancy to prevent congenital syphilis. Harms include testing and follow-up for false-positive test results and adverse effects from penicillin treatment.	[Wolff, Tracy; Shelton, Erica; Sessions, Cecili; Miller, Therese] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA	Agency for Healthcare Research & Quality	Wolff, T (corresponding author), Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, 540 Gaither Rd, Rockville, MD 20850 USA.							[Anonymous], [No title captured]; Berg AO, 2004, ANN FAM MED, V2, P362, DOI 10.1370/afm.215; *CDCP, 2007, SURV 2006 NAT PROF S; Chakraborty R, 2008, ARCH DIS CHILD, V93, P105, DOI 10.1136/adc.2006.103515; Cheng JQ, 2007, SEX TRANSM INFECT, V83, P347, DOI 10.1136/sti.2006.023655; Edozien A. O., 2004, Morbidity and Mortality Weekly Report, V53, P716; Geusau A, 2005, INT J STD AIDS, V16, P722, DOI 10.1258/095646205774763207; Hollier LM, 2003, AM J OBSTET GYNECOL, V189, P1178, DOI 10.1067/S0002-9378(03)00547-7; Johannes CB, 2007, DRUG SAFETY, V30, P705, DOI 10.2165/00002018-200730080-00007; Majeroni BA, 2007, AM FAM PHYSICIAN, V76, P265; Nelson HD, 2004, SCREENING SYPHILIS B; Puho EH, 2007, CLEFT PALATE-CRAN J, V44, P194, DOI 10.1597/05-208.1; Tinajeros F, 2006, SEX TRANSM INFECT, V82, pV17, DOI 10.1136/sti.2006.022640; US Preventive Services Task Force, 2008, AHRQ PUBL; Walker GJA, 2007, SEMIN FETAL NEONAT M, V12, P198, DOI 10.1016/j.siny.2007.01.019	15	38	38	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					710	U8		10.7326/0003-4819-150-10-200905190-00009	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451578	Green Submitted			2022-12-28	WOS:000266285300007
J	Fan, HY; Liu, ZL; Shimada, M; Sterneck, E; Johnson, PF; Hedrick, SM; Richards, JS				Fan, Heng-Yu; Liu, Zhilin; Shimada, Masayuki; Sterneck, Esta; Johnson, Peter F.; Hedrick, Stephen M.; Richards, JoAnne S.			MAPK3/1 (ERK1/2) in Ovarian Granulosa Cells Are Essential for Female Fertility	SCIENCE			English	Article							C/EBP-BETA; CUMULUS EXPANSION; KNOCKOUT MICE; MOUSE; EXPRESSION; OVULATION; FOLLICLE; PHOSPHORYLATION; COMMUNICATION; ACTIVATION	A surge of luteinizing hormone (LH) from the pituitary gland triggers ovulation, oocyte maturation, and luteinization for successful reproduction in mammals. Because the signaling molecules RAS and ERK1/2 ( extracellular signal-regulated kinases 1 and 2) are activated by an LH surge in granulosa cells of preovulatory follicles, we disrupted Erk1/2 in mouse granulosa cells and provide in vivo evidence that these kinases are necessary for LH-induced oocyte resumption of meiosis, ovulation, and luteinization. In addition, biochemical analyses and selected disruption of the Cebpb gene in granulosa cells demonstrate that C/EBPb (CCAAT/Enhancer-binding protein-beta) is a critical downstream mediator of ERK1/2 activation. Thus, ERK1/2 and C/EBPb constitute an in vivo LH-regulated signaling pathway that controls ovulation- and luteinization-related events.	[Fan, Heng-Yu; Liu, Zhilin; Richards, JoAnne S.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Shimada, Masayuki] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Appl Anim Sci, Higashihiroshima 7398528, Japan; [Sterneck, Esta] NCI, Lab Cell & Dev Signaling, Ctr Canc Res, Frederick, MD 21702 USA; [Johnson, Peter F.] NCI, Basic Res Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Hedrick, Stephen M.] Univ Calif San Diego, Dept Cell & Mol Biol, La Jolla, CA 92093 USA; [Hedrick, Stephen M.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	Baylor College of Medicine; Hiroshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; University of California System; University of California San Diego	Richards, JS (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	joanner@bcm.edu	Shimada, Masayuki/Q-3673-2016; Hedrick, Stephen M/E-9171-2010; Johnson, Peter/A-1940-2012	Shimada, Masayuki/0000-0002-6500-2088; Sterneck, Esta/0000-0001-7716-8766; Johnson, Peter/0000-0002-4145-4725; Hedrick, Stephen/0000-0002-6345-8751	NIH [NIH-HD16229, NIH-HD07495, NIH-HD07165]; Project II; Japan Society for the Promotion of Science [18688016]; Intramural Research Program of NIH; National Cancer Institute, Center for Cancer Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007165, R01HD016229, U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, R37HD016229, R56HD016229] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010307, ZIABC010328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021372] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project II; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Pouyssegur and J. Shao for providing Erk1 mice and adenoviral vector of C/EBPSS, respectively. This work was supported by NIH grants NIH HD16229, NIH HD07495, Project II J.S.R., Grant in Aid for Scientific Research No. 18688016 from the Japan Society for the Promotion of Science M.S., Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research P.F.J. and E.S., and NIH Postdoctoral Training Grant NIH HD07165 H.Y.F. The Gene Expression Omnibus accession number for microarray data is GSE15135.	Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gershon E, 2007, FASEB J, V21, P1893, DOI 10.1096/fj.06-7688com; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Maizels ET, 1998, ENDOCRINOLOGY, V139, P3353, DOI 10.1210/en.139.7.3353; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Sela-Abramovich S, 2005, ENDOCRINOLOGY, V146, P1236, DOI 10.1210/en.2004-1006; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221	18	431	452	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					938	941		10.1126/science.1171396	http://dx.doi.org/10.1126/science.1171396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443782	Green Accepted			2022-12-28	WOS:000266048800039
J	Goldman, SR; Ebright, RH; Nickels, BE				Goldman, Seth R.; Ebright, Richard H.; Nickels, Bryce E.			Direct Detection of Abortive RNA Transcripts in Vivo	SCIENCE			English	Article							LAC UV5 PROMOTER; POLYMERASE; ESCAPE; INITIATION; VITRO; REGION; SIGMA(70); MECHANISM; ELEMENTS; PROTEIN	During transcription initiation in vitro, prokaryotic and eukaryotic RNA polymerase ( RNAP) can engage in abortive initiation-the synthesis and release of short (2 to 15 nucleotides) RNA transcripts-before productive initiation. It has not been known whether abortive initiation occurs in vivo. Using hybridization with locked nucleic acid probes, we directly detected abortive transcripts in bacteria. In addition, we show that in vivo abortive initiation shows characteristics of in vitro abortive initiation: Abortive initiation increases upon stabilizing interactions between RNAP and either promoter DNA or sigma factor, and also upon deleting elongation factor GreA. Abortive transcripts may have functional roles in regulating gene expression in vivo.	[Goldman, Seth R.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Dept Chem, Piscataway, NJ 08854 USA; [Ebright, Richard H.] Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Howard Hughes Medical Institute; Rutgers State University New Brunswick	Nickels, BE (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.	bnickels@waksman.rutgers.edu	Ebright, Richard/O-3321-2019; Nickels, Bryce/AAF-2549-2020	Ebright, Richard/0000-0001-8915-7140; Nickels, Bryce/0000-0001-7449-8831	NIH [GM41376]; Howard Hughes Medical Institute; Pew Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pew Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hochschild, A. Revyakin, and J. Roberts for materials, and A. Gann, S. Garrity, A. Hochschild, L. Hsu, W. McAllister, E. McGlinn, and R. Sousa for discussion. Work was supported by NIH grant GM41376 and a Howard Hughes Medical Institute Investigatorship to R.H.E. and by a Pew Scholars Award to B.E.N.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Chan CL, 2001, J BIOL CHEM, V276, P38201; ELLINGER T, 1994, J MOL BIOL, V239, P455, DOI 10.1006/jmbi.1994.1388; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hsu LLM, 2003, BIOCHEMISTRY-US, V42, P3777, DOI 10.1021/bi026954e; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; KAMMERER W, 1986, EMBO J, V5, P2995, DOI 10.1002/j.1460-2075.1986.tb04597.x; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Ko DC, 1998, GENE DEV, V12, P3276, DOI 10.1101/gad.12.20.3276; Leibman M, 2007, EMBO J, V26, P1579, DOI 10.1038/sj.emboj.7601612; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; Monsalve M, 1996, EMBO J, V15, P383, DOI 10.1002/j.1460-2075.1996.tb00368.x; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v	18	81	84	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					927	928		10.1126/science.1169237	http://dx.doi.org/10.1126/science.1169237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443781	Green Accepted			2022-12-28	WOS:000266048800035
J	Guarda, G; Dostert, C; Staehli, F; Cabalzar, K; Castillo, R; Tardivel, A; Schneider, P; Tschopp, J				Guarda, Greta; Dostert, Catherine; Staehli, Francesco; Cabalzar, Katrin; Castillo, Rosa; Tardivel, Aubry; Schneider, Pascal; Tschopp, Juerg			T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes	NATURE			English	Article							DENDRITIC CELLS; LYMPH-NODES; MICE; ACTIVATION; DEFICIENT; CRYSTALS; MEMBERS; FAMILY; MOUSE	Inflammation is a protective attempt by the host to remove injurious stimuli and initiate the tissue healing process(1). The inflammatory response must be actively terminated, however, because failure to do so can result in 'bystander' damage to tissues and diseases such as arthritis or type-2 diabetes. Yet the mechanisms controlling excessive inflammatory responses are still poorly understood. Here we show that mouse effector and memory CD4(+) T cells abolish macrophage inflammasome-mediated caspase-1 activation and subsequent interleukin 1 beta release in a cognate manner. Inflammasome inhibition is observed for all tested NLRP1 (commonly called NALP1) and NLRP3 (NALP3 or cryopyrin) activators, whereas NLRC4 (IPAF) inflammasome function and release of other inflammatory mediators such as CXCL2, interleukin 6 and tumour necrosis factor are not affected. Suppression of the NLRP3 inflammasome requires cell-to-cell contact and can be mimicked by macrophage stimulation with selected ligands of the tumour necrosis factor family, such as CD40L (also known as CD40LG). In a NLRP3-dependent peritonitis model, effector CD4(+) T cells are responsible for decreasing neutrophil recruitment in an antigen-dependent manner. Our findings reveal an unexpected mechanism of inflammasome inhibition, whereby effector and memory T cells suppress potentially damaging inflammation, yet leave the primary inflammatory response, crucial for the onset of immunity, intact.	[Guarda, Greta; Dostert, Catherine; Staehli, Francesco; Cabalzar, Katrin; Castillo, Rosa; Tardivel, Aubry; Schneider, Pascal; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemim Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Guarda, Greta/G-1921-2011; Staehli, Francesco/B-1350-2009; Dostert, Catherine/AAJ-5473-2020	Schneider, Pascal/0000-0003-0677-9409; Guarda, Greta/0000-0001-9243-6116	Swiss National Science foundation; NCCR Molecular Oncology; EMBO	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); EMBO(European Molecular Biology Organization (EMBO))	We thank H. Acha-Orbea, P. Launois, E. Luescher, H. R. MacDonald, P. Romero, M. Kopf and R. Flavell for knockout and transgenic mice; H. Acha-Orbea and M. Eckert for critical reading and comments; A. Yazdi for discussions; and M. Braun and D. Labes for technical help. This work was in part supported by the 4 Swiss National Science foundation and the NCCR Molecular Oncology. C. D. is supported by an EMBO long-term fellowship.	Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Burger D, 2002, ARTHRITIS RES THER, V4, pS169, DOI 10.1186/ar558; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Maloy KJ, 2005, IMMUNOL LETT, V97, P189, DOI 10.1016/j.imlet.2005.01.004; Martin-Fontecha A, 2008, J EXP MED, V205, P2561, DOI 10.1084/jem.20081212; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; McDermott MF, 2007, TRENDS MOL MED, V13, P381, DOI 10.1016/j.molmed.2007.07.005; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; Palm NW, 2007, NAT MED, V13, P1142, DOI 10.1038/nm1007-1142b; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	29	195	213	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					269	U136		10.1038/nature08100	http://dx.doi.org/10.1038/nature08100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19494813				2022-12-28	WOS:000267761000043
J	Ohya, T; Miaczynska, M; Coskun, U; Lommer, B; Runge, A; Drechsel, D; Kalaidzidis, Y; Zerial, M				Ohya, Takeshi; Miaczynska, Marta; Coskun, Unal; Lommer, Barbara; Runge, Anja; Drechsel, David; Kalaidzidis, Yannis; Zerial, Marino			Reconstitution of Rab- and SNARE-dependent membrane fusion by synthetic endosomes	NATURE			English	Article							TRANSPORT-VESICLE; GDP/GTP EXCHANGE; EFFECTOR EEA1; ALPHA-SNAP; COMPLEX; PROTEINS; DOCKING; SPECIFICITY; DOMAIN; DISSOCIATION	Rab GTPases and SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) are evolutionarily conserved essential components of the eukaryotic intracellular transport system. Although pairing of cognate SNAREs is sufficient to fuse membranes in vitro, a complete reconstitution of the Rab-SNARE machinery has never been achieved. Here we report the reconstitution of the early endosomal canine Rab5 GTPase, its key regulators and effectors together with SNAREs into proteoliposomes using a set of 17 recombinant human proteins. These vesicles behave like minimal 'synthetic' endosomes, fusing with purified early endosomes or with each other in vitro. Membrane fusion measured by content-mixing and morphological assays requires the cooperativity between Rab5 effectors and cognate SNAREs which, together, form a more efficient 'core machinery' than SNAREs alone. In reconstituting a fusion mechanism dependent on both a Rab GTPase and SNAREs, our work shows that the two machineries act coordinately to increase the specificity and efficiency of the membrane tethering and fusion process.	[Ohya, Takeshi; Miaczynska, Marta; Coskun, Unal; Lommer, Barbara; Runge, Anja; Drechsel, David; Kalaidzidis, Yannis; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01309 Dresden, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01309 Dresden, Germany.	zerial@mpi-cbg.de	Coskun, Ünal/F-4683-2011; Kalaidzidis, Yannis/H-3094-2016	Coskun, Ünal/0000-0003-4375-3144; Kalaidzidis, Yannis/0000-0002-6137-1193; Miaczynska, Marta/0000-0003-0031-5267	German Ministry for Education and Research [0313082J]; EU Integrated Project EndoTrack; DFG; Max Planck Society; The Nakatomi Foundation	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); EU Integrated Project EndoTrack; DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); The Nakatomi Foundation	We are grateful to K. Simons and B. Hoflack for discussions, to C. Stroupe and W. Wickner for sharing unpublished information, and to G. Marsne, I. Baines, W. Huttner, K. Simons, C. Stroupe and W. Wickner for critical reading of the manuscript. We acknowledge support by the systems biology network HepatoSys of the German Ministry for Education and Research ( BMBF, grant 0313082J), the EU Integrated Project EndoTrack, the DFG and the Max Planck Society ( including the Max Planck Partner Group grant to M. Z. and M. M.). T. O. was supported by The Nakatomi Foundation.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rothman JE, 1997, SCIENCE, V276, P1212, DOI 10.1126/science.276.5316.1212; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zimmerberg J, 2006, NAT CHEM BIOL, V2, P564, DOI 10.1038/nchembio1106-564; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	50	156	160	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1091	U77		10.1038/nature08107	http://dx.doi.org/10.1038/nature08107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19458617				2022-12-28	WOS:000267636700035
J	He, J; Jin, ZC; Yu, DH				He, Jia; Jin, Zhichao; Yu, Danghui			Statistical reporting in Chinese biomedical journals	LANCET			English	Editorial Material							MEDICAL-RESEARCH; ERRORS		[He, Jia; Jin, Zhichao] Second Mil Med Univ, Fac Hlth Serv, Dept Hlth Stat, Shanghai 200433, Peoples R China	Naval Medical University	He, J (corresponding author), Second Mil Med Univ, Fac Hlth Serv, Dept Hlth Stat, Shanghai 200433, Peoples R China.	hejia63@yahoo.com	Jin, Zhichao/AAF-7234-2019	He, Jia/0000-0002-2338-9501; Jin, Zhichao/0000-0002-3180-6475				ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Altman DG, 2002, JAMA-J AM MED ASSOC, V287, P2765, DOI 10.1001/jama.287.21.2765; Altman DG, 2000, STAT MED, V19, P3275, DOI 10.1002/1097-0258(20001215)19:23<3275::AID-SIM626>3.0.CO;2-M; [Anonymous], 2005, NAT MED, V11, P1; *EQUATOR NETW, RES CTR GOOD REP HLT; Ercan I.Y., 2007, EUR J GEN MED, V4, P128; Holmes TH, 2004, AM J PHYSIOL-ENDOC M, V286, pE495, DOI 10.1152/ajpendo.00484.2003; HU LP, 2006, SCI FOCUS, V4, P9; ICMJE (International Committee of Medical Journal Editors), UN REQ MAN UNPUB; MCGUIGAN SM, 1995, BRIT J PSYCHIAT, V167, P683, DOI 10.1192/bjp.167.5.683; MOHER D, CONSORT STATEMENT RE; Strasak AM, 2007, SWISS MED WKLY, V137, P44, DOI 10.4414/smw.2007.11587; Wang QA, 1998, JAMA-J AM MED ASSOC, V280, P283, DOI 10.1001/jama.280.3.283	13	12	18	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2009	373	9681					2091	2093		10.1016/S0140-6736(09)60867-9	http://dx.doi.org/10.1016/S0140-6736(09)60867-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19446326				2022-12-28	WOS:000267229700008
J	Fraser, C; Donnelly, CA; Cauchemez, S; Hanage, WP; Van Kerkhove, MD; Hollingsworth, TD; Griffin, J; Baggaley, RF; Jenkins, HE; Lyons, EJ; Jombart, T; Hinsley, WR; Grassly, NC; Balloux, F; Ghani, AC; Ferguson, NM; Rambaut, A; Pybus, OG; Lopez-Gatell, H; Alpuche-Aranda, CM; Chapela, IB; Zavala, EP; Guevara, DME; Checchi, F; Garcia, E; Hugonnet, S; Roth, C				Fraser, Christophe; Donnelly, Christl A.; Cauchemez, Simon; Hanage, William P.; Van Kerkhove, Maria D.; Hollingsworth, T. Deirdre; Griffin, Jamie; Baggaley, Rebecca F.; Jenkins, Helen E.; Lyons, Emily J.; Jombart, Thibaut; Hinsley, Wes R.; Grassly, Nicholas C.; Balloux, Francois; Ghani, Azra C.; Ferguson, Neil M.; Rambaut, Andrew; Pybus, Oliver G.; Lopez-Gatell, Hugo; Alpuche-Aranda, Celia M.; Bojorquez Chapela, Ietza; Palacios Zavala, Ethel; Espejo Guevara, Dulce Ma.; Checchi, Francesco; Garcia, Erika; Hugonnet, Stephane; Roth, Cathy		WHO Rapid Pandemic Assessment Coll	Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings	SCIENCE			English	Article							TRANSMISSIBILITY; STRATEGIES; MORTALITY; IMPACT	A novel influenza A (H1N1) virus has spread rapidly across the globe. Judging its pandemic potential is difficult with limited data, but nevertheless essential to inform appropriate health responses. By analyzing the outbreak in Mexico, early data on international spread, and viral genetic diversity, we make an early assessment of transmissibility and severity. Our estimates suggest that 23,000 (range 6000 to 32,000) individuals had been infected in Mexico by late April, giving an estimated case fatality ratio (CFR) of 0.4% (range: 0.3 to 1.8%) based on confirmed and suspected deaths reported to that time. In a community outbreak in the small community of La Gloria, Veracruz, no deaths were attributed to infection, giving an upper 95% bound on CFR of 0.6%. Thus, although substantial uncertainty remains, clinical severity appears less than that seen in the 1918 influenza pandemic but comparable with that seen in the 1957 pandemic. Clinical attack rates in children in La Gloria were twice that in adults (<15 years of age: 61%; >= 15 years: 29%). Three different epidemiological analyses gave basic reproduction number (R-0) estimates in the range of 1.4 to 1.6, whereas a genetic analysis gave a central estimate of 1.2. This range of values is consistent with 14 to 73 generations of human-to-human transmission having occurred in Mexico to late April. Transmissibility is therefore substantially higher than that of seasonal flu, and comparable with lower estimates of R0 obtained from previous influenza pandemics.	[Fraser, Christophe; Donnelly, Christl A.; Cauchemez, Simon; Hanage, William P.; Van Kerkhove, Maria D.; Hollingsworth, T. Deirdre; Griffin, Jamie; Baggaley, Rebecca F.; Jenkins, Helen E.; Lyons, Emily J.; Jombart, Thibaut; Hinsley, Wes R.; Grassly, Nicholas C.; Balloux, Francois; Ghani, Azra C.; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Rambaut, Andrew] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Lopez-Gatell, Hugo; Bojorquez Chapela, Ietza; Palacios Zavala, Ethel] FCO De P Miranda, Directorate Gen Epidemiol, Mexico City 01480, DF, Mexico; [Alpuche-Aranda, Celia M.] Natl Inst Epidemiol Diagnosis & Reference, Mexico City 11340, DF, Mexico; [Espejo Guevara, Dulce Ma.] Secretaria Salud Serv Salud Veracruz Soconusco 36, Xalapa, Veracruz, Mexico; [Checchi, Francesco; Garcia, Erika; Hugonnet, Stephane; Roth, Cathy] WHO, Geneva, Switzerland	Imperial College London; University of Edinburgh; University of Oxford; World Health Organization	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, Norfolk Pl, London W2 1PG, England.	neil.ferguson@imperial.ac.uk	Balloux, Francois/X-7856-2019; Ghani, Azra/B-8560-2009; Rambaut, Andrew/B-2481-2009; Hollingsworth, Deirdre/D-2421-2009; Balloux, Francois/D-4783-2009; Ferguson, Neil/B-8578-2008; Grassly, Nicholas C/C-6381-2008; Pybus, Oliver G/B-2640-2012; Fraser, Christophe/A-8109-2008; Hanage, Bill/CAF-1813-2022	Balloux, Francois/0000-0003-1978-7715; Rambaut, Andrew/0000-0003-4337-3707; Hollingsworth, Deirdre/0000-0001-5962-4238; Balloux, Francois/0000-0003-1978-7715; Ferguson, Neil/0000-0002-1154-8093; Grassly, Nicholas C/0000-0001-6067-4507; Pybus, Oliver G/0000-0002-8797-2667; Fraser, Christophe/0000-0003-2399-9657; Checchi, Francesco/0000-0001-9030-5382; Jenkins, Helen/0000-0003-4749-1591; Ghani, Azra/0000-0002-0007-4910; Van Kerkhove, Maria/0000-0002-6135-0018; Baggaley, Rebecca/0000-0002-4688-3924; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Donnelly, Christl/0000-0002-0195-2463	Medical Research Council UK Centre; National Institute of General Medical Sciences (NIH) Models of Infectious Disease Agent Study (MIDAS); The Royal Society; Research Councils UK; Bill and Melinda Gates Foundation; The Wellcome Trust [GR082623MA]; Biotechnology and Biological Sciences Research Council UK; Microsoft Research; Medical Research Council; Medical Research Council [G0600719B, G0600719] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; MRC [G0600719] Funding Source: UKRI	Medical Research Council UK Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of General Medical Sciences (NIH) Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); The Royal Society(Royal Society of London); Research Councils UK(UK Research & Innovation (UKRI)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); The Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Microsoft Research(Microsoft); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all those in Mexico and WHO (in particular J. Fitzner, K. Vandemaele and A. Merianos) who helped to collate the data used in this analysis. We also thank A. Borquez for help with translation and data collection and R. Eggo for data collation. We thank R. Anderson, K. Fukada, R. Hatchett, M. Lipsitch, D. Shay and L. Wolfson for useful discussions and comments. We thank the U.S. Centers for Disease Control; the Instituto de Salud Carlos III, Spain; Statens Erum Institut, Denmark; Erasmus MC Rotterdam, Netherlands; University of Regensburg, Germany; and the WHO collaborating centre for Reference and Research on Influenza, Australia, for posting viral sequences on GenBank. The work at Imperial College was funded by the Medical Research Council UK Centre grant. We also acknowledge additional support for individual staff members from the National Institute of General Medical Sciences (NIH) Models of Infectious Disease Agent Study (MIDAS) programme, The Royal Society (C.F., W.P.H., N.C.G., A.R., O.G.P.), Research Councils UK (S.C.), Bill and Melinda Gates Foundation (M.V.K., T.D.H., J.G.), The Wellcome Trust (R.F.B., grant GR082623MA), Biotechnology and Biological Sciences Research Council UK (T.J.), Microsoft Research (W.R.H.), and a studentship from the Medical Research Council (H.E.J.). GenBank accession numbers: GQ117067 [GenBank] , FJ973557 [GenBank] , FJ966082 [GenBank] , FJ966952 [GenBank] , FJ966960 [GenBank] , FJ966974 [GenBank] , FJ966971 [GenBank] , FJ969511 [GenBank] , GQ117040 [GenBank] , FJ985753 [GenBank] , GQ117119 [GenBank] , FJ982430 [GenBank] , GQ117097 [GenBank] , GQ117059 [GenBank] , GQ117103 [GenBank] , GQ117112 [GenBank] , CY039527 [GenBank] , FJ984364 [GenBank] , FJ984397 [GenBank] , FJ985763 [GenBank] , FJ974021 [GenBank] , GQ117056 [GenBank] , and FJ966982 [GenBank] for the main analysis and CY039527 [GenBank] , FJ966082 [GenBank] , FJ966959 [GenBank] , FJ966960 [GenBank] , FJ966974 [GenBank] , FJ969509 [GenBank] , FJ969511 [GenBank] , FJ966952 [GenBank] , FJ966982 [GenBank] , FJ971076 [GenBank] , and FJ973557 [GenBank] for the preliminary analysis.	Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Frost W.H., 1919, PUBLIC HLTH REPORTS, V34, P491, DOI [10.2307/4575056, DOI 10.2307/4575056]; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; GLEZEN WP, 1982, J INFECT DIS, V146, P313, DOI 10.1093/infdis/146.3.313; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; HUDMAN LE, 2002, GEOGRAPHY TRAVEL TOU; Lackenby A, 2008, EURO SURVEILL, V13; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; *MEX DIR GEN ADJ E, 2009, BROT INFL PORC MEX; *MEX DIR GEN ADJ E, 2009, BROT INFL HUM A H1N1; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; *WHO, SWIN INFL UPD 15	22	1355	1438	8	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1557	1561		10.1126/science.1176062	http://dx.doi.org/10.1126/science.1176062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19433588	Green Accepted			2022-12-28	WOS:000267130600043
J	Iglehart, JK				Iglehart, John K.			Building Momentum as Democrats Forge Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BAUCUS M, 2009, DESCRIPTION POLICY O; BAUCUS M, CALL ACTION HLTH REF; HACKER JS, 2009, HLTH COMPETITION STR; Nichols L.M., 2009, MODEST PROPOSAL COMP; SHEILS J, 2009, COST COVERAGE IMPACT	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2385	2387		10.1056/NEJMp0903872	http://dx.doi.org/10.1056/NEJMp0903872			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453DN	19439732				2022-12-28	WOS:000266590500001
J	Nolet, G				Nolet, Guust			Slabs Do Not Go Gently	SCIENCE			English	Editorial Material							DETACHMENT; SUBDUCTION; TOMOGRAPHY; SEISMICITY; MAGMATISM; BREAKOFF; IMAGE; PLATE; MODEL		[Nolet, Guust] Univ Nice, Geosci Azur, F-06560 Sophia Antipolis, France; [Nolet, Guust] CNRS, F-06560 Sophia Antipolis, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Nolet, G (corresponding author), Univ Nice, Geosci Azur, 250 Rue A Einstein, F-06560 Sophia Antipolis, France.	nolet@geoazur.unice.fr	Nolet, Guust/F-3142-2013	Nolet, Guust/0000-0002-2709-1518				CAHILL T, 1992, J GEOPHYS RES-SOL EA, V97, P17503, DOI 10.1029/92JB00493; CHATELAIN JL, 1992, GEOPHYS RES LETT, V19, P1507, DOI 10.1029/92GL01389; DAVIES JH, 1995, EARTH PLANET SC LETT, V129, P85, DOI 10.1016/0012-821X(94)00237-S; HAGER BH, 1984, J GEOPHYS RES, V89, P6003, DOI 10.1029/JB089iB07p06003; Lallemand S, 2001, TECTONOPHYSICS, V335, P229, DOI 10.1016/S0040-1951(01)00071-3; Levin V, 2002, NATURE, V418, P763, DOI 10.1038/nature00973; MCCAFFREY R, 1985, J GEOPHYS RES-SOLID, V90, P4511, DOI 10.1029/JB090iB06p04511; Obayashi M, 2009, SCIENCE, V324, P1173, DOI 10.1126/science.1172496; Sigloch K, 2008, NAT GEOSCI, V1, P458, DOI 10.1038/ngeo231; Simons F., 2006, EOS T AM GEOPHYS UN, V31, P305, DOI DOI 10.1029/2006E0310002; SPAKMAN W, 1988, GEOPHYS RES LETT, V15, P60, DOI 10.1029/GL015i001p00060; vanderLee S, 1997, NATURE, V386, P266, DOI 10.1038/386266a0; VON BLANCKENBURG F, 1995, TECTONICS, V14, P120, DOI 10.1029/94TC02051; Wortel MJR, 2000, SCIENCE, V290, P1910, DOI 10.1126/science.290.5498.1910	14	19	19	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1152	1153		10.1126/science.1174664	http://dx.doi.org/10.1126/science.1174664			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478171				2022-12-28	WOS:000266410100030
J	Gatenby, RA				Gatenby, Robert A.			A change of strategy in the war on cancer	NATURE			English	Editorial Material							RIBONUCLEOTIDE REDUCTASE; CELL-LINES; RESISTANCE		[Gatenby, Robert A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA; [Gatenby, Robert A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Gatenby, RA (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA.	robert.gatenby@moffitt.org						Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; GATENBY RA, CANC RES IN PRESS; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Izzo JG, 2006, MOL CANCER THER, V5, P2844, DOI 10.1158/1535-7163.MCT-06-0351; Scappini B, 2004, CANCER-AM CANCER SOC, V100, P1459, DOI 10.1002/cncr.20131	5	240	254	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 28	2009	459	7246					508	509		10.1038/459508a	http://dx.doi.org/10.1038/459508a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478766	Bronze			2022-12-28	WOS:000266370500018
J	Bellamy, L; Casas, JP; Hingorani, AD; Williams, D				Bellamy, Leanne; Casas, Juan-Pablo; Hingorani, Aroon D.; Williams, David			Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis	LANCET			English	Review							ABNORMAL GLUCOSE-TOLERANCE; METABOLIC SYNDROME; RISK-FACTORS; FOLLOW-UP; WOMEN; PREGNANCY; HISTORY; PREVALENCE; INSULIN; ASSOCIATION	Background Women with gestational diabetes are at increased risk of developing type 2 diabetes, but the risk and time of onset have not been fully quantified. We therefore did a comprehensive systematic review and meta-analysis to assess the strength of association between these conditions and the effect of factors that might modify the risk. Methods We identified cohort studies in which women who had developed type 2 diabetes after gestational diabetes were followed up between Jan 1, 1960, and Jan 31, 2009, from Embase and Medline. 205 relevant reports were hand searched. We selected 20 studies that included 675 455 women and 10 859 type 2 diabetic events. We calculated and pooled unadjusted relative risks (RRs) with 95% CIs for each study using a random-effects model. Subgroups analysed were the number of cases of type 2 diabetes, ethnic origin, duration of follow-up, maternal age, body-mass index, and diagnostic criteria. Findings Women with gestational diabetes had an increased risk of developing type 2 diabetes compared with those who had a normoglycaemic pregnancy (RR 7.43, 95% CI 4.79-11.51). Although the largest study (659 164 women; 9502 cases of type 2 diabetes) had the largest RR (12.6, 95% CI 12.15-13.19), RRs were generally consistent among the subgroups assessed. Interpretation Increased awareness of the magnitude and timing of the risk of type 2 diabetes after gestational diabetes among patients and clinicians could provide an opportunity to test and use dietary, lifestyle, and pharmacological interventions that might prevent or delay the onset of type 2 diabetes in affected women. Funding None.	[Williams, David] UCL, Inst Womens Hlth, London NW1 2PG, England; [Casas, Juan-Pablo] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Bellamy, Leanne] Northwick Pk Hosp & Clin Res Ctr, London, England; [Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London	Williams, D (corresponding author), UCL, Inst Womens Hlth, 250 Euston Rd, London NW1 2PG, England.	d.j.williams@ucl.ac.uk	Williams, David/AFW-0581-2022	Williams, David/0000-0002-8186-9124; Hingorani, Aroon/0000-0001-8365-0081	British Heart Foundation Senior Research Fellow [FS051/125]	British Heart Foundation Senior Research Fellow	A proportion of DW's salary was received by the University College London/University College London Hospital from the Department of Health's National Institute for Health Research Biomedical Research Centre. ADH is a British Heart Foundation Senior Research Fellow (FS051/125). We thank Reecha Sofat for statistical support.	Aberg AEB, 2002, ACTA OBSTET GYN SCAN, V81, P11, DOI 10.1046/j.0001-6349.2001.00000.x; Albareda M, 2003, DIABETES CARE, V26, P1199, DOI 10.2337/diacare.26.4.1199; American Diabetes Association, 1985, DIABETES S2, V34, P123; [Anonymous], 1998, Diabetes Care, V21 Suppl 2, pB1; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; BENJAMIN E, 1993, DIABETES CARE, V16, P1231, DOI 10.2337/diacare.16.9.1231; Bian XM, 2000, CHINESE MED J-PEKING, V113, P759; Canadian Institute for Health Information, DISCH ABSTR DAT; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Cho YM, 2009, DIABETOLOGIA, V52, P253, DOI 10.1007/s00125-008-1196-4; *CTR REV DISS, 2001, 4 CTR REV DISS; DAMM P, 1994, DIABETIC MED, V11, P558, DOI 10.1111/j.1464-5491.1994.tb02035.x; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Ferraz TB, 2007, DIABETES RES CLIN PR, V78, P23, DOI 10.1016/j.diabres.2007.01.025; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gunderson EP, 2007, DIABETES, V56, P2990, DOI 10.2337/db07-1024; HARRIS M, 1979, DIABETES, V28, P1039; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jarvela IY, 2006, DIABETES CARE, V29, P607, DOI 10.2337/diacare.29.03.06.dc05-1118; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim C, 2007, DIABETES CARE, V30, P2281, DOI 10.2337/dc07-0618; Kim C, 2006, AM J PUBLIC HEALTH, V96, P1643, DOI 10.2105/AJPH.2005.065722; Ko GTC, 1999, AUST NZ J OBSTET GYN, V39, P478; Krishnaveni GV, 2007, DIABETES RES CLIN PR, V78, P398, DOI 10.1016/j.diabres.2007.06.002; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lee H, 2008, DIABETES RES CLIN PR, V81, P124, DOI 10.1016/j.diabres.2008.02.017; LIND T, 1991, DIABETES, V40, P8, DOI 10.2337/diab.40.2.S8; Linne Y, 2002, BJOG-INT J OBSTET GY, V109, P1227; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Madarasz Eszter, 2008, Orvosi Hetilap, V149, P831, DOI 10.1556/OH.2008.28242; METZGER BE, 1991, DIABETES, V40, P197, DOI 10.2337/diab.40.2.S197; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Morimitsu LK, 2007, DIABETES RES CLIN PR, V78, P340, DOI 10.1016/j.diabres.2007.04.013; Osei K, 1998, DIABETES CARE, V21, P1250, DOI 10.2337/diacare.21.8.1250; OSULLIVAN JB, 1964, DIABETES, V13, P278; OSULLIVAN JB, 1984, CARBOHYD METABOL, V4, P287; PERSSON B, 1991, DIABETES, V40, P136, DOI 10.2337/diab.40.2.S136; Petersen M, 2003, DIABETES CARE, V26, P917; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Reunanen A, 2000, DIABETES CARE, V23, P1265, DOI 10.2337/diacare.23.9.1265; Stage E, 2004, DIABETES RES CLIN PR, V63, P67, DOI 10.1016/j.diabres.2003.08.009; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TERAMO K, 1996, NAISTENTAUDIT SYNNTY, P513; Vambergue A, 2008, DIABETIC MED, V25, P58, DOI 10.1111/j.1464-5491.2007.02306.x; W.H. Organization, 1999, DEFINITION DIAGNOSIS; *WHO, 1999, WHO TECHN REP SER, V727; *WHO, 1998, WHO TECHN REP SER, V727; World Health Organization, 1985, WHO TECHN REP SER, V727	52	2056	2135	10	240	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1773	1779		10.1016/S0140-6736(09)60731-5	http://dx.doi.org/10.1016/S0140-6736(09)60731-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465232				2022-12-28	WOS:000266337300032
J	Solberg, KE				Solberg, Kristin Elisabeth			Pakistan's refugee crisis raises health concerns	LANCET			English	Editorial Material																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 23	2009	373	9677					1750	1751		10.1016/S0140-6736(09)60966-1	http://dx.doi.org/10.1016/S0140-6736(09)60966-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19480061				2022-12-28	WOS:000266337300013
J	Bell, CM; Hatch, WV; Fischer, HD; Cernat, G; Paterson, JM; Gruneir, A; Gill, SS; Bronskill, SE; Anderson, GM; Rochon, PA				Bell, Chaim M.; Hatch, Wendy V.; Fischer, Hadas D.; Cernat, Geta; Paterson, J. Michael; Gruneir, Andrea; Gill, Sudeep S.; Bronskill, Susan E.; Anderson, Geoffrey M.; Rochon, Paula A.			Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FLOPPY-IRIS-SYNDROME; BENIGN PROSTATIC HYPERPLASIA; ALPHA(1)-ADRENERGIC RECEPTOR ANTAGONISTS; ACUTE ENDOPHTHALMITIS; CLINICAL-OUTCOMES; POPULATION; FLOMAX; POWER; RISK	Context Both benign prostatic hyperplasia (BPH) and cataract formation are common in older men. The alpha-adrenergic receptor blocker tamsulosin is frequently prescribed to treat BPH, and research suggests this drug may increase the intraoperative difficulty of cataract surgery. No studies have documented whether use of tamsulosin or other alpha-blocker drug therapies affect the risk of serious postoperative adverse events. Objective To assess the risk of adverse events following cataract surgery in older men prescribed tamsulosin or other alpha-blocking drugs used to treat BPH. Design, Setting, and Patients Nested case-control analysis of a population-based retrospective cohort study using linked health care databases from Ontario, Canada. We included all men aged 66 years or older who had cataract surgery between 2002 and 2007 (N=96 128). Main Outcome Measures A composite of procedures signifying retinal detachment, lost lens or lens fragment, or endophthalmitis occurring within 14 days after cataract surgery. The risk of these adverse events was compared between men treated with tamsulosin or other alpha-blockers and men with no exposure to these medications in the year prior to cataract surgery. We separately examined the association of drug exposure that was either recent ( within the 14 days before surgery) or previous (15-365 days before surgery). Results Overall, 3550 patients (3.7%) in the cohort had recent exposure to tamsulosin and 7426 patients (7.7%) had recent exposure to other alpha-blockers. Two hundred eighty-four patients (0.3%) had an adverse event. We randomly matched 280 of the cases to 1102 controls according to their age, surgeon, and year of surgery. Adverse events were significantly more common among patients with recent tamsulosin exposure (7.5% vs 2.7%; adjusted odds ratio [OR], 2.33; 95% confidence interval [CI], 1.22-4.43) but were not associated with recent exposure to other alpha-blockers (7.5% vs 8.0%; adjusted OR, 0.91; 95% CI, 0.54-1.54) or to previous exposure to either tamsulosin (<= 1.8% vs 1%; adjusted OR, 0.94; 95% CI, 0.27-3.34) or other alpha-blockers (2.9% vs 2.1%; adjusted OR, 1.08; 95% CI, 0.47-2.48). This corresponds to an estimated number needed to harm (NNH) of 255 (95% CI, 99-1666). Conclusions Exposure to tamsulosin within 14 days of cataract surgery was significantly associated with serious postoperative ophthalmic adverse events. There were no significant associations with exposure to other alpha-blocker medications used to treat BPH. JAMA. 2009;301(19):1991-1996 www.jama.com	[Bell, Chaim M.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.; Fischer, Hadas D.; Cernat, Geta; Paterson, J. Michael; Gruneir, Andrea; Gill, Sudeep S.; Bronskill, Susan E.; Anderson, Geoffrey M.; Rochon, Paula A.] Inst Clin Evaluat Sci0, Toronto, ON, Canada; [Bell, Chaim M.; Rochon, Paula A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.; Bronskill, Susan E.; Anderson, Geoffrey M.; Rochon, Paula A.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hatch, Wendy V.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Gruneir, Andrea; Rochon, Paula A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Gruneir, Andrea] Baycrest, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada; [Paterson, J. Michael] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Gill, Sudeep S.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Baycrest; McMaster University; Queens University - Canada	Bell, CM (corresponding author), St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	bellc@smh.toronto.on.ca	Bell, Chaim/C-4611-2015; Rochon, Paula A/J-2918-2016	Bell, Chaim/0000-0002-3778-9469; Rochon, Paula A/0000-0002-5973-4151	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes [OTG-88591]; Interdisciplinary Capacity Enhancement [HOA-80075]; CIHR Institute of Gender and Health; CIHR Institute of Aging; Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes(Canadian Institutes of Health Research (CIHR)); Interdisciplinary Capacity Enhancement; CIHR Institute of Gender and Health(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Aging(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by Team Grant OTG-88591 from the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes and by an Interdisciplinary Capacity Enhancement Grant, HOA-80075, from the CIHR Institute of Gender and Health and the CIHR Institute of Aging. Dr Bell is supported by a New Investigator Award from the CIHR Institute of Aging. This study was conducted at the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC).	Armitage JN, 2007, BRIT MED J, V335, P1199, DOI 10.1136/bmj.39377.617269.55; Bell CM, 2007, OPHTHALMOLOGY, V114, P405, DOI 10.1016/j.ophtha.2006.08.036; Bendel RE, 2006, J CATARACT REFR SURG, V32, P1603, DOI 10.1016/j.jcrs.2006.04.039; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Blouin MC, 2007, J CATARACT REFR SURG, V33, P1227, DOI 10.1016/j.jcrs.2007.03.032; *BOEHR ING, BOEHR ING ANN REP 20; *BOEHR ING, 2007, FLOM TAMS HYDR PACK; Cantrell MA, 2008, ANN PHARMACOTHER, V42, P558, DOI 10.1345/aph.1K679; Chadha V, 2007, BRIT J OPHTHALMOL, V91, P40, DOI 10.1136/bjo.2006.103036; Chang DF, 2007, OPHTHALMOLOGY, V114, P957, DOI 10.1016/j.ophtha.2007.01.011; Chang DF, 2005, J CATARACT REFR SURG, V31, P664, DOI 10.1016/j.jcrs.2005.02.027; Cheung CMG, 2007, AM J OPHTHALMOL, V143, P1070, DOI 10.1016/j.ajo.2007.02.044; Cheung CMG, 2006, J CATARACT REFR SURG, V32, P1336, DOI 10.1016/j.jcrs.2006.03.034; Desai P, 1999, BRIT J OPHTHALMOL, V83, P1336, DOI 10.1136/bjo.83.12.1336; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Gurbaxani A, 2007, EYE, V21, P331, DOI 10.1038/sj.eye.6702172; Habib MS, 2005, BRIT J OPHTHALMOL, V89, P1143, DOI 10.1136/bjo.2005.070235; Hatch WV, 2009, OPHTHALMOLOGY, V116, P425, DOI 10.1016/j.ophtha.2008.09.039; Lawrentschuk N, 2006, BJU INT, V97, P2, DOI 10.1111/j.1464-410X.2006.05960.x; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lundstrom M, 2002, ACTA OPHTHALMOL SCAN, V80, P248, DOI 10.1034/j.1600-0420.2002.800304.x; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Morlet N, 2003, BRIT J OPHTHALMOL, V87, P574, DOI 10.1136/bjo.87.5.574; Nguyen DQ, 2007, EYE, V21, P443, DOI 10.1038/sj.eye.6702616; Norregaard JC, 1999, OPHTHALMOLOGY, V106, P42, DOI 10.1016/S0161-6420(99)90004-0; Osher RH, 2006, J CATARACT REFR SURG, V32, P547, DOI 10.1016/j.jcrs.2006.01.008; Oshika T, 2007, AM J OPHTHALMOL, V143, P150, DOI 10.1016/j.ajo.2006.07.046; Parssinen O, 2006, INVEST OPHTH VIS SCI, V47, P3766, DOI 10.1167/iovs.06-0153; Riley AF, 2002, BRIT J OPHTHALMOL, V86, P185, DOI 10.1136/bjo.86.2.185; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schwinn DA, 2006, SURV OPHTHALMOL, V51, P501, DOI 10.1016/j.survophthal.2006.06.011; Srinivasan S, 2007, J CATARACT REFR SURG, V33, P1826, DOI 10.1016/j.jcrs.2007.06.033; Talamaz T, 2007, EUR J OPHTHALMOL, V17, P909; *THOMS, 2005, PHYS DESK REF; USCINOWICZ T, 2005, COMMUNICATION   1014; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141; Williams A, 2006, ARCH OPHTHALMOL-CHIC, V124, P1308, DOI 10.1001/archopht.124.9.1308; Williams J. I., 1996, PATTERNS HLTH CARE O, P339; Wong TY, 2004, OPHTHALMOLOGY, V111, P699, DOI 10.1016/j.ophtha.2003.07.014	40	81	84	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					1991	1996		10.1001/jama.2009.683	http://dx.doi.org/10.1001/jama.2009.683			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454637				2022-12-28	WOS:000266159600023
J	Johnstone, J				Johnstone, Jennie			Review: Pneumococcal vaccination is not effective for preventing pneumonia, bacteremia, bronchitis, or mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Johnstone, J (corresponding author), McMaster Univ, Hamilton, ON, Canada.							[Anonymous], MMWR; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3	5	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-4	10.7326/0003-4819-150-10-200905190-02004	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451560				2022-12-28	WOS:000266285300024
J	Ellis, P; Barrett-Lee, P; Johnson, L; Cameron, D; Wardley, A; O'Reilly, S; Verrill, M; Smith, I; Yarnold, J; Coleman, R; Earl, H; Canney, P; Twelves, C; Poole, C; Bloomfield, D; Hopwood, P; Johnston, S; Dowsett, M; Bartlett, JMS; Ellis, I; Peckitt, C; Hall, E; Bliss, JM				Ellis, Paul; Barrett-Lee, Peter; Johnson, Lindsay; Cameron, David; Wardley, Andrew; O'Reilly, Susan; Verrill, Mark; Smith, Ian; Yarnold, John; Coleman, Robert; Earl, Helena; Canney, Peter; Twelves, Chris; Poole, Christopher; Bloomfield, David; Hopwood, Penelope; Johnston, Stephen; Dowsett, Mitchell; Bartlett, John M. S.; Ellis, Ian; Peckitt, Clare; Hall, Emma; Bliss, Judith M.		TACT Trial Management Grp; TACT Trialists	Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial	LANCET			English	Article							DOXORUBICIN PLUS CYCLOPHOSPHAMIDE; FOLLOW-UP; EUROPEAN-ORGANIZATION; EPIRUBICIN; PACLITAXEL; FLUOROURACIL; EXPRESSION; RESISTANCE; THERAPY; BENEFIT	Background Incorporation of a taxane as adjuvant treatment for early breast cancer offers potential for further improvement of anthracycline-based treatment. The UK TACT study (CRUK01/001) investigated whether sequential docetaxel after anthracycline chemotherapy would improve patient outcome compared with standard chemotherapy of similar duration. Methods in this multicentre, open-label, phase III, randomised controlled trial, 4162 women (aged >18 years) with node-positive or high-risk node-negative operable early breast cancer were randomly assigned by computer-generated permuted block randomisation to receive FEC (fluorouracil 600 mg/m(2), epirubicin 60 mg/m(2), cyclophosphamide 600 mg/m(2) at 3-weekly intervals) for four cycles followed by docetaxel (100 mg/m(2) at 3-weekly intervals) for four cycles (n=2073) or control (n=2089). For the control regimen, centres chose either FEC for eight cycles (n=1265) or epirubicin (100 mg/m(2) at 3-weekly intervals) for four cycles followed by CMF (cyclophosphamide 600 mg/m(2), methotrexate 40 mg/m(2), and fluorouracil 600 mg/m(2) at 4-weekly intervals) for four cycles (n=824). The primary endpoint was disease-free survival. Analysis was by intention to treat (ITT). This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN79718493. Findings All randomised patients were included in the ITT population. With a median follow-up of 62 months, disease-free survival events were seen in 517 of 2073 patients in the experimental group compared with 539 of 2089 controls (hazard ratio [HR] 0.95, 95% CI 0.85-1.08; p=0.44). 75.6% (95% Cl 73.7-77.5) of patients in the experimental group and 74.3% (72.3-76.2) of controls were alive and disease-free at 5 years. The proportion of patients who reported any acute grade 3 or 4 adverse event was significantly greater in the experimental group than in the control group (p<0.0001); the most frequent events were neutropenia (937 events vs 797 events), leucopenia (507 vs 362), and lethargy (456 vs 272). Interpretation This study did not show any overall gain from the addition of docetaxel to standard anthracycline chemotherapy. Exploration of predictive biomarker-defined subgroups might have the potential to better target the use of taxane-based therapy.	[Ellis, Paul] Guys & St Thomas NHS Trust, London, England; [Barrett-Lee, Peter] Velindre NHS Trust, Cardiff, Wales; [Johnson, Lindsay; Peckitt, Clare; Hall, Emma; Bliss, Judith M.] Inst Canc Res, Sutton, Surrey, England; [Cameron, David] Univ Leeds, Leeds, W Yorkshire, England; [Wardley, Andrew; Hopwood, Penelope] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England; [O'Reilly, Susan] Clatterbridge Ctr Oncol, Bebington, England; [Verrill, Mark] Newcastle Upon Tyne Hosp NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Smith, Ian; Yarnold, John; Johnston, Stephen; Dowsett, Mitchell] Royal Marsden NHS Trust, London, England; [Smith, Ian; Yarnold, John; Johnston, Stephen; Dowsett, Mitchell] Royal Marsden NHS Trust, Sutton, Surrey, England; [Coleman, Robert] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Earl, Helena] Addenbrookes Hosp, Cambridge, England; [Canney, Peter] Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland; [Twelves, Chris] St James Univ Hosp, Leeds, W Yorkshire, England; [Poole, Christopher] Univ Warwick, Warwick, England; [Bloomfield, David] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; [Bartlett, John M. S.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Ellis, Ian] Nottingham Univ Hosp NHS Trust, Nottingham, England	Guy's & St Thomas' NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Leeds; Christie NHS Foundation Trust; Christie Hospital; Clatterbridge Cancer Centre; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Weston Park Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Beatson Oncology Centre; Saint James's University Hospital; University of Warwick; University of Brighton; University of Edinburgh; Nottingham University Hospital NHS Trust	Ellis, P (corresponding author), Guys Hosp, Dept Med Oncol, 4th Floor,Thomas Guy House, London SE1 9RT, England.	paul.ellis@gstt.nhs.uk	Wardley, Andrew Michael/GLU-5636-2022; Wardley, Andrew/N-8135-2015; Coleman, Robert/E-4346-2019; Cameron, David A/C-7781-2013; Perren, Timothy/D-5387-2013	Wardley, Andrew Michael/0000-0002-9639-0888; Wardley, Andrew/0000-0002-9639-0888; Cameron, David A/0000-0002-2717-7979; Hickish, Tamas/0000-0001-6770-7279; Verrill, Mark/0000-0002-8676-1120; Barrett-Lee, peter/0000-0002-6246-7357; Perren, Timothy/0000-0001-8472-8856; Ellis, Ian/0000-0001-5292-8474; Earl, Helena/0000-0003-1549-8094; Hall, Emma/0000-0001-5999-5020; Bliss, Judith/0000-0001-7957-7424	Cancer Research UK [CRUK 01/001]; Sanofi-Aventis; Pfizer; Roche	Cancer Research UK(Cancer Research UK); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Roche(Roche Holding)	The research costs of the TACT trial were met by Cancer Research UK (CRUK 01/001) and by educational grants from Sanofi-Aventis, Pfizer, and Roche. Trial recruitment was facilitated within centres by the NIHR-funded National Cancer Research Network. We thank all the patients Who Participated in this study, the doctors. nurses, radiographers, physicists, pathologists, and data managers at the participating centres, and the laboratory staff at Royal Marsden Hospital (London, UK), Nottingham City Hospital (Nottingham, UK), and Glasgow Royal Infirmary (Glasgow, UK). Recognition goes to all the trials unit staff at the Information & Statistics Division (ISD), Edinburgh (formerly SCTN), Cancer Trials & Research Unit (CTRU), Leeds. Wales Cancer Trials Network (WCTN), Cardiff, CRUK & UCL Cancer Trials Centre, London and The Institute of Cancer Research's Clinical Trials & Statistics Unit (ICR-CTSU), Sutton, who contributed to trial management and to data collection, with special thanks to M McLinden (ISD),) Copeland (CTRU Leeds), and A Yongue (ICR-CTSU). We would also like to thank the Independent Data Monitoring and Trial Steering Committees for their oversight of the trial and D Mills (ICR-CTSU) for helping to prepare the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Andre F, 2008, J CLIN ONCOL, V26, P2636, DOI 10.1200/JCO.2007.14.9146; Andre F, 2007, CLIN CANCER RES, V13, P2061, DOI 10.1158/1078-0432.CCR-06-2078; Bartlett J, 2009, CANCER RES, V69, P45; BIANCO AR, P AM SOC CLIN ON S18, V24; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; BURNELL MJ, 2007, P AN M AM SOC CLIN, V25, P550; CAMPBELL H, 2009, CANC RES, V69; Chang JC, 2008, BREAST CANCER RES TR, V108, P233, DOI 10.1007/s10549-007-9590-z; de Azambuja E, 2009, J CLIN ONCOL, V27, P720, DOI 10.1200/JCO.2008.17.2155; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; Dowsett M, 2003, J PATHOL, V199, P418, DOI 10.1002/path.1313; Ferguson T, 2007, COCHRANE DB SYST REV, V4; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Francis P, 2008, JNCI-J NATL CANCER I, V100, P121, DOI 10.1093/jnci/djm287; Fumoleau P, 2003, J CLIN ONCOL, V21, P298, DOI 10.1200/JCO.2003.04.148; Gianni L., 2005, J CLIN ONCOL, V23, P513; Goldstein LJ, 2008, J CLIN ONCOL, V26, P4092, DOI 10.1200/JCO.2008.16.7841; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hopwood P, 2008, EJC SUPPL, V6, P196, DOI 10.1016/S1359-6349(08)70806-1; HOPWOOD P, 2008, P AM SOC CLIN ON S15, V26; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; JOHNSON L, 2005, BRIT J CANCER, V92, P1697; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Mamounas EP, 2005, J CLIN ONCOL, V23, P3686, DOI 10.1200/JCO.2005.10.517; Martin M, 2008, ANN ONCOL, V19, P77; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Martin M, 2007, BREAST, V16, pS127, DOI 10.1016/j.breast.2007.09.001; Martin M, 2008, JNCI-J NATL CANCER I, V100, P805, DOI 10.1093/jnci/djn151; McCubrey JA, 2008, ADV ENZYME REGUL, V48, P113, DOI 10.1016/j.advenzreg.2008.02.006; Moore A, 2007, NEW ENGL J MED, V357, P1547, DOI 10.1056/NEJMe078153; National Cancer Institute, 1998, CANC THER EV PROGR C; *NORTHR GRUMM CORP, MEDDRA VERS 10 0; Poole CJ, 2006, NEW ENGL J MED, V355, P1851, DOI 10.1056/NEJMoa052084; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	141	142	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2009	373	9676					1681	1692		10.1016/S0140-6736(09)60740-6	http://dx.doi.org/10.1016/S0140-6736(09)60740-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RP	19447249	Green Published			2022-12-28	WOS:000266209800016
J	Lupp, C				Lupp, Claudia			MICROBIAL OCEANOGRAPHY	NATURE			English	Editorial Material																			0	1	1	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					179	179		10.1038/459179a	http://dx.doi.org/10.1038/459179a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445FR	19444202	Bronze			2022-12-28	WOS:000266036100026
J	Muss, HB; Berry, DA; Cirrincione, CT; Theodoulou, M; Mauer, AM; Kornblith, AB; Partridge, AH; Dressler, LG; Cohen, HJ; Becker, HP; Kartcheske, PA; Wheeler, JD; Perez, EA; Wolff, AC; Gralow, JR; Burstein, HJ; Mahmood, AA; Magrinat, G; Parker, BA; Hart, RD; Grenier, D; Norton, L; Hudis, CA; Winer, EP				Muss, Hyman B.; Berry, Donald A.; Cirrincione, Constance T.; Theodoulou, Maria; Mauer, Ann M.; Kornblith, Alice B.; Partridge, Ann H.; Dressler, Lynn G.; Cohen, Harvey J.; Becker, Heather P.; Kartcheske, Patricia A.; Wheeler, Judith D.; Perez, Edith A.; Wolff, Antonio C.; Gralow, Julie R.; Burstein, Harold J.; Mahmood, Ahmad A.; Magrinat, Gutav; Parker, Barbara A.; Hart, Ronald D.; Grenier, Debjani; Norton, Larry; Hudis, Clifford A.; Winer, Eric P.		CALGB Investigators	Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONSENSUS RECOMMENDATIONS; DOSE-INTENSITY; FOLLOW-UP; PHASE-II; THERAPY; SURVIVAL; CYCLOPHOSPHAMIDE; DOXORUBICIN; TRIAL; AGE	BACKGROUND Older women with breast cancer are underrepresented in clinical trials, and data on the effects of adjuvant chemotherapy in such patients are scant. We tested for the noninferiority of capecitabine as compared with standard chemotherapy in women with breast cancer who were 65 years of age or older. METHODS We randomly assigned patients with stage I, II, IIIA, or IIIB breast cancer to standard chemotherapy (either cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide plus doxorubicin) or capecitabine. Endocrine therapy was recommended after chemotherapy in patients with hormone-receptor-positive tumors. A Bayesian statistical design was used with a range in sample size from 600 to 1800 patients. The primary end point was relapse-free survival. RESULTS When the 600th patient was enrolled, the probability that, with longer follow-up, capecitabine therapy was highly likely to be inferior to standard chemotherapy met a prescribed level, and enrollment was discontinued. After an additional year of follow-up, the hazard ratio for disease recurrence or death in the capecitabine group was 2.09 (95% confidence interval, 1.38 to 3.17; P<0.001). Patients who were randomly assigned to capecitabine were twice as likely to have a relapse and almost twice as likely to die as patients who were randomly assigned to standard chemotherapy (P = 0.02). At 3 years, the rate of relapse-free survival was 68% in the capecitabine group versus 85% in the standard-chemotherapy group, and the overall survival rate was 86% versus 91%. Two patients in the capecitabine group died of treatment-related complications; as compared with patients receiving capecitabine, twice as many patients receiving standard chemotherapy had moderate-to-severe toxic effects (64% vs. 33%). CONCLUSIONS Standard adjuvant chemotherapy is superior to capecitabine in patients with early-stage breast cancer who are 65 years of age or older. (ClinicalTrials.gov number, NCT00024102.)	[Muss, Hyman B.] Univ Vermont, Burlington, VT 05405 USA; [Berry, Donald A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Cirrincione, Constance T.; Kartcheske, Patricia A.] Duke Univ, Med Ctr, Ctr Stat, CALGB, Durham, NC USA; [Theodoulou, Maria; Norton, Larry; Hudis, Clifford A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Mauer, Ann M.; Becker, Heather P.] CALGB, Chicago, IL USA; [Kornblith, Alice B.; Partridge, Ann H.; Cohen, Harvey J.; Winer, Eric P.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Muss, Hyman B.] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA; [Perez, Edith A.] N Cent Canc Treatment Grp, Rochester, MN USA; [Wolff, Antonio C.] Eastern Cooperat Oncol Grp, Philadelphia, PA USA; [Gralow, Julie R.] SW Oncol Grp, Ann Arbor, MI USA; [Magrinat, Gutav] SE Canc Control Consortium, Community Clin Oncol Program, Goldsboro, NC USA; [Parker, Barbara A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Hart, Ronald D.] Mt Sinai Sch Med, New York, NY USA; [Grenier, Debjani] Canadian Canc Soc Res Inst, Toronto, ON, Canada	University of Vermont; University of Texas System; UTMD Anderson Cancer Center; Duke University; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; Southwest Oncology Group; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Muss, HB (corresponding author), Univ N Carolina, Div Hematol Oncol, 170 Manning Dr,Campus Box 7305,3rd Fl, Chapel Hill, NC 27599 USA.	hyman.muss@gmail.com	Hudis, Clifford/AAW-9482-2021; Wolff, Antonio C./T-8796-2019	Hudis, Clifford/0000-0001-7144-8791; Wolff, Antonio C./0000-0003-3734-1063; Norton, Larry/0000-0003-3701-9250	NATIONAL CANCER INSTITUTE [U10CA085850, U10CA031946, U10CA033601] Funding Source: NIH RePORTER; NCI NIH HHS [CA33601, U10 CA033601-24, U10 CA033601, U10 CA085850, U10 CA031946, U10CA85850, CA31946, U10 CA031946-21, U10 CA085850-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P2356; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Blum JL, 1999, J CLIN ONCOL, V17, P485, DOI 10.1200/JCO.1999.17.2.485; Bonneterre J, 2005, J CLIN ONCOL, V23, P2686, DOI 10.1200/JCO.2005.05.059; Budman DR, 1998, J NATL CANCER I, V90, P1205, DOI 10.1093/jnci/90.16.1205; CHRISTMAN K, 1992, JAMA-J AM MED ASSOC, V268, P57, DOI 10.1001/jama.268.1.57; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; Eaker S, 2006, PLOS MED, V3, P321, DOI 10.1371/journal.pmed.0030025; Fargeot P, 2004, J CLIN ONCOL, V22, P4674, DOI 10.1200/JCO.2004.02.145; Fargeot P, 2005, J CLIN ONCOL, V23, P4238, DOI 10.1200/JCO.2005.01.2286; Fisher B, 2001, J CLIN ONCOL, V19, P931, DOI 10.1200/JCO.2001.19.4.931; FISHER B, 1990, J CLIN ONCOL, V8, P1483, DOI 10.1200/JCO.1990.8.9.1483; Gradishar W J, 2001, Oncology (Williston Park), V15, P69; Hebert-Croteau N, 1999, CANCER-AM CANCER SOC, V85, P1104, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1104::AID-CNCR14>3.0.CO;2-1; Hebert-Croteau N, 2004, J CLIN ONCOL, V22, P3685, DOI 10.1200/JCO.2004.07.018; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Ibrahim NK, 1996, ARCH INTERN MED, V156, P882, DOI 10.1001/archinte.156.8.882; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kemeny MM, 2003, J CLIN ONCOL, V21, P2268, DOI 10.1200/JCO.2003.09.124; KEMENY MM, 2004, J CLIN ONCOL, V22, P4811; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; Liu G, 1997, J CLIN ONCOL, V15, P110, DOI 10.1200/JCO.1997.15.1.110; Lyman GH, 2003, J CLIN ONCOL, V21, P4524, DOI 10.1200/JCO.2003.05.002; Muss HB, 2005, JAMA-J AM MED ASSOC, V293, P1073, DOI 10.1001/jama.293.9.1073; Muss HB, 2007, J CLIN ONCOL, V25, P3699, DOI 10.1200/JCO.2007.10.9710; *NAT CANC I, 2008, COMM TOX CRIT; O'Shaughnessy JA, 2001, ANN ONCOL, V12, P1247, DOI 10.1023/A:1012281104865; OReilly SM, 1998, P AM SOC CLIN ONCOLO, V17, p163A; PARTRIDGE AH, 2008, J CLIN ONCOL S, V26, pS347; Patt DA, 2007, J CLIN ONCOL, V25, P3871, DOI 10.1200/JCO.2007.12.0832; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Sateren WB, 2002, J CLIN ONCOL, V20, P2109, DOI 10.1200/JCO.2002.08.056; *SURV EP END RES, SURV EP END RES CANC; Wildiers H, 2007, LANCET ONCOL, V8, P1101, DOI 10.1016/S1470-2045(07)70378-9; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	40	387	401	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2055	2065		10.1056/NEJMoa0810266	http://dx.doi.org/10.1056/NEJMoa0810266			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439741	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000266011200004
J	Mccoy, D; Kembhavi, G; Patel, J; Luintel, A				McCoy, David; Kembhavi, Gayatri; Patel, Jinesh; Luintel, Akish			The Bill & Melinda Gates Foundation's grant-making programme for global health	LANCET			English	Article								The Bill & Melinda Gates Foundation is a major contributor to global health; its influence on international health policy and the design of global health programmes and initiatives is profound. Although the foundation's contribution to global health generally receives acclaim, fairly little is known about its grant-making programme. We undertook an analysis of 1094 global health grants awarded between January 1998, and December, 2007. We found that the total value of these grants was USS8.95 billion, of which $5.82 billion (65%) was shared by only 20 organisations. Nevertheless, a wide range of global health organisations, such as WHO, the GAVI Alliance, the World Bank, the Global Fund to Fight AIDS, Tuberculosis and Malaria, prominent universities, and non-governmental organisations received grants. $3.62 billion (40% of all funding) was given to supranational organisations. Of the remaining amount, 82% went to recipients based in the USA. just over a third ($3.27 billion) of funding was allocated to research and development (mainly for vaccines and microbicides), or to basic science research. The findings of this report raise several questions about the foundation's global health grant-making programme, which needs further research and assessment.	[McCoy, David; Kembhavi, Gayatri] Ctr Int Hlth & Dev, London WC1N 1EH, England; [Patel, Jinesh; Luintel, Akish] UCL, London, England	University of London; University College London; University of London; University College London	Mccoy, D (corresponding author), Ctr Int Hlth & Dev, 30 Guilford St, London WC1N 1EH, England.	d.mccoy@ucl.ac.uk						*BILL M GAT FDN, FDN FACT SHEET; *BILL M GAT FDN, ANN REP 2007 BILL M; CERRELL J, 2007, FINANCE DEV, V44; Damon A., 2007, GATES FDN RISE FREE, P22; Edwards M., 2008, JUST ANOTHER EMPEROR; FLEISHMANN JL, 2007, FDN GREAT AM SECRET; *GAT FDN, BILL M GAT FDN TAX R; Gates Bill, 2009 ANN LETT B GATE; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; MARTEN R, 2008, TRANSFORMING DEV ROL, P1; MCCOY D, HLTH POLICY IN PRESS; MCCOY D, 2008, GLOBAL HLTH WATCH, V2, P240; MCNEIL DG, 2008, NY TIMES        0304; MCNEIL DG, 2008, NY TIMES        0216; MORAN M, 2009, NEGLECTED DIS RES DE; *PATH, FIN; PILLER C, 2007, LOS ANGELES TIM 0107; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; RENZ L, 2006, INT GRANTMAKING UPDA; Rockefeller Foundation, 2007, SMART GLOB BEN MOR P; Sridhar D, 2008, LANCET, V372, P1185, DOI 10.1016/S0140-6736(08)61485-3; Walt G, 2000, TROP MED INT HEALTH, V5, P467, DOI 10.1046/j.1365-3156.2000.00596.x; *WHO, INF M GLOB HLTH LEAD; World Health Organization, 2004, GLOB BURD DIS 2004 U	24	158	160	0	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1645	1653		10.1016/S0140-6736(09)60571-7	http://dx.doi.org/10.1016/S0140-6736(09)60571-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445QJ	19427959				2022-12-28	WOS:000266066300035
J	Raya, A; Rodriguez-Piza, I; Guenechea, G; Vassena, R; Navarro, S; Barrero, MJ; Consiglio, A; Castella, M; Rio, P; Sleep, E; Gonzalez, F; Tiscornia, G; Garreta, E; Aasen, T; Veiga, A; Verma, IM; Surralles, J; Bueren, J; Belmonte, JCI				Raya, Angel; Rodriguez-Piza, Ignasi; Guenechea, Guillermo; Vassena, Rita; Navarro, Susana; Jose Barrero, Maria; Consiglio, Antonella; Castella, Maria; Rio, Paula; Sleep, Eduard; Gonzalez, Federico; Tiscornia, Gustavo; Garreta, Elena; Aasen, Trond; Veiga, Anna; Verma, Inder M.; Surralles, Jordi; Bueren, Juan; Izpisua Belmonte, Juan Carlos			Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells	NATURE			English	Article							LENTIVIRAL VECTORS; GENE-THERAPY; GENERATION; MOUSE; EFFICIENT; FIBROBLASTS; MOSAICISM; PROMOTER; FANCD2; DAMAGE	The generation of induced pluripotent stem (iPS) cells has enabled the derivation of patient-specific pluripotent cells and provided valuable experimental platforms to model human disease. Patient-specific iPS cells are also thought to hold great therapeutic potential, although direct evidence for this is still lacking. Here we show that, on correction of the genetic defect, somatic cells from Fanconi anaemia patients can be reprogrammed to pluripotency to generate patient-specific iPS cells. These cell lines appear indistinguishable from human embryonic stem cells and iPS cells from healthy individuals. Most importantly, we show that corrected Fanconi-anaemia-specific iPS cells can give rise to haematopoietic progenitors of the myeloid and erythroid lineages that are phenotypically normal, that is, disease-free. These data offer proof-of-concept that iPS cell technology can be used for the generation of disease-corrected, patient-specific cells with potential value for cell therapy applications.	[Raya, Angel; Rodriguez-Piza, Ignasi; Navarro, Susana; Jose Barrero, Maria; Sleep, Eduard; Gonzalez, Federico; Tiscornia, Gustavo; Garreta, Elena; Aasen, Trond; Veiga, Anna; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Raya, Angel] ICREA, Madrid 28040, Spain; [Raya, Angel; Sleep, Eduard; Garreta, Elena; Aasen, Trond] Networking Ctr Biomed Res Bioengn Biomat & Nanome, Madrid 28040, Spain; [Guenechea, Guillermo; Navarro, Susana; Rio, Paula; Bueren, Juan] CIEMAT, Hematopoiesis & Gene Therapy Div, E-28040 Madrid, Spain; [Guenechea, Guillermo; Navarro, Susana; Castella, Maria; Rio, Paula; Surralles, Jordi; Bueren, Juan] Networking Ctr Biomed Res Rare Dis CIBERER, I-25123 Brescia, Italy; [Consiglio, Antonella] Univ Brescia, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; [Castella, Maria; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra 08193, Spain; [Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; ICREA; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; University of Brescia; Autonomous University of Barcelona; Salk Institute; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader 88, Barcelona 08003, Spain.	belmonte@salk.edu	Castella, Maria/J-8304-2015; Navarro, Susana/L-9300-2014; Aasen, Trond/B-5279-2013; consiglio, antonella/G-1815-2016; Barrero, Maria J./Q-1785-2017; Rio, Paula/G-8681-2015; consiglio, antonella/AAA-5864-2019; Guenechea, Guillermo/L-6119-2014; Garreta, Elena/AAQ-4739-2020; Tiscornia, Gustavo/F-4423-2012; Bueren, Juan/L-6112-2014; Raya, Angel/E-6205-2010; Surrallés, Jordi/AAE-7667-2020	Navarro, Susana/0000-0002-0764-5384; Aasen, Trond/0000-0003-0763-2695; consiglio, antonella/0000-0002-3988-6254; Barrero, Maria J./0000-0002-5990-7040; Rio, Paula/0000-0002-5424-5543; consiglio, antonella/0000-0002-3988-6254; Guenechea, Guillermo/0000-0001-7679-0895; Garreta, Elena/0000-0002-1071-9794; Bueren, Juan/0000-0002-3228-7013; Raya, Angel/0000-0003-2189-9775; Veiga, Anna/0000-0002-0943-9904; Surralles, Jordi/0000-0002-4041-7519; Tiscornia, Gustavo/0000-0002-1841-5330; Vassena, Rita/0000-0002-0846-0365; Gonzalez Grassi, Federico/0000-0002-7147-2246	MEC; DIUE; Ramon y Cajal program; ICREA-Academia program; Ministerio de Educacion y Ciencia [BFU2006-12251, SAF2005-00058, SAF2006-3440]; Genoma Espana (FANCOGENE); European Commission 'Marie-Curie Reintegration Grant' [MIRG-CT-2007-046523]; European Program CONSERT [LSHB-CT-2004-5242]; Fondo de Investigaciones Sanitarias [RETIC-RD06/0010/0016, PI061897, PI061099]; Marato de TV3 [063430]; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Marcelino Botin; Fundacion Cellex; ICREA Funding Source: Custom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER	MEC(European Commission); DIUE; Ramon y Cajal program(Spanish Government); ICREA-Academia program(ICREA); Ministerio de Educacion y Ciencia(Spanish Government); Genoma Espana (FANCOGENE); European Commission 'Marie-Curie Reintegration Grant'(European CommissionEuropean Commission Joint Research Centre); European Program CONSERT; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Marato de TV3; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Marcelino Botin; Fundacion Cellex(Foundation CELLEX); ICREA(ICREA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are indebted to FA patients and their families for their cooperation. We are grateful to I. Badell, J. Couselo, A. Almeida and D. Schindler for collaboration in providing samples from FA patients, J. A. Casado for subtyping studies, M. Edel, J. Bilic, V. Pekarik and members of the laboratory for comments on the manuscript, J. M. Andres-Vaquero for assistance with flow cytometry, R. Pujol for assistance with cytogenetics, M. J. Ramirez for immunofluorescence studies, B. Aran, M. Carrio and Y. Munoz for assistance with cell culture techniques, E. Melo, L. Mulero and M. Marti for bioimaging assistance, and Y. Richaud, T. Lopez Rovira and M. L. Lozano for technical assistance. I. R.-P. and E. S. were recipients of pre-doctoral fellowships from MEC and DIUE, respectively. M. J. B. and G. T. were partially supported by the Ramon y Cajal program, and J. S. by the ICREA-Academia program. This work was partially supported by the Ministerio de Educacion y Ciencia grants BFU2006-12251, SAF2005-00058, SAF2006-3440, and Genoma Espana (FANCOGENE), European Commission 'Marie-Curie Reintegration Grant' MIRG-CT-2007-046523 and European Program CONSERT LSHB-CT-2004-5242, the Fondo de Investigaciones Sanitarias (RETIC-RD06/0010/0016, PI061897, PI061099), Marato de TV3 (063430), the G. Harold and Leila Y. Mathers Charitable Foundation, Fundacion Marcelino Botin, and Fundacion Cellex.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Almarza E, 2007, MOL THER, V15, P1487, DOI 10.1038/sj.mt.6300213; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Casado JA, 2007, J MED GENET, V44, P241, DOI 10.1136/jmg.2006.044719; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Gonzalez-Murillo A, 2008, BLOOD, V112, P3138, DOI 10.1182/blood-2008-03-142661; Gregory JJ, 2001, P NATL ACAD SCI USA, V98, P2532, DOI 10.1073/pnas.051609898; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Guardiola P, 2000, BLOOD, V95, P422; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; JACOME A, MOL THER IN PRESS; Ji JF, 2008, STEM CELLS, V26, P2485, DOI 10.1634/stemcells.2008-0642; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kelly PF, 2007, MOL THER, V15, P211, DOI 10.1038/sj.mt.6300033; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Larghero J, 2002, BLOOD, V100, P3051, DOI 10.1182/blood-2002-07-2069; Liu JM, 1999, HUM GENE THER, V10, P2337, DOI 10.1089/10430349950016988; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; RAYA A, COLD SPRING IN PRESS; Rio P, 2008, BLOOD, V112, P4853, DOI 10.1182/blood-2008-05-156356; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wagner JE, 2007, BLOOD, V109, P2256, DOI 10.1182/blood-2006-07-036657; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	48	529	567	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					53	U61		10.1038/nature08129	http://dx.doi.org/10.1038/nature08129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19483674	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000267545200028
J	Hirschfield, GM; Liu, XD; Xu, C; Lu, Y; Xie, G; Lu, Y; Gu, XJ; Walker, EJ; Jing, KY; Juran, BD; Mason, AL; Myers, RP; Peltekian, KM; Ghent, CN; Coltescu, C; Atkinson, EJ; Heathcote, EJ; Lazaridis, KN; Amos, CI; Siminovitch, KA				Hirschfield, Gideon M.; Liu, Xiangdong; Xu, Chun; Lu, Yue; Xie, Gang; Lu, Yan; Gu, Xiangjun; Walker, Erin J.; Jing, Kaiyan; Juran, Brian D.; Mason, Andrew L.; Myers, Robert P.; Peltekian, Kevork M.; Ghent, Cameron N.; Coltescu, Catalina; Atkinson, Elizabeth J.; Heathcote, E. Jenny; Lazaridis, Konstantinos N.; Amos, Christopher I.; Siminovitch, Katherine A.			Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIMITOCHONDRIAL ANTIBODIES; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCUS; ULCERATIVE-COLITIS; LARGE-SCALE; DISEASE; GENE; POPULATION	BACKGROUND Primary biliary cirrhosis is a chronic granulomatous cholangitis, characteristically associated with antimitochondrial antibodies. Twin and family aggregation data suggest that there is a significant genetic predisposition to primary biliary cirrhosis, but the susceptibility loci are unknown. METHODS To identify genetic loci conferring a risk for primary biliary cirrhosis, we carried out a genomewide association analysis in which DNA samples from 2072 Canadian and U. S. subjects (536 patients with primary biliary cirrhosis and 1536 controls) were genotyped for more than 300,000 single-nucleotide polymorphisms (SNPs). Sixteen of the SNPs most strongly associated with primary biliary cirrhosis were genotyped in two independent replication sets. We carried out fine-mapping studies across three loci associated with primary biliary cirrhosis. RESULTS We found significant associations between primary biliary cirrhosis and 13 loci across the HLA class II region; the HLA-DQB1 locus (encoding the major histocompatibility complex class II, DQ beta chain 1) had the strongest association (P = 1.78x10(-19); odds ratio for patients vs. controls, 1.75). Primary biliary cirrhosis was also significantly and reproducibly associated with two SNPs at the IL12A locus (encoding interleukin-12 alpha), rs6441286 (P = 2.42x10(-14); odds ratio, 1.54) and rs574808 (P = 1.88x10(-13); odds ratio, 1.54), and one SNP at the IL12RB2 locus (encoding interleukin-12 receptor beta 2), rs3790567 (P = 2.76x10(-11); odds ratio, 1.51). Fine-mapping analysis showed that a five-allele haplotype in the 3' flank of IL12A was significantly associated with primary biliary cirrhosis (P = 1.15x10(-34)). We found a modest genomewide association (P<5.0x10(-5)) with the risk of disease for SNPs at the STAT4 locus (encoding signal transducer and activator of transcription 4) and the CTLA4 locus (encoding cytotoxic T-lymphocyte-associated protein 4) and 10 other loci. CONCLUSIONS Our data show significant associations between primary biliary cirrhosis and common genetic variants at the HLA class II, IL12A, and IL12RB2 loci and suggest that the interleukin-12 immunoregulatory signaling axis is relevant to the pathophysiology of primary biliary cirrhosis. (ClinicalTrials.gov number, NCT00242125.)	[Hirschfield, Gideon M.; Liu, Xiangdong; Xu, Chun; Xie, Gang; Lu, Yan; Walker, Erin J.; Heathcote, E. Jenny; Siminovitch, Katherine A.] Univ Toronto, Toronto, ON, Canada; [Hirschfield, Gideon M.; Coltescu, Catalina; Heathcote, E. Jenny] Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Mason, Andrew L.] Univ Alberta, Edmonton, AB, Canada; [Myers, Robert P.] Univ Calgary, Calgary, AB, Canada; [Peltekian, Kevork M.] Dalhousie Univ, Halifax, NS, Canada; [Ghent, Cameron N.] London Hlth Sci Ctr, London, ON, Canada; [Lu, Yue; Gu, Xiangjun; Jing, Kaiyan; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Juran, Brian D.; Atkinson, Elizabeth J.; Lazaridis, Konstantinos N.] Mayo Clin, Coll Med, Rochester, MN USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alberta; University of Calgary; Dalhousie University; London Health Sciences Centre; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic	Siminovitch, KA (corresponding author), Mt Sinai Hosp, 600 Univ Ave,Room 778D, Toronto, ON M5G 1X5, Canada.	ksimin@mshri.on.ca	Peltekian, Kevork M/D-1083-2010; Walker, Erin J/H-5302-2013; Hirschfield, Gideon M/M-2143-2015; Siminovitch, Katherine/K-1475-2013; Mason, Andrew/D-2938-2013	Peltekian, Kevork M/0000-0002-9560-5576; Walker, Erin J/0000-0001-8476-7302; Hirschfield, Gideon M/0000-0002-6736-2255; Mason, Andrew/0000-0002-0470-9522	McLaughlin Centre for Molecular Medicine; Canada Research Chair award; Sherman Family Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK078527, R01DK080670, K23DK068290] Funding Source: NIH RePORTER	McLaughlin Centre for Molecular Medicine; Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Sherman Family Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	support from the Immunogenomics Program of the McLaughlin Centre for Molecular Medicine, from a Canada Research Chair award, and from the Sherman Family Foundation. No other potential conflict of interest relevant to this article was reported.	Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Donaldson P, 2007, CLIN GASTROENTEROL H, V5, P755, DOI 10.1016/j.cgh.2007.02.012; Donaldson PT, 2006, HEPATOLOGY, V44, P667, DOI 10.1002/hep.21316; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Filipe-Santos O, 2007, SEMIN IMMUNOL, V19, P136, DOI 10.1016/j.smim.2007.02.002; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gershwin ME, 2008, HEPATOLOGY, V47, P737, DOI 10.1002/hep.22042; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Invernizzi P, 2005, CLIN GASTROENTEROL H, V3, P401, DOI 10.1016/S1542-3565(04)00678-0; Invernizzi P, 2008, HEPATOLOGY, V48, P1906, DOI 10.1002/hep.22567; Irie J, 2006, J EXP MED, V203, P1209, DOI 10.1084/jem.20051911; Jones DEJ, 1999, J HEPATOL, V30, P402, DOI 10.1016/S0168-8278(99)80097-X; Juran BD, 2008, GASTROENTEROLOGY, V135, P1200, DOI 10.1053/j.gastro.2008.06.077; Kaplan MM, 2006, NEW ENGL J MED, V354, P313; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Lazaridis KN, 2007, HEPATOLOGY, V46, P785, DOI 10.1002/hep.21749; Mochida A, 2007, TISSUE ANTIGENS, V70, P128, DOI 10.1111/j.1399-0039.2007.00866.x; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; POUPON RE, 1994, NEW ENGL J MED, V330, P1342, DOI 10.1056/NEJM199405123301903; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pulickal AS, 2008, J TROP PEDIATRICS, V54, P269, DOI 10.1093/tropej/fmm119; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Traherne JA, 2006, HUM MOL GENET, V15, P155, DOI 10.1093/hmg/ddi436; Valentonyte R, 2005, NAT GENET, V37, P652, DOI 10.1038/ng0605-652a; Wakabayashi K, 2006, HEPATOLOGY, V44, P1240, DOI 10.1002/hep.21385; Walker EJ, 2009, ARTHRITIS RHEUM-US, V60, P931, DOI 10.1002/art.24412; Watt FE, 2004, QJM-INT J MED, V97, P397, DOI 10.1093/qjmed/hch078	41	458	477	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2544	2555		10.1056/NEJMoa0810440	http://dx.doi.org/10.1056/NEJMoa0810440			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19458352	Green Accepted			2022-12-28	WOS:000266813800009
J	Rubin, EJ				Rubin, Eric J.			The Granuloma in Tuberculosis - Friend or Foe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Rubin, Eric/0000-0001-5120-962X				Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072	4	38	40	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2009	360	23					2471	2473		10.1056/NEJMcibr0902539	http://dx.doi.org/10.1056/NEJMcibr0902539			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453DN	19494225				2022-12-28	WOS:000266590500017
J	Welsh, RM; Selin, LK				Welsh, Raymond M.; Selin, Liisa K.			Attrition of memory CD8 T cells	NATURE			English	Letter							VIRAL-INFECTIONS; INTERFERON; DEPLETION; RESPONSES; IMMUNITY; ANTIGEN; EROSION		[Welsh, Raymond M.; Selin, Liisa K.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Welsh, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	raymond.welsh@umassmed.edu		Selin, Liisa/0000-0002-6993-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017672, R01AI081675] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI081675, R01 AI081675-26, R01 AI017672-24, R01 AI017672] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bahl K, 2006, J IMMUNOL, V176, P4284, DOI 10.4049/jimmunol.176.7.4284; Dudani R, 2008, J IMMUNOL, V181, P1700, DOI 10.4049/jimmunol.181.3.1700; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Jiang J, 2005, J IMMUNOL, V175, P1820, DOI 10.4049/jimmunol.175.3.1820; Jiang J, 2003, J IMMUNOL, V171, P4352, DOI 10.4049/jimmunol.171.8.4352; Kim SK, 2004, J IMMUNOL, V172, P3139, DOI 10.4049/jimmunol.172.5.3139; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Smith DK, 2002, J IMMUNOL, V169, P1197, DOI 10.4049/jimmunol.169.3.1197; Varga SM, 2001, J IMMUNOL, V166, P1554, DOI 10.4049/jimmunol.166.3.1554; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486	12	20	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 4	2009	459	7247					E3	E4		10.1038/nature08091	http://dx.doi.org/10.1038/nature08091			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19494857	Green Accepted			2022-12-28	WOS:000266608600032
J	Sargent, JD; Heatherton, TF				Sargent, James D.; Heatherton, Todd F.			Comparison of Trends for Adolescent Smoking and Smoking in Movies, 1990-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VIEWING SMOKING; INITIATION		[Sargent, James D.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03756 USA; [Heatherton, Todd F.] Dartmouth Coll, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Sargent, JD (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03756 USA.	james.d.sargent@dartmouth.edu	Heatherton, Todd F/H-5478-2011; Sargent, James D/I-2773-2013		NCI NIH HHS [R01 CA077026-12, R01 CA077026, CA-77026] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077026] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dalton MA, 2003, LANCET, V362, P281, DOI 10.1016/S0140-6736(03)13970-0; National Cancer Institute, 2008, TOB CONTR MON, V19; Titus-Ernstoff L, 2008, PEDIATRICS, V121, P15, DOI 10.1542/peds.2007-0051; TRENDS PREVALENCE US	5	25	27	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2211	2213		10.1001/jama.2009.745	http://dx.doi.org/10.1001/jama.2009.745			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	452PQ	19491181	Bronze, Green Accepted			2022-12-28	WOS:000266554100017
J	Behrens, TEJ; Hunt, LT; Rushworth, MFS				Behrens, Timothy E. J.; Hunt, Laurence T.; Rushworth, Matthew F. S.			The Computation of Social Behavior	SCIENCE			English	Review							DECISION-MAKING; NEURAL CIRCUITRY; CORTEX; TRUST; PREDICTION; MECHANISMS; BRAIN	Neuroscientists are beginning to advance explanations of social behavior in terms of underlying brain mechanisms. Two distinct networks of brain regions have come to the fore. The first involves brain regions that are concerned with learning about reward and reinforcement. These same reward-related brain areas also mediate preferences that are social in nature even when no direct reward is expected. The second network focuses on regions active when a person must make estimates of another person's intentions. However, it has been difficult to determine the precise roles of individual brain regions within these networks or how activities in the two networks relate to one another. Some recent studies of reward-guided behavior have described brain activity in terms of formal mathematical models; these models can be extended to describe mechanisms that underlie complex social exchange. Such a mathematical formalism defines explicit mechanistic hypotheses about internal computations underlying regional brain activity, provides a framework in which to relate different types of activity and understand their contributions to behavior, and prescribes strategies for performing experiments under strong control.	[Behrens, Timothy E. J.] John Radcliffe Hosp, Oxford Ctr Funct MRI Brain FMRIB Ctr, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Behrens, TEJ (corresponding author), John Radcliffe Hosp, Oxford Ctr Funct MRI Brain FMRIB Ctr, Oxford OX3 9DU, England.	behrens@fmrib.ox.ac.uk; lhunt@fmrib.ox.ac.uk; matthew.rushworth@psy.ox.ac.uk	Hunt, Laurence/ABA-1691-2021	Hunt, Laurence/0000-0002-8393-8533; Rushworth, Matthew/0000-0002-5578-9884; Behrens, Timothy/0000-0003-0048-1177	UK Medical Research Council; Wellcome Trust; Medical Research Council [G0600994, G0700399, G0501316] Funding Source: researchfish; MRC [G0600994, G0501316, G0700399] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the UK Medical Research Council (T.E.J.B., M.F.S.R.) and the Wellcome Trust (L.T.H.).	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Corrado G, 2007, J NEUROSCI, V27, P8178, DOI 10.1523/JNEUROSCI.1590-07.2007; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Holekamp KE, 2007, PHILOS T R SOC B, V362, P523, DOI 10.1098/rstb.2006.1993; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Ramnani N, 2004, NAT NEUROSCI, V7, P85, DOI 10.1038/nn1168; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; ROLLS ET, 1999, BRAIN EMOTION; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2008, PHILOS T R SOC B, V363, P3845, DOI 10.1098/rstb.2008.0158; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; VANHOESEN GW, 1993, NEUROBIOLOGY CINGULA; Yoshida W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000254	37	296	298	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1160	1164		10.1126/science.1169694	http://dx.doi.org/10.1126/science.1169694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19478175				2022-12-28	WOS:000266410100034
J	Moncrieff, J; Cohen, D				Moncrieff, Joanna; Cohen, David			How do psychiatric drugs work?	BRITISH MEDICAL JOURNAL			English	Editorial Material							SCHIZOPHRENIA; SSRIS		[Moncrieff, Joanna] UCL, Dept Psychiat & Behav Sci, London W1N 8AA, England; [Cohen, David] Florida Int Univ, Sch Social Work, Miami, FL 33199 USA	University of London; University College London; State University System of Florida; Florida International University	Moncrieff, J (corresponding author), UCL, Dept Psychiat & Behav Sci, Mortimer St, London W1N 8AA, England.	j.moncrieff@ucl.ac.uk						ABSE DW, 1960, AM J PSYCHIAT, V116, P973, DOI 10.1176/ajp.116.11.973; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1038/nrdp.2016.65; Cohen D., 1997, PLACEBO PANACEA PUTT, P173; Cohen D., 2007, DEBATES NEUROSCIENCE, V1, P44; DENIKER P, 1960, COMPR PSYCHIAT, V1, P92, DOI 10.1016/S0010-440X(60)80013-2; Dumont GJH, 2005, BRIT J CLIN PHARMACO, V59, P495, DOI 10.1111/j.1365-2125.2005.02342.x; HEALY D, 1989, J ROY SOC MED, V82, P615, DOI 10.1177/014107688908201018; Jacobs D., 1999, INT J RISK SAFETY ME, V12, P37; JOHNSON RH, 1988, VET MICROBIOL, V16, P25, DOI 10.1016/0378-1135(88)90124-1; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Mizrahi R, 2005, PROG NEURO-PSYCHOPH, V29, P859, DOI 10.1016/j.pnpbp.2005.03.001; Moncrieff J, 2005, BMJ-BRIT MED J, V331, P155, DOI 10.1136/bmj.331.7509.155; Moncrieff J, 1997, BRIT J PSYCHIAT, V171, P113, DOI 10.1192/bjp.171.2.113; Moncrieff J., 2008, MYTH CHEM CURE CRITI; MONCRIEFF J, HARV REV PS IN PRESS; MONCRIEFF J, 2009, ACTA PSYCHIAT S 0212; Opbroek A, 2002, INT J NEUROPSYCHOPH, V5, P147, DOI 10.1017/S1461145702002870; PRIEN RF, 1972, ARCH GEN PSYCHIAT, V26, P146; WOLKOWITZ OM, 1991, AM J PSYCHIAT, V148, P714	19	25	26	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 29	2009	338								b1963	10.1136/bmj.b1963	http://dx.doi.org/10.1136/bmj.b1963			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WV	19482870	Green Published, Green Submitted			2022-12-28	WOS:000266502500002
J	Palfreyman, MT				Palfreyman, Mark T.			With Happyhour, Everyone's Under the Table	CELL			English	Editorial Material									Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Palfreyman, MT (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	markthomas.palfreyman@imp.ac.at						Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Johnson D A, 1980, Adv Exp Med Biol, V126, P65; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Mulholland PJ, 2009, ALCOHOL CLIN EXP RES, V33, P1125, DOI 10.1111/j.1530-0277.2009.00936.x; Scholz H, 2009, J NEUROGENET, V23, P111, DOI 10.1080/01677060802471676; Wolf FW, 2002, J NEUROSCI, V22, P11035	9	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					802	804		10.1016/j.cell.2009.05.016	http://dx.doi.org/10.1016/j.cell.2009.05.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19490888	Bronze			2022-12-28	WOS:000266454800010
J	Smolke, CD				Smolke, Christina D.			It's the DNA That Counts	SCIENCE			English	Editorial Material							INVERSION RECOMBINATION SWITCH; GENE-EXPRESSION; CELLS; CONSTRUCTION; DEVICES; DESIGN; MEMORY		Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Smolke, CD (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	csmolke@stanford.edu						Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Swinburne IA, 2008, GENE DEV, V22, P2342, DOI 10.1101/gad.1696108; Weber W, 2007, BIOTECHNOL BIOENG, V98, P894, DOI 10.1002/bit.21463; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011	15	5	12	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 29	2009	324	5931					1156	1157		10.1126/science.1174843	http://dx.doi.org/10.1126/science.1174843			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	450OG	19478174				2022-12-28	WOS:000266410100033
J	Kim, M; Ogawa, M; Fujita, Y; Yoshikawa, Y; Nagai, T; Koyama, T; Nagai, S; Lange, A; Fassler, R; Sasakawa, C				Kim, Minsoo; Ogawa, Michinaga; Fujita, Yukihiro; Yoshikawa, Yuko; Nagai, Takeshi; Koyama, Tomohiro; Nagai, Shinya; Lange, Anika; Faessler, Reinhard; Sasakawa, Chihiro			Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment	NATURE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI; SHIGELLA-FLEXNERI; PROTEIN-KINASE; ILK; PATHOGENICITY; REPERTOIRE; EXPRESSION; MECHANISM; VIRULENCE	The rapid turnover and exfoliation of mucosal epithelial cells provides an innate defence system against bacterial infection(1,2). Nevertheless, many pathogenic bacteria, including Shigella, are able to surmount exfoliation and colonize the epithelium efficiently(3,4). Here we show that the Shigella flexneri effector OspE(5,6) (consisting of OspE1 and OspE2 proteins), which is highly conserved among enteropathogenic Escherichia coli, enterohaemorrhagic E. coli, Citrobacter rodentium and Salmonella strains(7), reinforces host cell adherence to the basement membrane by interacting with integrin-linked kinase (ILK)(8). The number of focal adhesions was augmented along with membrane fraction ILK by ILK-OspE binding. The interaction between ILK and OspE increased cell surface levels of beta 1 integrin and suppressed phosphorylation of focal adhesion kinase and paxillin, which are required for rapid turnover of focal adhesion in cell motility(9). Nocodazole-washout-induced focal adhesion disassembly was blocked by expression of OspE. Polarized epithelial cells infected with a Shigella mutant lacking the ospE gene underwent more rapid cell detachment than cells infected with wild-type Shigella. Infection of guinea pig colons with Shigella corroborated the pivotal role of the OspE-ILK interaction in suppressing epithelial detachment, increasing bacterial cell-to-cell spreading, and promoting bacterial colonization. These results indicate that Shigella sustain their infectious foothold by using special tactics to prevent detachment of infected cells.	[Kim, Minsoo; Sasakawa, Chihiro] Univ Tokyo, Int Res Ctr Infect Dis, Dept Infect Dis Control, Minato Ku, Tokyo 1088639, Japan; [Ogawa, Michinaga; Fujita, Yukihiro; Yoshikawa, Yuko; Nagai, Takeshi; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan; [Kim, Minsoo; Ogawa, Michinaga; Fujita, Yukihiro; Yoshikawa, Yuko; Nagai, Takeshi; Sasakawa, Chihiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Koyama, Tomohiro; Nagai, Shinya] Nippon Inst Biol Sci, Tokyo 1980024, Japan; [Lange, Anika; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82151 Martinsried, Germany	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Max Planck Society	Sasakawa, C (corresponding author), Univ Tokyo, Int Res Ctr Infect Dis, Dept Infect Dis Control, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp		Kim, Minsoo/0000-0001-8536-8653	Deutsche Forschungsgemeinschaft [SFB576]; Max Planck Society; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science and Technology Agency (JSTA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JSTA)(Japan Science & Technology Agency (JST))	We thank S. Ohmi, H. Fukuda and C. Takamura for MALDI-TOF analysis. We thank S. Yamaji and Y. Ishigatsubo for discussion. We thank the members of the Sasakawa laboratory, especially H. Mimuro, M. Suzuki and H. Ashida, for their advice. We are grateful to R. Whittier and T. Tezuka for critical reading of the manuscript. We thank H. Erickson for fibronectin fragment expression vector. This work was supported by the Deutsche Forschungsgemeinschaft (SFB576), the Max Planck Society, a Grant-in-Aid for the Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and the Special Coordination Funds for Promoting Science from Japan Science and Technology Agency (JSTA).	Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Boulter E, 2006, FASEB J, V20, P1489, DOI 10.1096/fj.05-4579fje; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Chu HY, 2006, MOL CELL BIOL, V26, P1817, DOI 10.1128/MCB.26.5.1817-1825.2006; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kim M, 2008, EMBO REP, V9, P878, DOI 10.1038/embor.2008.125; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miura M, 2006, INFECT IMMUN, V74, P2587, DOI 10.1128/IAI.74.5.2587-2595.2006; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Ogawa M, 2003, MOL MICROBIOL, V48, P913, DOI 10.1046/j.1365-2958.2003.03489.x; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; SASAKAWA C, 1986, INFECT IMMUN, V51, P470, DOI 10.1128/IAI.51.2.470-475.1986; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077	37	130	134	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					578	U109		10.1038/nature07952	http://dx.doi.org/10.1038/nature07952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19489119				2022-12-28	WOS:000266370500041
J	Sasaki, E; Suemizu, H; Shimada, A; Hanazawa, K; Oiwa, R; Kamioka, M; Tomioka, I; Sotomaru, Y; Hirakawa, R; Eto, T; Shiozawa, S; Maeda, T; Ito, M; Ito, R; Kito, C; Yagihashi, C; Kawai, K; Miyoshi, H; Tanioka, Y; Tamaoki, N; Habu, S; Okano, H; Nomura, T				Sasaki, Erika; Suemizu, Hiroshi; Shimada, Akiko; Hanazawa, Kisaburo; Oiwa, Ryo; Kamioka, Michiko; Tomioka, Ikuo; Sotomaru, Yusuke; Hirakawa, Reiko; Eto, Tomoo; Shiozawa, Seiji; Maeda, Takuji; Ito, Mamoru; Ito, Ryoji; Kito, Chika; Yagihashi, Chie; Kawai, Kenji; Miyoshi, Hiroyuki; Tanioka, Yoshikuni; Tamaoki, Norikazu; Habu, Sonoko; Okano, Hideyuki; Nomura, Tatsuji			Generation of transgenic non-human primates with germline transmission	NATURE			English	Article							LENTIVIRAL GENE-TRANSFER; PLURIPOTENT STEM-CELLS; SPINAL-CORD-INJURY; MARMOSET MONKEY; MODEL; ESTABLISHMENT; EXPRESSION; DISEASE; CATTLE	The common marmoset (Callithrix jacchus) is increasingly attractive for use as a non-human primate animal model in biomedical research. It has a relatively high reproduction rate for a primate, making it potentially suitable for transgenic modification. Although several attempts have been made to produce non-human transgenic primates, transgene expression in the somatic tissues of live infants has not been demonstrated by objective analyses such as polymerase chain reaction with reverse transcription or western blots. Here we show that the injection of a self-inactivating lentiviral vector in sucrose solution into marmoset embryos results in transgenic common marmosets that expressed the transgene in several organs. Notably, we achieved germline transmission of the transgene, and the transgenic offspring developed normally. The successful creation of transgenic marmosets provides a new animal model for human disease that has the great advantage of a close genetic relationship with humans. This model will be valuable to many fields of biomedical research.	[Sasaki, Erika; Suemizu, Hiroshi; Shimada, Akiko; Oiwa, Ryo; Kamioka, Michiko; Tomioka, Ikuo; Hirakawa, Reiko; Eto, Tomoo; Shiozawa, Seiji; Maeda, Takuji; Ito, Mamoru; Ito, Ryoji; Kito, Chika; Yagihashi, Chie; Kawai, Kenji; Tanioka, Yoshikuni; Tamaoki, Norikazu; Nomura, Tatsuji] Cent Inst Expt Anim, Miyamae Ku, Kanagawa 2160001, Japan; [Hanazawa, Kisaburo] Juntendo Univ, Nerima Hosp, Dept Urol, Nerima Ku, Tokyo 1778521, Japan; [Tomioka, Ikuo; Hirakawa, Reiko] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Shiozawa, Seiji; Maeda, Takuji; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Minami Ku, Hiroshima 7348551, Japan; [Miyoshi, Hiroyuki] RIKEN, BioResource Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki 3050074, Japan; [Habu, Sonoko] Tokai Univ, Sch Med, Dept Immunol, Kanagawa 2591193, Japan	Juntendo University; Keio University; Keio University; Hiroshima University; RIKEN; Tokai University	Sasaki, E (corresponding author), Cent Inst Expt Anim, Miyamae Ku, 1430 Nogawa, Kanagawa 2160001, Japan.	esasaki@ciea.or.jp; hidokano@sc.itc.keio.ac.jp	Okano, Hideyuki/I-7584-2019; Miyoshi, Hiroyuki/G-9808-2013; Shiozawa, Seiji/L-1248-2013	Shiozawa, Seiji/0000-0002-3504-5415; Tomioka, Ikuo/0000-0002-1471-6419; Suemizu, Hiroshi/0000-0002-3706-2454	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Government to Keio University; Solution-Oriented Research for Science and Technology (SORST) of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21240042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government to Keio University; Solution-Oriented Research for Science and Technology (SORST) of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank F. Toyoda, S. Ohba, T. Inoue, Y. Sawada and M. Yokoyama for technical assistance with the animal experiments and care. E. S. is an associate professor of the Global COE program for human metabolomic systems biology assigned to Keio University. This study was also supported by the Global COE program for Education and Research Centre for Stem Cell Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Japanese Government to Keio University. This study was also supported by funds from Solution-Oriented Research for Science and Technology (SORST) of the Japan Science and Technology Agency and grants from MEXT to H. O. and from Special Coordination Funds for Promoting Science and Technology of MEXT to S. H.	Ando K, 2008, PSYCHOPHARMACOLOGY, V195, P509, DOI 10.1007/s00213-007-0929-2; Bai Y, 2003, GENE THER, V10, P1446, DOI 10.1038/sj.gt.3302026; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Chan AWS, 1998, P NATL ACAD SCI USA, V95, P14028, DOI 10.1073/pnas.95.24.14028; Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309; Eslamboli A, 2005, BRAIN RES BULL, V68, P140, DOI 10.1016/j.brainresbull.2005.08.005; Hofmann A, 2004, BIOL REPROD, V71, P405, DOI 10.1095/biolreprod.104.028472; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Ito R, 2008, IMMUNOL LETT, V121, P116, DOI 10.1016/j.imlet.2008.09.007; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Kuederling I, 2000, AM J PRIMATOL, V52, P149, DOI 10.1002/1098-2345(200011)52:3<149::AID-AJP4>3.0.CO;2-B; LOPATA A, 1988, FERTIL STERIL, V50, P503; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Ross CN, 2007, P NATL ACAD SCI USA, V104, P6278, DOI 10.1073/pnas.0607426104; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; SUMMERS PM, 1987, J REPROD FERTIL, V79, P241; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wolfgang MJ, 2001, P NATL ACAD SCI USA, V98, P10728, DOI 10.1073/pnas.181336098; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	513	535	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					523	U50		10.1038/nature08090	http://dx.doi.org/10.1038/nature08090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19478777				2022-12-28	WOS:000266370500029
J	Alluri, R; Chetty, M; Currie, GP				Alluri, Ratna; Chetty, Mahendran; Currie, Graeme P.			Case report Cough and breathlessness not responding to inhalers	BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERSENSITIVITY PNEUMONITIS		[Alluri, Ratna; Chetty, Mahendran; Currie, Graeme P.] Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland	University of Aberdeen	Alluri, R (corresponding author), Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland.	ratna.alluri@nhs.net		Currie, Graeme P/0000-0002-5711-9147				American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], 2008, THORAX S4, V63, piv1; Heaney LG, 2005, LANCET, V365, P974, DOI 10.1016/S0140-6736(05)71087-4; Patel AM, 2001, J ALLERGY CLIN IMMUN, V108, P661; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691; Yi EHS, 2002, CRIT REV CL LAB SCI, V39, P581, DOI 10.1080/10408360290795583	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2009	338								b1862	10.1136/bmj.b1862	http://dx.doi.org/10.1136/bmj.b1862			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WT	19474027				2022-12-28	WOS:000266502300003
J	Rathmell, JC; Newgard, CB				Rathmell, Jeffrey C.; Newgard, Christopher B.			A Glucose-to-Gene Link	SCIENCE			English	Editorial Material							ATP CITRATE LYASE; CELL-GROWTH		[Rathmell, Jeffrey C.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Rathmell, JC (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	newga002@mc.duke.edu			NCI NIH HHS [R01 CA123350, R01 CA123350-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123350] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; SZUTOWICZ A, 1979, BRIT J CANCER, V39, P681, DOI 10.1038/bjc.1979.120; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Turyn J, 2003, HORM METAB RES, V35, P565, DOI 10.1055/s-2003-43500; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	7	43	43	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1021	1022		10.1126/science.1174665	http://dx.doi.org/10.1126/science.1174665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460991	Green Accepted			2022-12-28	WOS:000266246700024
J	Diaz, RC				Diaz, Rodney C.			Patulous Eustachian Tube and Eustachian-Tube Dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Diaz, RC (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.	rcdiaz@ucdavis.edu							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					E27	E27		10.1056/NEJMicm073137	http://dx.doi.org/10.1056/NEJMicm073137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458361				2022-12-28	WOS:000266206000010
J	Chivukula, RR; Mendell, JT				Chivukula, Raghu R.; Mendell, Joshua T.			Abate and Switch: miR-145 in Stem Cell Differentiation	CELL			English	Editorial Material							MICRORNAS; SOX2		[Chivukula, Raghu R.; Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Mendell, JT (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	jmendell@jhmi.edu			NIGMS NIH HHS [T32 GM007814, T32 GM007309] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309, T32GM007814] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Kim VN, 2008, NAT GENET, V40, P1391, DOI 10.1038/ng1208-1391; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Michael MZ, 2003, MOL CANCER RES, V1, P882; NIMMO RA, 2009, CHROMOSOMA IN PRESS, DOI DOI 10.1007/S00412-009-0210-Z; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299	9	32	37	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					606	608		10.1016/j.cell.2009.04.059	http://dx.doi.org/10.1016/j.cell.2009.04.059			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450510	Bronze			2022-12-28	WOS:000266114100010
J	He, L; Sabet, A; Djedjos, S; Miller, R; Sun, XJ; Hussain, MA; Radovick, S; Wondisford, FE				He, Ling; Sabet, Amin; Djedjos, Stephen; Miller, Ryan; Sun, Xiaojian; Hussain, Mehboob A.; Radovick, Sally; Wondisford, Fredric E.			Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein	CELL			English	Article							KINASE-C; GLUCOSE-PRODUCTION; COACTIVATOR TORC2; PKC-LAMBDA; DOMAIN; LIVER; METABOLISM; ACTIVATION; MECHANISMS; EXPRESSION	Insulin resistance and elevated glucagon levels result in nonsuppressible hepatic glucose production and hyperglycemia in patients with type 2 diabetes. The CREB coactivator complex controls transcription of hepatic gluconeogenic enzyme genes. Here, we show that both the antidiabetic agent metformin and insulin phosphorylate the transcriptional coactivator CREB binding protein (CBP) at serine 436 via PKCL/lambda. This event triggers the dissociation of the CREB-CBP-TORC2 transcription complex and reduces gluconeogenic enzyme gene expression. Mice carrying a germline mutation of this CBP phosphorylation site (S436A) demonstrate resistance to the hypoglycemic effect of both insulin and metformin. Obese, hyperglycemic mice display hepatic insulin resistance, but metformin is still effective in treating the hyperglycemia of these mice since it stimulates CBP phosphorylation by bypassing the block in insulin signaling. Our findings point to CBP phosphorylation at Ser436 by metformin as critical for its therapeutic effect, and as a potential target for pharmaceutical intervention.	[He, Ling; Sabet, Amin; Miller, Ryan; Hussain, Mehboob A.; Wondisford, Fredric E.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA; [Djedjos, Stephen; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Physiol & Med, Baltimore, MD 21287 USA; [Sun, Xiaojian] Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Chicago	Wondisford, FE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA.	fwondis1@jhmi.edu		Sabet, Amin/0000-0001-5876-0502	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK063349]; Baltimore Diabetes Research and Training Center [P60DK079637]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD041859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063349, R01DK081472, P30DK079637, P60DK079637] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Baltimore Diabetes Research and Training Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK063349 and by the Baltimore Diabetes Research and Training Center Grant P60DK079637 (F. E. W., P. I.).	AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Goodman RH, 2000, GENE DEV, V14, P1553; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; SELBIE LA, 1993, J BIOL CHEM, V268, P24296; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	30	346	360	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					635	646		10.1016/j.cell.2009.03.016	http://dx.doi.org/10.1016/j.cell.2009.03.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450513	Green Accepted, Bronze			2022-12-28	WOS:000266114100013
J	Annas, GJ				Annas, George J.			Globalized Clinical Trials and Informed Consent	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ETHICS		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Kimmelman J, 2009, LANCET, V373, P13, DOI 10.1016/S0140-6736(08)61936-4; Stephens Joe, 2000, WASHINGTON POST 1217, pA1	4	47	48	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2050	2053		10.1056/NEJMp0901474	http://dx.doi.org/10.1056/NEJMp0901474			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	444WN	19439740				2022-12-28	WOS:000266011200003
J	Iglehart, JK				Iglehart, John K.			HEALTH CARE 2009 Congressional Action on Health Care Reform - An Update	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		DADAYAN L, PERSONAL INCOME TAX; *DEP HLTH HUM SERV, 2009 ANN REP BOARDS; ORSZAG PR, 2009, WALL STREET J, pA13; PEAR R, 2009, DESCRIPTION POLICY O; Pear Robert, 2009, NY TIMES, pA18	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2593	2595		10.1056/NEJMp0904517	http://dx.doi.org/10.1056/NEJMp0904517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458WR	19458351	Bronze			2022-12-28	WOS:000267060000001
J	Dennis, M; Cranswick, G; Deary, A; Fraser, A; Graham, C; Grant, S; Gunkel, A; Hunter, J; MacRae, A; Perry, D; Soosay, V; Williams, C; Williamson, A; Young, A; Dennis, M; Sandercock, PAG; Reid, J; Graham, C; Murray, G; Venables, G; Rudd, A; Bowler, G; Cranswick, G; Lewis, S; Rudd, A; Sandercock, PAG; Celani, MG; Ricci, S; Lindley, R; Hautvast, M; Paterson, M; Reid, J; Ting, T; Baigent, C; Bamford, J; Slattery, J				Dennis, M.; Cranswick, G.; Deary, A.; Fraser, A.; Graham, C.; Grant, S.; Gunkel, A.; Hunter, J.; MacRae, A.; Perry, D.; Soosay, V.; Williams, C.; Williamson, A.; Young, A.; Dennis, M.; Sandercock, P. A. G.; Reid, J.; Graham, C.; Murray, G.; Venables, G.; Rudd, A.; Bowler, G.; Cranswick, G.; Lewis, S.; Rudd, A.; Sandercock, P. A. G.; Celani, M. G.; Ricci, S.; Lindley, R.; Hautvast, M.; Paterson, M.; Reid, J.; Ting, T.; Baigent, C.; Bamford, J.; Slattery, J.		CLOTS Trials Collaboration	Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial	LANCET			English	Article							ISCHEMIC-STROKE; PREVENTION	Background Deep vein thrombosis (DVT) and pulmonary embolism are common after stroke. in small trials of patients undergoing surgery, graduated compression stockings (GCS) reduce the risk of DVT. National stroke guidelines extrapolating from these trials recommend their use in patients with stroke despite insufficient evidence. We assessed the effectiveness of thigh-length GCS to reduce DVT after stroke. Methods in this outcome-blinded, randomised controlled trial, 2518 patients who were admitted to hospital within 1 week of an acute stroke and who were immobile were enrolled from 64 centres in the UK, Italy, and Australia. Patients were allocated via a central randomisation system to routine care plus thigh-length GCS (n=1256) or to routine care plus avoidance of GCS (n=1262). A technician who was blinded to treatment allocation undertook compression Doppler ultrasound of both legs at about 7-10 days and, when practical, again at 25-30 days after enrolment. The primary outcome was the occurrence of symptomatic or asymptomatic DVT in the popliteal or femoral veins. Analyses were by intention to treat. This study is registered, number ISRCTN28163533. Findings All patients were included in the analyses. The primary outcome occurred in 126 (10.0%) patients allocated to thigh-length GCS and in 133 (10.5%) allocated to avoid GCS, resulting in a non-significant absolute reduction in risk of 0.5% (95% CI -1.9% to 2.9%). Skin breaks, ulcers, blisters, and skin necrosis were significantly more common in patients allocated to GCS than in those allocated to avoid their use (64 [5%] vs 16 [1%]; odds ratio 4.18, 95% CI 2.40-7.27). Interpretation These data do not lend support to the use of thigh-length GCS in patients admitted to hospital with acute stroke. National guidelines for stroke might need to be revised on the basis of these results.	[Dennis, M.] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dennis, M (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Bramwell Dott Bldg, Edinburgh EH4 2XU, Midlothian, Scotland.	martin.dennis@ed.ac.uk	celani, maria grazia/AAF-4143-2020; Hankey, Graeme J/H-4968-2014; Lindley, Richard/B-8148-2013; Barilaro, Alessandro/AAB-8373-2020; Zedde, Marialuisa/T-4692-2019; Bamford, John/ABE-6218-2021; Buchan, Alastair M/B-9095-2009; Macleod, Malcolm Robert/B-2052-2010; Bath, Philip/F-9020-2011	Hankey, Graeme J/0000-0002-6044-7328; Lindley, Richard/0000-0002-0104-5679; Zedde, Marialuisa/0000-0001-7530-818X; Buchan, Alastair M/0000-0002-2918-5200; Macleod, Malcolm Robert/0000-0001-9187-9839; Kwan, Joseph/0000-0003-4635-3322; Cranswick, Gina/0000-0002-4479-6034; Oke, Anthony/0000-0002-0874-5950; Geier, Petr/0000-0001-9198-6247; Brown, Martin M/0000-0002-3273-1356; Chatterjee, Kausik/0000-0002-3093-1469; Price, Christopher/0000-0003-3566-3157; Chiarandini, Stefano/0000-0003-2204-6117; Spence, Kaye/0000-0003-1241-9303; Tyrrell, Pippa/0000-0001-9609-1231; dennis, martin/0000-0003-1148-8972; , M. Grazia/0000-0003-1480-263X; Bath, Philip/0000-0003-2734-5132; Murray, Gordon/0000-0001-9866-4734; Hinkle, Janice/0000-0002-6817-5785	Chief Scientist Office of the Scottish Government [CZH/4/7]; Chest Heart and Stroke Scotland [03/01]; Medical Research Council of the UK [G0200531]; Medical Research Council [G0800803, G0200531] Funding Source: researchfish; MRC [G0800803, G0200531] Funding Source: UKRI	Chief Scientist Office of the Scottish Government; Chest Heart and Stroke Scotland; Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The trial was funded by research grants from the Chief Scientist Office of the Scottish Government (reference CZH/4/7), Chest Heart and Stroke Scotland (reference 03/01), and the Medical Research Council of the UK (reference G0200531). The graduated compression stockings were donated to centres by Tyco Healthcare (Covidien) who also trained nursing staff in their sizing, fitting, and monitoring. We thank all the patients and their families who participated in CLOTS, the nursing and rachology staff who assisted at collaborating sites, and the UK stroke research network staff without whom the trial would not have been possible.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; *AG NAT ACCR EV SA, 2002, PRIS CHARG IN PAT AD; [Anonymous], 2008, MAN PAT STROK TIA AS; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; De Silva DA, 2006, CEREBROVASC DIS, V22, P245, DOI 10.1159/000094011; *HOUS COMM HLTH CO, 2005, 2 REP SESS 2004 05; KAY TWH, 1986, MED J AUSTRALIA, V145, P290, DOI 10.5694/j.1326-5377.1986.tb101128.x; Kelly J, 2004, STROKE, V35, P2320, DOI 10.1161/01.STR.0000140741.13279.4f; KIERKEGAARD A, 1993, EUR HEART J, V14, P1365, DOI 10.1093/eurheartj/14.10.1365; MAZZONE C, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001922.PUB2; MERRETT ND, 1993, POSTGRAD MED J, V69, P232, DOI 10.1136/pgmj.69.809.232; Muir KW, 2000, QJM-INT J MED, V93, P359, DOI 10.1093/qjmed/93.6.359; *NAT I HLTH CLIN E, 2009, VEN THROMB RED RISK; *NAT STROK FDN AUS, 2007, ACUT STROK MAN; *NZ GUID GROUP, 2003, LIF STROK NZ GUID MA; Raftery J, 2005, HEALTH TECHNOL ASSES, V9, pIII; Royal College of Physicians, 2004, NAT CLIN GUID STROK; Sandercock PAG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000024.pub3; Scottish Intercollegiate Guidelines Network, 2002, MAN PAT STROK REH PR; *SPREAD, 2007, IT GUID STROK PREV M; The European Stroke Organization (ESO) Executive Committee and ESO Writing Committee, 2008, GUID MAN ISCH STROK	21	280	293	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1958	1965		10.1016/S0140-6736(09)60941-7	http://dx.doi.org/10.1016/S0140-6736(09)60941-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19477503	Green Published, Green Accepted			2022-12-28	WOS:000266832500030
J	Kickler, TS				Kickler, Thomas Stephen			Dr William W. Duke: Pioneer in Platelet Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLEEDING-TIME; BLOOD-PLATELETS; TRANSFUSION; COAGULATION		Johns Hopkins Univ Hosp, Hematol & Coagulat Lab, Dept Pathol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Kickler, TS (corresponding author), Johns Hopkins Univ Hosp, Hematol & Coagulat Lab, Dept Pathol, Meyer B 121,600 N Broadway St, Baltimore, MD 21231 USA.	tkickler@jhmi.edu						BRINKHOUS KM, 1983, JAMA-J AM MED ASSOC, V250, P1210, DOI 10.1001/jama.250.9.1210; CASES A, 1992, KIDNEY INT, V42, P668, DOI 10.1038/ki.1992.333; Duke WW, 1910, J AMER MED ASSOC, V55, P1185, DOI 10.1001/jama.1910.04330140029009; Duke WW, 1911, J EXP MED, V14, P265, DOI 10.1084/jem.14.3.265; ESCOLAR G, 1988, TRANSFUSION, V28, P406, DOI 10.1046/j.1537-2995.1988.28588337325.x; Galen R.S., 1975, NORMALITY PREDICTIVE, P9; HARKER LA, 1980, BLOOD, V56, P824; HARKER LA, 1972, NEW ENGL J MED, V287, P155, DOI 10.1056/NEJM197207272870401; Kaushansky K, 1998, NEW ENGL J MED, V339, P746, DOI 10.1056/NEJM199809103391107; Lind SE, 2007, PLATELETS, 2ND EDITION, P485, DOI 10.1016/B978-012369367-9/50787-4; POWERS P, 1998, ARCH SURG-CHICAGO, V133, P134; SELLING L, 1916, J HOPKINS HOSP REP, V17, P83; Stroncek DF, 2007, LANCET, V370, P427, DOI 10.1016/S0140-6736(07)61198-2; Undas A, 2001, BLOOD, V98, P2423, DOI 10.1182/blood.V98.8.2423; Wintrobe MM., 1980, BLOOD PURE ELOQUENT, P1	15	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2267	2269		10.1001/jama.2009.787	http://dx.doi.org/10.1001/jama.2009.787			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19491190	Bronze			2022-12-28	WOS:000266554100027
J	Kroenke, K; Bair, MJ; Damush, TM; Wu, JW; Hoke, S; Sutherland, J; Tu, WZ				Kroenke, Kurt; Bair, Matthew J.; Damush, Teresa M.; Wu, Jingwei; Hoke, Shawn; Sutherland, Jason; Tu, Wanzhu			Optimized Antidepressant Therapy and Pain Self-management in Primary Care Patients With Depression and Musculoskeletal Pain A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BACK-PAIN; LATE-LIFE DEPRESSION; COGNITIVE-BEHAVIORAL THERAPY; LONGER-TERM OUTCOMES; COLLABORATIVE CARE; CLINICAL-TRIALS; OLDER-ADULTS; IMMPACT RECOMMENDATIONS; SYMPTOM SYNDROMES; MENTAL-DISORDERS	Context Pain and depression are the most common physical and psychological symptoms in primary care, respectively. Moreover, they co-occur 30% to 50% of the time and have adverse effects on quality of life, disability, and health care costs. Objective To determine if a combined pharmacological and behavioral intervention improves both depression and pain in primary care patients with musculoskeletal pain and comorbid depression. Design, Setting, and Patients Randomized controlled trial (Stepped Care for Affective Disorders and Musculoskeletal Pain [SCAMP]) conducted at 6 community-based clinics and 5 Veterans Affairs general medicine clinics in Indianapolis, Indiana. Recruitment occurred from January 2005 to June 2007 and follow-up concluded in June 2008. The 250 patients had low back, hip, or knee pain for 3 months or longer and at least moderate depression severity (Patient Health Questionnaire 9 score >= 10). Intervention Patients were randomly assigned to the intervention (n=123) or to usual care (n=127). The intervention consisted of 12 weeks of optimized antidepressant therapy (step 1) followed by 6 sessions of a pain self-management program over 12 weeks (step 2), and a continuation phase of therapy for 6 months (step 3). Main Outcome Measures Depression (20-item Hopkins Symptom Checklist), pain severity and interference (Brief Pain Inventory), and global improvement in pain at 12 months. Results At 12 months, 46 of the 123 intervention patients (37.4%) had a 50% or greater reduction in depression severity from baseline compared with 21 of 127 usual care patients (16.5%) (relative risk [RR], 2.3; 95% confidence interval [CI], 1.5-3.2), corresponding to a much lower number of patients with major depression (50[40.7%] vs 87 [68.5%], respectively; RR, 0.6 [95% CI, 0.4-0.8]). Also, a clinically significant (>= 30%) reduction in pain was much more likely in intervention patients ( 51 intervention patients [41.5%] vs 22 usual care patients [ 17.3%]; RR, 2.4 [95% CI, 1.6-3.2]), as was global improvement in pain (58[47.2%] vs 16 [12.6%], respectively; RR, 3.7 [95% CI, 2.3-6.1]). More intervention patients also experienced benefits in terms of the primary outcome, which was a combined improvement in both depression and pain (32 intervention patients [26.0%] vs 10 usual care patients [7.9%]; RR, 3.3 [95% CI, 1.8-5.4]). Conclusion Optimized antidepressant therapy followed by a pain self-management program resulted in substantial improvement in depression as well as moderate reductions in pain severity and disability. Trial Registration clinicaltrials.gov Identifier: NCT00118430 JAMA. 2009; 301(20):2099-2110 www.jama.com	[Kroenke, Kurt; Bair, Matthew J.; Damush, Teresa M.; Hoke, Shawn; Tu, Wanzhu] Regenstrief Inst Inc, Indianapolis, IN 46202 USA; [Kroenke, Kurt; Bair, Matthew J.; Damush, Teresa M.] Indiana Univ, Sch Med, Div Gen Internal Med, Indianapolis, IN USA; [Kroenke, Kurt; Bair, Matthew J.; Damush, Teresa M.] Indiana Univ, Sch Med, Div Geriatr, Indianapolis, IN USA; [Wu, Jingwei; Tu, Wanzhu] Indiana Univ, Sch Med, Div Biostat, Indianapolis, IN USA; [Kroenke, Kurt; Damush, Teresa M.; Hoke, Shawn] Roudebush VAMC, VA HSR&D Ctr Excellence Implementat Evidence Base, Indianapolis, IN USA; [Sutherland, Jason] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Dartmouth College	Kroenke, K (corresponding author), Regenstrief Inst Inc, 6th Floor,1050 Wishard Blvd, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org	Wu, Jing/GZK-5063-2022	Kroenke, Kurt/0000-0002-0114-4669	National Institute of Mental Health [R01 MH-071268]; Eli Lilly; Pfizer; Wyeth; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071268] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eli Lilly(Eli Lilly); Pfizer(Pfizer); Wyeth(Wyeth); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grant R01 MH-071268 ( awarded to Dr Kroenke) from the National Institute of Mental Health.	Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; BANDURA A, 1986, SOCIAL FDN THOUGHT A; Callahan CM, 2006, J GEN INTERN MED, V21, P1125, DOI 10.1111/j.1525-1497.2006.00603.x; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Cintron A, 2006, J PALLIAT MED, V9, P1454, DOI 10.1089/jpm.2006.9.1454; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Cleeland CS, 1989, ADV PAIN RES THER, P391, DOI DOI 10.1093/BRAIN/113.5.1589; Damush TM, 2003, ARTHRIT RHEUM-ARTHR, V49, P179, DOI 10.1002/art.10995; Damush TM, 2003, ARCH INTERN MED, V163, P2632, DOI 10.1001/archinte.163.21.2632; Damush TM, 2002, ARTHRIT RHEUM-ARTHR, V47, P372, DOI 10.1002/art.10382; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gill D, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001312.pub2; Herbert RD, 2000, AUST J PHYSIOTHER, V46, P309, DOI 10.1016/S0004-9514(14)60292-0; Holman HR, 2006, ANN INTERN MED, V144, P617, DOI 10.7326/0003-4819-144-8-200604180-00014; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jackson JL, 2006, CNS SPECTRUMS, V11, P212, DOI 10.1017/S1092852900014383; JENSEN MP, 1992, PAIN, V50, P157, DOI 10.1016/0304-3959(92)90156-6; Jung AC, 1997, J GEN INTERN MED, V12, P384, DOI 10.1007/s11606-006-5088-3; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Katon WJ, 2005, ARCH GEN PSYCHIAT, V62, P1313, DOI 10.1001/archpsyc.62.12.1313; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Krebs EE, 2008, PSYCHOSOMATICS, V49, P191, DOI 10.1176/appi.psy.49.3.191; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Kroenke K, 2003, INT J METH PSYCH RES, V12, P34, DOI 10.1002/mpr.140; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; KROENKE K, GEN HOSP PS IN PRESS; Kroenke K, 2008, PAIN, V134, P209, DOI 10.1016/j.pain.2007.09.021; Kroenke K, 2007, GEN HOSP PSYCHIAT, V29, P506, DOI 10.1016/j.genhosppsych.2007.08.005; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; Lorig K, 2003, MED CARE, V41, P699, DOI 10.1097/00005650-200306000-00001; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lynch ME, 2001, J PSYCHIATR NEUROSCI, V26, P30; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Pariser Dave, 2005, J Geriatr Phys Ther, V28, P67; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rubenstein LV, 2006, ANN INTERN MED, V145, P544, DOI 10.7326/0003-4819-145-7-200610030-00013; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; SCHADT M, 1992, DISPLAYS, V13, P11, DOI 10.1016/0141-9382(92)90004-B; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sternbach RA, 1986, CLIN J PAIN, V2, P49, DOI DOI 10.1097/00002508-198602010-00008; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Thielke SM, 2007, AM J GERIAT PSYCHIAT, V15, P699, DOI 10.1097/JGP.0b013e3180325a2d; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Unutzer J, 2008, AM J MANAG CARE, V14, P95; Von Korff M, 2001, ANN INTERN MED, V134, P911, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00016; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283; Warsi A, 2003, ARTHRITIS RHEUM-US, V48, P2207, DOI 10.1002/art.11210; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Williams JW, 2000, JAMA-J AM MED ASSOC, V284, P1519, DOI 10.1001/jama.284.12.1519; Williams LS, 2003, J NEUROL NEUROSUR PS, V74, P1587, DOI 10.1136/jnnp.74.11.1587; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	69	298	299	0	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2099	2110		10.1001/jama.2009.723	http://dx.doi.org/10.1001/jama.2009.723			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449KF	19470987	Bronze, Green Accepted			2022-12-28	WOS:000266328800022
J	Mazzone, T				Mazzone, Theodore			Hyperglycaemia and coronary heart disease: the meta picture	LANCET			English	Editorial Material							DIABETES-MELLITUS; GLUCOSE CONTROL; PREVENTION		Univ Illinois, Dept Med, Chicago, IL 61612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mazzone, T (corresponding author), Univ Illinois, Dept Med, Chicago, IL 61612 USA.	tmazzone@uic.edu						Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mazzone T, 2007, AM J MED, V120, pS26, DOI 10.1016/j.amjmed.2007.07.005; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	11	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1737	1738		10.1016/S0140-6736(09)60957-0	http://dx.doi.org/10.1016/S0140-6736(09)60957-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19465212				2022-12-28	WOS:000266337300004
J	Squyres, SW; Knoll, AH; Arvidson, RE; Ashley, JW; Bell, JF; Calvin, WM; Christensen, PR; Clark, BC; Cohen, BA; de Souza, PA; Edgar, L; Farrand, WH; Fleischer, I; Gellert, R; Golombek, MP; Grant, J; Grotzinger, J; Hayes, A; Herkenhoff, KE; Johnson, JR; Jolliff, B; Klingelhofer, G; Knudson, A; Li, R; Mccoy, TJ; McLennan, SM; Ming, DW; Mittlefehldt, DW; Morris, RV; Rice, JW; Schroder, C; Sullivan, RJ; Yen, A; Yingst, RA				Squyres, S. W.; Knoll, A. H.; Arvidson, R. E.; Ashley, J. W.; Bell, J. F., III; Calvin, W. M.; Christensen, P. R.; Clark, B. C.; Cohen, B. A.; de Souza, P. A., Jr.; Edgar, L.; Farrand, W. H.; Fleischer, I.; Gellert, R.; Golombek, M. P.; Grant, J.; Grotzinger, J.; Hayes, A.; Herkenhoff, K. E.; Johnson, J. R.; Jolliff, B.; Klingelhoefer, G.; Knudson, A.; Li, R.; McCoy, T. J.; McLennan, S. M.; Ming, D. W.; Mittlefehldt, D. W.; Morris, R. V.; Rice, J. W., Jr.; Schroeder, C.; Sullivan, R. J.; Yen, A.; Yingst, R. A.			Exploration of Victoria Crater by the Mars Rover Opportunity	SCIENCE			English	Article							MERIDIANI-PLANUM; BURNS FORMATION	The Mars rover Opportunity has explored Victoria crater, a similar to 750-meter eroded impact crater formed in sulfate-rich sedimentary rocks. Impact-related stratigraphy is preserved in the crater walls, and meteoritic debris is present near the crater rim. The size of hematite-rich concretions decreases up-section, documenting variation in the intensity of groundwater processes. Layering in the crater walls preserves evidence of ancient wind-blown dunes. Compositional variations with depth mimic those similar to 6 kilometers to the north and demonstrate that water-induced alteration at Meridiani Planum was regional in scope.	[Squyres, S. W.; Bell, J. F., III; Sullivan, R. J.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Knoll, A. H.] Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; [Arvidson, R. E.; Jolliff, B.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; [Ashley, J. W.; Christensen, P. R.; Knudson, A.; Rice, J. W., Jr.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Calvin, W. M.] Univ Nevada, Reno, NV 89557 USA; [Clark, B. C.] Lockheed Martin Corp, Littleton, CO 80127 USA; [Cohen, B. A.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [de Souza, P. A., Jr.] CSIRO, Tasmanian Informat & Commun Technol Ctr, Hobart, Tas 7000, Australia; [Edgar, L.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Farrand, W. H.] Space Sci Inst, Boulder, CO 80301 USA; [Fleischer, I.; Klingelhoefer, G.; Schroeder, C.] Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, Mainz, Germany; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Golombek, M. P.; Yen, A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Grant, J.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Herkenhoff, K. E.; Johnson, J. R.] US Geol Survey, Flagstaff, AZ 86001 USA; [Li, R.] Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; [McCoy, T. J.] Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA; [McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Ming, D. W.; Mittlefehldt, D. W.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Yingst, R. A.] Univ Wisconsin, Green Bay, WI 54311 USA	Cornell University; Harvard University; Washington University (WUSTL); Arizona State University; Arizona State University-Tempe; Nevada System of Higher Education (NSHE); University of Nevada Reno; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Commonwealth Scientific & Industrial Research Organisation (CSIRO); California Institute of Technology; Johannes Gutenberg University of Mainz; University of Guelph; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; United States Department of the Interior; United States Geological Survey; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian National Museum of Natural History; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Wisconsin System	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Space Sci Bldg, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Schröder, Christian/B-3870-2009; de Souza, Paulo A/B-8961-2008; Hayes, Alexander G/P-2024-2014; de Souza, Paulo/W-2993-2019; de Souza, Paulo/P-7294-2019; Sullivan, Robert/AAR-8193-2020; Johnson, Jeffrey R/F-3972-2015; COHEN, BARBARA/AAV-8199-2021	Schröder, Christian/0000-0002-7935-6039; de Souza, Paulo A/0000-0002-0091-8925; Hayes, Alexander G/0000-0001-6397-2630; de Souza, Paulo/0000-0002-0091-8925; Johnson, Jeffrey R/0000-0002-5586-4901; McLennan, Scott/0000-0003-4259-7178; Grant, John/0000-0001-8276-1281; Cohen, Barbara/0000-0001-5896-5903; McCoy, Timothy/0000-0002-4573-3553	NASA	NASA(National Aeronautics & Space Administration (NASA))	This research was carried out for the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Amundson R, 2008, GEOCHIM COSMOCHIM AC, V72, P3845, DOI 10.1016/j.gca.2008.04.038; Bell JF, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002444; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bland PA, 2000, ICARUS, V144, P21, DOI 10.1006/icar.1999.6253; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Calvin WM, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003048; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Farrand WH, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002773; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Grant JA, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003155; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; Herkenhoff KE, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003100; KIMURA M, 1991, P NIPR S ANT MET, V4, P263; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Knoll AH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002949; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Schroeder C, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002990; Squyres SW, 2006, SCIENCE, V313, P1403, DOI 10.1126/science.1130890; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Weitz CM, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002541	23	118	119	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1058	1061		10.1126/science.1170355	http://dx.doi.org/10.1126/science.1170355			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461001	Green Submitted			2022-12-28	WOS:000266246700038
J	van Ramshorst, J; Bax, JJ; Beeres, SLMA; Dibbets-Schneider, P; Roes, SD; Stokkel, MPM; de Roos, A; Fibbe, WE; Zwaginga, JJ; Boersma, E; Schalij, MJ; Atsma, DE				van Ramshorst, Jan; Bax, Jeroen J.; Beeres, Saskia L. M. A.; Dibbets-Schneider, Petra; Roes, Stijntje D.; Stokkel, Marcel P. M.; de Roos, Albert; Fibbe, Willem E.; Zwaginga, Jaap J.; Boersma, Eric; Schalij, Martin J.; Atsma, Douwe E.			Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; STEM-CELLS; ANGINA; HEART; REVASCULARIZATION; TRANSPLANTATION; MULTICENTER; PERFUSION; DELIVERY	Context Previous studies have suggested that bone marrow cell injection may improve myocardial perfusion and left ventricular (LV) function in patients with chronic myocardial ischemia. Objective To investigate the effect of intramyocardial bone marrow cell injection on myocardial perfusion and LV function in patients with chronic myocardial ischemia. Design, Setting, and Patients Randomized, double-blind, placebo-controlled trial at a Netherlands university hospital, May 1, 2005-March 3, 2008 (6-month follow-up ended September 2008) of 50 patients with chronic myocardial ischemia ( mean age [SD], 64 [ 8] years; 43 men). Inclusion criteria: severe angina pectoris despite optimal medical therapy and myocardial ischemia. All patients were ineligible for conventional revascularization. Interventions Intramyocardial injection of 100 x 106 autologous bone marrow derived mononuclear cells or placebo solution. Main Outcome Measures Primarily, the summed stress score, a 17-segment score for stress myocardial perfusion assessed by Tc-99m tetrofosmin single-photon emission computed tomography ( SPECT). Secondary included LV ejection fraction (LVEF), Canadian Cardiovascular Society (CCS) class, and Seattle Angina Questionnaire quality-of-life score ( mean difference >5% considered clinically significant). Results After 3-month follow-up, the summed stress score (mean [SD]) improved from 23.5 (4.7) to 20.1 (4.6) (P<.001) in the bone marrow cell group, compared with a decrease from 24.8 (5.5) to 23.7 (5.4) (P=.004) in the placebo group. In the bone marrow cell-treated patients who underwent magnetic resonance imaging (MRI), a 3% absolute increase in LVEF was observed at 3 months(95% CI, 0.5% to 4.7%; n=18), but the placebo group showed no improvement. CCS angina score improved significantly in the bone marrow cell group (6-month absolute difference, -0.79; 95% CI, -1.10 to -0.48; P<.001) compared with no significant improvement in the placebo group. Quality-of-life score increased from 56% (9%) to 64% (12%) at 3 months and 69% (12%) at 6 months in bone marrow cell-treated patients, compared with a smaller increase in the placebo group from 57% (11%) to 61% (14%) to 64% (17%). The improvements in CCS class and quality of life score were significantly greater in bone marrow cell-treated patients than in placebo-treated patients (P=.03 and P=.04, respectively). Conclusions In this short-term study of patients with chronic myocardial ischemia refractory to medical treatment, intramyocardial bone marrow cell injection resulted in a statistically significant but modest improvement in myocardial perfusion compared with placebo. Further studies are required to assess long-term results and efficacy for mortality and morbidity. Trial Registrations trialregister.nl Identifier: NTR400 and isrctn.org Identifier: ISRCTN58194927 JAMA. 2009;301(19):1997-2004 www.jama.com	[van Ramshorst, Jan; Bax, Jeroen J.; Beeres, Saskia L. M. A.; Schalij, Martin J.; Atsma, Douwe E.] Leiden Univ, Dept Cardiol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Dibbets-Schneider, Petra; Stokkel, Marcel P. M.] Leiden Univ, Dept Nucl Med, Med Ctr, NL-2300 RC Leiden, Netherlands; [Roes, Stijntje D.; de Roos, Albert] Leiden Univ, Dept Radiol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Fibbe, Willem E.; Zwaginga, Jaap J.] Leiden Univ, Dept Hematol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Boersma, Eric] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Atsma, DE (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands.	d.e.atsma@lumc.nl			Boston Scientific; BMS Medical Imaging; St. Jude Medical, Medtronic, Biotronik, Edwards Lifesciences; GE Healthcare; Boston Scientific, Medtronic, and Biotronik	Boston Scientific(Boston Scientific); BMS Medical Imaging; St. Jude Medical, Medtronic, Biotronik, Edwards Lifesciences(MedtronicSt. Jude Medical); GE Healthcare(General ElectricGE Healthcare); Boston Scientific, Medtronic, and Biotronik(MedtronicBoston Scientific)	Bax reports receiving grants from Boston Scientific, BMS Medical Imaging, St. Jude Medical, Medtronic, Biotronik, Edwards Lifesciences, and GE Healthcare. Dr Schalij reports receiving grants from Boston Scientific, Medtronic, and Biotronik. The other authors report no financial disclosures.	Allen KB, 2004, ANN THORAC SURG, V77, P1228, DOI 10.1016/j.athoracsur.2004.01.008; Arora RR, 1999, J AM COLL CARDIOL, V33, P1833, DOI 10.1016/S0735-1097(99)00140-0; Beeres SLMA, 2008, HEART, V94, P1214, DOI 10.1136/hrt.2008.149476; Beeres SLMA, 2008, J MAGN RESON IMAGING, V27, P992, DOI 10.1002/jmri.21081; Beeres SLMA, 2006, J NUCL MED, V47, P574; Briguori C, 2006, AM HEART J, V151, P674, DOI 10.1016/j.ahj.2005.04.033; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; Fuchs S, 2006, AM J CARDIOL, V97, P823, DOI 10.1016/j.amjcard.2005.09.132; Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1; Leon MB, 2005, J AM COLL CARDIOL, V46, P1812, DOI 10.1016/j.jacc.2005.06.079; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Meluzin J, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.004; Rahimi AR, 2007, JAMA-J AM MED ASSOC, V297, P1063, DOI 10.1001/jama.297.10.1063; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Tse HF, 2007, EUR HEART J, V28, P2998, DOI 10.1093/eurheartj/ehm485; vanderGeest RJ, 1997, J COMPUT ASSIST TOMO, V21, P756, DOI 10.1097/00004728-199709000-00019; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	23	233	241	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					1997	2004		10.1001/jama.2009.685	http://dx.doi.org/10.1001/jama.2009.685			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454638	Bronze			2022-12-28	WOS:000266159600024
J	Rannou, F; Dimet, J; Boutron, I; Baron, G; Fayad, F; Mace, Y; Beaudreuil, J; Richette, P; Ravaud, P; Revel, M; Poiraudeau, S				Rannou, Francois; Dimet, Jerome; Boutron, Isabelle; Baron, Gabriel; Fayad, Fouad; Mace, Yann; Beaudreuil, Johann; Richette, Pascal; Ravaud, Philippe; Revel, Michel; Poiraudeau, Serge			Splint for Base-of-Thumb Osteoarthritis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL DISABILITY SCALE; HAND OSTEOARTHRITIS; RHEUMATOID HAND; RELIABILITY; SENSITIVITY; PREVALENCE; ARTHRITIS; VALIDITY	Background: Some guidelines recommend splinting for base-of-thumb osteoarthritis, despite lack of evidence of efficacy. Objective: To assess the efficacy and acceptability of a splint for base-of-thumb osteoarthritis. Design: Multicenter, randomized trial. Randomization was computer-generated, and allocation was concealed by faxing centralized treatment assignment to investigators at the time of enrollment. Patients and investigators were not blinded to assignment, and patients self-reported outcomes. Setting: 2 tertiary care hospitals in France. Patients: 112 patients (101 women) with base-of-thumb osteoarthritis. Intervention: Custom-made neoprene splint (n = 57) or usual care (n = 55). Measurements: Primary outcome was change in pain level assessed on a visual analogue scale (VAS) (range, 0 to 100 mm) from baseline to 1 month. Secondary outcomes were change in measures of hand disability at 1 month and change in pain level and measures of disability at 12 months. Tolerance and adherence with the splint were recorded. Results: At 1 month, no difference in change occurred in pain level from baseline in the intervention and control groups (adjusted mean change, -10.1 vs. -10.7; between-group difference, 0.6 [95% CI, -7.9 to 9.1]; P = 0.89). Disability was assessed by the Cochin Hand Function Scale score ( range, 0 to 90) or patient-perceived disability ( VAS, 0 to 100 mm). At 12 months, change in pain from baseline was greater in the intervention group than in the control group ( adjusted mean change, -22.2 vs. -7.9; between-group difference, -14.3 [CI, -23.4 to -5.2]; P = 0.002). The Cochin Hand Function Scale score was -1.9 versus 4.3 (between-group difference, -6.3 [CI, -10.9 to -1.7]; P = 0.008) and patient-perceived disability was -11.6 versus 1.5 ( between-group difference, -13.1 [CI, -21.8 to -4.4]; P = 0.003). At 12 months, 86% of the intervention group had worn the splint for more than 5 nights a week, and no adverse effects were observed. Limitation: Patients, health care providers, and outcome assessors were not blinded. Conclusion: For patients with base-of-thumb osteoarthritis, wearing a splint had no effect on pain at 1 month but improved pain and disability at 12 months. Primary Funding Source: Programme Hospitalier de Recherche Clinique National.	[Poiraudeau, Serge] Hop Bichat Claude Bernard, Hop Cochin, AP HP, Serv Med Phys & Readaptat, F-75679 Paris 14, France; Hop Lariboisiere, Paris, France; Univ Paris 05, Paris, France; Univ Paris 07, F-75221 Paris 05, France; INSERM, F-75654 Paris 13, France; Inst Federatif Rech Handicap, Paris, France; Ctr Hosp Reg, Unite Rech Clin, La Roche Sur Yon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre Hospitalier Annecy Genevois; CHD Vendee	Poiraudeau, S (corresponding author), Hop Bichat Claude Bernard, Hop Cochin, AP HP, Serv Med Phys & Readaptat, 27 Rue Faubourg, F-75679 Paris 14, France.	serge.poiraudeau@cch.aphp.fr	ravaud, philippe/C-1694-2009	Poiraudeau, Serge/0000-0002-1988-9124; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206; Beaudreuil, Johann/0000-0003-2478-6362	Programme Hospitalier de Recherche Clinique National [02038]	Programme Hospitalier de Recherche Clinique National	By the Programme Hospitalier de Recherche Clinique National ( PHRC AOM grant 02038).	Boutron I, 2005, J CLIN EPIDEMIOL, V58, P1233, DOI 10.1016/j.jclinepi.2005.05.004; Boutron I, 2005, J CLIN EPIDEMIOL, V58, P1220, DOI 10.1016/j.jclinepi.2005.04.006; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Chevalier X, 2000, OSTEOARTHR CARTILAGE, V8, pS70, DOI 10.1053/joca.2000.0341; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Duruoz MT, 1996, J RHEUMATOL, V23, P1167; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hochberg MC, 2000, OSTEOARTHR CARTILAGE, V8, pS38; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; KALLMAN DA, 1989, ARTHRITIS RHEUM, V32, P1584, DOI 10.1002/anr.1780321213; KAPANDJI A, 1986, Annales de Chirurgie de la Main, V5, P67, DOI 10.1016/S0753-9053(86)80053-9; KAPANDJI A, 1987, Annales de Chirurgie de la Main, V6, P288, DOI 10.1016/S0753-9053(87)80037-6; Lefevre-Colau MM, 2003, ARCH PHYS MED REHAB, V84, P1032, DOI 10.1016/S0003-9993(03)00128-X; Maheu E, 2007, ANN RHEUM DIS, V66, P464, DOI 10.1136/ard.2006.060277; Mallinckrodt Craig H, 2003, J Biopharm Stat, V13, P179, DOI 10.1081/BIP-120019265; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Poiraudeau S, 2000, ARTHRIT CARE RES, V13, P296, DOI 10.1002/1529-0131(200010)13:5<296::AID-ANR9>3.0.CO;2-F; Poiraudeau S, 2001, OSTEOARTHR CARTILAGE, V9, P570, DOI 10.1053/joca.2001.0422; Poole J U, 2000, J Hand Ther, V13, P91; Spacek E, 2004, OSTEOARTHR CARTILAGE, V12, P366, DOI 10.1016/j.joca.2004.01.005; Tubach F, 2007, J RHEUMATOL, V34, P1188; Wajon A, 2005, AUST J PHYSIOTHER, V51, P245, DOI 10.1016/S0004-9514(05)70005-2; Weiss S, 2000, J Hand Ther, V13, P218; Weiss Susan, 2004, J Hand Ther, V17, P401, DOI 10.1197/j.jht.2004.07.002; Wilder FV, 2006, OSTEOARTHR CARTILAGE, V14, P953, DOI 10.1016/j.joca.2006.04.013; Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091	29	101	103	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					661	U1		10.7326/0003-4819-150-10-200905190-00003	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451573				2022-12-28	WOS:000266285300001
J	Munoz, MJ; Santangelo, MSP; Paronetto, MP; de la Mata, M; Pelisch, F; Boireau, S; Glover-Cutter, K; Ben-Dov, C; Blaustein, M; Lozano, JJ; Bird, G; Bentley, D; Bertrand, E; Kornblihtt, AR				Munoz, Manuel J.; Perez Santangelo, M. Soledad; Paronetto, Maria P.; de la Mata, Manuel; Pelisch, Federico; Boireau, Stephanie; Glover-Cutter, Kira; Ben-Dov, Claudia; Blaustein, Matias; Lozano, Juan J.; Bird, Gregory; Bentley, David; Bertrand, Edouard; Kornblihtt, Alberto R.			DNA Damage Regulates Alternative Splicing through Inhibition of RNA Polymerase II Elongation	CELL			English	Article							PRE-MESSENGER-RNA; SUBCELLULAR-DISTRIBUTION; PROCESSING FACTORS; GENOTOXIC STRESS; IN-VIVO; TRANSCRIPTION; GENE; P53; PHOSPHORYLATION; ALTERS	DNA damage induces apoptosis and many apoptotic genes are regulated via alternative splicing (AS), but little is known about the control mechanisms. Here we show that ultraviolet irradiation (UV) affects cotranscriptional AS in a p53-independent way, through the hyperphosphorylation of RNA polymerase II carboxy-terminal domain (CTD) and a subsequent inhibition of transcriptional elongation, estimated in vivo and in real time. Phosphomimetic CTD mutants not only display lower elongation but also duplicate the UV effect on AS. Consistently, nonphosphorylatable mutants prevent the UV effect. Apoptosis promoted by UV in cells lacking p53 is prevented when the change in AS of the apoptotic gene bcl-x is reverted, confirming the relevance of this mechanism. Splicing-sensitive microarrays revealed a significant overlap of the subsets of genes that have changed AS with UV and those that have reduced expression, suggesting that transcriptional coupling to AS is a key feature of the DNA-damage response.	[Munoz, Manuel J.; Perez Santangelo, M. Soledad; de la Mata, Manuel; Pelisch, Federico; Blaustein, Matias; Kornblihtt, Alberto R.] Univ Buenos Aires, Lab Fisiologia & Biologia Mol, Dept Fisiologia Biologia Mol & Celular, IFIBYNE CONICET,Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Glover-Cutter, Kira; Bird, Gregory; Bentley, David] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Paronetto, Maria P.; Ben-Dov, Claudia; Lozano, Juan J.] Ctr Regulacio Genom, Barcelona 08003, Spain; [Boireau, Stephanie; Bertrand, Edouard] IGMM CNRS UMR 5535, F-34293 Montpellier, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Kornblihtt, AR (corresponding author), Univ Buenos Aires, Lab Fisiologia & Biologia Mol, Dept Fisiologia Biologia Mol & Celular, IFIBYNE CONICET,Fac Ciencias Exactas & Nat, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	ark@fbmc.fcen.uba.ar	Paronetto, Maria Paola/A-9578-2012; Blaustein, Matías/ABF-7951-2020; Pelisch, Federico/C-3815-2011; Pelisch, Federico/H-9219-2013; Glover-Cutter, Kira/S-9046-2016	Paronetto, Maria Paola/0000-0001-5324-0903; Blaustein, Matías/0000-0001-6309-6888; Perez-Santangelo, Maria Soledad/0000-0002-3497-9603; Kornblihtt, Alberto/0000-0003-4322-0831; Lozano, Juan Jose/0000-0001-7613-3908; bertrand, edouard/0000-0002-9642-7994; Pelisch, Federico/0000-0003-4575-1492; Glover-Cutter, Kira/0000-0002-7321-8604; Munoz, Manuel J./0000-0002-1152-5449; de la Mata, Manuel/0000-0003-0631-4038	Fundacion Antorchas; ANPCYT of Argentina; European AS Network (EURASNET); Howard Hughes Medical Institute; NIH [GM58613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058613] Funding Source: NIH RePORTER	Fundacion Antorchas; ANPCYT of Argentina(ANPCyT); European AS Network (EURASNET); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wang for providing PD166326 and V. Gottifredi, S. Kim, M. Raices, M. D'Angelo, R. Verdun, N. Lavagnino, V. Buggiano, G. Soria, and the members of the Srebrow and Kornblihtt labs for help and support. This work was supported by grants to A. R. K. from the Fundacion Antorchas, the ANPCYT of Argentina, and the European AS Network (EURASNET); M. J. M., M. B., and M. d. l. M. are recipients of fellowships and A. R. K. is a career investigator of the CONICET. A. R. K. is an international research scholar of the Howard Hughes Medical Institute. Work in D.B.'s lab is supported by NIH grant GM58613. M. J. M. designed, performed, and interpreted the results of most experiments. M. S. P. S., M. d. l. M., M. B., and F. P. helped perform some experiments. S. B. and E. B. performed the FRAP experiments. G. B., K. G. C., and D. B. generated the CTD mutants and performed the ChIP experiments. M. P. P. and C. B-D. performed the microarray experiments. A. R. K. coordinated the work and prepared the manuscript.	Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Fededa JP, 2005, MOL CELL, V19, P393, DOI 10.1016/j.molcel.2005.06.035; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Lazarev D, 2007, RNA, V13, P1546, DOI 10.1261/rna.595907; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nicholls CD, 2004, J BIOL CHEM, V279, P24171, DOI 10.1074/jbc.M401049200; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shomron N, 2005, J CELL SCI, V118, P1151, DOI 10.1242/jcs.01720; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200	40	224	228	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					708	720		10.1016/j.cell.2009.03.010	http://dx.doi.org/10.1016/j.cell.2009.03.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450518	Bronze			2022-12-28	WOS:000266114100019
J	Perry, JW				Perry, Joseph W.			Two Beams Squeeze Feature Sizes in Optical Lithography	SCIENCE			English	Editorial Material									[Perry, Joseph W.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Perry, Joseph W.] Georgia Inst Technol, Ctr Organ Photon & Elect, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Perry, JW (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	joe.perry@gatech.edu	Perry, Joseph W/B-7191-2011	Perry, Joseph W/0000-0003-1101-7337				Andrew TL, 2009, SCIENCE, V324, P917, DOI 10.1126/science.1167704; Bratton D, 2006, POLYM ADVAN TECHNOL, V17, P94, DOI 10.1002/pat.662; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Li LJ, 2009, SCIENCE, V324, P910, DOI 10.1126/science.1168996; Scott TF, 2009, SCIENCE, V324, P913, DOI 10.1126/science.1167610; Totzeck M, 2007, NAT PHOTONICS, V1, P629, DOI 10.1038/nphoton.2007.218	6	11	11	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					892	893		10.1126/science.1174224	http://dx.doi.org/10.1126/science.1174224			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443774				2022-12-28	WOS:000266048800024
J	Bates, DW; Larizgoitia, I; Prasopa-Plaizier, N; Jha, AK				Bates, David W.; Larizgoitia, Itziar; Prasopa-Plaizier, Nittita; Jha, Ashish K.		WHO World Alliance Patient Safety	Global priorities for patient safety research	BRITISH MEDICAL JOURNAL			English	Editorial Material							PATIENTS AFTER-DISCHARGE; ADVERSE EVENTS; HOSPITALIZED-PATIENTS; IATROGENIC INJURY; CARE; AUSTRALIA; QUALITY		[Bates, David W.; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Bates, David W.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Bates, David W.; Jha, Ashish K.] Harvard Univ, Sch Med, Boston, MA USA; [Larizgoitia, Itziar; Prasopa-Plaizier, Nittita] WHO World Alliance Patient Safety, Geneva, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; World Health Organization	Bates, DW (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med, 1620 Tremont St, Boston, MA 02115 USA.	dbates@partners.org	Madiba, T E/N-6069-2013; Madiba, T E/ABI-8313-2020; Bates, David/AAE-7283-2019	Madiba, T E/0000-0002-0155-9143; Madiba, T E/0000-0002-0155-9143; 				Ahmed QA, 2006, LANCET, V367, P1025, DOI 10.1016/S0140-6736(06)68431-6; ARORA N, ASSESSMENT INJECTION; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Blaya JA, 2008, INT J TUBERC LUNG D, V12, P921; Brennan TA, 2004, QUAL SAF HEALTH CARE, V13, P145, DOI 10.1136/qhc.13.2.145; Brown BB, 1968, DELPHI PROCESS METHO; Davis Peter, 2003, N Z Med J, V116, pU624; Davis Peter, 2002, N Z Med J, V115, pU271; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Herrera-Kiengelher L, 2005, CHEST, V128, P3900, DOI 10.1378/chest.128.6.3900; *LEAPFR GROUP, LEAPFR HOSP SERV REP; Runciman WB, 2000, INT J QUAL HEALTH C, V12, P379, DOI 10.1093/intqhc/12.5.379; Schioler T, 2001, Ugeskr Laeger, V163, P5370; The Research Priority Setting Working Group of the World Alliance for Patient Safety, 2008, SUMM EV PAT SAF IMPL; Thomas EJ, 2000, INT J QUAL HEALTH C, V12, P371, DOI 10.1093/intqhc/12.5.371; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; *WHO, LAUNCH 9 PAT SAF; WHO, 2007, 1 REG WORKSH PAT SAF; WHO, 5 MOM HAND HYG; *WHO, 2008, TOP PRIOR SETT RES P; World Health Organization, WORLD ALL PAT SAF; Zafarghandi MR, 2003, J TRAUMA, V55, P459, DOI 10.1097/01.TA.0000027132.39340.FE	24	92	92	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2009	338								b1775	10.1136/bmj.b1775	http://dx.doi.org/10.1136/bmj.b1775			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	446JA	19443552				2022-12-28	WOS:000266116700003
J	Kronick, R				Kronick, Richard			Medicare and HMOs - The Search for Accountability	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, Div Hlth Care Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kronick, R (corresponding author), Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, Div Hlth Care Sci, La Jolla, CA 92093 USA.							Berenson RA, 2009, HEALTH AFFAIR, V28, pW29, DOI 10.1377/hlthaff.28.1.w29; Centers for Medicare & Medicaid Services, 2009, ADV NOT METH CHANG C; *CTR MED MED SERV, 2009, ANN CAL YEAR CY 2010; *MED PAYM ADV COMM, 2008, DAT BOOK HEALTHC SPE, P125; Medicare Payment Advisory Commission, 2021, REP C MED PAYM POL	5	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2048	2050		10.1056/NEJMp0810149	http://dx.doi.org/10.1056/NEJMp0810149			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	444WN	19439739				2022-12-28	WOS:000266011200002
J	Larsen, CR; Soerensen, JL; Grantcharov, TP; Dalsgaard, T; Schouenborg, L; Ottosen, C; Schroeder, TV; Ottesen, BS				Larsen, Christian R.; Soerensen, Jette L.; Grantcharov, Teodor P.; Dalsgaard, Torur; Schouenborg, Lars; Ottosen, Christian; Schroeder, Torben V.; Ottesen, Bent S.			Effect of virtual reality training on laparoscopic surgery: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBJECTIVE ASSESSMENT; LEARNING-CURVE; OPERATING-ROOM; TECHNICAL SKILLS; SIMULATION; CHOLECYSTECTOMIES; PERFORMANCE; RESIDENTS; OUTCOMES; HEALTH	Objective To assess the effect of virtual reality training on an actual laparoscopic operation. Design Prospective randomised controlled and blinded trial. Setting Seven gynaecological departments in the Zeeland region of Denmark. Participants 24 first and second year registrars specialising in gynaecology and obstetrics. Interventions Proficiency based virtual reality simulator training in laparoscopic salpingectomy and standard clinical education (controls). Main outcome measure The main outcome measure was technical performance assessed by two independent observers blinded to trainee and training status using a previously validated general and task specific rating scale. The secondary outcome measure was operation time in minutes. Results The simulator trained group (n=11) reached a median total score of 33 points (interquartile range 32-36 points), equivalent to the experience gained after 20-50 laparoscopic procedures, whereas the control group (n=10) reached a median total score of 23 (22-27) points, equivalent to the experience gained from fewer than five procedures (P<0.001). The median total operation time in the simulator trained group was 12 minutes (interquartile range 10-14 minutes) and in the control group was 24 (20-29) minutes (P<0.001). The observers' inter-rater agreement was 0.79. Conclusion Skills in laparoscopic surgery can be increased in a clinically relevant manner using proficiency based virtual reality simulator training. The performance level of novices was increased to that of intermediately experienced laparoscopists and operation time was halved. Simulator training should be considered before trainees carry out laparoscopic procedures. Trial registration ClinicalTrials.gov NCT00311792.	[Soerensen, Jette L.] Juliane Marie Ctr, Dept Obstet, Copenhagen, Denmark; [Grantcharov, Teodor P.] St Michaels Hosp, Div Gen Surg, Toronto, ON M5B 1W8, Canada; [Dalsgaard, Torur; Schouenborg, Lars; Ottosen, Christian] Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark; [Schroeder, Torben V.] Copenhagen Univ Hosp, Rigshosp, Abdominal Ctr, Dept Vasc Surg, Copenhagen, Denmark; [Ottesen, Bent S.] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Copenhagen, Denmark	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen		crl@dadlner.dk	Sørensen, Jette Led/B-7286-2018; Sørensen, Jette Led/X-4556-2019	Sørensen, Jette Led/0000-0002-7320-2784; Sørensen, Jette Led/0000-0002-7320-2784; Schroeder, Torben/0000-0002-9827-9438	Copenhagen University Rigshospitalet Hospital	Copenhagen University Rigshospitalet Hospital	This project was supported by Copenhagen University Rigshospitalet Hospital. Trygfondet supplied various materials including computer hardware. Det Calssenske Fidecommis' Jubilaeumsfond provided travel expenses. Aase and Ejner Danielsens foundation provided software maintenance and updates, DVD recorders, and a TV monitor. The Danish Society for the Protection of Laboratory Animals provided computer hardware and software. All phases of the present work including design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the final manuscript were done independent of the funders.	Adibe OO, 2006, J PEDIATR SURG, V41, P1676, DOI 10.1016/j.jpedsurg.2006.05.051; Aggarwal R, 2006, BJOG-INT J OBSTET GY, V113, P1382, DOI 10.1111/j.1471-0528.2006.01148.x; Ahlberg G, 2002, SURG ENDOSC, V16, P126, DOI 10.1007/s00464-001-9025-6; Ahlberg G, 2007, AM J SURG, V193, P797, DOI 10.1016/j.amjsurg.2006.06.050; Avital S, 2006, ISRAEL MED ASSOC J, V8, P683; Bridges M, 1999, AM J SURG, V177, P28, DOI 10.1016/S0002-9610(98)00289-X; BRUHAT MA, 1993, CURR OPIN OBSTET GYN, V5, P260; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Carlsson S, 2006, SCAND J UROL NEPHROL, V40, P103, DOI 10.1080/00365590500368120; Eto M, 2006, INT J UROL, V13, P671, DOI 10.1111/j.1442-2042.2006.01383.x; Fleisch MC, 2007, J MINIM INVAS GYN, V14, P293, DOI 10.1016/j.jmig.2006.10.012; Garry R, 2006, BEST PRACT RES CL OB, V20, P89, DOI 10.1016/j.bpobgyn.2005.10.003; Grantcharov TP, 2008, BRIT MED J, V336, P1129, DOI 10.1136/bmj.39517.686956.47; Grantcharov TP, 2004, BRIT J SURG, V91, P146, DOI 10.1002/bjs.4407; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; Karvonen J, 2007, SURG ENDOSC, V21, P1069, DOI 10.1007/s00464-007-9316-7; Keus F, 2006, BEST PRACT RES CL GA, V20, P1031, DOI 10.1016/j.bpg.2006.05.008; Kneebone R, 2003, MED EDUC, V37, P267, DOI 10.1046/j.1365-2923.2003.01440.x; Kneebone RL, 2006, MED EDUC, V40, P987, DOI 10.1111/j.1365-2929.2006.02558.x; Kumar Udaya, 2006, Curr Urol Rep, V7, P120, DOI 10.1007/s11934-006-0070-5; Larsen CR, 2008, BJOG-INT J OBSTET GY, V115, P908, DOI 10.1111/j.1471-0528.2008.01732.x; Larsen CR, 2006, SURG ENDOSC, V20, P1460, DOI 10.1007/s00464-005-0745-x; Lingard L, 2002, MED EDUC, V36, P728, DOI 10.1046/j.1365-2923.2002.01271.x; MEYERS WC, 1991, NEW ENGL J MED, V324, P1073; Moorthy K, 2003, BMJ-BRIT MED J, V327, P1032, DOI 10.1136/bmj.327.7422.1032; NEZHAT C, 2000, OPERATIVE GYNECOLOGI, P246; PETERS JD, 2002, OBG MANAGEMENT, V14, P47; Rosenmuller M, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-35; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; Sutherland LM, 2006, ANN SURG, V243, P291, DOI 10.1097/01.sla.0000200839.93965.26	30	287	287	1	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2009	338								b1802	10.1136/bmj.b1802	http://dx.doi.org/10.1136/bmj.b1802			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JA	19443914	Green Published, hybrid			2022-12-28	WOS:000266116700004
J	Plint, AC; Johnson, DW; Patel, H; Wiebe, N; Math, M; Correll, R; Brant, R; Mitton, C; Gouin, S; Bhatt, M; Joubert, G; Black, KJL; Turner, T; Whitehouse, S; Klassen, TP				Plint, Amy C.; Johnson, David W.; Patel, Hema; Wiebe, Natasha; Math, M.; Correll, Rhonda; Brant, Rollin; Mitton, Craig; Gouin, Serge; Bhatt, Maala; Joubert, Gary; Black, Karen J. L.; Turner, Troy; Whitehouse, Sandra; Klassen, Terry P.		Pediat Emergency Res Canada	Epinephrine and Dexamethasone in Children with Bronchiolitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEBULIZED RACEMIC ADRENALINE; ACUTE VIRAL BRONCHIOLITIS; SHORT-TERM; CLINICAL-EFFICACY; RANDOMIZED TRIAL; DOUBLE-BLIND; INFANTS; SALBUTAMOL; CORTICOSTEROIDS; SUPPRESSION	BACKGROUND Although numerous studies have explored the benefit of using nebulized epinephrine or corticosteroids alone to treat infants with bronchiolitis, the effectiveness of combining these medications is not well established. METHODS We conducted a multicenter, double-blind, placebo-controlled trial in which 800 infants (6 weeks to 12 months of age) with bronchiolitis who were seen in the pediatric emergency department were randomly assigned to one of four study groups. One group received two treatments of nebulized epinephrine (3 ml of epinephrine in a 1: 1000 solution per treatment) and a total of six oral doses of dexamethasone (1.0 mg per kilogram of body weight in the emergency department and 0.6 mg per kilogram for an additional 5 days) (the epinephrine-dexamethasone group), the second group received nebulized epinephrine and oral placebo (the epinephrine group), the third received nebulized placebo and oral dexamethasone (the dexamethasone group), and the fourth received nebulized placebo and oral placebo (the placebo group). The primary outcome was hospital admission within 7 days after the day of enrollment (the initial visit to the emergency department). RESULTS Baseline clinical characteristics were similar among the four groups. By the seventh day, 34 infants (17.1%) in the epinephrine-dexamethasone group, 47 (23.7%) in the epinephrine group, 51 (25.6%) in the dexamethasone group, and 53 (26.4%) in the placebo group had been admitted to the hospital. In the unadjusted analysis, only the infants in the epinephrine-dexamethasone group were significantly less likely than those in the placebo group to be admitted by day 7 (relative risk, 0.65; 95% confidence interval, 0.45 to 0.95, P = 0.02). However, with adjustment for multiple comparisons, this result was rendered insignificant (P = 0.07). There were no serious adverse events. CONCLUSIONS Among infants with bronchiolitis treated in the emergency department, combined therapy with dexamethasone and epinephrine may significantly reduce hospital admissions. (Current Controlled Trials number, ISRCTN56745572.)	[Plint, Amy C.] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Plint, Amy C.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Plint, Amy C.] Univ Ottawa, Dept Emergency Med, Ottawa, ON K1N 6N5, Canada; [Johnson, David W.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Johnson, David W.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 1N4, Canada; [Johnson, David W.] Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada; [Patel, Hema; Bhatt, Maala] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Patel, Hema; Bhatt, Maala] Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; [Wiebe, Natasha] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Turner, Troy; Klassen, Terry P.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Correll, Rhonda] Childrens Hosp Eastern Ontario, Res Inst, Clin Res Unit, Ottawa, ON K1H 8L1, Canada; [Brant, Rollin] Univ British Columbia, Dept Stat, Vancouver, BC V5Z 1M9, Canada; [Whitehouse, Sandra] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 1M9, Canada; [Brant, Rollin] British Columbia Childrens Hosp, Child & Family Res Inst, Vancouver, BC V6H 3V4, Canada; [Mitton, Craig] Univ British Columbia Okanagan, Dept Hlth Studies, Kelowna, BC, Canada; [Gouin, Serge] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Gouin, Serge] Ctr Hosp Univ St Justing, Montreal, PQ, Canada; [Joubert, Gary] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; [Joubert, Gary] Univ Western Ontario, Dept Med, London, ON N6A 3K7, Canada; [Joubert, Gary] London Hlth Sci Ctr, London, ON, Canada; [Joubert, Gary] Childrens Hosp, London, ON, Canada; [Black, Karen J. L.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Black, Karen J. L.] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; [Black, Karen J. L.] IWK Hlth Ctr, Halifax, NS, Canada; [Turner, Troy; Klassen, Terry P.] Stollery Childrens Hosp, Edmonton, AB, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; McGill University; McGill University; University of Alberta; University of Alberta; University of Ottawa; Children's Hospital of Eastern Ontario; University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia Okanagan; Universite de Montreal; Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Dalhousie University; Dalhousie University; Dalhousie University; Stollery Children's Hospital	Plint, AC (corresponding author), Childrens Hosp Eastern Ontario, 401 Smyth Ave, Ottawa, ON K1H 8L1, Canada.	plint@cheo.on.ca	Bhatt, Maala/AGF-6509-2022; Plint, Amy/AAE-2250-2020; Wiebe, Natasha/V-7803-2019	Wiebe, Natasha/0000-0002-5613-1582; Brant, Rollin/0000-0002-8026-2451; Bhatt, Maala/0000-0003-1265-3482; Klassen, Terry/0000-0002-5309-7091	Canadian Institutes of Health Research; Alberta Children's Hospital Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Children's Hospital Foundation	Supported by grants from the Canadian Institutes of Health Research and Alberta Children's Hospital Foundation. Dr. Plint was supported in part by a salary award from the Canadian Institutes of Health Research.	Barnes PJ, 2007, EUR RESPIR J, V29, P587, DOI 10.1183/09031936.00080306; Bentur L, 2005, ACTA PAEDIATR, V94, P866, DOI 10.1080/08035250510028407; Blackmon LR, 2002, PEDIATRICS, V109, P330; CORNELI HM, 2008, NEW ENGL J MED, V359, P1972; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Fisher L.D., 1990, STAT ISSUES DRUG RES, P331, DOI DOI 10.1201/9780203738610; Flores G, 1997, PEDIATRICS, V100, P233, DOI 10.1542/peds.100.2.233; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Hartling L, 2003, ARCH PEDIAT ADOL MED, V157, P957, DOI 10.1001/archpedi.157.10.957; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; KLASSEN TP, 1991, J PEDIATR-US, V118, P807, DOI 10.1016/S0022-3476(05)80051-4; KLASSEN TP, 1991, J PEDIATR, V119, P1010; KRISTJANSSON S, 1993, ARCH DIS CHILD, V69, P650, DOI 10.1136/adc.69.6.650; Kuyucu S, 2004, PEDIATR INT, V46, P539, DOI 10.1111/j.1442-200x.2004.01944.x; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; LOWELL DI, 1987, PEDIATRICS, V79, P939; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; MENON K, 1995, J PEDIATR-US, V126, P1004, DOI 10.1016/S0022-3476(95)70234-2; MILNER AD, 1989, THORAX, V44, P1, DOI 10.1136/thx.44.1.1; NJOO H, 2001, RESP DIS CANADA, P65; Patel H, 2003, J PEDIATR-US, V142, P509, DOI 10.1067/mpd.2003.196; Pauwels RA, 1998, NEW ENGL J MED, V338, P139; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; REIJONEN T, 1995, ARCH PEDIAT ADOL MED, V149, P686, DOI 10.1001/archpedi.1995.02170190096017; SANCHEZ I, 1993, J PEDIATR-US, V122, P145, DOI 10.1016/S0022-3476(05)83508-5; Schuh S, 2002, J PEDIATR-US, V140, P27, DOI 10.1067/mpd.2002.120271; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Stang P, 2001, ARCH PEDIAT ADOL MED, V155, P95, DOI 10.1001/archpedi.155.1.95; STRECK WF, 1979, AM J MED, V66, P910, DOI 10.1016/0002-9343(79)90444-3; TAL A, 1983, PEDIATRICS, V71, P13; Welliver J R, 1993, Pediatr Rev, V14, P134, DOI 10.1542/pir.14-4-134; WENNERGREN G, 1991, ACTA PAEDIATR SCAND, V80, P375, DOI 10.1111/j.1651-2227.1991.tb11865.x; WENNING GK, 1994, ACTA NEUROL SCAND, V89, P270; Westfall PH, 1997, J AM STAT ASSOC, V92, P299, DOI 10.2307/2291474; ZORA JA, 1986, J ALLERGY CLIN IMMUN, V77, P9, DOI 10.1016/0091-6749(86)90315-5	39	162	167	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2079	2089		10.1056/NEJMoa0900544	http://dx.doi.org/10.1056/NEJMoa0900544			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439742				2022-12-28	WOS:000266011200006
J	Baek, KH; Zaslavsky, A; Lynch, RC; Britt, C; Okada, Y; Siarey, RJ; Lensch, MW; Park, IH; Yoon, SS; Minami, T; Korenberg, JR; Folkman, J; Daley, GQ; Aird, WC; Galdzicki, Z; Ryeom, S				Baek, Kwan-Hyuck; Zaslavsky, Alexander; Lynch, Ryan C.; Britt, Carmella; Okada, Yoshiaki; Siarey, Richard J.; Lensch, M. William; Park, In-Hyun; Yoon, Sam S.; Minami, Takashi; Korenberg, Julie R.; Folkman, Judah; Daley, George Q.; Aird, William C.; Galdzicki, Zygmunt; Ryeom, Sandra			Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1	NATURE			English	Article							CRITICAL REGION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; CYCLOSPORINE-A; MOUSE MODEL; ANGIOGENESIS; VEGF; TARGET; CHROMOSOME-21; REGRESSION	The incidence of many cancer types is significantly reduced in individuals with Down's syndrome(1-4), and it is thought that this broad cancer protection is conferred by the increased expression of one or more of the 231 supernumerary genes on the extra copy of chromosome 21. One such gene is Down's syndrome candidate region-1 (DSCR1, also known as RCAN1), which encodes a protein that suppresses vascular endothelial growth factor ( VEGF)mediated angiogenic signalling by the calcineurin pathway(5-10). Here we show that DSCR1 is increased in Down's syndrome tissues and in a mouse model of Down's syndrome. Furthermore, we show that the modest increase in expression afforded by a single extra transgenic copy of Dscr1 is sufficient to confer significant suppression of tumour growth in mice, and that such resistance is a consequence of a deficit in tumour angiogenesis arising from suppression of the calcineurin pathway. We also provide evidence that attenuation of calcineurin activity by DSCR1, together with another chromosome 21 gene Dyrk1a, may be sufficient to markedly diminish angiogenesis. These data provide a mechanism for the reduced cancer incidence in Down's syndrome and identify the calcineurin signalling pathway, and its regulators DSCR1 and DYRK1A, as potential therapeutic targets in cancers arising in all individuals.	[Baek, Kwan-Hyuck; Zaslavsky, Alexander; Lynch, Ryan C.; Britt, Carmella; Folkman, Judah; Ryeom, Sandra] Childrens Hosp Boston, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Okada, Yoshiaki; Aird, William C.] Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Vasc Biol Res Ctr, Boston, MA 02115 USA; [Siarey, Richard J.; Galdzicki, Zygmunt] Uniformed Serv Univ Hlth Serv, Sch Med, Mol & Cellular Biol Program, Dept Anat Physiol & Genet Neurosci, Bethesda, MD 20814 USA; [Lensch, M. William; Park, In-Hyun; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Dept Med, Boston, MA 02115 USA; [Lensch, M. William; Park, In-Hyun; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Yoon, Sam S.] Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA; [Minami, Takashi] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Korenberg, Julie R.] Univ Utah, Inst Brain, Salt Lake City, UT 84108 USA; [Korenberg, Julie R.] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; University of Tokyo; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ryeom, S (corresponding author), Childrens Hosp Boston, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA.	sandra.ryeom@childrens.harvard.edu	Okada, Yoshiaki/M-8718-2017		Howard Hughes Medical Institute; Harvard Stem Cell Institute; National Institute of Health Director's Pioneer Award; NHLBI; Jerome Lejeune Foundation; USUHS; Smith Family Medical Foundation; Garrett B. Smith Foundation; Annie's Fun Foundation; NATIONAL CANCER INSTITUTE [R01CA118374] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Stem Cell Institute; National Institute of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jerome Lejeune Foundation; USUHS; Smith Family Medical Foundation; Garrett B. Smith Foundation; Annie's Fun Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Evan, C. Kim, K. Cichowski and J. Italiano for critical discussions and advice. This work was supported by the Howard Hughes Medical Institute ( G. Q. D.), Harvard Stem Cell Institute ( G. Q. D.), the National Institute of Health Director's Pioneer Award ( G. Q. D.), NHLBI ( W. C. A.), Jerome Lejeune Foundation ( Z. G.), USUHS ( Z. G.), the Smith Family Medical Foundation ( S. R.), the Garrett B. Smith Foundation ( S. R.) and Annie's Fun Foundation ( S. R.).	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Fulcher T, 1998, BRIT J OPHTHALMOL, V82, P407, DOI 10.1136/bjo.82.4.407; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Harashima C, 2006, CELL MOL NEUROBIOL, V26, P719, DOI 10.1007/s10571-006-9066-4; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; MURDOCH JC, 1977, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.6081.226; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Patja K, 2006, INT J CANCER, V118, P1769, DOI 10.1002/ijc.21518; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Satge D, 1998, CANCER RES, V58, P448; SHI YP, 1994, MAMM GENOME, V5, P337, DOI 10.1007/BF00356551; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176	30	264	270	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1126	U113		10.1038/nature08062	http://dx.doi.org/10.1038/nature08062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19458618	Green Accepted			2022-12-28	WOS:000267636700043
J	Goldacre, MJ; Davidson, JM; Lambert, TW				Goldacre, Michael J.; Davidson, Jean M.; Lambert, Trevor W.			Retention in the British National Health Service of medical graduates trained in Britain: cohort studies	BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM; DOCTORS; QUESTIONNAIRE; PLACES; WOMEN	Objective To report the percentage of graduates from British medical schools who eventually practise medicine in the British NHS. Design Cohort studies using postal questionnaires, employment data, and capture-recapture analysis. Setting Great Britain. Subjects 32 430 graduates from all British medical schools in nine graduation cohorts from 1974 to 2002, subdivided into home based medical students ( those whose homes were in Great Britain when they entered medical school) and those from overseas ( whose homes were outside Great Britain when they entered medical school). Main outcome measures Working in the NHS at seven census points from two to 27 years after qualification. Results Of home based doctors, 88% of men (6807 of 7754) and 88% of women (7909 of 8985) worked as doctors in the NHS two years after qualification. The corresponding values were 87% of men (7483 of 8646) and 86% of women (7364 of 8594) at five years; 86% ( 6803 of 7872) and 86% (5407 of 6321) at 10 years; 85% (5404 of 6331) and 84% (3206 of 3820) at 15 years; and 82% ( 2534 of 3089) and 81% (1132 of 1395) at 20 years. Attrition from the NHS had not increased in recent cohorts compared with older ones at similar times after graduation. Of overseas students, 76% (776 of 1020) were in the NHS at two years, 72% (700 of 972) at five years, 63% (448 of 717) at ten years, and 52% (128 of 248) at 20 years. Conclusions The majority of British medical graduates from British medical schools practise in the NHS in both the short and long term. Differences between men and women in this respect are negligible. A majority of doctors from overseas homes remain in Britain for their years as junior doctors, but eventually about half leave the NHS.	[Goldacre, Michael J.; Davidson, Jean M.; Lambert, Trevor W.] Univ Oxford, UK Med Careers Res Grp, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Unit Hlth Care Epidemiol, Dept Publ Hlth, Old Rd Campus, Oxford OX7 3LF, England.	michael.goldacre@dphp.ox.ac.uk		Lambert, Trevor/0000-0001-9688-3036	Policy Research Programme of the English Department of Health; English NIHR Coordinating Centre for Research Capacity Development	Policy Research Programme of the English Department of Health; English NIHR Coordinating Centre for Research Capacity Development	The UK Medical Careers Research Group is funded by the Policy Research Programme of the English Department of Health. The Unit of Health Care Epidemiology is funded by the English NIHR Coordinating Centre for Research Capacity Development.	Borman E, 2007, BRIT MED J, V335, P591, DOI 10.1136/bmj.39302.403021.94; Byrne E, 2007, BRIT MED J, V335, P590, DOI 10.1136/bmj.39302.639792.94; *DEP HLTH WORKF DI, 2008, MOD MED CAR MMC ENGL; Eckhert NL, 2002, MED EDUC, V36, P606, DOI 10.1046/j.1365-2923.2002.01257.x; Goldacre MJ, 2001, MED EDUC, V35, P337, DOI 10.1046/j.1365-2923.2001.00939.x; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Kilminster S, 2007, MED EDUC, V41, P39, DOI 10.1111/j.1365-2929.2006.02645.x; Lambert Trevor, 2004, J Health Serv Res Policy, V9, P234, DOI 10.1258/1355819042250212; Lambert TW, 1998, BRIT MED J, V317, P1429, DOI 10.1136/bmj.317.7170.1429; Lambert TW, 1996, BRIT MED J, V313, P19, DOI 10.1136/bmj.313.7048.19; Levinson W, 2004, ANN INTERN MED, V141, P471, DOI 10.7326/0003-4819-141-6-200409210-00013; Moss PJ, 2004, BMJ-BRIT MED J, V329, P1263, DOI 10.1136/bmj.38247.594769.AE	12	18	18	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 3	2009	338								b1977	10.1136/bmj.b1977	http://dx.doi.org/10.1136/bmj.b1977			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AG	19493940	Green Published, hybrid			2022-12-28	WOS:000266726300006
J	Saeki, Y; Toh-e, A; Kudo, T; Kawamura, H; Tanaka, K				Saeki, Yasushi; Toh-e, Akio; Kudo, Tai; Kawamura, Hitomi; Tanaka, Keiji			Multiple Proteasome-Interacting Proteins Assist the Assembly of the Yeast 19S Regulatory Particle	CELL			English	Article							26 S-PROTEASOME; SACCHAROMYCES-CEREVISIAE; UBIQUITIN SYSTEM; 20S PROTEASOMES; CDNA CLONING; HSM3 GENE; GANKYRIN; DEGRADATION; SUBUNITS; ATPASES	The 26S proteasomeis a highly conserved multisubunit protease that degrades ubiquitinated proteins in eukaryotic cells. The 26S proteasome consists of the proteolytic core particle (CP) and one or two 19S regulatory particles (RPs). Although the mechanisms of CP assembly are well described, the mechanism of RP assembly is largely unknown. Here, we show that four proteasome-interacting proteins (PIPs), Nas2/p27, Nas6/gankyrin, Rpn14/PAAF1, and Hsm3/S5b, bind specific Rpt subunits of the RP and interact each other genetically. Lack of these PIPs resulted in defective assembly of the 26S proteasome at an early stage, suggesting that these proteins are bona fide RP chaperones. Each of the RP chaperones formed distinct specific subassemblies of the base components and escorted them to mature RPs. Our results indicate that the RP assembly is a highly organized and elaborate process orchestrated by multiple proteasome-dedicated chaperones.	[Saeki, Yasushi; Toh-e, Akio; Kudo, Tai; Kawamura, Hitomi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science	Toh-e, A (corresponding author), Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Lab Frontier Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	toue-ak@igakuken.or.jp; tanaka-kj@igakuken.or.jp	Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453	Ministry of Education, Science, Sports, Culture, and Technology ( MEXT) of Japan; Target Protein Project of MEXT	Ministry of Education, Science, Sports, Culture, and Technology ( MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Target Protein Project of MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank B. P. Cormack for kindly providing the yEGFP1 plasmid. We are grateful to all members of K.T.'s laboratory for the useful discussions. This work was supported by grants from the Ministry of Education, Science, Sports, Culture, and Technology ( MEXT) of Japan ( to A. T. and K. T.) and the Target Protein Project of MEXT ( Y. S. and K. T.).	Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Fedorova IV, 2004, MUTAT RES-FUND MOL M, V554, P67, DOI 10.1016/j.mrfmmm.2004.03.003; Fedorova IV, 1998, GENETICS, V148, P963; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hori T, 1998, GENE, V216, P113, DOI 10.1016/S0378-1119(98)00309-6; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2008, EMBO REP, V9, P1237, DOI 10.1038/embor.2008.190; Lozano G, 2005, CANCER CELL, V8, P3, DOI 10.1016/j.ccr.2005.06.014; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Rencus-Lazar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002239; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Takeuchi J, 1999, MOL CELL BIOL, V19, P6575; TANAKA K, 1988, J BIOL CHEM, V263, P16209; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Tone Y, 2002, GENE DEV, V16, P3142, DOI 10.1101/gad.1025602; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Yahalom A, 2008, PLANT J, V53, P300, DOI 10.1111/j.1365-313X.2007.03347.x; Yen HCS, 2003, CELL CYCLE, V2, P81, DOI 10.4161/cc.2.2.340	52	125	132	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					900	913		10.1016/j.cell.2009.05.005	http://dx.doi.org/10.1016/j.cell.2009.05.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19446323	Bronze			2022-12-28	WOS:000266454800020
J	Hung, CC; Lee, JC				Hung, Chung-Ching; Lee, Jih-Chin			Pharyngeal Mass in a Patient with B-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hung, Chung-Ching; Lee, Jih-Chin] Tri Serv Gen Hosp, Taipei 114, Taiwan	Tri-Service General Hospital	Hung, CC (corresponding author), Tri Serv Gen Hosp, Taipei 114, Taiwan.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2340	2340		10.1056/NEJMicm0800492	http://dx.doi.org/10.1056/NEJMicm0800492			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474431				2022-12-28	WOS:000266367300010
J	Suzuki, Y; Watanabe, J; Fukui, N; Ozdemir, V; Someya, T				Suzuki, Yutaro; Watanabe, Junzo; Fukui, Naoki; Ozdemir, Vural; Someya, Toshiyuki			Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OLANZAPINE; INSULIN		[Suzuki, Yutaro; Watanabe, Junzo; Fukui, Naoki; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan; [Ozdemir, Vural] Univ Montreal, Fac Med, Dept Med Sociale & Prevent, Programmes Bioeth, Montreal, PQ H3C 3J7, Canada	Niigata University; Universite de Montreal	Someya, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan.	psy@med.niigata-u.ac.jp	Someya, Toshiyuki/ABD-1878-2021					Melkersson K, 2004, EUR NEUROPSYCHOPHARM, V14, P115, DOI 10.1016/S0924-977X(03)00072-5; Melkersson KI, 2000, J CLIN PSYCHIAT, V61, P742, DOI 10.4088/JCP.v61n1006	2	7	7	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2009	338								a1792	10.1136/bmj.a1792	http://dx.doi.org/10.1136/bmj.a1792			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WS	19470561				2022-12-28	WOS:000266502200001
J	[Anonymous]				[Anonymous]			Diabetes-a global threat	LANCET			English	Editorial Material																			0	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1735	1735						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	449NM	19465209	Bronze			2022-12-28	WOS:000266337300001
J	Mitchell, AL; Pearce, S				Mitchell, Anna L.; Pearce, Simon			Case report An elderly woman with weight loss and diarrhoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTOR; THYROTROPIN; SUPPRESSION; DISEASE; TSH		[Pearce, Simon] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK		a.l.mitchell@ncl.ac.uk	Pearce, Simon/AAB-3692-2019	Pearce, Simon/0000-0001-8384-8063; Mitchell, Anna L/0000-0002-9946-183X	Medical Research Council [G0500783] Funding Source: Medline; MRC [G0500783] Funding Source: UKRI; National Institute for Health Research [ACF-2007-01-004] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; GLINOER D, 1990, J CLIN ENDOCR METAB, V71, P276, DOI 10.1210/jcem-71-2-276; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hangaard J, 1996, J CLIN ENDOCR METAB, V81, P2502, DOI 10.1210/jc.81.7.2502; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; KENNEDY RL, 1989, CLIN CHEM, V35, P1882; Ogrin C, 2005, ENDOCR J, V52, P265, DOI 10.1507/endocrj.52.265; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; Pearce SHS, 2004, CLIN ENDOCRINOL, V61, P589, DOI 10.1111/j.1365-2265.2004.02135.x; Roti E, 2001, THYROID, V11, P493, DOI 10.1089/105072501300176453; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Vaidya B, 2008, CLIN ENDOCRINOL, V68, P814, DOI 10.1111/j.1365-2265.2007.03097.x; WEHMANN RE, 1985, NEW ENGL J MED, V312, P546, DOI 10.1056/NEJM198502283120904; WINGERT TD, 1979, NEUROLOGY, V29, P1073, DOI 10.1212/WNL.29.7.1073	19	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2009	338								b1721	10.1136/bmj.b1721	http://dx.doi.org/10.1136/bmj.b1721			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NS	19457972				2022-12-28	WOS:000266269900002
J	Kowdley, KV; Irani, S				Kowdley, Kris V.; Irani, Shayan			The Glasgow-Blatchford Bleeding Score identified patients with upper GI bleeding who could be managed as outpatients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UPPER-GASTROINTESTINAL HEMORRHAGE		[Kowdley, Kris V.; Irani, Shayan] Virginia Mason Med Ctr, Seattle, WA 98101 USA	Virginia Mason Medical Center	Kowdley, KV (corresponding author), Virginia Mason Med Ctr, Seattle, WA 98101 USA.		Kowdley, Kris/AAF-5202-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002957] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24 DK002957] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Das A, 2008, GASTROENTEROLOGY, V134, P65, DOI 10.1053/j.gastro.2007.10.037; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Stanley AJ, 2009, LANCET, V373, P42, DOI 10.1016/S0140-6736(08)61769-9	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10							JC5-14	10.7326/0003-4819-150-10-200905190-02014	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451570				2022-12-28	WOS:000266285300034
J	Charles, P; Giraudeau, B; Dechartres, A; Baron, G; Ravaud, P				Charles, Pierre; Giraudeau, Bruno; Dechartres, Agnes; Baron, Gabriel; Ravaud, Philippe			Reporting of sample size calculation in randomised controlled trials: review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MEDICAL-RESEARCH; STATISTICS; ETHICS	Objectives To assess quality of reporting of sample size calculation, ascertain accuracy of calculations, and determine the relevance of assumptions made when calculating sample size in randomised controlled trials. Design Review. Data sources We searched MEDLINE for all primary reports of two arm parallel group randomised controlled trials of superiority with a single primary outcome published in six high impact factor general medical journals between 1 January 2005 and 31 December 2006. All extra material related to design of trials (other articles, online material, online trial registration) was systematically assessed. Data extracted by use of a standardised form included parameters required for sample size calculation and corresponding data reported in results sections of articles. We checked completeness of reporting of the sample size calculation, systematically replicated the sample size calculation to assess its accuracy, then quantified discrepancies between a priori hypothesised parameters necessary for calculation and a posteriori estimates. Results Of the 215 selected articles, 10 (5%) did not report any sample size calculation and 92 (43%) did not report all the required parameters. The difference between the sample size reported in the article and the replicated sample size calculation was greater than 10% in 47 (30%) of the 157 reports that gave enough data to recalculate the sample size. The difference between the assumptions for the control group and the observed data was greater than 30% in 31% (n=45) of articles and greater than 50% in 17% (n=24). Only 73 trials (34%) reported all data required to calculate the sample size, had an accurate calculation, and used accurate assumptions for the control group. Conclusions Sample size calculation is still inadequately reported, often erroneous, and based on assumptions that are frequently inaccurate. Such a situation raises questions about how sample size is calculated in randomised controlled trials.	[Charles, Pierre; Giraudeau, Bruno; Baron, Gabriel; Ravaud, Philippe] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris, France; [Charles, Pierre; Baron, Gabriel; Ravaud, Philippe] Univ Paris 07, UFR Med, Paris, France; [Charles, Pierre; Giraudeau, Bruno; Baron, Gabriel; Ravaud, Philippe] INSERM, U738, Paris, France; [Giraudeau, Bruno] Ctr Invest Clin 202, INSERM, Tours, France; [Giraudeau, Bruno] Univ Tours, Tours, France; [Giraudeau, Bruno] CHRU Tours, Tours, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Ravaud, P (corresponding author), Hop Bichat Claude Bernard, Secteur Claude Bernard, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris 18, France.	philippe.ravaud@bch.aphp.fr	ravaud, philippe/C-1694-2009; Giraudeau, Bruno/L-9003-2015	Giraudeau, Bruno/0000-0003-3031-8258; Ravaud, Philippe/0000-0001-8264-9206	Direction Regionale des Affaires Sanitaires et Sociales; Federation Hospitaliere de France; Assistance Publique des Hopitaux de Paris	Direction Regionale des Affaires Sanitaires et Sociales; Federation Hospitaliere de France; Assistance Publique des Hopitaux de Paris	PC received financial support from Direction Regionale des Affaires Sanitaires et Sociales. AD received financial support from Federation Hospitaliere de France and Assistance Publique des Hopitaux de Paris. The authors were independent from the funding bodies.	ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; Altman DG, 2002, BMJ-BRIT MED J, V325, P492; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; [Anonymous], 1999, STAT MED, V18, P1905; Bacchetti P, 2002, BRIT MED J, V324, P1271, DOI 10.1136/bmj.324.7348.1271; Bacchetti P, 2005, AM J EPIDEMIOL, V161, P105, DOI 10.1093/aje/kwi014; Bacchetti P, 2008, BIOMETRICS, V64, P577, DOI [10.1111/j.1541-0420.2008.01004.x, 10.1111/j.1541-0420.2008.01004_1.x]; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Edwards SJL, 1997, LANCET, V350, P804, DOI 10.1016/S0140-6736(97)02290-3; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; Guyatt GH, 2008, PLOS MED, V5, P3, DOI 10.1371/journal.pmed.0050004; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; LAKATOS E, 2001, BIOSTATISTICS CLIN T; Machin D, 1997, SAMPLE SIZE TABLES C; MEINERT CL, 1984, CONTROL CLIN TRIALS, V5, P328, DOI 10.1016/S0197-2456(84)80013-6; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Senn S., 2021, THE BLIND DAT; Simon R, 2008, BIOMETRICS, V64, P589, DOI 10.1111/j.1541-0420.2008.01004_4.x; Vickers AJ, 2003, J CLIN EPIDEMIOL, V56, P717, DOI 10.1016/S0895-4356(03)00141-0; Weaver CS, 2004, STROKE, V35, P1216, DOI 10.1161/01.STR.0000125010.70652.93; Wooding W. M, 1994, PLANNING PHARM CLIN	25	175	179	3	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2009	338								b1732	10.1136/bmj.b1732	http://dx.doi.org/10.1136/bmj.b1732			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446IX	19435763	Green Published, hybrid			2022-12-28	WOS:000266116400004
J	Black, RE; Bhan, MK; Chopra, M; Rudan, I; Victora, CG				Black, Robert E.; Bhan, Maharaj K.; Chopra, Mickey; Rudan, Igor; Victora, Cesar G.			Accelerating the health impact of the Gates Foundation	LANCET			English	Editorial Material							CHILD DEATHS; PRIORITIES; DIARRHEA		[Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Bhan, Maharaj K.] All India Inst Med Sci, New Delhi, India; [Chopra, Mickey] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor] Univ Edinburgh, Sch Med, Dept Publ Hlth Sci, Edinburgh, Midlothian, Scotland; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Split; University of Edinburgh; Universidade Federal de Pelotas	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	rblack@jhsph.edu	Victora, Cesar Gomes/Y-2455-2019; Rudan, Igor/I-1467-2012; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Rudan, Igor/0000-0001-6993-6884; Victora, Cesar G/0000-0002-2465-2180; Black, Robert/0000-0001-9926-7984				Bennett S, 2008, LANCET, V372, P1571, DOI 10.1016/S0140-6736(08)61658-X; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Enserink M, 2009, SCIENCE, V323, P38; Fontaine O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000041; GATES B, 2009, 2009 ANN LETT B GATE; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Mccoy D, 2009, LANCET, V373, P1645, DOI 10.1016/S0140-6736(09)60571-7; Moran M, 2009, PLOS MED, V6, P137, DOI 10.1371/journal.pmed.1000030; Rudan I, 2007, LANCET INFECT DIS, V7, P56, DOI 10.1016/S1473-3099(06)70687-9	13	19	19	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2009	373	9675					1584	1585		10.1016/S0140-6736(09)60886-2	http://dx.doi.org/10.1016/S0140-6736(09)60886-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19427941				2022-12-28	WOS:000266066300007
J	Pormann, PE				Pormann, Peter E.			The art of medicine Female patients and practitioners in medieval Islam	LANCET			English	Editorial Material									Univ Warwick, Dept Class & Ancient Hist, Coventry CV4 7AL, W Midlands, England	University of Warwick	Pormann, PE (corresponding author), Univ Warwick, Dept Class & Ancient Hist, Coventry CV4 7AL, W Midlands, England.	p.e.pormann@warwick.ac.uk						Brockopp Jonathan E., 2008, MUSLIM MED ETHICS TH; El Fadl K. A., 2001, SPEAKING GODS NAME I; Giladi A., 1999, INFANTS PARENTS WET, V34; Musallam B., 1983, SEX SOC ISLAM BIRTH; Nutton V., 2008, RUFUS EPHESUS MELANC, P139; Pormann P.E., 2007, MEDIEVAL ISLAMIC MED	6	14	14	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1598	1599		10.1016/S0140-6736(09)60895-3	http://dx.doi.org/10.1016/S0140-6736(09)60895-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19437603				2022-12-28	WOS:000266066300016
J	Algra, A; Jacoba, P				Algra, Ale; Greving, Jacoba P.			Aspirin in primary prevention: sex and baseline risk matter	LANCET			English	Editorial Material							EVENTS		[Algra, Ale] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands; [Algra, Ale; Greving, Jacoba P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Algra, A (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands.	a.algra@umcutrecht.nl		Algra, Ale/0000-0003-2858-5808				Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Christie Bryan, 2006, BMJ, V333, P988, DOI 10.1136/bmj.39024.405602.DB; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010	7	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2009	373	9678					1821	1822		10.1016/S0140-6736(09)61003-5	http://dx.doi.org/10.1016/S0140-6736(09)61003-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19482200				2022-12-28	WOS:000266616400004
J	Costello, A; Abbas, M; Allen, A; Ball, S; Bell, S; Bellamy, R; Friel, S; Groce, N; Johnson, A; Kett, M; Lee, M; Levy, C; Maslin, M; Mccoy, D; McGuire, B; Montgomery, H; Napier, D; Pagel, C; Patel, J; Antonio, J; de Oliveira, P; Redclift, N; Rees, H; Rogger, D; Scott, J; Stephenson, J; Twigg, J; Wolff, J; Patterson, C				Costello, Anthony; Abbas, Mustafa; Allen, Adriana; Ball, Sarah; Bell, Sarah; Bellamy, Richard; Friel, Sharon; Groce, Nora; Johnson, Anne; Kett, Maria; Lee, Maria; Levy, Caren; Maslin, Mark; McCoy, David; McGuire, Bill; Montgomery, Hugh; Napier, David; Pagel, Christina; Patel, Jinesh; Antonio, Jose; de Oliveira, Puppim; Redclift, Nanneke; Rees, Hannah; Rogger, Daniel; Scott, Joanne; Stephenson, Judith; Twigg, John; Wolff, Jonathan; Patterson, Craig			Managing the health effects of climate change	LANCET			English	Review							PUBLIC-HEALTH; AFRICAN HIGHLANDS; HUMAN-SETTLEMENTS; FOOD SECURITY; GLOBAL HEALTH; HEAT-WAVE; MALARIA; ADAPTATION; IMPACTS; DISEASE		[Costello, Anthony; Ball, Sarah; Patterson, Craig] UCL, Inst Global Hlth, London WC1N 1EH, England; [Abbas, Mustafa; Patel, Jinesh] UCL, Sch Med, London WC1N 1EH, England; [Allen, Adriana; Levy, Caren; de Oliveira, Puppim] UCL, Dev Planning Unit, London WC1N 1EH, England; [Bell, Sarah] UCL, Dept Civil Environm & Geomat Engn, London WC1N 1EH, England; [Bellamy, Richard] UCL, Dept Polit Sci, London WC1N 1EH, England; [Friel, Sharon] UCL, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England; [Groce, Nora; Kett, Maria] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, London WC1N 1EH, England; [Johnson, Anne] UCL, Div Populat Hlth, London WC1N 1EH, England; [Lee, Maria; Scott, Joanne] UCL, Fac Laws, London WC1N 1EH, England; [Maslin, Mark] UCL, Inst Environm, London WC1N 1EH, England; [McCoy, David] UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England; [McGuire, Bill; Twigg, John] UCL, Aon Benfield UCL Hazard Res Ctr, London WC1N 1EH, England; [Montgomery, Hugh] UCL, Inst Human Hlth & Performance, London WC1N 1EH, England; [Napier, David; Redclift, Nanneke] UCL, Dept Anthropol, London WC1N 1EH, England; [Pagel, Christina] UCL, Clin Operat Res Unit, London WC1N 1EH, England; [Rees, Hannah] UCL, Dept Life Sci, London WC1N 1EH, England; [Rogger, Daniel] UCL, Dept Econ, London WC1N 1EH, England; [Stephenson, Judith] UCL, Inst Womens Hlth, London WC1N 1EH, England; [Wolff, Jonathan] UCL, Dept Philosophy, London WC1N 1EH, England	University of London; University College London; University of London; University College London; UCL Medical School; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Costello, A (corresponding author), UCL, Inst Global Hlth, 30 Guilford St, London WC1N 1EH, England.	a.costello@ich.ucl.ac.uk	Chesters, Heather/C-6089-2009; Montgomery, Hugh/L-1229-2019; Bellamy, Richard P/A-2728-2013; Kett, Maria/AAA-3421-2022; de Oliveira, Jose Antonio Puppim/J-2824-2014; Montgomery, Hugh/C-2592-2008	Bellamy, Richard P/0000-0002-9823-0626; Kett, Maria/0000-0002-1975-7674; de Oliveira, Jose Antonio Puppim/0000-0001-5000-6265; Maslin, Mark/0000-0001-9957-3463; Montgomery, Hugh/0000-0001-8797-5019; Wolff, Jonathan/0000-0003-2608-5674; Bell, Sarah/0000-0001-5289-4358; lee, maria/0000-0001-7778-2766; Groce, Nora/0000-0002-7885-7042; Friel, Sharon/0000-0002-8345-5435; Pagel, Christina/0000-0002-2857-1628	National Institute for Health Research [NF-SI-0508-10244] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		*ACTIONAID, 2008, CER OFF ACTIONAID PO; *ACTIONAID INT, 2008, UNJ WAT CLIM CHANG F; Aguirre AA, 2008, ANN NY ACAD SCI, V1149, P1, DOI 10.1196/annals.1428.052; Allen A., 2002, SUSTAINABLE URBANISA; ALLEN A, BUILT IN RE IN PRESS; Allen KM, 2006, DISASTERS, V30, P81, DOI 10.1111/j.1467-9523.2006.00308.x; Altieri M. A., 1990, Agroecology., P551; [Anonymous], ECONOMIST; de Oliveira JAP, 2009, HABITAT INT, V33, P253, DOI 10.1016/j.habitatint.2008.10.006; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Ayres JG, 2009, EUR RESPIR J, V34, P295, DOI 10.1183/09031936.00003409; Baer H, 2008, GLOBAL WARMING POLIT; Barnett J, 2003, GLOBAL ENVIRON CHANG, V13, P7, DOI 10.1016/S0959-3780(02)00080-8; BARNETT J, 2007, POLITICAL GEOGRAPHY, V26, P627; Bates B.C., 2008, CLIMATE CHANGE WATER; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Benthall J., 1993, DISASTERS RELIEF MED; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLAIR T, 2008, CLIMATE GROUP BREAKI; BRIDSALL N, 2001, POPULATION MATTERS D, P6; BROWN C, 2007, CLIMATE CHANGE FORCE; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Brown RA, 1997, AGR FOREST METEOROL, V83, P171, DOI 10.1016/S0168-1923(96)02352-0; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Campbell-Lendrum DH, 2003, CLIMATE CHANGE HUMAN; Campbell-Lendrum D, 2007, B WORLD HEALTH ORGAN, V85, P235, DOI 10.2471/BLT.06.039503; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cardenas R, 2008, ANN NY ACAD SCI, V1149, P326, DOI 10.1196/annals.1428.094; Castles S, 2002, 70 UNHCR; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chivian E, 2008, SUSTAINING LIFE HUMA; Cleland J, 2009, BEST PRACT RES CL OB, V23, P165, DOI 10.1016/j.bpobgyn.2008.11.002; Clement J, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-1; Cohen M. J., 2008, IMPACT CLIMATE CHANG; *COMM AFR, 2009, OUR COMM INT REP COM; CONE R, 2003, SOCIAL CULTURAL LIVE, P232; COTTER J, 2008, FOOD SECURITY CLIMAT; De US, 2004, NAT HAZARDS, V31, P487, DOI 10.1023/B:NHAZ.0000023363.93647.c7; *DEV IN, 2005, AID DAT REP; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; European Commission, 2007, AD CLIM CHANG EUR OP; Friel S, 2008, LANCET, V372, P1677, DOI 10.1016/S0140-6736(08)61692-X; FRIMAN RN, 2007, HUMAN TRAFFICKING HU; Fritze Jessica G, 2008, Int J Ment Health Syst, V2, P13, DOI 10.1186/1752-4458-2-13; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Gilbert M, 2008, REV SCI TECH OIE, V27, P459, DOI 10.20506/rst.27.2.1821; *GLOB ENV FAC, 2 AIACC REG WORKSH L; GOLDSTONE J, 2001, ENV CONFLICT; Grant R. W., 2004, ACCOUNTABILITY ABUSE; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Green D, 2009, MED J AUSTRALIA, V190, P4, DOI 10.5694/j.1326-5377.2009.tb02250.x; Guha-Sapir D., 2004, 30 YEARS NATURAL DIS; HAILS C, LIVING PLANET REPORT; Hajjar R, 2008, AGR ECOSYST ENVIRON, V123, P261, DOI 10.1016/j.agee.2007.08.003; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hales Simon, 2007, Reviews on Environmental Health, V22, P295; Handmer J., 2007, HDB DISASTER EMERGEN; HANEY TJ, 2007, SOCIOLOGY KATRINA PE, P8; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; HAY SI, 2006, FORESIGHT POPULATION, P40; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoffmann B, 2008, J TOXICOL ENV HEAL A, V71, P759, DOI 10.1080/15287390801985539; Houghton J., 2004, GLOBAL WARMING COMPL; Huq S, 2007, ENVIRON URBAN, V19, P3, DOI 10.1177/0956247807078058; Husain Tahir, 2008, Int J Environ Res Public Health, V5, P204, DOI 10.3390/ijerph5040204; *IAASTD, INT ASS AGR KNOWL SC; *IFRC, 2008, WORLD DIS REP 2008; IPCC, 2000, SPECIAL REPORT EMISS; Jiang J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008749; JOHANSSON TB, 2004, WORLD ENERGY ASSESSM; JOWITT J, UN SAYS EAT LESS MEA; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keim ME, 2008, AM J PREV MED, V35, P508, DOI 10.1016/j.amepre.2008.08.022; Klein R.J.T., 2003, ENVIRON HAZARDS-UK, V5, P35, DOI [10.1016/j.hazards.2004.02.001, DOI 10.1016/J.HAZARDS.2004.02.001]; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; Kovats RS, 2005, RISK ANAL, V25, P1409, DOI 10.1111/j.1539-6924.2005.00688.x; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2003, SCIENCE, V299, P1032, DOI 10.1126/science.1077838; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Manyena SB, 2006, DISASTERS, V30, P433; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822; MASLIN M, 2008, GLOBAL WARMING VERY; McCoy D., 2009, MAKING SENSE GLOBAL; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; McMichael AJ, 2008, LANCET, V371, P1895, DOI 10.1016/S0140-6736(08)60811-9; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Menne B., 2002, International Journal of Global Environmental Issues, V2, P181, DOI 10.1504/IJGENVI.2002.002399; Metz B., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1017/CBO9780511546013; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; MUNICH RE, 2008, NATURAL CATASTROPHES; Myers N., 2005, ENV REFUGEES EMERGEN; *OECD, 2007, AGR POL OECD COUNTR; Orr Jackie, 2006, PANIC DIARIES GENEAL; Pace N, 2008, LANCET, V371, P1648, DOI 10.1016/S0140-6736(08)60707-2; Parry M., 2008, NATURE REPORTS CLIMA, DOI [DOI 10.1038/CLIMATE.2008.50, 10.1038/climate.2008.50]; Parry ML, 2007, CLIMATE CHANGE 2007; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2007, ECOHEALTH, V4, P397, DOI 10.1007/s10393-007-0141-1; Pelling Mark, 2003, VULNERABILITY CITIES; Pielke R, 2008, NATURE, V452, P531, DOI 10.1038/452531a; Pinto RF, 2008, PUBLIC ADMIN DEVELOP, V28, P340, DOI 10.1002/pad.516; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Randolph SE, 2008, REV SCI TECH OIE, V27, P367, DOI 10.20506/rst.27.2.1805; Randolph SE, 2008, CURR OPIN INFECT DIS, V21, P462, DOI 10.1097/QCO.0b013e32830ce74b; Reiter P, 2004, LANCET INFECT DIS, V4, P323, DOI 10.1016/S1473-3099(04)01038-2; Revi A, 2008, ENVIRON URBAN, V20, P207, DOI 10.1177/0956247808089157; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Rockel B, 2007, CLIMATIC CHANGE, V81, P267, DOI 10.1007/s10584-006-9227-y; Romero Lankao P, 2007, ENVIRON URBAN, V19, P157; Rweyemamu M., 2006, INFECT DIS PREPARING; Satterthwaite David, 2007, HUMAN SETTLEMENTS DI; Schellnhuber H J, 2006, AVOIDING DANGEROUS C; Scherr S. J., 1999, Food, Agriculture and the Environment Discussion Paper - International Food Policy Research Institute; Sen A, 1983, POVERTY FAMINES ESSA; Sheeran J, 2008, LANCET, V371, P180, DOI 10.1016/S0140-6736(07)61870-4; *SIWI IFPRI IUCN I, 2005, CSD13 SIWI IFPRI IUC; Smith MC, 2008, AM BOOK REV, V29, P25, DOI 10.1353/abr.2008.0001; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STAHL T, 2006, HLTH POLICIES PROSPE; Sterl A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034071; Stern Nicholas, 2006, STERN REV EC CLIMATE; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; TAYLOR RG, EOS T AM GE IN PRESS; TELLEZ VM, LESSONS FOOD CRISIS; Twigg J., 2004, Disaster risk reduction: mitigation and preparedness in development and emergency programming; Twigg J., 2007, NAT HAZARDS REV, V1, P1; Ulbrich U, 2008, J CLIMATE, V21, P1669, DOI 10.1175/2007JCLI1992.1; [UN Department of Economic and Social Affairs Population Division], 2006, ESAPWP200 UN DEP EC; UN Department of Economic and Social Affairs Population Division, 2006, WORLD POP PROSP 2006; *UN FRAM CONV CLIM, AD FUND; *UN INT STRAT DIS, 2008, IND PROGR GUID MEAS; UN Millennium Project, 2005, INV DEV PRACT PLAN A; *UN STAT DIV, MILL DEV GOALS IND; UNDP, 2004, GLOB REP RED DIS RIS; *UNDP GLOB ENV FAC, 2004, RECL LAND SUST LIV; *UNEP, UNEP ANN REP 2007; UNFCCC, 2007, P NAME C 2 INT C GRE; UNFPA, 2008, STAT WORLD POP 2008; *UNFPA, 2002, STAT WORLD POP 2002; *UNFPA AL GUTTM I, 2004, ADD IT BEN INV SEX R; United Nations Development Programme, 2007, 20072008 UN DEV PROG; United Nations International Strategy for Disaster Reduction, 2004, LIV RISK GLOB REV DI; Venton P., 2008, Linking climate change adaptation and disaster risk reduction; Von Braun J, 2007, WORLD FOOD SITUATION; Washington R., 2004, AFRICAN CLIMATE REPO; Weart S.R, 2004, DISCOVERY GLOBAL WAR; WEDO, 2008, GEND CLIM CHANG HUM; Wilkinson P, 2007, LANCET, V370, P965, DOI 10.1016/S0140-6736(07)61252-5; Wilkinson Richard, 2009, SPIRIT LEVEL WHY MOR; Wisner B., 2004, At risk: natural hazards, people's vulnerability and disasters; *WORLD BANK, CLIM INV FUNDS; *WORLD TRAD ORG, TRIPS PUBL HLTH; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; UN WORLD C DIS RED H; REGIONAL GREENHOUSE; 2009, CLIMATE CHANGE GLOBA; ANN REPORT UK CLIMAT; 2008, WASHINGTON POST 0415	170	1448	1491	29	579	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2009	373	9676					1693	1733		10.1016/S0140-6736(09)60935-1	http://dx.doi.org/10.1016/S0140-6736(09)60935-1			41	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	447RP	19447250				2022-12-28	WOS:000266209800017
